54
Guidelines for Prevention of Mother to Child Transmission (PMTCT) of HIV/AIDS in Kenya (3rd Edition) 1 107 Guidelines for Prevention of Mother to Child Transmission (PMTCT) of HIV/AIDS in Kenya (3rd Edition)

Guidelines for Prevention of Mother to Child Transmission

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

1

07

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

MIN

ISTR

Y O

F H

EALT

H

Rep

ublic

of K

enya

Gui

delin

es fo

r

Prev

entio

n of

Mot

her t

o C

hild

Tr

ansm

issi

on (P

MTC

T) o

f HIV

AID

S

in K

enya

NA

TIO

NA

L A

IDS

amp S

TI C

ON

TRO

L PR

OG

RA

MM

E

PO

BO

X 19

361-

002

00

NA

IRO

BI

Third

Edi

tion

200

9

1

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

106

Enq

uiri

es r

egar

ding

thes

e PM

TCT

Gui

delin

es s

houl

d be

add

ress

ed to

Dire

ctor

N

atio

nal A

IDS

and

STI C

ontr

ol P

rogr

amm

e (N

ASC

OP)

M

inis

try

of H

ealth

P

O B

ox 1

9361

- 00

200

N

airo

bi K

enya

Te

leph

one

+25

4 20

272

9502

272

9549

Fa

x +

254

20 2

71 0

518

or 2

72 9

502

Em

ail

head

nasc

op

icon

nect

co

ke

Web

site

ww

wa

idsk

enya

org

Third

edi

tion

Cop

yrig

ht copy

200

9 M

inis

try o

f Hea

lth G

over

nmen

t of K

enya

105

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

2

A

ppen

dix

VII

I Li

st o

f Con

trib

utor

s

Dr

Ayi

si R

ober

t K

Dep

uty

Hea

d N

ASC

OP

PMTC

T Pr

grm

Mng

r

MO

H-N

ASC

OP

Dr

Abd

alla

h S

aade

H

IV T

rain

er J

HPI

EG

O

Ms

Ake

lola

Rut

h

Nut

ritio

n amp

HIV

Man

ager

MO

H-N

ASC

OP

Mr

Dey

a J

osph

at

PMTC

T Pr

ogra

m O

ffice

r M

OH

-NA

SCO

P

Dr

Die

lem

ans

Pau

l

Mat

erna

l Neo

nata

l Hea

lth (M

NH

) Adv

isor

EH

SD

RH

Ms

Gitu

to A

nnie

W

Prog

ram

Offi

cer

MO

H-D

RH

Dr

Inw

ani

Iren

e

Paed

iatr

icia

n IC

AR

T K

NH

Mr

Isav

wa

Ant

hony

D

ata

Prog

ram

Man

ager

CD

C K

enya

Dr

Kar

anja

Dom

inic

PM

TCT

Prog

ram

Man

ager

PA

THFI

ND

ER

Inte

rnat

iona

l

Dr

Kia

rie

Jam

es N

PM

TCT

Prog

ram

Man

ager

KN

HU

ON

Dr

Kig

en B

atile

l Pr

ogra

m M

anag

er M

OH

-DR

H

Ms

Koe

ch R

osel

ine

Pr

ogra

m O

ffice

r M

OH

-DR

H

Dr

Mac

hari

a S

heila

R

H S

ervi

ces

Spec

ialis

t U

SAID

K

Dr

Mat

u L

ucy

PM

TCT

Prog

ram

Man

ager

USA

IDK

Ms

Mau

a J

udith

Pr

ogra

m O

ffice

r D

RH

-MO

H

Prof

Mbo

ri-N

gach

a D

Se

nior

Tec

hnic

al A

dvis

or A

ssoc

iate

Pro

fess

or

of P

aedi

atri

cs C

DC

Ken

ya U

oN

Dr

Mud

any

Mild

red

Te

chni

cal A

dvis

or C

DC

Ken

ya

Ms

Muh

enje

Ody

lia

Beh

avio

ral S

cien

tist

CD

C K

enya

Ms

Mut

sots

o W

infr

ed

PMTC

T Te

chni

cal A

dvis

orP

rogr

am M

anag

er C

DC

Ken

ya

Ms

Mut

uku

Ter

esia

H

IV T

rain

er J

HPI

EG

O

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

3

104

App

endi

x V

II

103

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Ms

Mw

anga

ngi

Alic

e Pr

ogra

m O

ffice

r D

RH

-MO

H

Ms

Mw

angi

Nan

cy

PMTC

T A

dmin

istr

ativ

e A

ssis

tant

CD

C K

enya

Mr

Ndw

iga

Fra

ncis

Pr

ogra

m O

ffice

r M

OH

-NA

SCO

P

Prof

Ndu

ati

Rut

h

Ass

ocia

te P

rofe

ssor

of P

aedi

atri

cs U

oN

Dr

Nju

guna

Cha

rles

Pr

ogra

m A

ssoc

iate

MSH

RPM

Plu

s

Mr

Nya

beri

Dav

id

Prog

ram

Offi

cer

MO

H-D

RH

Mr

Ode

ra J

W

Prog

ram

Coo

rdin

ator

GTZ

Ms

Olu

och

Pat

rici

a Te

chni

cal A

dvis

or C

DC

Ken

ya

Mr

Olu

och

Tom

Te

chni

cal A

dvis

or C

DC

Ken

ya

Dr

Onrsquo

gech

Joh

n

Prog

ram

Coo

rdin

ator

KN

H

Dr

Otie

no-N

yuny

a B

Se

nior

Lec

ture

rH

ead

of D

epar

tmen

t PM

TCT

Dir

ecto

rM

oi U

nive

rsity

AM

PATH

Dr

Oum

a C

hris

PM

TCT

Prog

ram

Offi

cer

UN

ICE

F

Dr

Saw

e F

redr

ick

K

Dep

uty

Dir

ecto

r W

RP

Mr

Soo

Leo

nard

Pr

ogra

m M

anag

er W

RP

Dr

Vak

il S

obha

N

Tech

nica

l Adv

isor

AR

T Pr

ogra

m N

ASC

OP

Ms

Way

ua R

uth

Prog

ram

Offi

cer

MO

H-D

RH

Dr

Yon

ga I

sabe

lla

PMTC

T Te

chni

cal A

dvis

or E

GPA

F

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

Tabl

e of

Con

tent

s Li

st o

f con

trib

utor

s 3

Tabl

e of

con

tent

s 5

Ack

now

ledg

emen

ts

10

Fore

wor

d 11

Abb

revi

atio

ns a

nd A

cron

yms

12

Exe

cutiv

e Su

mm

ary

16

Cha

pter

1

Bac

kgro

und

20

11T

he G

loba

l Pan

dem

ic

20

12

Mag

nitu

de o

f HIV

in P

regn

ancy

in

22

13

Ris

ks o

f Tra

nsm

issi

on o

f MTC

T at

Diff

eren

t Tim

e Pe

riod

s 23

14

Ris

k Fa

ctor

s of

MTC

T of

HIV

24

15

Ben

efits

of P

MTC

T of

HIV

25

16

Ben

efits

of H

IV C

ouns

ellin

g amp

Tes

ting

25

17

The

Four

-pro

nged

App

roac

h to

PM

TCT

26

18

Ove

rvie

w o

f the

New

PM

TCT

Gui

delin

es

28

19

Obj

ectiv

es amp

Org

anis

atio

n of

the

Gui

delin

es

28

110

U

sing

the

Gui

delin

es

29

Cha

pter

2 A

nten

atal

Car

e an

d Pr

even

tion

of M

TCT

of H

IV

32

21

Intr

oduc

tion

32

5

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4 B

acte

riolo

gica

l con

firm

atio

n

App

ropr

iate

clin

ical

sam

ples

incl

ude

sput

um

gast

ric

aspi

rate

s an

d ce

rtai

n ot

her

mat

eria

ls

Sin

ce m

ost

TB

in c

hild

ren

is in

infa

nts

and

youn

g ch

ildre

n s

putu

m

indu

ctio

n m

ay b

e do

ne fi

rst

or g

astr

ic a

spira

tions

and

exp

ecto

ratio

ns

a S

putu

m In

duct

ion

Spu

tum

indu

ctio

n is

saf

e an

d ef

fect

ive

in c

hild

ren

of a

ll ag

es a

nd t

he b

acte

rial

yi

elds

a]r

e as

goo

d or

bet

ter

that

for

gas

tric

asp

irate

s

b G

astr

ic a

spira

tion

Thi

s is

per

form

ed in

you

ng c

hild

ren

who

are

una

ble

or u

nwill

ing

to

expe

ctor

ate

sput

um

A g

astr

ic a

spir

ate

shou

ld b

e ob

tain

ed o

n ea

ch o

f th

e th

ree

cons

ecut

ive

mor

ning

s

c E

xpec

tora

tions

S

putu

m s

houl

d al

way

s be

obt

aine

d in

adu

lts a

nd o

lder

chi

ldre

n gt1

0 ye

ars

of

age

susp

ecte

d of

hav

ing

pulm

onar

y T

B

Bac

teri

al y

ield

s ar

e hi

gher

in o

lder

chi

ldre

n

Thr

ee s

putu

m s

peci

men

s sh

ould

be

obta

ined

an

on-

the

ndashspo

t sp

ecim

en (

at t

he

first

eva

luat

ion)

an

ear

ly m

orni

ng s

peci

men

and

a s

econ

d on

-the

-spo

t sp

ecim

en

Spu

tum

indu

ctio

n is

saf

e an

d ef

fect

ive

in c

hild

ren

of a

ll ag

es a

nd t

he b

acte

rial

yi

elds

are

as

good

or

bett

er t

han

for

gast

ric a

spira

tes

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

102

NO

TES

1 H

isto

ry

bull A

sk f

or s

ympt

oms

cons

iste

nt w

ith T

B in

clud

ing

chro

nic

coug

hgt 2

wee

ks

feve

r- b

ody

tem

pera

ture

of

38 o C

for

14 d

ays

afte

r co

mm

on c

ause

s su

ch a

s m

alar

ia a

nd p

neum

onia

hav

e be

en e

xclu

ded

wei

ght

loss

or

failu

re t

o th

rive

(

also

look

at

the

grow

th c

hart

) a

nd o

r ni

ght

swea

ts

Enq

uire

whe

ther

the

pat

ient

has

bee

n in

clo

se c

onta

ct w

ith s

mea

r-po

sitiv

e pu

lshym

onar

y T

B (

usua

lly a

par

ent

or o

ther

mem

ber

of th

e fa

mily

)

2 C

linic

al e

xam

inat

ion

a P

hysi

cal s

igns

hig

hly

sugg

estiv

e of

ext

ra p

ulm

onar

y T

B

bull O

ften

the

mai

n cl

inic

al f

indi

ng is

just

fai

lure

to

thriv

e

bull G

ibus

es

peci

ally

of

rece

nt o

nset

(re

sulti

ng f

rom

ver

tebr

al T

B)

bull N

on-p

ainf

ul e

nlar

ged

cerv

ical

lym

phad

enop

athy

with

fis

tula

for

mat

ion

b P

hysi

cal s

igns

req

uiri

ng in

vest

igat

ions

to

excl

ude

extr

a pu

lmon

ary

TB

bull M

enin

gitis

not

res

pond

ing

to a

ntib

iotic

s tr

eatm

ent

bull P

leur

al e

ffus

ion

bull P

eric

ardi

al e

ffus

ion

bull D

iste

nded

abd

omen

with

asc

itis

bull N

on-p

ainf

ul e

nlar

ged

lym

ph n

odes

with

out

fistu

la f

orm

atio

n

bull N

on-p

ainf

ul e

nlar

ged

join

t

Sig

ns o

f tu

berc

ulin

hyp

erse

nsiti

vity

3 M

anto

ux te

st

A m

anto

ux t

est

shou

ld b

e re

gard

ed p

ositi

ve a

s fo

llow

s

bull I

n hi

gh-r

isk

child

ren

(inc

lude

s H

IV-i

nfec

ted

child

ren

and

seve

rely

mal

shyno

uris

hed

child

ren

) gt

5mm

dia

met

er o

f in

dura

tion

bull I

n al

l oth

er c

hild

ren(

whe

ther

the

y ha

ve r

ecei

ved

BC

G o

r no

t)

gt10m

m d

ishyam

eter

of i

ndur

atio

n

101

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

22

Ope

ratio

nal G

uide

lines

32

23

Job

Aid

s 34

24

App

endi

ces

13

Cha

pter

3 I

ntra

part

um C

are

38

31

Intr

oduc

tion

38

32

Ope

ratio

nal G

uide

lines

38

Cha

pter

4

Use

of A

RVs

in P

regn

ancy

for T

reat

men

t amp P

MTC

T of

HIV

infe

ctio

n 42

41

Intr

oduc

tion

42

42

Ope

ratio

nal G

uide

lines

43

Cha

pter

5 I

mm

edia

te P

ostn

atal

and

Neo

nata

l Car

e

51

51

Intr

oduc

tion

51

52

Ope

ratio

nal G

uide

lines

51

Cha

pter

6 L

ate

Post

nata

l Car

e an

d Fa

mily

Pla

nnin

g

54

61

Intr

oduc

tion

54

62

Ope

ratio

nal G

uide

lines

54

Cha

pter

7 H

IV D

iagn

osis

in C

hild

ren

58

71

Intr

oduc

tion

58

72

Ope

ratio

nal G

uide

lines

59

72

0 G

uide

lines

for

HIV

Dia

gnos

is in

Chi

ldre

n

59

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

72

1 H

IV N

egat

ive

Infa

nt a

t 6 w

eeks

or

Firs

t Con

tact

59

72

2 H

IV P

ositi

ve In

fant

by

DN

A P

CR

60

72

3 C

ompr

ehen

sive

Car

e fo

r H

IV-e

xpos

ed In

fant

61

D

IAG

NO

STIC

ALG

OR

ITH

MFO

R P

ULM

ON

AR

Y T

B IN

CH

ILD

REN

Cha

pter

8

Feed

ing

Infa

nts

and

Youn

g C

hild

ren

Bor

n to

HIV

infe

cted

mot

hers

62

81

Intr

oduc

tion

62

82

Ope

ratio

nal G

uide

lines

on

Infa

nt F

eedi

ng (0

-6 m

onth

s)

63

83

Ope

ratio

nal G

uide

lines

on

Feed

ing

Chi

ldre

n 6

mon

ths

and

olde

r 64

84

Nut

ritio

nal C

are

and

Supp

ort o

f HIV

infe

cted

Chi

ldre

n 64

85

Ext

ract

s fr

om R

esea

rch

on In

fant

Fee

ding

and

HIV

AID

S 65

Cha

pter

9

Car

e an

d Fo

llow

up

of C

hild

ren

of H

IV-in

fect

ed m

othe

rs 7

3

91

Intr

oduc

tion

73

92

Ope

ratio

nal G

uide

lines

74

Cha

pter

10

Mon

itorin

g an

d Ev

alua

tion

of P

MTC

T se

rvic

es

83

101

In

trod

uctio

n 83

102

O

pera

tiona

l Gui

delin

es

85

Bib

liogr

aphy

91

Job

Aid

sR

efer

ence

s

91

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

App

endi

x V

I

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

100

App

endi

x V

C

OM

MO

N A

DV

ERSE

EFF

ECTS

OF

AR

V U

SE D

UR

ING

PR

EGN

AN

CY

Cla

ss

Adv

erse

effe

cts

Nuc

leos

ide

Nuc

leot

ide

Rev

erse

Tra

nscr

ipta

se In

hibi

tors

( NR

TIs)

Zido

vudi

ne(A

ZT)

Nau

seau

La

miv

idin

e (3

TC)

Dia

rhoe

a

Stav

udin

e (d

4T)

Hyp

erse

nsiti

vity

(AB

C)

Aba

cavi

r(A

BC

) A

naem

ia(A

ZT)

Teno

fovi

r(TF

VTD

F)

Emitr

icita

bine

(FTC

)

Non

- Nuc

leos

ide

Rev

erse

Tra

nscr

ipta

se In

hibi

tors

(NN

RTI

s)

Nev

irapi

ne(N

VP)

Del

avird

in

Efav

irenz

(EFV

)

Pro

teas

e In

hibi

tors

(PIs

)

Saqu

inav

ir(SQ

V)

Indi

navi

r(ID

V)

Rito

navi

r(R

TV)

Nel

finav

ir(N

LF)

Lopi

navi

rrito

navi

r(LP

Vr)

A

taza

navi

r(A

TV)

Fose

mpr

enav

ir Ti

pana

vir(

TPV)

D

arun

avir(

DR

V)

Ras

h

Elev

ated

live

r enz

ymes

(c

omm

on w

ith N

VP in

hig

h C

D4

co

unt)

EFV

CN

S ef

fect

s(se

datio

n in

-so

mni

a v

ivid

dre

ams

diz

zine

ss

conf

usio

n fe

elin

g of

lsquod

isen

gage

men

trsquo

Tera

toge

nici

ty

GI i

ntol

eran

ce

Hep

atot

oxic

ity

Lipo

dyst

roph

y

Dys

lipid

emia

s

Insu

lin re

sist

ance

Hyp

ergl

ycae

mia

La

ctic

aci

dosi

s an

d he

patic

ste

a-to

sis

Cou

nsel

ing

and

Follo

w-u

p Ti

ps

May

not

be

wel

l-tol

erat

ed in

ear

l pr

egna

ncy

whe

n

mor

ning

sic

knes

s is

com

mon

M

ay in

crea

se ri

sk o

f non

-ad

here

nce

May

hav

e in

adeq

uate

blo

od le

vels

A

ll A

RVs

sho

uld

be d

isco

ntin

ued

and

rest

arte

d w

hen

Namp

V is

gon

e or

effe

ctiv

ely

trea

ted

Fo

llow

-up

labs

CB

C L

FTs

If ra

sh in

1st

2 w

ks d

o no

t inc

reas

e N

VP d

ose

and

cont

act c

linic

ian

Mild

rash

may

be

man

aged

with

an

tihis

tam

ines

A

void

cor

ticos

tero

ids

durin

g N

VP

dose

esc

alat

ion

EFV

shou

ld b

e ta

ken

initi

ally

at

bed

time

Avo

id E

FV in

wom

en o

f hig

h ch

ild-b

earin

g po

tent

ial

Do

not o

pera

te h

eavy

mac

hine

ry

Mon

itor g

luco

se le

vels

A

sk re

gula

rly fo

r sym

ptom

s of

hy

perg

lyca

emia

M

onito

r hep

atic

tran

sam

inas

es

(ALT

and

AST

) par

ticul

arly

dur

ing

the

first

18

wee

ks o

f the

rapy

w

hen

this

toxi

city

is m

ost l

ikel

y Ta

ke w

ith fo

od

Ant

iem

etic

s A

ntim

otili

ty

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

App

endi

ces

92

App

endi

x I

WH

O C

linic

al S

tagi

ng o

f HIV

AID

S fo

r A

dults

and

A

dole

scen

ts w

ith C

onfir

med

HIV

infe

ctio

n 92

App

endi

x II

C

ontr

acep

tive

Opt

ions

for

Peop

le L

ivin

g w

ith H

IV

95

App

endi

x II

I U

se o

f AR

Vs

for

Trea

tmen

t and

PM

TCT

of H

IV in

AN

C

97

App

endi

x IV

Use

Of A

RV

s fo

r PM

TCT

of H

IV in

Lab

our

And

Del

iver

y U

nit

98

App

endi

x V

Com

mon

Adv

erse

Effe

cts

of A

RV

Use

Dur

ing

Preg

nanc

y 99

App

endi

x V

I D

iagn

ostic

alg

orith

m fo

r pu

lmon

ary

TB in

Chi

ldre

n 10

0

App

endi

x V

II I

nteg

rate

d M

onito

ring

and

Eval

uatio

n Re

port

For

m M

OH

726

10

3

App

endi

x V

III

Rep

rodu

ctiv

e H

ealth

HIV

AID

S R

epor

t For

m M

OH

711

10

4

Lis

t of T

able

s

Tabl

e 1

1 A

dult

HIV

-pre

vale

nce

Est

imat

e by

Pro

vinc

e in

200

6 21

Tabl

e 1

2 E

stim

ated

Mag

nitu

de o

f MTC

T in

Ken

ya 2

007

22

Tabl

e 1

3 Tr

ansm

ission

Pat

tern

s in

Brea

stfee

ding

and

Non

bre

astfe

edin

g Pop

ulat

ions

23

Tabl

e 1

4 R

isk

Fact

ors

for

MTC

T of

HIV

24

Tabl

e 1

5 Th

e Fo

ur-p

rong

ed A

ppro

ach

App

lied

to th

e PM

TCT

Gui

delin

es

30

Tabl

e 2

1 E

ssen

tial P

acka

ge o

f Int

egra

ted

Ant

enat

al C

are

Serv

ices

33

Tabl

e 4

1 R

ecom

men

datio

ns fo

r In

itiat

ing

AR

V T

reat

men

t in

Preg

nant

Wom

en B

ased

on

Clin

ical

Sta

ge a

nd A

vaila

bilit

y of

CD

4 co

unt

44

Tabl

e 4

2 R

ecom

men

ded

Firs

t Lin

e A

RT

Reg

imen

for

Trea

ting

Preg

nant

Wom

en a

nd P

roph

ylac

tic R

egim

en fo

r In

fant

s 45

Tabl

e 4

3a R

ecom

men

ded

Firs

t Lin

e A

RV

Pro

phyl

axis

to P

reve

nt H

IV

46

Infe

ctio

n in

Infa

nts

Am

ong

preg

nant

Wom

en P

rese

ntin

gB

efor

e 38

Wee

ks

Tabl

e 4

3b A

ltern

ativ

e A

RV

Pro

phyl

axis

to P

reve

nt H

IV In

fect

ion

in In

fant

s 4

6 A

mon

g Pr

egna

nt W

omen

Pre

sent

ing

Bef

ore

38 W

eeks

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

9

9

47

IV

Wom

en w

ho h

ave

not r

ecei

ved

Intr

apar

tum

AR

T or

A

RV

Pro

phyl

axis

with

H

IV

Infe

ctio

n

Tabl

e 4

4 A

RV

Pro

phyl

axis

for

PMTC

T am

ong

Preg

nant

Wom

en w

ho h

ave

not r

ecei

ved

Ant

enat

al A

RT

or P

roph

ylax

is

App

endi

x Ta

ble

45

Cho

ice

of H

AA

RT

for

Preg

nant

Wom

en b

ased

on

CD

4 co

unt

47

Tabl

e 4

6 A

RV

Pro

phyl

actic

Reg

imen

s fo

r In

fant

s B

orn

to H

IV-p

ositi

ve

49

Tabl

e 9

1 D

ose

of C

o-tr

imox

azol

e fo

r PC

P pr

ophy

laxi

s 76

Tabl

e 9

2 W

HO

Rec

omm

enda

tions

for

Follo

w-u

p of

an

HIV

-exp

osed

Chi

ld

79

Tabl

e 10

1 C

ontr

acep

tive

Met

hods

for

Use

in C

oupl

es a

nd W

omen

Liv

ing

96

Figu

re 2

1 R

apid

HIV

Ser

ial T

estin

g A

lgor

ithm

35

Figu

re 8

1 G

uide

lines

for

Cou

nsel

ling

on H

IV a

nd In

fant

feed

ing

66

Job

Aid

s an

d IE

C M

ater

ials

on

Infa

nt a

nd Y

oung

Chi

ld F

eedi

ng

67

List

of F

igur

es

Figu

re 1

01

Mon

itori

ng a

nd E

valu

atio

n D

ata

Flow

in K

enya

84

September 0 8

USE OF ARVs FOR PMTCT OF HIV IN LABOUR AND DELIVERY UNITSALL MOTHERS

1 History 2 Examination3 Establish motherrsquos HIV status4 Offer HIV counseling and testing for mother with unknown HIV status5 Provide standard obstetrical management and care

HIV NEGATIVECounsel on risk reduction

HIV POSITIVE

Establish Motherrsquos use of ARVs in pregnancy and give appropriate ARVs as shown in boxesbelow

Regardless of Duration received HAART

Action

i Give mother ARV dose as per regimen

ii Post partu m Infant Give Infant sd Nevi rapine 2mgkg with in 72 hours of birthPL US 3T C 4mgkg BD for 1 w eek an d AZT syrup 4 m gkg BD for 6 w eeks

iii Post partum mother Continue w ith AR Vs as per regimen

MOTHE R RECEIVED HAART IN PREGNANCY

F OR MORE INFORMAT ION CONT ACT THE NATIONAL AIDSSTD CONTROL PROGRAMME (NASCOP)PO BO X 19361-00202 NAIROBI TEL 0202729502 FAX 020 2710518

MINISTRY OF HEALTH

bull G ive mo ther sd Nevirap ine 200m g AZT 600mg and 3TC 150 mg stat

bull Post partum Infant Give Infant sd Nevirapine 2mgkg within 72 ho urs of birth PL US

3TC syrup 4mg kg BD for 1 week and AZT syrup 4 mg kg BD fo r 6 w eeks

bull Post partum mother Give moth er AZT 300mg amp 3TC 150 mg BID for 7 d ays

MO THER RECEIVED AZT IN PREGNANCY OR NO ARVs TAKE N IN PREGNANCY

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

98

MINISTRY OF HEALTH

USE OF ARVs FOR TREATMENT AND PMTCT OF HIV IN ANC

App

endi

x II

I

Ack

now

ledg

emen

ts

ALL M O THERS1 History 2 Health Information3 Examination4 In vestigations (with informed consent for HIV test)

HIV NEGATIVE1 P rov id e pos t-te s t HIV pr ev e nti v e

i nter ve ntion s defi ned i n na tion alHT C gui de li nes

2 Re fe r for othe r p os t-te st HIVp re ve ntive inte rv e nti ons no tavai lable in the cli nic b ut avail ab le w ithi n the fa c ili ty

HIV PO SI TI VE1 C ounsel on risk reduction2 Per form WH O clinical staging for H IV disease3 D etermine CD 4 level (if testing facilities available)4 D etermine Gestation age and HB level5 Give ARVrsquos as shown below6 Provide or refer for other post-test HIV interventions defined in national HTC

guidelines

1 WHO clin ica l stage I o r II w ith CD4 cell co unt gt 350mm3 OR 2 WHO clin ica l stage I o r II no CD4 cell co unt do ne3 HB =8 gdl OR n o clinical feat ures of anaemia

bull Initiate AZT 30 0mg BD daily at 28 weeks gestation or any time periodimmediately there after

bull Monitor for clinical featur es of anemia and treatbull Dispense ANC Nev ir apine 200mg PLUS AZT 600mg + 3TC 1 50mg for

moth er to tak e at onset of labourbull Dispense NVP syrup to give infant at birth

bull At on set o f l abo uro Administer Nevirapine 20 0mg AZT 600mg 3TC 150 mg

stat to moth erbull Post p artum

o Give Infa nt sd Nevirapine 2mgk g within 72 hours ofbirth PLUS 3TC 4mg BD for 1 w eek and AZT syrup 4 mgkg BD for 6 w eeks

o Give mother AZT30 0 mg 3 TC 150 BID for 7 day s

1 WHO clinical stag e I or II with CD4 c ell count gt 35 0 mm3 OR 2 WHO clinical stag e I or II w ith no C D4 c ell c ount done

bull Dispense ANC Nevirapine 2 00mg PLUS AZ T 600 mg + 3TC 150mgfo r mo ther to take at onse t of labour

bull Dispense NVP sy rup to give infant at birthbull At Onset of lab our

o Administe r sd Nevirapine AZT 6 00 mg and 3TC1 50mg stat

bull Po st Par tu mo G iv e Infant sd Nev ir apine 2mg kg w ithin 72

h ours of bir th PLUS 3T C 4mgkg BD fo r 1 week a nd AZT syrup 4mgkg BD for 6 we eks

o G iv e mother AZ T300 mg 3TC 1 50 mg BID for 7d ays

1 Any gest ational age2 WHO clin ica l stage III or IV of HIV dis ease regardles s of CD4 cell count OR3 WHO clin ica l stages I or II of HIV d is ease with CD4 cell count =350mm3 ()

bull Refer to Clinician for Evaluation and initiation of NNRTI based ART as pernation al ART guidelines

bull At O nset of Lab ou ro G ive mo ther ARV dos e as per r egimen

bull Post par tumo G ive Infan t sd Nev ira pine 2mgkg within 72 hours of b irth PLUS

3TC 4mgkg and AZT syr up 4 mgkg BD for 6 weeks o G ive mo ther ARVs as per regimen

4 If no HAART av ailable man age the wo man as ind icated in box no2 a nd refer to ARTsite appro priately

F O R M OR E IN FOR M AT IO N CO N T AC T T H E N ATI ON A L A IDS STD C O NTR O L PR O G RAM ME ( N ASC O P)P O B OX 19361-00202 N AIR OBI TEL 0202729502 FAX 020 2710518

EL IGIBL E FO R T R EATMEN T

N O T E LIG IBLE FO R TR EA TM ET AN D PR ESE NTING B ELO W 3 8 W EE KSGESTA TIO N N OT ELIGIB LE FOR TREA TMEN T AN D PR ESE NTING gt 3 8 W EEK S

GE STATIO N

Plea se notebull Pregnan t w omen with WHO clinical stag e I or II plus CD4 cell co unt gt250 mm3 and = 350 mm3 can be initiated on ART wher e a PI based HAART re gimen is av ailable NVP hypersen sitivity h as been previously r eported amon g women in this gr oup initiated on N NRT I based

ART re gimens Where PI ba sed ART reg imen is not av ailab le r efer the patient to a site whe re th e regimen is availab le or c ontinue to ma nage th e w oman a s is indicated in box No 2bull The grading of ana emia in pregna ncy is gt 8-10 Milda nemia gt 6 -8 Moderate anem ia lt 6 Sever e anemiabull Treatment if common p ath ologies ruled out Mild anae mia haematinics irrespectiv e of gestatio n Moder ate a naemia tr ansfusion if close to term gt36 weeks otherwise give haema tinics Severe an aemia transfus ion irr espe ctive of ge statio n Do not stop AZT if Hb dr op s but

would manage it as above and only stop if continues to fall or fails to res pon d des pite transfusion

The

thir

d ed

ition

of

Gui

delin

es f

or P

reve

ntio

n of

Mot

her-

to-C

hild

Tra

nsm

issi

on o

f H

IV A

IDS

in K

enya

is a

res

ult o

f effo

rts

of m

any

indi

vidu

als

and

orga

niza

tions

in th

eco

untr

y T

he T

echn

ical

Wor

king

Gro

up o

n PM

TCT

led

thes

e ef

fort

s M

embe

rs o

f the

te

am r

evie

wed

all

the

mod

ules

rev

ised

and

in s

ome

case

s re

-wro

te th

e m

odul

es b

ased

on

the

seco

nd e

ditio

n to

mak

e th

em u

p to

dat

e an

d in

line

with

cur

rent

sci

entif

ic e

vishy

denc

e an

d ex

peri

ence

We

ackn

owle

dge

the

cont

ribu

tors

and

rev

iew

ers

of t

he c

urre

ntan

d pr

evio

us e

ditio

ns O

f sp

ecia

l m

entio

n ar

e th

e fo

llow

ing

Ken

ya O

bste

tric

al a

nd

Gyn

aeco

logi

cal S

ocie

ty (K

OG

S) t

he U

nive

rsity

of N

airo

bi a

nd M

oi U

nive

rsity

We

wou

ld l

ike

to t

hank

the

fol

low

ing

inst

itutio

ns f

or t

echn

ical

as

wel

l as

fin

anci

al

supp

ort

duri

ng t

he r

evis

ion

of t

he g

uide

lines

N

atio

nal A

IDS

and

STD

Con

trol

Pro

shygr

amm

e (N

ASC

OP)

the

Div

isio

n of

Rep

rodu

ctiv

e H

ealth

Cen

ters

for

Dis

ease

Con

trol

and

Prev

entio

n (C

DC

) It

is n

ot p

ossi

ble

to m

entio

n al

l ind

ivid

uals

and

org

aniz

atio

ns

that

par

ticip

ated

in th

is im

port

ant e

xerc

ise

To

all o

f you

Asa

nte

Sana

Min

istr

y of

Hea

lth

September 2008

97

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

10

Fore

wor

d

The

Min

istr

y of

Hea

lth (

MoH

) is

com

mitt

ed t

o de

velo

pmen

t of

effe

ctiv

e PM

TCT

proshy

gram

mes

Gui

delin

es a

re a

n im

port

ant

part

of t

he G

over

nmen

t st

rate

gy t

o re

duce

MTC

Tan

d is

in

line

with

the

Nat

iona

l H

ealth

Sec

tor

Stra

tegi

c Pl

an I

I (N

HSS

PII)

and

Ken

yaN

atio

nal A

IDS

Stra

tegi

c Pl

an (K

NA

SP) 2

000-

2010

whi

ch fo

cuse

s on

pri

ority

are

as o

f pre

shyve

ntio

n of

new

infe

ctio

ns i

mpr

ovin

g qu

ality

of l

ife o

f tho

se in

fect

ed a

nd a

ffect

ed a

nd m

itishy

gatio

n of

soc

ial a

nd e

cono

mic

impa

ct o

f the

infe

ctio

n

MTC

T is

the

pre

dom

inan

t m

ode

of t

rans

mis

sion

of

HIV

in

infa

nts

and

youn

g ch

ildre

n

This

tra

nsm

issi

on o

ccur

s du

ring

pre

gnan

cy

labo

ur a

nd d

eliv

ery

and

am

ong

brea

stfe

d ba

bies

in

the

post

-par

tum

per

iod

Mem

bers

of t

he T

echn

ical

Wor

king

Gro

up (T

WG

) on

PMTC

T re

view

ed t

he m

odul

es o

f the

se

cond

edi

tion

rev

ised

and

in s

ome

case

s re

-wro

te th

e m

odul

es b

ased

on

up to

dat

e kn

owlshy

edge

and

in

line

with

cur

rent

sci

entif

ic e

vide

nce

and

expe

rien

ce T

he T

WG

con

sist

s of

agr

oup

of p

rofe

ssio

nals

dra

wn

from

var

ious

dis

cipl

ines

tha

t ar

e im

plem

entin

g an

dor

man

shyag

ing

PMTC

T T

he g

roup

ado

pted

and

ada

pted

the

late

st r

ecom

men

datio

ns o

f the

WH

O o

nPM

TCT

as w

ell a

s va

riou

s na

tiona

l gui

delin

es o

n H

IV p

reve

ntio

n tr

eatm

ent a

nd c

are

A f

our-

pron

ged

appr

oach

thr

ough

the

var

ious

rep

rodu

ctiv

e lif

e cy

cles

as

prop

osed

by

the

Inte

r-A

genc

y Ta

sk T

eam

(IA

TT)

on c

hild

ren

and

HIV

and

AID

S w

as a

dopt

ed i

n th

ese

guid

elin

es w

ith e

mph

asis

bei

ng p

lace

on

all t

he fo

ur p

rong

s

For

any

of t

he P

MTC

T in

terv

entio

ns t

o be

suc

cess

fully

impl

emen

ted

coun

selin

g an

d te

stshy

ing

(CT)

mus

t fir

st b

e do

ne R

outin

e H

IV te

stin

g w

ith o

pt-o

ut o

ptio

n is

rec

omm

ende

d T

his

is fo

llow

ed b

y ap

prop

riat

e m

edic

al s

urgi

cal i

nter

vent

ions

incl

udin

g an

tiret

rovi

ral p

roph

yshyla

xis

saf

er o

bste

tric

pra

ctic

es a

s w

ell a

s in

fant

feed

ing

coun

selin

g an

d pr

ovis

ion

of a

ppro

shypr

iate

infa

nt fe

edin

g H

IV-p

ositi

ve w

omen

are

ass

esse

d cl

inic

ally

usi

ng W

HO

sta

ging

and

whe

re f

easi

ble

imm

unol

ogic

al a

sses

smen

t us

ing

CD

4 ce

ll co

unt

HIV

exp

osed

infa

nts

are

test

ed th

roug

h ea

rly

infa

nt d

iagn

osis

(EID

)

In th

ese

guid

elin

es m

ore

effic

acio

us r

egim

ens

are

intr

oduc

ed fo

r th

e fir

st ti

me

whi

le in

forshy

mat

ion

and

coun

selin

g on

inf

ant

feed

ing

follo

ws

the

AFA

SS (

Ava

ilabl

e f

easi

ble

acc

eptshy

able

saf

e an

d su

stai

nabl

e) c

rite

ria

The

mod

ule

on m

onito

ring

and

eva

luat

ion

addr

esse

s is

sues

of d

ata

colle

ctio

n c

olla

tion

and

repo

rtin

g as

wel

l as

use

of d

ata

for

deci

sion

-mak

ing

at th

e fa

cilit

y-le

vel

We

hope

that

app

ropr

iate

impl

emen

tatio

n in

stru

men

ts w

ill b

e us

ed to

ope

ratio

naliz

e th

ese

guid

elin

es

Tabl

e 11

1

Con

trac

eptiv

e M

etho

ds fo

r Use

in

Cou

ples

and

Wom

en L

ivin

g w

ith H

IV In

fect

ion

MET

HO

D

CO

MM

ENTS

Con

dom

s bull

M

ale

amp f

emal

e co

ndom

s av

aila

ble

bull

P

rovi

de d

ual p

rote

ctio

n ag

ains

t STI

sH

IV

amp p

regn

ancy

bull

R

equi

re a

ttent

ion

amp ca

re

for c

orre

ct u

se e

ach

time

bull

M

ay re

quire

co-

oper

atio

n of

par

tner

Hor

mon

al

bull V

ery

effe

ctiv

e an

d ea

sy to

use

M

etho

ds

bull S

uita

ble

for s

hort-

or lo

ng-

term

use

bull

Rev

ersi

ble

bull A

ssoc

iate

d w

ith n

on-

cont

race

ptiv

e he

alth

ben

efits

bull

Ser

ious

com

plic

atio

ns

extre

mel

y ra

re

Intra

uter

ine

bull

H

ighl

y ef

fect

ive

long

-term

C

ontra

cept

ive

reve

rsib

le m

etho

d

Dev

ice

bull

Rem

ains

in p

lace

up

to 1

2 ye

ars

bull

A

lmos

t 100

per

cent

ef

fect

ive

bull

H

as n

o ef

fect

on

ferti

lity

whe

n us

ed b

y nu

llipar

ous

wom

en

bull

Sho

uld

not b

e pr

ovid

ed to

w

omen

with

hig

h ris

k se

xual

life

styl

e bull

B

acte

rial S

TIs

shou

ld b

e sc

reen

ed fo

r and

or

treat

ed a

s a

prec

autio

n pr

ior t

o in

serti

on o

f IU

CD

Ste

riliz

atio

n bull

Goo

d v

ery

effe

ctiv

e fo

r co

uple

s or

indi

vidu

als

who

w

ant n

o m

ore

child

ren

bull S

afe

sim

ple

surg

ical

pr

oced

ure

Con

side

red

perm

anen

t

US

E IN

HIV

PO

SITI

VE

PA

TIE

NTS

bull

Can

and

sho

uld

be u

sed

at a

ll st

ages

of H

IV

infe

ctio

n bull

C

an a

nd s

houl

d be

use

d by

pat

ient

s on

AR

T

bull

Cor

rect

and

con

sist

ent u

se b

y H

IV in

fect

ed p

atie

nts

is

reco

mm

ende

d re

gard

less

of t

he u

se o

f oth

er m

etho

ds

of c

ontra

cept

ion

(dua

l con

trace

ptio

n)

bull C

an b

e us

ed w

ithou

t res

trict

ion

in H

IV+

wom

en n

ot o

n AR

T bull

Can

be

used

with

out r

estri

ctio

n in

all

HIV

+ w

omen

for

emer

genc

y co

ntra

cept

ion

bull S

ome

AR

V dr

ugs

may

redu

ce m

etho

d ef

fect

iven

ess

bull

DM

PA

Im

plan

ts c

an h

owev

er b

e us

ed w

ith A

RT

reshy

inje

ctio

n of

DM

PA

sho

uld

be d

one

at 1

0-12

wee

ks

bull If

horm

onal

met

hod

is c

hose

n c

ondo

ms

shou

ld s

till b

e us

ed c

orre

ctly

and

con

sist

ently

bull

Attr

activ

e m

etho

d fo

r wom

en w

ith H

IV w

ho d

esire

ver

y re

liabl

e pr

egna

ncy

prot

ectio

n bull

C

an b

e in

serte

d in

HIV

+ w

omen

who

do

not h

ave

WH

O

Sta

ge 4

dis

ease

AID

S d

efin

ing

illne

ss

bull

For w

omen

with

sta

ge 4

dis

ease

IUD

can

be

inse

rted

once

they

are

on

ART

and

have

con

trolle

d sy

mpt

oms

of s

ever

e ill

ness

bull N

o m

edic

al re

ason

s to

den

y st

eriliz

atio

n to

clie

nts

w

ith H

IV

bull P

roce

dure

may

be

dela

yed

in e

vent

of a

cute

HIV

-rel

ated

in

fect

ion

or s

tage

4 d

isea

se p

endi

ng im

mun

e re

cons

titut

ion

bull E

ncou

rage

con

dom

use

as

wel

l

DM

PA =

Dep

ot M

edro

xypr

oges

tero

ne A

ceta

te (D

epo-

Prov

era)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

1

96

App

endi

x II

CO

NTR

AC

EPTI

VE

OPT

ION

SFO

R P

EOPL

E L I

VIN

G W

ITH

HIV

It

has

bee

n sh

own

in a

num

ber

of s

tudi

es o

f coh

orts

of H

IV p

ositi

ve w

omen

tha

t so

me

choo

se t

o co

ntin

ue s

exua

l act

ivity

des

pite

kno

wle

dge

of t

heir

sta

tus

Evi

denc

e of

con

shyce

ptio

n ha

s de

mon

stra

ted

that

fert

ility

in H

IV p

ositi

ve w

omen

for

the

mos

t pa

rt is

unshy

affe

cted

H

owev

er c

erta

in c

ondi

tions

may

affe

ct fe

rtili

ty s

uch

as lo

w b

ody

mas

s in

dex

A

IDS

and

inte

rcur

rent

illn

ess

esp

ecia

lly t

uber

culo

sis

Put

ting

wom

en w

ho a

re H

IV

infe

cted

on

cont

race

ptiv

es is

one

of t

he m

eans

of p

reve

ntin

g m

othe

r to

chi

ld t

rans

mis

shysi

on o

f HIV

(PM

TCT)

It is

the

rig

ht o

f HIV

infe

cted

wom

en t

o m

ake

thei

r ow

n de

cisi

ons

rega

rdin

g re

prod

ucshy

tion

The

y m

ay w

ish

to h

ave

mor

e ba

bies

lim

it th

eir

fam

ilies

or

avoi

d pr

egna

ncy

alto

shyge

ther

The

hea

lth c

are

prov

ider

s th

ey c

onsu

lt sh

ould

ena

ble

them

to

mak

e in

form

edch

oice

s by

them

selv

es

The

follo

win

g co

ntra

cept

ive

met

hods

are

ava

ilabl

e in

Ken

ya -

pro

gest

eron

e on

ly p

ills

lo

w d

ose

com

bine

d or

al c

ontr

acep

tives

de

pot

med

roxy

prog

este

rone

ace

tate

(D

MPA

shyde

po)

levo

norg

estr

el a

nd e

tono

gest

rel i

mpl

ants

Em

erge

ncy

cont

race

ptiv

e pi

lls c

oppe

rin

trau

teri

ne c

ontr

acep

tive

devi

ces

bar

rier

met

hods

fem

ale

and

mal

e st

erili

satio

n ar

e al

so a

vaila

ble

Som

e dr

ugs

inte

ract

with

hor

mon

al c

ontr

acep

tives

A

nd c

oncu

rren

t us

e sh

ould

be

avoi

ded

The

se d

rugs

incl

ude

bull P

rote

ase

inhi

bito

rs ndash

Rito

navi

r N

elfin

avir

Lop

inav

ir w

ith R

itona

vir

bull N

on-n

ucle

otid

e re

vers

e tr

ansc

ript

ase

inhi

bito

rs (

NN

RT

Is)

ndash N

evir

apin

e

bull E

favi

renz

bull A

nti-T

B d

rugs

ndash R

ifam

pici

n an

d R

ifabu

tin

bull O

ther

dru

gs ndash

Gris

eofu

lvin

P

heno

barb

itone

C

arba

maz

epin

e P

heny

toin

All

the

abov

e do

not

app

ly i

n th

e fa

ce o

f ot

her

med

ical

con

ditio

ns t

hat

are

cont

ra-

indi

catio

ns f

or t

he v

ario

us m

etho

ds e

g k

now

n ca

rdio

vasc

ular

dis

ease

hep

atic

con

dishy

tions

sm

okin

g h

igh

bloo

d pr

essu

re a

nd th

rom

boem

bolic

dis

orde

rs

The

follo

win

g ta

ble

sum

mar

ises

maj

or is

sues

reg

ardi

ng u

se o

f diff

eren

t co

ntra

cept

ives

by H

IV-p

ositi

ve w

omen

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Abb

revi

atio

ns a

nd A

cron

yms

AFA

SS

Acc

epta

ble

Fea

sibl

e A

fford

able

Sus

tain

able

and

Saf

e

Ab

Ant

i-bod

y

AID

S A

cqui

red

Imm

une

Def

icie

ncy

Synd

rom

e

ALT

Ala

nine

Tra

nsfe

rase

AN

C

Ant

enat

al C

are

AR

M

Art

ifici

al R

uptu

re o

f Mem

bran

es

AR

T

Ant

iret

rovi

ral T

hera

py

A

RV

A

ntir

etro

vira

l

AZT

A

zido

thym

idin

e (Z

idov

udin

e or

ZD

V)

AZT

3TC

Com

bivi

r

3TC

Lam

ivud

ine

BC

C

Beh

avio

ur C

hang

e C

omm

unic

atio

n

BC

G

Bac

ille

Cal

met

te G

ueri

ne v

acci

ne

BFH

I B

aby

Frie

ndly

Hos

pita

l Ini

tiativ

e

BID

BD

ldquoT

wic

e a

dayrdquo

CD

C (K

) C

entr

es fo

r D

isea

se C

ontr

ol a

nd P

reve

ntio

n K

enya

CN

S C

entr

al N

ervo

us S

yste

m

CS

Cae

sare

an S

ectio

n

CT

Cou

nsel

ling

and

Test

ing

CTX

CTZ

Cot

rim

oxaz

ole

d4T

Stav

udin

e

D

ASC

O

Dis

tric

t AID

SST

I Coo

rdin

ator

G

uid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

5

12

DB

S D

ried

Blo

od S

pot s

peci

men

DN

A

Deo

xyri

bonu

clei

c A

cid

DR

H

Div

isio

n of

Rep

rodu

ctiv

e H

ealth

EC

V

Ext

erna

l Cep

halic

Ver

sion

EFV

Efa

vire

nz

EID

E

arly

Infa

nt D

iagn

osis

ELI

SA

Enz

yme

Link

ed Im

mun

osor

bent

Ass

ay

FBC

Fu

ll B

lood

Cou

nt

GTZ

G

erm

an T

echn

ical

Coo

pera

tion

HA

AR

T

Hig

hly

Act

ive

Ant

iret

rovi

ral T

hera

py

Hb

Hae

mog

lobi

n

HIV

H

uman

Imm

unod

efic

ienc

y Vi

rus

IATT

Inte

r-A

genc

y Ta

sk T

eam

IMC

I In

tegr

ated

Man

agem

ent o

f Chi

ldho

od Il

lnes

s

IPPT

Inte

rmitt

ent P

resu

mpt

ive

Trea

tmen

t for

Mal

aria

ITN

s In

sect

icid

es T

reat

ed N

ets

IUC

D

Intr

a U

teri

ne C

ontr

acep

tive

Dev

ice

KD

HS

Ken

ya D

emog

raph

ic a

nd H

ealth

Sur

vey

KE

PI

Ken

ya E

xpan

ded

Prog

ram

me

on Im

mun

izat

ion

KO

GS

Ken

ya O

bste

tric

al a

nd G

ynae

colo

gica

l Soc

iety

KN

H

Ken

yatt

a N

atio

nal H

ospi

tal

LAM

Lact

atio

nal A

men

orrh

oea

Met

hod

Mamp

E

Mon

itori

ng a

nd E

valu

atio

n

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

Cyt

omeg

alov

irus

infe

ctio

n (r

etin

itis

or in

fect

ion

of o

ther

org

ans)

9

Cen

tral

ner

vous

sys

tem

tox

opla

smos

is

10

HIV

enc

epha

lopa

thy

11

Ext

rapu

lmon

ary

cryp

toco

ccos

is in

clud

ing

men

ingi

tis

12

Dis

sem

inat

ed n

on-t

uber

culo

us m

ycob

acte

rial

infe

ctio

n

13

Pro

gres

sive

mul

tifoc

al le

ukoe

ncep

halo

path

y

14

Chr

onic

cry

ptos

pori

dios

is

15

Chr

onic

isos

poria

sis

16

Dis

sem

inat

ed m

ycos

is (

extr

apul

mon

ary

hist

opla

smos

is

or c

occi

diom

ycos

is)

17

Rec

urre

nt s

eptic

aem

ia (

incl

udin

g no

n-ty

phoi

dal S

alm

onel

la)

18

Lym

phom

a (c

ereb

ral o

r B

-cel

l non

-Hod

gkin

s)

19

Inv

asiv

e ce

rvic

al c

arci

nom

a

20

Aty

pica

l dis

sem

inat

ed le

ishm

ania

sis

21

Sym

ptom

atic

HIV

-ass

ocia

ted

neph

ropa

thy

or s

ympt

omat

ic H

IV-

asso

ciat

ed

22

Car

diom

yopa

thy

Ple

ase

note

S

igns

and s

ympto

ms

of

HIV

was

ting s

yndro

me

incl

ude

Unex

pla

ined

invo

lunta

ry w

eight

loss

(gt

10

base

line

body

wei

ght)

with o

bvi

ous

was

ting o

f body

mas

s in

dex

lt185

PLU

S

unex

pla

ined

chro

nic

dia

rrhoea

(lo

ose

or

wat

ery

stools

thre

e or

more

tim

es d

aily

) re

port

ed

for

longer

than

one

month

OR r

eport

s of

feve

r or

nig

ht

swea

ts f

or

more

than

one

month

w

ithout

oth

er c

ause

and lack

of

resp

onse

to a

ntibio

tics

or

antim

ala

rial ag

ents

M

ala

ria

must

be

excl

uded

in m

ala

ria

pro

ne

area

s

Fo

r th

e purp

ose

of

the

WH

O s

tagin

g s

yste

m

adole

sents

and a

dults

are

def

ined

as

adults

aged

ge15 y

ears

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

3

94

CLI

NIC

AL

STA

GE

3 1

Une

xpla

ined

sev

ere

wei

ght

loss

(gt1

0 o

f pr

esum

ed o

r m

easu

red

bo

dy w

eigh

t)

2

Une

xpla

ined

chr

onic

dia

rrho

ea fo

r lo

nger

tha

n on

e m

onth

3

Une

xpla

ined

per

sist

ent

feve

r (a

bove

37

5degC

inte

rmitt

ent

or c

onst

ant

for

long

er t

han

one

mon

th)

4

Per

sist

ent

oral

can

didi

asis

5

Ora

l hai

ry le

ukop

laki

a

6

Pul

mon

ary

tube

rcul

osis

7

Tub

ercu

lous

Lym

phad

enop

athy

8

Sev

ere

bact

eria

l inf

ectio

ns (

such

as

pneu

mon

ia

empy

ema

pyo

myo

sitis

bo

ne o

r jo

int

infe

ctio

n m

enin

gitis

or

bact

erae

mia

)

9

Acu

te n

ecro

tizin

g ul

cera

tive

stom

atiti

s g

ingi

vitis

or

perio

dont

itis

10

Une

xpla

ined

ana

emia

(lt8

gdl

) n

eutr

opae

nia

(lt0

5 times1

09 pe

rlitr

e) a

ndo

r ch

roni

c th

rom

bocy

topa

enia

(lt5

0times10

9 per

litr

e)

CLI

NIC

AL

STA

GE

4 1

HIV

was

ting

synd

rom

e

2

Pne

umoc

ystis

pne

umon

ia

3

Rec

urre

nt s

ever

e ba

cter

ial p

neum

onia

4

Chr

onic

her

pes

sim

plex

infe

ctio

n (o

rola

bial

ge

nita

l or

anor

ecta

l of

mor

e th

an o

ne

mon

thrsquos

dur

atio

n or

vis

cera

l at

any

site

)

5

Oes

opha

geal

can

didi

asis

(or

can

didi

asis

of

trac

hea

bro

nchi

or

lung

s)

6

Ext

rapu

lmon

ary

tube

rcul

osis

exc

ept

Tub

ercu

lous

Lym

ph a

deno

path

y

7

Kap

osirsquos

sar

com

a

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

MC

H

Mat

erna

l and

Chi

ld H

ealth

MoH

M

inis

try

of H

ealth

MSF

M

edic

ins

Sans

Fro

ntie

rs

M

TCT

Mot

her-

To-C

hild

Tra

nsm

issi

on

NA

SCO

P N

atio

nal A

IDS

and

STD

Con

trol

Pro

gram

me

NV

P

Nev

irap

ine

OD

ldquoO

nce

a D

ayrdquo

OI

Opp

ortu

nist

ic In

fect

ion

OPV

O

ral P

olio

Vac

cine

PASC

O

Prov

inci

al A

IDS

STI C

oord

inat

or

PCP

Pneu

moc

ystis

jiro

veci

i pne

umon

ia

PCR

Po

lym

eras

e C

hain

Rea

ctio

n

PI

Prot

ease

Inhi

bito

r

PLW

HA

Pe

rson

sPe

ople

Liv

ing

With

HIV

AID

S

PMTC

T

Prev

entio

n of

Mot

her

To C

hild

Tra

nsm

issi

on

RD

A

Rec

omm

ende

d D

aily

Allo

wan

ce

RH

Rep

rodu

ctiv

e H

ealth

RN

A

Rib

onuc

leic

Aci

d

SdN

VP

Si

ngle

dos

e N

evir

apin

e

SRH

Se

xual

and

Rep

rodu

ctiv

e H

ealth

STD

Se

xual

ly T

rans

mitt

ed D

isea

se

STI

Sexu

ally

Tra

nsm

itted

Infe

ctio

n

TB

Tube

rcul

osis

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

3

14

TBA

s Tr

aditi

onal

Bir

th A

tten

dant

s

TLC

To

tal L

ymph

ocyt

e C

ount

TT

Teta

nus

Toxo

id v

acci

ne

UN

ICE

F U

nite

d N

atio

ns C

hild

renrsquo

s Fu

nd

UN

GA

SS

Uni

ted

Nat

ions

Gen

eral

Ass

embl

y Sp

ecia

l Ses

sion

on

HIV

AID

S

UoN

Uni

vers

ity o

f Nai

robi

VC

T V

olun

tary

Cou

nsel

ling

and

Test

ing

VIA

V

isua

l Ins

pect

ion

usin

g A

ceto

ne

VD

RL

Ven

erea

l Dis

ease

Res

earc

h La

bora

tory

(tes

t for

syp

hilis

)

WH

O

Wor

ld H

ealth

Org

anis

atio

n

WR

P W

alte

r R

eed

Prog

ram

App

endi

x I

WH

O C

LIN

ICA

L S T

AG

ING

OF

HIV

AID

S FO

R A

DU

LTS

AN

D A

DO

LES-

CEN

TSW

ITH

CO

NFI

RM

ED H

IV IN

FEC

TIO

N

CLI

NIC

AL

STA

GE

1

bull

Asy

mpt

omat

ic

bull

Per

sist

ent

gene

raliz

ed ly

mph

aden

opat

hy

CLI

NIC

AL

STA

GE

2 1

Une

xpla

ined

mod

erat

e w

eigh

t lo

ss (

lt10

of

pres

umed

or

mea

sure

d bo

dy w

eigh

t)

2

Rec

urre

nt u

pper

res

pira

tory

tra

ct in

fect

ions

(si

nusi

tis

tons

illiti

s

otiti

s m

edia

and

pha

ryng

itis)

3

Her

pes

Zos

ter

4

Ang

ular

Che

ilitis

5

Rec

urre

nt o

ral u

lcer

atio

n

6

Pap

ular

pru

ritic

eru

ptio

ns

7

Seb

orrh

oeic

der

mat

itis

8

Fun

gal n

ail i

nfec

tions

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

5

92

Bib

liog

raph

y 1

Offic

e of

the

Pres

iden

t N

ational

AID

S C

ontr

ol Counci

l K

enya

Nat

ional H

IVA

IDS

Str

ate

gic

pla

n 2

0056

-20091

0

2

Rep

ublic

of

Ken

ya

Nat

ional AID

S C

ontr

ol C

ounci

l N

atio

nal H

IVA

IDS M

onitori

ng

and E

valu

atio

n F

ram

ework

3

Rep

ublic

of

Ken

ya

Nat

ional AID

S C

ontr

ol C

ounci

l N

atio

nal H

IVA

IDS M

onitori

ng

and E

valu

atio

n I

mple

men

tation M

anual

Job

Aid

sR

efer

ence

s 1

MoH

AN

C R

egis

ters

2

MoH

Mat

ernity

Reg

iste

rs

3

MoH

Post

-nata

l Reg

iste

rs

4

Mat

ernal

and C

hild

Wel

fare

Han

dbook

5

Rep

roduct

ive

Hea

lth S

ervi

ces

month

ly r

eport

6

MoH

Form

726

(Appen

dix

IV)

7

MoH

Form

727

8

MO

H F

orm

711

Exec

utiv

e Su

mm

ary

The

Rev

ised

Gui

delin

es (3

rd

editi

on) f

or P

reve

ntio

n of

Mot

her

to C

hild

Tra

nsm

issi

on(P

MTC

T) o

f H

IV a

nd A

IDS

addr

esse

s th

e ri

sks

of m

othe

r-to

-chi

ld t

rans

mis

sion

(MTC

T) o

f H

IV a

nd A

IDS

usin

g m

ore

effic

acio

us in

terv

entio

ns t

han

in t

he p

revi

ous

editi

ons

The

Gui

delin

es a

re i

n lin

e w

ith K

enya

rsquos N

atio

nal

Hea

lth S

ecto

r St

rate

gic

Plan

II

(NH

SSP

II)

and

are

anch

ored

on

the

Ken

ya N

atio

nal

AID

S St

rate

gic

Plan

(KN

ASP

) 20

00-2

010

whi

ch f

ocus

es o

n th

e pr

iori

ty a

reas

of

prev

entio

n of

new

inf

ecshy

tions

im

prov

ing

the

qual

ity o

f life

of p

eopl

e in

fect

ed a

nd a

ffect

ed b

y H

IV a

nd A

IDS

and

miti

gatio

n of

the

soc

ial a

nd e

cono

mic

impa

ct o

f the

infe

ctio

n O

ne o

f the

pri

ority

ar

eas

of N

HSS

P II

is

adhe

renc

e to

set

clin

ical

and

pub

lic h

ealth

sta

ndar

ds

The

Gui

delin

es w

ere

deve

lope

d th

roug

h a

part

icip

ator

y an

d co

nsul

tativ

e pr

oces

s th

at

drew

par

ticip

ants

fro

m p

ublic

hea

lth i

nstit

utio

ns

NG

Os

FB

Os

aca

dem

ic a

nd r

eshyse

arch

ins

titut

ions

and

dev

elop

men

t pa

rtne

rs

The

proc

ess

was

co-

ordi

nate

d by

N

ASC

OP

with

tech

nica

l and

fina

ncia

l sup

port

from

CD

C (K

)

HIV

infe

ctio

n ha

s re

vers

ed g

ains

rea

lised

in c

hild

hea

lth a

nd s

urvi

val i

n th

e la

st d

ecshy

ade

in K

enya

The

infe

ctio

n ha

s al

so c

ontr

ibut

ed s

igni

fican

tly t

o th

e co

mm

on c

ompl

ishyca

tions

of

preg

nanc

y in

man

y co

untr

ies

Glo

bally

mor

e th

an 6

300

00 c

hild

ren

wer

ein

fect

ed w

ith H

IV t

hrou

gh M

TCT

in 2

003

In

2007

K

enya

had

a p

opul

atio

n es

tishym

ated

at

34 m

illio

n t

he n

umbe

r of

bir

ths

per

annu

m w

as 1

73

mill

ion

the

HIV

prev

alen

ce a

mon

g pr

egna

nt m

othe

rs w

as 6

7 p

er c

ent

and

the

tota

l num

ber

of b

irth

s to

HIV

-infe

cted

mot

hers

exp

osed

to

MTC

T w

as 1

638

00

Ass

umin

g a

tran

smis

sion

rate

of 4

0 pe

r ce

nt a

nd in

the

abs

ence

of a

ny in

terv

entio

n t

he n

umbe

r of

HIV

pos

ishytiv

e in

fant

s pe

r an

num

wou

ld b

e 65

520

Ken

ya A

IDS

Indi

cato

r su

rvey

(KA

IS) 2

007

HIV

ser

opre

vale

nce

amon

g ad

ults

age

d 15

-49

year

s is

78

Var

ious

inte

rven

tions

hav

e be

en p

ut in

pla

ce t

o re

spon

d to

the

em

ergi

ng c

halle

nges

an

d co

nstr

aint

s to

MTC

T ac

ross

the

cou

ntry

Ana

lysi

s of

effe

ctiv

enes

s of

the

var

ious

ap

proa

ches

nee

ded

to m

anag

e ri

sks

of M

TCT

prov

ides

val

uabl

e in

sigh

ts th

at n

eces

sishy

tate

the

ado

ptio

n of

mor

e ef

ficac

ious

car

e an

d tr

eatm

ent

regi

men

s T

hese

ins

ight

s ha

ve in

form

ed t

he d

evel

opm

ent

of n

ew G

uide

lines

The

Gui

delin

es in

corp

orat

e th

ese

chan

ges

and

are

reco

mm

ende

d fo

r us

e by

hea

lth p

rofe

ssio

nals

and

hea

lth in

stitu

tions

at a

ll le

vels

of c

are

The

Gui

delin

es w

ill e

nhan

ce th

e ca

paci

ty o

f hea

lth c

are

prov

ider

sto

giv

e m

ore

effic

ient

and

effe

ctiv

e se

rvic

es t

o H

IV p

ositi

ve e

xpec

tant

mot

hers

and

ne

wbo

rns

The

Gui

delin

es h

ave

ten

chap

ters

and

cov

er th

e fo

llow

ing

just

ifyin

g th

e ne

ed fo

r sp

eshyci

fic m

anag

emen

t of

HIV

pos

itive

wom

en c

are

befo

re d

urin

g an

d af

ter

preg

nanc

yus

e of

ant

iret

rovi

ral t

hera

py in

pre

gnan

cy p

ostn

atal

car

e fa

mily

pla

nnin

g e

arly

inshy

fant

dia

gnos

is

feed

ing

car

e an

d fo

llow

-up

of H

IV-in

fect

ed i

nfan

ts

and

mon

itori

ng

and

eval

uatio

n A

dditi

onal

inf

orm

atio

n on

WH

O s

tagi

ng

cont

race

ptiv

e op

tions

for

PLW

As

and

a su

mm

ary

of A

RV

use

in P

MTC

T is

giv

en in

the

appe

ndic

es

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

1

16

The

Gui

delin

es h

ave

also

inc

orpo

rate

d ba

sic

info

rmat

ion

that

pro

gram

man

ager

sne

ed in

ord

er to

mak

e th

eir

inst

itutio

ns P

MTC

T-fr

iend

ly T

his

info

rmat

ion

is fo

und

in

the

boxe

s an

d ap

pend

ices

Sum

mar

ies

of t

he i

nfor

mat

ion

cont

aine

d in

the

tex

t ar

e fo

und

in th

e ta

bles

The

Gui

delin

es p

rovi

de a

bac

kgro

und

to t

he P

MTC

T pr

oble

m in

the

wor

ld i

n A

fric

a an

d in

Ken

ya T

hey

also

giv

e de

tails

on

HIV

in p

regn

ancy

the

tran

smis

sion

pat

tern

sof

MTC

T an

d de

scri

be t

he b

enef

its o

f pr

even

ting

mot

her-

to-c

hild

tra

nsm

issi

on(P

MTC

T) T

hey

also

pro

vide

info

rmat

ion

on in

terv

entio

ns n

eces

sary

to

redu

ce M

TCT

that

incl

ude

coun

selli

ng a

nd te

stin

g la

bora

tory

inve

stig

atio

ns o

bste

tric

inte

rven

tions

and

trea

tmen

tpro

phyl

axis

The

ante

nata

l man

agem

ent

for

HIV

pos

itive

wom

en i

nclu

ding

pol

icy

guid

e jo

b ai

dsw

ith s

umm

aris

ed e

ssen

tial p

acka

ge o

f int

egra

ted

ante

nata

l car

e se

rvic

es a

re d

etai

led

in C

hapt

er 2

Cha

pter

3 p

rovi

des

info

rmat

ion

on i

ntra

part

um c

are

Thi

s is

the

man

agem

ent

ofw

omen

from

the

onse

t of l

abou

r to

del

iver

y A

t thi

s st

age

it is

impo

rtan

t to

esta

blis

hth

e H

IV s

tatu

s of

wom

en p

rior

to d

eliv

ery

or d

urin

g la

bour

Gui

delin

es s

houl

d be

folshy

low

ed fo

r al

l wom

en a

dmitt

ed to

labo

ur a

nd d

eliv

ery

To

cond

uct v

agin

al d

eliv

erie

s fo

r H

IV p

ositi

ve w

omen

m

odifi

ed r

outin

e ca

re i

s gi

ven

The

gui

delin

es p

rovi

de a

reshy

min

der

on th

e ac

tiviti

es e

ssen

tial t

o ca

rry

out f

or s

afe

vagi

nal d

eliv

ery

for

all w

omen

no

t ju

st fo

r th

ose

infe

cted

with

HIV

It

is r

ecom

men

ded

that

the

re s

houl

d be

no

disshy

crim

inat

ion

or is

olat

ion

of H

IV p

ositi

ve w

omen

dur

ing

labo

ur a

nd d

eliv

ery

Del

iver

y th

roug

h el

ectiv

e ca

esar

ean

sect

ion

redu

ces

the

risk

of

HIV

MTC

T as

com

pare

d to

vagi

nal d

eliv

ery

amon

g H

IV p

ositi

ve w

omen

Whe

re C

S is

per

form

ed a

s an

em

erge

ncy

or e

lect

ivel

y a

ntib

iotic

s sh

ould

be

give

n

Ant

iret

rovi

ral (

AR

V) t

hera

py is

dis

cuss

ed in

det

ail i

n C

hapt

er 4

Thi

s in

clud

es t

hershy

apy

for

the

mot

her

befo

re la

bour

dur

ing

labo

ur a

nd a

fter

del

iver

y a

nd fo

r th

e in

fant

afte

r de

liver

y C

urre

ntly

N

evir

apin

e is

the

rec

omm

ende

d re

gim

en H

owev

er

shor

tco

urse

effi

caci

ous

AR

V d

rug

regi

men

s ca

n be

im

plem

ente

d in

res

ourc

e lim

ited

setshy

tings

AR

Vs

are

used

bot

h fo

r tr

eatm

ent

and

for

PMTC

T in

HIV

inf

ecte

d pr

egna

ntw

omen

and

thei

r ne

onat

es

Gui

delin

es f

or t

he p

ostp

artu

m c

are

of t

he m

othe

r an

d ca

re f

or H

IV e

xpos

ed in

fant

s ar

e de

taile

d in

Cha

pter

5 I

n C

hapt

er 6

the

Gui

de p

rovi

des

deta

iled

info

rmat

ion

on

late

pos

tnat

al c

are

and

fam

ily p

lann

ing

HIV

pos

itive

wom

en c

an u

se a

ll ty

pes

of fa

mshy

ily p

lann

ing

base

d on

sta

ndar

d el

igib

ility

cri

teri

a as

exp

licitl

y ou

tline

d in

the

text

Gui

delin

es fo

r in

fant

dia

gnos

is c

are

and

trea

tmen

t ar

e di

scus

sed

in C

hapt

er 7

Cur

shyre

ntly

the

re is

no

test

to

diffe

rent

iate

bet

wee

n an

tibod

ies

from

the

mot

her

and

thos

e pr

oduc

ed b

y th

e ba

by T

o id

entif

y H

IV in

fect

ed in

fant

s le

ss t

han

18 m

onth

s D

NA

or

RN

A ndash

PC

R te

st is

cur

rent

ly r

ecom

men

ded

HIV

exp

osed

infa

nts

at 6

wee

ks a

nd s

ick

infa

nts

at 1

2 m

onth

s sh

ould

hav

e ac

cess

to

DB

S fo

r D

NA

PC

R H

IV e

xpos

ed in

fant

ssh

ould

be

star

ted

on c

otri

mox

azol

e fr

om 6

wee

ks A

ll m

othe

rs w

ith 6

wee

k ol

d in

fant

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

E

Upt

ake

of c

ouns

ellin

g an

d te

stin

g in

Mat

erni

ty c

linic

Rat

io o

f m

ater

nity

clie

nts

with

unk

now

n H

IV s

tatu

s w

ho a

re c

ouns

elle

d an

d te

sted

for H

IV in

mat

erni

ty

Num

erat

or

Num

ber o

f pre

gnan

t wom

en a

dmitt

ed in

to m

ater

nity

with

un

know

n H

IV s

tatu

s th

at a

re c

ouns

elle

d an

d te

sted

for H

IV

durin

g la

bour

or a

fter d

eliv

ery

Den

omin

ator

N

umbe

r of p

regn

ant w

omen

adm

itted

into

mat

erni

ty

with

unk

now

n H

IV s

tatu

s

F

Mat

erni

ty m

othe

r AR

V pr

ophy

laxi

s up

take

R

atio

of H

IV in

fect

ed m

othe

rs in

mat

erni

ty c

linic

rece

ivin

g pr

even

tive

A

RV

pro

phyl

axis

Num

erat

or

Num

ber o

f HIV

-infe

cted

mot

hers

adm

itted

in m

ater

nity

takshy

ing

or re

porte

d to

hav

e ta

ken

the

mot

her d

ose(

s) o

f pre

venshy

tive

AR

V p

roph

ylax

is

Den

omin

ator

N

umbe

r of p

regn

ant w

omen

adm

itted

into

mat

erni

ty w

ho

are

HIV

-infe

cted

G

Infa

nt A

RV

prop

hyla

xis

upta

ke

Rat

io o

f inf

ants

bor

n to

HIV

-infe

cted

mot

hers

in m

ater

nity

clin

ic

rece

ivin

g pr

even

tive

AR

V p

roph

ylax

is

Num

erat

or

Num

ber o

f inf

ants

bor

n to

HIV

-infe

cted

mot

hers

who

rece

ive

prev

entiv

e

Den

omin

ator

N

umbe

r of i

nfan

ts b

orn

to H

IV-in

fect

ed m

othe

rs

Num

ber o

f pre

gnan

t wom

en a

dmitt

ed in

to m

ater

nity

who

are

H

IV-in

fect

ed is

use

d to

app

roxi

mat

e th

is n

umbe

r

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

7

90

With

the

mea

sure

men

ts li

sted

abo

ve t

he fo

llow

ing

perf

orm

ance

indi

cato

rs

for m

onito

ring

PMTC

T ac

tiviti

es a

re c

alcu

late

d

A

Upt

ake

of c

ouns

ellin

g an

d te

stin

g in

Ant

enat

al c

linic

R

atio

of a

nten

atal

clie

nts

who

wer

e co

unse

lled

and

test

ed fo

r HIV

Num

erat

or

This

is n

umbe

r of p

regn

ant w

omen

atte

ndin

g th

eir f

irst

ante

nata

l clin

ic v

isit

who

are

test

ed fo

r HIV

Den

omin

ator

N

umbe

r of n

ew v

isits

to th

e an

tena

tal c

linic

B

Ant

enat

al H

IV s

erop

reva

lenc

e

Rat

io o

f Ant

enat

al p

regn

ant w

omen

test

ed fo

r HIV

that

are

HIV

infe

cted

Num

erat

or

Num

ber o

f clie

nts

who

test

HIV

pos

itive

Den

omin

ator

To

tal n

umbe

r of p

regn

ant w

omen

test

ed fo

r HIV

in a

nten

ashyta

l clin

ic

C

Ant

enat

al m

othe

r AR

V pr

ophy

laxi

s up

take

R

atio

of k

now

n H

IV in

fect

ed p

regn

ant w

omen

in a

nten

atal

clin

ic

rece

ivin

g A

RV

pre

vent

ive

prop

hyla

xis

Num

erat

or

Tota

l num

ber o

f HIV

-infe

cted

pre

gnan

t wom

en in

ant

enat

al

clin

ic re

ceiv

ing

mot

her p

reve

ntiv

e A

RV

pro

phyl

axis

Den

omin

ator

To

tal n

umbe

r of p

regn

ant w

omen

who

are

HIV

-infe

cted

in

the

ante

nata

l clin

ic

D

Ant

enat

al in

fant

AR

V pr

ophy

laxi

s up

take

R

atio

of k

now

n H

IV-in

fect

ed p

regn

ant w

omen

in a

nten

atal

clin

ic w

ho

rece

ive

infa

nt d

ose(

s) o

f pre

vent

ive

AR

V p

roph

ylax

is

Num

erat

or

Tota

l num

ber o

f HIV

infe

cted

pre

gnan

t wom

en in

an

tena

tal c

linic

rece

ivin

g in

fant

dos

e(s)

pre

vent

ive

A

RV

pro

phyl

axis

Den

omin

ator

To

tal n

umbe

r of p

regn

ant w

omen

who

are

HIV

-infe

cted

in

the

ante

nata

l clin

ic

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

shou

ld h

ave

rout

ine

HIV

ant

ibod

y te

st

Gui

delin

es f

or f

eedi

ng in

fant

s an

d yo

ung

child

ren

born

to

HIV

infe

cted

mot

hers

are

di

scus

sed

in C

hapt

er 8

The

Min

istr

y of

Hea

lth r

ecom

men

ds p

rom

otio

n of

exc

lusi

vebr

east

feed

ing

for

the

first

6 m

onth

s of

life

Whe

re r

epla

cem

ent f

eedi

ng is

acc

epta

ble

feas

ible

af

ford

able

su

stai

nabl

e an

d sa

fe (

AFA

SS)

avoi

danc

e of

bre

astf

eedi

ng b

yH

IV-in

fect

ed w

omen

is

reco

mm

ende

d (W

HO

200

6) D

iscu

ssio

n on

diff

eren

t ty

pes

offe

edin

g al

tern

ativ

es t

o br

east

feed

ing

is c

aptu

red

in t

he t

ext

Thes

e op

tions

exi

st f

orth

e m

othe

r to

cho

ose

with

the

aid

of

coun

selli

ng I

deal

ly c

oupl

e de

cisi

on-m

akin

g is

enco

urag

ed f

or t

he H

IV p

ositi

ve m

othe

r F

or t

he H

IV n

egat

ive

mot

her

exc

lusi

ve

brea

stfe

edin

g is

rec

omm

ende

d fo

r 6

mon

ths

or le

ss fo

llow

ed b

y w

eani

ng

Car

e an

d fo

llow

-up

of c

hild

ren

of H

IV-in

fect

ed m

othe

rs is

dis

cuss

ed in

det

ail i

n C

hapshy

ter

9 A

ll ch

ildre

n bo

rn t

o H

IV i

nfec

ted

mot

hers

sho

uld

be f

ollo

wed

up

clos

ely

from

birt

h th

roug

h 2

year

s T

able

92

pro

vide

s th

e W

HO

rec

omm

ende

d fo

llow

up

deta

ils

Sim

ilarl

y t

he m

othe

rs s

houl

d be

sup

port

ed t

o pr

ovid

e op

timal

infa

nt fe

edin

g an

d to

av

oid

mix

ed fe

edin

g w

ithin

6 m

onth

s

In C

hapt

er 1

0 t

he G

uide

lines

exp

lain

the

ben

efits

of

mon

itori

ng a

nd e

valu

atio

n of

PMTC

T pr

ogra

ms

Mamp

E p

rovi

des

an o

ppor

tuni

ty t

o m

easu

re a

nd a

ppra

ise

perf

orm

shyan

ce w

ithin

def

ined

tim

e fr

ame

to e

nsur

e ac

com

plis

hmen

t of s

et g

oals

and

obj

ectiv

es

PMTC

T se

rvic

es m

ust

be g

uide

d by

tim

ely

and

accu

rate

dat

a re

port

ed f

rom

the

heal

th f

acili

ties

thr

ough

the

dis

tric

t an

d pr

ovin

cial

lev

els

to

the

natio

nal

leve

l at

NA

SCO

P

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

9

18

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

(xiii

) H

IV in

fect

ed in

mat

erni

ty w

ard

Num

ber

of p

regn

ant

wom

en a

dmitt

ed in

to

mat

erni

ty c

linic

who

are

HIV

infe

cted

In

clud

es b

oth

thos

e w

ho w

ere

adm

itted

al

read

y kn

owin

g th

ey a

re H

IV-i

nfec

ted

and

thos

e w

ho w

ere

test

ed a

nd r

ecei

ved

thei

r re

sults

in m

ater

nity

clin

ic T

his

is o

btai

ned

from

the

mat

erni

ty r

egis

ter

(xiv

) P

reve

ntiv

e A

RV

pro

phyl

axis

in m

ater

nity

war

d (m

othe

r do

se)

Num

ber

of

preg

nant

wom

en a

dmitt

ed in

mat

erni

ty t

akin

g or

rep

orte

d to

hav

e ta

ken

the

mot

her

dose

(s)

of p

reve

ntiv

e A

RV

pro

phyl

axis

T

his

is o

btai

ned

from

the

m

ater

nity

reg

iste

r

(xv)

Inf

ant

prev

entiv

e A

RV

pro

phyl

axis

in m

ater

nity

clin

ic

war

d N

umbe

r of

inshy

fant

s bo

rn in

mat

erni

ty r

ecei

ving

the

infa

nt p

reve

ntiv

e A

RV

pro

phyl

axis

in t

he

mat

erni

ty c

linic

T

his

is o

btai

ned

from

the

mat

erni

ty r

egis

ter

(xvi

) D

eliv

erie

s T

otal

num

ber

of p

regn

ant

wom

en d

eliv

erin

g at

the

hea

lth fa

cilit

y

(xvi

i) C

ouns

ellin

g on

infa

nt f

eedi

ng o

ptio

ns

Num

ber

of m

othe

rs d

eliv

erin

g at

the

he

alth

fac

ility

cou

nsel

led

on in

fant

fee

ding

opt

ions

T

his

is o

btai

ned

from

the

m

ater

nity

reg

iste

r

(xvi

ii) I

nfan

t te

stin

g at

6 w

eeks

bull N

umbe

r of

infa

nts

test

ed f

or H

IV a

t 6

wee

ks o

ld

bull N

umbe

r of

infa

nts

test

ing

HIV

-pos

itive

T

his

is o

btai

ned

from

labo

rato

ry

regi

ster

(xix

) R

efer

red

for

care

and

tre

atm

ent

bull N

umbe

r of

HIV

infe

cted

wom

en a

ttend

ing

ante

nata

l clin

ic t

hat

is r

efer

red

for

HIV

car

e an

d tr

eatm

ent

bull N

umbe

r of

HIV

infe

cted

wom

en in

mat

erni

ty t

hat

is r

efer

red

for

HIV

car

e an

d tr

eatm

ent

bull N

umbe

r H

IV in

fect

ed in

fant

s re

ferr

ed f

or H

IV c

are

and

trea

tmen

t T

his

is

ob

tain

ed f

rom

ant

enat

al a

nd m

ater

nity

reg

iste

rs

(xx)

Ini

tiate

d on

Cot

rim

oxaz

ole

Num

ber

of H

IV in

fect

ed p

regn

ant

wom

en a

ttend

ing

ante

nata

l clin

ic th

at h

as

been

initi

ated

on

Cot

rimox

azol

e T

his

is o

btai

ned

from

the

ant

enat

al r

egis

ter

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

9

88

Th

e da

ta is

pre

sent

ed u

sing

def

ined

per

form

ance

indi

cato

rs th

at in

clud

e th

e fo

llow

ing

(i)

New

clie

nts

first

ant

enat

al c

linic

vis

its

Num

ber

of p

regn

ant

wom

en a

ttend

ing

thei

r fir

st a

nten

atal

vis

it fo

r th

e cu

rren

t pr

egna

ncy

at t

he h

ealth

fac

ility

T

his

is

obta

ined

fro

m t

he a

nten

atal

reg

iste

r

(ii)

Ret

urn

visi

tsr

evis

its

Num

ber

of r

etur

n an

tena

tal c

linic

vis

itsr

evis

its

atte

nded

by

the

preg

nant

wom

en a

t th

e fa

cilit

y T

his

is o

btai

ned

from

the

an

tena

tal r

egis

ter

(iii)

C

ouns

ellin

g an

d te

stin

g fo

r H

IV in

ant

enat

al c

linic

Tot

al n

umbe

r of

pre

gnan

t w

omen

cou

nsel

led

and

test

ed f

or H

IV a

t th

e an

tena

tal c

linic

w

heth

er t

his

is d

one

on th

e fir

st a

nten

atal

vis

it or

a la

ter

visi

t T

his

is o

btai

ned

from

the

an

tena

tal r

egis

ter

(iv)

H

IV c

ouns

ellin

g an

d te

stin

g at

fir

st a

nten

atal

clin

ic v

isit

Num

ber

of p

regn

ant

wom

en a

tten

ding

the

ir fir

st a

nten

atal

clin

ic v

isit

for

curr

ent

preg

nanc

y w

ho a

re

test

ed f

or H

IV

Thi

s is

obt

aine

d fr

om t

he a

nten

atal

reg

iste

r

(v)

Lear

ning

HIV

sta

tus

in a

nten

atal

clin

ic

Num

ber

of a

nten

atal

clin

ic p

regn

ant

wom

en t

este

d fo

r H

IV w

ho r

ecei

ve t

heir

HIV

res

ults

w

heth

er t

his

is d

one

on t

he

first

ant

enat

al c

linic

vis

it or

at

a la

ter

visi

t T

his

is o

btai

ned

from

the

ant

enat

al

regi

ster

(vi)

HIV

infe

cted

in a

nten

atal

clin

ic

Num

ber

of a

nten

atal

clin

ic p

regn

ant

wom

en

who

are

HIV

-inf

ecte

d on

the

late

st t

est

durin

g th

e pr

egna

ncy

Thi

s is

obt

aine

d fr

om t

he a

nten

atal

reg

iste

r

(vii)

Pre

vent

ive

AR

V p

roph

ylax

is in

ant

enat

al c

linic

(m

othe

r do

se)

Num

ber

of

preg

nant

wom

en in

the

ant

enat

al c

linic

rec

eivi

ng t

he m

othe

r do

se(s

) of

pre

venshy

tive

AR

V p

roph

ylax

is

Thi

s is

obt

aine

d fr

om t

he a

nten

atal

reg

iste

r

(viii

) P

reve

ntiv

e A

RV

pro

phyl

axis

in a

nten

atal

clin

ic (

infa

nt d

ose)

N

umbe

r of

pr

egna

nt w

omen

in t

he A

nten

atal

clin

ic is

sued

with

the

infa

nt d

ose(

s) o

f pr

even

shytiv

e A

RV

pro

phyl

axis

T

his

is o

btai

ned

from

the

ant

enat

al r

egis

ter

(ix)

New

clie

nts

in m

ater

nity

clin

ic

Num

ber

of p

regn

ant

wom

en a

tten

ding

the

Mashy

tern

ity c

linic

for

the

firs

t tim

e T

his

is o

btai

ned

from

the

mat

erni

ty r

egis

ter

(x)

Unk

now

n H

IV s

tatu

s at

mat

erni

ty

Num

ber

of p

regn

ant

wom

en a

dmitt

ed in

to

the

mat

erni

ty w

ith u

nkno

wn

HIV

sta

tus

Thi

s is

obt

aine

d fr

om t

he m

ater

nity

reg

isshy

ter

(xi)

Cou

nsel

ling

and

test

ing

for

HIV

in m

ater

nity

war

dT

otal

num

ber

of p

regn

ant

wom

en a

dmitt

ed in

to m

ater

nity

with

unk

now

n st

atus

tha

t ar

e co

unse

lled

and

test

ed fo

r H

IV d

urin

g la

bour

or

afte

r de

liver

y T

his

is o

btai

ned

from

the

mat

erni

ty

regi

ster

(xii)

Lea

rnin

g H

IV s

tatu

s in

mat

erni

ty w

ard

Num

ber

of p

regn

ant

wom

en a

dmitt

ed

into

mat

erni

ty a

nd t

este

d fo

r H

IV w

ho r

ecei

ved

thei

r H

IV r

esul

ts

Thi

s is

obt

aine

d fr

om t

he m

ater

nity

reg

iste

r

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Cha

pter

1

Bac

kgro

und

11

THE

GLO

BA

L P A

ND

EMIC

Ove

r 38

mill

ion

peop

le a

re li

ving

with

HIV

AID

S w

orld

wid

e a

nd a

bout

two-

thir

ds o

r 25

m

illio

n of

PLW

HA

liv

e in

sub

-Sah

aran

Afr

ica1

H

IVA

IDS

mai

nly

affe

cts

peop

le o

fre

prod

uctiv

e ag

e an

d in

crea

sing

ly a

ffect

s w

omen

w

ho n

ow a

ccou

nt f

or 5

7 o

f ne

win

fect

ions

in s

ub-S

ahar

an A

fric

a w

here

wom

en a

re 3

0 m

ore

likel

y to

be

livin

g w

ith

HIV

AID

S th

an m

en a

nd y

oung

wom

en a

ged

15-2

4 ar

e ne

arly

four

tim

es m

ore

likel

y to

be

inf

ecte

d th

an t

heir

mal

e co

unte

rpar

ts2

Youn

g m

arri

ed w

omen

w

ho a

re o

ften

m

onog

amou

s h

ave

beco

me

one

of t

he g

roup

s m

ost

vuln

erab

le t

o H

IV i

n th

e re

gion

Th

is r

equi

res

new

and

rap

id r

espo

nses

that

bro

aden

the

focu

s be

yond

trad

ition

al ldquoh

igh

risk

rdquo gro

ups

like

com

mer

cial

sex

wor

kers

tru

ck d

rive

rs a

nd d

rug

user

s

To r

each

you

ng m

arri

ed w

omen

w

ho m

ay n

ot b

e aw

are

of t

heir

vul

nera

bilit

y H

IV

AID

S pr

even

tion

ca

re

and

supp

ort

activ

ities

m

ust

be

inte

grat

ed

into

al

read

yes

tabl

ishe

d he

alth

ser

vice

s th

at a

re u

sed

by t

he g

ener

al p

opul

atio

n A

n es

timat

ed

630

000

child

ren

wor

ld-w

ide

beca

me

infe

cted

with

HIV

in

2003

mdash m

ost

thro

ugh

MTC

T3

The

risk

of

an H

IV-in

fect

ed m

othe

r pa

ssin

g th

e vi

rus

to h

er i

nfan

t du

ring

pr

egna

ncy

labo

ur a

nd d

eliv

ery

or in

the

post

nata

l per

iod

is 1

in 3

if n

othi

ng is

don

e to

re

duce

this

ris

k I

n ot

her

wor

ds o

ut o

f 100

infa

nts

born

to w

omen

with

HIV

AID

S an

d w

ithou

t in

terv

entio

n 6

0-75

of t

hem

will

not

be

infe

cted

Of t

he o

ne-t

hird

who

bec

ome

infe

cted

abo

ut 5

-10

babi

es w

ill b

e in

fect

ed d

urin

g pr

egna

ncy

15

will

be

infe

cted

dur

ing

labo

ur a

nd d

eliv

ery

whi

le 5

-15

will

be

infe

cted

dur

ing

brea

stfe

edin

g l

arge

ly b

eing

de

pend

ent

on b

reas

tfee

ding

pra

ctic

es a

nd o

n th

e du

ratio

n of

bre

astfe

edin

g4 I

n 20

03

near

ly 5

000

00 c

hild

ren

died

of A

IDS-

rela

ted

caus

es M

ost

child

ren

born

with

HIV

die

befo

re th

ey r

each

thei

r fif

th b

irth

day

with

mos

t not

sur

vivi

ng b

eyon

d tw

o ye

ars5

The

high

rat

es o

f M

TCT

in d

evel

opin

g co

untr

ies

com

pare

d to

muc

h lo

wer

rat

es i

nri

cher

cou

ntri

es

illus

trat

e gr

owin

g in

equa

litie

s in

glo

bal

heal

th

In t

he w

ealth

y co

untr

ies

the

rat

e of

MTC

T is

les

s th

an 2

b

ecau

se o

f w

ides

prea

d ac

cess

to

antishy

retr

ovir

al th

erap

y (A

RT)

pla

nned

cae

sare

an s

ectio

ns (C

S) t

he m

eans

to s

afel

y fo

rmul

afe

ed a

nd a

cces

s to

qua

lity

med

ical

ser

vice

s I

n po

orer

cou

ntri

es li

ke K

enya

the

re is

a

30-4

0 c

hanc

e th

at a

n H

IV-p

ositi

ve b

reas

tfee

ding

mot

her

will

pas

s H

IV to

her

chi

ld in

th

e ab

senc

e of

the

se s

ervi

ces

In

such

set

tings

it

is c

ritic

al t

hat

prev

entio

n pr

oced

ures

be i

nteg

rate

d in

to e

xist

ing

sexu

al a

nd r

epro

duct

ive

heal

th (

SRH

) an

d m

ater

nal

and

child

hea

lth (

MC

H)

serv

ices

re

achi

ng a

s m

any

wom

en a

s po

ssib

le a

nd l

ower

ing

tran

smis

sion

rat

es A

lthou

gh p

harm

aceu

tical

com

pany

don

atio

ns d

onor

sup

port

and

othe

r go

vern

men

t in

itiat

ives

hav

e he

lped

exp

and

acce

ss t

o H

IV t

estin

g fo

r pr

egna

ntw

omen

and

use

of a

ntir

etro

vira

l dru

gs li

ke N

evir

apin

e w

hich

red

uce

the

chan

ce o

f HIV

tr

ansm

issi

on s

till o

nly

10

of p

regn

ant w

omen

glo

bally

hav

e ac

cess

to th

ese

drug

s6

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

7

20

HIV

AID

S tr

ansm

issi

on fr

om m

othe

r to

chi

ld in

Ken

ya is

one

of t

he b

igge

st h

ealth

and

de

velo

pmen

t cha

lleng

es in

Ken

ya A

ccor

ding

to th

e 20

03 D

emog

raph

ic a

nd H

ealth

Sur

shyve

y7 6

7

or

over

12

mill

ion

Ken

yan

adul

ts w

ere

livin

g w

ith H

IVA

IDS

in 2

003

The

re

has

been

a s

tead

y de

clin

e in

HIV

ser

opre

vale

nce

in K

enya

In

2005

the

pre

vale

nce

rate

w

as e

stim

ated

at 5

9

and

as

per

the

2006

sta

tistic

s th

e pr

eval

ence

rat

e am

ong

adul

tsha

d dr

oppe

d to

51

8

Acc

ordi

ng t

o 20

07 K

enya

AID

S In

dica

tor

Surv

ey (

KA

IS)8a

the

H

IV s

erop

reva

lenc

e in

Ken

ya is

cur

rent

ly 7

8

am

ong

adul

ts a

ged

15-4

9 ye

ars

bei

nghi

gher

in

wom

en (

87

) th

an i

n m

en (

56

) Y

oung

wom

en a

re m

ore

vuln

erab

le i

n K

enya

tha

n m

en a

s ev

iden

ced

by a

nea

rly

9 p

reva

lenc

e ra

te a

mon

g w

omen

and

unshy

der

5 a

mon

g m

en9

Ther

e ar

e w

ide

vari

atio

ns b

etw

een

urba

n an

d ru

ral

area

s b

etw

een

regi

ons

bet

wee

n ad

ults

and

you

ng p

eopl

e an

d be

twee

n m

en a

nd w

omen

The

re h

as b

een

a no

tabl

e dr

op

in t

he n

umbe

r of

new

inf

ectio

ns

with

an

estim

ated

60

000

new

inf

ectio

ns i

n 20

05

drop

ping

to 5

500

0 in

200

6 In

fant

s an

d yo

ung

child

ren

unde

r 15

yea

rs a

ccou

nt fo

r 16

of

all

new

HIV

infe

ctio

ns m

ainl

y as

a r

esul

t of M

TCT

Mos

t of t

he n

ew in

fect

ions

occ

ur

amon

g yo

ung

peop

le i

n w

hom

the

mai

n m

ode

of t

rans

mis

sion

is t

hrou

gh s

exua

l int

ershy

cour

se

Tabl

e 1

1 A

dult

HIV

-Pre

vale

nce

Estim

ate

by P

rovi

nce

in 2

006

Prov

ince

N

umbe

r of H

IV +

Pre

vale

nce

()

Nai

robi

Cen

tral

Coa

st

Eas

tern

N E

aste

rn

Nya

nza

Rift

Val

ley

Wes

tern

Tota

l

197

000

960

00

930

00

720

00

900

0 18

300

0

171

000

112

000

11

milli

on

Tota

l

101

41

59

28

14

78

38

53

51

Mal

e

80

17

50

11

09

61

26

42

35

Fem

ale

123

65

69

44

18

96

49

64

67

Mal

eFe

mal

e R

atio

15

38

14

40

20

16

19

15

19

all t

he d

ata

from

the

prov

ince

s (a

nd r

efer

ral h

ospi

tals

) Th

e ag

greg

ated

dat

a is

di

ssem

inat

ed t

o th

e H

ealth

Man

agem

ent

Info

rmat

ion

Syst

em N

atio

nal A

IDS

Con

trol

Cou

ncilrsquo

s (N

AC

C)

natio

nal

data

ban

k an

d re

sour

ce c

entr

e T

he f

ocal

pe

rson

s he

re a

re t

he d

irec

tor

NA

CC

and

the

Mamp

E m

anag

er D

ata

is d

isse

mishy

nate

d ba

ck to

the

prov

ince

s an

d re

ferr

al h

ospi

tals

for

use

in d

ecis

ion-

mak

ing

7

Dat

a flo

w f

rom

fac

ility

lev

el t

o na

tiona

l le

vel

At

the

heal

th f

acili

ty P

MTC

T in

divi

dual

le

vel d

ata

reco

rded

in t

he M

oH s

tand

ardi

sed

regi

ster

s (A

NC

Mashy

tern

ity a

nd P

ostn

atal

) is

sum

mar

ised

ag

greg

ated

on

a m

onth

ly b

asis

ont

o M

oH F

orm

726

F

orm

726

is

then

for

war

ded

upw

ards

to

the

dist

rict

Lev

el

(DA

SCO

rsquos O

ffice

) for

agg

rega

tion

of th

e D

istr

ict l

evel

dat

a on

to F

orm

727

Cop

shyie

s of

For

m 7

26 a

nd F

orm

727

are

forw

arde

d to

the

Nat

iona

l Offi

ce (N

ASC

OP)

w

ith a

noth

er c

opy

of F

orm

727

bei

ng s

ent t

o th

e Pr

ovin

cial

Offi

ce (P

ASC

O)

8

Dat

a di

ssem

inat

ion

Thi

s is

car

ried

out

at

all

leve

ls s

tart

ing

from

fac

ility

to

natio

nal l

evel

It i

s th

e re

spon

sibi

lity

of N

AC

C to

coo

rdin

ate

the

diss

emin

atio

n an

d us

e of

all

HIV

AID

S da

ta a

nd in

form

atio

n fo

r na

tiona

l res

pons

e J

APR

a

join

t pro

gram

me

of a

ll st

akeh

olde

rs in

HIV

AID

S re

ceiv

es a

nd u

ses

the

data

to

disc

uss

the

chal

leng

es a

chie

vem

ents

and

les

sons

lea

rnt

from

HIV

AID

S an

d gi

ves

feed

back

for n

atio

nal r

espo

nse

9

PMTC

T in

dica

tors

and

thei

r so

urce

s H

ealth

car

e fa

cilit

ies

colle

ct th

e fo

llow

ing

data

as

a m

inim

um t

o be

use

d in

the

mon

itori

ng o

f PM

TCT

prog

ram

s T

he

data

is

to b

e ag

greg

ated

on

a m

onth

ly b

asis

ont

o th

e M

inis

try

of H

ealth

In

tegr

ated

Mon

itori

ng a

nd E

valu

atio

n R

epor

t For

m M

oH 7

26 u

sing

dat

a fr

om

the

Min

istr

y of

Hea

lth

Ken

ya A

nten

atal

and

Mat

erni

ty R

egis

ters

(D

eliv

ery

Reg

iste

r) M

oH 4

05 a

nd M

oH 3

33 r

espe

ctiv

ely

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

2

1

86

102

O

PER

ATI

ON

AL

GU

IDEL

INES

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed in

the

mon

itorin

g an

d ev

alua

-tio

n of

PM

TCT

serv

ices

1

W

ithin

PM

TCT

prog

ram

s d

ata

is c

olle

cted

and

rep

orte

d at

the

fol

low

ing

leve

ls I

ndiv

idua

l fa

cilit

y d

istr

ict

prov

inci

al a

nd n

atio

nal

2

Indi

vidu

al l

evel

The

com

bine

d m

othe

r an

d ch

ild h

ealth

boo

klet

pro

vide

s de

shyta

iled

info

rmat

ion

on t

he w

oman

and

chi

ld i

nclu

ding

the

HIV

sta

tus

oth

er

HIV

car

e se

rvic

es d

rugs

del

iver

y in

form

atio

n im

mun

isat

ion

gro

wth

mon

itorshy

ing

and

othe

r par

amet

ers

3

Faci

lity

leve

l da

ta c

aptu

re t

ools

The

MoH

has

sta

ndar

dise

d re

gist

ers

for

reshy

cord

ing

data

at

faci

litie

s T

hese

inc

lude

the

Rev

ised

AN

C R

egis

ter

Rev

ised

M

ater

nity

Reg

iste

r an

d Po

st N

atal

Reg

iste

r an

d W

orkl

oad

MO

H 7

17 O

ther

re

gist

ers

incl

ude

Chi

ld H

ealth

and

Nut

ritio

n In

form

atio

n Sy

stem

and

Inshy

patie

nt M

orbi

dity

and

Mor

talit

y F

orm

711

and

the

Rep

rodu

ctiv

e H

ealth

Ser

shyvi

ces

mon

thly

rep

orts

are

use

d fo

r m

akin

g fa

cilit

y le

vel s

umm

arie

s on

PM

TCT

and

repr

oduc

tive

heal

th s

ervi

ces

3 F

acili

ty le

vel d

ata

capt

ure

tool

s T

he M

oH

has

stan

dard

ized

reg

iste

rs f

or r

ecor

ding

dat

a at

fac

ilitie

s T

hese

inc

lude

the

R

evis

ed A

NC

Reg

iste

r R

evis

ed M

ater

nity

Reg

iste

r an

d Po

st N

atal

Reg

iste

r an

d w

orkl

oad

MO

H 7

17 O

ther

reg

iste

rs in

clud

e C

hild

Hea

lth a

nd N

utri

tion

Info

rmat

ion

Syst

em a

nd I

n-pa

tient

mor

bidi

ty a

nd m

orta

lity

Fo

rm 7

26 a

nd

the

Rep

rodu

ctiv

e he

alth

ser

vice

s m

onth

ly r

epor

ts a

re u

sed

for

mak

ing

faci

lity

leve

l sum

mar

ies

on P

MTC

T an

d re

prod

uctiv

e he

alth

ser

vice

s

4

Dis

tric

t le

vel

data

For

m 7

27 i

s us

ed t

o su

mm

aris

e an

d re

port

dis

tric

t le

vel

data

Oth

er s

umm

ary

repo

rtin

g to

ols

are

also

use

d to

rep

ort

dist

rict

leve

l inshy

form

atio

n A

t th

e di

stri

ct le

vel

the

DAS

CO

rsquos of

fice

aggr

egat

es d

ata

from

sev

shyer

al h

ealth

faci

lity

spec

ific

Form

726

ont

o Fo

rm 7

27 th

at is

use

d to

sum

mar

ise

and

repo

rt d

istr

ict l

evel

dat

a

5

Prov

inci

al l

evel

dat

a A

t th

e pr

ovin

cial

lev

el t

he P

ASC

O r

ecei

ves

Form

727

da

ta f

rom

the

res

pect

ive

DA

SCO

rsquos of

fices

in

the

prov

ince

for

the

ir o

wn

data

us

e an

d re

cord

s A

cop

y of

the

sam

e is

sen

t to

the

Nat

iona

l Offi

ce (N

ASC

OP)

by

the

DA

SCO

rsquos of

fice

At

the

prov

inci

al le

vel

the

dist

rict

leve

l dat

a is

agg

reshy

gate

d to

giv

e th

e pr

ovin

cial

leve

l dat

a

6 N

atio

nal

leve

l da

ta

At

the

natio

nal

leve

l th

e M

ampE

Man

ager

rec

eive

s da

ta

from

the

PASC

Os

for

each

of t

he p

rovi

nces

Dat

a is

als

o re

ceiv

ed fr

om th

e R

eshyfe

rral

hos

pita

ls a

nd o

ther

fac

ilitie

s at

the

ref

erra

l ho

spita

l or

ter

tiary

lev

el

The

data

rec

eive

d at

the

nat

iona

l lev

el is

als

o co

pied

to

the

Hea

d of

NA

SCO

P an

d PM

TCT

prog

ram

me

man

ager

The

Mamp

E m

anag

er a

t NA

SCO

P ag

greg

ates

85

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

12

MA

GN

ITU

DE

OF

HIV

IN P

REG

NA

NC

YIN

KEN

YA

Ken

ya N

atio

nal

AID

SST

I C

ontr

ol P

rogr

amm

e (N

ASC

OP)

est

imat

es t

hat

ther

e w

ere

12

mill

ion

babi

es b

orn

in 2

006

in K

enya

and

that

as

man

y as

9

of p

regn

ant w

omen

inK

enya

wer

e liv

ing

with

HIV

AID

S10

At

leas

t 50

000

to

600

00 i

nfan

ts i

n K

enya

wer

e th

ough

t to

hav

e be

en i

nfec

ted

with

H

IV a

s a

resu

lt of

MTC

T th

at y

ear

With

an

estim

ated

pop

ulat

ion

of 3

72

mill

ion

in th

eye

ar 2

007

the

num

ber

of b

irth

s in

200

7 w

as 1

73

mill

ion

With

an

HIV

pre

vale

nce

of 6

7

the

num

ber

of H

IV -

expo

sed

babi

es is

114

101

and

at

leas

t 45

640

HIV

-pos

itive

bab

ies

are

born

ass

umin

g a

40

tran

smis

sion

(Tab

le 1

2)

Tabl

e 1

2 E

stim

ated

mag

nitu

de o

f MTC

T in

Ken

ya 2

007

Popu

latio

n (E

stim

ates

200

7)

372

mill

ion

Birt

hs p

er a

nnum

1

73 m

illio

n

HIV

pre

vale

nce

in m

othe

rs

67

Tota

l num

ber o

f birt

hs to

HIV

-infe

cted

mot

hers

exp

osed

14

110

1 to

MTC

T as

sum

ing

no m

ultip

le p

regn

ancy

Num

ber o

f HIV

pos

itive

infa

nts

per a

nnum

in K

enya

45

640

as

sum

ing

40

tran

smis

sion

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

22

13

RIS

KS

OF

T RA

NSM

ISSI

ON

OF

MTC

T A

T D

IFFE

REN

T

T

IME

P ER

IOD

S

In K

enya

an

estim

ated

40

000

to 5

000

0 in

fant

s ar

e in

fect

ed w

ith H

IV a

nnua

lly d

ue to

m

othe

r-to

-chi

ld t

rans

mis

sion

Th

is c

an o

ccur

in u

tero

dur

ing

labo

ur a

nd d

eliv

ery

and

thro

ugh

brea

stfe

edin

g D

urin

g pr

egna

ncy

abo

ut 5

to

8 pe

rcen

t of

HIV

-exp

osed

bab

ies

beco

me

infe

cted

thr

ough

tra

nsm

issi

on a

cros

s th

e pl

acen

ta L

abou

r an

d de

liver

y po

ses

the

grea

test

ris

k fo

r tr

ansm

issi

on w

ith 1

0 to

20

perc

ent

of e

xpos

ed i

nfan

ts b

ecom

ing

infe

cted

at t

his

time

Bre

astf

eedi

ng a

lso

expo

ses

infa

nts

to H

IV

Whe

n m

othe

rs b

reas

tfee

d fo

r 18

to

24m

onth

s an

othe

r 10

to 1

5 pe

rcen

t of i

nfan

ts b

ecom

e in

fect

ed T

hus

in n

on-b

reas

tfee

ding

po

pula

tions

with

out

antir

etro

vira

l tre

atm

ent

appr

oxim

atel

y 15

to

30 p

erce

nt in

fant

s w

ill b

ecom

e in

fect

ed

with

pro

long

ed b

reas

tfee

ding

25

to

45 p

erce

nt i

nfan

ts w

ill

beco

me

infe

cted

Tabl

e 1

3 T

rans

mis

sion

pat

tern

s in

bre

astfe

edin

g an

d no

n br

east

feed

ing

popu

latio

ns

Tran

smis

sion

rate

in

Tim

ing

No

Bre

astfe

edin

g B

reas

tfeed

ing

Bre

astfe

edin

g th

roug

h

thro

ugh

6

mon

ths

18 to

24

mon

ths

Dur

ing

preg

nanc

y 05

to 1

0 05

to 1

0 05

to 1

0

Dur

ing

labo

ur

10 to

20

10 to

20

10 to

20

Thro

ugh

brea

stfe

edin

g 10

to 2

0 05

to 1

0 05

to 1

0

Ear

ly (f

irst 2

mon

ths)

10

to 2

0 05

to 1

0 05

to 1

0

Late

(afte

r 2 m

onth

s)

10 to

20

01 to

05

05 to

10

Ove

rall

15 to

30

25 to

35

30 to

45

Sou

rce

De

Coc

k K

M (2

002)

Form

MoH

711

has

bee

n re

com

men

ded

to r

epla

ce F

orm

MoH

726

HIV

Mamp

E d

ata

flow

pip

elin

e fr

om t

he i

ndiv

idua

l he

alth

fac

ilitie

s t

o th

e di

stri

ct a

ndpr

ovin

cial

leve

ls u

p to

the

cent

ral o

r na

tiona

l lev

els

at N

ASC

OP

and

NA

CC

is s

umm

ashyri

sed

in F

igur

e 1

01

Figu

re 1

01

HIV

Mon

itorin

g an

d Ev

alua

tion

data

flow

pip

elin

e in

Ken

ya

HM

IS

NA

SC

OP

N

ACC

H

ead

Nat

iona

l Dat

a B

ank

amp

Res

ourc

e C

entre

M

E M

anag

er

The

Dire

ctor

P

rogr

amm

e M

anag

er

ME

Man

ager

Ref

erra

l Hos

pita

ls

CE

Os

Spe

cial

ists

The

Prov

ince

P

MO

P

AS

CO

P

AR

TO

PH

RIO

P

CO

The

Dis

trict

D

MO

D

AS

CO

Dat

a en

try

cler

k D

AR

TO

DH

RIO

Hea

lth F

acilit

y P

ublic

Sec

tor

FBO

etc

23

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

84

Cha

pter

10

Mon

itorin

g an

d Ev

alua

tion

of P

MTC

T Se

rvic

es

101

IN

TRO

DU

CTI

ON

PMTC

T pr

ogra

m m

onito

ring

and

eva

luat

ion

activ

ities

pro

vide

the

oppo

rtun

ity to

mea

sshyur

e an

d ap

prai

se p

erfo

rman

ce w

ithin

def

ined

par

amet

ers

that

ens

ure

acco

mpl

ishm

ent

of g

oals

and

obj

ectiv

es

Ken

ya is

com

mitt

ed to

the

ldquoThr

ee-o

nesrdquo

pri

ncip

les

whi

ch a

re

bull O

ne a

gree

d A

IDS

Act

ion

Fra

mew

ork

that

pro

vide

s th

e ba

sis

for

coor

dina

ting

the

wor

k pl

an o

f al

l par

tner

s

bull O

ne N

atio

nal A

IDS

Coo

rdin

atin

g A

utho

rity

with

a b

road

-bas

ed

mul

tisec

tora

l man

date

bull O

ne a

gree

d co

untr

y-le

vel M

onito

ring

and

Eva

luat

ion

(M

ampE

) sy

stem

In l

ine

with

thi

s t

he c

ount

ry h

as d

evel

oped

the

Nat

iona

l H

IVA

IDS

Mon

itori

ng a

ndE

valu

atio

n Fr

amew

ork

that

pro

vide

s st

akeh

olde

rs w

ith a

too

l fo

r w

ell

coor

dina

ted

in

terl

inke

d an

d fu

nctio

nal H

IVA

IDS

Mamp

E s

yste

m t

hat

allo

ws

for

effic

ient

mon

itori

ngof

int

erve

ntio

ns i

n ac

hiev

ing

the

natio

nal

prog

ram

mat

ic g

oals

usi

ng d

efin

ed t

arge

ts

This

pro

vide

s th

e fr

amew

ork

for M

ampE

act

iviti

es w

ithin

PM

TCT

prog

ram

s

Nat

iona

l PM

TCT

data

is

repo

rted

usi

ng M

oH I

nteg

rate

d M

onito

ring

and

Eva

luat

ion

Rep

ortin

g Fo

rms

For

m M

oH 7

11 o

r Fo

rm M

oH 7

27

Indi

vidu

al P

MTC

T da

ta is

col

shyle

cted

at

the

heal

th f

acili

ties

offe

ring

PM

TCT

serv

ices

usi

ng s

tand

ard

MoH

reg

iste

rs(A

NC

Mat

erni

ty a

nd P

ostn

atal

Reg

iste

rs)

On

mon

thly

bas

is t

he h

ealth

faci

litie

s w

ill a

ggre

gate

the

dat

a fr

om t

he r

egis

ters

on

to

Form

MoH

711

or

MO

H 7

26 w

hich

is th

en fo

rwar

ded

upw

ards

to th

e D

ASC

Orsquos

offic

e A

copy

is

left

at

the

heal

th f

acili

ty f

or t

heir

ow

n da

ta u

se

At

the

dist

rict

lev

el

the

DA

SCO

rsquos of

fice

aggr

egat

es d

ata

from

sev

eral

hea

lth f

acili

ty s

peci

fic F

orm

726

ont

o Fo

rm M

oH 7

27 (o

r Fo

rm 7

11) t

hat

is u

sed

to s

umm

aris

e an

d re

port

dis

tric

t le

vel d

ata

B

oth

Form

726

and

For

m M

oH 7

27 a

re th

en s

ent t

o N

ASC

OP

A c

opy

of th

e Fo

rm 7

27

or F

orm

711

is s

ent t

o th

e PA

SCO

and

ano

ther

to th

e he

alth

faci

litie

s in

the

dist

rict

for

thei

r ow

n da

ta u

se

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

14

RIS

K F

AC

TOR

SFO

R M

TCT

OF

HIV

M

any

fact

ors

are

know

n or

sus

pect

ed t

o in

crea

se t

he r

isk

of a

n H

IV in

fect

ed m

othe

r tr

ansm

ittin

g th

e vi

rus

to h

er i

nfan

t Th

ese

fact

ors

incl

ude

the

HIV

vir

al l

oad

in t

he

mot

her

as

wel

l as

othe

r m

ater

nal

obst

etri

cal

vira

l and

infa

nt fa

ctor

s (T

able

14

)

The

mos

t sig

nific

ant r

isk

fact

or a

ppea

rs to

be

the

HIV

vir

al lo

ad in

the

mot

her

thou

gh

the

othe

r fa

ctor

s m

ay a

lso

cont

ribu

te t

o in

crea

sing

an

infa

ntrsquos

expo

sure

or

susc

eptib

ilshyity

to

acqu

irin

g H

IV S

ome

fact

ors

may

cau

se a

bre

akdo

wn

in t

he p

rote

ctio

n of

fere

d to

the

foet

us b

y th

e pl

acen

ta w

hich

in n

orm

al c

ircu

mst

ance

s w

ould

not

allo

w H

IV to

cro

ssth

e pl

acen

ta fr

om m

othe

r to

foet

us

Tran

smis

sion

dur

ing

labo

ur a

nd d

eliv

ery

occu

rs w

hen

the

infa

nt s

ucks

im

bibe

s or

asshy

pira

tes

mat

erna

l bl

ood

or c

ervi

cal

secr

etio

ns t

hat

cont

ain

HIV

or

whe

n it

has

othe

r m

ucou

s m

embr

ane

expo

sure

Tab

le 1

4

Ris

k fa

ctor

s fo

r M

TCT

of H

IV

Stro

ng e

vide

nce

Lim

ited

evid

ence

VIR

AL

MA

TER

NA

L

OB

STE

TRIC

AL

FETA

LIN

FAN

T

BR

EA

ST-

FEE

DIN

G

Hig

h vi

ral l

oad

Imm

une

defic

ienc

y (lo

w

CD

4 co

unt)

HIV

infe

ctio

n ac

quire

d du

ring

preg

nanc

y o

r br

east

feed

ing

perio

d

Vagi

nal d

eliv

ery

(com

pare

d to

ele

ctiv

e ca

esar

ean

sect

ion)

ru

ptur

e of

the

mem

bran

es

for m

ore

than

4 h

ours

Prem

atur

ity

Dur

atio

n of

bre

astfe

edin

g

mix

ed fe

edin

g b

reas

t di

seas

e (m

astit

isc

rack

ed

nipp

les)

Vira

l res

ista

nce

(theo

retic

al p

ossi

bilit

y)

Vira

l gen

otyp

e an

d ph

enot

ype

Vita

min

A d

efic

ienc

y a

naem

ia s

exua

lly

trans

mitt

ed d

isea

ses

ch

orio

amni

oniti

s fr

eque

nt u

npro

tect

ed

sexu

al in

terc

ours

e m

ultip

le s

exua

l pa

rtner

s s

mok

ing

inje

ctin

g dr

ug a

buse

Inva

sive

or t

raum

atic

pro

cedu

res

in

stru

men

tal d

eliv

erie

s a

mni

ocen

tesi

s

epis

ioto

my

ext

erna

l cep

halic

ver

sion

(E

CV

) et

c i

ntra

partu

m h

aem

orrh

age

Lesi

ons

of s

kin

and

or m

ucou

s m

embr

anes

Ora

l thr

ush

(bab

y)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

3

24

15

BEN

EFIT

SO

F P R

EVEN

TIN

G M

OTH

ER-T

O-C

HIL

D

T

RA

NSM

ISSI

ON

OF

HIV

A

IDS

rela

ted

deat

hs a

re r

ever

sing

gai

ns m

ade

in c

hild

hea

lth a

nd s

urvi

val i

n K

enya

C

arin

g fo

r H

IV-in

fect

ed c

hild

ren

has

maj

or e

cono

mic

and

soc

ial

impa

cts

on f

amili

es

and

heal

th s

yste

ms

Thu

s at

the

nat

iona

l lev

el p

reve

ntin

g M

TCT

has

the

pote

ntia

l to

incr

ease

the

unde

rsta

ndin

g an

d ac

cept

ance

of t

he H

IVA

IDS

epid

emic

and

thos

e liv

ing

with

HIV

AID

S C

ouns

ellin

g t

estin

g an

d co

mm

unity

sen

sitis

atio

n ca

n co

ntri

bute

to

redu

cing

stig

ma

Red

uctio

n of

MTC

T of

HIV

bull

Dec

reas

es n

umbe

rs o

f H

IV in

fect

ed c

hild

ren

bull

Incr

ease

s ch

ild h

ealth

and

sur

viva

l

bull

Dec

reas

es t

he lo

ad o

n th

e he

alth

sys

tem

bull

Giv

es a

n op

port

unity

to im

prov

e an

d ex

pand

hea

lth s

ervi

ces

as w

ell a

s to

str

engt

hen

the

exis

ting

heal

th in

fras

truc

ture

16

BEN

EFIT

SO

F H

IV C

OU

NSE

LLIN

GA

ND T

ESTI

NG

(CT)

(a) I

t pro

mot

es b

ehav

iour

cha

nge

by

bull R

educ

ing

high

ris

k be

havi

our

for

HIV

bull Id

entif

ying

HIV

dis

cord

ant

coup

les

bull In

crea

sing

the

use

of

dual

met

hods

of f

amily

pla

nnin

g an

d S

TI

prev

entio

n

bull Im

prov

ing

ante

nata

l car

e

bull G

uidi

ng in

fant

fee

ding

(b) I

t ena

bles

pre

vent

ive

ther

apy

for

bull

Mal

aria

bull O

ppor

tuni

stic

infe

ctio

ns (

eg

Pne

umoc

ystis

jiro

veci

i pn

eum

onia

)

bull T

B

25

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

82

Foo

tnot

es

9

Use

oth

er o

ptions

for

child

ren o

ver

9 k

ilogra

ms

10

Use

reg

ula

r or

double

-str

ength

tab

lets

for

child

ren o

ver

16 k

ilogra

ms

NO

T A

PP

LIC

AB

LE

bullPsp

sm

ear

The

fram

ewor

k be

low

illu

stra

tes

poin

ts o

f int

egra

tion

of c

ompr

ehen

sive

HIV

ca

re p

acka

ge in

to e

xist

ing

child

hea

lth s

ervi

ces

Fram

ewor

k for

integ

ratio

n F

rom

Ped

iatr

ic H

IV P

reve

nti

on

to C

are

A

Co

nce

ptu

al F

ram

ewo

rk N

ewb

orn

In

fan

t W

om

an

H

IV e

duca

tion

Pre

gn

an

cy

prev

entio

n C

T

bull F

ocus

ed A

NC

incl

udin

g

AR

V p

roph

ylax

is s

tagi

ng

STI

syph

ilis

CT

Z p

roph

ylax

isA

RT

M

alar

ia tr

eatm

ent amp

pre

vent

ion

CD

4 w

here

ava

ilabl

e in

clud

ing

IPT

amp I

TNs

Infa

nt f

eedi

ng c

ouns

elin

g (I

FC)

Lab

ou

r an

d D

eliv

ery

U

nive

rsal

pre

caut

ions

CT

for

unt

este

d m

othe

rs in

clud

ing

bull D

eliv

ery

care

bull E

OC

-Em

erge

ncy

obst

etri

c ca

re

part

ner

bull R

efer

ral s

yste

m

AR

V p

roph

ylax

is

(mot

her

and

infa

nt)

AR

T C

TZ

pro

phyl

axis

Exc

lusi

ve b

reas

t fe

edin

g or

rep

lace

men

t fe

edin

g

Post

Na

tal

Ca

re

Infa

nt fe

edin

g co

unse

ling

bull B

reas

t hea

lth

Dia

gnos

is (

antib

ody)

if

bull Se

xual

hea

lth

expo

sure

unk

now

n bull

Fam

ily

plan

ning

D

NA

PC

R if

exp

osed

CT

Z p

roph

ylax

is I

FC-

infa

nt f

eedi

ng c

ouns

elin

g

CT

for

unt

este

d m

othe

rs

CT

for

par

tner

D

BS

resu

lt I

FC

IFC

Wea

ning

Bf

eedi

ng

cess

atio

n s

uppo

rt

bullBre

ast e

xam

D

iagn

osis

(an

tibod

y

bullPap

sm

ear

test

) C

T f

or n

egat

ive

wom

en a

nd p

artn

ers

Dia

gnos

is (

antib

ody

test

)

New

born

Ca

re

bull B

CG

bull P

olio

0

bull Is

sue

child

hea

th c

ard

bullEnt

er b

irth

wei

ght

HIV

an

d A

RV

Exp

osur

e st

atus

on

chi

ld h

ealth

car

d Tw

o w

eeks

Infa

nt fe

edin

g co

unse

ling

Six

wee

ks

Imm

uniz

atio

ngr

owth

mon

itori

ng

Ten

wee

ks

im

mun

izat

ion

GM

Fou

rtee

n w

eeks

Im

mun

izat

ion

grow

th m

onito

ring

Si

x m

onth

s

Com

plem

enta

ry fe

eds

Vita

min

A S

uppl

emen

tatio

n

9 m

onth

s

imm

uniz

atio

nG

M

12 amp

18

mon

ths

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

17

(c) I

t pro

mot

es a

cces

s to

ear

ly m

edic

al c

are

bull

Obs

tetr

ical

car

e

bull T

B th

erap

y

bull M

alar

ia t

reat

men

t

bull S

TI t

reat

men

t

bull A

RV

the

rapy

for

mot

her

and

fam

ily

(d) I

t hel

ps to

pla

n fo

r the

futu

re

bull In

fant

fee

ding

sup

port

sys

tem

s

bull F

amily

pla

nnin

g

bull P

erso

nal a

nd f

inan

cial

dec

isio

ns

(e) I

t ena

bles

pre

vent

ive

ther

apy

of m

alar

ia a

nd

othe

r opp

ortu

nist

ic in

fect

ions

suc

h a

PCP

(f) It

giv

es ti

me

to p

lan

for t

he fu

ture

eg

inf

ant

feed

ing

supp

ort s

yste

ms

TH

E F O

UR-P

RO

NG

ED A

PPR

OA

CH

TO P

MTC

T Th

e In

ter

Age

ncy

Task

Tea

m o

n Pr

even

tion

of H

IV T

rans

mis

sion

in p

regn

ant

wom

en

mot

hers

and

the

ir c

hild

ren

(IA

TT)

has

prop

osed

a f

our-

pron

ged

appr

oach

for

the

pre

shyve

ntio

n of

HIV

tra

nsm

issi

on t

hat

targ

ets

non-

preg

nant

and

pre

gnan

t w

omen

mot

hers

and

thei

r ch

ildre

n

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

1

26

The

four

pro

ngs

are

1 P

rimar

y pr

even

tion

of H

IV in

fect

ion

in w

omen

2 P

reve

ntio

n of

uni

nten

ded

preg

nanc

y am

ong

HIV

-inf

ecte

d w

omen

3 I

nter

vent

ions

to

redu

ce t

rans

mis

sion

fro

m H

IV-i

nfec

ted

preg

nant

and

la

ctat

ing

wom

en t

o th

eir

child

ren

4 C

are

and

supp

ort

of w

omen

ch

ildre

n an

d fa

mili

es in

fect

ed a

nd

affe

cted

by

HIV

and

AID

S (

The

PM

TC

T-p

lus)

Ove

rall

the

cov

erag

e of

PM

TCT

prog

ram

mes

and

the

upt

ake

of s

ervi

ces

prov

ided

thro

ugh

thes

e pr

ogra

mm

es

incl

udin

g H

IV

test

ing

and

coun

selli

ng

and

AR

V

prop

hyla

xis

are

still

ver

y lo

w I

n 20

06 w

orld

wid

e le

ss t

han

10

of

preg

nant

wom

ente

stin

g H

IV-p

ositi

ve r

ecei

ved

AR

V d

rugs

for

PMTC

T11

In K

enya

acc

ordi

ng to

the

2007

Ken

ya A

IDS

Indi

cato

r Su

rvey

(KA

IS) 7

the

re h

as b

een

a sm

all i

ncre

ase

in H

IV te

stin

g am

ong

wom

en a

nd m

en c

ompa

red

to th

e 20

03 K

DH

S

KA

IS s

how

s th

at t

houg

h a

vast

maj

ority

(83

)

of H

IV-in

fect

ed w

omen

and

men

in

Ken

ya d

o no

t kn

ow t

heir

HIV

sta

tus

the

re h

as b

een

a cl

ear

and

dram

atic

incr

ease

inco

vera

ge o

f HIV

-tes

ting

amon

g A

NC

clin

ic a

tten

dees

PMTC

T se

rvic

es a

re t

here

fore

im

port

ant

entr

y po

ints

for

HIV

pre

vent

ion

and

trea

tshym

ent

Ove

rall

AR

V c

over

age

for

HIV

infe

cted

peo

ple

who

nee

d tr

eatm

ent

in K

enya

ison

ly 3

5

bull 9

0

of K

enya

n w

omen

who

del

iver

ed in

the

last

4 y

ears

att

end

AN

C

bull 5

7 o

f th

ose

atte

ndin

g A

NC

tes

ted

for

HIV

bull A

mon

g H

IV in

fect

ed w

omen

with

rec

ent

birt

hs

47

wer

e te

sted

in

AN

C

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

(8)

HIV

dis

ease

sta

ging

in H

IV-in

fect

ed c

hild

ren

Dis

ease

sta

ging

with

or

with

out

labo

rato

ry s

uppo

rt f

ollo

ws

HIV

dia

gshyno

sis

Sta

ging

HIV

dis

ease

pro

vide

s a

guid

e to

the

prog

nosi

s an

d in

tershy

vent

ions

nee

ded

at th

e di

ffere

nt s

tage

s (R

efer

to C

hapt

er 5

and

8)

(9)

AR

V th

erap

y

Chi

ldre

n w

ho a

re e

ligib

le fo

r A

RT

shou

ld b

e lin

ked

with

the

AR

T pr

oshygr

am a

nd p

rovi

ded

with

trea

tmen

t acc

ordi

ng to

Nat

iona

l Gui

delin

es a

sso

on a

s an

HIV

dia

gnos

is i

s m

ade

Ear

ly t

reat

men

t si

gnifi

cant

ly r

eshydu

ces

mor

talit

y in

HIV

infe

cted

chi

ldre

n

(10)

C

omm

unic

atio

n

Com

mun

icat

ing

with

car

e-pr

ovid

ers

and

prov

idin

g ps

ycho

soci

al s

upshy

port

for

the

child

mot

her

care

give

r an

d fa

mily

are

a c

ruci

al c

ompo

nent

of

car

e

Pare

nts

care

give

rs a

ndo

r th

e ch

ild n

eed

to p

artic

ipat

e in

mak

ing

deci

shysi

ons

and

plan

ning

app

ropr

iate

car

e fo

r th

e ch

ild i

nclu

ding

dec

isio

nsab

out t

hera

py a

nd w

here

the

child

sho

uld

rece

ive

care

In

this

res

pect

he

alth

wor

kers

mus

t en

sure

tha

t th

e fa

mily

con

side

rs t

he s

ocia

l nee

ds

of H

IV in

fect

ed a

nd a

ffect

ed c

hild

ren

Hea

lth c

are

wor

kers

sho

uld

ensu

re th

at th

ey p

rovi

de a

dequ

ate

time

for

care

give

rs to

ask

que

stio

ns s

o th

at th

ey c

an fu

lly u

nder

stan

d th

e im

plishy

catio

ns o

f HIV

and

HIV

tes

ting

for

them

selv

es a

nd fo

r th

eir

child

ren

H

ealth

car

e w

orke

rs s

houl

d co

unse

l car

egiv

ers

on d

iscl

osur

e in

clud

ing

disc

losu

re to

the

child

(11)

R

efer

rals

Ref

erra

ls a

re a

n im

port

ant p

art o

f man

agin

g an

HIV

exp

osed

or

infe

cted

chi

ld

Thes

e in

clud

e re

ferr

als

to

bull H

ighe

r le

vels

of s

peci

alis

ed c

are

for

furt

her

inve

stig

atio

ns a

nd

trea

tmen

t

bull S

ocia

l sup

port

pro

gram

mes

bull C

omm

unity

-bas

ed c

are

prog

ram

mes

bull P

ITC

site

s fo

r pa

rent

s an

d si

blin

gs

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

2

7

80

Tabl

e 9

2 W

HO

Rec

omm

enda

tions

for

Follo

w-u

p of

an

HIV

-Exp

osed

Chi

ld

bull A

t birt

h (f

or in

fant

s de

liver

ed a

t ho

me)

bull A

t age

1 t

o 2

wee

ks (

mai

nly

for

infa

nt f

eedi

ng c

ouns

elin

g)

bull A

t ag

e 6

10

and

14

wee

ks (

for

imm

uniz

atio

n an

d in

fant

fee

ding

co

unse

ling)

bull A

fter

age

14

wee

ks

mon

thly

thr

ough

age

12

mon

ths

bull A

fter

age

12 m

onth

s e

very

3 m

onth

s th

roug

h 24

mon

ths

bull A

t 18

mon

ths

do

conf

irm

ator

y H

IV la

bora

tory

test

(if

ther

e ar

e no

re

sour

ces

for

an e

arlie

r an

tigen

-bas

ed t

est)

bull A

fter

2 ye

ars

a m

inim

um o

f ye

arly

vis

its

For t

he H

IV-in

fect

ed f

ollo

w th

ese

guid

elin

es

From

M

onito

r

6 w

eeks

ndash12

mon

ths

Mon

thly

12 ndash

24 m

onth

s Ev

ery

3 m

onth

s

24 m

onth

s an

d on

war

ds

Yea

rly i

f not

sym

ptom

atic

If sy

mpt

omat

ic f

ollo

w u

p as

nee

ded

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

18

OV

ERV

IEW

OF

THE

NEW

PM

TCT

GU

IDEL

INES

Ken

yarsquos

Min

istr

y of

Hea

lth (

MO

H)

thro

ugh

NA

SCO

P h

as t

aken

sev

eral

act

ions

to

expa

nd a

nd s

tren

gthe

n PM

TCT

inte

rven

tions

in

the

coun

try

In

2000

a

Nat

iona

lTe

chni

cal

Wor

king

Gro

up (

TWG

) on

PM

TCT

was

for

med

Th

e TW

G

co-c

hair

ed b

yN

ASC

OP

and

the

Div

isio

n of

Rep

rodu

ctiv

e H

ealth

co

ordi

nate

s im

plem

enta

tion

and

prov

ides

tec

hnic

al s

uppo

rt t

o th

e N

atio

nal

PMTC

T Pr

ogra

m

The

TWG

ser

ves

as a

foru

m t

o up

date

sta

keho

lder

s an

d di

scus

s ch

alle

nges

and

upc

omin

g ac

tiviti

es

The

TWG

is

also

res

pons

ible

for

upd

atin

g na

tiona

l gu

idel

ines

for

PM

TCT

The

nat

iona

l PM

TCT

prog

ram

was

offi

cial

ly l

aunc

hed

in 2

002

NA

SCO

P al

so e

stab

lishe

d se

vera

lpi

lot P

MTC

T si

tes

thro

ugho

ut th

e co

untr

y an

d pr

epar

ed n

atio

nal P

MTC

T gu

idel

ines

The

goal

of t

he n

atio

nal P

MTC

T pr

ogra

m is

in li

ne w

ith th

e go

al s

et o

ut a

t the

Uni

ted

Nat

ions

Gen

eral

Ass

embl

y Sp

ecia

l Ses

sion

on

HIV

AID

S (U

NG

ASS

) in

2001

to

redu

ceth

e pr

opor

tion

of in

fant

s in

fect

ed w

ith H

IV b

y 20

b

y th

e ye

ar 2

005

and

50

by

2010

In

Ken

ya t

he n

atio

nal P

MTC

T pr

ogra

m p

lann

ed t

o ex

tend

its

serv

ices

to

at le

ast

80

of

all

heal

th f

acili

ties

by 2

0071

2 A

ccor

ding

to

the

2003

PM

TCT

serv

ice

stat

istic

sap

prox

imat

ely

9 o

f al

l pr

egna

nt w

omen

rec

eive

d PM

TCT

serv

ices

in

that

yea

rC

urre

ntly

mor

e th

an 5

0 o

f al

l pr

egna

nt w

omen

in

Ken

ya r

ecei

ve P

MTC

T se

rvic

es

Thes

e gu

idel

ines

are

bas

ed o

n a

publ

ic h

ealth

app

roac

h to

car

e t

akin

g in

to c

onsi

dera

shytio

n is

sues

of

feas

ibili

ty a

nd a

ccep

tabi

lity

in

addi

tion

to e

ffica

cy a

nd c

ost-

bene

fit i

ndi

ffere

nt s

ettin

gs

The

guid

elin

es a

re e

xpec

ted

to i

mpr

ove

the

upta

ke

qual

ity a

nd

effe

ctiv

enes

s of

PM

TCT

serv

ices

in th

e co

untr

y

19

OB

JEC

TIV

ESA

ND O

RG

AN

ISA

TIO

NO

FTH

E G

UID

ELIN

ES

The

PMTC

T gu

idel

ines

are

par

t of

the

impl

emen

tatio

n in

stru

men

ts t

owar

ds u

nive

rsal

ac

cess

to

PMTC

T se

rvic

es a

nd a

res

pons

e to

the

cal

l to

actio

n to

war

ds H

IV-fr

ee a

ndA

IDS-

free

gen

erat

ion

Tog

ethe

r w

ith tw

o ot

her

guid

elin

es (A

RV

Ther

apy

in A

dults

and

Ad

oles

cent

s an

d AR

V Th

erap

y in

Inf

ants

and

You

ng C

hild

ren)

th

ey f

orm

a t

rilo

gy

aim

ed a

t co

ntex

tual

isin

g an

d m

ains

trea

min

g th

e W

HO

tri

logy

of

guid

elin

es o

n H

IVA

IDS

prev

entio

n an

d tr

eatm

ent

The

cont

ext

reso

urce

s an

d de

man

ds o

f PM

TCT

prog

ram

mes

diff

er g

reat

ly a

cros

s co

unshy

trie

s an

d ev

en a

cros

s pr

ogra

mm

es w

ithin

the

sam

e co

untr

y C

onsi

deri

ng t

his

vari

abilshy

ity t

hese

gui

delin

es in

clud

e th

e cu

rren

t con

sens

us o

n be

st p

ract

ices

as

wel

l as

alte

rnashy

tives

whi

ch m

ight

be

mor

e ap

prop

riat

e in

par

ticul

ar s

ettin

gs E

xper

ts a

gree

tha

t th

e ldquos

tate

of

the

artrdquo

in

PMTC

T is

cha

ngin

g ra

pidl

y an

d th

at r

ecom

men

datio

ns w

ill c

ershy

tain

ly a

lter

with

adv

ance

s in

med

ical

sci

ence

and

as

mor

e pr

ogra

mm

e ex

peri

ence

is

docu

men

ted

and

diss

emin

ated

The

are

as o

f A

RV

pro

phyl

axis

and

inf

ant

feed

ing

are

part

icul

arly

sub

ject

to r

apid

cha

nge

In 2

005

the

WH

O is

sued

pro

pose

d re

visi

ons

to it

s re

com

men

datio

ns o

n th

e us

e of

ant

ishyre

trov

iral

dru

gs f

or P

MTC

T T

he r

ecom

men

datio

ns w

ere

the

prod

uct

of e

xper

ts w

ho

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

9

28

conv

ened

to

disc

uss

impo

rtan

t ne

w i

nfor

mat

ion

conc

erni

ng t

he d

evel

opm

ent

of r

esis

shyta

nce

in w

omen

and

chi

ldre

n us

ing

sing

le d

ose

nevi

rapi

ne (S

dNV

P) fo

r PM

TCT

as w

ell

as n

ew c

linic

al fi

ndin

gs o

n st

rate

gies

that

mig

ht r

educ

e th

e de

velo

pmen

t of r

esis

tanc

e

Bas

ed o

n th

e ne

w W

HO

gui

delin

es K

enya

rsquos TW

G h

as d

evel

oped

sim

ple

pra

ctic

al a

nd

evid

ence

-bas

ed r

ecom

men

datio

ns o

n PM

TCT

that

wou

ld w

ork

in a

var

iety

of r

esou

rce-

limite

d en

viro

nmen

ts a

nd c

linic

al s

ituat

ions

that

con

fron

t hea

lthca

re w

orke

rs n

ot o

nly

in K

enya

but

als

o in

oth

er d

evel

opin

g co

untr

ies

110

U

SIN

GTH

E G

UID

ELIN

ES

Thes

e gu

idel

ines

are

inte

nded

prim

arily

for u

se b

y PM

TCT

prov

ider

s Th

ese

inclu

de n

urse

sm

idw

ives

clin

ical o

ffice

rs d

octo

rs c

ouns

ello

rs n

utrit

ioni

sts

and

othe

r he

alth

care

pro

fesshy

sion

als

They

will

als

o be

use

ful a

s a re

fere

nce

for p

rogr

amm

e m

anag

ers a

t fac

ility

dis

trict

pr

ovin

cial

and

nat

iona

l lev

els

thro

ugho

ut th

e he

alth

sec

tor

The

guid

elin

es a

re d

ivid

ed in

tote

n ch

apte

rs a

s out

lined

in T

able

15

The

spec

ific

obje

ctiv

es o

f the

new

PM

TCT

guid

elin

es a

re to

bull O

utlin

e th

e po

licy

issu

es in

pro

vidi

ng P

MT

CT

serv

ices

bull R

ecom

men

d op

erat

iona

l gui

delin

es to

be

follo

wed

by

heal

th c

are

prov

ider

s of

PM

TC

T se

rvic

es

bull E

nabl

e pr

ovid

ers

of P

MT

CT

to s

elec

t an

d pr

escr

ibe

AR

Vs

for

prop

hyla

xis

agai

nst

MT

CT

and

for

trea

tmen

t of

pre

gnan

t w

omen

in

fant

s an

d yo

ung

child

ren

bull S

tand

ardi

se t

he c

are

and

coun

selli

ng g

iven

by

PM

TC

T s

ervi

ce

prov

ider

s re

gard

ing

risk

of

MT

CT

and

on

PM

TC

T

bull I

mpr

ove

PM

TC

T se

rvic

es u

sing

eas

y-to

-use

job

aids

and

a

stan

dard

ised

Mamp

E s

yste

m

Prev

entin

g TB

Fo

r chi

ldre

n ex

pose

d to

sm

ear p

ositi

ve tu

berc

ulos

is

bull E

xclu

de a

ctiv

e T

B th

roug

h ca

refu

l his

tory

ph

ysic

al e

xam

and

in

vest

igat

ions

bull

If

ther

e is

no

evid

ence

of

activ

e T

B

star

t on

IN

H f

or p

roph

ylax

is f

or 6

m

onth

s (I

PT

) bull

If

TB

is p

rese

nt

star

t on

TB

tre

atm

ent

as p

er N

atio

nal T

B g

uide

lines

If

a ch

ild is

bor

n to

a m

othe

r with

act

ive

TB

bull S

tart

on

INH

pro

phyl

axis

(IP

T)

and

give

for

3 m

onth

s bull

Afte

r 3

mon

ths

do a

man

toux

bull

If

man

toux

is n

egat

ive

sto

p IN

H a

nd g

ive

BC

G

bull I

f man

toux

is p

ositi

ve a

t 3

mon

ths

con

tinue

for

a f

urth

er 3

mon

ths

bull A

t the

end

of

prop

hyla

xis

re-v

alua

te f

or a

ctiv

e T

B

|

If no

evi

denc

e of

act

ive

TB d

o no

t tre

at fo

r TB

|

If th

ere

is e

vide

nce

of a

ctiv

e TB

tre

at fo

r TB

as

per N

atio

nal

TB g

uide

lines

(6)

Trea

tmen

t of a

cute

infe

ctio

ns a

nd o

ther

HIV

-rel

ated

con

ditio

ns

HIV

-exp

osed

chi

ldre

n ar

e su

scep

tible

to c

omm

on in

fect

ions

as

wel

l as

OIs

for

the

HIV

infe

cted

and

HIV

may

alte

r th

e in

cide

nce

pre

senshy

tatio

n an

d re

spon

se t

o co

nven

tiona

l th

erap

y I

n so

me

case

s m

ore

aggr

essi

ve a

nd lo

nger

tre

atm

ent

cour

ses

may

be

nece

ssar

y a

s tr

eatshy

men

t fai

lure

s ar

e m

ore

freq

uent

(7)

Reg

ular

follo

w-u

p ca

re amp

refe

rral

s

Reg

ular

follo

w-u

p is

the

back

bone

to c

arin

g fo

r th

e H

IV e

xpos

ed c

hilshy

dren

and

ens

ures

opt

imal

hea

lthca

re a

nd p

sych

osoc

ial s

uppo

rt to

the

fam

ily W

HO

has

mad

e re

com

men

datio

ns o

n fr

eque

ncy

of fo

llow

-up

as s

how

n in

Tab

le 9

2 T

his

is t

he m

inim

um a

nd m

ore

freq

uent

con

shyta

ct w

ith t

he h

ealth

car

e sy

stem

may

be

indi

cate

d fo

r H

IV in

fect

ed

child

ren

and

espe

cial

ly if

they

are

on

anti-

retr

ovir

al tr

eatm

ent

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

2

9

78

Pro

phyl

axis

aga

inst

Pne

umoc

ysti

s ji

rove

cii

Pne

umon

ia (

PC

P)

in c

hild

ren

whe

re C

otri

mox

azol

e is

con

trai

ndic

ated

Ta

ble

15

The

Fou

r-Pr

onge

d A

ppro

ach

App

lied

to th

e PM

TCT

Gui

delin

e

Alte

rnat

ive

drug

s to

use

if C

TX is

con

train

dica

ted

are

give

n be

low

A s

econ

d ch

oice

wou

ld b

e ei

ther

dap

sone

or

atov

aqui

ne

Dap

sone

bull C

hild

ren

gt 1

mon

th

2 m

gkg

24

hour

s or

ally

onc

e da

ily

bull I

f bot

h C

TX

and

Dap

sone

are

con

trai

ndic

ated

(e

g

in c

hilshy

dren

with

G6P

D d

efic

ienc

y w

ho g

et h

aem

olys

is w

ith C

TX

and

D

apso

ne)

the

n us

e ei

ther

Ato

vaqu

one

bull

30m

gkg

day

for

age

1-3

mon

ths

bull H

ighe

r do

se 4

5mg

kgd

ay f

or a

ge 4

-24

mon

ths

OR

Aer

osol

ized

Pen

tam

idin

e

bull 3

00 m

g in

6 m

l wat

er v

ia in

hala

tion

nebu

lizer

onc

e m

onth

ly

bull c

hild

ren

gt 5

year

s

Cha

pter

CH

AP

TER

1

Bac

kgro

und

CH

AP

TER

2

Ant

enat

al C

are

and

Pre

vent

ion

of M

TCT

of H

IV

CH

AP

TER

3

Intra

partu

m C

are

Pron

g 1

Prim

ary

prev

entio

n of

HIV

in

fect

ion

in w

omen

Pron

g 2

Prev

entio

n of

un

inte

nded

pr

egna

ncy

amon

g H

IV in

fect

ed w

omen

Pron

g 3

Inte

rven

tions

to

redu

ce

tran

smis

sion

from

H

IV in

fect

ed

preg

nant

and

la

ctat

ing

wom

en to

th

eir c

hild

ren

Pron

g 4

Car

e an

d su

ppor

t of

wom

en c

hild

ren

and

fam

ilies

in

fect

ed a

nd

affe

cted

by

HIV

A

IDS

C

HA

PTE

R 4

U

se o

f Ant

iretro

vira

l D

rugs

in P

regn

ancy

fo

r Tre

atm

ent a

nd

Pre

vent

ion

of M

othe

r to

Chi

ld

Tran

smis

sion

of H

IV

Infe

ctio

n

CH

AP

TER

5

Imm

edia

te P

ostn

atal

an

d N

eona

tal C

are

CH

AP

TER

6

Late

Pos

tnat

al C

are

and

Fam

ily P

lann

ing

CH

AP

TER

7

HIV

Dia

gnos

is in

C

hild

ren

CH

AP

TER

8

Feed

ing

Infa

nts

and

Youn

g C

hild

ren

born

to

HIV

infe

cted

m

othe

rs

CH

AP

TER

9

Car

e an

d Fo

llow

-up

of C

hild

ren

of H

IV

infe

cted

mot

hers

C

HA

PTE

R 1

0

Mon

itorin

g an

d E

valu

atio

n of

PM

TCT

se

rvic

es

77

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

30

For

each

of t

hese

cha

pter

s (e

xcep

t ch

apte

r on

e on

bac

kgro

und)

the

gui

delin

es g

ive

anin

trod

uctio

n fo

llow

ed b

y po

licy

stat

emen

ts t

hen

oper

atio

nal g

uide

lines

of w

hat p

rovi

dshyer

s sh

ould

do

to r

educ

e m

othe

r-to

-chi

ld t

rans

mis

sion

of

HIV

and

or

to i

mpr

ove

thei

r pe

rfor

man

ce a

nd th

e ef

fect

iven

ess

of th

eir s

ervi

ces

A li

st o

f job

aid

s fo

r us

e by

the

hea

lthca

re p

rovi

der

follo

ws

the

oper

atio

nal g

uide

lines

and

whe

re n

eces

sary

a li

st o

f ap

pend

ices

and

add

ition

al d

ocum

ents

tha

t m

ay b

e re

shyfe

rred

to

but

are

cons

ider

ed t

oo b

ig o

r de

taile

d to

be

incl

uded

with

in t

he m

ain

body

of

the

guid

elin

es

Foo

tnot

es

1

UN

AID

S (

2004)

Rep

ort

on t

he

Glo

bal AID

S E

pid

emic

Ava

ilable

at

ww

wu

nai

ds

org

2

Ibid

2004

3

It

is

import

ant

to r

ecognis

e th

at t

he

use

of

the

phra

se M

TC

T in n

o w

ay is

inte

nded

to

pla

ce b

lam

e on t

he

moth

er

who m

ay o

r m

ay n

ot

know

her

HIV

sta

tus

who t

ransm

its

the

viru

s to

her

child

Pa

thfinder

ack

now

ledges

that

man

y tim

es p

regnant

wom

en

may

hav

e bee

n infe

cted

by

thei

r m

ale

par

tner

and d

o n

ot

hav

e th

e ab

ility

to n

egoti-

ate

safe

r se

x o

r to

see

k M

TC

T s

ervi

ces

for

fear

of

viole

nce

st

igm

a o

r ab

andonm

ent

if t

hei

r st

atu

s is

rev

eale

d

Path

finder

uphold

s th

e re

pro

duct

ive

rights

of

all w

om

en t

o

choose

if

and w

hen

to h

ave

child

ren

regar

dle

ss o

f H

IV-s

tatu

s

4

W

HO

CD

C

Dep

artm

ent

of

Hea

lth a

nd H

um

an S

ervi

ces

(2004)

Pre

vention o

f M

oth

er-t

o-C

hild

Tra

nsm

issi

on o

f H

IV

Gen

eric

Tra

inin

g P

acka

ge

Gen

eva

Sw

itze

r-la

nd

WH

O

5

U

NAID

S (

2004)

Rep

ort

on t

he

Glo

bal AID

S E

pid

emic

Ava

ilable

at

ww

wu

nai

ds

org

6

Polic

y Pro

ject

(2004)

Cove

rage

of

sele

cted

ser

vice

s fo

r H

IVA

IDS p

reve

ntion a

nd

care

in low

and m

iddle

-inco

me

countr

ies

in 2

003

Ava

ilable

at

ww

wp

olia

pro

ject

com

7

Cen

tral Bure

au o

f Sta

tist

ics

(CBS)

[Ken

ya]

Min

istr

y of

Hea

lth (

MO

H)

[Ken

ya]

and

ORC M

acro

(2004)

Ken

ya D

emogra

phic

and H

ealth S

urv

ey 2

003

Cal

vert

on

Mar

y-la

nd

CBSM

OH

an

d O

RC M

acr

o

8

Nat

ional AID

S C

ontr

ol Counci

l 2

007

8a

Ken

ya A

IDS I

ndic

ato

r Surv

ey 2

007

9

Ibid

2004

10

NASCO

P (

2002)

Surv

eilla

nce

data

as

cite

d in N

ASCO

PM

OH

(2

003)

Nat

ional

PM

CT

Str

ate

gic

Managem

ent

Pla

n 2

003-2

007

111

2 A

IDS in K

enya

Tre

nds

Inte

rven

tions

and I

mpact

7th

editio

n

(2005)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Who

Nee

ds P

CP

Prop

hyla

xis

bull A

ll in

fant

s bo

rn t

o H

IV-i

nfec

ted

mot

hers

irr

espe

ctiv

e of

any

ant

iret

rovi

ral

ther

apy

duri

ng p

regn

ancy

and

labo

ur

Pro

phyl

axis

con

tinue

s un

til th

e in

fant

is 1

2 m

onth

s or

is P

CR

neg

ativ

e or

ant

ibod

y ne

gativ

e w

hich

ever

co

mes

ear

lier

bull A

ll in

fant

s id

entif

ied

as H

IV-i

nfec

ted

duri

ng th

e fir

st y

ear

of li

fe b

y a

PC

R

test

or

by a

clin

ical

dia

gnos

is o

f H

IV in

fect

ion

and

a po

sitiv

e an

tibod

y te

st

bull C

hild

ren

olde

r th

an 1

2 m

onth

s w

ith s

ympt

omat

ic H

IV d

isea

se o

r an

A

IDS

-def

inin

g ill

ness

(W

HO

sta

ge I

I an

d III

se

e ch

apte

r 5)

or

with

CD

4 lt

15

or

TLC

150

0m

m3

bull A

ny c

hild

with

a h

isto

ry o

f P

CP

sho

uld

cont

inue

with

sec

onda

ry

prop

hyla

xis

(dai

ly C

T)

for

life

Clin

icia

ns s

houl

d cl

earl

y in

form

HIV

inf

ecte

d m

othe

rs a

t de

liver

y th

at t

heir

chi

ldre

n ne

ed p

roph

ylax

is a

gain

st P

CP

star

ting

at 6

wee

ks o

f age

unt

il it

is e

stab

lishe

d th

at th

e ch

ild i

s no

t H

IV i

nfec

ted

A p

ract

ical

way

to

ensu

re t

hat

mot

hers

and

oth

er h

ealth

wor

kers

are

inf

orm

ed i

s to

mak

e a

note

on

the

child

rsquos im

mun

izat

ion

card

at

birt

h st

atin

g ldquoP

leas

e gi

ve c

o-tr

imox

azol

e (5

mg

kgd

ay o

rally

dai

ly) f

rom

6 w

eeks

of a

gerdquo

Tabl

e 9

1 D

ose

of C

otrim

oxaz

ole

for P

CP

Prop

hyla

xis

Wei

ght o

f C

hild

(kg)

1ndash4

5ndash8

9ndash16

17ndash5

0

gt 50

CT

tabl

ets

20 m

g TM

P1

00

mg

SM

X p

edia

tric

stre

ngth

(120

mg)

1 ta

b

2 ta

bs

Cot

rimox

azol

e su

spen

sion

40

mg

TMP

200

mg

SM

X

5ml (

240

mg)

25

ml

5 m

l

10 m

l

CT

tabl

ets

80 m

g TM

P4

00 m

g S

MX

re

gula

r stre

ngth

(4

80 m

g)

frac14 ta

b

frac12 ta

b

1 ta

b

2 ta

bs

2 ta

bs

CT

Tabl

ets

160

mg

TMP

800

mg

SM

X

Dou

ble

stre

ngth

(9

60 m

g) -

frac14 ta

b

frac12 ta

b

1 ta

b

1 ta

b

In r

are

case

s a

s in

chi

ldre

n w

ith G

6PD

def

icie

ncy

CTX

may

be

cont

rain

dica

ted

G

uid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

3

1

76

(3)

Mon

itor

the

child

rsquos g

row

th a

nd d

evel

opm

ent

as a

mea

ns o

f id

entif

ying

the

ch

ild w

ho is

faili

ng to

thriv

e an

d al

so a

s a

tool

for m

onito

ring

the

effe

ct o

f int

ershy

vent

ions

(4)

Ens

ure

that

im

mun

isat

ions

are

sta

rted

and

com

plet

ed

acco

rdin

g to

the

re

com

men

datio

ns o

f the

nat

iona

l im

mun

isat

ion

sche

dule

|

Add

ition

al c

onsi

dera

tions

are

as

follo

ws

bull

Whe

n co

nsid

erin

g BC

G v

acci

natio

n at

a la

ter a

ge

(re-

vacc

inat

ion

for n

o sc

ar o

r mis

sed

earli

er v

acci

natio

n)

excl

ude

sym

ptom

atic

HIV

infe

ctio

n

bull

Do

not g

ive

yello

w fe

ver v

acci

ne to

sym

ptom

atic

HIV

-infe

cted

chi

lshydr

en H

owev

er a

sym

ptom

atic

chi

ldre

n in

end

emic

are

as s

houl

d re

shyce

ive

the

yello

w fe

ver v

acci

ne a

t 9 m

onth

s of

age

bull

Mea

sles

vac

cine

sho

uld

be g

iven

to H

IV in

fect

ed c

hild

ren

at 6

and

9

mon

ths

sinc

e H

IV in

fect

ed c

hild

ren

expe

rienc

e m

uch

mor

e se

vere

di

seas

e w

ith w

ild m

easl

es v

irus

whi

ch o

utw

eigh

s th

e ris

k of

a m

ilder

illn

ess

from

the

vacc

ine

(5)

Pro

vide

pro

phyl

axis

for o

ppor

tuni

stic

infe

ctio

ns

|

Pro

phyl

axis

aga

inst

Pne

umoc

ystis

jiro

veci

i Pne

umon

ia

bull

Pne

umoc

ystis

jiro

veci

i (fo

rmer

ly P

neum

ocys

tis c

arin

ii) p

neum

onia

(PC

P)

is a

sig

nific

ant c

ause

of m

orbi

dity

and

mor

talit

y am

ong

youn

g in

fant

s in

A

frica

Co-

trim

oxaz

ole

(CTX

) pro

phyl

axis

sig

nific

antly

redu

ces

the

inci

shyde

nce

and

seve

rity

of P

CP

Add

ition

al b

enef

its o

f co-

trim

oxaz

ole

incl

ude

prot

ectio

n ag

ains

t com

mon

bac

teria

l inf

ectio

ns t

oxop

lasm

osis

and

mashy

laria

All

child

ren

born

to H

IV in

fect

ed m

othe

rs s

houl

d re

ceiv

e pr

ophy

shyla

xis

agai

nst P

CP

at l

east

dur

ing

the

first

yea

r of l

ife o

r unt

il th

ey a

re

prov

en to

be

unin

fect

ed (s

ee b

ox b

elow

)

bull

CTX

is c

lear

ly th

e dr

ug o

f cho

ice

for p

roph

ylax

is b

ecau

se o

f its

hig

h

effic

acy

rela

tive

safe

ty l

ow c

ost a

nd b

road

ant

imic

robi

al s

pect

rum

In

cas

e of

CTX

hyp

erse

nsiti

vity

des

ensi

tizat

ion

is re

com

men

ded

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

CH

AP

TE

R 2

Ant

enat

al C

are

and

Prev

entio

n of

MTC

T of

HIV

21

INTR

OD

UC

TIO

N

HIV

inf

ectio

n ha

s em

erge

d in

Ken

ya a

s th

e m

ost

impo

rtan

t he

alth

ris

k fa

ctor

for

m

othe

rs a

nd t

heir

chi

ldre

n an

d ha

s a

grea

t im

pact

on

the

long

ter

m o

utco

me

ofpr

egna

ncy

and

child

sur

viva

l A

ll pr

egna

nt w

omen

sho

uld

be e

ncou

rage

d to

lear

n th

eir

HIV

infe

ctio

n st

atus

as

wel

l as

that

of t

heir

sex

ual p

artn

ers

O

nly

by k

now

ing

onersquos

H

IV s

tatu

s ca

n th

e he

alth

wor

kers

mak

e ap

prop

riat

e he

alth

car

e m

anag

emen

t re

com

men

datio

ns a

nd t

he c

oupl

e m

ake

appr

opri

ate

deci

sion

s ab

out

mai

ntai

ning

the

ir

heal

th a

nd t

hat

of t

heir

unb

orn

baby

Pr

e-co

ncep

tion

care

is

enco

urag

ed w

here

an

oppo

rtun

ity a

rise

s an

d a

birt

h pl

an is

dis

cuss

ed w

ith th

e pr

egna

nt w

oman

In m

ost

case

s t

he p

regn

ant

wom

an w

ill n

ot h

ave

HIV

infe

ctio

n P

regn

ancy

offe

rs a

n op

port

une

time

to d

iscu

ss p

reve

ntio

n of

HIV

inf

ectio

n as

man

y w

omen

com

e in

toco

ntac

t w

ith h

ealth

ser

vice

s fo

r th

e fir

st (

and

in s

ome

case

s th

e on

ly)

time

duri

ng

preg

nanc

y

In K

enya

50

o

f m

arri

ed H

IV p

ositi

ve p

erso

ns h

ave

an H

IV n

egat

ive

spou

se1

Ther

efor

e k

now

ing

the

HIV

inf

ectio

n st

atus

of

onersquos

par

tner

is

criti

cal

Add

ition

ally

th

is f

orm

s an

im

port

ant

entr

y po

int

for

esta

blis

hing

pre

vent

ion

with

po

sitiv

e (P

WP)

pro

gram

s am

ong

coup

les

as w

ell a

s pr

ovid

ing

acce

ss to

HIV

pre

vent

ion

ca

re a

nd tr

eatm

ent s

ervi

ces

for

the

who

le fa

mily

PMTC

T pr

ovid

es a

n op

port

unity

for

prev

entin

g ne

w p

aedi

atri

c H

IV in

fect

ions

as

wel

l as

for

reac

hing

the

10 to

20

of H

IV p

ositi

ve p

regn

ant w

omen

who

mee

t WH

O e

ligib

ilshyity

cri

teri

a fo

r in

itiat

ing

AR

T fo

r th

eir

own

heal

th N

ew in

fect

ions

and

hig

h vi

ral l

oads

duri

ng p

regn

ancy

pos

e th

e gr

eate

st r

isk

of M

TCT

to t

he u

nbor

n ba

by t

hus

prim

ary

prev

entio

n A

RV

pro

phyl

axis

as

wel

l as

trea

tmen

t at t

his

time

is c

ritic

al G

iven

that

25

perc

ent o

f wom

en in

Ken

ya h

ave

an u

nwan

ted

preg

nanc

y s

tren

gthe

ning

the

link

to F

P se

rvic

es a

nd c

ondo

m a

cces

s fo

r du

al p

rote

ctio

n of

fers

a c

hanc

e to

fur

ther

pre

vent

MTC

T2

22

OPE

RA

TIO

NA

L G

UID

ELIN

ES

Ant

enat

al c

are

and

prev

entio

n of

MTC

T du

ring

thi

s pe

riod

can

be

sum

mar

ised

usi

ngan

ess

entia

l pa

ckag

e of

int

egra

ted

ante

nata

l ca

re s

ervi

ces

as s

how

n in

Tab

le 2

1

This

ou

tline

s th

e pa

ckag

e of

ca

re

to

be

prov

ided

to

ev

ery

wom

an

atte

ndin

g A

NC

ser

vice

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

5

32

Tabl

e 2

1 Es

sent

ial P

acka

ge o

f Int

egra

ted

Ant

enat

al C

are

Serv

ices

Gro

up e

duca

tion

Incl

ude

info

rmat

ion

on fo

ur A

NC

vis

its b

reas

tfeed

ing

mat

erna

l and

infa

nt n

utrit

ion

per

sona

l hyg

iene

birt

h pr

epar

edne

ss d

ange

r sig

ns p

reve

ntio

n of

com

plic

atio

ns s

kille

d bi

rth a

ttend

ance

fam

ily p

lann

ing

imm

uniz

atio

n sc

hedu

le

post

-nat

al c

are

and

HIV

and

AID

S m

anag

emen

t

Clie

nt h

isto

ry O

btai

n ro

utin

e da

ta in

clud

ing

med

ical

obs

tetri

c a

nd p

sych

osoc

ial h

isto

ry D

eter

min

e dr

ug h

isto

ry k

now

n al

lerg

ies

and

use

of a

ltern

ativ

e m

edic

ines

suc

h as

her

bal p

rodu

cts

Phy

sica

l exa

min

atio

n In

clud

e vi

tal s

igns

ins

pect

ion

aus

culta

tion

and

palp

atio

n

Abd

omin

al a

nd g

enita

l exa

min

atio

n In

clud

e in

spec

tion

pal

patio

n fo

etal

aus

culta

tion

spe

culu

m a

nd b

iman

ual e

xam

inat

ions

w

here

indi

cate

d

AN

C P

rofil

e R

outin

e te

sts

for s

yphi

lis H

b b

lood

gro

up a

nd R

hesu

s fa

ctor

urin

alys

is a

nd p

rovi

de ra

pid

HIV

test

ing

to th

e pr

egna

nt w

oman

and

her

par

tner

if a

ccom

pany

ing

her

If in

dica

ted

chec

k sp

utum

for A

AFB

and

CD

4 co

unt

Cou

nsel

ing

on b

irth

prep

ared

ness

Sup

port

the

preg

nant

wom

an a

nd h

er p

artn

er to

dev

elop

an

indi

vidu

al b

irth

plan

that

in

clud

es p

lace

of d

eliv

ery

with

ski

lled

birth

atte

ndan

ce e

mer

genc

y tra

nspo

rt b

irth

com

pani

onsh

ip a

nd re

adin

ess

for i

nfan

t ca

re

Cou

nsel

ing

on p

regn

ancy

dan

ger s

igns

Pro

vide

wom

en w

ith in

form

atio

n an

d in

stru

ctio

ns o

n se

ekin

g ea

rly c

are

for p

regshy

nanc

y co

mpl

icat

ions

suc

h as

ble

edin

g fe

ver

seve

re h

eada

che

sw

olle

n fe

et f

its o

r con

vuls

ions

Cou

nsel

ing

on in

fant

feed

ing

All

wom

en re

quire

infa

nt-fe

edin

g co

unse

ling

and

supp

ort

Exc

lusi

ve b

reas

tfeed

ing

for s

ix

mon

ths

shou

ld b

e pr

omot

ed a

s th

e no

rm fo

r all

wom

en re

gard

less

of H

IV s

tatu

s W

omen

infe

cted

with

HIV

nee

d to

be

gu

ided

in th

e se

lect

ion

of s

afer

infa

nt-fe

edin

g op

tions

(ref

er to

WH

O g

uide

lines

and

MO

H c

ircul

ar o

n in

fant

and

you

ng c

hild

fe

edin

g)

Nut

ritio

nal a

sses

smen

t co

unse

ling

and

educ

atio

n In

clud

e iro

n m

ultiv

itam

in a

nd fo

late

sup

plem

enta

tion

mon

itor f

or a

naeshy

mia

ade

quat

e ca

loric

and

nut

rient

inta

ke a

nd re

com

men

d re

alis

tic d

iet a

djus

tmen

ts b

ased

on

loca

l res

ourc

es a

nd n

eeds

of

HIV

+ pr

egna

nt w

omen

(at l

east

10

mor

e of

the

RD

A)

Cou

nsel

ing

on H

IV a

nd A

IDS

Pro

vide

wom

en w

ith in

form

atio

n an

d in

stru

ctio

ns o

n se

ekin

g he

alth

car

e fo

r

sym

ptom

s of

HIV

dis

ease

pro

gres

sion

suc

h as

freq

uent

and

recu

rrent

illn

esse

s c

hron

ic p

ersi

sten

t dia

rrho

ea c

andi

dias

is

feve

r w

astin

g or

sig

ns o

f any

opp

ortu

nist

ic in

fect

ion

Lin

k w

omen

to A

IDS

trea

tmen

t and

oth

er s

uppo

rt pr

ogra

mm

es w

here

av

aila

ble

Cou

nsel

ing

the

HIV

neg

ativ

e w

oman

and

her

par

tner

Pro

vide

info

rmat

ion

on re

peat

test

ing

risk

redu

ctio

n an

d pa

rtner

test

ing

RTI

scr

eeni

ng A

ll w

omen

with

hig

h ris

k se

xual

his

tory

or p

rese

ntin

g w

ith s

igns

of R

TI s

uch

as a

bnor

mal

gen

ital d

isch

arge

ge

nita

l ulc

ers

and

pelv

ic in

flam

mat

ory

dise

ase

shou

ld b

e sc

reen

ed a

nd m

anag

ed a

ccor

ding

to K

enya

pro

toco

ls

Tube

rcul

osis

(TB

) A

ll w

omen

pre

sent

ing

for A

NC

ser

vice

s w

ith a

cou

gh o

f mor

e th

an 2

wee

ksrsquo d

urat

ion

shou

ld b

e sc

reen

ed

for T

B re

gard

less

of H

IV s

tatu

s F

ollo

w K

enya

pro

toco

ls fo

r scr

eeni

ng p

roph

ylax

is a

nd tr

eatm

ent

Teta

nus

toxo

id im

mun

isat

ions

Adm

inis

ter a

ccor

ding

to c

urre

nt K

EP

I TT

Imm

uniz

atio

n S

ched

ule

Dew

orm

ing

All

preg

nant

wom

en s

houl

d re

ceiv

e an

ti-he

lmin

thes

afte

r firs

t trim

este

r as

per t

he g

uide

lines

on

m

ater

nal n

utrit

ion

Ant

imal

aria

ls I

TNs

All

preg

nant

wom

en in

mal

aria

end

emic

are

as s

houl

d sl

eep

unde

r an

ITN

and

rece

ive

SP

inte

rmitt

ent

pres

umpt

ive

treat

men

t acc

ordi

ng to

the

Nat

iona

l Mal

aria

gui

delin

es

AR

V a

nd O

ppor

tuni

stic

Infe

ctio

ns p

roph

ylax

is (d

urin

g pr

egna

ncy)

Pro

vide

AR

V C

TX a

nd o

ther

pro

phyl

actic

m

edic

atio

ns a

ccor

ding

to th

e K

enya

AR

T pr

otoc

ol o

n O

I pro

phyl

axis

and

use

of A

RV

s in

pre

gnan

cy

AR

V tr

eatm

ent d

urin

g pr

egna

ncy

Pro

vide

HA

AR

T w

ithin

the

MC

H s

ettin

g ac

cord

ing

to th

e K

enya

pro

toco

l on

use

of A

RV

s

Est

ablis

h cl

ear r

efer

ral n

etw

orks

with

sen

ior c

linic

ians

Pre

vent

ion

with

Pos

itive

s E

ncou

rage

pos

itive

livi

ng d

iscl

osur

e c

orre

ct a

nd c

onsi

sten

t con

dom

use

and

pro

vide

psy

chos

oshyci

al s

uppo

rt to

the

affe

cted

fam

ilies

For

the

HIV

-infe

cted

and

affe

cted

fam

ilies

est

ablis

h an

dor

stre

ngth

en li

nkag

es to

car

e

treat

men

t and

sup

port

serv

ices

incl

udin

g po

st-p

artu

m fo

llow

up

Effe

ctiv

e co

ntra

cept

ion

plan

Cou

nsel

abo

ut o

ther

fam

ily p

lann

ing

met

hods

em

phas

izin

g on

par

tner

invo

lvem

ent

and

dual

pro

tect

ion

met

hods

to a

void

unw

ante

d pr

egna

ncy

new

infe

ctio

n re

-infe

ctio

n an

d fu

rther

tran

smis

sion

Sourc

e K

enya

Nat

ional PM

TC

T T

rain

ing C

urr

iculu

m

2005

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

92

OPE

RA

TIO

NA

L G

UID

ELIN

ES

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed in

the

care

and

fo

llow

-up

of c

hild

ren

of H

IV-in

fect

ed m

othe

rs

bull A

ll ch

ildre

n bo

rn t

o H

IV in

fect

ed m

othe

rs s

houl

d be

see

n in

the

he

alth

car

e fa

cilit

y w

ithin

tw

o w

eeks

of

deliv

ery

bull F

or a

ll H

IV e

xpos

ed in

fant

s m

onth

ly f

ollo

w u

p vi

sits

are

re

com

men

ded

begi

nnin

g at

six

wee

ks t

hrou

gh 2

yea

rs

bull W

here

pos

sibl

e v

isits

sho

uld

be li

nked

to

the

imm

unis

atio

n an

d

grow

th m

onito

ring

vis

its

bull A

ll H

IV e

xpos

ed in

fant

s sh

ould

be

star

ted

on C

otri

mox

azol

e

prop

hyla

xis

from

6 w

eeks

of

age

bull F

or in

fant

s w

ho te

st H

IV p

ositi

ve b

y D

NA

PC

R b

efor

e 18

mon

ths

or

by a

ntib

ody

test

aft

er 1

8 m

onth

s of

age

co

-trim

oxaz

ole

shou

ld b

e gi

ven

daily

for

life

bull F

or in

fant

s w

ho te

st H

IV n

egat

ive

|

If th

ey h

ave

stop

ped

brea

stfe

edin

g fo

r 2 m

onth

s or

mor

e s

top

C

otrim

oxaz

ole

|

If st

ill br

east

feed

ing

con

tinue

Cot

rimox

azol

e un

til tw

o m

onth

s af

ter

com

plet

e ce

ssat

ion

of b

reas

tfeed

ing

bull C

ompr

ehen

sive

car

e fo

r th

e H

IV e

xpos

ed o

r in

fect

ed in

fant

s sh

ould

be

pro

vide

d in

the

bro

ader

con

text

of

othe

r ch

ild h

ealth

car

e st

rate

gies

Hea

lth w

orke

rs s

houl

d pr

ovid

e th

e fo

llow

ing

pack

age

of c

are

as a

min

imum

to

thes

e ch

ildre

n

(1)

Con

firm

HIV

sta

tus

as e

arly

as

poss

ible

(R

efer

to C

hapt

er 7

)

(2)

M

othe

rs s

houl

d be

sup

porte

d to

pro

vide

opt

imal

infa

nt fe

edin

g an

d pa

rticu

larly

to

avoi

d m

ixed

feed

ing

in th

e fir

st 6

mon

ths

of li

fe I

t is

impo

rtant

that

infa

nt fe

edin

g ch

oice

s at

initi

atio

n of

feed

ing

follo

win

g ea

rly in

fant

dia

gnos

is a

t wea

ning

and

at

the

time

of in

trodu

ctio

n of

com

plem

enta

ry fe

eds

are

guid

ed b

y th

e A

FAS

S c

riter

ia

(Ref

er to

Cha

pter

8)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

3

3

74

Cha

pter

9

Car

e an

d Fo

llow

-up

of C

hild

ren

of H

IV-in

fect

ed M

othe

rs

91

INTR

OD

UC

TIO

N

PMTC

T in

terv

entio

ns re

duce

but

do

not e

limin

ate

the

risk

of H

IV tr

ansm

issi

on fr

om m

othshy

ers t

o th

eir i

nfan

ts a

nd y

oung

child

ren

Bot

h H

IV-in

fect

ed a

nd u

ninf

ecte

d ex

pose

d ch

ildre

n ha

ve in

crea

sed

risk

s of

infe

ctio

n an

d de

ath

from

com

mon

chi

ldho

od in

fect

ions

The

sur

shyvi

val o

f H

IV-e

xpos

ed c

hild

ren

whe

ther

or

not

they

are

inf

ecte

d i

s cl

osel

y lin

ked

to t

he

heal

th a

nd s

urvi

val o

f the

ir m

othe

rs T

here

fore

lon

g-te

rm b

enef

its o

f PM

TCT

prog

ram

s w

ill o

nly

be s

usta

ined

if t

here

is o

ngoi

ng c

ompr

ehen

sive

car

e fo

r th

e ch

ildre

n an

d th

eir

mot

hers

and

or c

are

give

rs

HIV

exp

osed

chi

ldre

n ar

e vu

lner

able

to

the

com

mon

illn

esse

s af

fect

ing

othe

r ch

ildre

n

Thes

e in

fect

ions

incl

ude

neon

atal

infe

ctio

ns m

alar

ia p

neum

onia

dia

rrho

ea m

easl

es a

nd

othe

r vac

cine

pre

vent

able

dis

ease

s H

IV in

fect

ed ch

ildre

n ar

e lik

ely

to s

uffe

r mor

e se

vere

ly

and

have

a h

ighe

r lik

elih

ood

of d

ying

from

com

mon

chi

ldho

od il

lnes

ses

than

non

-infe

cted

ch

ildre

n W

here

as m

alnu

triti

on c

ause

s 53

o

f all

child

hood

dea

ths

HIV

exp

osed

chi

ldre

n ar

e m

ore

vuln

erab

le to

it th

an n

on-in

fect

ed c

hild

ren

Thi

s is

bec

ause

HIV

exp

osed

child

ren

have

hig

her

calo

ric

requ

irem

ents

as

a re

sult

of th

eir

HIV

infe

ctio

n th

e pr

esen

ce o

f opp

orshy

tuni

stic

infe

ctio

ns a

nd o

ther

com

plic

atio

ns re

late

d to

AID

S

Regu

lar

follo

w u

p ca

re is

cri

tical

for

an in

fant

bor

n to

a m

othe

r w

ith H

IVA

IDS

The

com

shypr

ehen

sive

car

e of

HIV

exp

osed

chi

ldre

n in

clud

ing

nutr

ition

im

mun

isat

ion

mon

itori

ng o

f gr

owth

and

dev

elop

men

t pr

even

tion

and

trea

tmen

t of

opp

ortu

nist

ic in

fect

ions

and

ear

ly

infa

nt d

iagn

osis

of

HIV

is f

easi

ble

in r

esou

rce-

cons

trai

ned

sett

ings

and

sig

nific

antly

imshy

prov

es th

e su

rviv

al o

f the

se ch

ildre

n

23

JOB A

IDS

Prov

ider

s ar

e en

cour

aged

to re

fer t

o th

e ap

prop

riate

job

aid(

s) w

hen

deal

ing

with

spe

cific

issu

es

bull P

MT

CT

test

ing

and

coun

selli

ng t

ools

bull C

oupl

e co

unse

lling

tool

s

bull A

NC

alg

orith

ms

for

AR

V p

roph

ylax

is a

nd in

fant

fee

ding

gui

delin

es

as a

dapt

ed f

rom

WH

O g

uide

lines

bull P

reve

ntio

n w

ith p

ositi

ves

tool

kit

on d

iscl

osur

e

bull F

ocus

ed a

nte-

nata

l car

e

bull M

alar

ia in

pre

gnan

cy

bull T

B in

pre

gnan

cy

bull K

EP

I S

ched

ule

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

3

34

A ra

pid

HIV

test

ing

algo

rithm

for s

eria

l tes

ting

is il

lust

rate

d be

low

35

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Pre-Test Education and or Counselling

First HIV Rapid Test ndashDETERMINE

Negative TestResult

Counsel for Negative Result

Positive TestResult

Second HIV Rapid Test ndashBIOLINE

Positive Test ResultCounsel for

Positive Result

NegativeTestResult

Third HIV Rapid Test ndashUNIGOLD

Positive Test ResultCounsel for

Positive Result

Negative Test ResultCounsel for

Negative Result

Figure 32 Rapid HIV testing algorithm Serial testing

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

72

M

othe

r and

Chi

ld H

ealth

Boo

klet

71

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

36

Cha

pter

ref

eren

ces

Rep

ublic

of

Ken

ya M

inis

try

of

Hea

lth

Div

isio

n o

f Rep

roduct

ive

Hea

lth

National G

uid

e-lin

es f

or

Qual

ity

Obst

etri

cs a

nd P

erin

atal Car

e (

2004)

WH

O

UN

FPA

UN

ICEF

World B

ank

Manag

ing C

om

plic

atio

ns

in P

regnan

cy a

nd C

hild

birth

A g

uid

e fo

r m

idw

ives

and d

oct

ors

(2003)

WH

O

Sta

ndar

ds

for

Mat

ernal

and N

eonat

al C

are

(2006)

WH

O

Antire

trovi

ral dru

gs

for

trea

ting p

regnan

t w

om

en a

nd p

reve

nting H

IV infe

ctio

ns

in

infa

nts

in r

esourc

e lim

ited

set

tings

Tow

ard

s U

niv

ersa

l Acc

ess

Rec

om

men

dations

for

a public

hea

lth a

ppro

ach (

2006)

Min

istr

y of

Hea

lth

Nat

ional AID

S amp

STD

Contr

ol Pro

gra

mm

e (N

ASCO

P)

Guid

elin

es f

or

Antire

trovi

ral dru

g t

her

apy

in K

enya

(2005)

Min

istr

y of

Hea

lth

Ken

ya N

atio

nal

Rep

roduct

ive

Hea

lth I

nst

ruct

ional M

anual

for

Ser

vice

Pro

vider

s (M

arch

2005)

Nat

ional AID

S amp

STD

Contr

ol Pro

gra

mm

e K

enya

AID

S I

ndic

ator

Syr

vey

Foo

tnot

es

1

2Ken

ya D

emogra

phic

and H

ealth S

urv

ey (

KD

HS)

2003

37

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

70

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

CH

AP

TE

R 3

Intr

apar

tum

Car

e 3

1 IN

TRO

DU

CTI

ON

Intr

apar

tum

car

e is

the

man

agem

ent

of w

omen

fro

m t

he o

nset

of

labo

ur t

o de

liver

y T

his

peri

od p

oses

the

grea

test

ris

k fo

r tr

ansm

issi

on o

f HIV

from

the

mot

her

to th

e ch

ild (M

TCT)

w

ith 1

0 to

20

perc

ent o

f exp

osed

infa

nts

beco

min

g in

fect

ed a

t thi

s tim

e in

the

abse

nce

of a

ny

inte

rven

tion

1 In

the

con

text

of

HIV

AID

S it

is t

here

fore

im

port

ant

to e

stab

lish

the

HIV

stat

us o

f wom

en p

rior

to o

r du

ring

labo

ur a

nd d

eliv

ery

and

prov

ide

inte

rven

tions

aim

ed a

t re

duci

ng th

e ri

sk o

f tra

nsm

issi

on W

ith a

ppro

pria

te in

terv

entio

ns t

he r

isk

of M

TCT

can

bere

duce

d si

gnifi

cant

ly

32

OPE

RA

TIO

NA

L G

UID

ELIN

ES

a) O

ptim

al In

trap

artu

m C

are

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed fo

r all

wom

en a

dmitt

ed

to la

bour

and

del

iver

y un

its 2

3

1 M

inim

ise

vagi

nal e

xam

inat

ions

2 U

se a

sept

ic t

echn

ique

s in

con

duct

ing

deliv

ery

3 A

void

rou

tine

artif

icia

l rup

ture

of m

embr

anes

(A

RM

)

4 A

void

pro

long

ed la

bour

5 A

void

unn

eces

sary

trau

ma

duri

ng d

eliv

ery

6 M

inim

ise

the

risk

of p

ostp

artu

m h

aem

orrh

age

7 U

se s

afe

bloo

d tr

ansf

usio

n pr

actic

es

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

9

38

b) S

peci

fic M

anag

emen

t of H

IV P

ositi

ve P

regn

ant W

omen

Pro

phyl

acti

c A

ntir

etro

vira

l the

rapi

es4

The

AR

V p

roph

ylac

tic r

egim

en d

epen

ds o

n w

heth

er th

e m

othe

r ha

d A

RV

s du

ring

pre

gshyna

ncy

or n

ot T

hus

the

heal

th c

are

wor

ker s

houl

d es

tabl

ish

the

regi

men

use

d du

ring

th

e A

NC

whe

ther

the

wom

an h

ad ta

ken

the

SdN

VP

and

AZT

at t

he o

nset

of l

abou

r an

d de

term

ine

the

appr

opri

ate

intr

a-pa

rtum

AR

V c

are

as p

er th

e al

gori

thm

s on

pag

e80

(App

endi

x II

I) p

age

81 (A

ppen

dix

IV) a

nd a

s su

mm

aris

ed b

elow

No

AR

Vs t

aken

in p

regn

ancy

Mot

her i

n ea

rly la

bour

(up

to 4

cm c

ervi

cal d

ilata

tion)

bull

Int

rapa

rtum

per

iod

Giv

e m

othe

r S

dNV

P 2

00m

g A

ZT

600

mg

and

3T

C 1

50m

g st

at

bull P

ostp

artu

m m

othe

r G

ive

mot

her

AZ

T 3

00m

g an

d 3T

C 1

50m

g B

D

for

7 da

ys

bull P

ostp

artu

m p

erio

d G

ive

infa

nt S

d N

evir

apin

e 2

mg

kg w

ithin

72

hour

s of

birt

h P

LUS

3T

C 4

mg

kg B

D fo

r 1

wee

k an

d A

ZT

syr

up 4

mg

kg

BD

for

6 w

eeks

Mot

her r

ecei

ved

AZT

300

mg

BD

in P

regn

ancy

bull P

ostp

artu

m

Giv

e in

fant

Sd

Nev

irap

ine

2mg

kg w

ithin

72

hour

s of

birt

h

PLU

S 3

TC

4m

gkg

BD

for

1 w

eek

and

AZ

T sy

rup

4 m

gkg

BD

for

6 w

eeks

Mot

her r

ecei

ved

HA

AR

T in

Pre

gnan

cy

Reg

ardl

ess

of d

urat

ion

rece

ived

HA

AR

T bull

Giv

e m

othe

r A

RV

dos

e as

per

reg

imen

bull P

ostp

artu

m

Giv

e In

fant

Sd

Nev

irap

ine

2mg

kg w

ithin

72

hour

s of

bir

th

PLU

S 3

TC

4m

gkg

BD

for

1 w

eek

and

AZ

T sy

rup

4 m

gkg

BD

for

6 w

eeks

Mod

e of

del

iver

y E

lect

ive

caes

area

n se

ctio

n (C

S) r

educ

es t

he r

isk

of H

IV M

TCT

as c

ompa

red

to v

agin

al

deliv

ery

but

will

not

be

avai

labl

e in

man

y se

ttin

gs in

our

cou

ntry

Whe

re C

S is

per

shyfo

rmed

(ele

ctiv

e or

em

erge

ncy)

in H

IV p

ositi

ve w

omen

the

y sh

ould

rec

eive

pro

phyl

actic

an

tibio

tics

If

the

CS

is p

erfo

rmed

aft

er p

rolo

nged

lab

our

or r

uptu

re o

f m

embr

anes

lo

nger

cour

ses

of a

ntib

iotic

s sh

ould

be

cons

ider

ed

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

3

9

68

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Supp

ort d

urin

g la

bour

E

mot

iona

l su

ppor

t du

ring

lab

our

is i

mpo

rtan

t fo

r al

l w

omen

and

may

be

even

mor

ene

cess

ary

for

an H

IV p

ositi

ve w

oman

who

is c

once

rned

abo

ut h

er c

ondi

tion

and

risk

of

HIV

tran

smis

sion

to c

hild

Whe

neve

r po

ssib

le d

urin

g la

bour

war

d st

aff m

ust b

e se

nsishy

tive

to t

he fe

ars

and

conc

erns

of t

he H

IV p

ositi

ve m

othe

r ab

out

her

infe

ctio

n a

nd h

owm

uch

she

had

told

her

par

tner

Indu

ctio

n of

labo

ur

Indu

ctio

n of

labo

ur m

ay b

e as

soci

ated

with

incr

ease

d ri

sk o

f H

IV M

TCT

Car

eful

asshy

sess

men

t of

the

nee

d fo

r an

d de

sira

bilit

y of

ind

uctio

n ra

ther

tha

n C

S is

nec

essa

ry

Whe

n in

duct

ion

of la

bour

is c

hose

n m

embr

anes

sho

uld

be le

ft in

tact

for

as lo

ng a

s po

sshysi

ble

Syn

toci

non

shou

ld n

ot b

e us

ed w

ith in

tact

mem

bran

es

Indi

catio

ns fo

r ele

ctiv

e C

S A

lthou

gh e

lect

ive

CS

will

not

be

avai

labl

e in

mos

t hea

lth fa

cilit

ies

as a

rou

tine

for

HIV

posi

tive

wom

en t

here

may

be

som

e ca

ses

that

mer

it co

nsid

erat

ion

for

CS

The

se i

nshycl

ude

preg

nanc

ies

whe

re l

abou

r is

exp

ecte

d to

be

prol

onge

d or

whe

re o

ther

obs

tetr

ic

com

plic

atio

ns m

ay b

e as

soci

ated

with

incr

ease

d ri

sk o

f tra

nsm

issi

on (e

g a

brup

tio p

lashy

cent

ae

plac

enta

pra

evia

pr

e-te

rm r

uptu

re o

f m

embr

anes

pr

evio

us C

S an

d br

eech

pr

esen

tatio

n)

Man

agem

ent o

f lab

our a

nd d

eliv

ery

Labo

ur a

nd d

eliv

ery

man

agem

ent

shou

ld fo

llow

opt

imal

obs

tetr

ic m

anag

emen

t gu

ideshy

lines

(R

efer

to

Opt

imal

Int

rapa

rtum

car

e ab

ove

and

Nat

iona

l G

uide

lines

for

Qua

lity

Obs

tetr

ics

and

IMPA

C C

are

Man

ual)

RO

LEO

FTH

E C

OM

MU

NIT

Y

A la

rge

prop

ortio

n (6

0) o

f wom

en in

Ken

ya is

del

iver

ed o

utsid

e th

e he

alth

sys

tem

s by

fam

ilym

embe

rs n

eigh

bour

s and

TBA

s

bull T

here

is n

eed

to e

duca

te th

e co

mm

unity

on

the

risk

of M

TC

T an

d w

ays

of

prev

entio

n

bull T

hose

ass

istin

g th

e de

liver

ies

need

to u

nder

stan

d th

eir

own

risk

of in

fect

ion

and

how

to p

rote

ct th

emse

lves

bull T

he c

omm

unity

sho

uld

be e

ncou

rage

d to

faci

litat

e m

othe

rs to

del

iver

in

heal

th fa

cilit

ies

bull T

he c

omm

unity

sho

uld

be e

ncou

rage

d to

ref

er to

hea

lth fa

cilit

ies

all c

hild

ren

born

at h

ome

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

7

40

Fi

gure

81

Gui

delin

es fo

r Cou

nsel

ling

on H

IV a

nd In

fant

feed

ingJ

ob A

ids

Cha

pter

ref

eren

ces

an

d IE

C M

ater

ials

on

Infa

nt a

nd Y

oung

Chi

ld F

eedi

ng

1R

epublic

of

Ken

ya

Min

istr

y of

Hea

lth

Ess

ential

Obst

etric

Car

e M

anual

for

Hea

lth

Ser

vice

Pro

vider

s in

Ken

ya (

3rd

Editio

n J

an 2

006)

Foo

tnot

es

1 D

e Cock

KM

2002

2 K

enya

National

Rep

roduct

ive

Hea

lth I

nst

ruct

ion M

anual

for

Ser

vice

Pro

vider

s (2

006)

3 D

ivis

ion o

f Rep

roduct

ive

Hea

lth

Guid

elin

es f

or

Qual

ity

Obst

etri

cs a

nd P

erin

ata

l Car

e

(2004)

4 W

HO

Antire

tovi

ral dru

gs

for

trea

ting p

regnan

t w

om

en a

nd p

reve

nting H

IV infe

ctio

n in

infa

nts

to

ward

s univ

ersa

l acc

ess

(2006)

41

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

66

85

EXTR

AC

TSFR

OM

RES

EAR

CH

ON

I NFA

NT

F EED

ING

A

ND H

IVA

IDS

Evid

ence

ava

ilabl

e fr

om c

urre

nt re

sear

ch d

ata

show

s th

at

bull I

ncre

ased

ris

k of

mor

talit

y w

ith r

epla

cem

ent

feed

ing

is s

igni

fican

t

bull H

IV f

ree

surv

ival

rat

e at

18

mon

ths

of a

ge d

oes

not

sign

ifica

ntly

var

y be

twee

n a

brea

stfe

d an

d re

plac

emen

t fed

chi

ld

bull M

odifi

ed a

nim

alrsquos

milk

doe

s no

t pr

ovid

e ad

equa

te n

utrit

ion

for

ch

ildre

n le

ss t

han

6 m

onth

s he

nce

mic

ronu

trie

nts

shou

ld b

e gi

ven

un

der

thes

e ci

rcum

stan

ces

bull A

brup

t ce

ssat

ion

of b

reas

tfee

ding

is n

o lo

nger

rec

omm

ende

d

bull E

xclu

sive

bre

astf

eedi

ng u

p to

6 m

onth

s is

rec

omm

ende

d un

less

re

plac

emen

t fee

ding

can

mee

t AF

AS

S c

rite

ria

Cha

pter

4

Use

of A

ntire

trov

iral D

rugs

in P

regn

ancy

for T

reat

men

t and

for

Prev

entio

n of

Mot

her-

to-C

hild

Tra

nsm

issi

on o

f HIV

Infe

ctio

n

41

INTR

OD

UC

TIO

N

With

out

any

inte

rven

tion

up

to 4

0 pe

rcen

t of

HIV

pos

itive

wom

en w

ill t

rans

mit

the

infe

ctio

n to

the

ir c

hild

ren

duri

ng p

regn

ancy

lab

our

and

brea

stfe

edin

g U

se o

f ant

iret

shyro

vira

l dru

gs (A

RV

s) o

bste

tric

inte

rven

tions

and

avo

idan

ce o

f all

brea

stfe

edin

g fo

r pr

eshyve

ntio

n of

mot

her

to c

hild

tran

smis

sion

of H

IV in

fect

ion

(PM

TCT)

has

red

uced

the

risk

of m

othe

r to

chi

ld tr

ansm

issi

on o

f HIV

infe

ctio

n (M

TCT)

to le

ss th

an 2

per

cent

in d

evel

shyop

ed c

ount

ries

Shor

t cou

rse

effic

acio

us A

RV

dru

g re

gim

ens

can

redu

ce th

e ri

sk o

f MTC

T to

2-4

per

cent

and

can

be i

mpl

emen

ted

in r

esou

rce-

limite

d se

ttin

gs o

n a

popu

latio

n-ba

sed

publ

ic

heal

th s

cale

AR

Vs

are

used

bot

h fo

r th

e tr

eatm

ent

of H

IV d

isea

se a

nd fo

r PM

TCT

in

HIV

-infe

cted

pre

gnan

t w

omen

and

the

ir n

eona

tes

Ant

iret

rovi

ral t

reat

men

t (A

RT)

for

wom

en w

ho q

ualif

y fo

r it

pro

long

s an

d im

prov

es t

he q

ualit

y of

the

ir l

ives

The

sur

shyvi

val

of t

he c

hild

is

clos

ely

inte

rlin

ked

with

the

hea

lth a

nd s

urvi

val

of t

he m

othe

r

Wom

en e

ligib

le fo

r A

RT

shou

ld b

e st

arte

d on

trea

tmen

t as

soon

as

poss

ible

Pre

gnan

cy

is n

ot a

rea

son

to d

elay

AR

T W

omen

who

are

alr

eady

on

AR

T be

fore

bec

omin

g pr

egshy

nant

sho

uld

cont

inue

with

thei

r tr

eatm

ent

In c

erta

in s

ituat

ions

mod

ifica

tions

may

be

need

ed to

mak

e tr

eatm

ent s

afer

for

the

mot

her

and

the

unbo

rn b

aby

The

bene

fits

of u

sing

AR

Vs

to t

reat

HIV

-infe

cted

pre

gnan

t w

omen

and

or

PMTC

T ou

tshyw

eigh

the

ris

ks H

owev

er w

hen

AR

T or

oth

er s

hort

cou

rse

AR

V r

egim

ens

are

used

ba

selin

e ev

alua

tion

and

mon

itori

ng is

enc

oura

ged

to e

nsur

e th

e sa

fety

of t

he m

othe

rsan

d th

eir

new

born

s L

inka

ges

of H

IV-in

fect

ed p

regn

ant

wom

en a

nd t

heir

chi

ldre

n to

ot

her

care

and

sup

port

pro

gram

s at

hea

lth f

acili

ty a

nd c

omm

unity

lev

els

shou

ld b

e en

sure

d

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

5

42

42

OPE

RA

TIO

NA

L G

UID

ELIN

ES

All

HIV

-infe

cted

pre

gnan

t w

omen

sho

uld

be c

ouns

elle

d on

com

preh

ensi

ve H

IV c

are

incl

udin

g us

e of

AR

Vs

for

thei

r ow

n he

alth

and

for

PMTC

T

All

HIV

-infe

cted

pre

gnan

t wom

en s

houl

d ha

ve th

eir H

IV d

isea

se

stag

ed u

sing

bull W

HO

clin

ical

sta

ging

(se

e A

ppen

dix

1) a

nd

bull I

mm

unol

ogic

al s

tagi

ng (

CD

4 co

unt)

(se

e ta

ble

1)

The

wom

en s

houl

d al

so b

e sc

reen

ed a

nd tr

eate

d fo

r op

port

unis

tic in

fect

ions

(OIs

) inc

ludi

ngTu

berc

ulos

is (T

B)

All

HIV

-infe

cted

pre

gnan

t wom

en s

houl

d ha

ve b

asel

ine

labo

rato

ry a

nd o

ther

nec

essa

rydi

agno

stic

eva

luat

ions

Thes

e di

agno

stic

s sh

ould

incl

ude

bull R

outin

e an

tena

tal c

are

labo

rato

ry in

vest

igat

ions

that

are

nor

mal

ly

done

for

all

preg

nant

wom

en

haem

oglo

bin

(Hb)

rh

esus

blo

od

grou

p an

d A

BO

typ

ing

VD

RL

uri

ne a

naly

sis

and

scre

enin

g fo

r S

TI

bull A

LT a

nd c

reat

inin

e le

vels

for

wom

en e

ligib

le f

or H

AA

RT

Prop

hyla

xis

amp m

icro

nutr

ient

sup

plem

enta

tion

bull

Cot

rimox

azol

e (C

TX) o

ne d

oubl

e st

reng

th o

r tw

o si

ngle

stre

ngth

tabl

ets

once

dai

ly

bull

Mul

tivita

min

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

83

OPE

RA

TIO

NA

L G

UID

ELIN

ESO

N F

EED

ING

CH

ILD

REN

6 M

ON

THS

AN

DO

LDER

The

follo

win

g sh

ould

gui

de fe

edin

g fo

r chi

ldre

n 6

mon

ths

and

olde

r

bull A

t 6

mon

ths

oth

er f

orm

s of

milk

alo

ne a

re n

ot a

dequ

ate

to m

eet

the

baby

rsquos n

utrit

iona

l req

uire

men

ts

bull C

ompl

emen

tary

foo

ds s

houl

d be

intr

oduc

ed w

ith c

ontin

ued

br

east

feed

ing

or w

ith r

epla

cem

ent

feed

ing

until

a n

utrit

iona

lly

adeq

uate

die

t ca

n be

sus

tain

ed w

ithou

t m

ilk

bull A

brup

t ces

satio

n of

bre

astf

eedi

ng s

houl

d be

dis

cour

aged

to

avoi

d

trau

ma

for

both

the

mot

her

and

the

baby

bull M

ilk s

houl

d co

ntin

ue a

s an

impo

rtan

t co

mpo

nent

of

the

diet

bull C

ompl

emen

tary

foo

ds s

houl

d be

enr

iche

d fr

om lo

cally

ava

ilabl

e

fam

ily f

oods

84

NU

TRIT

ION

AL

CA

RE

AN

D S

UPP

OR

TO

F H

IV

INFE

CTE

DC

HIL

DR

EN

bull E

nerg

y ne

eds

for

asym

ptom

atic

HIV

infe

cted

chi

ldre

n in

crea

se b

y 10

pe

rcen

t to

mai

ntai

n gr

owth

as

com

pare

d to

the

non-

infe

cted

chi

ldre

n

bull T

here

is n

o ev

iden

ce o

f in

crea

sed

prot

ein

requ

irem

ents

The

re

quir

emen

ts s

houl

d be

bas

ed o

n in

divi

dual

sym

ptom

s an

d ne

eds

bull M

icro

nutr

ient

req

uire

men

ts d

o no

t ch

ange

W

HO

rec

omm

ends

not

m

ore

than

one

RD

A

(For

fur

ther

det

ails

re

fer

to K

enya

n G

uide

lines

on

nutr

ition

and

HIV

A

IDS

)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

3

64

82

OPE

RA

TIO

NA

L G

UID

ELIN

ESO

N I N

FAN

TFE

EDIN

G (0

-6 M

ON

THS)

The

follo

win

g sh

ould

gui

de in

fant

feed

ing

for t

he fi

rst 6

mon

ths

bull A

ll w

omen

and

men

irre

spec

tive

of th

eir

HIV

sta

tus

shou

ld r

ecei

ve

coun

selin

g an

d de

mon

stra

tions

on

how

to s

afel

y fe

ed t

heir

babi

es

duri

ng t

he a

nten

atal

and

pos

tnat

al f

ollo

w u

p

bull T

he m

ost

appr

opria

te in

fant

fee

ding

opt

ion

for

an H

IV in

fect

ed

mot

her

shou

ld c

ontin

ue t

o de

pend

on

indi

vidu

al c

ircu

mst

ance

s an

d

the

av

aila

ble

supp

ort

bull E

very

HIV

infe

cted

wom

an s

houl

d be

eva

luat

ed a

t ev

ery

visi

t to

ch

eck

whe

ther

her

soc

ial

econ

omic

and

hea

lth s

tatu

s ha

s ch

ange

d

suff

icie

ntly

eno

ugh

to a

ffec

t he

r in

fant

fee

ding

opt

ion

bull E

xclu

sive

bre

astf

eedi

ng fo

r H

IV in

fect

ed w

omen

for

the

firs

t 6

mon

ths

of t

he in

fant

rsquos li

fe is

adv

isab

le

unle

ss r

epla

cem

ent f

eedi

ng is

ac

cept

able

fea

sibl

e a

ffor

dabl

e s

usta

inab

le a

nd s

afe

for

them

and

th

eir

infa

nts

befo

re t

hat t

ime

bull W

hen

repl

acem

ent

feed

ing

is a

ccep

tabl

e f

easi

ble

aff

orda

ble

su

stai

nabl

e an

d sa

fe

avoi

danc

e of

exc

lusi

ve b

reas

tfee

ding

by

HIV

in

fect

ed w

omen

is r

ecom

men

ded

bull I

f th

e co

nditi

ons

for

repl

acem

ent

feed

ing

are

still

not

met

for

6

mon

ths

then

co

ntin

uatio

n of

bre

astf

eedi

ng w

ith a

dditi

onal

co

mpl

emen

tary

fee

ding

is r

ecom

men

ded

giv

ing

prio

rity

to t

he lo

cally

av

aila

ble

food

s

bull I

nfan

t fe

edin

g de

cisi

ons

for

all H

IV e

xpos

ed in

fant

s sh

ould

be

base

d on

the

AF

AS

S c

riter

ia e

ven

whe

re e

arly

infa

nt d

iagn

osis

(E

ID)

is

avai

labl

e

bull B

reas

tfeed

ing

mot

hers

of

infa

nts

and

youn

g ch

ildre

n w

ho a

re k

now

n to

be

HIV

infe

cted

sho

uld

be s

tron

gly

enco

urag

ed to

con

tinue

bre

ast

feed

ing

How

ever

br

east

feed

ing

HIV

infe

cted

mot

hers

sho

uld

be

give

n nu

triti

on s

uppo

rt (

nutr

ition

al c

ouns

elin

g e

duca

tion

foo

d an

d nu

triti

onal

sup

plem

ents

)

63

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

44

Sulp

hur-

base

d in

term

itten

t pr

esum

ptiv

e m

alar

ia t

reat

men

t (I

PT) s

houl

d no

t be

giv

en

to w

omen

who

are

on

CTX

pro

phyl

axis

AR

V us

e

bull A

RV

s ar

e us

ed fo

r tr

eatin

g H

IV-i

nfec

ted

elig

ible

wom

en a

ndo

r fo

r pr

even

tion

of m

othe

r-to

-chi

ld tr

ansm

issi

on

bull H

IV-i

nfec

ted

preg

nant

wom

en e

ligib

le f

or A

RT

sho

uld

initi

ate

AR

T

as s

oon

as p

ossi

ble

as s

how

n in

Tab

le 4

1

bull H

IV-i

nfec

ted

preg

nant

wom

en a

lread

y on

AR

T b

efor

e be

com

ing

preg

nant

sho

uld

cont

inue

AR

T

The

bab

y sh

ould

be

give

n A

RV

pr

ophy

laxi

s so

on a

fter

birt

h as

sho

wn

in T

able

42

Tabl

e 4

1 R

ecom

men

datio

ns fo

r ini

tiatin

g A

RV

trea

tmen

t in

preg

nant

w

omen

bas

ed o

n cl

inic

al s

tage

and

ava

ilabi

lity

of C

D4

Cou

nt

WH

O

CD

4 te

stin

g

CD

4 te

stin

g

Clin

ical

Sta

ge

not a

vaila

ble

avai

labl

e

1 D

o no

t Tre

at

Trea

t if C

D4le

350

cells

mm

3

2 D

o no

t Tre

at

Trea

t if C

D4 le

350

cells

mm

3

3 Tr

eat

Trea

t irre

spec

tive

of C

D4

coun

t (c

onsi

der C

D4

valu

es fo

r bet

ter

man

agem

ent)

4 Tr

eat

Trea

t irre

spec

tive

of C

D4

cell

coun

t

Sourc

e A

dopte

d f

rom

WH

O

Anti-r

etro

vira

l dru

gs

for

trea

ting p

regnant

wom

en a

nd p

re-

venting H

IV infe

ctio

ns

Tabl

e 4

2 R

ecom

men

ded

first

-line

AR

T re

gim

en fo

r tre

atin

g pr

egna

nt w

omen

and

pro

phyl

actic

regi

men

for i

nfan

ts

Mot

her

Ant

epar

tum

AZ

T +

3TC

+ N

VP D

aily

Intra

partu

m

AZT

+ 3T

C +

NVP

Dai

ly

Pos

tpar

tum

AZ

T +

3TC

+ N

VP D

aily

Infa

nt p

roph

ylax

is

Sd

NV

P 2

mg

kg s

tat w

ithin

72

hour

s 3T

C X

1 w

eek

(4

mg

kg B

ID)

AZT

X 6

wee

ks (4

mg

kg B

ID)

Mat

erna

l dos

ages

AZT

300

mg

BID

3TC

150

mg

BID

NV

P 2

00 m

g O

D fo

r tw

o w

eeks

the

reaf

ter 2

00 m

g B

ID

Infa

nt D

osag

es

NV

P

2mg

kg s

tat w

ithin

72

hour

s

AZT

4mg

kg B

ID X

6 w

eeks

3TC

4m

gkg

BID

X 1

wee

k

Cha

pter

8

Feed

ing

Infa

nts

and

Youn

g C

hild

ren

Bor

n to

HIV

Infe

cted

Mot

hers

81

INTR

OD

UC

TIO

N T

RA

NSM

ISSI

ON

OF

HIV

THR

OU

GH

B

REA

STFE

EDIN

G

In A

fric

a 3

to 4

out

of e

very

10

infa

nts

born

to H

IV in

fect

ed w

omen

acq

uire

HIV

infe

cshytio

n T

here

is t

here

fore

a 5

ndash 2

0 pe

rcen

t ri

sk o

f inf

ants

bor

n to

HIV

pos

itive

mot

hers

ac

quir

ing

infe

ctio

n th

roug

h br

east

-fe

edin

g if

ther

e ar

e no

inte

rven

tions

in

pla

ce

For

wom

en w

ho a

re i

nshyfe

cted

with

HIV

for

the

first

tim

e or

w

ho a

re r

e-in

fect

ed w

ith a

diff

eren

t st

rain

of H

IV d

urin

g th

e br

east

feed

shyin

g ph

ase

the

ris

k in

crea

ses

up t

o29

per

cen

t H

alf (

12)

of H

IV b

reas

t m

ilk t

rans

mis

sion

tak

es p

lace

by

6 w

eeks

and

thre

e qu

arte

rs (3

4) b

y 6

mon

ths

Mix

ed fe

edin

g in

crea

ses

the

risk

of

brea

st m

ilk t

rans

mis

sion

of

HIV

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

5

62

For

prop

hyla

xis

the

reco

mm

enda

tions

are

ran

ked

and

will

dep

end

on t

ime

of fi

rst

conshy

tact

with

the

wom

an H

IV-in

fect

ed p

regn

ant w

omen

who

are

not

elig

ible

for

AR

T or

in

72

3 C

OM

PREH

ENSI

VE

CA

RE

FOR H

IV-E

XPO

SED

CH

ILD

REN

w

hom

it is

not

pos

sibl

e to

sta

rt A

RT

imm

edia

tely

and

the

mot

her

is b

eing

see

n be

twee

n28

and

38

wee

ks o

f pr

egna

ncy

sho

uld

be s

tart

ed o

n re

com

men

ded

mor

e ef

ficac

ious

shor

t co

urse

pro

phyl

actic

AR

V r

egim

ens

as s

how

n in

Tab

le 4

3a

The

bab

y sh

ould

als

obe

giv

en A

RV

pro

phyl

axis

soo

n af

ter

birt

h as

sho

wn

in th

e sa

me

tabl

e T

he r

egim

ens

asou

tline

d be

low

are

for

prop

hyla

xis

and

not f

or tr

eatm

ent

MINI

STRY

OF H

EAL

TH

Tabl

e 4

3a R

ecom

men

ded

Firs

t Lin

e A

RV

prop

hyla

xis

ALGO

RITH

M FO

R EA

RLY

INFA

NTDI

AGNO

SISFO

R HI

VEX

POSE

DCH

ILDRE

N

to p

reve

nt H

IV in

fect

ion

in in

fant

s A

mon

g Pr

egna

nt W

omen

Pr

esen

ting

Bef

ore

38 W

eeks

Ran

king

Ti

me

of A

dmin

istr

atio

n

WEL

L CHI

LD

SICK

CHI

LD

(Man

age

pres

entin

g ill

ness

and

stab

ilize

)

STAR

T CO

TRIM

OXAZ

OLE

PROP

HYLA

XIS

FOR M

OR E

INFOR

MATIO

N C ON

TACT

THE N

ATI O

NAL A

IDS S

TD CO

NTRO

L PRO

GRAM

ME ( N

ASCO

P) PO

BOX

19 36

1-00

20 2 N

AIRO

BI TE

L 02

02 72

95 02

FAX 0

2 0 2 7

1 05 1

8

Exp

osur

e sta

tus s

houl

d be

det

erm

ined

for a

ll in

fants

of u

nkno

wn s

tatu

s at t

he

6 we

ek v

isit o

r firs

t con

t act

Coun

sel o

n inf

ant f

eedi

ng a

s per

nat

iona

l gui

delin

es

Conf

irma

tory

ABt

est

at 1

8 M

onth

s

Eval

uate

for

ART

star

t on

ARV

if el

igibl

e

If HI

V+ a

t 12

Mont

hs

Evalu

ate f

or A

RT

Start

on

ARV

if eli

gible

6 Wee

ks D

BS (P

CR)

HIV

+

If HI

V-sto

p CT

X if

not

BF

for a

t lea

st 2

Mont

hs

HI

V-

Antib

ody

test

ing

12 M

onth

s

Conf

irmat

ory

ABte

st at

18 M

onth

s

Conf

irmat

ory A

B te

st at

18 M

onth

s

Eval

uate

for A

RT

star

t on

ARV

if el

igible

If HIV

+ at

12

Mon

ths

Eval

uate

for A

RT

Star

t on

ARV

if el

igibl

e

If lt1

2 Mon

ths D

BS (P

CR)

If gt

12m

o An

tibod

y te

st

HIV

+

If HIV-

stop

CTX

if n

ot

BF

for a

t lea

st 2

Mont

hs

HI

V-

Antib

ody

testi

ng

12 M

onth

s

Conf

irma

tory

AB

test

at 1

8 Mo

nths

Exp

osur

e sta

tus s

hould

be de

term

ined

for a

ll in

fant

s of u

nkno

wn st

atus

at th

e 6w

eek

visit

or fi

rst c

onta

ct

Co

unse

l on

infa

nt fe

edin

g as

per n

atio

nal g

uideli

nes

Pre

gnan

cy

Labo

ur

Pos

tpar

tum

Mat

erna

l In

fant

Rec

omm

ende

d

AZT(

28-3

8 w

eeks

ge

stat

ion)

sd

NV

P

+ AZ

T+3T

C

AZT+

3TC

X

7 da

ys

sdN

VP

PL

US

3TC

X1

wee

k +

AZT

X

6 w

eeks

Tabl

e 4

3b b

elow

sho

ws

alte

rnat

ive

prop

hyla

ctic

regi

men

s fo

r w

omen

pre

sent

ing

befo

re 3

8 w

eeks

of p

regn

ancy

Ran

king

Ti

me

of A

dmin

istr

atio

n

Alte

rnat

ive

Min

imum

Pre

gnan

cy

AZT(

28-3

8 w

eeks

)

Labo

ur

sd N

VP

+

AZT(

600m

gs

stat

)

sdN

VP

+ A

ZT+3

TC

Pos

tpar

tum

AZT+

3TC

X

7 da

ys

Infa

nt

sdN

VP

+

3TC

X 7

da

ys +

AZT

X

6 w

eeks

sdN

VP

+

3TC

day

s +

AZT

X 6

wee

ks

HIV

-infe

cted

pre

gnan

t w

omen

who

are

see

n fo

r th

e fir

st t

ime

afte

r 38

wee

ks o

f pr

egshy

nanc

y or

in la

bour

sho

uld

be g

iven

AR

V p

roph

ylac

tic r

egim

ens

as s

how

n in

Tab

le 4

4

The

baby

sho

uld

also

be

give

n A

RV

pro

phyl

axis

soo

n af

ter

birt

h as

sho

wn

in t

he s

ame

Bot

h H

IV-in

fect

ed a

nd u

ninf

ecte

d ch

ildre

n re

quir

e co

mpr

ehen

sive

car

e (R

efer

to C

hap-

tabl

ete

r 8

and

9)

61

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

46

Tabl

e 4

4 A

RV

prop

hyla

xis

for P

MTC

T am

ong

preg

nant

wom

en w

ho

have

not

rece

ived

ant

enat

al A

RT

or p

roph

ylax

is

Ran

king

Ti

me

of A

dmin

istr

atio

n

La

bour

P

ostp

artu

m

Mat

erna

l In

fant

Rec

omm

ende

d

sdN

VP

AZ

T+3T

C

SdN

VP

+

X 7

days

P

LUS

3TC

X 1

wee

k +

AZT+

3TC

AZ

T X

6 w

eeks

Min

imum

sd

NV

P

-S

dNV

P

PLU

S 3

TC X

1 w

eek

+

AZT

X 6

wee

ks

Dos

ages

Mot

her

Bab

y

NV

P

200

mg

stat

2m

gkg

sta

t with

in 7

2 ho

urs

AZT

300

mg

BID

4m

gkg

BID

X 6

wee

ks

3TC

15

0 m

g BI

D

4mg

kg B

ID X

1 w

eek

Tabl

e 4

5 R

ecom

men

ded

HA

AR

T fo

r Pre

gnan

t Wom

en

base

d on

CD

4 C

ount

and

Sta

ge o

f Pre

gnan

cy

CD

4 C

ount

H

AA

RT

Trim

este

r C

ells

mm

3

72

2 H

IV P

OSI

TIV

EIN

FAN

TB

Y D

NA

PC

R

bull A

ll H

IV p

ositi

ve in

fant

s sh

ould

be

eval

uate

d fo

r el

igib

ility

for

antishy

retr

ovir

al tr

eatm

ent

and

linke

d to

car

e an

d tr

eatm

ent

as a

ppro

pria

te

bull W

HO

clin

ical

sta

ging

sho

uld

be d

one

for

all H

IV p

ositi

ve in

fant

s

Chi

ldre

n w

ho a

re a

t W

HO

Clin

ical

sta

ge 3

or

4 ar

e el

igib

le f

or

antir

etro

vira

l tre

atm

ent

bull A

ll H

IV p

ositi

ve in

fant

s sh

ould

be

asse

ssed

for

CD

4 co

unt

whe

re

poss

ible

and

ava

ilabl

e R

efer

to

AR

T g

uide

lines

for

CD

4 co

unts

tha

t de

term

ine

elig

ibili

ty f

or A

RT

for

chi

ldre

n of

diff

eren

t ag

e br

acke

ts

bull A

ll H

IV-p

ositi

ve in

fant

s sh

ould

hav

e a

visi

ble

guar

dian

or

care

-tak

er

befo

re t

hey

can

be s

tart

ed o

n A

RT

bull A

ll H

IV-p

ositi

ve in

fant

s sh

ould

be

star

ted

on C

otri

mox

azol

e fr

om 6

w

eeks

or

on f

irst

cont

act t

here

afte

r

bull A

ll H

IV-p

ositi

ve in

fant

s sh

ould

be

star

ted

on A

RT

if el

igib

le

bull B

reas

tfeed

ing

shou

ld b

e en

cour

aged

for

all

HIV

-pos

itive

infa

nts

for

a

min

imum

of t

wo

year

s (

Ref

er t

o C

hapt

er 8

)

bull F

or a

ll H

IV-p

ositi

ve in

fant

s p

erfo

rm a

ntib

ody

test

ing

at 9

mon

ths

12

mon

ths

and

conf

irm

at

18 m

onth

s

1st T

rimes

ter

2nd T

rimes

ter

3rd T

rimes

ter

lt250

A

ZT+

3TC

+NV

P

AZ

T+3T

C+N

VP

AZT+

3TC

+NVP

250-

350

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

gt 35

0

A

ZT+3

TC+L

PVr

OR

A

BC

+3TC

+LPV

r

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

47

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

60

72

OPE

RA

TIO

NA

L G

UID

ELIN

ES

72

0 G

UID

ELIN

ESFO

R H

IV D

IAG

NO

SIS

INC

HIL

DR

EN

bull P

erfo

rm r

outin

e ra

pid

HIV

ant

ibod

y te

sts

for

all m

othe

rs o

f 6

wee

k ol

d in

fant

s pr

esen

ting

with

unk

now

n st

atus

bull P

erfo

rm r

outin

e dr

y bl

ood

spot

s (D

BS

) fo

r D

NA

PC

R f

or a

ll in

fant

s kn

own

to b

e H

IV-e

xpos

ed a

t 6

wee

ks

bull P

erfo

rm r

outin

e an

tibod

y te

stin

g fo

r al

l sic

k in

fant

s in

out

patie

nt a

nd

paed

iatr

ic w

ards

to

esta

blis

h H

IV e

xpos

ure

infe

ctio

n st

atus

bull P

erfo

rm D

BS

for

all

HIV

-exp

osed

sic

k in

fant

s un

der

12 m

onth

s

bull A

ll H

IV-e

xpos

ed in

fant

s sh

ould

be

star

ted

on C

otri

mox

azol

e fr

om 6

w

eeks

of

age

or o

n fir

st c

onta

ct th

erea

fter

bull R

efer

to

chap

ter

on c

are

and

follo

w u

p of

the

HIV

-exp

osed

infe

cted

in

fant

72

1 H

IV N

EGA

TIV

EIN

FAN

TA

TA

GE

6 W

EEK

SO

RFI

RST

CO

NTA

CT

Perf

orm

ant

ibod

y te

stin

g at

9 m

onth

s an

d 12

mon

ths

of a

ge

bull I

f H

IV n

egat

ive

at 1

2 m

onth

s an

d st

ill b

reas

tfee

ding

co

ntin

ue

Cot

rim

oxaz

ole

bull I

f not

bre

astf

eedi

ng f

or a

t le

ast

2 m

onth

s s

top

Cot

rim

oxaz

ole

bull P

erfo

rm c

onfir

mat

ory

antib

ody

test

ing

at 1

8 m

onth

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Mat

erna

l dos

ages

AZT

30

0 m

g B

ID

3TC

15

0 m

g BI

D

NVP

200

mg

OD

for t

wo

wee

ks t

here

afte

r 200

mg

BID

AB

C

300m

g B

ID

LPV

r (4

001

00)

2 ta

blet

s B

ID

EFV

60

0mg

QID

Not

es I

mpo

rtan

t con

side

ratio

ns th

at m

odify

cho

ice

of A

RV

s du

ring

pre

gnan

cy in

clud

e C

D4

coun

t m

ater

nal a

naem

ia a

nd

stag

e of

pre

gnan

cy

bull 2

NR

TIs

(A

ZT

and

3TC

) ac

ting

as a

ldquotr

eatm

ent

back

bone

rdquo w

ith a

dditi

on o

f an

N

NR

TI (

NV

P)

rem

ains

the

pre

ferr

ed fi

rst-

line

AR

V t

hera

py in

res

ourc

e-po

or

sett

ings

bull P

rote

ase

inhi

bito

rs b

ased

reg

imen

s ar

e pr

efer

able

whe

n C

D4

coun

t is

high

er

than

250

bull R

epla

ce A

ZT

with

d4T

if H

blt 8

gm

dL

bull

EF

V m

ay b

e us

ed in

stea

d of

NV

P a

fter

first

trim

este

r

bull

Usu

ally

AR

V s

houl

d be

with

held

if C

D4

coun

t is

not

ava

ilabl

e or

not

don

e

AR

V is

how

ever

use

d fo

r P

MT

CT

and

or in

adv

ance

d H

IV d

isea

se (

WH

O

Sta

ge 3

or

4) ir

resp

ectiv

e of

CD

4 co

unt

Bab

ies

who

se

mot

hers

di

d no

t re

ceiv

e an

tepa

rtum

or

in

trap

artu

m

AR

Vpr

ophy

laxi

s sh

ould

be

give

n A

RV

pro

phyl

axis

as

show

n in

Tab

le 4

6

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

9

48

Tabl

e 4

6 A

RV

prop

hyla

ctic

regi

men

s fo

r inf

ants

bor

n to

H

IV-p

ositi

ve w

omen

who

hav

e no

t rec

eive

d an

tepa

rtum

or

intr

apar

tum

AR

T or

AR

V pr

ophy

laxi

s

Ran

king

T

ime

of a

dmin

istr

atio

n an

d In

fant

dos

age

sdN

VP (2

mg

kg s

tat)

PLU

S 3T

C (4

mg

kg B

ID) X

1 w

eek

+ AZ

T (4

mg

kg

BID

) X 6

wee

ks

Rec

omm

ende

d

sdN

VP (2

mg

kg s

tat)

Min

imum

sdN

VP

is g

iven

to th

e in

fant

with

in 7

2 ho

urs

of b

irth

Plea

se n

ote

A

t fir

st c

onta

ct a

ll H

IV i

nfec

ted

preg

nant

wom

en s

houl

d be

giv

en s

dNV

P ta

blet

s to

take

hom

e w

ith t

hem

The

y sh

ould

be

inst

ruct

ed t

o ta

ke t

he t

able

ts a

t th

e on

set

of la

shybo

ur i

f lab

our

occu

rs o

utsi

de h

ealth

faci

lity

sett

ings

The

y sh

ould

als

o be

giv

en N

VP

3T

C a

nd A

ZT s

yrup

for

thei

r ba

bies

to b

e ad

min

iste

red

soon

aft

er b

irth

Som

e w

omen

with

a C

D4

coun

t gr

eate

r th

an 2

50 c

ells

microl

on

Nev

irap

ine

(NV

P)-b

ased

AR

T m

ay d

evel

op N

VP

hype

rsen

sitiv

e re

actio

ns t

hat

can

be li

fe t

hrea

teni

ng I

n th

ese

guid

elin

es it

is r

ecom

men

ded

that

for

preg

nant

wom

en w

ith C

D4

mor

e th

an 2

50 N

VP-

base

d re

gim

en m

ay s

till

be u

sed

but

with

clo

se m

onito

ring

O

ther

wis

e th

e re

com

shym

ende

d re

gim

en to

use

with

CD

4 co

unt a

bove

250

is a

PI-

base

d H

AA

RT

regi

men

Whe

n si

ngle

dos

e N

VP

(sdN

VP)

is u

sed

in P

MTC

T s

ome

wom

en a

nd c

hild

ren

may

deshy

velo

p re

sist

ance

to

NV

P th

at m

ay l

imit

futu

re u

se o

f N

on-N

ucle

osid

e R

ever

se T

ranshy

scri

ptas

e In

hibi

tors

(NN

RTI

s) t

o tr

eat

them

Th

e ri

sk o

f NN

RTI

res

ista

nce

is p

artic

ushyla

rly

high

if

two

dose

s of

sdN

VP

are

give

n T

here

fore

SdN

VP

shou

ld n

ever

be

used

mor

e th

an o

nce

in a

ny o

ne p

regn

ancy

Whe

re p

ossi

ble

AZT

3TC

sho

uld

be g

iven

for

7 da

ys t

o co

ver

the

NV

P ta

il bo

th in

the

mot

her

and

the

baby

Th

e ba

by is

the

n co

ntin

shyue

d on

AZT

for

a to

tal o

f 6 w

eeks

for

prop

hyla

xis

agai

nst M

TCT

HIV

-infe

cted

pre

gnan

t w

omen

sta

rtin

g zi

dovu

dine

(A

ZT)

cont

aini

ng r

egim

ens

shou

ld

have

hae

mog

lobi

n (H

b) le

vels

abo

ve 8

gm

dl

The

Hb

leve

l sho

uld

be c

heck

ed m

onth

ly

for

the

first

thr

ee m

onth

s W

here

pos

sibl

e A

ZT s

houl

d be

use

d in

stea

d of

sta

vudi

ne(d

4T)

Clin

ical

judg

emen

t can

be

used

to e

stim

ate

Hb

leve

ls a

nd in

itiat

e AR

V pr

ophy

laxi

s if l

aboshy

rato

ry te

sts a

re u

nava

ilabl

e

Efa

vire

nz (

EFV

) m

ay b

e te

rato

geni

c if

used

in t

he f

irst

tri

mes

ter

If t

he p

atie

nt is

on

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Cha

pter

7

HIV

Dia

gnos

is in

Chi

ldre

n 7

1 IN

TRO

DU

CTI

ON

In g

ener

al

a ch

ild m

ay b

e te

sted

und

er a

num

ber

of c

ircu

mst

ance

s T

hese

inc

lude

sh

ortly

aft

er b

irth

for

earl

y di

agno

sis

of H

IV f

or th

e pu

rpos

es o

f ind

ivid

ual d

iagn

osis

in

a ch

ild w

ho is

ill (

eg

tho

se p

rese

ntin

g w

ith a

n H

IV r

elat

ed il

lnes

s) i

n ca

ses

whe

re a

child

has

eith

er b

een

expo

sed

or is

pot

entia

lly e

xpos

ed t

o H

IV e

g t

hrou

gh m

othe

r-to

shych

ild t

rans

mis

sion

se

xual

abu

se

sexu

al a

ctiv

ity

with

in a

hea

lthca

re s

ettin

g (e

g

thro

ugh

cont

amin

ated

nee

dles

or

rece

ipt

of p

oten

tially

infe

ctio

us b

lood

) th

roug

h ot

her

mea

ns a

nd in

orp

hans

Ear

ly i

nfan

t di

agno

sis

(EID

) re

fers

to

the

mak

ing

of H

IV d

iagn

osis

in

infa

nts

and

youn

g ch

ildre

n be

fore

18

mon

ths

of a

ge E

ID g

ives

an

oppo

rtun

ity fo

r ea

rly

iden

tific

ashytio

n of

HIV

infe

cted

infa

nts

(des

pite

PM

TCT)

and

ear

ly li

nkag

e to

car

e an

d tr

eatm

ent

Dis

ease

pro

gres

sion

in H

IV in

fect

ed in

fant

s is

fast

with

a h

igh

mor

talit

y ra

te (gt

50

)by

2 y

ears

of a

ge T

he m

edia

n ag

e of

dea

th in

the

first

two

year

s is

6 m

onth

s H

IV a

ntishy

body

tes

ting

amon

g ch

ildre

n ag

ed 1

8 m

onth

s or

mor

e is

abl

e to

det

erm

ine

whe

ther

a

child

is in

fect

ed o

r no

t

Dur

ing

preg

nanc

y m

othe

rs g

ive

thei

r ba

bies

ant

ibod

ies

to in

fect

ions

the

y ha

ve e

xper

ishyen

ced

and

thes

e an

tibod

ies

wan

e w

ith ti

me

Ant

ibod

y te

stin

g in

chi

ldre

n ag

ed le

ss th

an

18 m

onth

s id

entif

ies

child

ren

who

hav

e be

en e

xpos

ed to

thei

r m

othe

rsrsquo H

IV in

fect

ion

or

who

may

be

trul

y in

fect

ed a

nd a

re m

akin

g H

IV a

ntib

odie

s C

urre

ntly

the

re is

no

test

to

diff

eren

tiate

the

mot

herrsquos

ant

ibod

ies

from

tho

se p

rodu

ced

by t

he b

aby

In

orde

r to

id

entif

y th

e H

IV-in

fect

ed c

hild

age

d le

ss t

han

18 m

onth

s a

sec

ond

test

is r

equi

red

for

all b

abie

s te

stin

g po

sitiv

e on

ant

ibod

y te

stin

g or

kno

wn

to b

e H

IV-e

xpos

ed (m

othe

r is

H

IV-p

ositi

ve)

Infa

nt D

NA

(or

RN

A) P

CR

tes

ting

is t

he c

urre

nt r

ecom

men

ded

met

hod

for

EID

Sinc

e m

ost b

abie

s lo

se m

ater

nal a

ntib

odie

s (A

b) b

y 12

mon

ths

a n

egat

ive

antib

ody

test

will

ide

ntify

uni

nfec

ted

babi

es a

s lo

ng a

s th

ey a

re n

ot s

till

brea

stfe

edin

g A

pos

itive

antib

ody

test

at

12 m

onth

s a

lthou

gh h

ighl

y lik

ely

to b

e di

agno

stic

may

stil

l be

due

topa

ssiv

ely

carr

ied

mat

erna

l ant

ibod

ies

Suc

h te

sts

need

to

be c

onfir

med

by

PCR

tes

ting

or r

epea

t ant

ibod

y te

st a

t 18

mon

ths

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

9

58

CARE

SU

PPO

RTAN

DTR

EATM

ENT

FOR

HIV

PO

SITI

VEM

OTH

ERAN

DCH

ILD

HIV

-pos

itive

mot

hers

requ

ire c

are

and

supp

ort w

hich

incl

udes

bull

Cou

nsel

ing

bull P

roph

ylax

is a

nd tr

eatm

ent

bull L

ink

to s

uppo

rt g

roup

s an

d as

sess

men

t of

the

nee

d fo

r A

RT

bull E

arly

infa

nt d

iagn

osis

sho

uld

be p

rovi

ded

at s

ix w

eeks

usi

ng D

NA

shyP

CR

tes

ting

Cha

pter

ref

eren

ces

1

Rep

ublic

of

Ken

ya M

inis

try

of

Hea

lth

Div

isio

n o

f Rep

roduct

ive

Hea

lth

Pla

nnin

g

Guid

elin

es f

or

serv

ice

pro

vider

s

Rev

ised

in M

arch

2006

Foo

tnot

es

1

Pre

ble

and P

iwoz

2001

2

WH

O

Contr

ace

ptive

Elig

ibili

ty C

rite

ria

Guid

e

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

EFV

bef

ore

beco

min

g pr

egna

nt i

t sho

uld

be s

ubsi

tute

d w

ith N

VP

in th

e 1s

t tri

mes

ter

In c

ase

of s

ever

e hy

pere

mes

is g

ravi

daru

m A

RT

may

nee

d to

be

brie

fly in

terr

upte

d

On

aver

age

mot

her-

to-c

hild

tra

nsm

issi

on r

ates

are

15

for

sdN

VP

65

fo

r m

ore

effishy

caci

ous

dual

reg

imen

s an

d 2

4 fo

r 3-

drug

AR

V c

ombi

natio

n

Futu

re P

ersp

ectiv

es

Ext

ende

d pr

ophy

laxi

s w

ith 3

AR

V d

rug

com

bina

tions

sta

rtin

g du

ring

pre

gnan

cy a

nd

cont

inui

ng a

fter

del

iver

y fo

r a

peri

od o

f up

to

6 m

onth

s a

mon

g H

IV-in

fect

ed b

reas

t-fe

edin

g m

othe

rs h

as b

een

show

n in

a f

ew r

ecen

t an

d is

olat

ed s

tudi

es a

nd p

ilot

proshy

gram

me

to le

ad to

low

er b

reas

tfee

ding

-rel

ated

pos

tnat

al M

TCT

Thi

s ap

proa

ch m

ay b

e co

nsid

ered

whe

re th

is is

feas

ible

acc

epta

ble

saf

e an

d w

here

adh

eren

ce c

an b

e as

sure

d

Mor

e st

udie

s on

this

issu

e ar

e ex

pect

ed

Thre

e A

RV

dru

g co

mbi

natio

ns g

iven

to

HIV

pos

itive

pre

gnan

t w

omen

who

are

not

yet

el

igib

le fo

r in

itiat

ion

of A

RTs

for

thei

r ow

n he

alth

als

o le

ad to

low

er M

TCT

and

may

be

cons

ider

ed in

pro

gram

mes

with

the

capa

city

to in

itiat

e th

e re

gim

en a

nd fo

llow

up

such

wom

en S

uch

inte

rven

tion

is in

itiat

ed a

t ar

ound

28

wee

ks o

r so

on a

fter

and

sto

pped

af

ter

birt

h if

CD

4 co

unt i

s st

ill a

bove

350

cel

lsm

m3

App

endi

ces

Appen

dix

I

Appen

dix

II

Appen

dix

III

Appen

dix

IV

WH

O C

linic

al S

tagin

g o

f H

IVA

IDS f

or

Adults

and A

dole

scen

ts

w

ith c

onfirm

ed H

IV infe

ctio

n

Contr

acep

tive

Options

for

Peo

ple

Liv

ing w

ith H

IV

Sum

mar

y of

ARV D

rug U

se f

or

PMTCT o

f H

IV

In

tegra

ted M

onitori

ng a

nd E

valu

ation R

eport

Form

MO

H 7

26

Cha

pter

ref

eren

ces

1

Sum

mar

y of

ARV D

rugs

Adve

rse

Effec

ts a

nd M

anag

emen

t T

able

6-1

0

pages

101-1

12 o

f G

uid

elin

es f

or

Antire

trovi

ral D

rug T

her

apy

in K

enya

3rd

Editio

n

De-

cem

ber

2005

2

Dru

g I

nte

ract

ions

Tab

le 7

-10

pag

es 1

12-1

22 o

f G

uid

elin

es f

or

Antire

trovi

ral

Dru

g T

her

apy

in K

enya

3rd

editio

n

Dec

2005

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

7

50

Cha

pter

5

Imm

edia

te P

ostn

atal

and

Neo

nata

l Car

e 5

1 IN

TRO

DU

CTI

ON

Imm

edia

te p

ostn

atal

and

neo

nata

l car

e re

fers

to th

e pa

ckag

e of

ser

vice

s pr

ovid

ed to

the

mot

her

and

infa

nt b

efor

e th

ey le

ave

the

heal

th fa

cilit

y (u

p to

48

hour

s) a

fter

del

iver

yTh

e pe

riod

pro

vide

s an

opp

ortu

nity

to e

duca

te a

ll m

othe

rs a

bout

HIV

to

prov

ide

coun

shyse

lling

and

tes

ting

if it

was

not

don

e pr

evio

usly

and

to

rein

forc

e th

e ed

ucat

ion

proshy

vide

d du

ring

the

ant

enat

al p

erio

d B

oth

HIV

inf

ecte

d an

d H

IV u

ninf

ecte

d m

othe

rs

shou

ld r

ecei

ve th

is e

duca

tion

and

coun

selli

ng b

efor

e di

scha

rge

52

OPE

RA

TIO

NA

L G

UID

ELIN

ES

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed fo

r all

wom

en a

nd

infa

nts

in th

e im

med

iate

pos

t par

tum

per

iod

a)

Opt

imal

pos

tpar

tum

car

e

bull R

outin

e ca

re in

clud

ing

brea

st e

xam

inat

ion

exa

min

atio

n of

the

ute

rus

ex

amin

atio

n of

the

per

ineu

m a

nd lo

chia

pa

ssag

e of

uri

ne r

egul

arly

pr

oper

hyg

iene

to

prev

ent

infe

ctio

n c

heck

ing

for

sign

s of

ana

emia

fe

ver

and

tach

ycar

dia

bull D

iscu

ss m

ater

nal n

utri

tion

bull E

stab

lish

the

HIV

sta

tus

of t

he m

othe

rs in

clud

ing

thos

e gi

ving

birt

h ou

tsid

e th

e he

alth

inst

itutio

n se

tting

bull P

rovi

de H

IV C

T f

or m

othe

rs w

ith u

nkno

wn

HIV

sta

tus

bull E

ncou

rage

HIV

res

ults

dis

clos

ure

and

part

ner

test

ing

bull F

ollo

w t

he s

tand

ard

guid

elin

es o

n th

e ca

re o

f a n

ewbo

rn (

IMP

AC

C

are

Man

ual)

bull A

ll ba

bies

sho

uld

rece

ive

thei

r ro

utin

e im

mun

izat

ion

(OP

V a

nd B

CG

) in

th

eir

first

hou

rs o

f lif

e1

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Con

trac

eptio

n A

ll m

othe

rs r

egar

dles

s of

the

ir H

IV s

tatu

s h

ave

a ri

ght

to r

ecei

ve a

dequ

ate

info

rmashy

tion

on a

vaila

ble

met

hods

of f

amily

pla

nnin

g an

d to

mak

e an

info

rmed

cho

ice

on w

hat

is b

est

for

them

H

IV-in

fect

ed w

omen

who

are

not

bre

astf

eedi

ng s

houl

d in

itiat

e a

relia

ble

cont

race

ptiv

e m

etho

d by

2-4

wee

ks p

ostp

artu

m

This

is

in a

dditi

on t

o th

epr

oper

and

con

sist

ent

use

of t

he c

ondo

m a

s a

form

of

dual

pro

tect

ion

All

met

hods

of

cont

race

ptio

n ca

n be

use

d by

HIV

pos

itive

wom

en b

ased

on

stan

dard

med

ical

elig

ibili

tycr

iteri

a in

clud

ing

taki

ng c

are

of d

rug

inte

ract

ions

as

outli

ned

belo

w2

bull L

acta

tiona

l Am

enor

rhoe

a M

etho

d (L

AM

) S

uita

ble

for

excl

usiv

ely

brea

stfe

edin

g H

IV in

fect

ed w

omen

who

hav

e no

t re

sum

ed m

ense

s

bull H

orm

onal

con

trac

eptio

n A

ll ho

rmon

al c

ontr

acep

tives

can

be

used

in

HIV

pos

itive

wom

en in

clud

ing

thos

e on

HA

AR

T

Com

bine

d or

al

cont

race

ptiv

es a

re c

ontr

aind

icat

ed f

or u

se w

ith d

rugs

that

indu

ce

hepa

tic m

icro

-enz

yme

that

may

red

uce

the

effe

ctiv

enes

s of

hor

mon

al

cont

race

ptiv

es

Som

e an

ti-T

Bs

ant

iret

rovi

rals

an

tifun

gals

and

ant

i-ep

ilept

ics

and

in c

ondi

tions

tha

t ca

use

mal

abso

rptio

n8

bull I

ntra

-ute

rine

con

trac

eptiv

e de

vice

s (I

UC

Ds)

IU

CD

s ar

e no

t co

ntra

indi

cate

d in

HIV

pos

itive

wom

en

In s

ever

ely

imm

uno

supp

rese

d w

omen

use

sho

uld

not

be d

isco

ntin

ued

but

new

inse

rtio

n is

dis

cour

aged

as

it m

ay b

e as

soci

ated

with

incr

ease

d ri

sk o

f in

fect

ion

duri

ng t

he in

sert

ion

proc

ess

bull S

urgi

cal m

etho

ds S

urgi

cal c

ontr

acep

tion

shou

ld b

e of

fere

d to

HIV

po

sitiv

e w

omen

and

the

ir pa

rtne

rs

bull B

arri

er m

etho

ds

Fem

ale

and

mal

e co

ndom

s pr

ovid

e pr

otec

tion

agai

nst

ST

Ds

and

redu

ce t

he r

isk

of H

IV t

rans

mis

sion

and

sho

uld

be

enco

urag

ed a

lone

or

toge

ther

with

oth

er c

ontr

acep

tive

met

hods

bull S

perm

icid

es

Use

d in

con

junc

tion

with

bar

rier

met

hods

spe

rmic

ides

w

ill p

rovi

de a

dditi

onal

con

trac

eptiv

e pr

otec

tion

How

ever

sp

erm

icid

es s

houl

d no

t be

use

d al

one

as t

hey

can

incr

ease

the

ris

k of

HIV

acq

uisi

tion

bull E

mer

genc

y co

ntra

cept

ion

HIV

pos

itive

wom

en s

houl

d be

info

rmed

ab

out

emer

genc

y co

ntra

cept

ion

whe

re it

is a

vaila

ble

and

how

to

obta

in a

nd u

se it

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

1

56

Bre

ast c

are

in b

reas

tfeed

ing

mot

hers

bull E

ncou

rage

dai

ly c

lean

ing

of t

he b

reas

ts a

nd a

void

ing

the

appl

icat

ion

of lo

tions

bull T

reat

mat

erna

l vag

inal

can

didi

asis

and

infa

nt o

ral c

andi

dias

is

bull E

duca

te m

othe

r on

opt

imal

bre

astf

eedi

ng te

chni

que

incl

udin

g la

tchi

ng

on t

echn

ique

ex

lusi

ve b

reas

tfee

ding

and

rem

ovin

g ba

by f

rom

bre

ast

bull E

duca

te th

e m

othe

r on

bre

ast c

are

to p

reve

nt c

ompl

icat

ions

(cr

acki

ng

and

engo

rgem

ent)

bull E

xpre

ss a

nd h

eat

trea

t th

e m

ilk if

bre

ast

has

mas

titis

or

absc

ess

Opt

imal

pos

tpar

tum

car

e fo

r HIV

pos

itive

wom

en

Loch

ia

bull P

ut e

mph

asis

on

good

per

inea

l hyg

iene

and

pro

per

hand

ling

of b

ody

fluid

s

bull A

void

con

tam

inat

ing

the

baby

with

bod

y flu

ids

or w

ith b

eddi

ng s

oile

d w

ith lo

chia

bull S

hari

ng o

f be

ds b

y m

othe

rs in

the

hos

pita

l sho

uld

be d

isco

urag

ed

Cae

sare

an S

ectio

n

Bro

ad s

pect

rum

ant

ibio

tics

shou

ld b

e us

ed r

outin

ely

afte

r C

S

Esse

ntia

l mat

erna

l edu

catio

n an

d fo

llow

-up

bull M

onito

r fo

r br

east

and

pel

vic

infe

ctio

n at

all

post

nat

al c

linic

vis

its

bull E

duca

te o

n pr

ompt

hea

lth s

eeki

ng b

ehav

iour

bull H

ealth

edu

catio

n on

hyg

iene

lo

chia

and

bre

ast

care

bull A

void

sex

ual i

nter

cour

se f

or a

t lea

st 2

wee

ks a

fter

birt

h or

unt

il th

ere

is

no lo

nger

any

loch

ia r

ubra

or

sero

sa

bull D

o pa

p sm

ear

or V

IA a

t 4-

6 w

eeks

bull F

or e

very

sex

ual a

ctiv

ity

the

coup

le s

houl

d us

e co

ndom

s

bull D

iscu

ss f

amily

pla

nnin

g at

eve

ry o

ppor

tuni

ty a

nd p

rovi

de t

he

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Supp

ort

infa

nt fe

edin

g op

tions

For

all

HIV

neg

ativ

e w

omen

wom

en o

f unk

now

n H

IV

stat

us a

nd H

IV p

ositi

ve m

othe

rs o

ptin

g fo

r ex

clus

ive

brea

stfe

edin

g in

itiat

e br

east

feed

shyin

g w

ithin

hal

f hou

r of

bir

th a

nd fo

llow

oth

er g

uide

lines

as

per

Bab

y Fr

iend

ly H

ospi

tal

Initi

ativ

e2 (B

FHI)

bull G

ive

info

rmat

ion

on fa

mily

pla

nnin

g an

d du

al p

rote

ctio

n

bull C

ouns

el o

n H

IV r

isk

redu

ctio

n

bull S

ched

ule

post

nata

l clin

ic v

isits

at

2 w

eeks

and

at

4-6

wee

ks a

nd

com

plet

e m

othe

r-ch

ild b

ookl

et (

refe

r to

DR

H m

anua

l)

(b) S

peci

fic p

ostp

artu

m c

are

for H

IV p

ositi

ve w

omen

bull S

uppo

rt e

xclu

sive

bre

astf

eedi

ng u

nles

s m

othe

r ha

s ap

prop

riat

ely

opte

d fo

r an

d be

en c

ouns

elle

d on

rep

lace

men

t fe

edin

g an

tena

tally

bull I

nitia

te o

r co

ntin

ue c

o-tr

imox

azol

e pr

ophy

laxi

s -1

dou

ble

stre

ngth

tab

shyle

t da

ily

bull F

or H

IV p

ositi

ve m

othe

rs t

hat

rece

ived

sd

nevi

rapi

ne in

trap

artu

m

initi

shyat

e A

ZT

300m

g an

d 3T

C 1

50 m

g B

D f

or 1

wee

k

bull F

or n

ewly

dia

gnos

ed m

othe

rs

do H

IV s

tagi

ng

CD

4 co

unt

and

refe

r ap

prop

riat

ely

for

cont

inue

d ca

re

(c)

Spec

ific

care

for H

IV e

xpos

ed in

fant

s

bull F

or H

IV e

xpos

ed in

fant

s a

dmin

iste

r sd

NV

P 2

mg

kg s

tat

with

in 7

2 ho

urs

Giv

e A

ZT

4 m

gkg

BID

for

6 w

eeks

and

3T

C 4

mg

kg B

ID f

or 1

w

eek

Ref

er t

o C

hapt

er 4

bull R

efer

to C

hapt

er 8

for

deta

ils o

n in

fant

fee

ding

opt

ions

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

5

52

Cha

pter

ref

eren

ces

1

Rep

ublic

of

Ken

ya M

inis

try

of

Hea

lth

Div

isio

n o

f Rep

roduct

ive

Hea

lth

Nat

ional

Guid

elin

es f

or

Qual

ity

Obst

etri

cs a

nd P

erin

ata

l Car

e (2

004)

2

2R

epublic

of

Ken

ya M

inis

try

of

Hea

lth

Ess

ential

Obst

etri

c C

are

Man

ual

for

Hea

lth

Ser

vice

Pro

vider

s in

Ken

ya 3

rd E

ditio

n (

Jan 2

006)

Foo

tnot

es

1

WH

O r

ecom

men

ds

that

all

vacc

ines

should

be

giv

en t

o H

IV-s

ero-n

egat

ive

child

ren

and t

o a

sym

pto

mat

ic s

ero-p

osi

tive

s

The

only

vac

cines

to b

e w

ithhel

d f

rom

child

ren w

ith s

ympto

mat

ic A

IDS a

re B

CG

and

Yel

low

fev

er v

acc

ines

2

The

ldquoTen

Ste

psrdquo

of

BFH

I R

ecom

men

ded

Pra

ctic

es f

or

Mat

ernity

Ser

vice

s ad

apte

d f

or

W

HO

UN

ICEF

1989

Cha

pter

6

Late

Pos

tnat

al C

are

and

Fam

ily P

lann

ing

61

INTR

OD

UC

TIO

N

Late

pos

tnat

al c

are

is p

rovi

ded

to t

he m

othe

r an

d th

e ch

ild 4

8 ho

urs

to 6

wee

ks a

fter

deliv

ery

Dur

ing

this

per

iod

the

heal

th o

f the

mot

her

and

child

is a

sses

sed

and

clos

ely

mon

itore

d

The

risk

of M

TCT

duri

ng th

e po

stpa

rtum

per

iod

can

be r

educ

ed b

y pr

ovid

ing

HIV

cou

nshyse

lling

and

test

ing

pos

t-ex

posu

re p

roph

ylax

is fo

r ex

pose

d ba

bies

cou

nsel

ling

on a

ppro

shypr

iate

infa

nt fe

edin

g op

tions

and

bre

ast c

are

Pos

tpar

tum

car

e fo

r H

IV p

ositi

ve w

omen

shou

ld in

clud

e cl

inic

al s

tagi

ng C

D4

coun

t and

AR

T fo

r th

ose

who

qua

lify

Fam

ily p

lann

ing

serv

ices

are

am

ong

the

core

inte

rven

tions

of P

MTC

T pr

ovid

ed to

hel

pw

omen

det

erm

ine

futu

re c

hild

bear

ing

patt

erns

inc

ludi

ng t

he p

reve

ntio

n of

HIV

-in

fect

ed b

irth

s

Rep

rodu

ctiv

e he

alth

cou

nsel

ling

can

help

a w

oman

pra

ctis

e sa

fer

sex

and

dete

rmin

e he

r fu

ture

ch

ildbe

arin

g pa

tter

ns

on

a m

ore

resp

onsi

ble

and

info

rmed

bas

is1

62

OPE

RA

TIO

NA

L G

UID

ELIN

ES

Opt

imal

pos

tpar

tum

car

e fo

r all

wom

en

This

ent

ails

rou

tine

care

inc

ludi

ng b

reas

t ex

amin

atio

n e

xam

inat

ion

of t

he u

teru

s

exam

inat

ion

of t

he p

erin

eum

and

loch

ia p

assa

ge o

f uri

ne r

egul

arly

pro

per

hygi

ene

topr

even

t in

fect

ion

che

ckin

g fo

r si

gns

of a

nem

ia

feve

r an

d ta

chyc

ardi

a an

d do

ing

peri

neal

exe

rcis

es

Add

ition

al c

are

incl

udes

bull C

ouns

ellin

g an

d te

stin

g fo

r m

othe

rs o

f un

know

n H

IV s

tatu

s bull

Pro

visi

on o

f co

ndom

s an

d ris

k re

duct

ion

coun

selli

ng

bull C

ouns

ellin

g on

con

trac

eptiv

e op

tions

in

clud

ing

dual

met

hod

use

bull D

iscu

ssin

g m

ater

nal n

utrit

ion

bull M

alar

ia p

reve

ntio

n bull

Scr

eeni

ng f

or S

TI a

nd c

ervi

cal c

ance

r

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

3

54

ltlt ASCII85EncodePages false AllowTransparency false AutoPositionEPSFiles true AutoRotatePages None Binding Left CalGrayProfile (Dot Gain 20) CalRGBProfile (sRGB IEC61966-21) CalCMYKProfile (US Web Coated 050SWOP051 v2) sRGBProfile (sRGB IEC61966-21) CannotEmbedFontPolicy Warning CompatibilityLevel 14 CompressObjects Tags CompressPages true ConvertImagesToIndexed true PassThroughJPEGImages true CreateJobTicket false DefaultRenderingIntent Default DetectBlends true DetectCurves 00000 ColorConversionStrategy CMYK DoThumbnails false EmbedAllFonts false EmbedOpenType false ParseICCProfilesInComments true EmbedJobOptions true DSCReportingLevel 0 EmitDSCWarnings false EndPage -1 ImageMemory 1048576 LockDistillerParams false MaxSubsetPct 100 Optimize true OPM 1 ParseDSCComments true ParseDSCCommentsForDocInfo true PreserveCopyPage true PreserveDICMYKValues true PreserveEPSInfo true PreserveFlatness true PreserveHalftoneInfo false PreserveOPIComments true PreserveOverprintSettings true StartPage 1 SubsetFonts true TransferFunctionInfo Apply UCRandBGInfo Preserve UsePrologue false ColorSettingsFile () AlwaysEmbed [ true Arial-Black Arial-BoldItalicMT Arial-BoldMT Arial-ItalicMT ArialMT ArialNarrow ArialNarrow-Bold ArialNarrow-BoldItalic ArialNarrow-Italic ArialRoundedMTBold ArialUnicodeMS CenturySchoolbook CenturySchoolbook-Bold CenturySchoolbook-BoldItalic CenturySchoolbook-Italic Symbol Times-Bold Times-BoldItalic Times-Italic TimesNewRomanPS-BoldItalicMT TimesNewRomanPS-BoldMT TimesNewRomanPS-ItalicMT TimesNewRomanPSMT Times-Roman Verdana Verdana-Bold Verdana-BoldItalic Verdana-Italic Wingdings2 Wingdings3 Wingdings-Regular ] NeverEmbed [ true ] AntiAliasColorImages false CropColorImages true ColorImageMinResolution 300 ColorImageMinResolutionPolicy OK DownsampleColorImages true ColorImageDownsampleType Bicubic ColorImageResolution 300 ColorImageDepth -1 ColorImageMinDownsampleDepth 1 ColorImageDownsampleThreshold 150000 EncodeColorImages true ColorImageFilter DCTEncode AutoFilterColorImages true ColorImageAutoFilterStrategy JPEG ColorACSImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt ColorImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt JPEG2000ColorACSImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt JPEG2000ColorImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt AntiAliasGrayImages false CropGrayImages true GrayImageMinResolution 300 GrayImageMinResolutionPolicy OK DownsampleGrayImages true GrayImageDownsampleType Bicubic GrayImageResolution 300 GrayImageDepth -1 GrayImageMinDownsampleDepth 2 GrayImageDownsampleThreshold 150000 EncodeGrayImages true GrayImageFilter DCTEncode AutoFilterGrayImages true GrayImageAutoFilterStrategy JPEG GrayACSImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt GrayImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt JPEG2000GrayACSImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt JPEG2000GrayImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt AntiAliasMonoImages false CropMonoImages true MonoImageMinResolution 1200 MonoImageMinResolutionPolicy OK DownsampleMonoImages true MonoImageDownsampleType Bicubic MonoImageResolution 1200 MonoImageDepth -1 MonoImageDownsampleThreshold 150000 EncodeMonoImages true MonoImageFilter CCITTFaxEncode MonoImageDict ltlt K -1 gtgt AllowPSXObjects false CheckCompliance [ None ] PDFX1aCheck false PDFX3Check false PDFXCompliantPDFOnly false PDFXNoTrimBoxError true PDFXTrimBoxToMediaBoxOffset [ 000000 000000 000000 000000 ] PDFXSetBleedBoxToMediaBox true PDFXBleedBoxToTrimBoxOffset [ 000000 000000 000000 000000 ] PDFXOutputIntentProfile () PDFXOutputConditionIdentifier () PDFXOutputCondition () PDFXRegistryName () PDFXTrapped False CreateJDFFile false Description ltlt ARA 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 BGR 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 CHS ltFEFF4f7f75288fd94e9b8bbe5b9a521b5efa7684002000410064006f006200650020005000440046002065876863900275284e8e9ad88d2891cf76845370524d53705237300260a853ef4ee54f7f75280020004100630072006f0062006100740020548c002000410064006f00620065002000520065006100640065007200200035002e003000204ee553ca66f49ad87248672c676562535f00521b5efa768400200050004400460020658768633002gt CHT ltFEFF4f7f752890194e9b8a2d7f6e5efa7acb7684002000410064006f006200650020005000440046002065874ef69069752865bc9ad854c18cea76845370524d5370523786557406300260a853ef4ee54f7f75280020004100630072006f0062006100740020548c002000410064006f00620065002000520065006100640065007200200035002e003000204ee553ca66f49ad87248672c4f86958b555f5df25efa7acb76840020005000440046002065874ef63002gt CZE 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 DAN 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 DEU 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 ESP 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 ETI 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 FRA 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 GRE ltFEFF03a703c103b703c303b903bc03bf03c003bf03b903ae03c303c403b5002003b103c503c403ad03c2002003c403b903c2002003c103c503b803bc03af03c303b503b903c2002003b303b903b1002003bd03b1002003b403b703bc03b903bf03c503c103b303ae03c303b503c403b5002003ad03b303b303c103b103c603b1002000410064006f006200650020005000440046002003c003bf03c5002003b503af03bd03b103b9002003ba03b103c42019002003b503be03bf03c703ae03bd002003ba03b103c403ac03bb03bb03b703bb03b1002003b303b903b1002003c003c103bf002d03b503ba03c403c503c003c903c403b903ba03ad03c2002003b503c103b303b103c303af03b503c2002003c503c803b703bb03ae03c2002003c003bf03b903cc03c403b703c403b103c2002e0020002003a403b10020005000440046002003ad03b303b303c103b103c603b1002003c003bf03c5002003ad03c703b503c403b5002003b403b703bc03b903bf03c503c103b303ae03c303b503b9002003bc03c003bf03c103bf03cd03bd002003bd03b1002003b103bd03bf03b903c703c403bf03cd03bd002003bc03b5002003c403bf0020004100630072006f006200610074002c002003c403bf002000410064006f00620065002000520065006100640065007200200035002e0030002003ba03b103b9002003bc03b503c403b103b303b503bd03ad03c303c403b503c103b503c2002003b503ba03b403cc03c303b503b903c2002egt HEB 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 HRV (Za stvaranje Adobe PDF dokumenata najpogodnijih za visokokvalitetni ispis prije tiskanja koristite ove postavke Stvoreni PDF dokumenti mogu se otvoriti Acrobat i Adobe Reader 50 i kasnijim verzijama) HUN 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 ITA 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 JPN ltFEFF9ad854c18cea306a30d730ea30d730ec30b951fa529b7528002000410064006f0062006500200050004400460020658766f8306e4f5c6210306b4f7f75283057307e305930023053306e8a2d5b9a30674f5c62103055308c305f0020005000440046002030d530a130a430eb306f3001004100630072006f0062006100740020304a30883073002000410064006f00620065002000520065006100640065007200200035002e003000204ee5964d3067958b304f30533068304c3067304d307e305930023053306e8a2d5b9a306b306f30d530a930f330c8306e57cb30818fbc307f304c5fc59808306730593002gt KOR ltFEFFc7740020c124c815c7440020c0acc6a9d558c5ec0020ace0d488c9c80020c2dcd5d80020c778c1c4c5d00020ac00c7a50020c801d569d55c002000410064006f0062006500200050004400460020bb38c11cb97c0020c791c131d569b2c8b2e4002e0020c774b807ac8c0020c791c131b41c00200050004400460020bb38c11cb2940020004100630072006f0062006100740020bc0f002000410064006f00620065002000520065006100640065007200200035002e00300020c774c0c1c5d0c11c0020c5f40020c2180020c788c2b5b2c8b2e4002egt LTH 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 LVI 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 NLD (Gebruik deze instellingen om Adobe PDF-documenten te maken die zijn geoptimaliseerd voor prepress-afdrukken van hoge kwaliteit De gemaakte PDF-documenten kunnen worden geopend met Acrobat en Adobe Reader 50 en hoger) NOR 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 POL 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 PTB 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 RUM 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 RUS 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 SKY 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 SLV 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 SUO 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 SVE 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 TUR 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 UKR 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 ENU (Use these settings to create Adobe PDF documents best suited for high-quality prepress printing Created PDF documents can be opened with Acrobat and Adobe Reader 50 and later) gtgt Namespace [ (Adobe) (Common) (10) ] OtherNamespaces [ ltlt AsReaderSpreads false CropImagesToFrames true ErrorControl WarnAndContinue FlattenerIgnoreSpreadOverrides false IncludeGuidesGrids false IncludeNonPrinting false IncludeSlug false Namespace [ (Adobe) (InDesign) (40) ] OmitPlacedBitmaps false OmitPlacedEPS false OmitPlacedPDF false SimulateOverprint Legacy gtgt ltlt AddBleedMarks false AddColorBars false AddCropMarks false AddPageInfo false AddRegMarks false ConvertColors ConvertToCMYK DestinationProfileName () DestinationProfileSelector DocumentCMYK Downsample16BitImages true FlattenerPreset ltlt PresetSelector MediumResolution gtgt FormElements false GenerateStructure false IncludeBookmarks false IncludeHyperlinks false IncludeInteractive false IncludeLayers false IncludeProfiles false MultimediaHandling UseObjectSettings Namespace [ (Adobe) (CreativeSuite) (20) ] PDFXOutputIntentProfileSelector DocumentCMYK PreserveEditing true UntaggedCMYKHandling LeaveUntagged UntaggedRGBHandling UseDocumentProfile UseDocumentBleed false gtgt ]gtgt setdistillerparamsltlt HWResolution [2400 2400] PageSize [612000 792000]gtgt setpagedevice

MIN

ISTR

Y O

F H

EALT

H

Rep

ublic

of K

enya

Gui

delin

es fo

r

Prev

entio

n of

Mot

her t

o C

hild

Tr

ansm

issi

on (P

MTC

T) o

f HIV

AID

S

in K

enya

NA

TIO

NA

L A

IDS

amp S

TI C

ON

TRO

L PR

OG

RA

MM

E

PO

BO

X 19

361-

002

00

NA

IRO

BI

Third

Edi

tion

200

9

1

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

106

Enq

uiri

es r

egar

ding

thes

e PM

TCT

Gui

delin

es s

houl

d be

add

ress

ed to

Dire

ctor

N

atio

nal A

IDS

and

STI C

ontr

ol P

rogr

amm

e (N

ASC

OP)

M

inis

try

of H

ealth

P

O B

ox 1

9361

- 00

200

N

airo

bi K

enya

Te

leph

one

+25

4 20

272

9502

272

9549

Fa

x +

254

20 2

71 0

518

or 2

72 9

502

Em

ail

head

nasc

op

icon

nect

co

ke

Web

site

ww

wa

idsk

enya

org

Third

edi

tion

Cop

yrig

ht copy

200

9 M

inis

try o

f Hea

lth G

over

nmen

t of K

enya

105

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

2

A

ppen

dix

VII

I Li

st o

f Con

trib

utor

s

Dr

Ayi

si R

ober

t K

Dep

uty

Hea

d N

ASC

OP

PMTC

T Pr

grm

Mng

r

MO

H-N

ASC

OP

Dr

Abd

alla

h S

aade

H

IV T

rain

er J

HPI

EG

O

Ms

Ake

lola

Rut

h

Nut

ritio

n amp

HIV

Man

ager

MO

H-N

ASC

OP

Mr

Dey

a J

osph

at

PMTC

T Pr

ogra

m O

ffice

r M

OH

-NA

SCO

P

Dr

Die

lem

ans

Pau

l

Mat

erna

l Neo

nata

l Hea

lth (M

NH

) Adv

isor

EH

SD

RH

Ms

Gitu

to A

nnie

W

Prog

ram

Offi

cer

MO

H-D

RH

Dr

Inw

ani

Iren

e

Paed

iatr

icia

n IC

AR

T K

NH

Mr

Isav

wa

Ant

hony

D

ata

Prog

ram

Man

ager

CD

C K

enya

Dr

Kar

anja

Dom

inic

PM

TCT

Prog

ram

Man

ager

PA

THFI

ND

ER

Inte

rnat

iona

l

Dr

Kia

rie

Jam

es N

PM

TCT

Prog

ram

Man

ager

KN

HU

ON

Dr

Kig

en B

atile

l Pr

ogra

m M

anag

er M

OH

-DR

H

Ms

Koe

ch R

osel

ine

Pr

ogra

m O

ffice

r M

OH

-DR

H

Dr

Mac

hari

a S

heila

R

H S

ervi

ces

Spec

ialis

t U

SAID

K

Dr

Mat

u L

ucy

PM

TCT

Prog

ram

Man

ager

USA

IDK

Ms

Mau

a J

udith

Pr

ogra

m O

ffice

r D

RH

-MO

H

Prof

Mbo

ri-N

gach

a D

Se

nior

Tec

hnic

al A

dvis

or A

ssoc

iate

Pro

fess

or

of P

aedi

atri

cs C

DC

Ken

ya U

oN

Dr

Mud

any

Mild

red

Te

chni

cal A

dvis

or C

DC

Ken

ya

Ms

Muh

enje

Ody

lia

Beh

avio

ral S

cien

tist

CD

C K

enya

Ms

Mut

sots

o W

infr

ed

PMTC

T Te

chni

cal A

dvis

orP

rogr

am M

anag

er C

DC

Ken

ya

Ms

Mut

uku

Ter

esia

H

IV T

rain

er J

HPI

EG

O

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

3

104

App

endi

x V

II

103

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Ms

Mw

anga

ngi

Alic

e Pr

ogra

m O

ffice

r D

RH

-MO

H

Ms

Mw

angi

Nan

cy

PMTC

T A

dmin

istr

ativ

e A

ssis

tant

CD

C K

enya

Mr

Ndw

iga

Fra

ncis

Pr

ogra

m O

ffice

r M

OH

-NA

SCO

P

Prof

Ndu

ati

Rut

h

Ass

ocia

te P

rofe

ssor

of P

aedi

atri

cs U

oN

Dr

Nju

guna

Cha

rles

Pr

ogra

m A

ssoc

iate

MSH

RPM

Plu

s

Mr

Nya

beri

Dav

id

Prog

ram

Offi

cer

MO

H-D

RH

Mr

Ode

ra J

W

Prog

ram

Coo

rdin

ator

GTZ

Ms

Olu

och

Pat

rici

a Te

chni

cal A

dvis

or C

DC

Ken

ya

Mr

Olu

och

Tom

Te

chni

cal A

dvis

or C

DC

Ken

ya

Dr

Onrsquo

gech

Joh

n

Prog

ram

Coo

rdin

ator

KN

H

Dr

Otie

no-N

yuny

a B

Se

nior

Lec

ture

rH

ead

of D

epar

tmen

t PM

TCT

Dir

ecto

rM

oi U

nive

rsity

AM

PATH

Dr

Oum

a C

hris

PM

TCT

Prog

ram

Offi

cer

UN

ICE

F

Dr

Saw

e F

redr

ick

K

Dep

uty

Dir

ecto

r W

RP

Mr

Soo

Leo

nard

Pr

ogra

m M

anag

er W

RP

Dr

Vak

il S

obha

N

Tech

nica

l Adv

isor

AR

T Pr

ogra

m N

ASC

OP

Ms

Way

ua R

uth

Prog

ram

Offi

cer

MO

H-D

RH

Dr

Yon

ga I

sabe

lla

PMTC

T Te

chni

cal A

dvis

or E

GPA

F

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

Tabl

e of

Con

tent

s Li

st o

f con

trib

utor

s 3

Tabl

e of

con

tent

s 5

Ack

now

ledg

emen

ts

10

Fore

wor

d 11

Abb

revi

atio

ns a

nd A

cron

yms

12

Exe

cutiv

e Su

mm

ary

16

Cha

pter

1

Bac

kgro

und

20

11T

he G

loba

l Pan

dem

ic

20

12

Mag

nitu

de o

f HIV

in P

regn

ancy

in

22

13

Ris

ks o

f Tra

nsm

issi

on o

f MTC

T at

Diff

eren

t Tim

e Pe

riod

s 23

14

Ris

k Fa

ctor

s of

MTC

T of

HIV

24

15

Ben

efits

of P

MTC

T of

HIV

25

16

Ben

efits

of H

IV C

ouns

ellin

g amp

Tes

ting

25

17

The

Four

-pro

nged

App

roac

h to

PM

TCT

26

18

Ove

rvie

w o

f the

New

PM

TCT

Gui

delin

es

28

19

Obj

ectiv

es amp

Org

anis

atio

n of

the

Gui

delin

es

28

110

U

sing

the

Gui

delin

es

29

Cha

pter

2 A

nten

atal

Car

e an

d Pr

even

tion

of M

TCT

of H

IV

32

21

Intr

oduc

tion

32

5

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4 B

acte

riolo

gica

l con

firm

atio

n

App

ropr

iate

clin

ical

sam

ples

incl

ude

sput

um

gast

ric

aspi

rate

s an

d ce

rtai

n ot

her

mat

eria

ls

Sin

ce m

ost

TB

in c

hild

ren

is in

infa

nts

and

youn

g ch

ildre

n s

putu

m

indu

ctio

n m

ay b

e do

ne fi

rst

or g

astr

ic a

spira

tions

and

exp

ecto

ratio

ns

a S

putu

m In

duct

ion

Spu

tum

indu

ctio

n is

saf

e an

d ef

fect

ive

in c

hild

ren

of a

ll ag

es a

nd t

he b

acte

rial

yi

elds

a]r

e as

goo

d or

bet

ter

that

for

gas

tric

asp

irate

s

b G

astr

ic a

spira

tion

Thi

s is

per

form

ed in

you

ng c

hild

ren

who

are

una

ble

or u

nwill

ing

to

expe

ctor

ate

sput

um

A g

astr

ic a

spir

ate

shou

ld b

e ob

tain

ed o

n ea

ch o

f th

e th

ree

cons

ecut

ive

mor

ning

s

c E

xpec

tora

tions

S

putu

m s

houl

d al

way

s be

obt

aine

d in

adu

lts a

nd o

lder

chi

ldre

n gt1

0 ye

ars

of

age

susp

ecte

d of

hav

ing

pulm

onar

y T

B

Bac

teri

al y

ield

s ar

e hi

gher

in o

lder

chi

ldre

n

Thr

ee s

putu

m s

peci

men

s sh

ould

be

obta

ined

an

on-

the

ndashspo

t sp

ecim

en (

at t

he

first

eva

luat

ion)

an

ear

ly m

orni

ng s

peci

men

and

a s

econ

d on

-the

-spo

t sp

ecim

en

Spu

tum

indu

ctio

n is

saf

e an

d ef

fect

ive

in c

hild

ren

of a

ll ag

es a

nd t

he b

acte

rial

yi

elds

are

as

good

or

bett

er t

han

for

gast

ric a

spira

tes

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

102

NO

TES

1 H

isto

ry

bull A

sk f

or s

ympt

oms

cons

iste

nt w

ith T

B in

clud

ing

chro

nic

coug

hgt 2

wee

ks

feve

r- b

ody

tem

pera

ture

of

38 o C

for

14 d

ays

afte

r co

mm

on c

ause

s su

ch a

s m

alar

ia a

nd p

neum

onia

hav

e be

en e

xclu

ded

wei

ght

loss

or

failu

re t

o th

rive

(

also

look

at

the

grow

th c

hart

) a

nd o

r ni

ght

swea

ts

Enq

uire

whe

ther

the

pat

ient

has

bee

n in

clo

se c

onta

ct w

ith s

mea

r-po

sitiv

e pu

lshym

onar

y T

B (

usua

lly a

par

ent

or o

ther

mem

ber

of th

e fa

mily

)

2 C

linic

al e

xam

inat

ion

a P

hysi

cal s

igns

hig

hly

sugg

estiv

e of

ext

ra p

ulm

onar

y T

B

bull O

ften

the

mai

n cl

inic

al f

indi

ng is

just

fai

lure

to

thriv

e

bull G

ibus

es

peci

ally

of

rece

nt o

nset

(re

sulti

ng f

rom

ver

tebr

al T

B)

bull N

on-p

ainf

ul e

nlar

ged

cerv

ical

lym

phad

enop

athy

with

fis

tula

for

mat

ion

b P

hysi

cal s

igns

req

uiri

ng in

vest

igat

ions

to

excl

ude

extr

a pu

lmon

ary

TB

bull M

enin

gitis

not

res

pond

ing

to a

ntib

iotic

s tr

eatm

ent

bull P

leur

al e

ffus

ion

bull P

eric

ardi

al e

ffus

ion

bull D

iste

nded

abd

omen

with

asc

itis

bull N

on-p

ainf

ul e

nlar

ged

lym

ph n

odes

with

out

fistu

la f

orm

atio

n

bull N

on-p

ainf

ul e

nlar

ged

join

t

Sig

ns o

f tu

berc

ulin

hyp

erse

nsiti

vity

3 M

anto

ux te

st

A m

anto

ux t

est

shou

ld b

e re

gard

ed p

ositi

ve a

s fo

llow

s

bull I

n hi

gh-r

isk

child

ren

(inc

lude

s H

IV-i

nfec

ted

child

ren

and

seve

rely

mal

shyno

uris

hed

child

ren

) gt

5mm

dia

met

er o

f in

dura

tion

bull I

n al

l oth

er c

hild

ren(

whe

ther

the

y ha

ve r

ecei

ved

BC

G o

r no

t)

gt10m

m d

ishyam

eter

of i

ndur

atio

n

101

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

22

Ope

ratio

nal G

uide

lines

32

23

Job

Aid

s 34

24

App

endi

ces

13

Cha

pter

3 I

ntra

part

um C

are

38

31

Intr

oduc

tion

38

32

Ope

ratio

nal G

uide

lines

38

Cha

pter

4

Use

of A

RVs

in P

regn

ancy

for T

reat

men

t amp P

MTC

T of

HIV

infe

ctio

n 42

41

Intr

oduc

tion

42

42

Ope

ratio

nal G

uide

lines

43

Cha

pter

5 I

mm

edia

te P

ostn

atal

and

Neo

nata

l Car

e

51

51

Intr

oduc

tion

51

52

Ope

ratio

nal G

uide

lines

51

Cha

pter

6 L

ate

Post

nata

l Car

e an

d Fa

mily

Pla

nnin

g

54

61

Intr

oduc

tion

54

62

Ope

ratio

nal G

uide

lines

54

Cha

pter

7 H

IV D

iagn

osis

in C

hild

ren

58

71

Intr

oduc

tion

58

72

Ope

ratio

nal G

uide

lines

59

72

0 G

uide

lines

for

HIV

Dia

gnos

is in

Chi

ldre

n

59

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

72

1 H

IV N

egat

ive

Infa

nt a

t 6 w

eeks

or

Firs

t Con

tact

59

72

2 H

IV P

ositi

ve In

fant

by

DN

A P

CR

60

72

3 C

ompr

ehen

sive

Car

e fo

r H

IV-e

xpos

ed In

fant

61

D

IAG

NO

STIC

ALG

OR

ITH

MFO

R P

ULM

ON

AR

Y T

B IN

CH

ILD

REN

Cha

pter

8

Feed

ing

Infa

nts

and

Youn

g C

hild

ren

Bor

n to

HIV

infe

cted

mot

hers

62

81

Intr

oduc

tion

62

82

Ope

ratio

nal G

uide

lines

on

Infa

nt F

eedi

ng (0

-6 m

onth

s)

63

83

Ope

ratio

nal G

uide

lines

on

Feed

ing

Chi

ldre

n 6

mon

ths

and

olde

r 64

84

Nut

ritio

nal C

are

and

Supp

ort o

f HIV

infe

cted

Chi

ldre

n 64

85

Ext

ract

s fr

om R

esea

rch

on In

fant

Fee

ding

and

HIV

AID

S 65

Cha

pter

9

Car

e an

d Fo

llow

up

of C

hild

ren

of H

IV-in

fect

ed m

othe

rs 7

3

91

Intr

oduc

tion

73

92

Ope

ratio

nal G

uide

lines

74

Cha

pter

10

Mon

itorin

g an

d Ev

alua

tion

of P

MTC

T se

rvic

es

83

101

In

trod

uctio

n 83

102

O

pera

tiona

l Gui

delin

es

85

Bib

liogr

aphy

91

Job

Aid

sR

efer

ence

s

91

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

App

endi

x V

I

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

100

App

endi

x V

C

OM

MO

N A

DV

ERSE

EFF

ECTS

OF

AR

V U

SE D

UR

ING

PR

EGN

AN

CY

Cla

ss

Adv

erse

effe

cts

Nuc

leos

ide

Nuc

leot

ide

Rev

erse

Tra

nscr

ipta

se In

hibi

tors

( NR

TIs)

Zido

vudi

ne(A

ZT)

Nau

seau

La

miv

idin

e (3

TC)

Dia

rhoe

a

Stav

udin

e (d

4T)

Hyp

erse

nsiti

vity

(AB

C)

Aba

cavi

r(A

BC

) A

naem

ia(A

ZT)

Teno

fovi

r(TF

VTD

F)

Emitr

icita

bine

(FTC

)

Non

- Nuc

leos

ide

Rev

erse

Tra

nscr

ipta

se In

hibi

tors

(NN

RTI

s)

Nev

irapi

ne(N

VP)

Del

avird

in

Efav

irenz

(EFV

)

Pro

teas

e In

hibi

tors

(PIs

)

Saqu

inav

ir(SQ

V)

Indi

navi

r(ID

V)

Rito

navi

r(R

TV)

Nel

finav

ir(N

LF)

Lopi

navi

rrito

navi

r(LP

Vr)

A

taza

navi

r(A

TV)

Fose

mpr

enav

ir Ti

pana

vir(

TPV)

D

arun

avir(

DR

V)

Ras

h

Elev

ated

live

r enz

ymes

(c

omm

on w

ith N

VP in

hig

h C

D4

co

unt)

EFV

CN

S ef

fect

s(se

datio

n in

-so

mni

a v

ivid

dre

ams

diz

zine

ss

conf

usio

n fe

elin

g of

lsquod

isen

gage

men

trsquo

Tera

toge

nici

ty

GI i

ntol

eran

ce

Hep

atot

oxic

ity

Lipo

dyst

roph

y

Dys

lipid

emia

s

Insu

lin re

sist

ance

Hyp

ergl

ycae

mia

La

ctic

aci

dosi

s an

d he

patic

ste

a-to

sis

Cou

nsel

ing

and

Follo

w-u

p Ti

ps

May

not

be

wel

l-tol

erat

ed in

ear

l pr

egna

ncy

whe

n

mor

ning

sic

knes

s is

com

mon

M

ay in

crea

se ri

sk o

f non

-ad

here

nce

May

hav

e in

adeq

uate

blo

od le

vels

A

ll A

RVs

sho

uld

be d

isco

ntin

ued

and

rest

arte

d w

hen

Namp

V is

gon

e or

effe

ctiv

ely

trea

ted

Fo

llow

-up

labs

CB

C L

FTs

If ra

sh in

1st

2 w

ks d

o no

t inc

reas

e N

VP d

ose

and

cont

act c

linic

ian

Mild

rash

may

be

man

aged

with

an

tihis

tam

ines

A

void

cor

ticos

tero

ids

durin

g N

VP

dose

esc

alat

ion

EFV

shou

ld b

e ta

ken

initi

ally

at

bed

time

Avo

id E

FV in

wom

en o

f hig

h ch

ild-b

earin

g po

tent

ial

Do

not o

pera

te h

eavy

mac

hine

ry

Mon

itor g

luco

se le

vels

A

sk re

gula

rly fo

r sym

ptom

s of

hy

perg

lyca

emia

M

onito

r hep

atic

tran

sam

inas

es

(ALT

and

AST

) par

ticul

arly

dur

ing

the

first

18

wee

ks o

f the

rapy

w

hen

this

toxi

city

is m

ost l

ikel

y Ta

ke w

ith fo

od

Ant

iem

etic

s A

ntim

otili

ty

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

App

endi

ces

92

App

endi

x I

WH

O C

linic

al S

tagi

ng o

f HIV

AID

S fo

r A

dults

and

A

dole

scen

ts w

ith C

onfir

med

HIV

infe

ctio

n 92

App

endi

x II

C

ontr

acep

tive

Opt

ions

for

Peop

le L

ivin

g w

ith H

IV

95

App

endi

x II

I U

se o

f AR

Vs

for

Trea

tmen

t and

PM

TCT

of H

IV in

AN

C

97

App

endi

x IV

Use

Of A

RV

s fo

r PM

TCT

of H

IV in

Lab

our

And

Del

iver

y U

nit

98

App

endi

x V

Com

mon

Adv

erse

Effe

cts

of A

RV

Use

Dur

ing

Preg

nanc

y 99

App

endi

x V

I D

iagn

ostic

alg

orith

m fo

r pu

lmon

ary

TB in

Chi

ldre

n 10

0

App

endi

x V

II I

nteg

rate

d M

onito

ring

and

Eval

uatio

n Re

port

For

m M

OH

726

10

3

App

endi

x V

III

Rep

rodu

ctiv

e H

ealth

HIV

AID

S R

epor

t For

m M

OH

711

10

4

Lis

t of T

able

s

Tabl

e 1

1 A

dult

HIV

-pre

vale

nce

Est

imat

e by

Pro

vinc

e in

200

6 21

Tabl

e 1

2 E

stim

ated

Mag

nitu

de o

f MTC

T in

Ken

ya 2

007

22

Tabl

e 1

3 Tr

ansm

ission

Pat

tern

s in

Brea

stfee

ding

and

Non

bre

astfe

edin

g Pop

ulat

ions

23

Tabl

e 1

4 R

isk

Fact

ors

for

MTC

T of

HIV

24

Tabl

e 1

5 Th

e Fo

ur-p

rong

ed A

ppro

ach

App

lied

to th

e PM

TCT

Gui

delin

es

30

Tabl

e 2

1 E

ssen

tial P

acka

ge o

f Int

egra

ted

Ant

enat

al C

are

Serv

ices

33

Tabl

e 4

1 R

ecom

men

datio

ns fo

r In

itiat

ing

AR

V T

reat

men

t in

Preg

nant

Wom

en B

ased

on

Clin

ical

Sta

ge a

nd A

vaila

bilit

y of

CD

4 co

unt

44

Tabl

e 4

2 R

ecom

men

ded

Firs

t Lin

e A

RT

Reg

imen

for

Trea

ting

Preg

nant

Wom

en a

nd P

roph

ylac

tic R

egim

en fo

r In

fant

s 45

Tabl

e 4

3a R

ecom

men

ded

Firs

t Lin

e A

RV

Pro

phyl

axis

to P

reve

nt H

IV

46

Infe

ctio

n in

Infa

nts

Am

ong

preg

nant

Wom

en P

rese

ntin

gB

efor

e 38

Wee

ks

Tabl

e 4

3b A

ltern

ativ

e A

RV

Pro

phyl

axis

to P

reve

nt H

IV In

fect

ion

in In

fant

s 4

6 A

mon

g Pr

egna

nt W

omen

Pre

sent

ing

Bef

ore

38 W

eeks

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

9

9

47

IV

Wom

en w

ho h

ave

not r

ecei

ved

Intr

apar

tum

AR

T or

A

RV

Pro

phyl

axis

with

H

IV

Infe

ctio

n

Tabl

e 4

4 A

RV

Pro

phyl

axis

for

PMTC

T am

ong

Preg

nant

Wom

en w

ho h

ave

not r

ecei

ved

Ant

enat

al A

RT

or P

roph

ylax

is

App

endi

x Ta

ble

45

Cho

ice

of H

AA

RT

for

Preg

nant

Wom

en b

ased

on

CD

4 co

unt

47

Tabl

e 4

6 A

RV

Pro

phyl

actic

Reg

imen

s fo

r In

fant

s B

orn

to H

IV-p

ositi

ve

49

Tabl

e 9

1 D

ose

of C

o-tr

imox

azol

e fo

r PC

P pr

ophy

laxi

s 76

Tabl

e 9

2 W

HO

Rec

omm

enda

tions

for

Follo

w-u

p of

an

HIV

-exp

osed

Chi

ld

79

Tabl

e 10

1 C

ontr

acep

tive

Met

hods

for

Use

in C

oupl

es a

nd W

omen

Liv

ing

96

Figu

re 2

1 R

apid

HIV

Ser

ial T

estin

g A

lgor

ithm

35

Figu

re 8

1 G

uide

lines

for

Cou

nsel

ling

on H

IV a

nd In

fant

feed

ing

66

Job

Aid

s an

d IE

C M

ater

ials

on

Infa

nt a

nd Y

oung

Chi

ld F

eedi

ng

67

List

of F

igur

es

Figu

re 1

01

Mon

itori

ng a

nd E

valu

atio

n D

ata

Flow

in K

enya

84

September 0 8

USE OF ARVs FOR PMTCT OF HIV IN LABOUR AND DELIVERY UNITSALL MOTHERS

1 History 2 Examination3 Establish motherrsquos HIV status4 Offer HIV counseling and testing for mother with unknown HIV status5 Provide standard obstetrical management and care

HIV NEGATIVECounsel on risk reduction

HIV POSITIVE

Establish Motherrsquos use of ARVs in pregnancy and give appropriate ARVs as shown in boxesbelow

Regardless of Duration received HAART

Action

i Give mother ARV dose as per regimen

ii Post partu m Infant Give Infant sd Nevi rapine 2mgkg with in 72 hours of birthPL US 3T C 4mgkg BD for 1 w eek an d AZT syrup 4 m gkg BD for 6 w eeks

iii Post partum mother Continue w ith AR Vs as per regimen

MOTHE R RECEIVED HAART IN PREGNANCY

F OR MORE INFORMAT ION CONT ACT THE NATIONAL AIDSSTD CONTROL PROGRAMME (NASCOP)PO BO X 19361-00202 NAIROBI TEL 0202729502 FAX 020 2710518

MINISTRY OF HEALTH

bull G ive mo ther sd Nevirap ine 200m g AZT 600mg and 3TC 150 mg stat

bull Post partum Infant Give Infant sd Nevirapine 2mgkg within 72 ho urs of birth PL US

3TC syrup 4mg kg BD for 1 week and AZT syrup 4 mg kg BD fo r 6 w eeks

bull Post partum mother Give moth er AZT 300mg amp 3TC 150 mg BID for 7 d ays

MO THER RECEIVED AZT IN PREGNANCY OR NO ARVs TAKE N IN PREGNANCY

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

98

MINISTRY OF HEALTH

USE OF ARVs FOR TREATMENT AND PMTCT OF HIV IN ANC

App

endi

x II

I

Ack

now

ledg

emen

ts

ALL M O THERS1 History 2 Health Information3 Examination4 In vestigations (with informed consent for HIV test)

HIV NEGATIVE1 P rov id e pos t-te s t HIV pr ev e nti v e

i nter ve ntion s defi ned i n na tion alHT C gui de li nes

2 Re fe r for othe r p os t-te st HIVp re ve ntive inte rv e nti ons no tavai lable in the cli nic b ut avail ab le w ithi n the fa c ili ty

HIV PO SI TI VE1 C ounsel on risk reduction2 Per form WH O clinical staging for H IV disease3 D etermine CD 4 level (if testing facilities available)4 D etermine Gestation age and HB level5 Give ARVrsquos as shown below6 Provide or refer for other post-test HIV interventions defined in national HTC

guidelines

1 WHO clin ica l stage I o r II w ith CD4 cell co unt gt 350mm3 OR 2 WHO clin ica l stage I o r II no CD4 cell co unt do ne3 HB =8 gdl OR n o clinical feat ures of anaemia

bull Initiate AZT 30 0mg BD daily at 28 weeks gestation or any time periodimmediately there after

bull Monitor for clinical featur es of anemia and treatbull Dispense ANC Nev ir apine 200mg PLUS AZT 600mg + 3TC 1 50mg for

moth er to tak e at onset of labourbull Dispense NVP syrup to give infant at birth

bull At on set o f l abo uro Administer Nevirapine 20 0mg AZT 600mg 3TC 150 mg

stat to moth erbull Post p artum

o Give Infa nt sd Nevirapine 2mgk g within 72 hours ofbirth PLUS 3TC 4mg BD for 1 w eek and AZT syrup 4 mgkg BD for 6 w eeks

o Give mother AZT30 0 mg 3 TC 150 BID for 7 day s

1 WHO clinical stag e I or II with CD4 c ell count gt 35 0 mm3 OR 2 WHO clinical stag e I or II w ith no C D4 c ell c ount done

bull Dispense ANC Nevirapine 2 00mg PLUS AZ T 600 mg + 3TC 150mgfo r mo ther to take at onse t of labour

bull Dispense NVP sy rup to give infant at birthbull At Onset of lab our

o Administe r sd Nevirapine AZT 6 00 mg and 3TC1 50mg stat

bull Po st Par tu mo G iv e Infant sd Nev ir apine 2mg kg w ithin 72

h ours of bir th PLUS 3T C 4mgkg BD fo r 1 week a nd AZT syrup 4mgkg BD for 6 we eks

o G iv e mother AZ T300 mg 3TC 1 50 mg BID for 7d ays

1 Any gest ational age2 WHO clin ica l stage III or IV of HIV dis ease regardles s of CD4 cell count OR3 WHO clin ica l stages I or II of HIV d is ease with CD4 cell count =350mm3 ()

bull Refer to Clinician for Evaluation and initiation of NNRTI based ART as pernation al ART guidelines

bull At O nset of Lab ou ro G ive mo ther ARV dos e as per r egimen

bull Post par tumo G ive Infan t sd Nev ira pine 2mgkg within 72 hours of b irth PLUS

3TC 4mgkg and AZT syr up 4 mgkg BD for 6 weeks o G ive mo ther ARVs as per regimen

4 If no HAART av ailable man age the wo man as ind icated in box no2 a nd refer to ARTsite appro priately

F O R M OR E IN FOR M AT IO N CO N T AC T T H E N ATI ON A L A IDS STD C O NTR O L PR O G RAM ME ( N ASC O P)P O B OX 19361-00202 N AIR OBI TEL 0202729502 FAX 020 2710518

EL IGIBL E FO R T R EATMEN T

N O T E LIG IBLE FO R TR EA TM ET AN D PR ESE NTING B ELO W 3 8 W EE KSGESTA TIO N N OT ELIGIB LE FOR TREA TMEN T AN D PR ESE NTING gt 3 8 W EEK S

GE STATIO N

Plea se notebull Pregnan t w omen with WHO clinical stag e I or II plus CD4 cell co unt gt250 mm3 and = 350 mm3 can be initiated on ART wher e a PI based HAART re gimen is av ailable NVP hypersen sitivity h as been previously r eported amon g women in this gr oup initiated on N NRT I based

ART re gimens Where PI ba sed ART reg imen is not av ailab le r efer the patient to a site whe re th e regimen is availab le or c ontinue to ma nage th e w oman a s is indicated in box No 2bull The grading of ana emia in pregna ncy is gt 8-10 Milda nemia gt 6 -8 Moderate anem ia lt 6 Sever e anemiabull Treatment if common p ath ologies ruled out Mild anae mia haematinics irrespectiv e of gestatio n Moder ate a naemia tr ansfusion if close to term gt36 weeks otherwise give haema tinics Severe an aemia transfus ion irr espe ctive of ge statio n Do not stop AZT if Hb dr op s but

would manage it as above and only stop if continues to fall or fails to res pon d des pite transfusion

The

thir

d ed

ition

of

Gui

delin

es f

or P

reve

ntio

n of

Mot

her-

to-C

hild

Tra

nsm

issi

on o

f H

IV A

IDS

in K

enya

is a

res

ult o

f effo

rts

of m

any

indi

vidu

als

and

orga

niza

tions

in th

eco

untr

y T

he T

echn

ical

Wor

king

Gro

up o

n PM

TCT

led

thes

e ef

fort

s M

embe

rs o

f the

te

am r

evie

wed

all

the

mod

ules

rev

ised

and

in s

ome

case

s re

-wro

te th

e m

odul

es b

ased

on

the

seco

nd e

ditio

n to

mak

e th

em u

p to

dat

e an

d in

line

with

cur

rent

sci

entif

ic e

vishy

denc

e an

d ex

peri

ence

We

ackn

owle

dge

the

cont

ribu

tors

and

rev

iew

ers

of t

he c

urre

ntan

d pr

evio

us e

ditio

ns O

f sp

ecia

l m

entio

n ar

e th

e fo

llow

ing

Ken

ya O

bste

tric

al a

nd

Gyn

aeco

logi

cal S

ocie

ty (K

OG

S) t

he U

nive

rsity

of N

airo

bi a

nd M

oi U

nive

rsity

We

wou

ld l

ike

to t

hank

the

fol

low

ing

inst

itutio

ns f

or t

echn

ical

as

wel

l as

fin

anci

al

supp

ort

duri

ng t

he r

evis

ion

of t

he g

uide

lines

N

atio

nal A

IDS

and

STD

Con

trol

Pro

shygr

amm

e (N

ASC

OP)

the

Div

isio

n of

Rep

rodu

ctiv

e H

ealth

Cen

ters

for

Dis

ease

Con

trol

and

Prev

entio

n (C

DC

) It

is n

ot p

ossi

ble

to m

entio

n al

l ind

ivid

uals

and

org

aniz

atio

ns

that

par

ticip

ated

in th

is im

port

ant e

xerc

ise

To

all o

f you

Asa

nte

Sana

Min

istr

y of

Hea

lth

September 2008

97

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

10

Fore

wor

d

The

Min

istr

y of

Hea

lth (

MoH

) is

com

mitt

ed t

o de

velo

pmen

t of

effe

ctiv

e PM

TCT

proshy

gram

mes

Gui

delin

es a

re a

n im

port

ant

part

of t

he G

over

nmen

t st

rate

gy t

o re

duce

MTC

Tan

d is

in

line

with

the

Nat

iona

l H

ealth

Sec

tor

Stra

tegi

c Pl

an I

I (N

HSS

PII)

and

Ken

yaN

atio

nal A

IDS

Stra

tegi

c Pl

an (K

NA

SP) 2

000-

2010

whi

ch fo

cuse

s on

pri

ority

are

as o

f pre

shyve

ntio

n of

new

infe

ctio

ns i

mpr

ovin

g qu

ality

of l

ife o

f tho

se in

fect

ed a

nd a

ffect

ed a

nd m

itishy

gatio

n of

soc

ial a

nd e

cono

mic

impa

ct o

f the

infe

ctio

n

MTC

T is

the

pre

dom

inan

t m

ode

of t

rans

mis

sion

of

HIV

in

infa

nts

and

youn

g ch

ildre

n

This

tra

nsm

issi

on o

ccur

s du

ring

pre

gnan

cy

labo

ur a

nd d

eliv

ery

and

am

ong

brea

stfe

d ba

bies

in

the

post

-par

tum

per

iod

Mem

bers

of t

he T

echn

ical

Wor

king

Gro

up (T

WG

) on

PMTC

T re

view

ed t

he m

odul

es o

f the

se

cond

edi

tion

rev

ised

and

in s

ome

case

s re

-wro

te th

e m

odul

es b

ased

on

up to

dat

e kn

owlshy

edge

and

in

line

with

cur

rent

sci

entif

ic e

vide

nce

and

expe

rien

ce T

he T

WG

con

sist

s of

agr

oup

of p

rofe

ssio

nals

dra

wn

from

var

ious

dis

cipl

ines

tha

t ar

e im

plem

entin

g an

dor

man

shyag

ing

PMTC

T T

he g

roup

ado

pted

and

ada

pted

the

late

st r

ecom

men

datio

ns o

f the

WH

O o

nPM

TCT

as w

ell a

s va

riou

s na

tiona

l gui

delin

es o

n H

IV p

reve

ntio

n tr

eatm

ent a

nd c

are

A f

our-

pron

ged

appr

oach

thr

ough

the

var

ious

rep

rodu

ctiv

e lif

e cy

cles

as

prop

osed

by

the

Inte

r-A

genc

y Ta

sk T

eam

(IA

TT)

on c

hild

ren

and

HIV

and

AID

S w

as a

dopt

ed i

n th

ese

guid

elin

es w

ith e

mph

asis

bei

ng p

lace

on

all t

he fo

ur p

rong

s

For

any

of t

he P

MTC

T in

terv

entio

ns t

o be

suc

cess

fully

impl

emen

ted

coun

selin

g an

d te

stshy

ing

(CT)

mus

t fir

st b

e do

ne R

outin

e H

IV te

stin

g w

ith o

pt-o

ut o

ptio

n is

rec

omm

ende

d T

his

is fo

llow

ed b

y ap

prop

riat

e m

edic

al s

urgi

cal i

nter

vent

ions

incl

udin

g an

tiret

rovi

ral p

roph

yshyla

xis

saf

er o

bste

tric

pra

ctic

es a

s w

ell a

s in

fant

feed

ing

coun

selin

g an

d pr

ovis

ion

of a

ppro

shypr

iate

infa

nt fe

edin

g H

IV-p

ositi

ve w

omen

are

ass

esse

d cl

inic

ally

usi

ng W

HO

sta

ging

and

whe

re f

easi

ble

imm

unol

ogic

al a

sses

smen

t us

ing

CD

4 ce

ll co

unt

HIV

exp

osed

infa

nts

are

test

ed th

roug

h ea

rly

infa

nt d

iagn

osis

(EID

)

In th

ese

guid

elin

es m

ore

effic

acio

us r

egim

ens

are

intr

oduc

ed fo

r th

e fir

st ti

me

whi

le in

forshy

mat

ion

and

coun

selin

g on

inf

ant

feed

ing

follo

ws

the

AFA

SS (

Ava

ilabl

e f

easi

ble

acc

eptshy

able

saf

e an

d su

stai

nabl

e) c

rite

ria

The

mod

ule

on m

onito

ring

and

eva

luat

ion

addr

esse

s is

sues

of d

ata

colle

ctio

n c

olla

tion

and

repo

rtin

g as

wel

l as

use

of d

ata

for

deci

sion

-mak

ing

at th

e fa

cilit

y-le

vel

We

hope

that

app

ropr

iate

impl

emen

tatio

n in

stru

men

ts w

ill b

e us

ed to

ope

ratio

naliz

e th

ese

guid

elin

es

Tabl

e 11

1

Con

trac

eptiv

e M

etho

ds fo

r Use

in

Cou

ples

and

Wom

en L

ivin

g w

ith H

IV In

fect

ion

MET

HO

D

CO

MM

ENTS

Con

dom

s bull

M

ale

amp f

emal

e co

ndom

s av

aila

ble

bull

P

rovi

de d

ual p

rote

ctio

n ag

ains

t STI

sH

IV

amp p

regn

ancy

bull

R

equi

re a

ttent

ion

amp ca

re

for c

orre

ct u

se e

ach

time

bull

M

ay re

quire

co-

oper

atio

n of

par

tner

Hor

mon

al

bull V

ery

effe

ctiv

e an

d ea

sy to

use

M

etho

ds

bull S

uita

ble

for s

hort-

or lo

ng-

term

use

bull

Rev

ersi

ble

bull A

ssoc

iate

d w

ith n

on-

cont

race

ptiv

e he

alth

ben

efits

bull

Ser

ious

com

plic

atio

ns

extre

mel

y ra

re

Intra

uter

ine

bull

H

ighl

y ef

fect

ive

long

-term

C

ontra

cept

ive

reve

rsib

le m

etho

d

Dev

ice

bull

Rem

ains

in p

lace

up

to 1

2 ye

ars

bull

A

lmos

t 100

per

cent

ef

fect

ive

bull

H

as n

o ef

fect

on

ferti

lity

whe

n us

ed b

y nu

llipar

ous

wom

en

bull

Sho

uld

not b

e pr

ovid

ed to

w

omen

with

hig

h ris

k se

xual

life

styl

e bull

B

acte

rial S

TIs

shou

ld b

e sc

reen

ed fo

r and

or

treat

ed a

s a

prec

autio

n pr

ior t

o in

serti

on o

f IU

CD

Ste

riliz

atio

n bull

Goo

d v

ery

effe

ctiv

e fo

r co

uple

s or

indi

vidu

als

who

w

ant n

o m

ore

child

ren

bull S

afe

sim

ple

surg

ical

pr

oced

ure

Con

side

red

perm

anen

t

US

E IN

HIV

PO

SITI

VE

PA

TIE

NTS

bull

Can

and

sho

uld

be u

sed

at a

ll st

ages

of H

IV

infe

ctio

n bull

C

an a

nd s

houl

d be

use

d by

pat

ient

s on

AR

T

bull

Cor

rect

and

con

sist

ent u

se b

y H

IV in

fect

ed p

atie

nts

is

reco

mm

ende

d re

gard

less

of t

he u

se o

f oth

er m

etho

ds

of c

ontra

cept

ion

(dua

l con

trace

ptio

n)

bull C

an b

e us

ed w

ithou

t res

trict

ion

in H

IV+

wom

en n

ot o

n AR

T bull

Can

be

used

with

out r

estri

ctio

n in

all

HIV

+ w

omen

for

emer

genc

y co

ntra

cept

ion

bull S

ome

AR

V dr

ugs

may

redu

ce m

etho

d ef

fect

iven

ess

bull

DM

PA

Im

plan

ts c

an h

owev

er b

e us

ed w

ith A

RT

reshy

inje

ctio

n of

DM

PA

sho

uld

be d

one

at 1

0-12

wee

ks

bull If

horm

onal

met

hod

is c

hose

n c

ondo

ms

shou

ld s

till b

e us

ed c

orre

ctly

and

con

sist

ently

bull

Attr

activ

e m

etho

d fo

r wom

en w

ith H

IV w

ho d

esire

ver

y re

liabl

e pr

egna

ncy

prot

ectio

n bull

C

an b

e in

serte

d in

HIV

+ w

omen

who

do

not h

ave

WH

O

Sta

ge 4

dis

ease

AID

S d

efin

ing

illne

ss

bull

For w

omen

with

sta

ge 4

dis

ease

IUD

can

be

inse

rted

once

they

are

on

ART

and

have

con

trolle

d sy

mpt

oms

of s

ever

e ill

ness

bull N

o m

edic

al re

ason

s to

den

y st

eriliz

atio

n to

clie

nts

w

ith H

IV

bull P

roce

dure

may

be

dela

yed

in e

vent

of a

cute

HIV

-rel

ated

in

fect

ion

or s

tage

4 d

isea

se p

endi

ng im

mun

e re

cons

titut

ion

bull E

ncou

rage

con

dom

use

as

wel

l

DM

PA =

Dep

ot M

edro

xypr

oges

tero

ne A

ceta

te (D

epo-

Prov

era)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

1

96

App

endi

x II

CO

NTR

AC

EPTI

VE

OPT

ION

SFO

R P

EOPL

E L I

VIN

G W

ITH

HIV

It

has

bee

n sh

own

in a

num

ber

of s

tudi

es o

f coh

orts

of H

IV p

ositi

ve w

omen

tha

t so

me

choo

se t

o co

ntin

ue s

exua

l act

ivity

des

pite

kno

wle

dge

of t

heir

sta

tus

Evi

denc

e of

con

shyce

ptio

n ha

s de

mon

stra

ted

that

fert

ility

in H

IV p

ositi

ve w

omen

for

the

mos

t pa

rt is

unshy

affe

cted

H

owev

er c

erta

in c

ondi

tions

may

affe

ct fe

rtili

ty s

uch

as lo

w b

ody

mas

s in

dex

A

IDS

and

inte

rcur

rent

illn

ess

esp

ecia

lly t

uber

culo

sis

Put

ting

wom

en w

ho a

re H

IV

infe

cted

on

cont

race

ptiv

es is

one

of t

he m

eans

of p

reve

ntin

g m

othe

r to

chi

ld t

rans

mis

shysi

on o

f HIV

(PM

TCT)

It is

the

rig

ht o

f HIV

infe

cted

wom

en t

o m

ake

thei

r ow

n de

cisi

ons

rega

rdin

g re

prod

ucshy

tion

The

y m

ay w

ish

to h

ave

mor

e ba

bies

lim

it th

eir

fam

ilies

or

avoi

d pr

egna

ncy

alto

shyge

ther

The

hea

lth c

are

prov

ider

s th

ey c

onsu

lt sh

ould

ena

ble

them

to

mak

e in

form

edch

oice

s by

them

selv

es

The

follo

win

g co

ntra

cept

ive

met

hods

are

ava

ilabl

e in

Ken

ya -

pro

gest

eron

e on

ly p

ills

lo

w d

ose

com

bine

d or

al c

ontr

acep

tives

de

pot

med

roxy

prog

este

rone

ace

tate

(D

MPA

shyde

po)

levo

norg

estr

el a

nd e

tono

gest

rel i

mpl

ants

Em

erge

ncy

cont

race

ptiv

e pi

lls c

oppe

rin

trau

teri

ne c

ontr

acep

tive

devi

ces

bar

rier

met

hods

fem

ale

and

mal

e st

erili

satio

n ar

e al

so a

vaila

ble

Som

e dr

ugs

inte

ract

with

hor

mon

al c

ontr

acep

tives

A

nd c

oncu

rren

t us

e sh

ould

be

avoi

ded

The

se d

rugs

incl

ude

bull P

rote

ase

inhi

bito

rs ndash

Rito

navi

r N

elfin

avir

Lop

inav

ir w

ith R

itona

vir

bull N

on-n

ucle

otid

e re

vers

e tr

ansc

ript

ase

inhi

bito

rs (

NN

RT

Is)

ndash N

evir

apin

e

bull E

favi

renz

bull A

nti-T

B d

rugs

ndash R

ifam

pici

n an

d R

ifabu

tin

bull O

ther

dru

gs ndash

Gris

eofu

lvin

P

heno

barb

itone

C

arba

maz

epin

e P

heny

toin

All

the

abov

e do

not

app

ly i

n th

e fa

ce o

f ot

her

med

ical

con

ditio

ns t

hat

are

cont

ra-

indi

catio

ns f

or t

he v

ario

us m

etho

ds e

g k

now

n ca

rdio

vasc

ular

dis

ease

hep

atic

con

dishy

tions

sm

okin

g h

igh

bloo

d pr

essu

re a

nd th

rom

boem

bolic

dis

orde

rs

The

follo

win

g ta

ble

sum

mar

ises

maj

or is

sues

reg

ardi

ng u

se o

f diff

eren

t co

ntra

cept

ives

by H

IV-p

ositi

ve w

omen

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Abb

revi

atio

ns a

nd A

cron

yms

AFA

SS

Acc

epta

ble

Fea

sibl

e A

fford

able

Sus

tain

able

and

Saf

e

Ab

Ant

i-bod

y

AID

S A

cqui

red

Imm

une

Def

icie

ncy

Synd

rom

e

ALT

Ala

nine

Tra

nsfe

rase

AN

C

Ant

enat

al C

are

AR

M

Art

ifici

al R

uptu

re o

f Mem

bran

es

AR

T

Ant

iret

rovi

ral T

hera

py

A

RV

A

ntir

etro

vira

l

AZT

A

zido

thym

idin

e (Z

idov

udin

e or

ZD

V)

AZT

3TC

Com

bivi

r

3TC

Lam

ivud

ine

BC

C

Beh

avio

ur C

hang

e C

omm

unic

atio

n

BC

G

Bac

ille

Cal

met

te G

ueri

ne v

acci

ne

BFH

I B

aby

Frie

ndly

Hos

pita

l Ini

tiativ

e

BID

BD

ldquoT

wic

e a

dayrdquo

CD

C (K

) C

entr

es fo

r D

isea

se C

ontr

ol a

nd P

reve

ntio

n K

enya

CN

S C

entr

al N

ervo

us S

yste

m

CS

Cae

sare

an S

ectio

n

CT

Cou

nsel

ling

and

Test

ing

CTX

CTZ

Cot

rim

oxaz

ole

d4T

Stav

udin

e

D

ASC

O

Dis

tric

t AID

SST

I Coo

rdin

ator

G

uid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

5

12

DB

S D

ried

Blo

od S

pot s

peci

men

DN

A

Deo

xyri

bonu

clei

c A

cid

DR

H

Div

isio

n of

Rep

rodu

ctiv

e H

ealth

EC

V

Ext

erna

l Cep

halic

Ver

sion

EFV

Efa

vire

nz

EID

E

arly

Infa

nt D

iagn

osis

ELI

SA

Enz

yme

Link

ed Im

mun

osor

bent

Ass

ay

FBC

Fu

ll B

lood

Cou

nt

GTZ

G

erm

an T

echn

ical

Coo

pera

tion

HA

AR

T

Hig

hly

Act

ive

Ant

iret

rovi

ral T

hera

py

Hb

Hae

mog

lobi

n

HIV

H

uman

Imm

unod

efic

ienc

y Vi

rus

IATT

Inte

r-A

genc

y Ta

sk T

eam

IMC

I In

tegr

ated

Man

agem

ent o

f Chi

ldho

od Il

lnes

s

IPPT

Inte

rmitt

ent P

resu

mpt

ive

Trea

tmen

t for

Mal

aria

ITN

s In

sect

icid

es T

reat

ed N

ets

IUC

D

Intr

a U

teri

ne C

ontr

acep

tive

Dev

ice

KD

HS

Ken

ya D

emog

raph

ic a

nd H

ealth

Sur

vey

KE

PI

Ken

ya E

xpan

ded

Prog

ram

me

on Im

mun

izat

ion

KO

GS

Ken

ya O

bste

tric

al a

nd G

ynae

colo

gica

l Soc

iety

KN

H

Ken

yatt

a N

atio

nal H

ospi

tal

LAM

Lact

atio

nal A

men

orrh

oea

Met

hod

Mamp

E

Mon

itori

ng a

nd E

valu

atio

n

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

Cyt

omeg

alov

irus

infe

ctio

n (r

etin

itis

or in

fect

ion

of o

ther

org

ans)

9

Cen

tral

ner

vous

sys

tem

tox

opla

smos

is

10

HIV

enc

epha

lopa

thy

11

Ext

rapu

lmon

ary

cryp

toco

ccos

is in

clud

ing

men

ingi

tis

12

Dis

sem

inat

ed n

on-t

uber

culo

us m

ycob

acte

rial

infe

ctio

n

13

Pro

gres

sive

mul

tifoc

al le

ukoe

ncep

halo

path

y

14

Chr

onic

cry

ptos

pori

dios

is

15

Chr

onic

isos

poria

sis

16

Dis

sem

inat

ed m

ycos

is (

extr

apul

mon

ary

hist

opla

smos

is

or c

occi

diom

ycos

is)

17

Rec

urre

nt s

eptic

aem

ia (

incl

udin

g no

n-ty

phoi

dal S

alm

onel

la)

18

Lym

phom

a (c

ereb

ral o

r B

-cel

l non

-Hod

gkin

s)

19

Inv

asiv

e ce

rvic

al c

arci

nom

a

20

Aty

pica

l dis

sem

inat

ed le

ishm

ania

sis

21

Sym

ptom

atic

HIV

-ass

ocia

ted

neph

ropa

thy

or s

ympt

omat

ic H

IV-

asso

ciat

ed

22

Car

diom

yopa

thy

Ple

ase

note

S

igns

and s

ympto

ms

of

HIV

was

ting s

yndro

me

incl

ude

Unex

pla

ined

invo

lunta

ry w

eight

loss

(gt

10

base

line

body

wei

ght)

with o

bvi

ous

was

ting o

f body

mas

s in

dex

lt185

PLU

S

unex

pla

ined

chro

nic

dia

rrhoea

(lo

ose

or

wat

ery

stools

thre

e or

more

tim

es d

aily

) re

port

ed

for

longer

than

one

month

OR r

eport

s of

feve

r or

nig

ht

swea

ts f

or

more

than

one

month

w

ithout

oth

er c

ause

and lack

of

resp

onse

to a

ntibio

tics

or

antim

ala

rial ag

ents

M

ala

ria

must

be

excl

uded

in m

ala

ria

pro

ne

area

s

Fo

r th

e purp

ose

of

the

WH

O s

tagin

g s

yste

m

adole

sents

and a

dults

are

def

ined

as

adults

aged

ge15 y

ears

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

3

94

CLI

NIC

AL

STA

GE

3 1

Une

xpla

ined

sev

ere

wei

ght

loss

(gt1

0 o

f pr

esum

ed o

r m

easu

red

bo

dy w

eigh

t)

2

Une

xpla

ined

chr

onic

dia

rrho

ea fo

r lo

nger

tha

n on

e m

onth

3

Une

xpla

ined

per

sist

ent

feve

r (a

bove

37

5degC

inte

rmitt

ent

or c

onst

ant

for

long

er t

han

one

mon

th)

4

Per

sist

ent

oral

can

didi

asis

5

Ora

l hai

ry le

ukop

laki

a

6

Pul

mon

ary

tube

rcul

osis

7

Tub

ercu

lous

Lym

phad

enop

athy

8

Sev

ere

bact

eria

l inf

ectio

ns (

such

as

pneu

mon

ia

empy

ema

pyo

myo

sitis

bo

ne o

r jo

int

infe

ctio

n m

enin

gitis

or

bact

erae

mia

)

9

Acu

te n

ecro

tizin

g ul

cera

tive

stom

atiti

s g

ingi

vitis

or

perio

dont

itis

10

Une

xpla

ined

ana

emia

(lt8

gdl

) n

eutr

opae

nia

(lt0

5 times1

09 pe

rlitr

e) a

ndo

r ch

roni

c th

rom

bocy

topa

enia

(lt5

0times10

9 per

litr

e)

CLI

NIC

AL

STA

GE

4 1

HIV

was

ting

synd

rom

e

2

Pne

umoc

ystis

pne

umon

ia

3

Rec

urre

nt s

ever

e ba

cter

ial p

neum

onia

4

Chr

onic

her

pes

sim

plex

infe

ctio

n (o

rola

bial

ge

nita

l or

anor

ecta

l of

mor

e th

an o

ne

mon

thrsquos

dur

atio

n or

vis

cera

l at

any

site

)

5

Oes

opha

geal

can

didi

asis

(or

can

didi

asis

of

trac

hea

bro

nchi

or

lung

s)

6

Ext

rapu

lmon

ary

tube

rcul

osis

exc

ept

Tub

ercu

lous

Lym

ph a

deno

path

y

7

Kap

osirsquos

sar

com

a

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

MC

H

Mat

erna

l and

Chi

ld H

ealth

MoH

M

inis

try

of H

ealth

MSF

M

edic

ins

Sans

Fro

ntie

rs

M

TCT

Mot

her-

To-C

hild

Tra

nsm

issi

on

NA

SCO

P N

atio

nal A

IDS

and

STD

Con

trol

Pro

gram

me

NV

P

Nev

irap

ine

OD

ldquoO

nce

a D

ayrdquo

OI

Opp

ortu

nist

ic In

fect

ion

OPV

O

ral P

olio

Vac

cine

PASC

O

Prov

inci

al A

IDS

STI C

oord

inat

or

PCP

Pneu

moc

ystis

jiro

veci

i pne

umon

ia

PCR

Po

lym

eras

e C

hain

Rea

ctio

n

PI

Prot

ease

Inhi

bito

r

PLW

HA

Pe

rson

sPe

ople

Liv

ing

With

HIV

AID

S

PMTC

T

Prev

entio

n of

Mot

her

To C

hild

Tra

nsm

issi

on

RD

A

Rec

omm

ende

d D

aily

Allo

wan

ce

RH

Rep

rodu

ctiv

e H

ealth

RN

A

Rib

onuc

leic

Aci

d

SdN

VP

Si

ngle

dos

e N

evir

apin

e

SRH

Se

xual

and

Rep

rodu

ctiv

e H

ealth

STD

Se

xual

ly T

rans

mitt

ed D

isea

se

STI

Sexu

ally

Tra

nsm

itted

Infe

ctio

n

TB

Tube

rcul

osis

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

3

14

TBA

s Tr

aditi

onal

Bir

th A

tten

dant

s

TLC

To

tal L

ymph

ocyt

e C

ount

TT

Teta

nus

Toxo

id v

acci

ne

UN

ICE

F U

nite

d N

atio

ns C

hild

renrsquo

s Fu

nd

UN

GA

SS

Uni

ted

Nat

ions

Gen

eral

Ass

embl

y Sp

ecia

l Ses

sion

on

HIV

AID

S

UoN

Uni

vers

ity o

f Nai

robi

VC

T V

olun

tary

Cou

nsel

ling

and

Test

ing

VIA

V

isua

l Ins

pect

ion

usin

g A

ceto

ne

VD

RL

Ven

erea

l Dis

ease

Res

earc

h La

bora

tory

(tes

t for

syp

hilis

)

WH

O

Wor

ld H

ealth

Org

anis

atio

n

WR

P W

alte

r R

eed

Prog

ram

App

endi

x I

WH

O C

LIN

ICA

L S T

AG

ING

OF

HIV

AID

S FO

R A

DU

LTS

AN

D A

DO

LES-

CEN

TSW

ITH

CO

NFI

RM

ED H

IV IN

FEC

TIO

N

CLI

NIC

AL

STA

GE

1

bull

Asy

mpt

omat

ic

bull

Per

sist

ent

gene

raliz

ed ly

mph

aden

opat

hy

CLI

NIC

AL

STA

GE

2 1

Une

xpla

ined

mod

erat

e w

eigh

t lo

ss (

lt10

of

pres

umed

or

mea

sure

d bo

dy w

eigh

t)

2

Rec

urre

nt u

pper

res

pira

tory

tra

ct in

fect

ions

(si

nusi

tis

tons

illiti

s

otiti

s m

edia

and

pha

ryng

itis)

3

Her

pes

Zos

ter

4

Ang

ular

Che

ilitis

5

Rec

urre

nt o

ral u

lcer

atio

n

6

Pap

ular

pru

ritic

eru

ptio

ns

7

Seb

orrh

oeic

der

mat

itis

8

Fun

gal n

ail i

nfec

tions

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

5

92

Bib

liog

raph

y 1

Offic

e of

the

Pres

iden

t N

ational

AID

S C

ontr

ol Counci

l K

enya

Nat

ional H

IVA

IDS

Str

ate

gic

pla

n 2

0056

-20091

0

2

Rep

ublic

of

Ken

ya

Nat

ional AID

S C

ontr

ol C

ounci

l N

atio

nal H

IVA

IDS M

onitori

ng

and E

valu

atio

n F

ram

ework

3

Rep

ublic

of

Ken

ya

Nat

ional AID

S C

ontr

ol C

ounci

l N

atio

nal H

IVA

IDS M

onitori

ng

and E

valu

atio

n I

mple

men

tation M

anual

Job

Aid

sR

efer

ence

s 1

MoH

AN

C R

egis

ters

2

MoH

Mat

ernity

Reg

iste

rs

3

MoH

Post

-nata

l Reg

iste

rs

4

Mat

ernal

and C

hild

Wel

fare

Han

dbook

5

Rep

roduct

ive

Hea

lth S

ervi

ces

month

ly r

eport

6

MoH

Form

726

(Appen

dix

IV)

7

MoH

Form

727

8

MO

H F

orm

711

Exec

utiv

e Su

mm

ary

The

Rev

ised

Gui

delin

es (3

rd

editi

on) f

or P

reve

ntio

n of

Mot

her

to C

hild

Tra

nsm

issi

on(P

MTC

T) o

f H

IV a

nd A

IDS

addr

esse

s th

e ri

sks

of m

othe

r-to

-chi

ld t

rans

mis

sion

(MTC

T) o

f H

IV a

nd A

IDS

usin

g m

ore

effic

acio

us in

terv

entio

ns t

han

in t

he p

revi

ous

editi

ons

The

Gui

delin

es a

re i

n lin

e w

ith K

enya

rsquos N

atio

nal

Hea

lth S

ecto

r St

rate

gic

Plan

II

(NH

SSP

II)

and

are

anch

ored

on

the

Ken

ya N

atio

nal

AID

S St

rate

gic

Plan

(KN

ASP

) 20

00-2

010

whi

ch f

ocus

es o

n th

e pr

iori

ty a

reas

of

prev

entio

n of

new

inf

ecshy

tions

im

prov

ing

the

qual

ity o

f life

of p

eopl

e in

fect

ed a

nd a

ffect

ed b

y H

IV a

nd A

IDS

and

miti

gatio

n of

the

soc

ial a

nd e

cono

mic

impa

ct o

f the

infe

ctio

n O

ne o

f the

pri

ority

ar

eas

of N

HSS

P II

is

adhe

renc

e to

set

clin

ical

and

pub

lic h

ealth

sta

ndar

ds

The

Gui

delin

es w

ere

deve

lope

d th

roug

h a

part

icip

ator

y an

d co

nsul

tativ

e pr

oces

s th

at

drew

par

ticip

ants

fro

m p

ublic

hea

lth i

nstit

utio

ns

NG

Os

FB

Os

aca

dem

ic a

nd r

eshyse

arch

ins

titut

ions

and

dev

elop

men

t pa

rtne

rs

The

proc

ess

was

co-

ordi

nate

d by

N

ASC

OP

with

tech

nica

l and

fina

ncia

l sup

port

from

CD

C (K

)

HIV

infe

ctio

n ha

s re

vers

ed g

ains

rea

lised

in c

hild

hea

lth a

nd s

urvi

val i

n th

e la

st d

ecshy

ade

in K

enya

The

infe

ctio

n ha

s al

so c

ontr

ibut

ed s

igni

fican

tly t

o th

e co

mm

on c

ompl

ishyca

tions

of

preg

nanc

y in

man

y co

untr

ies

Glo

bally

mor

e th

an 6

300

00 c

hild

ren

wer

ein

fect

ed w

ith H

IV t

hrou

gh M

TCT

in 2

003

In

2007

K

enya

had

a p

opul

atio

n es

tishym

ated

at

34 m

illio

n t

he n

umbe

r of

bir

ths

per

annu

m w

as 1

73

mill

ion

the

HIV

prev

alen

ce a

mon

g pr

egna

nt m

othe

rs w

as 6

7 p

er c

ent

and

the

tota

l num

ber

of b

irth

s to

HIV

-infe

cted

mot

hers

exp

osed

to

MTC

T w

as 1

638

00

Ass

umin

g a

tran

smis

sion

rate

of 4

0 pe

r ce

nt a

nd in

the

abs

ence

of a

ny in

terv

entio

n t

he n

umbe

r of

HIV

pos

ishytiv

e in

fant

s pe

r an

num

wou

ld b

e 65

520

Ken

ya A

IDS

Indi

cato

r su

rvey

(KA

IS) 2

007

HIV

ser

opre

vale

nce

amon

g ad

ults

age

d 15

-49

year

s is

78

Var

ious

inte

rven

tions

hav

e be

en p

ut in

pla

ce t

o re

spon

d to

the

em

ergi

ng c

halle

nges

an

d co

nstr

aint

s to

MTC

T ac

ross

the

cou

ntry

Ana

lysi

s of

effe

ctiv

enes

s of

the

var

ious

ap

proa

ches

nee

ded

to m

anag

e ri

sks

of M

TCT

prov

ides

val

uabl

e in

sigh

ts th

at n

eces

sishy

tate

the

ado

ptio

n of

mor

e ef

ficac

ious

car

e an

d tr

eatm

ent

regi

men

s T

hese

ins

ight

s ha

ve in

form

ed t

he d

evel

opm

ent

of n

ew G

uide

lines

The

Gui

delin

es in

corp

orat

e th

ese

chan

ges

and

are

reco

mm

ende

d fo

r us

e by

hea

lth p

rofe

ssio

nals

and

hea

lth in

stitu

tions

at a

ll le

vels

of c

are

The

Gui

delin

es w

ill e

nhan

ce th

e ca

paci

ty o

f hea

lth c

are

prov

ider

sto

giv

e m

ore

effic

ient

and

effe

ctiv

e se

rvic

es t

o H

IV p

ositi

ve e

xpec

tant

mot

hers

and

ne

wbo

rns

The

Gui

delin

es h

ave

ten

chap

ters

and

cov

er th

e fo

llow

ing

just

ifyin

g th

e ne

ed fo

r sp

eshyci

fic m

anag

emen

t of

HIV

pos

itive

wom

en c

are

befo

re d

urin

g an

d af

ter

preg

nanc

yus

e of

ant

iret

rovi

ral t

hera

py in

pre

gnan

cy p

ostn

atal

car

e fa

mily

pla

nnin

g e

arly

inshy

fant

dia

gnos

is

feed

ing

car

e an

d fo

llow

-up

of H

IV-in

fect

ed i

nfan

ts

and

mon

itori

ng

and

eval

uatio

n A

dditi

onal

inf

orm

atio

n on

WH

O s

tagi

ng

cont

race

ptiv

e op

tions

for

PLW

As

and

a su

mm

ary

of A

RV

use

in P

MTC

T is

giv

en in

the

appe

ndic

es

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

1

16

The

Gui

delin

es h

ave

also

inc

orpo

rate

d ba

sic

info

rmat

ion

that

pro

gram

man

ager

sne

ed in

ord

er to

mak

e th

eir

inst

itutio

ns P

MTC

T-fr

iend

ly T

his

info

rmat

ion

is fo

und

in

the

boxe

s an

d ap

pend

ices

Sum

mar

ies

of t

he i

nfor

mat

ion

cont

aine

d in

the

tex

t ar

e fo

und

in th

e ta

bles

The

Gui

delin

es p

rovi

de a

bac

kgro

und

to t

he P

MTC

T pr

oble

m in

the

wor

ld i

n A

fric

a an

d in

Ken

ya T

hey

also

giv

e de

tails

on

HIV

in p

regn

ancy

the

tran

smis

sion

pat

tern

sof

MTC

T an

d de

scri

be t

he b

enef

its o

f pr

even

ting

mot

her-

to-c

hild

tra

nsm

issi

on(P

MTC

T) T

hey

also

pro

vide

info

rmat

ion

on in

terv

entio

ns n

eces

sary

to

redu

ce M

TCT

that

incl

ude

coun

selli

ng a

nd te

stin

g la

bora

tory

inve

stig

atio

ns o

bste

tric

inte

rven

tions

and

trea

tmen

tpro

phyl

axis

The

ante

nata

l man

agem

ent

for

HIV

pos

itive

wom

en i

nclu

ding

pol

icy

guid

e jo

b ai

dsw

ith s

umm

aris

ed e

ssen

tial p

acka

ge o

f int

egra

ted

ante

nata

l car

e se

rvic

es a

re d

etai

led

in C

hapt

er 2

Cha

pter

3 p

rovi

des

info

rmat

ion

on i

ntra

part

um c

are

Thi

s is

the

man

agem

ent

ofw

omen

from

the

onse

t of l

abou

r to

del

iver

y A

t thi

s st

age

it is

impo

rtan

t to

esta

blis

hth

e H

IV s

tatu

s of

wom

en p

rior

to d

eliv

ery

or d

urin

g la

bour

Gui

delin

es s

houl

d be

folshy

low

ed fo

r al

l wom

en a

dmitt

ed to

labo

ur a

nd d

eliv

ery

To

cond

uct v

agin

al d

eliv

erie

s fo

r H

IV p

ositi

ve w

omen

m

odifi

ed r

outin

e ca

re i

s gi

ven

The

gui

delin

es p

rovi

de a

reshy

min

der

on th

e ac

tiviti

es e

ssen

tial t

o ca

rry

out f

or s

afe

vagi

nal d

eliv

ery

for

all w

omen

no

t ju

st fo

r th

ose

infe

cted

with

HIV

It

is r

ecom

men

ded

that

the

re s

houl

d be

no

disshy

crim

inat

ion

or is

olat

ion

of H

IV p

ositi

ve w

omen

dur

ing

labo

ur a

nd d

eliv

ery

Del

iver

y th

roug

h el

ectiv

e ca

esar

ean

sect

ion

redu

ces

the

risk

of

HIV

MTC

T as

com

pare

d to

vagi

nal d

eliv

ery

amon

g H

IV p

ositi

ve w

omen

Whe

re C

S is

per

form

ed a

s an

em

erge

ncy

or e

lect

ivel

y a

ntib

iotic

s sh

ould

be

give

n

Ant

iret

rovi

ral (

AR

V) t

hera

py is

dis

cuss

ed in

det

ail i

n C

hapt

er 4

Thi

s in

clud

es t

hershy

apy

for

the

mot

her

befo

re la

bour

dur

ing

labo

ur a

nd a

fter

del

iver

y a

nd fo

r th

e in

fant

afte

r de

liver

y C

urre

ntly

N

evir

apin

e is

the

rec

omm

ende

d re

gim

en H

owev

er

shor

tco

urse

effi

caci

ous

AR

V d

rug

regi

men

s ca

n be

im

plem

ente

d in

res

ourc

e lim

ited

setshy

tings

AR

Vs

are

used

bot

h fo

r tr

eatm

ent

and

for

PMTC

T in

HIV

inf

ecte

d pr

egna

ntw

omen

and

thei

r ne

onat

es

Gui

delin

es f

or t

he p

ostp

artu

m c

are

of t

he m

othe

r an

d ca

re f

or H

IV e

xpos

ed in

fant

s ar

e de

taile

d in

Cha

pter

5 I

n C

hapt

er 6

the

Gui

de p

rovi

des

deta

iled

info

rmat

ion

on

late

pos

tnat

al c

are

and

fam

ily p

lann

ing

HIV

pos

itive

wom

en c

an u

se a

ll ty

pes

of fa

mshy

ily p

lann

ing

base

d on

sta

ndar

d el

igib

ility

cri

teri

a as

exp

licitl

y ou

tline

d in

the

text

Gui

delin

es fo

r in

fant

dia

gnos

is c

are

and

trea

tmen

t ar

e di

scus

sed

in C

hapt

er 7

Cur

shyre

ntly

the

re is

no

test

to

diffe

rent

iate

bet

wee

n an

tibod

ies

from

the

mot

her

and

thos

e pr

oduc

ed b

y th

e ba

by T

o id

entif

y H

IV in

fect

ed in

fant

s le

ss t

han

18 m

onth

s D

NA

or

RN

A ndash

PC

R te

st is

cur

rent

ly r

ecom

men

ded

HIV

exp

osed

infa

nts

at 6

wee

ks a

nd s

ick

infa

nts

at 1

2 m

onth

s sh

ould

hav

e ac

cess

to

DB

S fo

r D

NA

PC

R H

IV e

xpos

ed in

fant

ssh

ould

be

star

ted

on c

otri

mox

azol

e fr

om 6

wee

ks A

ll m

othe

rs w

ith 6

wee

k ol

d in

fant

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

E

Upt

ake

of c

ouns

ellin

g an

d te

stin

g in

Mat

erni

ty c

linic

Rat

io o

f m

ater

nity

clie

nts

with

unk

now

n H

IV s

tatu

s w

ho a

re c

ouns

elle

d an

d te

sted

for H

IV in

mat

erni

ty

Num

erat

or

Num

ber o

f pre

gnan

t wom

en a

dmitt

ed in

to m

ater

nity

with

un

know

n H

IV s

tatu

s th

at a

re c

ouns

elle

d an

d te

sted

for H

IV

durin

g la

bour

or a

fter d

eliv

ery

Den

omin

ator

N

umbe

r of p

regn

ant w

omen

adm

itted

into

mat

erni

ty

with

unk

now

n H

IV s

tatu

s

F

Mat

erni

ty m

othe

r AR

V pr

ophy

laxi

s up

take

R

atio

of H

IV in

fect

ed m

othe

rs in

mat

erni

ty c

linic

rece

ivin

g pr

even

tive

A

RV

pro

phyl

axis

Num

erat

or

Num

ber o

f HIV

-infe

cted

mot

hers

adm

itted

in m

ater

nity

takshy

ing

or re

porte

d to

hav

e ta

ken

the

mot

her d

ose(

s) o

f pre

venshy

tive

AR

V p

roph

ylax

is

Den

omin

ator

N

umbe

r of p

regn

ant w

omen

adm

itted

into

mat

erni

ty w

ho

are

HIV

-infe

cted

G

Infa

nt A

RV

prop

hyla

xis

upta

ke

Rat

io o

f inf

ants

bor

n to

HIV

-infe

cted

mot

hers

in m

ater

nity

clin

ic

rece

ivin

g pr

even

tive

AR

V p

roph

ylax

is

Num

erat

or

Num

ber o

f inf

ants

bor

n to

HIV

-infe

cted

mot

hers

who

rece

ive

prev

entiv

e

Den

omin

ator

N

umbe

r of i

nfan

ts b

orn

to H

IV-in

fect

ed m

othe

rs

Num

ber o

f pre

gnan

t wom

en a

dmitt

ed in

to m

ater

nity

who

are

H

IV-in

fect

ed is

use

d to

app

roxi

mat

e th

is n

umbe

r

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

7

90

With

the

mea

sure

men

ts li

sted

abo

ve t

he fo

llow

ing

perf

orm

ance

indi

cato

rs

for m

onito

ring

PMTC

T ac

tiviti

es a

re c

alcu

late

d

A

Upt

ake

of c

ouns

ellin

g an

d te

stin

g in

Ant

enat

al c

linic

R

atio

of a

nten

atal

clie

nts

who

wer

e co

unse

lled

and

test

ed fo

r HIV

Num

erat

or

This

is n

umbe

r of p

regn

ant w

omen

atte

ndin

g th

eir f

irst

ante

nata

l clin

ic v

isit

who

are

test

ed fo

r HIV

Den

omin

ator

N

umbe

r of n

ew v

isits

to th

e an

tena

tal c

linic

B

Ant

enat

al H

IV s

erop

reva

lenc

e

Rat

io o

f Ant

enat

al p

regn

ant w

omen

test

ed fo

r HIV

that

are

HIV

infe

cted

Num

erat

or

Num

ber o

f clie

nts

who

test

HIV

pos

itive

Den

omin

ator

To

tal n

umbe

r of p

regn

ant w

omen

test

ed fo

r HIV

in a

nten

ashyta

l clin

ic

C

Ant

enat

al m

othe

r AR

V pr

ophy

laxi

s up

take

R

atio

of k

now

n H

IV in

fect

ed p

regn

ant w

omen

in a

nten

atal

clin

ic

rece

ivin

g A

RV

pre

vent

ive

prop

hyla

xis

Num

erat

or

Tota

l num

ber o

f HIV

-infe

cted

pre

gnan

t wom

en in

ant

enat

al

clin

ic re

ceiv

ing

mot

her p

reve

ntiv

e A

RV

pro

phyl

axis

Den

omin

ator

To

tal n

umbe

r of p

regn

ant w

omen

who

are

HIV

-infe

cted

in

the

ante

nata

l clin

ic

D

Ant

enat

al in

fant

AR

V pr

ophy

laxi

s up

take

R

atio

of k

now

n H

IV-in

fect

ed p

regn

ant w

omen

in a

nten

atal

clin

ic w

ho

rece

ive

infa

nt d

ose(

s) o

f pre

vent

ive

AR

V p

roph

ylax

is

Num

erat

or

Tota

l num

ber o

f HIV

infe

cted

pre

gnan

t wom

en in

an

tena

tal c

linic

rece

ivin

g in

fant

dos

e(s)

pre

vent

ive

A

RV

pro

phyl

axis

Den

omin

ator

To

tal n

umbe

r of p

regn

ant w

omen

who

are

HIV

-infe

cted

in

the

ante

nata

l clin

ic

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

shou

ld h

ave

rout

ine

HIV

ant

ibod

y te

st

Gui

delin

es f

or f

eedi

ng in

fant

s an

d yo

ung

child

ren

born

to

HIV

infe

cted

mot

hers

are

di

scus

sed

in C

hapt

er 8

The

Min

istr

y of

Hea

lth r

ecom

men

ds p

rom

otio

n of

exc

lusi

vebr

east

feed

ing

for

the

first

6 m

onth

s of

life

Whe

re r

epla

cem

ent f

eedi

ng is

acc

epta

ble

feas

ible

af

ford

able

su

stai

nabl

e an

d sa

fe (

AFA

SS)

avoi

danc

e of

bre

astf

eedi

ng b

yH

IV-in

fect

ed w

omen

is

reco

mm

ende

d (W

HO

200

6) D

iscu

ssio

n on

diff

eren

t ty

pes

offe

edin

g al

tern

ativ

es t

o br

east

feed

ing

is c

aptu

red

in t

he t

ext

Thes

e op

tions

exi

st f

orth

e m

othe

r to

cho

ose

with

the

aid

of

coun

selli

ng I

deal

ly c

oupl

e de

cisi

on-m

akin

g is

enco

urag

ed f

or t

he H

IV p

ositi

ve m

othe

r F

or t

he H

IV n

egat

ive

mot

her

exc

lusi

ve

brea

stfe

edin

g is

rec

omm

ende

d fo

r 6

mon

ths

or le

ss fo

llow

ed b

y w

eani

ng

Car

e an

d fo

llow

-up

of c

hild

ren

of H

IV-in

fect

ed m

othe

rs is

dis

cuss

ed in

det

ail i

n C

hapshy

ter

9 A

ll ch

ildre

n bo

rn t

o H

IV i

nfec

ted

mot

hers

sho

uld

be f

ollo

wed

up

clos

ely

from

birt

h th

roug

h 2

year

s T

able

92

pro

vide

s th

e W

HO

rec

omm

ende

d fo

llow

up

deta

ils

Sim

ilarl

y t

he m

othe

rs s

houl

d be

sup

port

ed t

o pr

ovid

e op

timal

infa

nt fe

edin

g an

d to

av

oid

mix

ed fe

edin

g w

ithin

6 m

onth

s

In C

hapt

er 1

0 t

he G

uide

lines

exp

lain

the

ben

efits

of

mon

itori

ng a

nd e

valu

atio

n of

PMTC

T pr

ogra

ms

Mamp

E p

rovi

des

an o

ppor

tuni

ty t

o m

easu

re a

nd a

ppra

ise

perf

orm

shyan

ce w

ithin

def

ined

tim

e fr

ame

to e

nsur

e ac

com

plis

hmen

t of s

et g

oals

and

obj

ectiv

es

PMTC

T se

rvic

es m

ust

be g

uide

d by

tim

ely

and

accu

rate

dat

a re

port

ed f

rom

the

heal

th f

acili

ties

thr

ough

the

dis

tric

t an

d pr

ovin

cial

lev

els

to

the

natio

nal

leve

l at

NA

SCO

P

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

9

18

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

(xiii

) H

IV in

fect

ed in

mat

erni

ty w

ard

Num

ber

of p

regn

ant

wom

en a

dmitt

ed in

to

mat

erni

ty c

linic

who

are

HIV

infe

cted

In

clud

es b

oth

thos

e w

ho w

ere

adm

itted

al

read

y kn

owin

g th

ey a

re H

IV-i

nfec

ted

and

thos

e w

ho w

ere

test

ed a

nd r

ecei

ved

thei

r re

sults

in m

ater

nity

clin

ic T

his

is o

btai

ned

from

the

mat

erni

ty r

egis

ter

(xiv

) P

reve

ntiv

e A

RV

pro

phyl

axis

in m

ater

nity

war

d (m

othe

r do

se)

Num

ber

of

preg

nant

wom

en a

dmitt

ed in

mat

erni

ty t

akin

g or

rep

orte

d to

hav

e ta

ken

the

mot

her

dose

(s)

of p

reve

ntiv

e A

RV

pro

phyl

axis

T

his

is o

btai

ned

from

the

m

ater

nity

reg

iste

r

(xv)

Inf

ant

prev

entiv

e A

RV

pro

phyl

axis

in m

ater

nity

clin

ic

war

d N

umbe

r of

inshy

fant

s bo

rn in

mat

erni

ty r

ecei

ving

the

infa

nt p

reve

ntiv

e A

RV

pro

phyl

axis

in t

he

mat

erni

ty c

linic

T

his

is o

btai

ned

from

the

mat

erni

ty r

egis

ter

(xvi

) D

eliv

erie

s T

otal

num

ber

of p

regn

ant

wom

en d

eliv

erin

g at

the

hea

lth fa

cilit

y

(xvi

i) C

ouns

ellin

g on

infa

nt f

eedi

ng o

ptio

ns

Num

ber

of m

othe

rs d

eliv

erin

g at

the

he

alth

fac

ility

cou

nsel

led

on in

fant

fee

ding

opt

ions

T

his

is o

btai

ned

from

the

m

ater

nity

reg

iste

r

(xvi

ii) I

nfan

t te

stin

g at

6 w

eeks

bull N

umbe

r of

infa

nts

test

ed f

or H

IV a

t 6

wee

ks o

ld

bull N

umbe

r of

infa

nts

test

ing

HIV

-pos

itive

T

his

is o

btai

ned

from

labo

rato

ry

regi

ster

(xix

) R

efer

red

for

care

and

tre

atm

ent

bull N

umbe

r of

HIV

infe

cted

wom

en a

ttend

ing

ante

nata

l clin

ic t

hat

is r

efer

red

for

HIV

car

e an

d tr

eatm

ent

bull N

umbe

r of

HIV

infe

cted

wom

en in

mat

erni

ty t

hat

is r

efer

red

for

HIV

car

e an

d tr

eatm

ent

bull N

umbe

r H

IV in

fect

ed in

fant

s re

ferr

ed f

or H

IV c

are

and

trea

tmen

t T

his

is

ob

tain

ed f

rom

ant

enat

al a

nd m

ater

nity

reg

iste

rs

(xx)

Ini

tiate

d on

Cot

rim

oxaz

ole

Num

ber

of H

IV in

fect

ed p

regn

ant

wom

en a

ttend

ing

ante

nata

l clin

ic th

at h

as

been

initi

ated

on

Cot

rimox

azol

e T

his

is o

btai

ned

from

the

ant

enat

al r

egis

ter

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

9

88

Th

e da

ta is

pre

sent

ed u

sing

def

ined

per

form

ance

indi

cato

rs th

at in

clud

e th

e fo

llow

ing

(i)

New

clie

nts

first

ant

enat

al c

linic

vis

its

Num

ber

of p

regn

ant

wom

en a

ttend

ing

thei

r fir

st a

nten

atal

vis

it fo

r th

e cu

rren

t pr

egna

ncy

at t

he h

ealth

fac

ility

T

his

is

obta

ined

fro

m t

he a

nten

atal

reg

iste

r

(ii)

Ret

urn

visi

tsr

evis

its

Num

ber

of r

etur

n an

tena

tal c

linic

vis

itsr

evis

its

atte

nded

by

the

preg

nant

wom

en a

t th

e fa

cilit

y T

his

is o

btai

ned

from

the

an

tena

tal r

egis

ter

(iii)

C

ouns

ellin

g an

d te

stin

g fo

r H

IV in

ant

enat

al c

linic

Tot

al n

umbe

r of

pre

gnan

t w

omen

cou

nsel

led

and

test

ed f

or H

IV a

t th

e an

tena

tal c

linic

w

heth

er t

his

is d

one

on th

e fir

st a

nten

atal

vis

it or

a la

ter

visi

t T

his

is o

btai

ned

from

the

an

tena

tal r

egis

ter

(iv)

H

IV c

ouns

ellin

g an

d te

stin

g at

fir

st a

nten

atal

clin

ic v

isit

Num

ber

of p

regn

ant

wom

en a

tten

ding

the

ir fir

st a

nten

atal

clin

ic v

isit

for

curr

ent

preg

nanc

y w

ho a

re

test

ed f

or H

IV

Thi

s is

obt

aine

d fr

om t

he a

nten

atal

reg

iste

r

(v)

Lear

ning

HIV

sta

tus

in a

nten

atal

clin

ic

Num

ber

of a

nten

atal

clin

ic p

regn

ant

wom

en t

este

d fo

r H

IV w

ho r

ecei

ve t

heir

HIV

res

ults

w

heth

er t

his

is d

one

on t

he

first

ant

enat

al c

linic

vis

it or

at

a la

ter

visi

t T

his

is o

btai

ned

from

the

ant

enat

al

regi

ster

(vi)

HIV

infe

cted

in a

nten

atal

clin

ic

Num

ber

of a

nten

atal

clin

ic p

regn

ant

wom

en

who

are

HIV

-inf

ecte

d on

the

late

st t

est

durin

g th

e pr

egna

ncy

Thi

s is

obt

aine

d fr

om t

he a

nten

atal

reg

iste

r

(vii)

Pre

vent

ive

AR

V p

roph

ylax

is in

ant

enat

al c

linic

(m

othe

r do

se)

Num

ber

of

preg

nant

wom

en in

the

ant

enat

al c

linic

rec

eivi

ng t

he m

othe

r do

se(s

) of

pre

venshy

tive

AR

V p

roph

ylax

is

Thi

s is

obt

aine

d fr

om t

he a

nten

atal

reg

iste

r

(viii

) P

reve

ntiv

e A

RV

pro

phyl

axis

in a

nten

atal

clin

ic (

infa

nt d

ose)

N

umbe

r of

pr

egna

nt w

omen

in t

he A

nten

atal

clin

ic is

sued

with

the

infa

nt d

ose(

s) o

f pr

even

shytiv

e A

RV

pro

phyl

axis

T

his

is o

btai

ned

from

the

ant

enat

al r

egis

ter

(ix)

New

clie

nts

in m

ater

nity

clin

ic

Num

ber

of p

regn

ant

wom

en a

tten

ding

the

Mashy

tern

ity c

linic

for

the

firs

t tim

e T

his

is o

btai

ned

from

the

mat

erni

ty r

egis

ter

(x)

Unk

now

n H

IV s

tatu

s at

mat

erni

ty

Num

ber

of p

regn

ant

wom

en a

dmitt

ed in

to

the

mat

erni

ty w

ith u

nkno

wn

HIV

sta

tus

Thi

s is

obt

aine

d fr

om t

he m

ater

nity

reg

isshy

ter

(xi)

Cou

nsel

ling

and

test

ing

for

HIV

in m

ater

nity

war

dT

otal

num

ber

of p

regn

ant

wom

en a

dmitt

ed in

to m

ater

nity

with

unk

now

n st

atus

tha

t ar

e co

unse

lled

and

test

ed fo

r H

IV d

urin

g la

bour

or

afte

r de

liver

y T

his

is o

btai

ned

from

the

mat

erni

ty

regi

ster

(xii)

Lea

rnin

g H

IV s

tatu

s in

mat

erni

ty w

ard

Num

ber

of p

regn

ant

wom

en a

dmitt

ed

into

mat

erni

ty a

nd t

este

d fo

r H

IV w

ho r

ecei

ved

thei

r H

IV r

esul

ts

Thi

s is

obt

aine

d fr

om t

he m

ater

nity

reg

iste

r

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Cha

pter

1

Bac

kgro

und

11

THE

GLO

BA

L P A

ND

EMIC

Ove

r 38

mill

ion

peop

le a

re li

ving

with

HIV

AID

S w

orld

wid

e a

nd a

bout

two-

thir

ds o

r 25

m

illio

n of

PLW

HA

liv

e in

sub

-Sah

aran

Afr

ica1

H

IVA

IDS

mai

nly

affe

cts

peop

le o

fre

prod

uctiv

e ag

e an

d in

crea

sing

ly a

ffect

s w

omen

w

ho n

ow a

ccou

nt f

or 5

7 o

f ne

win

fect

ions

in s

ub-S

ahar

an A

fric

a w

here

wom

en a

re 3

0 m

ore

likel

y to

be

livin

g w

ith

HIV

AID

S th

an m

en a

nd y

oung

wom

en a

ged

15-2

4 ar

e ne

arly

four

tim

es m

ore

likel

y to

be

inf

ecte

d th

an t

heir

mal

e co

unte

rpar

ts2

Youn

g m

arri

ed w

omen

w

ho a

re o

ften

m

onog

amou

s h

ave

beco

me

one

of t

he g

roup

s m

ost

vuln

erab

le t

o H

IV i

n th

e re

gion

Th

is r

equi

res

new

and

rap

id r

espo

nses

that

bro

aden

the

focu

s be

yond

trad

ition

al ldquoh

igh

risk

rdquo gro

ups

like

com

mer

cial

sex

wor

kers

tru

ck d

rive

rs a

nd d

rug

user

s

To r

each

you

ng m

arri

ed w

omen

w

ho m

ay n

ot b

e aw

are

of t

heir

vul

nera

bilit

y H

IV

AID

S pr

even

tion

ca

re

and

supp

ort

activ

ities

m

ust

be

inte

grat

ed

into

al

read

yes

tabl

ishe

d he

alth

ser

vice

s th

at a

re u

sed

by t

he g

ener

al p

opul

atio

n A

n es

timat

ed

630

000

child

ren

wor

ld-w

ide

beca

me

infe

cted

with

HIV

in

2003

mdash m

ost

thro

ugh

MTC

T3

The

risk

of

an H

IV-in

fect

ed m

othe

r pa

ssin

g th

e vi

rus

to h

er i

nfan

t du

ring

pr

egna

ncy

labo

ur a

nd d

eliv

ery

or in

the

post

nata

l per

iod

is 1

in 3

if n

othi

ng is

don

e to

re

duce

this

ris

k I

n ot

her

wor

ds o

ut o

f 100

infa

nts

born

to w

omen

with

HIV

AID

S an

d w

ithou

t in

terv

entio

n 6

0-75

of t

hem

will

not

be

infe

cted

Of t

he o

ne-t

hird

who

bec

ome

infe

cted

abo

ut 5

-10

babi

es w

ill b

e in

fect

ed d

urin

g pr

egna

ncy

15

will

be

infe

cted

dur

ing

labo

ur a

nd d

eliv

ery

whi

le 5

-15

will

be

infe

cted

dur

ing

brea

stfe

edin

g l

arge

ly b

eing

de

pend

ent

on b

reas

tfee

ding

pra

ctic

es a

nd o

n th

e du

ratio

n of

bre

astfe

edin

g4 I

n 20

03

near

ly 5

000

00 c

hild

ren

died

of A

IDS-

rela

ted

caus

es M

ost

child

ren

born

with

HIV

die

befo

re th

ey r

each

thei

r fif

th b

irth

day

with

mos

t not

sur

vivi

ng b

eyon

d tw

o ye

ars5

The

high

rat

es o

f M

TCT

in d

evel

opin

g co

untr

ies

com

pare

d to

muc

h lo

wer

rat

es i

nri

cher

cou

ntri

es

illus

trat

e gr

owin

g in

equa

litie

s in

glo

bal

heal

th

In t

he w

ealth

y co

untr

ies

the

rat

e of

MTC

T is

les

s th

an 2

b

ecau

se o

f w

ides

prea

d ac

cess

to

antishy

retr

ovir

al th

erap

y (A

RT)

pla

nned

cae

sare

an s

ectio

ns (C

S) t

he m

eans

to s

afel

y fo

rmul

afe

ed a

nd a

cces

s to

qua

lity

med

ical

ser

vice

s I

n po

orer

cou

ntri

es li

ke K

enya

the

re is

a

30-4

0 c

hanc

e th

at a

n H

IV-p

ositi

ve b

reas

tfee

ding

mot

her

will

pas

s H

IV to

her

chi

ld in

th

e ab

senc

e of

the

se s

ervi

ces

In

such

set

tings

it

is c

ritic

al t

hat

prev

entio

n pr

oced

ures

be i

nteg

rate

d in

to e

xist

ing

sexu

al a

nd r

epro

duct

ive

heal

th (

SRH

) an

d m

ater

nal

and

child

hea

lth (

MC

H)

serv

ices

re

achi

ng a

s m

any

wom

en a

s po

ssib

le a

nd l

ower

ing

tran

smis

sion

rat

es A

lthou

gh p

harm

aceu

tical

com

pany

don

atio

ns d

onor

sup

port

and

othe

r go

vern

men

t in

itiat

ives

hav

e he

lped

exp

and

acce

ss t

o H

IV t

estin

g fo

r pr

egna

ntw

omen

and

use

of a

ntir

etro

vira

l dru

gs li

ke N

evir

apin

e w

hich

red

uce

the

chan

ce o

f HIV

tr

ansm

issi

on s

till o

nly

10

of p

regn

ant w

omen

glo

bally

hav

e ac

cess

to th

ese

drug

s6

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

7

20

HIV

AID

S tr

ansm

issi

on fr

om m

othe

r to

chi

ld in

Ken

ya is

one

of t

he b

igge

st h

ealth

and

de

velo

pmen

t cha

lleng

es in

Ken

ya A

ccor

ding

to th

e 20

03 D

emog

raph

ic a

nd H

ealth

Sur

shyve

y7 6

7

or

over

12

mill

ion

Ken

yan

adul

ts w

ere

livin

g w

ith H

IVA

IDS

in 2

003

The

re

has

been

a s

tead

y de

clin

e in

HIV

ser

opre

vale

nce

in K

enya

In

2005

the

pre

vale

nce

rate

w

as e

stim

ated

at 5

9

and

as

per

the

2006

sta

tistic

s th

e pr

eval

ence

rat

e am

ong

adul

tsha

d dr

oppe

d to

51

8

Acc

ordi

ng t

o 20

07 K

enya

AID

S In

dica

tor

Surv

ey (

KA

IS)8a

the

H

IV s

erop

reva

lenc

e in

Ken

ya is

cur

rent

ly 7

8

am

ong

adul

ts a

ged

15-4

9 ye

ars

bei

nghi

gher

in

wom

en (

87

) th

an i

n m

en (

56

) Y

oung

wom

en a

re m

ore

vuln

erab

le i

n K

enya

tha

n m

en a

s ev

iden

ced

by a

nea

rly

9 p

reva

lenc

e ra

te a

mon

g w

omen

and

unshy

der

5 a

mon

g m

en9

Ther

e ar

e w

ide

vari

atio

ns b

etw

een

urba

n an

d ru

ral

area

s b

etw

een

regi

ons

bet

wee

n ad

ults

and

you

ng p

eopl

e an

d be

twee

n m

en a

nd w

omen

The

re h

as b

een

a no

tabl

e dr

op

in t

he n

umbe

r of

new

inf

ectio

ns

with

an

estim

ated

60

000

new

inf

ectio

ns i

n 20

05

drop

ping

to 5

500

0 in

200

6 In

fant

s an

d yo

ung

child

ren

unde

r 15

yea

rs a

ccou

nt fo

r 16

of

all

new

HIV

infe

ctio

ns m

ainl

y as

a r

esul

t of M

TCT

Mos

t of t

he n

ew in

fect

ions

occ

ur

amon

g yo

ung

peop

le i

n w

hom

the

mai

n m

ode

of t

rans

mis

sion

is t

hrou

gh s

exua

l int

ershy

cour

se

Tabl

e 1

1 A

dult

HIV

-Pre

vale

nce

Estim

ate

by P

rovi

nce

in 2

006

Prov

ince

N

umbe

r of H

IV +

Pre

vale

nce

()

Nai

robi

Cen

tral

Coa

st

Eas

tern

N E

aste

rn

Nya

nza

Rift

Val

ley

Wes

tern

Tota

l

197

000

960

00

930

00

720

00

900

0 18

300

0

171

000

112

000

11

milli

on

Tota

l

101

41

59

28

14

78

38

53

51

Mal

e

80

17

50

11

09

61

26

42

35

Fem

ale

123

65

69

44

18

96

49

64

67

Mal

eFe

mal

e R

atio

15

38

14

40

20

16

19

15

19

all t

he d

ata

from

the

prov

ince

s (a

nd r

efer

ral h

ospi

tals

) Th

e ag

greg

ated

dat

a is

di

ssem

inat

ed t

o th

e H

ealth

Man

agem

ent

Info

rmat

ion

Syst

em N

atio

nal A

IDS

Con

trol

Cou

ncilrsquo

s (N

AC

C)

natio

nal

data

ban

k an

d re

sour

ce c

entr

e T

he f

ocal

pe

rson

s he

re a

re t

he d

irec

tor

NA

CC

and

the

Mamp

E m

anag

er D

ata

is d

isse

mishy

nate

d ba

ck to

the

prov

ince

s an

d re

ferr

al h

ospi

tals

for

use

in d

ecis

ion-

mak

ing

7

Dat

a flo

w f

rom

fac

ility

lev

el t

o na

tiona

l le

vel

At

the

heal

th f

acili

ty P

MTC

T in

divi

dual

le

vel d

ata

reco

rded

in t

he M

oH s

tand

ardi

sed

regi

ster

s (A

NC

Mashy

tern

ity a

nd P

ostn

atal

) is

sum

mar

ised

ag

greg

ated

on

a m

onth

ly b

asis

ont

o M

oH F

orm

726

F

orm

726

is

then

for

war

ded

upw

ards

to

the

dist

rict

Lev

el

(DA

SCO

rsquos O

ffice

) for

agg

rega

tion

of th

e D

istr

ict l

evel

dat

a on

to F

orm

727

Cop

shyie

s of

For

m 7

26 a

nd F

orm

727

are

forw

arde

d to

the

Nat

iona

l Offi

ce (N

ASC

OP)

w

ith a

noth

er c

opy

of F

orm

727

bei

ng s

ent t

o th

e Pr

ovin

cial

Offi

ce (P

ASC

O)

8

Dat

a di

ssem

inat

ion

Thi

s is

car

ried

out

at

all

leve

ls s

tart

ing

from

fac

ility

to

natio

nal l

evel

It i

s th

e re

spon

sibi

lity

of N

AC

C to

coo

rdin

ate

the

diss

emin

atio

n an

d us

e of

all

HIV

AID

S da

ta a

nd in

form

atio

n fo

r na

tiona

l res

pons

e J

APR

a

join

t pro

gram

me

of a

ll st

akeh

olde

rs in

HIV

AID

S re

ceiv

es a

nd u

ses

the

data

to

disc

uss

the

chal

leng

es a

chie

vem

ents

and

les

sons

lea

rnt

from

HIV

AID

S an

d gi

ves

feed

back

for n

atio

nal r

espo

nse

9

PMTC

T in

dica

tors

and

thei

r so

urce

s H

ealth

car

e fa

cilit

ies

colle

ct th

e fo

llow

ing

data

as

a m

inim

um t

o be

use

d in

the

mon

itori

ng o

f PM

TCT

prog

ram

s T

he

data

is

to b

e ag

greg

ated

on

a m

onth

ly b

asis

ont

o th

e M

inis

try

of H

ealth

In

tegr

ated

Mon

itori

ng a

nd E

valu

atio

n R

epor

t For

m M

oH 7

26 u

sing

dat

a fr

om

the

Min

istr

y of

Hea

lth

Ken

ya A

nten

atal

and

Mat

erni

ty R

egis

ters

(D

eliv

ery

Reg

iste

r) M

oH 4

05 a

nd M

oH 3

33 r

espe

ctiv

ely

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

2

1

86

102

O

PER

ATI

ON

AL

GU

IDEL

INES

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed in

the

mon

itorin

g an

d ev

alua

-tio

n of

PM

TCT

serv

ices

1

W

ithin

PM

TCT

prog

ram

s d

ata

is c

olle

cted

and

rep

orte

d at

the

fol

low

ing

leve

ls I

ndiv

idua

l fa

cilit

y d

istr

ict

prov

inci

al a

nd n

atio

nal

2

Indi

vidu

al l

evel

The

com

bine

d m

othe

r an

d ch

ild h

ealth

boo

klet

pro

vide

s de

shyta

iled

info

rmat

ion

on t

he w

oman

and

chi

ld i

nclu

ding

the

HIV

sta

tus

oth

er

HIV

car

e se

rvic

es d

rugs

del

iver

y in

form

atio

n im

mun

isat

ion

gro

wth

mon

itorshy

ing

and

othe

r par

amet

ers

3

Faci

lity

leve

l da

ta c

aptu

re t

ools

The

MoH

has

sta

ndar

dise

d re

gist

ers

for

reshy

cord

ing

data

at

faci

litie

s T

hese

inc

lude

the

Rev

ised

AN

C R

egis

ter

Rev

ised

M

ater

nity

Reg

iste

r an

d Po

st N

atal

Reg

iste

r an

d W

orkl

oad

MO

H 7

17 O

ther

re

gist

ers

incl

ude

Chi

ld H

ealth

and

Nut

ritio

n In

form

atio

n Sy

stem

and

Inshy

patie

nt M

orbi

dity

and

Mor

talit

y F

orm

711

and

the

Rep

rodu

ctiv

e H

ealth

Ser

shyvi

ces

mon

thly

rep

orts

are

use

d fo

r m

akin

g fa

cilit

y le

vel s

umm

arie

s on

PM

TCT

and

repr

oduc

tive

heal

th s

ervi

ces

3 F

acili

ty le

vel d

ata

capt

ure

tool

s T

he M

oH

has

stan

dard

ized

reg

iste

rs f

or r

ecor

ding

dat

a at

fac

ilitie

s T

hese

inc

lude

the

R

evis

ed A

NC

Reg

iste

r R

evis

ed M

ater

nity

Reg

iste

r an

d Po

st N

atal

Reg

iste

r an

d w

orkl

oad

MO

H 7

17 O

ther

reg

iste

rs in

clud

e C

hild

Hea

lth a

nd N

utri

tion

Info

rmat

ion

Syst

em a

nd I

n-pa

tient

mor

bidi

ty a

nd m

orta

lity

Fo

rm 7

26 a

nd

the

Rep

rodu

ctiv

e he

alth

ser

vice

s m

onth

ly r

epor

ts a

re u

sed

for

mak

ing

faci

lity

leve

l sum

mar

ies

on P

MTC

T an

d re

prod

uctiv

e he

alth

ser

vice

s

4

Dis

tric

t le

vel

data

For

m 7

27 i

s us

ed t

o su

mm

aris

e an

d re

port

dis

tric

t le

vel

data

Oth

er s

umm

ary

repo

rtin

g to

ols

are

also

use

d to

rep

ort

dist

rict

leve

l inshy

form

atio

n A

t th

e di

stri

ct le

vel

the

DAS

CO

rsquos of

fice

aggr

egat

es d

ata

from

sev

shyer

al h

ealth

faci

lity

spec

ific

Form

726

ont

o Fo

rm 7

27 th

at is

use

d to

sum

mar

ise

and

repo

rt d

istr

ict l

evel

dat

a

5

Prov

inci

al l

evel

dat

a A

t th

e pr

ovin

cial

lev

el t

he P

ASC

O r

ecei

ves

Form

727

da

ta f

rom

the

res

pect

ive

DA

SCO

rsquos of

fices

in

the

prov

ince

for

the

ir o

wn

data

us

e an

d re

cord

s A

cop

y of

the

sam

e is

sen

t to

the

Nat

iona

l Offi

ce (N

ASC

OP)

by

the

DA

SCO

rsquos of

fice

At

the

prov

inci

al le

vel

the

dist

rict

leve

l dat

a is

agg

reshy

gate

d to

giv

e th

e pr

ovin

cial

leve

l dat

a

6 N

atio

nal

leve

l da

ta

At

the

natio

nal

leve

l th

e M

ampE

Man

ager

rec

eive

s da

ta

from

the

PASC

Os

for

each

of t

he p

rovi

nces

Dat

a is

als

o re

ceiv

ed fr

om th

e R

eshyfe

rral

hos

pita

ls a

nd o

ther

fac

ilitie

s at

the

ref

erra

l ho

spita

l or

ter

tiary

lev

el

The

data

rec

eive

d at

the

nat

iona

l lev

el is

als

o co

pied

to

the

Hea

d of

NA

SCO

P an

d PM

TCT

prog

ram

me

man

ager

The

Mamp

E m

anag

er a

t NA

SCO

P ag

greg

ates

85

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

12

MA

GN

ITU

DE

OF

HIV

IN P

REG

NA

NC

YIN

KEN

YA

Ken

ya N

atio

nal

AID

SST

I C

ontr

ol P

rogr

amm

e (N

ASC

OP)

est

imat

es t

hat

ther

e w

ere

12

mill

ion

babi

es b

orn

in 2

006

in K

enya

and

that

as

man

y as

9

of p

regn

ant w

omen

inK

enya

wer

e liv

ing

with

HIV

AID

S10

At

leas

t 50

000

to

600

00 i

nfan

ts i

n K

enya

wer

e th

ough

t to

hav

e be

en i

nfec

ted

with

H

IV a

s a

resu

lt of

MTC

T th

at y

ear

With

an

estim

ated

pop

ulat

ion

of 3

72

mill

ion

in th

eye

ar 2

007

the

num

ber

of b

irth

s in

200

7 w

as 1

73

mill

ion

With

an

HIV

pre

vale

nce

of 6

7

the

num

ber

of H

IV -

expo

sed

babi

es is

114

101

and

at

leas

t 45

640

HIV

-pos

itive

bab

ies

are

born

ass

umin

g a

40

tran

smis

sion

(Tab

le 1

2)

Tabl

e 1

2 E

stim

ated

mag

nitu

de o

f MTC

T in

Ken

ya 2

007

Popu

latio

n (E

stim

ates

200

7)

372

mill

ion

Birt

hs p

er a

nnum

1

73 m

illio

n

HIV

pre

vale

nce

in m

othe

rs

67

Tota

l num

ber o

f birt

hs to

HIV

-infe

cted

mot

hers

exp

osed

14

110

1 to

MTC

T as

sum

ing

no m

ultip

le p

regn

ancy

Num

ber o

f HIV

pos

itive

infa

nts

per a

nnum

in K

enya

45

640

as

sum

ing

40

tran

smis

sion

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

22

13

RIS

KS

OF

T RA

NSM

ISSI

ON

OF

MTC

T A

T D

IFFE

REN

T

T

IME

P ER

IOD

S

In K

enya

an

estim

ated

40

000

to 5

000

0 in

fant

s ar

e in

fect

ed w

ith H

IV a

nnua

lly d

ue to

m

othe

r-to

-chi

ld t

rans

mis

sion

Th

is c

an o

ccur

in u

tero

dur

ing

labo

ur a

nd d

eliv

ery

and

thro

ugh

brea

stfe

edin

g D

urin

g pr

egna

ncy

abo

ut 5

to

8 pe

rcen

t of

HIV

-exp

osed

bab

ies

beco

me

infe

cted

thr

ough

tra

nsm

issi

on a

cros

s th

e pl

acen

ta L

abou

r an

d de

liver

y po

ses

the

grea

test

ris

k fo

r tr

ansm

issi

on w

ith 1

0 to

20

perc

ent

of e

xpos

ed i

nfan

ts b

ecom

ing

infe

cted

at t

his

time

Bre

astf

eedi

ng a

lso

expo

ses

infa

nts

to H

IV

Whe

n m

othe

rs b

reas

tfee

d fo

r 18

to

24m

onth

s an

othe

r 10

to 1

5 pe

rcen

t of i

nfan

ts b

ecom

e in

fect

ed T

hus

in n

on-b

reas

tfee

ding

po

pula

tions

with

out

antir

etro

vira

l tre

atm

ent

appr

oxim

atel

y 15

to

30 p

erce

nt in

fant

s w

ill b

ecom

e in

fect

ed

with

pro

long

ed b

reas

tfee

ding

25

to

45 p

erce

nt i

nfan

ts w

ill

beco

me

infe

cted

Tabl

e 1

3 T

rans

mis

sion

pat

tern

s in

bre

astfe

edin

g an

d no

n br

east

feed

ing

popu

latio

ns

Tran

smis

sion

rate

in

Tim

ing

No

Bre

astfe

edin

g B

reas

tfeed

ing

Bre

astfe

edin

g th

roug

h

thro

ugh

6

mon

ths

18 to

24

mon

ths

Dur

ing

preg

nanc

y 05

to 1

0 05

to 1

0 05

to 1

0

Dur

ing

labo

ur

10 to

20

10 to

20

10 to

20

Thro

ugh

brea

stfe

edin

g 10

to 2

0 05

to 1

0 05

to 1

0

Ear

ly (f

irst 2

mon

ths)

10

to 2

0 05

to 1

0 05

to 1

0

Late

(afte

r 2 m

onth

s)

10 to

20

01 to

05

05 to

10

Ove

rall

15 to

30

25 to

35

30 to

45

Sou

rce

De

Coc

k K

M (2

002)

Form

MoH

711

has

bee

n re

com

men

ded

to r

epla

ce F

orm

MoH

726

HIV

Mamp

E d

ata

flow

pip

elin

e fr

om t

he i

ndiv

idua

l he

alth

fac

ilitie

s t

o th

e di

stri

ct a

ndpr

ovin

cial

leve

ls u

p to

the

cent

ral o

r na

tiona

l lev

els

at N

ASC

OP

and

NA

CC

is s

umm

ashyri

sed

in F

igur

e 1

01

Figu

re 1

01

HIV

Mon

itorin

g an

d Ev

alua

tion

data

flow

pip

elin

e in

Ken

ya

HM

IS

NA

SC

OP

N

ACC

H

ead

Nat

iona

l Dat

a B

ank

amp

Res

ourc

e C

entre

M

E M

anag

er

The

Dire

ctor

P

rogr

amm

e M

anag

er

ME

Man

ager

Ref

erra

l Hos

pita

ls

CE

Os

Spe

cial

ists

The

Prov

ince

P

MO

P

AS

CO

P

AR

TO

PH

RIO

P

CO

The

Dis

trict

D

MO

D

AS

CO

Dat

a en

try

cler

k D

AR

TO

DH

RIO

Hea

lth F

acilit

y P

ublic

Sec

tor

FBO

etc

23

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

84

Cha

pter

10

Mon

itorin

g an

d Ev

alua

tion

of P

MTC

T Se

rvic

es

101

IN

TRO

DU

CTI

ON

PMTC

T pr

ogra

m m

onito

ring

and

eva

luat

ion

activ

ities

pro

vide

the

oppo

rtun

ity to

mea

sshyur

e an

d ap

prai

se p

erfo

rman

ce w

ithin

def

ined

par

amet

ers

that

ens

ure

acco

mpl

ishm

ent

of g

oals

and

obj

ectiv

es

Ken

ya is

com

mitt

ed to

the

ldquoThr

ee-o

nesrdquo

pri

ncip

les

whi

ch a

re

bull O

ne a

gree

d A

IDS

Act

ion

Fra

mew

ork

that

pro

vide

s th

e ba

sis

for

coor

dina

ting

the

wor

k pl

an o

f al

l par

tner

s

bull O

ne N

atio

nal A

IDS

Coo

rdin

atin

g A

utho

rity

with

a b

road

-bas

ed

mul

tisec

tora

l man

date

bull O

ne a

gree

d co

untr

y-le

vel M

onito

ring

and

Eva

luat

ion

(M

ampE

) sy

stem

In l

ine

with

thi

s t

he c

ount

ry h

as d

evel

oped

the

Nat

iona

l H

IVA

IDS

Mon

itori

ng a

ndE

valu

atio

n Fr

amew

ork

that

pro

vide

s st

akeh

olde

rs w

ith a

too

l fo

r w

ell

coor

dina

ted

in

terl

inke

d an

d fu

nctio

nal H

IVA

IDS

Mamp

E s

yste

m t

hat

allo

ws

for

effic

ient

mon

itori

ngof

int

erve

ntio

ns i

n ac

hiev

ing

the

natio

nal

prog

ram

mat

ic g

oals

usi

ng d

efin

ed t

arge

ts

This

pro

vide

s th

e fr

amew

ork

for M

ampE

act

iviti

es w

ithin

PM

TCT

prog

ram

s

Nat

iona

l PM

TCT

data

is

repo

rted

usi

ng M

oH I

nteg

rate

d M

onito

ring

and

Eva

luat

ion

Rep

ortin

g Fo

rms

For

m M

oH 7

11 o

r Fo

rm M

oH 7

27

Indi

vidu

al P

MTC

T da

ta is

col

shyle

cted

at

the

heal

th f

acili

ties

offe

ring

PM

TCT

serv

ices

usi

ng s

tand

ard

MoH

reg

iste

rs(A

NC

Mat

erni

ty a

nd P

ostn

atal

Reg

iste

rs)

On

mon

thly

bas

is t

he h

ealth

faci

litie

s w

ill a

ggre

gate

the

dat

a fr

om t

he r

egis

ters

on

to

Form

MoH

711

or

MO

H 7

26 w

hich

is th

en fo

rwar

ded

upw

ards

to th

e D

ASC

Orsquos

offic

e A

copy

is

left

at

the

heal

th f

acili

ty f

or t

heir

ow

n da

ta u

se

At

the

dist

rict

lev

el

the

DA

SCO

rsquos of

fice

aggr

egat

es d

ata

from

sev

eral

hea

lth f

acili

ty s

peci

fic F

orm

726

ont

o Fo

rm M

oH 7

27 (o

r Fo

rm 7

11) t

hat

is u

sed

to s

umm

aris

e an

d re

port

dis

tric

t le

vel d

ata

B

oth

Form

726

and

For

m M

oH 7

27 a

re th

en s

ent t

o N

ASC

OP

A c

opy

of th

e Fo

rm 7

27

or F

orm

711

is s

ent t

o th

e PA

SCO

and

ano

ther

to th

e he

alth

faci

litie

s in

the

dist

rict

for

thei

r ow

n da

ta u

se

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

14

RIS

K F

AC

TOR

SFO

R M

TCT

OF

HIV

M

any

fact

ors

are

know

n or

sus

pect

ed t

o in

crea

se t

he r

isk

of a

n H

IV in

fect

ed m

othe

r tr

ansm

ittin

g th

e vi

rus

to h

er i

nfan

t Th

ese

fact

ors

incl

ude

the

HIV

vir

al l

oad

in t

he

mot

her

as

wel

l as

othe

r m

ater

nal

obst

etri

cal

vira

l and

infa

nt fa

ctor

s (T

able

14

)

The

mos

t sig

nific

ant r

isk

fact

or a

ppea

rs to

be

the

HIV

vir

al lo

ad in

the

mot

her

thou

gh

the

othe

r fa

ctor

s m

ay a

lso

cont

ribu

te t

o in

crea

sing

an

infa

ntrsquos

expo

sure

or

susc

eptib

ilshyity

to

acqu

irin

g H

IV S

ome

fact

ors

may

cau

se a

bre

akdo

wn

in t

he p

rote

ctio

n of

fere

d to

the

foet

us b

y th

e pl

acen

ta w

hich

in n

orm

al c

ircu

mst

ance

s w

ould

not

allo

w H

IV to

cro

ssth

e pl

acen

ta fr

om m

othe

r to

foet

us

Tran

smis

sion

dur

ing

labo

ur a

nd d

eliv

ery

occu

rs w

hen

the

infa

nt s

ucks

im

bibe

s or

asshy

pira

tes

mat

erna

l bl

ood

or c

ervi

cal

secr

etio

ns t

hat

cont

ain

HIV

or

whe

n it

has

othe

r m

ucou

s m

embr

ane

expo

sure

Tab

le 1

4

Ris

k fa

ctor

s fo

r M

TCT

of H

IV

Stro

ng e

vide

nce

Lim

ited

evid

ence

VIR

AL

MA

TER

NA

L

OB

STE

TRIC

AL

FETA

LIN

FAN

T

BR

EA

ST-

FEE

DIN

G

Hig

h vi

ral l

oad

Imm

une

defic

ienc

y (lo

w

CD

4 co

unt)

HIV

infe

ctio

n ac

quire

d du

ring

preg

nanc

y o

r br

east

feed

ing

perio

d

Vagi

nal d

eliv

ery

(com

pare

d to

ele

ctiv

e ca

esar

ean

sect

ion)

ru

ptur

e of

the

mem

bran

es

for m

ore

than

4 h

ours

Prem

atur

ity

Dur

atio

n of

bre

astfe

edin

g

mix

ed fe

edin

g b

reas

t di

seas

e (m

astit

isc

rack

ed

nipp

les)

Vira

l res

ista

nce

(theo

retic

al p

ossi

bilit

y)

Vira

l gen

otyp

e an

d ph

enot

ype

Vita

min

A d

efic

ienc

y a

naem

ia s

exua

lly

trans

mitt

ed d

isea

ses

ch

orio

amni

oniti

s fr

eque

nt u

npro

tect

ed

sexu

al in

terc

ours

e m

ultip

le s

exua

l pa

rtner

s s

mok

ing

inje

ctin

g dr

ug a

buse

Inva

sive

or t

raum

atic

pro

cedu

res

in

stru

men

tal d

eliv

erie

s a

mni

ocen

tesi

s

epis

ioto

my

ext

erna

l cep

halic

ver

sion

(E

CV

) et

c i

ntra

partu

m h

aem

orrh

age

Lesi

ons

of s

kin

and

or m

ucou

s m

embr

anes

Ora

l thr

ush

(bab

y)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

3

24

15

BEN

EFIT

SO

F P R

EVEN

TIN

G M

OTH

ER-T

O-C

HIL

D

T

RA

NSM

ISSI

ON

OF

HIV

A

IDS

rela

ted

deat

hs a

re r

ever

sing

gai

ns m

ade

in c

hild

hea

lth a

nd s

urvi

val i

n K

enya

C

arin

g fo

r H

IV-in

fect

ed c

hild

ren

has

maj

or e

cono

mic

and

soc

ial

impa

cts

on f

amili

es

and

heal

th s

yste

ms

Thu

s at

the

nat

iona

l lev

el p

reve

ntin

g M

TCT

has

the

pote

ntia

l to

incr

ease

the

unde

rsta

ndin

g an

d ac

cept

ance

of t

he H

IVA

IDS

epid

emic

and

thos

e liv

ing

with

HIV

AID

S C

ouns

ellin

g t

estin

g an

d co

mm

unity

sen

sitis

atio

n ca

n co

ntri

bute

to

redu

cing

stig

ma

Red

uctio

n of

MTC

T of

HIV

bull

Dec

reas

es n

umbe

rs o

f H

IV in

fect

ed c

hild

ren

bull

Incr

ease

s ch

ild h

ealth

and

sur

viva

l

bull

Dec

reas

es t

he lo

ad o

n th

e he

alth

sys

tem

bull

Giv

es a

n op

port

unity

to im

prov

e an

d ex

pand

hea

lth s

ervi

ces

as w

ell a

s to

str

engt

hen

the

exis

ting

heal

th in

fras

truc

ture

16

BEN

EFIT

SO

F H

IV C

OU

NSE

LLIN

GA

ND T

ESTI

NG

(CT)

(a) I

t pro

mot

es b

ehav

iour

cha

nge

by

bull R

educ

ing

high

ris

k be

havi

our

for

HIV

bull Id

entif

ying

HIV

dis

cord

ant

coup

les

bull In

crea

sing

the

use

of

dual

met

hods

of f

amily

pla

nnin

g an

d S

TI

prev

entio

n

bull Im

prov

ing

ante

nata

l car

e

bull G

uidi

ng in

fant

fee

ding

(b) I

t ena

bles

pre

vent

ive

ther

apy

for

bull

Mal

aria

bull O

ppor

tuni

stic

infe

ctio

ns (

eg

Pne

umoc

ystis

jiro

veci

i pn

eum

onia

)

bull T

B

25

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

82

Foo

tnot

es

9

Use

oth

er o

ptions

for

child

ren o

ver

9 k

ilogra

ms

10

Use

reg

ula

r or

double

-str

ength

tab

lets

for

child

ren o

ver

16 k

ilogra

ms

NO

T A

PP

LIC

AB

LE

bullPsp

sm

ear

The

fram

ewor

k be

low

illu

stra

tes

poin

ts o

f int

egra

tion

of c

ompr

ehen

sive

HIV

ca

re p

acka

ge in

to e

xist

ing

child

hea

lth s

ervi

ces

Fram

ewor

k for

integ

ratio

n F

rom

Ped

iatr

ic H

IV P

reve

nti

on

to C

are

A

Co

nce

ptu

al F

ram

ewo

rk N

ewb

orn

In

fan

t W

om

an

H

IV e

duca

tion

Pre

gn

an

cy

prev

entio

n C

T

bull F

ocus

ed A

NC

incl

udin

g

AR

V p

roph

ylax

is s

tagi

ng

STI

syph

ilis

CT

Z p

roph

ylax

isA

RT

M

alar

ia tr

eatm

ent amp

pre

vent

ion

CD

4 w

here

ava

ilabl

e in

clud

ing

IPT

amp I

TNs

Infa

nt f

eedi

ng c

ouns

elin

g (I

FC)

Lab

ou

r an

d D

eliv

ery

U

nive

rsal

pre

caut

ions

CT

for

unt

este

d m

othe

rs in

clud

ing

bull D

eliv

ery

care

bull E

OC

-Em

erge

ncy

obst

etri

c ca

re

part

ner

bull R

efer

ral s

yste

m

AR

V p

roph

ylax

is

(mot

her

and

infa

nt)

AR

T C

TZ

pro

phyl

axis

Exc

lusi

ve b

reas

t fe

edin

g or

rep

lace

men

t fe

edin

g

Post

Na

tal

Ca

re

Infa

nt fe

edin

g co

unse

ling

bull B

reas

t hea

lth

Dia

gnos

is (

antib

ody)

if

bull Se

xual

hea

lth

expo

sure

unk

now

n bull

Fam

ily

plan

ning

D

NA

PC

R if

exp

osed

CT

Z p

roph

ylax

is I

FC-

infa

nt f

eedi

ng c

ouns

elin

g

CT

for

unt

este

d m

othe

rs

CT

for

par

tner

D

BS

resu

lt I

FC

IFC

Wea

ning

Bf

eedi

ng

cess

atio

n s

uppo

rt

bullBre

ast e

xam

D

iagn

osis

(an

tibod

y

bullPap

sm

ear

test

) C

T f

or n

egat

ive

wom

en a

nd p

artn

ers

Dia

gnos

is (

antib

ody

test

)

New

born

Ca

re

bull B

CG

bull P

olio

0

bull Is

sue

child

hea

th c

ard

bullEnt

er b

irth

wei

ght

HIV

an

d A

RV

Exp

osur

e st

atus

on

chi

ld h

ealth

car

d Tw

o w

eeks

Infa

nt fe

edin

g co

unse

ling

Six

wee

ks

Imm

uniz

atio

ngr

owth

mon

itori

ng

Ten

wee

ks

im

mun

izat

ion

GM

Fou

rtee

n w

eeks

Im

mun

izat

ion

grow

th m

onito

ring

Si

x m

onth

s

Com

plem

enta

ry fe

eds

Vita

min

A S

uppl

emen

tatio

n

9 m

onth

s

imm

uniz

atio

nG

M

12 amp

18

mon

ths

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

17

(c) I

t pro

mot

es a

cces

s to

ear

ly m

edic

al c

are

bull

Obs

tetr

ical

car

e

bull T

B th

erap

y

bull M

alar

ia t

reat

men

t

bull S

TI t

reat

men

t

bull A

RV

the

rapy

for

mot

her

and

fam

ily

(d) I

t hel

ps to

pla

n fo

r the

futu

re

bull In

fant

fee

ding

sup

port

sys

tem

s

bull F

amily

pla

nnin

g

bull P

erso

nal a

nd f

inan

cial

dec

isio

ns

(e) I

t ena

bles

pre

vent

ive

ther

apy

of m

alar

ia a

nd

othe

r opp

ortu

nist

ic in

fect

ions

suc

h a

PCP

(f) It

giv

es ti

me

to p

lan

for t

he fu

ture

eg

inf

ant

feed

ing

supp

ort s

yste

ms

TH

E F O

UR-P

RO

NG

ED A

PPR

OA

CH

TO P

MTC

T Th

e In

ter

Age

ncy

Task

Tea

m o

n Pr

even

tion

of H

IV T

rans

mis

sion

in p

regn

ant

wom

en

mot

hers

and

the

ir c

hild

ren

(IA

TT)

has

prop

osed

a f

our-

pron

ged

appr

oach

for

the

pre

shyve

ntio

n of

HIV

tra

nsm

issi

on t

hat

targ

ets

non-

preg

nant

and

pre

gnan

t w

omen

mot

hers

and

thei

r ch

ildre

n

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

1

26

The

four

pro

ngs

are

1 P

rimar

y pr

even

tion

of H

IV in

fect

ion

in w

omen

2 P

reve

ntio

n of

uni

nten

ded

preg

nanc

y am

ong

HIV

-inf

ecte

d w

omen

3 I

nter

vent

ions

to

redu

ce t

rans

mis

sion

fro

m H

IV-i

nfec

ted

preg

nant

and

la

ctat

ing

wom

en t

o th

eir

child

ren

4 C

are

and

supp

ort

of w

omen

ch

ildre

n an

d fa

mili

es in

fect

ed a

nd

affe

cted

by

HIV

and

AID

S (

The

PM

TC

T-p

lus)

Ove

rall

the

cov

erag

e of

PM

TCT

prog

ram

mes

and

the

upt

ake

of s

ervi

ces

prov

ided

thro

ugh

thes

e pr

ogra

mm

es

incl

udin

g H

IV

test

ing

and

coun

selli

ng

and

AR

V

prop

hyla

xis

are

still

ver

y lo

w I

n 20

06 w

orld

wid

e le

ss t

han

10

of

preg

nant

wom

ente

stin

g H

IV-p

ositi

ve r

ecei

ved

AR

V d

rugs

for

PMTC

T11

In K

enya

acc

ordi

ng to

the

2007

Ken

ya A

IDS

Indi

cato

r Su

rvey

(KA

IS) 7

the

re h

as b

een

a sm

all i

ncre

ase

in H

IV te

stin

g am

ong

wom

en a

nd m

en c

ompa

red

to th

e 20

03 K

DH

S

KA

IS s

how

s th

at t

houg

h a

vast

maj

ority

(83

)

of H

IV-in

fect

ed w

omen

and

men

in

Ken

ya d

o no

t kn

ow t

heir

HIV

sta

tus

the

re h

as b

een

a cl

ear

and

dram

atic

incr

ease

inco

vera

ge o

f HIV

-tes

ting

amon

g A

NC

clin

ic a

tten

dees

PMTC

T se

rvic

es a

re t

here

fore

im

port

ant

entr

y po

ints

for

HIV

pre

vent

ion

and

trea

tshym

ent

Ove

rall

AR

V c

over

age

for

HIV

infe

cted

peo

ple

who

nee

d tr

eatm

ent

in K

enya

ison

ly 3

5

bull 9

0

of K

enya

n w

omen

who

del

iver

ed in

the

last

4 y

ears

att

end

AN

C

bull 5

7 o

f th

ose

atte

ndin

g A

NC

tes

ted

for

HIV

bull A

mon

g H

IV in

fect

ed w

omen

with

rec

ent

birt

hs

47

wer

e te

sted

in

AN

C

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

(8)

HIV

dis

ease

sta

ging

in H

IV-in

fect

ed c

hild

ren

Dis

ease

sta

ging

with

or

with

out

labo

rato

ry s

uppo

rt f

ollo

ws

HIV

dia

gshyno

sis

Sta

ging

HIV

dis

ease

pro

vide

s a

guid

e to

the

prog

nosi

s an

d in

tershy

vent

ions

nee

ded

at th

e di

ffere

nt s

tage

s (R

efer

to C

hapt

er 5

and

8)

(9)

AR

V th

erap

y

Chi

ldre

n w

ho a

re e

ligib

le fo

r A

RT

shou

ld b

e lin

ked

with

the

AR

T pr

oshygr

am a

nd p

rovi

ded

with

trea

tmen

t acc

ordi

ng to

Nat

iona

l Gui

delin

es a

sso

on a

s an

HIV

dia

gnos

is i

s m

ade

Ear

ly t

reat

men

t si

gnifi

cant

ly r

eshydu

ces

mor

talit

y in

HIV

infe

cted

chi

ldre

n

(10)

C

omm

unic

atio

n

Com

mun

icat

ing

with

car

e-pr

ovid

ers

and

prov

idin

g ps

ycho

soci

al s

upshy

port

for

the

child

mot

her

care

give

r an

d fa

mily

are

a c

ruci

al c

ompo

nent

of

car

e

Pare

nts

care

give

rs a

ndo

r th

e ch

ild n

eed

to p

artic

ipat

e in

mak

ing

deci

shysi

ons

and

plan

ning

app

ropr

iate

car

e fo

r th

e ch

ild i

nclu

ding

dec

isio

nsab

out t

hera

py a

nd w

here

the

child

sho

uld

rece

ive

care

In

this

res

pect

he

alth

wor

kers

mus

t en

sure

tha

t th

e fa

mily

con

side

rs t

he s

ocia

l nee

ds

of H

IV in

fect

ed a

nd a

ffect

ed c

hild

ren

Hea

lth c

are

wor

kers

sho

uld

ensu

re th

at th

ey p

rovi

de a

dequ

ate

time

for

care

give

rs to

ask

que

stio

ns s

o th

at th

ey c

an fu

lly u

nder

stan

d th

e im

plishy

catio

ns o

f HIV

and

HIV

tes

ting

for

them

selv

es a

nd fo

r th

eir

child

ren

H

ealth

car

e w

orke

rs s

houl

d co

unse

l car

egiv

ers

on d

iscl

osur

e in

clud

ing

disc

losu

re to

the

child

(11)

R

efer

rals

Ref

erra

ls a

re a

n im

port

ant p

art o

f man

agin

g an

HIV

exp

osed

or

infe

cted

chi

ld

Thes

e in

clud

e re

ferr

als

to

bull H

ighe

r le

vels

of s

peci

alis

ed c

are

for

furt

her

inve

stig

atio

ns a

nd

trea

tmen

t

bull S

ocia

l sup

port

pro

gram

mes

bull C

omm

unity

-bas

ed c

are

prog

ram

mes

bull P

ITC

site

s fo

r pa

rent

s an

d si

blin

gs

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

2

7

80

Tabl

e 9

2 W

HO

Rec

omm

enda

tions

for

Follo

w-u

p of

an

HIV

-Exp

osed

Chi

ld

bull A

t birt

h (f

or in

fant

s de

liver

ed a

t ho

me)

bull A

t age

1 t

o 2

wee

ks (

mai

nly

for

infa

nt f

eedi

ng c

ouns

elin

g)

bull A

t ag

e 6

10

and

14

wee

ks (

for

imm

uniz

atio

n an

d in

fant

fee

ding

co

unse

ling)

bull A

fter

age

14

wee

ks

mon

thly

thr

ough

age

12

mon

ths

bull A

fter

age

12 m

onth

s e

very

3 m

onth

s th

roug

h 24

mon

ths

bull A

t 18

mon

ths

do

conf

irm

ator

y H

IV la

bora

tory

test

(if

ther

e ar

e no

re

sour

ces

for

an e

arlie

r an

tigen

-bas

ed t

est)

bull A

fter

2 ye

ars

a m

inim

um o

f ye

arly

vis

its

For t

he H

IV-in

fect

ed f

ollo

w th

ese

guid

elin

es

From

M

onito

r

6 w

eeks

ndash12

mon

ths

Mon

thly

12 ndash

24 m

onth

s Ev

ery

3 m

onth

s

24 m

onth

s an

d on

war

ds

Yea

rly i

f not

sym

ptom

atic

If sy

mpt

omat

ic f

ollo

w u

p as

nee

ded

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

18

OV

ERV

IEW

OF

THE

NEW

PM

TCT

GU

IDEL

INES

Ken

yarsquos

Min

istr

y of

Hea

lth (

MO

H)

thro

ugh

NA

SCO

P h

as t

aken

sev

eral

act

ions

to

expa

nd a

nd s

tren

gthe

n PM

TCT

inte

rven

tions

in

the

coun

try

In

2000

a

Nat

iona

lTe

chni

cal

Wor

king

Gro

up (

TWG

) on

PM

TCT

was

for

med

Th

e TW

G

co-c

hair

ed b

yN

ASC

OP

and

the

Div

isio

n of

Rep

rodu

ctiv

e H

ealth

co

ordi

nate

s im

plem

enta

tion

and

prov

ides

tec

hnic

al s

uppo

rt t

o th

e N

atio

nal

PMTC

T Pr

ogra

m

The

TWG

ser

ves

as a

foru

m t

o up

date

sta

keho

lder

s an

d di

scus

s ch

alle

nges

and

upc

omin

g ac

tiviti

es

The

TWG

is

also

res

pons

ible

for

upd

atin

g na

tiona

l gu

idel

ines

for

PM

TCT

The

nat

iona

l PM

TCT

prog

ram

was

offi

cial

ly l

aunc

hed

in 2

002

NA

SCO

P al

so e

stab

lishe

d se

vera

lpi

lot P

MTC

T si

tes

thro

ugho

ut th

e co

untr

y an

d pr

epar

ed n

atio

nal P

MTC

T gu

idel

ines

The

goal

of t

he n

atio

nal P

MTC

T pr

ogra

m is

in li

ne w

ith th

e go

al s

et o

ut a

t the

Uni

ted

Nat

ions

Gen

eral

Ass

embl

y Sp

ecia

l Ses

sion

on

HIV

AID

S (U

NG

ASS

) in

2001

to

redu

ceth

e pr

opor

tion

of in

fant

s in

fect

ed w

ith H

IV b

y 20

b

y th

e ye

ar 2

005

and

50

by

2010

In

Ken

ya t

he n

atio

nal P

MTC

T pr

ogra

m p

lann

ed t

o ex

tend

its

serv

ices

to

at le

ast

80

of

all

heal

th f

acili

ties

by 2

0071

2 A

ccor

ding

to

the

2003

PM

TCT

serv

ice

stat

istic

sap

prox

imat

ely

9 o

f al

l pr

egna

nt w

omen

rec

eive

d PM

TCT

serv

ices

in

that

yea

rC

urre

ntly

mor

e th

an 5

0 o

f al

l pr

egna

nt w

omen

in

Ken

ya r

ecei

ve P

MTC

T se

rvic

es

Thes

e gu

idel

ines

are

bas

ed o

n a

publ

ic h

ealth

app

roac

h to

car

e t

akin

g in

to c

onsi

dera

shytio

n is

sues

of

feas

ibili

ty a

nd a

ccep

tabi

lity

in

addi

tion

to e

ffica

cy a

nd c

ost-

bene

fit i

ndi

ffere

nt s

ettin

gs

The

guid

elin

es a

re e

xpec

ted

to i

mpr

ove

the

upta

ke

qual

ity a

nd

effe

ctiv

enes

s of

PM

TCT

serv

ices

in th

e co

untr

y

19

OB

JEC

TIV

ESA

ND O

RG

AN

ISA

TIO

NO

FTH

E G

UID

ELIN

ES

The

PMTC

T gu

idel

ines

are

par

t of

the

impl

emen

tatio

n in

stru

men

ts t

owar

ds u

nive

rsal

ac

cess

to

PMTC

T se

rvic

es a

nd a

res

pons

e to

the

cal

l to

actio

n to

war

ds H

IV-fr

ee a

ndA

IDS-

free

gen

erat

ion

Tog

ethe

r w

ith tw

o ot

her

guid

elin

es (A

RV

Ther

apy

in A

dults

and

Ad

oles

cent

s an

d AR

V Th

erap

y in

Inf

ants

and

You

ng C

hild

ren)

th

ey f

orm

a t

rilo

gy

aim

ed a

t co

ntex

tual

isin

g an

d m

ains

trea

min

g th

e W

HO

tri

logy

of

guid

elin

es o

n H

IVA

IDS

prev

entio

n an

d tr

eatm

ent

The

cont

ext

reso

urce

s an

d de

man

ds o

f PM

TCT

prog

ram

mes

diff

er g

reat

ly a

cros

s co

unshy

trie

s an

d ev

en a

cros

s pr

ogra

mm

es w

ithin

the

sam

e co

untr

y C

onsi

deri

ng t

his

vari

abilshy

ity t

hese

gui

delin

es in

clud

e th

e cu

rren

t con

sens

us o

n be

st p

ract

ices

as

wel

l as

alte

rnashy

tives

whi

ch m

ight

be

mor

e ap

prop

riat

e in

par

ticul

ar s

ettin

gs E

xper

ts a

gree

tha

t th

e ldquos

tate

of

the

artrdquo

in

PMTC

T is

cha

ngin

g ra

pidl

y an

d th

at r

ecom

men

datio

ns w

ill c

ershy

tain

ly a

lter

with

adv

ance

s in

med

ical

sci

ence

and

as

mor

e pr

ogra

mm

e ex

peri

ence

is

docu

men

ted

and

diss

emin

ated

The

are

as o

f A

RV

pro

phyl

axis

and

inf

ant

feed

ing

are

part

icul

arly

sub

ject

to r

apid

cha

nge

In 2

005

the

WH

O is

sued

pro

pose

d re

visi

ons

to it

s re

com

men

datio

ns o

n th

e us

e of

ant

ishyre

trov

iral

dru

gs f

or P

MTC

T T

he r

ecom

men

datio

ns w

ere

the

prod

uct

of e

xper

ts w

ho

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

9

28

conv

ened

to

disc

uss

impo

rtan

t ne

w i

nfor

mat

ion

conc

erni

ng t

he d

evel

opm

ent

of r

esis

shyta

nce

in w

omen

and

chi

ldre

n us

ing

sing

le d

ose

nevi

rapi

ne (S

dNV

P) fo

r PM

TCT

as w

ell

as n

ew c

linic

al fi

ndin

gs o

n st

rate

gies

that

mig

ht r

educ

e th

e de

velo

pmen

t of r

esis

tanc

e

Bas

ed o

n th

e ne

w W

HO

gui

delin

es K

enya

rsquos TW

G h

as d

evel

oped

sim

ple

pra

ctic

al a

nd

evid

ence

-bas

ed r

ecom

men

datio

ns o

n PM

TCT

that

wou

ld w

ork

in a

var

iety

of r

esou

rce-

limite

d en

viro

nmen

ts a

nd c

linic

al s

ituat

ions

that

con

fron

t hea

lthca

re w

orke

rs n

ot o

nly

in K

enya

but

als

o in

oth

er d

evel

opin

g co

untr

ies

110

U

SIN

GTH

E G

UID

ELIN

ES

Thes

e gu

idel

ines

are

inte

nded

prim

arily

for u

se b

y PM

TCT

prov

ider

s Th

ese

inclu

de n

urse

sm

idw

ives

clin

ical o

ffice

rs d

octo

rs c

ouns

ello

rs n

utrit

ioni

sts

and

othe

r he

alth

care

pro

fesshy

sion

als

They

will

als

o be

use

ful a

s a re

fere

nce

for p

rogr

amm

e m

anag

ers a

t fac

ility

dis

trict

pr

ovin

cial

and

nat

iona

l lev

els

thro

ugho

ut th

e he

alth

sec

tor

The

guid

elin

es a

re d

ivid

ed in

tote

n ch

apte

rs a

s out

lined

in T

able

15

The

spec

ific

obje

ctiv

es o

f the

new

PM

TCT

guid

elin

es a

re to

bull O

utlin

e th

e po

licy

issu

es in

pro

vidi

ng P

MT

CT

serv

ices

bull R

ecom

men

d op

erat

iona

l gui

delin

es to

be

follo

wed

by

heal

th c

are

prov

ider

s of

PM

TC

T se

rvic

es

bull E

nabl

e pr

ovid

ers

of P

MT

CT

to s

elec

t an

d pr

escr

ibe

AR

Vs

for

prop

hyla

xis

agai

nst

MT

CT

and

for

trea

tmen

t of

pre

gnan

t w

omen

in

fant

s an

d yo

ung

child

ren

bull S

tand

ardi

se t

he c

are

and

coun

selli

ng g

iven

by

PM

TC

T s

ervi

ce

prov

ider

s re

gard

ing

risk

of

MT

CT

and

on

PM

TC

T

bull I

mpr

ove

PM

TC

T se

rvic

es u

sing

eas

y-to

-use

job

aids

and

a

stan

dard

ised

Mamp

E s

yste

m

Prev

entin

g TB

Fo

r chi

ldre

n ex

pose

d to

sm

ear p

ositi

ve tu

berc

ulos

is

bull E

xclu

de a

ctiv

e T

B th

roug

h ca

refu

l his

tory

ph

ysic

al e

xam

and

in

vest

igat

ions

bull

If

ther

e is

no

evid

ence

of

activ

e T

B

star

t on

IN

H f

or p

roph

ylax

is f

or 6

m

onth

s (I

PT

) bull

If

TB

is p

rese

nt

star

t on

TB

tre

atm

ent

as p

er N

atio

nal T

B g

uide

lines

If

a ch

ild is

bor

n to

a m

othe

r with

act

ive

TB

bull S

tart

on

INH

pro

phyl

axis

(IP

T)

and

give

for

3 m

onth

s bull

Afte

r 3

mon

ths

do a

man

toux

bull

If

man

toux

is n

egat

ive

sto

p IN

H a

nd g

ive

BC

G

bull I

f man

toux

is p

ositi

ve a

t 3

mon

ths

con

tinue

for

a f

urth

er 3

mon

ths

bull A

t the

end

of

prop

hyla

xis

re-v

alua

te f

or a

ctiv

e T

B

|

If no

evi

denc

e of

act

ive

TB d

o no

t tre

at fo

r TB

|

If th

ere

is e

vide

nce

of a

ctiv

e TB

tre

at fo

r TB

as

per N

atio

nal

TB g

uide

lines

(6)

Trea

tmen

t of a

cute

infe

ctio

ns a

nd o

ther

HIV

-rel

ated

con

ditio

ns

HIV

-exp

osed

chi

ldre

n ar

e su

scep

tible

to c

omm

on in

fect

ions

as

wel

l as

OIs

for

the

HIV

infe

cted

and

HIV

may

alte

r th

e in

cide

nce

pre

senshy

tatio

n an

d re

spon

se t

o co

nven

tiona

l th

erap

y I

n so

me

case

s m

ore

aggr

essi

ve a

nd lo

nger

tre

atm

ent

cour

ses

may

be

nece

ssar

y a

s tr

eatshy

men

t fai

lure

s ar

e m

ore

freq

uent

(7)

Reg

ular

follo

w-u

p ca

re amp

refe

rral

s

Reg

ular

follo

w-u

p is

the

back

bone

to c

arin

g fo

r th

e H

IV e

xpos

ed c

hilshy

dren

and

ens

ures

opt

imal

hea

lthca

re a

nd p

sych

osoc

ial s

uppo

rt to

the

fam

ily W

HO

has

mad

e re

com

men

datio

ns o

n fr

eque

ncy

of fo

llow

-up

as s

how

n in

Tab

le 9

2 T

his

is t

he m

inim

um a

nd m

ore

freq

uent

con

shyta

ct w

ith t

he h

ealth

car

e sy

stem

may

be

indi

cate

d fo

r H

IV in

fect

ed

child

ren

and

espe

cial

ly if

they

are

on

anti-

retr

ovir

al tr

eatm

ent

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

2

9

78

Pro

phyl

axis

aga

inst

Pne

umoc

ysti

s ji

rove

cii

Pne

umon

ia (

PC

P)

in c

hild

ren

whe

re C

otri

mox

azol

e is

con

trai

ndic

ated

Ta

ble

15

The

Fou

r-Pr

onge

d A

ppro

ach

App

lied

to th

e PM

TCT

Gui

delin

e

Alte

rnat

ive

drug

s to

use

if C

TX is

con

train

dica

ted

are

give

n be

low

A s

econ

d ch

oice

wou

ld b

e ei

ther

dap

sone

or

atov

aqui

ne

Dap

sone

bull C

hild

ren

gt 1

mon

th

2 m

gkg

24

hour

s or

ally

onc

e da

ily

bull I

f bot

h C

TX

and

Dap

sone

are

con

trai

ndic

ated

(e

g

in c

hilshy

dren

with

G6P

D d

efic

ienc

y w

ho g

et h

aem

olys

is w

ith C

TX

and

D

apso

ne)

the

n us

e ei

ther

Ato

vaqu

one

bull

30m

gkg

day

for

age

1-3

mon

ths

bull H

ighe

r do

se 4

5mg

kgd

ay f

or a

ge 4

-24

mon

ths

OR

Aer

osol

ized

Pen

tam

idin

e

bull 3

00 m

g in

6 m

l wat

er v

ia in

hala

tion

nebu

lizer

onc

e m

onth

ly

bull c

hild

ren

gt 5

year

s

Cha

pter

CH

AP

TER

1

Bac

kgro

und

CH

AP

TER

2

Ant

enat

al C

are

and

Pre

vent

ion

of M

TCT

of H

IV

CH

AP

TER

3

Intra

partu

m C

are

Pron

g 1

Prim

ary

prev

entio

n of

HIV

in

fect

ion

in w

omen

Pron

g 2

Prev

entio

n of

un

inte

nded

pr

egna

ncy

amon

g H

IV in

fect

ed w

omen

Pron

g 3

Inte

rven

tions

to

redu

ce

tran

smis

sion

from

H

IV in

fect

ed

preg

nant

and

la

ctat

ing

wom

en to

th

eir c

hild

ren

Pron

g 4

Car

e an

d su

ppor

t of

wom

en c

hild

ren

and

fam

ilies

in

fect

ed a

nd

affe

cted

by

HIV

A

IDS

C

HA

PTE

R 4

U

se o

f Ant

iretro

vira

l D

rugs

in P

regn

ancy

fo

r Tre

atm

ent a

nd

Pre

vent

ion

of M

othe

r to

Chi

ld

Tran

smis

sion

of H

IV

Infe

ctio

n

CH

AP

TER

5

Imm

edia

te P

ostn

atal

an

d N

eona

tal C

are

CH

AP

TER

6

Late

Pos

tnat

al C

are

and

Fam

ily P

lann

ing

CH

AP

TER

7

HIV

Dia

gnos

is in

C

hild

ren

CH

AP

TER

8

Feed

ing

Infa

nts

and

Youn

g C

hild

ren

born

to

HIV

infe

cted

m

othe

rs

CH

AP

TER

9

Car

e an

d Fo

llow

-up

of C

hild

ren

of H

IV

infe

cted

mot

hers

C

HA

PTE

R 1

0

Mon

itorin

g an

d E

valu

atio

n of

PM

TCT

se

rvic

es

77

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

30

For

each

of t

hese

cha

pter

s (e

xcep

t ch

apte

r on

e on

bac

kgro

und)

the

gui

delin

es g

ive

anin

trod

uctio

n fo

llow

ed b

y po

licy

stat

emen

ts t

hen

oper

atio

nal g

uide

lines

of w

hat p

rovi

dshyer

s sh

ould

do

to r

educ

e m

othe

r-to

-chi

ld t

rans

mis

sion

of

HIV

and

or

to i

mpr

ove

thei

r pe

rfor

man

ce a

nd th

e ef

fect

iven

ess

of th

eir s

ervi

ces

A li

st o

f job

aid

s fo

r us

e by

the

hea

lthca

re p

rovi

der

follo

ws

the

oper

atio

nal g

uide

lines

and

whe

re n

eces

sary

a li

st o

f ap

pend

ices

and

add

ition

al d

ocum

ents

tha

t m

ay b

e re

shyfe

rred

to

but

are

cons

ider

ed t

oo b

ig o

r de

taile

d to

be

incl

uded

with

in t

he m

ain

body

of

the

guid

elin

es

Foo

tnot

es

1

UN

AID

S (

2004)

Rep

ort

on t

he

Glo

bal AID

S E

pid

emic

Ava

ilable

at

ww

wu

nai

ds

org

2

Ibid

2004

3

It

is

import

ant

to r

ecognis

e th

at t

he

use

of

the

phra

se M

TC

T in n

o w

ay is

inte

nded

to

pla

ce b

lam

e on t

he

moth

er

who m

ay o

r m

ay n

ot

know

her

HIV

sta

tus

who t

ransm

its

the

viru

s to

her

child

Pa

thfinder

ack

now

ledges

that

man

y tim

es p

regnant

wom

en

may

hav

e bee

n infe

cted

by

thei

r m

ale

par

tner

and d

o n

ot

hav

e th

e ab

ility

to n

egoti-

ate

safe

r se

x o

r to

see

k M

TC

T s

ervi

ces

for

fear

of

viole

nce

st

igm

a o

r ab

andonm

ent

if t

hei

r st

atu

s is

rev

eale

d

Path

finder

uphold

s th

e re

pro

duct

ive

rights

of

all w

om

en t

o

choose

if

and w

hen

to h

ave

child

ren

regar

dle

ss o

f H

IV-s

tatu

s

4

W

HO

CD

C

Dep

artm

ent

of

Hea

lth a

nd H

um

an S

ervi

ces

(2004)

Pre

vention o

f M

oth

er-t

o-C

hild

Tra

nsm

issi

on o

f H

IV

Gen

eric

Tra

inin

g P

acka

ge

Gen

eva

Sw

itze

r-la

nd

WH

O

5

U

NAID

S (

2004)

Rep

ort

on t

he

Glo

bal AID

S E

pid

emic

Ava

ilable

at

ww

wu

nai

ds

org

6

Polic

y Pro

ject

(2004)

Cove

rage

of

sele

cted

ser

vice

s fo

r H

IVA

IDS p

reve

ntion a

nd

care

in low

and m

iddle

-inco

me

countr

ies

in 2

003

Ava

ilable

at

ww

wp

olia

pro

ject

com

7

Cen

tral Bure

au o

f Sta

tist

ics

(CBS)

[Ken

ya]

Min

istr

y of

Hea

lth (

MO

H)

[Ken

ya]

and

ORC M

acro

(2004)

Ken

ya D

emogra

phic

and H

ealth S

urv

ey 2

003

Cal

vert

on

Mar

y-la

nd

CBSM

OH

an

d O

RC M

acr

o

8

Nat

ional AID

S C

ontr

ol Counci

l 2

007

8a

Ken

ya A

IDS I

ndic

ato

r Surv

ey 2

007

9

Ibid

2004

10

NASCO

P (

2002)

Surv

eilla

nce

data

as

cite

d in N

ASCO

PM

OH

(2

003)

Nat

ional

PM

CT

Str

ate

gic

Managem

ent

Pla

n 2

003-2

007

111

2 A

IDS in K

enya

Tre

nds

Inte

rven

tions

and I

mpact

7th

editio

n

(2005)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Who

Nee

ds P

CP

Prop

hyla

xis

bull A

ll in

fant

s bo

rn t

o H

IV-i

nfec

ted

mot

hers

irr

espe

ctiv

e of

any

ant

iret

rovi

ral

ther

apy

duri

ng p

regn

ancy

and

labo

ur

Pro

phyl

axis

con

tinue

s un

til th

e in

fant

is 1

2 m

onth

s or

is P

CR

neg

ativ

e or

ant

ibod

y ne

gativ

e w

hich

ever

co

mes

ear

lier

bull A

ll in

fant

s id

entif

ied

as H

IV-i

nfec

ted

duri

ng th

e fir

st y

ear

of li

fe b

y a

PC

R

test

or

by a

clin

ical

dia

gnos

is o

f H

IV in

fect

ion

and

a po

sitiv

e an

tibod

y te

st

bull C

hild

ren

olde

r th

an 1

2 m

onth

s w

ith s

ympt

omat

ic H

IV d

isea

se o

r an

A

IDS

-def

inin

g ill

ness

(W

HO

sta

ge I

I an

d III

se

e ch

apte

r 5)

or

with

CD

4 lt

15

or

TLC

150

0m

m3

bull A

ny c

hild

with

a h

isto

ry o

f P

CP

sho

uld

cont

inue

with

sec

onda

ry

prop

hyla

xis

(dai

ly C

T)

for

life

Clin

icia

ns s

houl

d cl

earl

y in

form

HIV

inf

ecte

d m

othe

rs a

t de

liver

y th

at t

heir

chi

ldre

n ne

ed p

roph

ylax

is a

gain

st P

CP

star

ting

at 6

wee

ks o

f age

unt

il it

is e

stab

lishe

d th

at th

e ch

ild i

s no

t H

IV i

nfec

ted

A p

ract

ical

way

to

ensu

re t

hat

mot

hers

and

oth

er h

ealth

wor

kers

are

inf

orm

ed i

s to

mak

e a

note

on

the

child

rsquos im

mun

izat

ion

card

at

birt

h st

atin

g ldquoP

leas

e gi

ve c

o-tr

imox

azol

e (5

mg

kgd

ay o

rally

dai

ly) f

rom

6 w

eeks

of a

gerdquo

Tabl

e 9

1 D

ose

of C

otrim

oxaz

ole

for P

CP

Prop

hyla

xis

Wei

ght o

f C

hild

(kg)

1ndash4

5ndash8

9ndash16

17ndash5

0

gt 50

CT

tabl

ets

20 m

g TM

P1

00

mg

SM

X p

edia

tric

stre

ngth

(120

mg)

1 ta

b

2 ta

bs

Cot

rimox

azol

e su

spen

sion

40

mg

TMP

200

mg

SM

X

5ml (

240

mg)

25

ml

5 m

l

10 m

l

CT

tabl

ets

80 m

g TM

P4

00 m

g S

MX

re

gula

r stre

ngth

(4

80 m

g)

frac14 ta

b

frac12 ta

b

1 ta

b

2 ta

bs

2 ta

bs

CT

Tabl

ets

160

mg

TMP

800

mg

SM

X

Dou

ble

stre

ngth

(9

60 m

g) -

frac14 ta

b

frac12 ta

b

1 ta

b

1 ta

b

In r

are

case

s a

s in

chi

ldre

n w

ith G

6PD

def

icie

ncy

CTX

may

be

cont

rain

dica

ted

G

uid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

3

1

76

(3)

Mon

itor

the

child

rsquos g

row

th a

nd d

evel

opm

ent

as a

mea

ns o

f id

entif

ying

the

ch

ild w

ho is

faili

ng to

thriv

e an

d al

so a

s a

tool

for m

onito

ring

the

effe

ct o

f int

ershy

vent

ions

(4)

Ens

ure

that

im

mun

isat

ions

are

sta

rted

and

com

plet

ed

acco

rdin

g to

the

re

com

men

datio

ns o

f the

nat

iona

l im

mun

isat

ion

sche

dule

|

Add

ition

al c

onsi

dera

tions

are

as

follo

ws

bull

Whe

n co

nsid

erin

g BC

G v

acci

natio

n at

a la

ter a

ge

(re-

vacc

inat

ion

for n

o sc

ar o

r mis

sed

earli

er v

acci

natio

n)

excl

ude

sym

ptom

atic

HIV

infe

ctio

n

bull

Do

not g

ive

yello

w fe

ver v

acci

ne to

sym

ptom

atic

HIV

-infe

cted

chi

lshydr

en H

owev

er a

sym

ptom

atic

chi

ldre

n in

end

emic

are

as s

houl

d re

shyce

ive

the

yello

w fe

ver v

acci

ne a

t 9 m

onth

s of

age

bull

Mea

sles

vac

cine

sho

uld

be g

iven

to H

IV in

fect

ed c

hild

ren

at 6

and

9

mon

ths

sinc

e H

IV in

fect

ed c

hild

ren

expe

rienc

e m

uch

mor

e se

vere

di

seas

e w

ith w

ild m

easl

es v

irus

whi

ch o

utw

eigh

s th

e ris

k of

a m

ilder

illn

ess

from

the

vacc

ine

(5)

Pro

vide

pro

phyl

axis

for o

ppor

tuni

stic

infe

ctio

ns

|

Pro

phyl

axis

aga

inst

Pne

umoc

ystis

jiro

veci

i Pne

umon

ia

bull

Pne

umoc

ystis

jiro

veci

i (fo

rmer

ly P

neum

ocys

tis c

arin

ii) p

neum

onia

(PC

P)

is a

sig

nific

ant c

ause

of m

orbi

dity

and

mor

talit

y am

ong

youn

g in

fant

s in

A

frica

Co-

trim

oxaz

ole

(CTX

) pro

phyl

axis

sig

nific

antly

redu

ces

the

inci

shyde

nce

and

seve

rity

of P

CP

Add

ition

al b

enef

its o

f co-

trim

oxaz

ole

incl

ude

prot

ectio

n ag

ains

t com

mon

bac

teria

l inf

ectio

ns t

oxop

lasm

osis

and

mashy

laria

All

child

ren

born

to H

IV in

fect

ed m

othe

rs s

houl

d re

ceiv

e pr

ophy

shyla

xis

agai

nst P

CP

at l

east

dur

ing

the

first

yea

r of l

ife o

r unt

il th

ey a

re

prov

en to

be

unin

fect

ed (s

ee b

ox b

elow

)

bull

CTX

is c

lear

ly th

e dr

ug o

f cho

ice

for p

roph

ylax

is b

ecau

se o

f its

hig

h

effic

acy

rela

tive

safe

ty l

ow c

ost a

nd b

road

ant

imic

robi

al s

pect

rum

In

cas

e of

CTX

hyp

erse

nsiti

vity

des

ensi

tizat

ion

is re

com

men

ded

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

CH

AP

TE

R 2

Ant

enat

al C

are

and

Prev

entio

n of

MTC

T of

HIV

21

INTR

OD

UC

TIO

N

HIV

inf

ectio

n ha

s em

erge

d in

Ken

ya a

s th

e m

ost

impo

rtan

t he

alth

ris

k fa

ctor

for

m

othe

rs a

nd t

heir

chi

ldre

n an

d ha

s a

grea

t im

pact

on

the

long

ter

m o

utco

me

ofpr

egna

ncy

and

child

sur

viva

l A

ll pr

egna

nt w

omen

sho

uld

be e

ncou

rage

d to

lear

n th

eir

HIV

infe

ctio

n st

atus

as

wel

l as

that

of t

heir

sex

ual p

artn

ers

O

nly

by k

now

ing

onersquos

H

IV s

tatu

s ca

n th

e he

alth

wor

kers

mak

e ap

prop

riat

e he

alth

car

e m

anag

emen

t re

com

men

datio

ns a

nd t

he c

oupl

e m

ake

appr

opri

ate

deci

sion

s ab

out

mai

ntai

ning

the

ir

heal

th a

nd t

hat

of t

heir

unb

orn

baby

Pr

e-co

ncep

tion

care

is

enco

urag

ed w

here

an

oppo

rtun

ity a

rise

s an

d a

birt

h pl

an is

dis

cuss

ed w

ith th

e pr

egna

nt w

oman

In m

ost

case

s t

he p

regn

ant

wom

an w

ill n

ot h

ave

HIV

infe

ctio

n P

regn

ancy

offe

rs a

n op

port

une

time

to d

iscu

ss p

reve

ntio

n of

HIV

inf

ectio

n as

man

y w

omen

com

e in

toco

ntac

t w

ith h

ealth

ser

vice

s fo

r th

e fir

st (

and

in s

ome

case

s th

e on

ly)

time

duri

ng

preg

nanc

y

In K

enya

50

o

f m

arri

ed H

IV p

ositi

ve p

erso

ns h

ave

an H

IV n

egat

ive

spou

se1

Ther

efor

e k

now

ing

the

HIV

inf

ectio

n st

atus

of

onersquos

par

tner

is

criti

cal

Add

ition

ally

th

is f

orm

s an

im

port

ant

entr

y po

int

for

esta

blis

hing

pre

vent

ion

with

po

sitiv

e (P

WP)

pro

gram

s am

ong

coup

les

as w

ell a

s pr

ovid

ing

acce

ss to

HIV

pre

vent

ion

ca

re a

nd tr

eatm

ent s

ervi

ces

for

the

who

le fa

mily

PMTC

T pr

ovid

es a

n op

port

unity

for

prev

entin

g ne

w p

aedi

atri

c H

IV in

fect

ions

as

wel

l as

for

reac

hing

the

10 to

20

of H

IV p

ositi

ve p

regn

ant w

omen

who

mee

t WH

O e

ligib

ilshyity

cri

teri

a fo

r in

itiat

ing

AR

T fo

r th

eir

own

heal

th N

ew in

fect

ions

and

hig

h vi

ral l

oads

duri

ng p

regn

ancy

pos

e th

e gr

eate

st r

isk

of M

TCT

to t

he u

nbor

n ba

by t

hus

prim

ary

prev

entio

n A

RV

pro

phyl

axis

as

wel

l as

trea

tmen

t at t

his

time

is c

ritic

al G

iven

that

25

perc

ent o

f wom

en in

Ken

ya h

ave

an u

nwan

ted

preg

nanc

y s

tren

gthe

ning

the

link

to F

P se

rvic

es a

nd c

ondo

m a

cces

s fo

r du

al p

rote

ctio

n of

fers

a c

hanc

e to

fur

ther

pre

vent

MTC

T2

22

OPE

RA

TIO

NA

L G

UID

ELIN

ES

Ant

enat

al c

are

and

prev

entio

n of

MTC

T du

ring

thi

s pe

riod

can

be

sum

mar

ised

usi

ngan

ess

entia

l pa

ckag

e of

int

egra

ted

ante

nata

l ca

re s

ervi

ces

as s

how

n in

Tab

le 2

1

This

ou

tline

s th

e pa

ckag

e of

ca

re

to

be

prov

ided

to

ev

ery

wom

an

atte

ndin

g A

NC

ser

vice

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

5

32

Tabl

e 2

1 Es

sent

ial P

acka

ge o

f Int

egra

ted

Ant

enat

al C

are

Serv

ices

Gro

up e

duca

tion

Incl

ude

info

rmat

ion

on fo

ur A

NC

vis

its b

reas

tfeed

ing

mat

erna

l and

infa

nt n

utrit

ion

per

sona

l hyg

iene

birt

h pr

epar

edne

ss d

ange

r sig

ns p

reve

ntio

n of

com

plic

atio

ns s

kille

d bi

rth a

ttend

ance

fam

ily p

lann

ing

imm

uniz

atio

n sc

hedu

le

post

-nat

al c

are

and

HIV

and

AID

S m

anag

emen

t

Clie

nt h

isto

ry O

btai

n ro

utin

e da

ta in

clud

ing

med

ical

obs

tetri

c a

nd p

sych

osoc

ial h

isto

ry D

eter

min

e dr

ug h

isto

ry k

now

n al

lerg

ies

and

use

of a

ltern

ativ

e m

edic

ines

suc

h as

her

bal p

rodu

cts

Phy

sica

l exa

min

atio

n In

clud

e vi

tal s

igns

ins

pect

ion

aus

culta

tion

and

palp

atio

n

Abd

omin

al a

nd g

enita

l exa

min

atio

n In

clud

e in

spec

tion

pal

patio

n fo

etal

aus

culta

tion

spe

culu

m a

nd b

iman

ual e

xam

inat

ions

w

here

indi

cate

d

AN

C P

rofil

e R

outin

e te

sts

for s

yphi

lis H

b b

lood

gro

up a

nd R

hesu

s fa

ctor

urin

alys

is a

nd p

rovi

de ra

pid

HIV

test

ing

to th

e pr

egna

nt w

oman

and

her

par

tner

if a

ccom

pany

ing

her

If in

dica

ted

chec

k sp

utum

for A

AFB

and

CD

4 co

unt

Cou

nsel

ing

on b

irth

prep

ared

ness

Sup

port

the

preg

nant

wom

an a

nd h

er p

artn

er to

dev

elop

an

indi

vidu

al b

irth

plan

that

in

clud

es p

lace

of d

eliv

ery

with

ski

lled

birth

atte

ndan

ce e

mer

genc

y tra

nspo

rt b

irth

com

pani

onsh

ip a

nd re

adin

ess

for i

nfan

t ca

re

Cou

nsel

ing

on p

regn

ancy

dan

ger s

igns

Pro

vide

wom

en w

ith in

form

atio

n an

d in

stru

ctio

ns o

n se

ekin

g ea

rly c

are

for p

regshy

nanc

y co

mpl

icat

ions

suc

h as

ble

edin

g fe

ver

seve

re h

eada

che

sw

olle

n fe

et f

its o

r con

vuls

ions

Cou

nsel

ing

on in

fant

feed

ing

All

wom

en re

quire

infa

nt-fe

edin

g co

unse

ling

and

supp

ort

Exc

lusi

ve b

reas

tfeed

ing

for s

ix

mon

ths

shou

ld b

e pr

omot

ed a

s th

e no

rm fo

r all

wom

en re

gard

less

of H

IV s

tatu

s W

omen

infe

cted

with

HIV

nee

d to

be

gu

ided

in th

e se

lect

ion

of s

afer

infa

nt-fe

edin

g op

tions

(ref

er to

WH

O g

uide

lines

and

MO

H c

ircul

ar o

n in

fant

and

you

ng c

hild

fe

edin

g)

Nut

ritio

nal a

sses

smen

t co

unse

ling

and

educ

atio

n In

clud

e iro

n m

ultiv

itam

in a

nd fo

late

sup

plem

enta

tion

mon

itor f

or a

naeshy

mia

ade

quat

e ca

loric

and

nut

rient

inta

ke a

nd re

com

men

d re

alis

tic d

iet a

djus

tmen

ts b

ased

on

loca

l res

ourc

es a

nd n

eeds

of

HIV

+ pr

egna

nt w

omen

(at l

east

10

mor

e of

the

RD

A)

Cou

nsel

ing

on H

IV a

nd A

IDS

Pro

vide

wom

en w

ith in

form

atio

n an

d in

stru

ctio

ns o

n se

ekin

g he

alth

car

e fo

r

sym

ptom

s of

HIV

dis

ease

pro

gres

sion

suc

h as

freq

uent

and

recu

rrent

illn

esse

s c

hron

ic p

ersi

sten

t dia

rrho

ea c

andi

dias

is

feve

r w

astin

g or

sig

ns o

f any

opp

ortu

nist

ic in

fect

ion

Lin

k w

omen

to A

IDS

trea

tmen

t and

oth

er s

uppo

rt pr

ogra

mm

es w

here

av

aila

ble

Cou

nsel

ing

the

HIV

neg

ativ

e w

oman

and

her

par

tner

Pro

vide

info

rmat

ion

on re

peat

test

ing

risk

redu

ctio

n an

d pa

rtner

test

ing

RTI

scr

eeni

ng A

ll w

omen

with

hig

h ris

k se

xual

his

tory

or p

rese

ntin

g w

ith s

igns

of R

TI s

uch

as a

bnor

mal

gen

ital d

isch

arge

ge

nita

l ulc

ers

and

pelv

ic in

flam

mat

ory

dise

ase

shou

ld b

e sc

reen

ed a

nd m

anag

ed a

ccor

ding

to K

enya

pro

toco

ls

Tube

rcul

osis

(TB

) A

ll w

omen

pre

sent

ing

for A

NC

ser

vice

s w

ith a

cou

gh o

f mor

e th

an 2

wee

ksrsquo d

urat

ion

shou

ld b

e sc

reen

ed

for T

B re

gard

less

of H

IV s

tatu

s F

ollo

w K

enya

pro

toco

ls fo

r scr

eeni

ng p

roph

ylax

is a

nd tr

eatm

ent

Teta

nus

toxo

id im

mun

isat

ions

Adm

inis

ter a

ccor

ding

to c

urre

nt K

EP

I TT

Imm

uniz

atio

n S

ched

ule

Dew

orm

ing

All

preg

nant

wom

en s

houl

d re

ceiv

e an

ti-he

lmin

thes

afte

r firs

t trim

este

r as

per t

he g

uide

lines

on

m

ater

nal n

utrit

ion

Ant

imal

aria

ls I

TNs

All

preg

nant

wom

en in

mal

aria

end

emic

are

as s

houl

d sl

eep

unde

r an

ITN

and

rece

ive

SP

inte

rmitt

ent

pres

umpt

ive

treat

men

t acc

ordi

ng to

the

Nat

iona

l Mal

aria

gui

delin

es

AR

V a

nd O

ppor

tuni

stic

Infe

ctio

ns p

roph

ylax

is (d

urin

g pr

egna

ncy)

Pro

vide

AR

V C

TX a

nd o

ther

pro

phyl

actic

m

edic

atio

ns a

ccor

ding

to th

e K

enya

AR

T pr

otoc

ol o

n O

I pro

phyl

axis

and

use

of A

RV

s in

pre

gnan

cy

AR

V tr

eatm

ent d

urin

g pr

egna

ncy

Pro

vide

HA

AR

T w

ithin

the

MC

H s

ettin

g ac

cord

ing

to th

e K

enya

pro

toco

l on

use

of A

RV

s

Est

ablis

h cl

ear r

efer

ral n

etw

orks

with

sen

ior c

linic

ians

Pre

vent

ion

with

Pos

itive

s E

ncou

rage

pos

itive

livi

ng d

iscl

osur

e c

orre

ct a

nd c

onsi

sten

t con

dom

use

and

pro

vide

psy

chos

oshyci

al s

uppo

rt to

the

affe

cted

fam

ilies

For

the

HIV

-infe

cted

and

affe

cted

fam

ilies

est

ablis

h an

dor

stre

ngth

en li

nkag

es to

car

e

treat

men

t and

sup

port

serv

ices

incl

udin

g po

st-p

artu

m fo

llow

up

Effe

ctiv

e co

ntra

cept

ion

plan

Cou

nsel

abo

ut o

ther

fam

ily p

lann

ing

met

hods

em

phas

izin

g on

par

tner

invo

lvem

ent

and

dual

pro

tect

ion

met

hods

to a

void

unw

ante

d pr

egna

ncy

new

infe

ctio

n re

-infe

ctio

n an

d fu

rther

tran

smis

sion

Sourc

e K

enya

Nat

ional PM

TC

T T

rain

ing C

urr

iculu

m

2005

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

92

OPE

RA

TIO

NA

L G

UID

ELIN

ES

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed in

the

care

and

fo

llow

-up

of c

hild

ren

of H

IV-in

fect

ed m

othe

rs

bull A

ll ch

ildre

n bo

rn t

o H

IV in

fect

ed m

othe

rs s

houl

d be

see

n in

the

he

alth

car

e fa

cilit

y w

ithin

tw

o w

eeks

of

deliv

ery

bull F

or a

ll H

IV e

xpos

ed in

fant

s m

onth

ly f

ollo

w u

p vi

sits

are

re

com

men

ded

begi

nnin

g at

six

wee

ks t

hrou

gh 2

yea

rs

bull W

here

pos

sibl

e v

isits

sho

uld

be li

nked

to

the

imm

unis

atio

n an

d

grow

th m

onito

ring

vis

its

bull A

ll H

IV e

xpos

ed in

fant

s sh

ould

be

star

ted

on C

otri

mox

azol

e

prop

hyla

xis

from

6 w

eeks

of

age

bull F

or in

fant

s w

ho te

st H

IV p

ositi

ve b

y D

NA

PC

R b

efor

e 18

mon

ths

or

by a

ntib

ody

test

aft

er 1

8 m

onth

s of

age

co

-trim

oxaz

ole

shou

ld b

e gi

ven

daily

for

life

bull F

or in

fant

s w

ho te

st H

IV n

egat

ive

|

If th

ey h

ave

stop

ped

brea

stfe

edin

g fo

r 2 m

onth

s or

mor

e s

top

C

otrim

oxaz

ole

|

If st

ill br

east

feed

ing

con

tinue

Cot

rimox

azol

e un

til tw

o m

onth

s af

ter

com

plet

e ce

ssat

ion

of b

reas

tfeed

ing

bull C

ompr

ehen

sive

car

e fo

r th

e H

IV e

xpos

ed o

r in

fect

ed in

fant

s sh

ould

be

pro

vide

d in

the

bro

ader

con

text

of

othe

r ch

ild h

ealth

car

e st

rate

gies

Hea

lth w

orke

rs s

houl

d pr

ovid

e th

e fo

llow

ing

pack

age

of c

are

as a

min

imum

to

thes

e ch

ildre

n

(1)

Con

firm

HIV

sta

tus

as e

arly

as

poss

ible

(R

efer

to C

hapt

er 7

)

(2)

M

othe

rs s

houl

d be

sup

porte

d to

pro

vide

opt

imal

infa

nt fe

edin

g an

d pa

rticu

larly

to

avoi

d m

ixed

feed

ing

in th

e fir

st 6

mon

ths

of li

fe I

t is

impo

rtant

that

infa

nt fe

edin

g ch

oice

s at

initi

atio

n of

feed

ing

follo

win

g ea

rly in

fant

dia

gnos

is a

t wea

ning

and

at

the

time

of in

trodu

ctio

n of

com

plem

enta

ry fe

eds

are

guid

ed b

y th

e A

FAS

S c

riter

ia

(Ref

er to

Cha

pter

8)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

3

3

74

Cha

pter

9

Car

e an

d Fo

llow

-up

of C

hild

ren

of H

IV-in

fect

ed M

othe

rs

91

INTR

OD

UC

TIO

N

PMTC

T in

terv

entio

ns re

duce

but

do

not e

limin

ate

the

risk

of H

IV tr

ansm

issi

on fr

om m

othshy

ers t

o th

eir i

nfan

ts a

nd y

oung

child

ren

Bot

h H

IV-in

fect

ed a

nd u

ninf

ecte

d ex

pose

d ch

ildre

n ha

ve in

crea

sed

risk

s of

infe

ctio

n an

d de

ath

from

com

mon

chi

ldho

od in

fect

ions

The

sur

shyvi

val o

f H

IV-e

xpos

ed c

hild

ren

whe

ther

or

not

they

are

inf

ecte

d i

s cl

osel

y lin

ked

to t

he

heal

th a

nd s

urvi

val o

f the

ir m

othe

rs T

here

fore

lon

g-te

rm b

enef

its o

f PM

TCT

prog

ram

s w

ill o

nly

be s

usta

ined

if t

here

is o

ngoi

ng c

ompr

ehen

sive

car

e fo

r th

e ch

ildre

n an

d th

eir

mot

hers

and

or c

are

give

rs

HIV

exp

osed

chi

ldre

n ar

e vu

lner

able

to

the

com

mon

illn

esse

s af

fect

ing

othe

r ch

ildre

n

Thes

e in

fect

ions

incl

ude

neon

atal

infe

ctio

ns m

alar

ia p

neum

onia

dia

rrho

ea m

easl

es a

nd

othe

r vac

cine

pre

vent

able

dis

ease

s H

IV in

fect

ed ch

ildre

n ar

e lik

ely

to s

uffe

r mor

e se

vere

ly

and

have

a h

ighe

r lik

elih

ood

of d

ying

from

com

mon

chi

ldho

od il

lnes

ses

than

non

-infe

cted

ch

ildre

n W

here

as m

alnu

triti

on c

ause

s 53

o

f all

child

hood

dea

ths

HIV

exp

osed

chi

ldre

n ar

e m

ore

vuln

erab

le to

it th

an n

on-in

fect

ed c

hild

ren

Thi

s is

bec

ause

HIV

exp

osed

child

ren

have

hig

her

calo

ric

requ

irem

ents

as

a re

sult

of th

eir

HIV

infe

ctio

n th

e pr

esen

ce o

f opp

orshy

tuni

stic

infe

ctio

ns a

nd o

ther

com

plic

atio

ns re

late

d to

AID

S

Regu

lar

follo

w u

p ca

re is

cri

tical

for

an in

fant

bor

n to

a m

othe

r w

ith H

IVA

IDS

The

com

shypr

ehen

sive

car

e of

HIV

exp

osed

chi

ldre

n in

clud

ing

nutr

ition

im

mun

isat

ion

mon

itori

ng o

f gr

owth

and

dev

elop

men

t pr

even

tion

and

trea

tmen

t of

opp

ortu

nist

ic in

fect

ions

and

ear

ly

infa

nt d

iagn

osis

of

HIV

is f

easi

ble

in r

esou

rce-

cons

trai

ned

sett

ings

and

sig

nific

antly

imshy

prov

es th

e su

rviv

al o

f the

se ch

ildre

n

23

JOB A

IDS

Prov

ider

s ar

e en

cour

aged

to re

fer t

o th

e ap

prop

riate

job

aid(

s) w

hen

deal

ing

with

spe

cific

issu

es

bull P

MT

CT

test

ing

and

coun

selli

ng t

ools

bull C

oupl

e co

unse

lling

tool

s

bull A

NC

alg

orith

ms

for

AR

V p

roph

ylax

is a

nd in

fant

fee

ding

gui

delin

es

as a

dapt

ed f

rom

WH

O g

uide

lines

bull P

reve

ntio

n w

ith p

ositi

ves

tool

kit

on d

iscl

osur

e

bull F

ocus

ed a

nte-

nata

l car

e

bull M

alar

ia in

pre

gnan

cy

bull T

B in

pre

gnan

cy

bull K

EP

I S

ched

ule

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

3

34

A ra

pid

HIV

test

ing

algo

rithm

for s

eria

l tes

ting

is il

lust

rate

d be

low

35

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Pre-Test Education and or Counselling

First HIV Rapid Test ndashDETERMINE

Negative TestResult

Counsel for Negative Result

Positive TestResult

Second HIV Rapid Test ndashBIOLINE

Positive Test ResultCounsel for

Positive Result

NegativeTestResult

Third HIV Rapid Test ndashUNIGOLD

Positive Test ResultCounsel for

Positive Result

Negative Test ResultCounsel for

Negative Result

Figure 32 Rapid HIV testing algorithm Serial testing

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

72

M

othe

r and

Chi

ld H

ealth

Boo

klet

71

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

36

Cha

pter

ref

eren

ces

Rep

ublic

of

Ken

ya M

inis

try

of

Hea

lth

Div

isio

n o

f Rep

roduct

ive

Hea

lth

National G

uid

e-lin

es f

or

Qual

ity

Obst

etri

cs a

nd P

erin

atal Car

e (

2004)

WH

O

UN

FPA

UN

ICEF

World B

ank

Manag

ing C

om

plic

atio

ns

in P

regnan

cy a

nd C

hild

birth

A g

uid

e fo

r m

idw

ives

and d

oct

ors

(2003)

WH

O

Sta

ndar

ds

for

Mat

ernal

and N

eonat

al C

are

(2006)

WH

O

Antire

trovi

ral dru

gs

for

trea

ting p

regnan

t w

om

en a

nd p

reve

nting H

IV infe

ctio

ns

in

infa

nts

in r

esourc

e lim

ited

set

tings

Tow

ard

s U

niv

ersa

l Acc

ess

Rec

om

men

dations

for

a public

hea

lth a

ppro

ach (

2006)

Min

istr

y of

Hea

lth

Nat

ional AID

S amp

STD

Contr

ol Pro

gra

mm

e (N

ASCO

P)

Guid

elin

es f

or

Antire

trovi

ral dru

g t

her

apy

in K

enya

(2005)

Min

istr

y of

Hea

lth

Ken

ya N

atio

nal

Rep

roduct

ive

Hea

lth I

nst

ruct

ional M

anual

for

Ser

vice

Pro

vider

s (M

arch

2005)

Nat

ional AID

S amp

STD

Contr

ol Pro

gra

mm

e K

enya

AID

S I

ndic

ator

Syr

vey

Foo

tnot

es

1

2Ken

ya D

emogra

phic

and H

ealth S

urv

ey (

KD

HS)

2003

37

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

70

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

CH

AP

TE

R 3

Intr

apar

tum

Car

e 3

1 IN

TRO

DU

CTI

ON

Intr

apar

tum

car

e is

the

man

agem

ent

of w

omen

fro

m t

he o

nset

of

labo

ur t

o de

liver

y T

his

peri

od p

oses

the

grea

test

ris

k fo

r tr

ansm

issi

on o

f HIV

from

the

mot

her

to th

e ch

ild (M

TCT)

w

ith 1

0 to

20

perc

ent o

f exp

osed

infa

nts

beco

min

g in

fect

ed a

t thi

s tim

e in

the

abse

nce

of a

ny

inte

rven

tion

1 In

the

con

text

of

HIV

AID

S it

is t

here

fore

im

port

ant

to e

stab

lish

the

HIV

stat

us o

f wom

en p

rior

to o

r du

ring

labo

ur a

nd d

eliv

ery

and

prov

ide

inte

rven

tions

aim

ed a

t re

duci

ng th

e ri

sk o

f tra

nsm

issi

on W

ith a

ppro

pria

te in

terv

entio

ns t

he r

isk

of M

TCT

can

bere

duce

d si

gnifi

cant

ly

32

OPE

RA

TIO

NA

L G

UID

ELIN

ES

a) O

ptim

al In

trap

artu

m C

are

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed fo

r all

wom

en a

dmitt

ed

to la

bour

and

del

iver

y un

its 2

3

1 M

inim

ise

vagi

nal e

xam

inat

ions

2 U

se a

sept

ic t

echn

ique

s in

con

duct

ing

deliv

ery

3 A

void

rou

tine

artif

icia

l rup

ture

of m

embr

anes

(A

RM

)

4 A

void

pro

long

ed la

bour

5 A

void

unn

eces

sary

trau

ma

duri

ng d

eliv

ery

6 M

inim

ise

the

risk

of p

ostp

artu

m h

aem

orrh

age

7 U

se s

afe

bloo

d tr

ansf

usio

n pr

actic

es

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

9

38

b) S

peci

fic M

anag

emen

t of H

IV P

ositi

ve P

regn

ant W

omen

Pro

phyl

acti

c A

ntir

etro

vira

l the

rapi

es4

The

AR

V p

roph

ylac

tic r

egim

en d

epen

ds o

n w

heth

er th

e m

othe

r ha

d A

RV

s du

ring

pre

gshyna

ncy

or n

ot T

hus

the

heal

th c

are

wor

ker s

houl

d es

tabl

ish

the

regi

men

use

d du

ring

th

e A

NC

whe

ther

the

wom

an h

ad ta

ken

the

SdN

VP

and

AZT

at t

he o

nset

of l

abou

r an

d de

term

ine

the

appr

opri

ate

intr

a-pa

rtum

AR

V c

are

as p

er th

e al

gori

thm

s on

pag

e80

(App

endi

x II

I) p

age

81 (A

ppen

dix

IV) a

nd a

s su

mm

aris

ed b

elow

No

AR

Vs t

aken

in p

regn

ancy

Mot

her i

n ea

rly la

bour

(up

to 4

cm c

ervi

cal d

ilata

tion)

bull

Int

rapa

rtum

per

iod

Giv

e m

othe

r S

dNV

P 2

00m

g A

ZT

600

mg

and

3T

C 1

50m

g st

at

bull P

ostp

artu

m m

othe

r G

ive

mot

her

AZ

T 3

00m

g an

d 3T

C 1

50m

g B

D

for

7 da

ys

bull P

ostp

artu

m p

erio

d G

ive

infa

nt S

d N

evir

apin

e 2

mg

kg w

ithin

72

hour

s of

birt

h P

LUS

3T

C 4

mg

kg B

D fo

r 1

wee

k an

d A

ZT

syr

up 4

mg

kg

BD

for

6 w

eeks

Mot

her r

ecei

ved

AZT

300

mg

BD

in P

regn

ancy

bull P

ostp

artu

m

Giv

e in

fant

Sd

Nev

irap

ine

2mg

kg w

ithin

72

hour

s of

birt

h

PLU

S 3

TC

4m

gkg

BD

for

1 w

eek

and

AZ

T sy

rup

4 m

gkg

BD

for

6 w

eeks

Mot

her r

ecei

ved

HA

AR

T in

Pre

gnan

cy

Reg

ardl

ess

of d

urat

ion

rece

ived

HA

AR

T bull

Giv

e m

othe

r A

RV

dos

e as

per

reg

imen

bull P

ostp

artu

m

Giv

e In

fant

Sd

Nev

irap

ine

2mg

kg w

ithin

72

hour

s of

bir

th

PLU

S 3

TC

4m

gkg

BD

for

1 w

eek

and

AZ

T sy

rup

4 m

gkg

BD

for

6 w

eeks

Mod

e of

del

iver

y E

lect

ive

caes

area

n se

ctio

n (C

S) r

educ

es t

he r

isk

of H

IV M

TCT

as c

ompa

red

to v

agin

al

deliv

ery

but

will

not

be

avai

labl

e in

man

y se

ttin

gs in

our

cou

ntry

Whe

re C

S is

per

shyfo

rmed

(ele

ctiv

e or

em

erge

ncy)

in H

IV p

ositi

ve w

omen

the

y sh

ould

rec

eive

pro

phyl

actic

an

tibio

tics

If

the

CS

is p

erfo

rmed

aft

er p

rolo

nged

lab

our

or r

uptu

re o

f m

embr

anes

lo

nger

cour

ses

of a

ntib

iotic

s sh

ould

be

cons

ider

ed

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

3

9

68

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Supp

ort d

urin

g la

bour

E

mot

iona

l su

ppor

t du

ring

lab

our

is i

mpo

rtan

t fo

r al

l w

omen

and

may

be

even

mor

ene

cess

ary

for

an H

IV p

ositi

ve w

oman

who

is c

once

rned

abo

ut h

er c

ondi

tion

and

risk

of

HIV

tran

smis

sion

to c

hild

Whe

neve

r po

ssib

le d

urin

g la

bour

war

d st

aff m

ust b

e se

nsishy

tive

to t

he fe

ars

and

conc

erns

of t

he H

IV p

ositi

ve m

othe

r ab

out

her

infe

ctio

n a

nd h

owm

uch

she

had

told

her

par

tner

Indu

ctio

n of

labo

ur

Indu

ctio

n of

labo

ur m

ay b

e as

soci

ated

with

incr

ease

d ri

sk o

f H

IV M

TCT

Car

eful

asshy

sess

men

t of

the

nee

d fo

r an

d de

sira

bilit

y of

ind

uctio

n ra

ther

tha

n C

S is

nec

essa

ry

Whe

n in

duct

ion

of la

bour

is c

hose

n m

embr

anes

sho

uld

be le

ft in

tact

for

as lo

ng a

s po

sshysi

ble

Syn

toci

non

shou

ld n

ot b

e us

ed w

ith in

tact

mem

bran

es

Indi

catio

ns fo

r ele

ctiv

e C

S A

lthou

gh e

lect

ive

CS

will

not

be

avai

labl

e in

mos

t hea

lth fa

cilit

ies

as a

rou

tine

for

HIV

posi

tive

wom

en t

here

may

be

som

e ca

ses

that

mer

it co

nsid

erat

ion

for

CS

The

se i

nshycl

ude

preg

nanc

ies

whe

re l

abou

r is

exp

ecte

d to

be

prol

onge

d or

whe

re o

ther

obs

tetr

ic

com

plic

atio

ns m

ay b

e as

soci

ated

with

incr

ease

d ri

sk o

f tra

nsm

issi

on (e

g a

brup

tio p

lashy

cent

ae

plac

enta

pra

evia

pr

e-te

rm r

uptu

re o

f m

embr

anes

pr

evio

us C

S an

d br

eech

pr

esen

tatio

n)

Man

agem

ent o

f lab

our a

nd d

eliv

ery

Labo

ur a

nd d

eliv

ery

man

agem

ent

shou

ld fo

llow

opt

imal

obs

tetr

ic m

anag

emen

t gu

ideshy

lines

(R

efer

to

Opt

imal

Int

rapa

rtum

car

e ab

ove

and

Nat

iona

l G

uide

lines

for

Qua

lity

Obs

tetr

ics

and

IMPA

C C

are

Man

ual)

RO

LEO

FTH

E C

OM

MU

NIT

Y

A la

rge

prop

ortio

n (6

0) o

f wom

en in

Ken

ya is

del

iver

ed o

utsid

e th

e he

alth

sys

tem

s by

fam

ilym

embe

rs n

eigh

bour

s and

TBA

s

bull T

here

is n

eed

to e

duca

te th

e co

mm

unity

on

the

risk

of M

TC

T an

d w

ays

of

prev

entio

n

bull T

hose

ass

istin

g th

e de

liver

ies

need

to u

nder

stan

d th

eir

own

risk

of in

fect

ion

and

how

to p

rote

ct th

emse

lves

bull T

he c

omm

unity

sho

uld

be e

ncou

rage

d to

faci

litat

e m

othe

rs to

del

iver

in

heal

th fa

cilit

ies

bull T

he c

omm

unity

sho

uld

be e

ncou

rage

d to

ref

er to

hea

lth fa

cilit

ies

all c

hild

ren

born

at h

ome

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

7

40

Fi

gure

81

Gui

delin

es fo

r Cou

nsel

ling

on H

IV a

nd In

fant

feed

ingJ

ob A

ids

Cha

pter

ref

eren

ces

an

d IE

C M

ater

ials

on

Infa

nt a

nd Y

oung

Chi

ld F

eedi

ng

1R

epublic

of

Ken

ya

Min

istr

y of

Hea

lth

Ess

ential

Obst

etric

Car

e M

anual

for

Hea

lth

Ser

vice

Pro

vider

s in

Ken

ya (

3rd

Editio

n J

an 2

006)

Foo

tnot

es

1 D

e Cock

KM

2002

2 K

enya

National

Rep

roduct

ive

Hea

lth I

nst

ruct

ion M

anual

for

Ser

vice

Pro

vider

s (2

006)

3 D

ivis

ion o

f Rep

roduct

ive

Hea

lth

Guid

elin

es f

or

Qual

ity

Obst

etri

cs a

nd P

erin

ata

l Car

e

(2004)

4 W

HO

Antire

tovi

ral dru

gs

for

trea

ting p

regnan

t w

om

en a

nd p

reve

nting H

IV infe

ctio

n in

infa

nts

to

ward

s univ

ersa

l acc

ess

(2006)

41

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

66

85

EXTR

AC

TSFR

OM

RES

EAR

CH

ON

I NFA

NT

F EED

ING

A

ND H

IVA

IDS

Evid

ence

ava

ilabl

e fr

om c

urre

nt re

sear

ch d

ata

show

s th

at

bull I

ncre

ased

ris

k of

mor

talit

y w

ith r

epla

cem

ent

feed

ing

is s

igni

fican

t

bull H

IV f

ree

surv

ival

rat

e at

18

mon

ths

of a

ge d

oes

not

sign

ifica

ntly

var

y be

twee

n a

brea

stfe

d an

d re

plac

emen

t fed

chi

ld

bull M

odifi

ed a

nim

alrsquos

milk

doe

s no

t pr

ovid

e ad

equa

te n

utrit

ion

for

ch

ildre

n le

ss t

han

6 m

onth

s he

nce

mic

ronu

trie

nts

shou

ld b

e gi

ven

un

der

thes

e ci

rcum

stan

ces

bull A

brup

t ce

ssat

ion

of b

reas

tfee

ding

is n

o lo

nger

rec

omm

ende

d

bull E

xclu

sive

bre

astf

eedi

ng u

p to

6 m

onth

s is

rec

omm

ende

d un

less

re

plac

emen

t fee

ding

can

mee

t AF

AS

S c

rite

ria

Cha

pter

4

Use

of A

ntire

trov

iral D

rugs

in P

regn

ancy

for T

reat

men

t and

for

Prev

entio

n of

Mot

her-

to-C

hild

Tra

nsm

issi

on o

f HIV

Infe

ctio

n

41

INTR

OD

UC

TIO

N

With

out

any

inte

rven

tion

up

to 4

0 pe

rcen

t of

HIV

pos

itive

wom

en w

ill t

rans

mit

the

infe

ctio

n to

the

ir c

hild

ren

duri

ng p

regn

ancy

lab

our

and

brea

stfe

edin

g U

se o

f ant

iret

shyro

vira

l dru

gs (A

RV

s) o

bste

tric

inte

rven

tions

and

avo

idan

ce o

f all

brea

stfe

edin

g fo

r pr

eshyve

ntio

n of

mot

her

to c

hild

tran

smis

sion

of H

IV in

fect

ion

(PM

TCT)

has

red

uced

the

risk

of m

othe

r to

chi

ld tr

ansm

issi

on o

f HIV

infe

ctio

n (M

TCT)

to le

ss th

an 2

per

cent

in d

evel

shyop

ed c

ount

ries

Shor

t cou

rse

effic

acio

us A

RV

dru

g re

gim

ens

can

redu

ce th

e ri

sk o

f MTC

T to

2-4

per

cent

and

can

be i

mpl

emen

ted

in r

esou

rce-

limite

d se

ttin

gs o

n a

popu

latio

n-ba

sed

publ

ic

heal

th s

cale

AR

Vs

are

used

bot

h fo

r th

e tr

eatm

ent

of H

IV d

isea

se a

nd fo

r PM

TCT

in

HIV

-infe

cted

pre

gnan

t w

omen

and

the

ir n

eona

tes

Ant

iret

rovi

ral t

reat

men

t (A

RT)

for

wom

en w

ho q

ualif

y fo

r it

pro

long

s an

d im

prov

es t

he q

ualit

y of

the

ir l

ives

The

sur

shyvi

val

of t

he c

hild

is

clos

ely

inte

rlin

ked

with

the

hea

lth a

nd s

urvi

val

of t

he m

othe

r

Wom

en e

ligib

le fo

r A

RT

shou

ld b

e st

arte

d on

trea

tmen

t as

soon

as

poss

ible

Pre

gnan

cy

is n

ot a

rea

son

to d

elay

AR

T W

omen

who

are

alr

eady

on

AR

T be

fore

bec

omin

g pr

egshy

nant

sho

uld

cont

inue

with

thei

r tr

eatm

ent

In c

erta

in s

ituat

ions

mod

ifica

tions

may

be

need

ed to

mak

e tr

eatm

ent s

afer

for

the

mot

her

and

the

unbo

rn b

aby

The

bene

fits

of u

sing

AR

Vs

to t

reat

HIV

-infe

cted

pre

gnan

t w

omen

and

or

PMTC

T ou

tshyw

eigh

the

ris

ks H

owev

er w

hen

AR

T or

oth

er s

hort

cou

rse

AR

V r

egim

ens

are

used

ba

selin

e ev

alua

tion

and

mon

itori

ng is

enc

oura

ged

to e

nsur

e th

e sa

fety

of t

he m

othe

rsan

d th

eir

new

born

s L

inka

ges

of H

IV-in

fect

ed p

regn

ant

wom

en a

nd t

heir

chi

ldre

n to

ot

her

care

and

sup

port

pro

gram

s at

hea

lth f

acili

ty a

nd c

omm

unity

lev

els

shou

ld b

e en

sure

d

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

5

42

42

OPE

RA

TIO

NA

L G

UID

ELIN

ES

All

HIV

-infe

cted

pre

gnan

t w

omen

sho

uld

be c

ouns

elle

d on

com

preh

ensi

ve H

IV c

are

incl

udin

g us

e of

AR

Vs

for

thei

r ow

n he

alth

and

for

PMTC

T

All

HIV

-infe

cted

pre

gnan

t wom

en s

houl

d ha

ve th

eir H

IV d

isea

se

stag

ed u

sing

bull W

HO

clin

ical

sta

ging

(se

e A

ppen

dix

1) a

nd

bull I

mm

unol

ogic

al s

tagi

ng (

CD

4 co

unt)

(se

e ta

ble

1)

The

wom

en s

houl

d al

so b

e sc

reen

ed a

nd tr

eate

d fo

r op

port

unis

tic in

fect

ions

(OIs

) inc

ludi

ngTu

berc

ulos

is (T

B)

All

HIV

-infe

cted

pre

gnan

t wom

en s

houl

d ha

ve b

asel

ine

labo

rato

ry a

nd o

ther

nec

essa

rydi

agno

stic

eva

luat

ions

Thes

e di

agno

stic

s sh

ould

incl

ude

bull R

outin

e an

tena

tal c

are

labo

rato

ry in

vest

igat

ions

that

are

nor

mal

ly

done

for

all

preg

nant

wom

en

haem

oglo

bin

(Hb)

rh

esus

blo

od

grou

p an

d A

BO

typ

ing

VD

RL

uri

ne a

naly

sis

and

scre

enin

g fo

r S

TI

bull A

LT a

nd c

reat

inin

e le

vels

for

wom

en e

ligib

le f

or H

AA

RT

Prop

hyla

xis

amp m

icro

nutr

ient

sup

plem

enta

tion

bull

Cot

rimox

azol

e (C

TX) o

ne d

oubl

e st

reng

th o

r tw

o si

ngle

stre

ngth

tabl

ets

once

dai

ly

bull

Mul

tivita

min

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

83

OPE

RA

TIO

NA

L G

UID

ELIN

ESO

N F

EED

ING

CH

ILD

REN

6 M

ON

THS

AN

DO

LDER

The

follo

win

g sh

ould

gui

de fe

edin

g fo

r chi

ldre

n 6

mon

ths

and

olde

r

bull A

t 6

mon

ths

oth

er f

orm

s of

milk

alo

ne a

re n

ot a

dequ

ate

to m

eet

the

baby

rsquos n

utrit

iona

l req

uire

men

ts

bull C

ompl

emen

tary

foo

ds s

houl

d be

intr

oduc

ed w

ith c

ontin

ued

br

east

feed

ing

or w

ith r

epla

cem

ent

feed

ing

until

a n

utrit

iona

lly

adeq

uate

die

t ca

n be

sus

tain

ed w

ithou

t m

ilk

bull A

brup

t ces

satio

n of

bre

astf

eedi

ng s

houl

d be

dis

cour

aged

to

avoi

d

trau

ma

for

both

the

mot

her

and

the

baby

bull M

ilk s

houl

d co

ntin

ue a

s an

impo

rtan

t co

mpo

nent

of

the

diet

bull C

ompl

emen

tary

foo

ds s

houl

d be

enr

iche

d fr

om lo

cally

ava

ilabl

e

fam

ily f

oods

84

NU

TRIT

ION

AL

CA

RE

AN

D S

UPP

OR

TO

F H

IV

INFE

CTE

DC

HIL

DR

EN

bull E

nerg

y ne

eds

for

asym

ptom

atic

HIV

infe

cted

chi

ldre

n in

crea

se b

y 10

pe

rcen

t to

mai

ntai

n gr

owth

as

com

pare

d to

the

non-

infe

cted

chi

ldre

n

bull T

here

is n

o ev

iden

ce o

f in

crea

sed

prot

ein

requ

irem

ents

The

re

quir

emen

ts s

houl

d be

bas

ed o

n in

divi

dual

sym

ptom

s an

d ne

eds

bull M

icro

nutr

ient

req

uire

men

ts d

o no

t ch

ange

W

HO

rec

omm

ends

not

m

ore

than

one

RD

A

(For

fur

ther

det

ails

re

fer

to K

enya

n G

uide

lines

on

nutr

ition

and

HIV

A

IDS

)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

3

64

82

OPE

RA

TIO

NA

L G

UID

ELIN

ESO

N I N

FAN

TFE

EDIN

G (0

-6 M

ON

THS)

The

follo

win

g sh

ould

gui

de in

fant

feed

ing

for t

he fi

rst 6

mon

ths

bull A

ll w

omen

and

men

irre

spec

tive

of th

eir

HIV

sta

tus

shou

ld r

ecei

ve

coun

selin

g an

d de

mon

stra

tions

on

how

to s

afel

y fe

ed t

heir

babi

es

duri

ng t

he a

nten

atal

and

pos

tnat

al f

ollo

w u

p

bull T

he m

ost

appr

opria

te in

fant

fee

ding

opt

ion

for

an H

IV in

fect

ed

mot

her

shou

ld c

ontin

ue t

o de

pend

on

indi

vidu

al c

ircu

mst

ance

s an

d

the

av

aila

ble

supp

ort

bull E

very

HIV

infe

cted

wom

an s

houl

d be

eva

luat

ed a

t ev

ery

visi

t to

ch

eck

whe

ther

her

soc

ial

econ

omic

and

hea

lth s

tatu

s ha

s ch

ange

d

suff

icie

ntly

eno

ugh

to a

ffec

t he

r in

fant

fee

ding

opt

ion

bull E

xclu

sive

bre

astf

eedi

ng fo

r H

IV in

fect

ed w

omen

for

the

firs

t 6

mon

ths

of t

he in

fant

rsquos li

fe is

adv

isab

le

unle

ss r

epla

cem

ent f

eedi

ng is

ac

cept

able

fea

sibl

e a

ffor

dabl

e s

usta

inab

le a

nd s

afe

for

them

and

th

eir

infa

nts

befo

re t

hat t

ime

bull W

hen

repl

acem

ent

feed

ing

is a

ccep

tabl

e f

easi

ble

aff

orda

ble

su

stai

nabl

e an

d sa

fe

avoi

danc

e of

exc

lusi

ve b

reas

tfee

ding

by

HIV

in

fect

ed w

omen

is r

ecom

men

ded

bull I

f th

e co

nditi

ons

for

repl

acem

ent

feed

ing

are

still

not

met

for

6

mon

ths

then

co

ntin

uatio

n of

bre

astf

eedi

ng w

ith a

dditi

onal

co

mpl

emen

tary

fee

ding

is r

ecom

men

ded

giv

ing

prio

rity

to t

he lo

cally

av

aila

ble

food

s

bull I

nfan

t fe

edin

g de

cisi

ons

for

all H

IV e

xpos

ed in

fant

s sh

ould

be

base

d on

the

AF

AS

S c

riter

ia e

ven

whe

re e

arly

infa

nt d

iagn

osis

(E

ID)

is

avai

labl

e

bull B

reas

tfeed

ing

mot

hers

of

infa

nts

and

youn

g ch

ildre

n w

ho a

re k

now

n to

be

HIV

infe

cted

sho

uld

be s

tron

gly

enco

urag

ed to

con

tinue

bre

ast

feed

ing

How

ever

br

east

feed

ing

HIV

infe

cted

mot

hers

sho

uld

be

give

n nu

triti

on s

uppo

rt (

nutr

ition

al c

ouns

elin

g e

duca

tion

foo

d an

d nu

triti

onal

sup

plem

ents

)

63

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

44

Sulp

hur-

base

d in

term

itten

t pr

esum

ptiv

e m

alar

ia t

reat

men

t (I

PT) s

houl

d no

t be

giv

en

to w

omen

who

are

on

CTX

pro

phyl

axis

AR

V us

e

bull A

RV

s ar

e us

ed fo

r tr

eatin

g H

IV-i

nfec

ted

elig

ible

wom

en a

ndo

r fo

r pr

even

tion

of m

othe

r-to

-chi

ld tr

ansm

issi

on

bull H

IV-i

nfec

ted

preg

nant

wom

en e

ligib

le f

or A

RT

sho

uld

initi

ate

AR

T

as s

oon

as p

ossi

ble

as s

how

n in

Tab

le 4

1

bull H

IV-i

nfec

ted

preg

nant

wom

en a

lread

y on

AR

T b

efor

e be

com

ing

preg

nant

sho

uld

cont

inue

AR

T

The

bab

y sh

ould

be

give

n A

RV

pr

ophy

laxi

s so

on a

fter

birt

h as

sho

wn

in T

able

42

Tabl

e 4

1 R

ecom

men

datio

ns fo

r ini

tiatin

g A

RV

trea

tmen

t in

preg

nant

w

omen

bas

ed o

n cl

inic

al s

tage

and

ava

ilabi

lity

of C

D4

Cou

nt

WH

O

CD

4 te

stin

g

CD

4 te

stin

g

Clin

ical

Sta

ge

not a

vaila

ble

avai

labl

e

1 D

o no

t Tre

at

Trea

t if C

D4le

350

cells

mm

3

2 D

o no

t Tre

at

Trea

t if C

D4 le

350

cells

mm

3

3 Tr

eat

Trea

t irre

spec

tive

of C

D4

coun

t (c

onsi

der C

D4

valu

es fo

r bet

ter

man

agem

ent)

4 Tr

eat

Trea

t irre

spec

tive

of C

D4

cell

coun

t

Sourc

e A

dopte

d f

rom

WH

O

Anti-r

etro

vira

l dru

gs

for

trea

ting p

regnant

wom

en a

nd p

re-

venting H

IV infe

ctio

ns

Tabl

e 4

2 R

ecom

men

ded

first

-line

AR

T re

gim

en fo

r tre

atin

g pr

egna

nt w

omen

and

pro

phyl

actic

regi

men

for i

nfan

ts

Mot

her

Ant

epar

tum

AZ

T +

3TC

+ N

VP D

aily

Intra

partu

m

AZT

+ 3T

C +

NVP

Dai

ly

Pos

tpar

tum

AZ

T +

3TC

+ N

VP D

aily

Infa

nt p

roph

ylax

is

Sd

NV

P 2

mg

kg s

tat w

ithin

72

hour

s 3T

C X

1 w

eek

(4

mg

kg B

ID)

AZT

X 6

wee

ks (4

mg

kg B

ID)

Mat

erna

l dos

ages

AZT

300

mg

BID

3TC

150

mg

BID

NV

P 2

00 m

g O

D fo

r tw

o w

eeks

the

reaf

ter 2

00 m

g B

ID

Infa

nt D

osag

es

NV

P

2mg

kg s

tat w

ithin

72

hour

s

AZT

4mg

kg B

ID X

6 w

eeks

3TC

4m

gkg

BID

X 1

wee

k

Cha

pter

8

Feed

ing

Infa

nts

and

Youn

g C

hild

ren

Bor

n to

HIV

Infe

cted

Mot

hers

81

INTR

OD

UC

TIO

N T

RA

NSM

ISSI

ON

OF

HIV

THR

OU

GH

B

REA

STFE

EDIN

G

In A

fric

a 3

to 4

out

of e

very

10

infa

nts

born

to H

IV in

fect

ed w

omen

acq

uire

HIV

infe

cshytio

n T

here

is t

here

fore

a 5

ndash 2

0 pe

rcen

t ri

sk o

f inf

ants

bor

n to

HIV

pos

itive

mot

hers

ac

quir

ing

infe

ctio

n th

roug

h br

east

-fe

edin

g if

ther

e ar

e no

inte

rven

tions

in

pla

ce

For

wom

en w

ho a

re i

nshyfe

cted

with

HIV

for

the

first

tim

e or

w

ho a

re r

e-in

fect

ed w

ith a

diff

eren

t st

rain

of H

IV d

urin

g th

e br

east

feed

shyin

g ph

ase

the

ris

k in

crea

ses

up t

o29

per

cen

t H

alf (

12)

of H

IV b

reas

t m

ilk t

rans

mis

sion

tak

es p

lace

by

6 w

eeks

and

thre

e qu

arte

rs (3

4) b

y 6

mon

ths

Mix

ed fe

edin

g in

crea

ses

the

risk

of

brea

st m

ilk t

rans

mis

sion

of

HIV

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

5

62

For

prop

hyla

xis

the

reco

mm

enda

tions

are

ran

ked

and

will

dep

end

on t

ime

of fi

rst

conshy

tact

with

the

wom

an H

IV-in

fect

ed p

regn

ant w

omen

who

are

not

elig

ible

for

AR

T or

in

72

3 C

OM

PREH

ENSI

VE

CA

RE

FOR H

IV-E

XPO

SED

CH

ILD

REN

w

hom

it is

not

pos

sibl

e to

sta

rt A

RT

imm

edia

tely

and

the

mot

her

is b

eing

see

n be

twee

n28

and

38

wee

ks o

f pr

egna

ncy

sho

uld

be s

tart

ed o

n re

com

men

ded

mor

e ef

ficac

ious

shor

t co

urse

pro

phyl

actic

AR

V r

egim

ens

as s

how

n in

Tab

le 4

3a

The

bab

y sh

ould

als

obe

giv

en A

RV

pro

phyl

axis

soo

n af

ter

birt

h as

sho

wn

in th

e sa

me

tabl

e T

he r

egim

ens

asou

tline

d be

low

are

for

prop

hyla

xis

and

not f

or tr

eatm

ent

MINI

STRY

OF H

EAL

TH

Tabl

e 4

3a R

ecom

men

ded

Firs

t Lin

e A

RV

prop

hyla

xis

ALGO

RITH

M FO

R EA

RLY

INFA

NTDI

AGNO

SISFO

R HI

VEX

POSE

DCH

ILDRE

N

to p

reve

nt H

IV in

fect

ion

in in

fant

s A

mon

g Pr

egna

nt W

omen

Pr

esen

ting

Bef

ore

38 W

eeks

Ran

king

Ti

me

of A

dmin

istr

atio

n

WEL

L CHI

LD

SICK

CHI

LD

(Man

age

pres

entin

g ill

ness

and

stab

ilize

)

STAR

T CO

TRIM

OXAZ

OLE

PROP

HYLA

XIS

FOR M

OR E

INFOR

MATIO

N C ON

TACT

THE N

ATI O

NAL A

IDS S

TD CO

NTRO

L PRO

GRAM

ME ( N

ASCO

P) PO

BOX

19 36

1-00

20 2 N

AIRO

BI TE

L 02

02 72

95 02

FAX 0

2 0 2 7

1 05 1

8

Exp

osur

e sta

tus s

houl

d be

det

erm

ined

for a

ll in

fants

of u

nkno

wn s

tatu

s at t

he

6 we

ek v

isit o

r firs

t con

t act

Coun

sel o

n inf

ant f

eedi

ng a

s per

nat

iona

l gui

delin

es

Conf

irma

tory

ABt

est

at 1

8 M

onth

s

Eval

uate

for

ART

star

t on

ARV

if el

igibl

e

If HI

V+ a

t 12

Mont

hs

Evalu

ate f

or A

RT

Start

on

ARV

if eli

gible

6 Wee

ks D

BS (P

CR)

HIV

+

If HI

V-sto

p CT

X if

not

BF

for a

t lea

st 2

Mont

hs

HI

V-

Antib

ody

test

ing

12 M

onth

s

Conf

irmat

ory

ABte

st at

18 M

onth

s

Conf

irmat

ory A

B te

st at

18 M

onth

s

Eval

uate

for A

RT

star

t on

ARV

if el

igible

If HIV

+ at

12

Mon

ths

Eval

uate

for A

RT

Star

t on

ARV

if el

igibl

e

If lt1

2 Mon

ths D

BS (P

CR)

If gt

12m

o An

tibod

y te

st

HIV

+

If HIV-

stop

CTX

if n

ot

BF

for a

t lea

st 2

Mont

hs

HI

V-

Antib

ody

testi

ng

12 M

onth

s

Conf

irma

tory

AB

test

at 1

8 Mo

nths

Exp

osur

e sta

tus s

hould

be de

term

ined

for a

ll in

fant

s of u

nkno

wn st

atus

at th

e 6w

eek

visit

or fi

rst c

onta

ct

Co

unse

l on

infa

nt fe

edin

g as

per n

atio

nal g

uideli

nes

Pre

gnan

cy

Labo

ur

Pos

tpar

tum

Mat

erna

l In

fant

Rec

omm

ende

d

AZT(

28-3

8 w

eeks

ge

stat

ion)

sd

NV

P

+ AZ

T+3T

C

AZT+

3TC

X

7 da

ys

sdN

VP

PL

US

3TC

X1

wee

k +

AZT

X

6 w

eeks

Tabl

e 4

3b b

elow

sho

ws

alte

rnat

ive

prop

hyla

ctic

regi

men

s fo

r w

omen

pre

sent

ing

befo

re 3

8 w

eeks

of p

regn

ancy

Ran

king

Ti

me

of A

dmin

istr

atio

n

Alte

rnat

ive

Min

imum

Pre

gnan

cy

AZT(

28-3

8 w

eeks

)

Labo

ur

sd N

VP

+

AZT(

600m

gs

stat

)

sdN

VP

+ A

ZT+3

TC

Pos

tpar

tum

AZT+

3TC

X

7 da

ys

Infa

nt

sdN

VP

+

3TC

X 7

da

ys +

AZT

X

6 w

eeks

sdN

VP

+

3TC

day

s +

AZT

X 6

wee

ks

HIV

-infe

cted

pre

gnan

t w

omen

who

are

see

n fo

r th

e fir

st t

ime

afte

r 38

wee

ks o

f pr

egshy

nanc

y or

in la

bour

sho

uld

be g

iven

AR

V p

roph

ylac

tic r

egim

ens

as s

how

n in

Tab

le 4

4

The

baby

sho

uld

also

be

give

n A

RV

pro

phyl

axis

soo

n af

ter

birt

h as

sho

wn

in t

he s

ame

Bot

h H

IV-in

fect

ed a

nd u

ninf

ecte

d ch

ildre

n re

quir

e co

mpr

ehen

sive

car

e (R

efer

to C

hap-

tabl

ete

r 8

and

9)

61

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

46

Tabl

e 4

4 A

RV

prop

hyla

xis

for P

MTC

T am

ong

preg

nant

wom

en w

ho

have

not

rece

ived

ant

enat

al A

RT

or p

roph

ylax

is

Ran

king

Ti

me

of A

dmin

istr

atio

n

La

bour

P

ostp

artu

m

Mat

erna

l In

fant

Rec

omm

ende

d

sdN

VP

AZ

T+3T

C

SdN

VP

+

X 7

days

P

LUS

3TC

X 1

wee

k +

AZT+

3TC

AZ

T X

6 w

eeks

Min

imum

sd

NV

P

-S

dNV

P

PLU

S 3

TC X

1 w

eek

+

AZT

X 6

wee

ks

Dos

ages

Mot

her

Bab

y

NV

P

200

mg

stat

2m

gkg

sta

t with

in 7

2 ho

urs

AZT

300

mg

BID

4m

gkg

BID

X 6

wee

ks

3TC

15

0 m

g BI

D

4mg

kg B

ID X

1 w

eek

Tabl

e 4

5 R

ecom

men

ded

HA

AR

T fo

r Pre

gnan

t Wom

en

base

d on

CD

4 C

ount

and

Sta

ge o

f Pre

gnan

cy

CD

4 C

ount

H

AA

RT

Trim

este

r C

ells

mm

3

72

2 H

IV P

OSI

TIV

EIN

FAN

TB

Y D

NA

PC

R

bull A

ll H

IV p

ositi

ve in

fant

s sh

ould

be

eval

uate

d fo

r el

igib

ility

for

antishy

retr

ovir

al tr

eatm

ent

and

linke

d to

car

e an

d tr

eatm

ent

as a

ppro

pria

te

bull W

HO

clin

ical

sta

ging

sho

uld

be d

one

for

all H

IV p

ositi

ve in

fant

s

Chi

ldre

n w

ho a

re a

t W

HO

Clin

ical

sta

ge 3

or

4 ar

e el

igib

le f

or

antir

etro

vira

l tre

atm

ent

bull A

ll H

IV p

ositi

ve in

fant

s sh

ould

be

asse

ssed

for

CD

4 co

unt

whe

re

poss

ible

and

ava

ilabl

e R

efer

to

AR

T g

uide

lines

for

CD

4 co

unts

tha

t de

term

ine

elig

ibili

ty f

or A

RT

for

chi

ldre

n of

diff

eren

t ag

e br

acke

ts

bull A

ll H

IV-p

ositi

ve in

fant

s sh

ould

hav

e a

visi

ble

guar

dian

or

care

-tak

er

befo

re t

hey

can

be s

tart

ed o

n A

RT

bull A

ll H

IV-p

ositi

ve in

fant

s sh

ould

be

star

ted

on C

otri

mox

azol

e fr

om 6

w

eeks

or

on f

irst

cont

act t

here

afte

r

bull A

ll H

IV-p

ositi

ve in

fant

s sh

ould

be

star

ted

on A

RT

if el

igib

le

bull B

reas

tfeed

ing

shou

ld b

e en

cour

aged

for

all

HIV

-pos

itive

infa

nts

for

a

min

imum

of t

wo

year

s (

Ref

er t

o C

hapt

er 8

)

bull F

or a

ll H

IV-p

ositi

ve in

fant

s p

erfo

rm a

ntib

ody

test

ing

at 9

mon

ths

12

mon

ths

and

conf

irm

at

18 m

onth

s

1st T

rimes

ter

2nd T

rimes

ter

3rd T

rimes

ter

lt250

A

ZT+

3TC

+NV

P

AZ

T+3T

C+N

VP

AZT+

3TC

+NVP

250-

350

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

gt 35

0

A

ZT+3

TC+L

PVr

OR

A

BC

+3TC

+LPV

r

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

47

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

60

72

OPE

RA

TIO

NA

L G

UID

ELIN

ES

72

0 G

UID

ELIN

ESFO

R H

IV D

IAG

NO

SIS

INC

HIL

DR

EN

bull P

erfo

rm r

outin

e ra

pid

HIV

ant

ibod

y te

sts

for

all m

othe

rs o

f 6

wee

k ol

d in

fant

s pr

esen

ting

with

unk

now

n st

atus

bull P

erfo

rm r

outin

e dr

y bl

ood

spot

s (D

BS

) fo

r D

NA

PC

R f

or a

ll in

fant

s kn

own

to b

e H

IV-e

xpos

ed a

t 6

wee

ks

bull P

erfo

rm r

outin

e an

tibod

y te

stin

g fo

r al

l sic

k in

fant

s in

out

patie

nt a

nd

paed

iatr

ic w

ards

to

esta

blis

h H

IV e

xpos

ure

infe

ctio

n st

atus

bull P

erfo

rm D

BS

for

all

HIV

-exp

osed

sic

k in

fant

s un

der

12 m

onth

s

bull A

ll H

IV-e

xpos

ed in

fant

s sh

ould

be

star

ted

on C

otri

mox

azol

e fr

om 6

w

eeks

of

age

or o

n fir

st c

onta

ct th

erea

fter

bull R

efer

to

chap

ter

on c

are

and

follo

w u

p of

the

HIV

-exp

osed

infe

cted

in

fant

72

1 H

IV N

EGA

TIV

EIN

FAN

TA

TA

GE

6 W

EEK

SO

RFI

RST

CO

NTA

CT

Perf

orm

ant

ibod

y te

stin

g at

9 m

onth

s an

d 12

mon

ths

of a

ge

bull I

f H

IV n

egat

ive

at 1

2 m

onth

s an

d st

ill b

reas

tfee

ding

co

ntin

ue

Cot

rim

oxaz

ole

bull I

f not

bre

astf

eedi

ng f

or a

t le

ast

2 m

onth

s s

top

Cot

rim

oxaz

ole

bull P

erfo

rm c

onfir

mat

ory

antib

ody

test

ing

at 1

8 m

onth

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Mat

erna

l dos

ages

AZT

30

0 m

g B

ID

3TC

15

0 m

g BI

D

NVP

200

mg

OD

for t

wo

wee

ks t

here

afte

r 200

mg

BID

AB

C

300m

g B

ID

LPV

r (4

001

00)

2 ta

blet

s B

ID

EFV

60

0mg

QID

Not

es I

mpo

rtan

t con

side

ratio

ns th

at m

odify

cho

ice

of A

RV

s du

ring

pre

gnan

cy in

clud

e C

D4

coun

t m

ater

nal a

naem

ia a

nd

stag

e of

pre

gnan

cy

bull 2

NR

TIs

(A

ZT

and

3TC

) ac

ting

as a

ldquotr

eatm

ent

back

bone

rdquo w

ith a

dditi

on o

f an

N

NR

TI (

NV

P)

rem

ains

the

pre

ferr

ed fi

rst-

line

AR

V t

hera

py in

res

ourc

e-po

or

sett

ings

bull P

rote

ase

inhi

bito

rs b

ased

reg

imen

s ar

e pr

efer

able

whe

n C

D4

coun

t is

high

er

than

250

bull R

epla

ce A

ZT

with

d4T

if H

blt 8

gm

dL

bull

EF

V m

ay b

e us

ed in

stea

d of

NV

P a

fter

first

trim

este

r

bull

Usu

ally

AR

V s

houl

d be

with

held

if C

D4

coun

t is

not

ava

ilabl

e or

not

don

e

AR

V is

how

ever

use

d fo

r P

MT

CT

and

or in

adv

ance

d H

IV d

isea

se (

WH

O

Sta

ge 3

or

4) ir

resp

ectiv

e of

CD

4 co

unt

Bab

ies

who

se

mot

hers

di

d no

t re

ceiv

e an

tepa

rtum

or

in

trap

artu

m

AR

Vpr

ophy

laxi

s sh

ould

be

give

n A

RV

pro

phyl

axis

as

show

n in

Tab

le 4

6

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

9

48

Tabl

e 4

6 A

RV

prop

hyla

ctic

regi

men

s fo

r inf

ants

bor

n to

H

IV-p

ositi

ve w

omen

who

hav

e no

t rec

eive

d an

tepa

rtum

or

intr

apar

tum

AR

T or

AR

V pr

ophy

laxi

s

Ran

king

T

ime

of a

dmin

istr

atio

n an

d In

fant

dos

age

sdN

VP (2

mg

kg s

tat)

PLU

S 3T

C (4

mg

kg B

ID) X

1 w

eek

+ AZ

T (4

mg

kg

BID

) X 6

wee

ks

Rec

omm

ende

d

sdN

VP (2

mg

kg s

tat)

Min

imum

sdN

VP

is g

iven

to th

e in

fant

with

in 7

2 ho

urs

of b

irth

Plea

se n

ote

A

t fir

st c

onta

ct a

ll H

IV i

nfec

ted

preg

nant

wom

en s

houl

d be

giv

en s

dNV

P ta

blet

s to

take

hom

e w

ith t

hem

The

y sh

ould

be

inst

ruct

ed t

o ta

ke t

he t

able

ts a

t th

e on

set

of la

shybo

ur i

f lab

our

occu

rs o

utsi

de h

ealth

faci

lity

sett

ings

The

y sh

ould

als

o be

giv

en N

VP

3T

C a

nd A

ZT s

yrup

for

thei

r ba

bies

to b

e ad

min

iste

red

soon

aft

er b

irth

Som

e w

omen

with

a C

D4

coun

t gr

eate

r th

an 2

50 c

ells

microl

on

Nev

irap

ine

(NV

P)-b

ased

AR

T m

ay d

evel

op N

VP

hype

rsen

sitiv

e re

actio

ns t

hat

can

be li

fe t

hrea

teni

ng I

n th

ese

guid

elin

es it

is r

ecom

men

ded

that

for

preg

nant

wom

en w

ith C

D4

mor

e th

an 2

50 N

VP-

base

d re

gim

en m

ay s

till

be u

sed

but

with

clo

se m

onito

ring

O

ther

wis

e th

e re

com

shym

ende

d re

gim

en to

use

with

CD

4 co

unt a

bove

250

is a

PI-

base

d H

AA

RT

regi

men

Whe

n si

ngle

dos

e N

VP

(sdN

VP)

is u

sed

in P

MTC

T s

ome

wom

en a

nd c

hild

ren

may

deshy

velo

p re

sist

ance

to

NV

P th

at m

ay l

imit

futu

re u

se o

f N

on-N

ucle

osid

e R

ever

se T

ranshy

scri

ptas

e In

hibi

tors

(NN

RTI

s) t

o tr

eat

them

Th

e ri

sk o

f NN

RTI

res

ista

nce

is p

artic

ushyla

rly

high

if

two

dose

s of

sdN

VP

are

give

n T

here

fore

SdN

VP

shou

ld n

ever

be

used

mor

e th

an o

nce

in a

ny o

ne p

regn

ancy

Whe

re p

ossi

ble

AZT

3TC

sho

uld

be g

iven

for

7 da

ys t

o co

ver

the

NV

P ta

il bo

th in

the

mot

her

and

the

baby

Th

e ba

by is

the

n co

ntin

shyue

d on

AZT

for

a to

tal o

f 6 w

eeks

for

prop

hyla

xis

agai

nst M

TCT

HIV

-infe

cted

pre

gnan

t w

omen

sta

rtin

g zi

dovu

dine

(A

ZT)

cont

aini

ng r

egim

ens

shou

ld

have

hae

mog

lobi

n (H

b) le

vels

abo

ve 8

gm

dl

The

Hb

leve

l sho

uld

be c

heck

ed m

onth

ly

for

the

first

thr

ee m

onth

s W

here

pos

sibl

e A

ZT s

houl

d be

use

d in

stea

d of

sta

vudi

ne(d

4T)

Clin

ical

judg

emen

t can

be

used

to e

stim

ate

Hb

leve

ls a

nd in

itiat

e AR

V pr

ophy

laxi

s if l

aboshy

rato

ry te

sts a

re u

nava

ilabl

e

Efa

vire

nz (

EFV

) m

ay b

e te

rato

geni

c if

used

in t

he f

irst

tri

mes

ter

If t

he p

atie

nt is

on

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Cha

pter

7

HIV

Dia

gnos

is in

Chi

ldre

n 7

1 IN

TRO

DU

CTI

ON

In g

ener

al

a ch

ild m

ay b

e te

sted

und

er a

num

ber

of c

ircu

mst

ance

s T

hese

inc

lude

sh

ortly

aft

er b

irth

for

earl

y di

agno

sis

of H

IV f

or th

e pu

rpos

es o

f ind

ivid

ual d

iagn

osis

in

a ch

ild w

ho is

ill (

eg

tho

se p

rese

ntin

g w

ith a

n H

IV r

elat

ed il

lnes

s) i

n ca

ses

whe

re a

child

has

eith

er b

een

expo

sed

or is

pot

entia

lly e

xpos

ed t

o H

IV e

g t

hrou

gh m

othe

r-to

shych

ild t

rans

mis

sion

se

xual

abu

se

sexu

al a

ctiv

ity

with

in a

hea

lthca

re s

ettin

g (e

g

thro

ugh

cont

amin

ated

nee

dles

or

rece

ipt

of p

oten

tially

infe

ctio

us b

lood

) th

roug

h ot

her

mea

ns a

nd in

orp

hans

Ear

ly i

nfan

t di

agno

sis

(EID

) re

fers

to

the

mak

ing

of H

IV d

iagn

osis

in

infa

nts

and

youn

g ch

ildre

n be

fore

18

mon

ths

of a

ge E

ID g

ives

an

oppo

rtun

ity fo

r ea

rly

iden

tific

ashytio

n of

HIV

infe

cted

infa

nts

(des

pite

PM

TCT)

and

ear

ly li

nkag

e to

car

e an

d tr

eatm

ent

Dis

ease

pro

gres

sion

in H

IV in

fect

ed in

fant

s is

fast

with

a h

igh

mor

talit

y ra

te (gt

50

)by

2 y

ears

of a

ge T

he m

edia

n ag

e of

dea

th in

the

first

two

year

s is

6 m

onth

s H

IV a

ntishy

body

tes

ting

amon

g ch

ildre

n ag

ed 1

8 m

onth

s or

mor

e is

abl

e to

det

erm

ine

whe

ther

a

child

is in

fect

ed o

r no

t

Dur

ing

preg

nanc

y m

othe

rs g

ive

thei

r ba

bies

ant

ibod

ies

to in

fect

ions

the

y ha

ve e

xper

ishyen

ced

and

thes

e an

tibod

ies

wan

e w

ith ti

me

Ant

ibod

y te

stin

g in

chi

ldre

n ag

ed le

ss th

an

18 m

onth

s id

entif

ies

child

ren

who

hav

e be

en e

xpos

ed to

thei

r m

othe

rsrsquo H

IV in

fect

ion

or

who

may

be

trul

y in

fect

ed a

nd a

re m

akin

g H

IV a

ntib

odie

s C

urre

ntly

the

re is

no

test

to

diff

eren

tiate

the

mot

herrsquos

ant

ibod

ies

from

tho

se p

rodu

ced

by t

he b

aby

In

orde

r to

id

entif

y th

e H

IV-in

fect

ed c

hild

age

d le

ss t

han

18 m

onth

s a

sec

ond

test

is r

equi

red

for

all b

abie

s te

stin

g po

sitiv

e on

ant

ibod

y te

stin

g or

kno

wn

to b

e H

IV-e

xpos

ed (m

othe

r is

H

IV-p

ositi

ve)

Infa

nt D

NA

(or

RN

A) P

CR

tes

ting

is t

he c

urre

nt r

ecom

men

ded

met

hod

for

EID

Sinc

e m

ost b

abie

s lo

se m

ater

nal a

ntib

odie

s (A

b) b

y 12

mon

ths

a n

egat

ive

antib

ody

test

will

ide

ntify

uni

nfec

ted

babi

es a

s lo

ng a

s th

ey a

re n

ot s

till

brea

stfe

edin

g A

pos

itive

antib

ody

test

at

12 m

onth

s a

lthou

gh h

ighl

y lik

ely

to b

e di

agno

stic

may

stil

l be

due

topa

ssiv

ely

carr

ied

mat

erna

l ant

ibod

ies

Suc

h te

sts

need

to

be c

onfir

med

by

PCR

tes

ting

or r

epea

t ant

ibod

y te

st a

t 18

mon

ths

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

9

58

CARE

SU

PPO

RTAN

DTR

EATM

ENT

FOR

HIV

PO

SITI

VEM

OTH

ERAN

DCH

ILD

HIV

-pos

itive

mot

hers

requ

ire c

are

and

supp

ort w

hich

incl

udes

bull

Cou

nsel

ing

bull P

roph

ylax

is a

nd tr

eatm

ent

bull L

ink

to s

uppo

rt g

roup

s an

d as

sess

men

t of

the

nee

d fo

r A

RT

bull E

arly

infa

nt d

iagn

osis

sho

uld

be p

rovi

ded

at s

ix w

eeks

usi

ng D

NA

shyP

CR

tes

ting

Cha

pter

ref

eren

ces

1

Rep

ublic

of

Ken

ya M

inis

try

of

Hea

lth

Div

isio

n o

f Rep

roduct

ive

Hea

lth

Pla

nnin

g

Guid

elin

es f

or

serv

ice

pro

vider

s

Rev

ised

in M

arch

2006

Foo

tnot

es

1

Pre

ble

and P

iwoz

2001

2

WH

O

Contr

ace

ptive

Elig

ibili

ty C

rite

ria

Guid

e

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

EFV

bef

ore

beco

min

g pr

egna

nt i

t sho

uld

be s

ubsi

tute

d w

ith N

VP

in th

e 1s

t tri

mes

ter

In c

ase

of s

ever

e hy

pere

mes

is g

ravi

daru

m A

RT

may

nee

d to

be

brie

fly in

terr

upte

d

On

aver

age

mot

her-

to-c

hild

tra

nsm

issi

on r

ates

are

15

for

sdN

VP

65

fo

r m

ore

effishy

caci

ous

dual

reg

imen

s an

d 2

4 fo

r 3-

drug

AR

V c

ombi

natio

n

Futu

re P

ersp

ectiv

es

Ext

ende

d pr

ophy

laxi

s w

ith 3

AR

V d

rug

com

bina

tions

sta

rtin

g du

ring

pre

gnan

cy a

nd

cont

inui

ng a

fter

del

iver

y fo

r a

peri

od o

f up

to

6 m

onth

s a

mon

g H

IV-in

fect

ed b

reas

t-fe

edin

g m

othe

rs h

as b

een

show

n in

a f

ew r

ecen

t an

d is

olat

ed s

tudi

es a

nd p

ilot

proshy

gram

me

to le

ad to

low

er b

reas

tfee

ding

-rel

ated

pos

tnat

al M

TCT

Thi

s ap

proa

ch m

ay b

e co

nsid

ered

whe

re th

is is

feas

ible

acc

epta

ble

saf

e an

d w

here

adh

eren

ce c

an b

e as

sure

d

Mor

e st

udie

s on

this

issu

e ar

e ex

pect

ed

Thre

e A

RV

dru

g co

mbi

natio

ns g

iven

to

HIV

pos

itive

pre

gnan

t w

omen

who

are

not

yet

el

igib

le fo

r in

itiat

ion

of A

RTs

for

thei

r ow

n he

alth

als

o le

ad to

low

er M

TCT

and

may

be

cons

ider

ed in

pro

gram

mes

with

the

capa

city

to in

itiat

e th

e re

gim

en a

nd fo

llow

up

such

wom

en S

uch

inte

rven

tion

is in

itiat

ed a

t ar

ound

28

wee

ks o

r so

on a

fter

and

sto

pped

af

ter

birt

h if

CD

4 co

unt i

s st

ill a

bove

350

cel

lsm

m3

App

endi

ces

Appen

dix

I

Appen

dix

II

Appen

dix

III

Appen

dix

IV

WH

O C

linic

al S

tagin

g o

f H

IVA

IDS f

or

Adults

and A

dole

scen

ts

w

ith c

onfirm

ed H

IV infe

ctio

n

Contr

acep

tive

Options

for

Peo

ple

Liv

ing w

ith H

IV

Sum

mar

y of

ARV D

rug U

se f

or

PMTCT o

f H

IV

In

tegra

ted M

onitori

ng a

nd E

valu

ation R

eport

Form

MO

H 7

26

Cha

pter

ref

eren

ces

1

Sum

mar

y of

ARV D

rugs

Adve

rse

Effec

ts a

nd M

anag

emen

t T

able

6-1

0

pages

101-1

12 o

f G

uid

elin

es f

or

Antire

trovi

ral D

rug T

her

apy

in K

enya

3rd

Editio

n

De-

cem

ber

2005

2

Dru

g I

nte

ract

ions

Tab

le 7

-10

pag

es 1

12-1

22 o

f G

uid

elin

es f

or

Antire

trovi

ral

Dru

g T

her

apy

in K

enya

3rd

editio

n

Dec

2005

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

7

50

Cha

pter

5

Imm

edia

te P

ostn

atal

and

Neo

nata

l Car

e 5

1 IN

TRO

DU

CTI

ON

Imm

edia

te p

ostn

atal

and

neo

nata

l car

e re

fers

to th

e pa

ckag

e of

ser

vice

s pr

ovid

ed to

the

mot

her

and

infa

nt b

efor

e th

ey le

ave

the

heal

th fa

cilit

y (u

p to

48

hour

s) a

fter

del

iver

yTh

e pe

riod

pro

vide

s an

opp

ortu

nity

to e

duca

te a

ll m

othe

rs a

bout

HIV

to

prov

ide

coun

shyse

lling

and

tes

ting

if it

was

not

don

e pr

evio

usly

and

to

rein

forc

e th

e ed

ucat

ion

proshy

vide

d du

ring

the

ant

enat

al p

erio

d B

oth

HIV

inf

ecte

d an

d H

IV u

ninf

ecte

d m

othe

rs

shou

ld r

ecei

ve th

is e

duca

tion

and

coun

selli

ng b

efor

e di

scha

rge

52

OPE

RA

TIO

NA

L G

UID

ELIN

ES

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed fo

r all

wom

en a

nd

infa

nts

in th

e im

med

iate

pos

t par

tum

per

iod

a)

Opt

imal

pos

tpar

tum

car

e

bull R

outin

e ca

re in

clud

ing

brea

st e

xam

inat

ion

exa

min

atio

n of

the

ute

rus

ex

amin

atio

n of

the

per

ineu

m a

nd lo

chia

pa

ssag

e of

uri

ne r

egul

arly

pr

oper

hyg

iene

to

prev

ent

infe

ctio

n c

heck

ing

for

sign

s of

ana

emia

fe

ver

and

tach

ycar

dia

bull D

iscu

ss m

ater

nal n

utri

tion

bull E

stab

lish

the

HIV

sta

tus

of t

he m

othe

rs in

clud

ing

thos

e gi

ving

birt

h ou

tsid

e th

e he

alth

inst

itutio

n se

tting

bull P

rovi

de H

IV C

T f

or m

othe

rs w

ith u

nkno

wn

HIV

sta

tus

bull E

ncou

rage

HIV

res

ults

dis

clos

ure

and

part

ner

test

ing

bull F

ollo

w t

he s

tand

ard

guid

elin

es o

n th

e ca

re o

f a n

ewbo

rn (

IMP

AC

C

are

Man

ual)

bull A

ll ba

bies

sho

uld

rece

ive

thei

r ro

utin

e im

mun

izat

ion

(OP

V a

nd B

CG

) in

th

eir

first

hou

rs o

f lif

e1

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Con

trac

eptio

n A

ll m

othe

rs r

egar

dles

s of

the

ir H

IV s

tatu

s h

ave

a ri

ght

to r

ecei

ve a

dequ

ate

info

rmashy

tion

on a

vaila

ble

met

hods

of f

amily

pla

nnin

g an

d to

mak

e an

info

rmed

cho

ice

on w

hat

is b

est

for

them

H

IV-in

fect

ed w

omen

who

are

not

bre

astf

eedi

ng s

houl

d in

itiat

e a

relia

ble

cont

race

ptiv

e m

etho

d by

2-4

wee

ks p

ostp

artu

m

This

is

in a

dditi

on t

o th

epr

oper

and

con

sist

ent

use

of t

he c

ondo

m a

s a

form

of

dual

pro

tect

ion

All

met

hods

of

cont

race

ptio

n ca

n be

use

d by

HIV

pos

itive

wom

en b

ased

on

stan

dard

med

ical

elig

ibili

tycr

iteri

a in

clud

ing

taki

ng c

are

of d

rug

inte

ract

ions

as

outli

ned

belo

w2

bull L

acta

tiona

l Am

enor

rhoe

a M

etho

d (L

AM

) S

uita

ble

for

excl

usiv

ely

brea

stfe

edin

g H

IV in

fect

ed w

omen

who

hav

e no

t re

sum

ed m

ense

s

bull H

orm

onal

con

trac

eptio

n A

ll ho

rmon

al c

ontr

acep

tives

can

be

used

in

HIV

pos

itive

wom

en in

clud

ing

thos

e on

HA

AR

T

Com

bine

d or

al

cont

race

ptiv

es a

re c

ontr

aind

icat

ed f

or u

se w

ith d

rugs

that

indu

ce

hepa

tic m

icro

-enz

yme

that

may

red

uce

the

effe

ctiv

enes

s of

hor

mon

al

cont

race

ptiv

es

Som

e an

ti-T

Bs

ant

iret

rovi

rals

an

tifun

gals

and

ant

i-ep

ilept

ics

and

in c

ondi

tions

tha

t ca

use

mal

abso

rptio

n8

bull I

ntra

-ute

rine

con

trac

eptiv

e de

vice

s (I

UC

Ds)

IU

CD

s ar

e no

t co

ntra

indi

cate

d in

HIV

pos

itive

wom

en

In s

ever

ely

imm

uno

supp

rese

d w

omen

use

sho

uld

not

be d

isco

ntin

ued

but

new

inse

rtio

n is

dis

cour

aged

as

it m

ay b

e as

soci

ated

with

incr

ease

d ri

sk o

f in

fect

ion

duri

ng t

he in

sert

ion

proc

ess

bull S

urgi

cal m

etho

ds S

urgi

cal c

ontr

acep

tion

shou

ld b

e of

fere

d to

HIV

po

sitiv

e w

omen

and

the

ir pa

rtne

rs

bull B

arri

er m

etho

ds

Fem

ale

and

mal

e co

ndom

s pr

ovid

e pr

otec

tion

agai

nst

ST

Ds

and

redu

ce t

he r

isk

of H

IV t

rans

mis

sion

and

sho

uld

be

enco

urag

ed a

lone

or

toge

ther

with

oth

er c

ontr

acep

tive

met

hods

bull S

perm

icid

es

Use

d in

con

junc

tion

with

bar

rier

met

hods

spe

rmic

ides

w

ill p

rovi

de a

dditi

onal

con

trac

eptiv

e pr

otec

tion

How

ever

sp

erm

icid

es s

houl

d no

t be

use

d al

one

as t

hey

can

incr

ease

the

ris

k of

HIV

acq

uisi

tion

bull E

mer

genc

y co

ntra

cept

ion

HIV

pos

itive

wom

en s

houl

d be

info

rmed

ab

out

emer

genc

y co

ntra

cept

ion

whe

re it

is a

vaila

ble

and

how

to

obta

in a

nd u

se it

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

1

56

Bre

ast c

are

in b

reas

tfeed

ing

mot

hers

bull E

ncou

rage

dai

ly c

lean

ing

of t

he b

reas

ts a

nd a

void

ing

the

appl

icat

ion

of lo

tions

bull T

reat

mat

erna

l vag

inal

can

didi

asis

and

infa

nt o

ral c

andi

dias

is

bull E

duca

te m

othe

r on

opt

imal

bre

astf

eedi

ng te

chni

que

incl

udin

g la

tchi

ng

on t

echn

ique

ex

lusi

ve b

reas

tfee

ding

and

rem

ovin

g ba

by f

rom

bre

ast

bull E

duca

te th

e m

othe

r on

bre

ast c

are

to p

reve

nt c

ompl

icat

ions

(cr

acki

ng

and

engo

rgem

ent)

bull E

xpre

ss a

nd h

eat

trea

t th

e m

ilk if

bre

ast

has

mas

titis

or

absc

ess

Opt

imal

pos

tpar

tum

car

e fo

r HIV

pos

itive

wom

en

Loch

ia

bull P

ut e

mph

asis

on

good

per

inea

l hyg

iene

and

pro

per

hand

ling

of b

ody

fluid

s

bull A

void

con

tam

inat

ing

the

baby

with

bod

y flu

ids

or w

ith b

eddi

ng s

oile

d w

ith lo

chia

bull S

hari

ng o

f be

ds b

y m

othe

rs in

the

hos

pita

l sho

uld

be d

isco

urag

ed

Cae

sare

an S

ectio

n

Bro

ad s

pect

rum

ant

ibio

tics

shou

ld b

e us

ed r

outin

ely

afte

r C

S

Esse

ntia

l mat

erna

l edu

catio

n an

d fo

llow

-up

bull M

onito

r fo

r br

east

and

pel

vic

infe

ctio

n at

all

post

nat

al c

linic

vis

its

bull E

duca

te o

n pr

ompt

hea

lth s

eeki

ng b

ehav

iour

bull H

ealth

edu

catio

n on

hyg

iene

lo

chia

and

bre

ast

care

bull A

void

sex

ual i

nter

cour

se f

or a

t lea

st 2

wee

ks a

fter

birt

h or

unt

il th

ere

is

no lo

nger

any

loch

ia r

ubra

or

sero

sa

bull D

o pa

p sm

ear

or V

IA a

t 4-

6 w

eeks

bull F

or e

very

sex

ual a

ctiv

ity

the

coup

le s

houl

d us

e co

ndom

s

bull D

iscu

ss f

amily

pla

nnin

g at

eve

ry o

ppor

tuni

ty a

nd p

rovi

de t

he

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Supp

ort

infa

nt fe

edin

g op

tions

For

all

HIV

neg

ativ

e w

omen

wom

en o

f unk

now

n H

IV

stat

us a

nd H

IV p

ositi

ve m

othe

rs o

ptin

g fo

r ex

clus

ive

brea

stfe

edin

g in

itiat

e br

east

feed

shyin

g w

ithin

hal

f hou

r of

bir

th a

nd fo

llow

oth

er g

uide

lines

as

per

Bab

y Fr

iend

ly H

ospi

tal

Initi

ativ

e2 (B

FHI)

bull G

ive

info

rmat

ion

on fa

mily

pla

nnin

g an

d du

al p

rote

ctio

n

bull C

ouns

el o

n H

IV r

isk

redu

ctio

n

bull S

ched

ule

post

nata

l clin

ic v

isits

at

2 w

eeks

and

at

4-6

wee

ks a

nd

com

plet

e m

othe

r-ch

ild b

ookl

et (

refe

r to

DR

H m

anua

l)

(b) S

peci

fic p

ostp

artu

m c

are

for H

IV p

ositi

ve w

omen

bull S

uppo

rt e

xclu

sive

bre

astf

eedi

ng u

nles

s m

othe

r ha

s ap

prop

riat

ely

opte

d fo

r an

d be

en c

ouns

elle

d on

rep

lace

men

t fe

edin

g an

tena

tally

bull I

nitia

te o

r co

ntin

ue c

o-tr

imox

azol

e pr

ophy

laxi

s -1

dou

ble

stre

ngth

tab

shyle

t da

ily

bull F

or H

IV p

ositi

ve m

othe

rs t

hat

rece

ived

sd

nevi

rapi

ne in

trap

artu

m

initi

shyat

e A

ZT

300m

g an

d 3T

C 1

50 m

g B

D f

or 1

wee

k

bull F

or n

ewly

dia

gnos

ed m

othe

rs

do H

IV s

tagi

ng

CD

4 co

unt

and

refe

r ap

prop

riat

ely

for

cont

inue

d ca

re

(c)

Spec

ific

care

for H

IV e

xpos

ed in

fant

s

bull F

or H

IV e

xpos

ed in

fant

s a

dmin

iste

r sd

NV

P 2

mg

kg s

tat

with

in 7

2 ho

urs

Giv

e A

ZT

4 m

gkg

BID

for

6 w

eeks

and

3T

C 4

mg

kg B

ID f

or 1

w

eek

Ref

er t

o C

hapt

er 4

bull R

efer

to C

hapt

er 8

for

deta

ils o

n in

fant

fee

ding

opt

ions

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

5

52

Cha

pter

ref

eren

ces

1

Rep

ublic

of

Ken

ya M

inis

try

of

Hea

lth

Div

isio

n o

f Rep

roduct

ive

Hea

lth

Nat

ional

Guid

elin

es f

or

Qual

ity

Obst

etri

cs a

nd P

erin

ata

l Car

e (2

004)

2

2R

epublic

of

Ken

ya M

inis

try

of

Hea

lth

Ess

ential

Obst

etri

c C

are

Man

ual

for

Hea

lth

Ser

vice

Pro

vider

s in

Ken

ya 3

rd E

ditio

n (

Jan 2

006)

Foo

tnot

es

1

WH

O r

ecom

men

ds

that

all

vacc

ines

should

be

giv

en t

o H

IV-s

ero-n

egat

ive

child

ren

and t

o a

sym

pto

mat

ic s

ero-p

osi

tive

s

The

only

vac

cines

to b

e w

ithhel

d f

rom

child

ren w

ith s

ympto

mat

ic A

IDS a

re B

CG

and

Yel

low

fev

er v

acc

ines

2

The

ldquoTen

Ste

psrdquo

of

BFH

I R

ecom

men

ded

Pra

ctic

es f

or

Mat

ernity

Ser

vice

s ad

apte

d f

or

W

HO

UN

ICEF

1989

Cha

pter

6

Late

Pos

tnat

al C

are

and

Fam

ily P

lann

ing

61

INTR

OD

UC

TIO

N

Late

pos

tnat

al c

are

is p

rovi

ded

to t

he m

othe

r an

d th

e ch

ild 4

8 ho

urs

to 6

wee

ks a

fter

deliv

ery

Dur

ing

this

per

iod

the

heal

th o

f the

mot

her

and

child

is a

sses

sed

and

clos

ely

mon

itore

d

The

risk

of M

TCT

duri

ng th

e po

stpa

rtum

per

iod

can

be r

educ

ed b

y pr

ovid

ing

HIV

cou

nshyse

lling

and

test

ing

pos

t-ex

posu

re p

roph

ylax

is fo

r ex

pose

d ba

bies

cou

nsel

ling

on a

ppro

shypr

iate

infa

nt fe

edin

g op

tions

and

bre

ast c

are

Pos

tpar

tum

car

e fo

r H

IV p

ositi

ve w

omen

shou

ld in

clud

e cl

inic

al s

tagi

ng C

D4

coun

t and

AR

T fo

r th

ose

who

qua

lify

Fam

ily p

lann

ing

serv

ices

are

am

ong

the

core

inte

rven

tions

of P

MTC

T pr

ovid

ed to

hel

pw

omen

det

erm

ine

futu

re c

hild

bear

ing

patt

erns

inc

ludi

ng t

he p

reve

ntio

n of

HIV

-in

fect

ed b

irth

s

Rep

rodu

ctiv

e he

alth

cou

nsel

ling

can

help

a w

oman

pra

ctis

e sa

fer

sex

and

dete

rmin

e he

r fu

ture

ch

ildbe

arin

g pa

tter

ns

on

a m

ore

resp

onsi

ble

and

info

rmed

bas

is1

62

OPE

RA

TIO

NA

L G

UID

ELIN

ES

Opt

imal

pos

tpar

tum

car

e fo

r all

wom

en

This

ent

ails

rou

tine

care

inc

ludi

ng b

reas

t ex

amin

atio

n e

xam

inat

ion

of t

he u

teru

s

exam

inat

ion

of t

he p

erin

eum

and

loch

ia p

assa

ge o

f uri

ne r

egul

arly

pro

per

hygi

ene

topr

even

t in

fect

ion

che

ckin

g fo

r si

gns

of a

nem

ia

feve

r an

d ta

chyc

ardi

a an

d do

ing

peri

neal

exe

rcis

es

Add

ition

al c

are

incl

udes

bull C

ouns

ellin

g an

d te

stin

g fo

r m

othe

rs o

f un

know

n H

IV s

tatu

s bull

Pro

visi

on o

f co

ndom

s an

d ris

k re

duct

ion

coun

selli

ng

bull C

ouns

ellin

g on

con

trac

eptiv

e op

tions

in

clud

ing

dual

met

hod

use

bull D

iscu

ssin

g m

ater

nal n

utrit

ion

bull M

alar

ia p

reve

ntio

n bull

Scr

eeni

ng f

or S

TI a

nd c

ervi

cal c

ance

r

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

3

54

ltlt ASCII85EncodePages false AllowTransparency false AutoPositionEPSFiles true AutoRotatePages None Binding Left CalGrayProfile (Dot Gain 20) CalRGBProfile (sRGB IEC61966-21) CalCMYKProfile (US Web Coated 050SWOP051 v2) sRGBProfile (sRGB IEC61966-21) CannotEmbedFontPolicy Warning CompatibilityLevel 14 CompressObjects Tags CompressPages true ConvertImagesToIndexed true PassThroughJPEGImages true CreateJobTicket false DefaultRenderingIntent Default DetectBlends true DetectCurves 00000 ColorConversionStrategy CMYK DoThumbnails false EmbedAllFonts false EmbedOpenType false ParseICCProfilesInComments true EmbedJobOptions true DSCReportingLevel 0 EmitDSCWarnings false EndPage -1 ImageMemory 1048576 LockDistillerParams false MaxSubsetPct 100 Optimize true OPM 1 ParseDSCComments true ParseDSCCommentsForDocInfo true PreserveCopyPage true PreserveDICMYKValues true PreserveEPSInfo true PreserveFlatness true PreserveHalftoneInfo false PreserveOPIComments true PreserveOverprintSettings true StartPage 1 SubsetFonts true TransferFunctionInfo Apply UCRandBGInfo Preserve UsePrologue false ColorSettingsFile () AlwaysEmbed [ true Arial-Black Arial-BoldItalicMT Arial-BoldMT Arial-ItalicMT ArialMT ArialNarrow ArialNarrow-Bold ArialNarrow-BoldItalic ArialNarrow-Italic ArialRoundedMTBold ArialUnicodeMS CenturySchoolbook CenturySchoolbook-Bold CenturySchoolbook-BoldItalic CenturySchoolbook-Italic Symbol Times-Bold Times-BoldItalic Times-Italic TimesNewRomanPS-BoldItalicMT TimesNewRomanPS-BoldMT TimesNewRomanPS-ItalicMT TimesNewRomanPSMT Times-Roman Verdana Verdana-Bold Verdana-BoldItalic Verdana-Italic Wingdings2 Wingdings3 Wingdings-Regular ] NeverEmbed [ true ] AntiAliasColorImages false CropColorImages true ColorImageMinResolution 300 ColorImageMinResolutionPolicy OK DownsampleColorImages true ColorImageDownsampleType Bicubic ColorImageResolution 300 ColorImageDepth -1 ColorImageMinDownsampleDepth 1 ColorImageDownsampleThreshold 150000 EncodeColorImages true ColorImageFilter DCTEncode AutoFilterColorImages true ColorImageAutoFilterStrategy JPEG ColorACSImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt ColorImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt JPEG2000ColorACSImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt JPEG2000ColorImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt AntiAliasGrayImages false CropGrayImages true GrayImageMinResolution 300 GrayImageMinResolutionPolicy OK DownsampleGrayImages true GrayImageDownsampleType Bicubic GrayImageResolution 300 GrayImageDepth -1 GrayImageMinDownsampleDepth 2 GrayImageDownsampleThreshold 150000 EncodeGrayImages true GrayImageFilter DCTEncode AutoFilterGrayImages true GrayImageAutoFilterStrategy JPEG GrayACSImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt GrayImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt JPEG2000GrayACSImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt JPEG2000GrayImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt AntiAliasMonoImages false CropMonoImages true MonoImageMinResolution 1200 MonoImageMinResolutionPolicy OK DownsampleMonoImages true MonoImageDownsampleType Bicubic MonoImageResolution 1200 MonoImageDepth -1 MonoImageDownsampleThreshold 150000 EncodeMonoImages true MonoImageFilter CCITTFaxEncode MonoImageDict ltlt K -1 gtgt AllowPSXObjects false CheckCompliance [ None ] PDFX1aCheck false PDFX3Check false PDFXCompliantPDFOnly false PDFXNoTrimBoxError true PDFXTrimBoxToMediaBoxOffset [ 000000 000000 000000 000000 ] PDFXSetBleedBoxToMediaBox true PDFXBleedBoxToTrimBoxOffset [ 000000 000000 000000 000000 ] PDFXOutputIntentProfile () PDFXOutputConditionIdentifier () PDFXOutputCondition () PDFXRegistryName () PDFXTrapped False CreateJDFFile false Description ltlt ARA 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 BGR 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 CHS ltFEFF4f7f75288fd94e9b8bbe5b9a521b5efa7684002000410064006f006200650020005000440046002065876863900275284e8e9ad88d2891cf76845370524d53705237300260a853ef4ee54f7f75280020004100630072006f0062006100740020548c002000410064006f00620065002000520065006100640065007200200035002e003000204ee553ca66f49ad87248672c676562535f00521b5efa768400200050004400460020658768633002gt CHT ltFEFF4f7f752890194e9b8a2d7f6e5efa7acb7684002000410064006f006200650020005000440046002065874ef69069752865bc9ad854c18cea76845370524d5370523786557406300260a853ef4ee54f7f75280020004100630072006f0062006100740020548c002000410064006f00620065002000520065006100640065007200200035002e003000204ee553ca66f49ad87248672c4f86958b555f5df25efa7acb76840020005000440046002065874ef63002gt CZE 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 DAN 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 DEU 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 ESP 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 ETI 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 FRA 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 GRE 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 HEB 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 HRV (Za stvaranje Adobe PDF dokumenata najpogodnijih za visokokvalitetni ispis prije tiskanja koristite ove postavke Stvoreni PDF dokumenti mogu se otvoriti Acrobat i Adobe Reader 50 i kasnijim verzijama) HUN ltFEFF004b0069007600e1006c00f30020006d0069006e0151007300e9006701710020006e0079006f006d00640061006900200065006c0151006b00e90073007a00ed007401510020006e0079006f006d00740061007400e100730068006f007a0020006c006500670069006e006b00e1006200620020006d0065006700660065006c0065006c0151002000410064006f00620065002000500044004600200064006f006b0075006d0065006e00740075006d006f006b0061007400200065007a0065006b006b0065006c0020006100200062006500e1006c006c00ed007400e10073006f006b006b0061006c0020006b00e90073007a00ed0074006800650074002e0020002000410020006c00e90074007200650068006f007a006f00740074002000500044004600200064006f006b0075006d0065006e00740075006d006f006b00200061007a0020004100630072006f006200610074002000e9007300200061007a002000410064006f00620065002000520065006100640065007200200035002e0030002c0020007600610067007900200061007a002000610074007400f3006c0020006b00e9007301510062006200690020007600650072007a006900f3006b006b0061006c0020006e00790069007400680061007400f3006b0020006d00650067002egt ITA 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 JPN ltFEFF9ad854c18cea306a30d730ea30d730ec30b951fa529b7528002000410064006f0062006500200050004400460020658766f8306e4f5c6210306b4f7f75283057307e305930023053306e8a2d5b9a30674f5c62103055308c305f0020005000440046002030d530a130a430eb306f3001004100630072006f0062006100740020304a30883073002000410064006f00620065002000520065006100640065007200200035002e003000204ee5964d3067958b304f30533068304c3067304d307e305930023053306e8a2d5b9a306b306f30d530a930f330c8306e57cb30818fbc307f304c5fc59808306730593002gt KOR ltFEFFc7740020c124c815c7440020c0acc6a9d558c5ec0020ace0d488c9c80020c2dcd5d80020c778c1c4c5d00020ac00c7a50020c801d569d55c002000410064006f0062006500200050004400460020bb38c11cb97c0020c791c131d569b2c8b2e4002e0020c774b807ac8c0020c791c131b41c00200050004400460020bb38c11cb2940020004100630072006f0062006100740020bc0f002000410064006f00620065002000520065006100640065007200200035002e00300020c774c0c1c5d0c11c0020c5f40020c2180020c788c2b5b2c8b2e4002egt LTH 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 LVI 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 NLD (Gebruik deze instellingen om Adobe PDF-documenten te maken die zijn geoptimaliseerd voor prepress-afdrukken van hoge kwaliteit De gemaakte PDF-documenten kunnen worden geopend met Acrobat en Adobe Reader 50 en hoger) NOR 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 POL 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 PTB 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 RUM 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 RUS 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 SKY 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 SLV 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 SUO 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 SVE ltFEFF0041006e007600e4006e00640020006400650020006800e4007200200069006e0073007400e4006c006c006e0069006e006700610072006e00610020006f006d002000640075002000760069006c006c00200073006b006100700061002000410064006f006200650020005000440046002d0064006f006b0075006d0065006e007400200073006f006d002000e400720020006c00e4006d0070006c0069006700610020006600f60072002000700072006500700072006500730073002d007500740073006b00720069006600740020006d006500640020006800f600670020006b00760061006c0069007400650074002e002000200053006b006100700061006400650020005000440046002d0064006f006b0075006d0065006e00740020006b0061006e002000f600700070006e00610073002000690020004100630072006f0062006100740020006f00630068002000410064006f00620065002000520065006100640065007200200035002e00300020006f00630068002000730065006e006100720065002egt TUR 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 UKR ltFEFF04120438043a043e0440043804410442043e043204430439044204350020044604560020043f043004400430043c043504420440043800200434043b044f0020044104420432043e04400435043d043d044f00200434043e043a0443043c0435043d044204560432002000410064006f006200650020005000440046002c0020044f043a04560020043d04300439043a04400430044904350020043f045604340445043e0434044f0442044c00200434043b044f0020043204380441043e043a043e044f043a04560441043d043e0433043e0020043f0435044004350434043404400443043a043e0432043e0433043e0020043404400443043a0443002e00200020042104420432043e04400435043d045600200434043e043a0443043c0435043d0442043800200050004400460020043c043e0436043d04300020043204560434043a0440043804420438002004430020004100630072006f006200610074002004420430002000410064006f00620065002000520065006100640065007200200035002e0030002004300431043e0020043f04560437043d04560448043e04570020043204350440044104560457002egt ENU (Use these settings to create Adobe PDF documents best suited for high-quality prepress printing Created PDF documents can be opened with Acrobat and Adobe Reader 50 and later) gtgt Namespace [ (Adobe) (Common) (10) ] OtherNamespaces [ ltlt AsReaderSpreads false CropImagesToFrames true ErrorControl WarnAndContinue FlattenerIgnoreSpreadOverrides false IncludeGuidesGrids false IncludeNonPrinting false IncludeSlug false Namespace [ (Adobe) (InDesign) (40) ] OmitPlacedBitmaps false OmitPlacedEPS false OmitPlacedPDF false SimulateOverprint Legacy gtgt ltlt AddBleedMarks false AddColorBars false AddCropMarks false AddPageInfo false AddRegMarks false ConvertColors ConvertToCMYK DestinationProfileName () DestinationProfileSelector DocumentCMYK Downsample16BitImages true FlattenerPreset ltlt PresetSelector MediumResolution gtgt FormElements false GenerateStructure false IncludeBookmarks false IncludeHyperlinks false IncludeInteractive false IncludeLayers false IncludeProfiles false MultimediaHandling UseObjectSettings Namespace [ (Adobe) (CreativeSuite) (20) ] PDFXOutputIntentProfileSelector DocumentCMYK PreserveEditing true UntaggedCMYKHandling LeaveUntagged UntaggedRGBHandling UseDocumentProfile UseDocumentBleed false gtgt ]gtgt setdistillerparamsltlt HWResolution [2400 2400] PageSize [612000 792000]gtgt setpagedevice

Enq

uiri

es r

egar

ding

thes

e PM

TCT

Gui

delin

es s

houl

d be

add

ress

ed to

Dire

ctor

N

atio

nal A

IDS

and

STI C

ontr

ol P

rogr

amm

e (N

ASC

OP)

M

inis

try

of H

ealth

P

O B

ox 1

9361

- 00

200

N

airo

bi K

enya

Te

leph

one

+25

4 20

272

9502

272

9549

Fa

x +

254

20 2

71 0

518

or 2

72 9

502

Em

ail

head

nasc

op

icon

nect

co

ke

Web

site

ww

wa

idsk

enya

org

Third

edi

tion

Cop

yrig

ht copy

200

9 M

inis

try o

f Hea

lth G

over

nmen

t of K

enya

105

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

2

A

ppen

dix

VII

I Li

st o

f Con

trib

utor

s

Dr

Ayi

si R

ober

t K

Dep

uty

Hea

d N

ASC

OP

PMTC

T Pr

grm

Mng

r

MO

H-N

ASC

OP

Dr

Abd

alla

h S

aade

H

IV T

rain

er J

HPI

EG

O

Ms

Ake

lola

Rut

h

Nut

ritio

n amp

HIV

Man

ager

MO

H-N

ASC

OP

Mr

Dey

a J

osph

at

PMTC

T Pr

ogra

m O

ffice

r M

OH

-NA

SCO

P

Dr

Die

lem

ans

Pau

l

Mat

erna

l Neo

nata

l Hea

lth (M

NH

) Adv

isor

EH

SD

RH

Ms

Gitu

to A

nnie

W

Prog

ram

Offi

cer

MO

H-D

RH

Dr

Inw

ani

Iren

e

Paed

iatr

icia

n IC

AR

T K

NH

Mr

Isav

wa

Ant

hony

D

ata

Prog

ram

Man

ager

CD

C K

enya

Dr

Kar

anja

Dom

inic

PM

TCT

Prog

ram

Man

ager

PA

THFI

ND

ER

Inte

rnat

iona

l

Dr

Kia

rie

Jam

es N

PM

TCT

Prog

ram

Man

ager

KN

HU

ON

Dr

Kig

en B

atile

l Pr

ogra

m M

anag

er M

OH

-DR

H

Ms

Koe

ch R

osel

ine

Pr

ogra

m O

ffice

r M

OH

-DR

H

Dr

Mac

hari

a S

heila

R

H S

ervi

ces

Spec

ialis

t U

SAID

K

Dr

Mat

u L

ucy

PM

TCT

Prog

ram

Man

ager

USA

IDK

Ms

Mau

a J

udith

Pr

ogra

m O

ffice

r D

RH

-MO

H

Prof

Mbo

ri-N

gach

a D

Se

nior

Tec

hnic

al A

dvis

or A

ssoc

iate

Pro

fess

or

of P

aedi

atri

cs C

DC

Ken

ya U

oN

Dr

Mud

any

Mild

red

Te

chni

cal A

dvis

or C

DC

Ken

ya

Ms

Muh

enje

Ody

lia

Beh

avio

ral S

cien

tist

CD

C K

enya

Ms

Mut

sots

o W

infr

ed

PMTC

T Te

chni

cal A

dvis

orP

rogr

am M

anag

er C

DC

Ken

ya

Ms

Mut

uku

Ter

esia

H

IV T

rain

er J

HPI

EG

O

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

3

104

App

endi

x V

II

103

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Ms

Mw

anga

ngi

Alic

e Pr

ogra

m O

ffice

r D

RH

-MO

H

Ms

Mw

angi

Nan

cy

PMTC

T A

dmin

istr

ativ

e A

ssis

tant

CD

C K

enya

Mr

Ndw

iga

Fra

ncis

Pr

ogra

m O

ffice

r M

OH

-NA

SCO

P

Prof

Ndu

ati

Rut

h

Ass

ocia

te P

rofe

ssor

of P

aedi

atri

cs U

oN

Dr

Nju

guna

Cha

rles

Pr

ogra

m A

ssoc

iate

MSH

RPM

Plu

s

Mr

Nya

beri

Dav

id

Prog

ram

Offi

cer

MO

H-D

RH

Mr

Ode

ra J

W

Prog

ram

Coo

rdin

ator

GTZ

Ms

Olu

och

Pat

rici

a Te

chni

cal A

dvis

or C

DC

Ken

ya

Mr

Olu

och

Tom

Te

chni

cal A

dvis

or C

DC

Ken

ya

Dr

Onrsquo

gech

Joh

n

Prog

ram

Coo

rdin

ator

KN

H

Dr

Otie

no-N

yuny

a B

Se

nior

Lec

ture

rH

ead

of D

epar

tmen

t PM

TCT

Dir

ecto

rM

oi U

nive

rsity

AM

PATH

Dr

Oum

a C

hris

PM

TCT

Prog

ram

Offi

cer

UN

ICE

F

Dr

Saw

e F

redr

ick

K

Dep

uty

Dir

ecto

r W

RP

Mr

Soo

Leo

nard

Pr

ogra

m M

anag

er W

RP

Dr

Vak

il S

obha

N

Tech

nica

l Adv

isor

AR

T Pr

ogra

m N

ASC

OP

Ms

Way

ua R

uth

Prog

ram

Offi

cer

MO

H-D

RH

Dr

Yon

ga I

sabe

lla

PMTC

T Te

chni

cal A

dvis

or E

GPA

F

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

Tabl

e of

Con

tent

s Li

st o

f con

trib

utor

s 3

Tabl

e of

con

tent

s 5

Ack

now

ledg

emen

ts

10

Fore

wor

d 11

Abb

revi

atio

ns a

nd A

cron

yms

12

Exe

cutiv

e Su

mm

ary

16

Cha

pter

1

Bac

kgro

und

20

11T

he G

loba

l Pan

dem

ic

20

12

Mag

nitu

de o

f HIV

in P

regn

ancy

in

22

13

Ris

ks o

f Tra

nsm

issi

on o

f MTC

T at

Diff

eren

t Tim

e Pe

riod

s 23

14

Ris

k Fa

ctor

s of

MTC

T of

HIV

24

15

Ben

efits

of P

MTC

T of

HIV

25

16

Ben

efits

of H

IV C

ouns

ellin

g amp

Tes

ting

25

17

The

Four

-pro

nged

App

roac

h to

PM

TCT

26

18

Ove

rvie

w o

f the

New

PM

TCT

Gui

delin

es

28

19

Obj

ectiv

es amp

Org

anis

atio

n of

the

Gui

delin

es

28

110

U

sing

the

Gui

delin

es

29

Cha

pter

2 A

nten

atal

Car

e an

d Pr

even

tion

of M

TCT

of H

IV

32

21

Intr

oduc

tion

32

5

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4 B

acte

riolo

gica

l con

firm

atio

n

App

ropr

iate

clin

ical

sam

ples

incl

ude

sput

um

gast

ric

aspi

rate

s an

d ce

rtai

n ot

her

mat

eria

ls

Sin

ce m

ost

TB

in c

hild

ren

is in

infa

nts

and

youn

g ch

ildre

n s

putu

m

indu

ctio

n m

ay b

e do

ne fi

rst

or g

astr

ic a

spira

tions

and

exp

ecto

ratio

ns

a S

putu

m In

duct

ion

Spu

tum

indu

ctio

n is

saf

e an

d ef

fect

ive

in c

hild

ren

of a

ll ag

es a

nd t

he b

acte

rial

yi

elds

a]r

e as

goo

d or

bet

ter

that

for

gas

tric

asp

irate

s

b G

astr

ic a

spira

tion

Thi

s is

per

form

ed in

you

ng c

hild

ren

who

are

una

ble

or u

nwill

ing

to

expe

ctor

ate

sput

um

A g

astr

ic a

spir

ate

shou

ld b

e ob

tain

ed o

n ea

ch o

f th

e th

ree

cons

ecut

ive

mor

ning

s

c E

xpec

tora

tions

S

putu

m s

houl

d al

way

s be

obt

aine

d in

adu

lts a

nd o

lder

chi

ldre

n gt1

0 ye

ars

of

age

susp

ecte

d of

hav

ing

pulm

onar

y T

B

Bac

teri

al y

ield

s ar

e hi

gher

in o

lder

chi

ldre

n

Thr

ee s

putu

m s

peci

men

s sh

ould

be

obta

ined

an

on-

the

ndashspo

t sp

ecim

en (

at t

he

first

eva

luat

ion)

an

ear

ly m

orni

ng s

peci

men

and

a s

econ

d on

-the

-spo

t sp

ecim

en

Spu

tum

indu

ctio

n is

saf

e an

d ef

fect

ive

in c

hild

ren

of a

ll ag

es a

nd t

he b

acte

rial

yi

elds

are

as

good

or

bett

er t

han

for

gast

ric a

spira

tes

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

102

NO

TES

1 H

isto

ry

bull A

sk f

or s

ympt

oms

cons

iste

nt w

ith T

B in

clud

ing

chro

nic

coug

hgt 2

wee

ks

feve

r- b

ody

tem

pera

ture

of

38 o C

for

14 d

ays

afte

r co

mm

on c

ause

s su

ch a

s m

alar

ia a

nd p

neum

onia

hav

e be

en e

xclu

ded

wei

ght

loss

or

failu

re t

o th

rive

(

also

look

at

the

grow

th c

hart

) a

nd o

r ni

ght

swea

ts

Enq

uire

whe

ther

the

pat

ient

has

bee

n in

clo

se c

onta

ct w

ith s

mea

r-po

sitiv

e pu

lshym

onar

y T

B (

usua

lly a

par

ent

or o

ther

mem

ber

of th

e fa

mily

)

2 C

linic

al e

xam

inat

ion

a P

hysi

cal s

igns

hig

hly

sugg

estiv

e of

ext

ra p

ulm

onar

y T

B

bull O

ften

the

mai

n cl

inic

al f

indi

ng is

just

fai

lure

to

thriv

e

bull G

ibus

es

peci

ally

of

rece

nt o

nset

(re

sulti

ng f

rom

ver

tebr

al T

B)

bull N

on-p

ainf

ul e

nlar

ged

cerv

ical

lym

phad

enop

athy

with

fis

tula

for

mat

ion

b P

hysi

cal s

igns

req

uiri

ng in

vest

igat

ions

to

excl

ude

extr

a pu

lmon

ary

TB

bull M

enin

gitis

not

res

pond

ing

to a

ntib

iotic

s tr

eatm

ent

bull P

leur

al e

ffus

ion

bull P

eric

ardi

al e

ffus

ion

bull D

iste

nded

abd

omen

with

asc

itis

bull N

on-p

ainf

ul e

nlar

ged

lym

ph n

odes

with

out

fistu

la f

orm

atio

n

bull N

on-p

ainf

ul e

nlar

ged

join

t

Sig

ns o

f tu

berc

ulin

hyp

erse

nsiti

vity

3 M

anto

ux te

st

A m

anto

ux t

est

shou

ld b

e re

gard

ed p

ositi

ve a

s fo

llow

s

bull I

n hi

gh-r

isk

child

ren

(inc

lude

s H

IV-i

nfec

ted

child

ren

and

seve

rely

mal

shyno

uris

hed

child

ren

) gt

5mm

dia

met

er o

f in

dura

tion

bull I

n al

l oth

er c

hild

ren(

whe

ther

the

y ha

ve r

ecei

ved

BC

G o

r no

t)

gt10m

m d

ishyam

eter

of i

ndur

atio

n

101

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

22

Ope

ratio

nal G

uide

lines

32

23

Job

Aid

s 34

24

App

endi

ces

13

Cha

pter

3 I

ntra

part

um C

are

38

31

Intr

oduc

tion

38

32

Ope

ratio

nal G

uide

lines

38

Cha

pter

4

Use

of A

RVs

in P

regn

ancy

for T

reat

men

t amp P

MTC

T of

HIV

infe

ctio

n 42

41

Intr

oduc

tion

42

42

Ope

ratio

nal G

uide

lines

43

Cha

pter

5 I

mm

edia

te P

ostn

atal

and

Neo

nata

l Car

e

51

51

Intr

oduc

tion

51

52

Ope

ratio

nal G

uide

lines

51

Cha

pter

6 L

ate

Post

nata

l Car

e an

d Fa

mily

Pla

nnin

g

54

61

Intr

oduc

tion

54

62

Ope

ratio

nal G

uide

lines

54

Cha

pter

7 H

IV D

iagn

osis

in C

hild

ren

58

71

Intr

oduc

tion

58

72

Ope

ratio

nal G

uide

lines

59

72

0 G

uide

lines

for

HIV

Dia

gnos

is in

Chi

ldre

n

59

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

72

1 H

IV N

egat

ive

Infa

nt a

t 6 w

eeks

or

Firs

t Con

tact

59

72

2 H

IV P

ositi

ve In

fant

by

DN

A P

CR

60

72

3 C

ompr

ehen

sive

Car

e fo

r H

IV-e

xpos

ed In

fant

61

D

IAG

NO

STIC

ALG

OR

ITH

MFO

R P

ULM

ON

AR

Y T

B IN

CH

ILD

REN

Cha

pter

8

Feed

ing

Infa

nts

and

Youn

g C

hild

ren

Bor

n to

HIV

infe

cted

mot

hers

62

81

Intr

oduc

tion

62

82

Ope

ratio

nal G

uide

lines

on

Infa

nt F

eedi

ng (0

-6 m

onth

s)

63

83

Ope

ratio

nal G

uide

lines

on

Feed

ing

Chi

ldre

n 6

mon

ths

and

olde

r 64

84

Nut

ritio

nal C

are

and

Supp

ort o

f HIV

infe

cted

Chi

ldre

n 64

85

Ext

ract

s fr

om R

esea

rch

on In

fant

Fee

ding

and

HIV

AID

S 65

Cha

pter

9

Car

e an

d Fo

llow

up

of C

hild

ren

of H

IV-in

fect

ed m

othe

rs 7

3

91

Intr

oduc

tion

73

92

Ope

ratio

nal G

uide

lines

74

Cha

pter

10

Mon

itorin

g an

d Ev

alua

tion

of P

MTC

T se

rvic

es

83

101

In

trod

uctio

n 83

102

O

pera

tiona

l Gui

delin

es

85

Bib

liogr

aphy

91

Job

Aid

sR

efer

ence

s

91

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

App

endi

x V

I

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

100

App

endi

x V

C

OM

MO

N A

DV

ERSE

EFF

ECTS

OF

AR

V U

SE D

UR

ING

PR

EGN

AN

CY

Cla

ss

Adv

erse

effe

cts

Nuc

leos

ide

Nuc

leot

ide

Rev

erse

Tra

nscr

ipta

se In

hibi

tors

( NR

TIs)

Zido

vudi

ne(A

ZT)

Nau

seau

La

miv

idin

e (3

TC)

Dia

rhoe

a

Stav

udin

e (d

4T)

Hyp

erse

nsiti

vity

(AB

C)

Aba

cavi

r(A

BC

) A

naem

ia(A

ZT)

Teno

fovi

r(TF

VTD

F)

Emitr

icita

bine

(FTC

)

Non

- Nuc

leos

ide

Rev

erse

Tra

nscr

ipta

se In

hibi

tors

(NN

RTI

s)

Nev

irapi

ne(N

VP)

Del

avird

in

Efav

irenz

(EFV

)

Pro

teas

e In

hibi

tors

(PIs

)

Saqu

inav

ir(SQ

V)

Indi

navi

r(ID

V)

Rito

navi

r(R

TV)

Nel

finav

ir(N

LF)

Lopi

navi

rrito

navi

r(LP

Vr)

A

taza

navi

r(A

TV)

Fose

mpr

enav

ir Ti

pana

vir(

TPV)

D

arun

avir(

DR

V)

Ras

h

Elev

ated

live

r enz

ymes

(c

omm

on w

ith N

VP in

hig

h C

D4

co

unt)

EFV

CN

S ef

fect

s(se

datio

n in

-so

mni

a v

ivid

dre

ams

diz

zine

ss

conf

usio

n fe

elin

g of

lsquod

isen

gage

men

trsquo

Tera

toge

nici

ty

GI i

ntol

eran

ce

Hep

atot

oxic

ity

Lipo

dyst

roph

y

Dys

lipid

emia

s

Insu

lin re

sist

ance

Hyp

ergl

ycae

mia

La

ctic

aci

dosi

s an

d he

patic

ste

a-to

sis

Cou

nsel

ing

and

Follo

w-u

p Ti

ps

May

not

be

wel

l-tol

erat

ed in

ear

l pr

egna

ncy

whe

n

mor

ning

sic

knes

s is

com

mon

M

ay in

crea

se ri

sk o

f non

-ad

here

nce

May

hav

e in

adeq

uate

blo

od le

vels

A

ll A

RVs

sho

uld

be d

isco

ntin

ued

and

rest

arte

d w

hen

Namp

V is

gon

e or

effe

ctiv

ely

trea

ted

Fo

llow

-up

labs

CB

C L

FTs

If ra

sh in

1st

2 w

ks d

o no

t inc

reas

e N

VP d

ose

and

cont

act c

linic

ian

Mild

rash

may

be

man

aged

with

an

tihis

tam

ines

A

void

cor

ticos

tero

ids

durin

g N

VP

dose

esc

alat

ion

EFV

shou

ld b

e ta

ken

initi

ally

at

bed

time

Avo

id E

FV in

wom

en o

f hig

h ch

ild-b

earin

g po

tent

ial

Do

not o

pera

te h

eavy

mac

hine

ry

Mon

itor g

luco

se le

vels

A

sk re

gula

rly fo

r sym

ptom

s of

hy

perg

lyca

emia

M

onito

r hep

atic

tran

sam

inas

es

(ALT

and

AST

) par

ticul

arly

dur

ing

the

first

18

wee

ks o

f the

rapy

w

hen

this

toxi

city

is m

ost l

ikel

y Ta

ke w

ith fo

od

Ant

iem

etic

s A

ntim

otili

ty

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

App

endi

ces

92

App

endi

x I

WH

O C

linic

al S

tagi

ng o

f HIV

AID

S fo

r A

dults

and

A

dole

scen

ts w

ith C

onfir

med

HIV

infe

ctio

n 92

App

endi

x II

C

ontr

acep

tive

Opt

ions

for

Peop

le L

ivin

g w

ith H

IV

95

App

endi

x II

I U

se o

f AR

Vs

for

Trea

tmen

t and

PM

TCT

of H

IV in

AN

C

97

App

endi

x IV

Use

Of A

RV

s fo

r PM

TCT

of H

IV in

Lab

our

And

Del

iver

y U

nit

98

App

endi

x V

Com

mon

Adv

erse

Effe

cts

of A

RV

Use

Dur

ing

Preg

nanc

y 99

App

endi

x V

I D

iagn

ostic

alg

orith

m fo

r pu

lmon

ary

TB in

Chi

ldre

n 10

0

App

endi

x V

II I

nteg

rate

d M

onito

ring

and

Eval

uatio

n Re

port

For

m M

OH

726

10

3

App

endi

x V

III

Rep

rodu

ctiv

e H

ealth

HIV

AID

S R

epor

t For

m M

OH

711

10

4

Lis

t of T

able

s

Tabl

e 1

1 A

dult

HIV

-pre

vale

nce

Est

imat

e by

Pro

vinc

e in

200

6 21

Tabl

e 1

2 E

stim

ated

Mag

nitu

de o

f MTC

T in

Ken

ya 2

007

22

Tabl

e 1

3 Tr

ansm

ission

Pat

tern

s in

Brea

stfee

ding

and

Non

bre

astfe

edin

g Pop

ulat

ions

23

Tabl

e 1

4 R

isk

Fact

ors

for

MTC

T of

HIV

24

Tabl

e 1

5 Th

e Fo

ur-p

rong

ed A

ppro

ach

App

lied

to th

e PM

TCT

Gui

delin

es

30

Tabl

e 2

1 E

ssen

tial P

acka

ge o

f Int

egra

ted

Ant

enat

al C

are

Serv

ices

33

Tabl

e 4

1 R

ecom

men

datio

ns fo

r In

itiat

ing

AR

V T

reat

men

t in

Preg

nant

Wom

en B

ased

on

Clin

ical

Sta

ge a

nd A

vaila

bilit

y of

CD

4 co

unt

44

Tabl

e 4

2 R

ecom

men

ded

Firs

t Lin

e A

RT

Reg

imen

for

Trea

ting

Preg

nant

Wom

en a

nd P

roph

ylac

tic R

egim

en fo

r In

fant

s 45

Tabl

e 4

3a R

ecom

men

ded

Firs

t Lin

e A

RV

Pro

phyl

axis

to P

reve

nt H

IV

46

Infe

ctio

n in

Infa

nts

Am

ong

preg

nant

Wom

en P

rese

ntin

gB

efor

e 38

Wee

ks

Tabl

e 4

3b A

ltern

ativ

e A

RV

Pro

phyl

axis

to P

reve

nt H

IV In

fect

ion

in In

fant

s 4

6 A

mon

g Pr

egna

nt W

omen

Pre

sent

ing

Bef

ore

38 W

eeks

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

9

9

47

IV

Wom

en w

ho h

ave

not r

ecei

ved

Intr

apar

tum

AR

T or

A

RV

Pro

phyl

axis

with

H

IV

Infe

ctio

n

Tabl

e 4

4 A

RV

Pro

phyl

axis

for

PMTC

T am

ong

Preg

nant

Wom

en w

ho h

ave

not r

ecei

ved

Ant

enat

al A

RT

or P

roph

ylax

is

App

endi

x Ta

ble

45

Cho

ice

of H

AA

RT

for

Preg

nant

Wom

en b

ased

on

CD

4 co

unt

47

Tabl

e 4

6 A

RV

Pro

phyl

actic

Reg

imen

s fo

r In

fant

s B

orn

to H

IV-p

ositi

ve

49

Tabl

e 9

1 D

ose

of C

o-tr

imox

azol

e fo

r PC

P pr

ophy

laxi

s 76

Tabl

e 9

2 W

HO

Rec

omm

enda

tions

for

Follo

w-u

p of

an

HIV

-exp

osed

Chi

ld

79

Tabl

e 10

1 C

ontr

acep

tive

Met

hods

for

Use

in C

oupl

es a

nd W

omen

Liv

ing

96

Figu

re 2

1 R

apid

HIV

Ser

ial T

estin

g A

lgor

ithm

35

Figu

re 8

1 G

uide

lines

for

Cou

nsel

ling

on H

IV a

nd In

fant

feed

ing

66

Job

Aid

s an

d IE

C M

ater

ials

on

Infa

nt a

nd Y

oung

Chi

ld F

eedi

ng

67

List

of F

igur

es

Figu

re 1

01

Mon

itori

ng a

nd E

valu

atio

n D

ata

Flow

in K

enya

84

September 0 8

USE OF ARVs FOR PMTCT OF HIV IN LABOUR AND DELIVERY UNITSALL MOTHERS

1 History 2 Examination3 Establish motherrsquos HIV status4 Offer HIV counseling and testing for mother with unknown HIV status5 Provide standard obstetrical management and care

HIV NEGATIVECounsel on risk reduction

HIV POSITIVE

Establish Motherrsquos use of ARVs in pregnancy and give appropriate ARVs as shown in boxesbelow

Regardless of Duration received HAART

Action

i Give mother ARV dose as per regimen

ii Post partu m Infant Give Infant sd Nevi rapine 2mgkg with in 72 hours of birthPL US 3T C 4mgkg BD for 1 w eek an d AZT syrup 4 m gkg BD for 6 w eeks

iii Post partum mother Continue w ith AR Vs as per regimen

MOTHE R RECEIVED HAART IN PREGNANCY

F OR MORE INFORMAT ION CONT ACT THE NATIONAL AIDSSTD CONTROL PROGRAMME (NASCOP)PO BO X 19361-00202 NAIROBI TEL 0202729502 FAX 020 2710518

MINISTRY OF HEALTH

bull G ive mo ther sd Nevirap ine 200m g AZT 600mg and 3TC 150 mg stat

bull Post partum Infant Give Infant sd Nevirapine 2mgkg within 72 ho urs of birth PL US

3TC syrup 4mg kg BD for 1 week and AZT syrup 4 mg kg BD fo r 6 w eeks

bull Post partum mother Give moth er AZT 300mg amp 3TC 150 mg BID for 7 d ays

MO THER RECEIVED AZT IN PREGNANCY OR NO ARVs TAKE N IN PREGNANCY

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

98

MINISTRY OF HEALTH

USE OF ARVs FOR TREATMENT AND PMTCT OF HIV IN ANC

App

endi

x II

I

Ack

now

ledg

emen

ts

ALL M O THERS1 History 2 Health Information3 Examination4 In vestigations (with informed consent for HIV test)

HIV NEGATIVE1 P rov id e pos t-te s t HIV pr ev e nti v e

i nter ve ntion s defi ned i n na tion alHT C gui de li nes

2 Re fe r for othe r p os t-te st HIVp re ve ntive inte rv e nti ons no tavai lable in the cli nic b ut avail ab le w ithi n the fa c ili ty

HIV PO SI TI VE1 C ounsel on risk reduction2 Per form WH O clinical staging for H IV disease3 D etermine CD 4 level (if testing facilities available)4 D etermine Gestation age and HB level5 Give ARVrsquos as shown below6 Provide or refer for other post-test HIV interventions defined in national HTC

guidelines

1 WHO clin ica l stage I o r II w ith CD4 cell co unt gt 350mm3 OR 2 WHO clin ica l stage I o r II no CD4 cell co unt do ne3 HB =8 gdl OR n o clinical feat ures of anaemia

bull Initiate AZT 30 0mg BD daily at 28 weeks gestation or any time periodimmediately there after

bull Monitor for clinical featur es of anemia and treatbull Dispense ANC Nev ir apine 200mg PLUS AZT 600mg + 3TC 1 50mg for

moth er to tak e at onset of labourbull Dispense NVP syrup to give infant at birth

bull At on set o f l abo uro Administer Nevirapine 20 0mg AZT 600mg 3TC 150 mg

stat to moth erbull Post p artum

o Give Infa nt sd Nevirapine 2mgk g within 72 hours ofbirth PLUS 3TC 4mg BD for 1 w eek and AZT syrup 4 mgkg BD for 6 w eeks

o Give mother AZT30 0 mg 3 TC 150 BID for 7 day s

1 WHO clinical stag e I or II with CD4 c ell count gt 35 0 mm3 OR 2 WHO clinical stag e I or II w ith no C D4 c ell c ount done

bull Dispense ANC Nevirapine 2 00mg PLUS AZ T 600 mg + 3TC 150mgfo r mo ther to take at onse t of labour

bull Dispense NVP sy rup to give infant at birthbull At Onset of lab our

o Administe r sd Nevirapine AZT 6 00 mg and 3TC1 50mg stat

bull Po st Par tu mo G iv e Infant sd Nev ir apine 2mg kg w ithin 72

h ours of bir th PLUS 3T C 4mgkg BD fo r 1 week a nd AZT syrup 4mgkg BD for 6 we eks

o G iv e mother AZ T300 mg 3TC 1 50 mg BID for 7d ays

1 Any gest ational age2 WHO clin ica l stage III or IV of HIV dis ease regardles s of CD4 cell count OR3 WHO clin ica l stages I or II of HIV d is ease with CD4 cell count =350mm3 ()

bull Refer to Clinician for Evaluation and initiation of NNRTI based ART as pernation al ART guidelines

bull At O nset of Lab ou ro G ive mo ther ARV dos e as per r egimen

bull Post par tumo G ive Infan t sd Nev ira pine 2mgkg within 72 hours of b irth PLUS

3TC 4mgkg and AZT syr up 4 mgkg BD for 6 weeks o G ive mo ther ARVs as per regimen

4 If no HAART av ailable man age the wo man as ind icated in box no2 a nd refer to ARTsite appro priately

F O R M OR E IN FOR M AT IO N CO N T AC T T H E N ATI ON A L A IDS STD C O NTR O L PR O G RAM ME ( N ASC O P)P O B OX 19361-00202 N AIR OBI TEL 0202729502 FAX 020 2710518

EL IGIBL E FO R T R EATMEN T

N O T E LIG IBLE FO R TR EA TM ET AN D PR ESE NTING B ELO W 3 8 W EE KSGESTA TIO N N OT ELIGIB LE FOR TREA TMEN T AN D PR ESE NTING gt 3 8 W EEK S

GE STATIO N

Plea se notebull Pregnan t w omen with WHO clinical stag e I or II plus CD4 cell co unt gt250 mm3 and = 350 mm3 can be initiated on ART wher e a PI based HAART re gimen is av ailable NVP hypersen sitivity h as been previously r eported amon g women in this gr oup initiated on N NRT I based

ART re gimens Where PI ba sed ART reg imen is not av ailab le r efer the patient to a site whe re th e regimen is availab le or c ontinue to ma nage th e w oman a s is indicated in box No 2bull The grading of ana emia in pregna ncy is gt 8-10 Milda nemia gt 6 -8 Moderate anem ia lt 6 Sever e anemiabull Treatment if common p ath ologies ruled out Mild anae mia haematinics irrespectiv e of gestatio n Moder ate a naemia tr ansfusion if close to term gt36 weeks otherwise give haema tinics Severe an aemia transfus ion irr espe ctive of ge statio n Do not stop AZT if Hb dr op s but

would manage it as above and only stop if continues to fall or fails to res pon d des pite transfusion

The

thir

d ed

ition

of

Gui

delin

es f

or P

reve

ntio

n of

Mot

her-

to-C

hild

Tra

nsm

issi

on o

f H

IV A

IDS

in K

enya

is a

res

ult o

f effo

rts

of m

any

indi

vidu

als

and

orga

niza

tions

in th

eco

untr

y T

he T

echn

ical

Wor

king

Gro

up o

n PM

TCT

led

thes

e ef

fort

s M

embe

rs o

f the

te

am r

evie

wed

all

the

mod

ules

rev

ised

and

in s

ome

case

s re

-wro

te th

e m

odul

es b

ased

on

the

seco

nd e

ditio

n to

mak

e th

em u

p to

dat

e an

d in

line

with

cur

rent

sci

entif

ic e

vishy

denc

e an

d ex

peri

ence

We

ackn

owle

dge

the

cont

ribu

tors

and

rev

iew

ers

of t

he c

urre

ntan

d pr

evio

us e

ditio

ns O

f sp

ecia

l m

entio

n ar

e th

e fo

llow

ing

Ken

ya O

bste

tric

al a

nd

Gyn

aeco

logi

cal S

ocie

ty (K

OG

S) t

he U

nive

rsity

of N

airo

bi a

nd M

oi U

nive

rsity

We

wou

ld l

ike

to t

hank

the

fol

low

ing

inst

itutio

ns f

or t

echn

ical

as

wel

l as

fin

anci

al

supp

ort

duri

ng t

he r

evis

ion

of t

he g

uide

lines

N

atio

nal A

IDS

and

STD

Con

trol

Pro

shygr

amm

e (N

ASC

OP)

the

Div

isio

n of

Rep

rodu

ctiv

e H

ealth

Cen

ters

for

Dis

ease

Con

trol

and

Prev

entio

n (C

DC

) It

is n

ot p

ossi

ble

to m

entio

n al

l ind

ivid

uals

and

org

aniz

atio

ns

that

par

ticip

ated

in th

is im

port

ant e

xerc

ise

To

all o

f you

Asa

nte

Sana

Min

istr

y of

Hea

lth

September 2008

97

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

10

Fore

wor

d

The

Min

istr

y of

Hea

lth (

MoH

) is

com

mitt

ed t

o de

velo

pmen

t of

effe

ctiv

e PM

TCT

proshy

gram

mes

Gui

delin

es a

re a

n im

port

ant

part

of t

he G

over

nmen

t st

rate

gy t

o re

duce

MTC

Tan

d is

in

line

with

the

Nat

iona

l H

ealth

Sec

tor

Stra

tegi

c Pl

an I

I (N

HSS

PII)

and

Ken

yaN

atio

nal A

IDS

Stra

tegi

c Pl

an (K

NA

SP) 2

000-

2010

whi

ch fo

cuse

s on

pri

ority

are

as o

f pre

shyve

ntio

n of

new

infe

ctio

ns i

mpr

ovin

g qu

ality

of l

ife o

f tho

se in

fect

ed a

nd a

ffect

ed a

nd m

itishy

gatio

n of

soc

ial a

nd e

cono

mic

impa

ct o

f the

infe

ctio

n

MTC

T is

the

pre

dom

inan

t m

ode

of t

rans

mis

sion

of

HIV

in

infa

nts

and

youn

g ch

ildre

n

This

tra

nsm

issi

on o

ccur

s du

ring

pre

gnan

cy

labo

ur a

nd d

eliv

ery

and

am

ong

brea

stfe

d ba

bies

in

the

post

-par

tum

per

iod

Mem

bers

of t

he T

echn

ical

Wor

king

Gro

up (T

WG

) on

PMTC

T re

view

ed t

he m

odul

es o

f the

se

cond

edi

tion

rev

ised

and

in s

ome

case

s re

-wro

te th

e m

odul

es b

ased

on

up to

dat

e kn

owlshy

edge

and

in

line

with

cur

rent

sci

entif

ic e

vide

nce

and

expe

rien

ce T

he T

WG

con

sist

s of

agr

oup

of p

rofe

ssio

nals

dra

wn

from

var

ious

dis

cipl

ines

tha

t ar

e im

plem

entin

g an

dor

man

shyag

ing

PMTC

T T

he g

roup

ado

pted

and

ada

pted

the

late

st r

ecom

men

datio

ns o

f the

WH

O o

nPM

TCT

as w

ell a

s va

riou

s na

tiona

l gui

delin

es o

n H

IV p

reve

ntio

n tr

eatm

ent a

nd c

are

A f

our-

pron

ged

appr

oach

thr

ough

the

var

ious

rep

rodu

ctiv

e lif

e cy

cles

as

prop

osed

by

the

Inte

r-A

genc

y Ta

sk T

eam

(IA

TT)

on c

hild

ren

and

HIV

and

AID

S w

as a

dopt

ed i

n th

ese

guid

elin

es w

ith e

mph

asis

bei

ng p

lace

on

all t

he fo

ur p

rong

s

For

any

of t

he P

MTC

T in

terv

entio

ns t

o be

suc

cess

fully

impl

emen

ted

coun

selin

g an

d te

stshy

ing

(CT)

mus

t fir

st b

e do

ne R

outin

e H

IV te

stin

g w

ith o

pt-o

ut o

ptio

n is

rec

omm

ende

d T

his

is fo

llow

ed b

y ap

prop

riat

e m

edic

al s

urgi

cal i

nter

vent

ions

incl

udin

g an

tiret

rovi

ral p

roph

yshyla

xis

saf

er o

bste

tric

pra

ctic

es a

s w

ell a

s in

fant

feed

ing

coun

selin

g an

d pr

ovis

ion

of a

ppro

shypr

iate

infa

nt fe

edin

g H

IV-p

ositi

ve w

omen

are

ass

esse

d cl

inic

ally

usi

ng W

HO

sta

ging

and

whe

re f

easi

ble

imm

unol

ogic

al a

sses

smen

t us

ing

CD

4 ce

ll co

unt

HIV

exp

osed

infa

nts

are

test

ed th

roug

h ea

rly

infa

nt d

iagn

osis

(EID

)

In th

ese

guid

elin

es m

ore

effic

acio

us r

egim

ens

are

intr

oduc

ed fo

r th

e fir

st ti

me

whi

le in

forshy

mat

ion

and

coun

selin

g on

inf

ant

feed

ing

follo

ws

the

AFA

SS (

Ava

ilabl

e f

easi

ble

acc

eptshy

able

saf

e an

d su

stai

nabl

e) c

rite

ria

The

mod

ule

on m

onito

ring

and

eva

luat

ion

addr

esse

s is

sues

of d

ata

colle

ctio

n c

olla

tion

and

repo

rtin

g as

wel

l as

use

of d

ata

for

deci

sion

-mak

ing

at th

e fa

cilit

y-le

vel

We

hope

that

app

ropr

iate

impl

emen

tatio

n in

stru

men

ts w

ill b

e us

ed to

ope

ratio

naliz

e th

ese

guid

elin

es

Tabl

e 11

1

Con

trac

eptiv

e M

etho

ds fo

r Use

in

Cou

ples

and

Wom

en L

ivin

g w

ith H

IV In

fect

ion

MET

HO

D

CO

MM

ENTS

Con

dom

s bull

M

ale

amp f

emal

e co

ndom

s av

aila

ble

bull

P

rovi

de d

ual p

rote

ctio

n ag

ains

t STI

sH

IV

amp p

regn

ancy

bull

R

equi

re a

ttent

ion

amp ca

re

for c

orre

ct u

se e

ach

time

bull

M

ay re

quire

co-

oper

atio

n of

par

tner

Hor

mon

al

bull V

ery

effe

ctiv

e an

d ea

sy to

use

M

etho

ds

bull S

uita

ble

for s

hort-

or lo

ng-

term

use

bull

Rev

ersi

ble

bull A

ssoc

iate

d w

ith n

on-

cont

race

ptiv

e he

alth

ben

efits

bull

Ser

ious

com

plic

atio

ns

extre

mel

y ra

re

Intra

uter

ine

bull

H

ighl

y ef

fect

ive

long

-term

C

ontra

cept

ive

reve

rsib

le m

etho

d

Dev

ice

bull

Rem

ains

in p

lace

up

to 1

2 ye

ars

bull

A

lmos

t 100

per

cent

ef

fect

ive

bull

H

as n

o ef

fect

on

ferti

lity

whe

n us

ed b

y nu

llipar

ous

wom

en

bull

Sho

uld

not b

e pr

ovid

ed to

w

omen

with

hig

h ris

k se

xual

life

styl

e bull

B

acte

rial S

TIs

shou

ld b

e sc

reen

ed fo

r and

or

treat

ed a

s a

prec

autio

n pr

ior t

o in

serti

on o

f IU

CD

Ste

riliz

atio

n bull

Goo

d v

ery

effe

ctiv

e fo

r co

uple

s or

indi

vidu

als

who

w

ant n

o m

ore

child

ren

bull S

afe

sim

ple

surg

ical

pr

oced

ure

Con

side

red

perm

anen

t

US

E IN

HIV

PO

SITI

VE

PA

TIE

NTS

bull

Can

and

sho

uld

be u

sed

at a

ll st

ages

of H

IV

infe

ctio

n bull

C

an a

nd s

houl

d be

use

d by

pat

ient

s on

AR

T

bull

Cor

rect

and

con

sist

ent u

se b

y H

IV in

fect

ed p

atie

nts

is

reco

mm

ende

d re

gard

less

of t

he u

se o

f oth

er m

etho

ds

of c

ontra

cept

ion

(dua

l con

trace

ptio

n)

bull C

an b

e us

ed w

ithou

t res

trict

ion

in H

IV+

wom

en n

ot o

n AR

T bull

Can

be

used

with

out r

estri

ctio

n in

all

HIV

+ w

omen

for

emer

genc

y co

ntra

cept

ion

bull S

ome

AR

V dr

ugs

may

redu

ce m

etho

d ef

fect

iven

ess

bull

DM

PA

Im

plan

ts c

an h

owev

er b

e us

ed w

ith A

RT

reshy

inje

ctio

n of

DM

PA

sho

uld

be d

one

at 1

0-12

wee

ks

bull If

horm

onal

met

hod

is c

hose

n c

ondo

ms

shou

ld s

till b

e us

ed c

orre

ctly

and

con

sist

ently

bull

Attr

activ

e m

etho

d fo

r wom

en w

ith H

IV w

ho d

esire

ver

y re

liabl

e pr

egna

ncy

prot

ectio

n bull

C

an b

e in

serte

d in

HIV

+ w

omen

who

do

not h

ave

WH

O

Sta

ge 4

dis

ease

AID

S d

efin

ing

illne

ss

bull

For w

omen

with

sta

ge 4

dis

ease

IUD

can

be

inse

rted

once

they

are

on

ART

and

have

con

trolle

d sy

mpt

oms

of s

ever

e ill

ness

bull N

o m

edic

al re

ason

s to

den

y st

eriliz

atio

n to

clie

nts

w

ith H

IV

bull P

roce

dure

may

be

dela

yed

in e

vent

of a

cute

HIV

-rel

ated

in

fect

ion

or s

tage

4 d

isea

se p

endi

ng im

mun

e re

cons

titut

ion

bull E

ncou

rage

con

dom

use

as

wel

l

DM

PA =

Dep

ot M

edro

xypr

oges

tero

ne A

ceta

te (D

epo-

Prov

era)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

1

96

App

endi

x II

CO

NTR

AC

EPTI

VE

OPT

ION

SFO

R P

EOPL

E L I

VIN

G W

ITH

HIV

It

has

bee

n sh

own

in a

num

ber

of s

tudi

es o

f coh

orts

of H

IV p

ositi

ve w

omen

tha

t so

me

choo

se t

o co

ntin

ue s

exua

l act

ivity

des

pite

kno

wle

dge

of t

heir

sta

tus

Evi

denc

e of

con

shyce

ptio

n ha

s de

mon

stra

ted

that

fert

ility

in H

IV p

ositi

ve w

omen

for

the

mos

t pa

rt is

unshy

affe

cted

H

owev

er c

erta

in c

ondi

tions

may

affe

ct fe

rtili

ty s

uch

as lo

w b

ody

mas

s in

dex

A

IDS

and

inte

rcur

rent

illn

ess

esp

ecia

lly t

uber

culo

sis

Put

ting

wom

en w

ho a

re H

IV

infe

cted

on

cont

race

ptiv

es is

one

of t

he m

eans

of p

reve

ntin

g m

othe

r to

chi

ld t

rans

mis

shysi

on o

f HIV

(PM

TCT)

It is

the

rig

ht o

f HIV

infe

cted

wom

en t

o m

ake

thei

r ow

n de

cisi

ons

rega

rdin

g re

prod

ucshy

tion

The

y m

ay w

ish

to h

ave

mor

e ba

bies

lim

it th

eir

fam

ilies

or

avoi

d pr

egna

ncy

alto

shyge

ther

The

hea

lth c

are

prov

ider

s th

ey c

onsu

lt sh

ould

ena

ble

them

to

mak

e in

form

edch

oice

s by

them

selv

es

The

follo

win

g co

ntra

cept

ive

met

hods

are

ava

ilabl

e in

Ken

ya -

pro

gest

eron

e on

ly p

ills

lo

w d

ose

com

bine

d or

al c

ontr

acep

tives

de

pot

med

roxy

prog

este

rone

ace

tate

(D

MPA

shyde

po)

levo

norg

estr

el a

nd e

tono

gest

rel i

mpl

ants

Em

erge

ncy

cont

race

ptiv

e pi

lls c

oppe

rin

trau

teri

ne c

ontr

acep

tive

devi

ces

bar

rier

met

hods

fem

ale

and

mal

e st

erili

satio

n ar

e al

so a

vaila

ble

Som

e dr

ugs

inte

ract

with

hor

mon

al c

ontr

acep

tives

A

nd c

oncu

rren

t us

e sh

ould

be

avoi

ded

The

se d

rugs

incl

ude

bull P

rote

ase

inhi

bito

rs ndash

Rito

navi

r N

elfin

avir

Lop

inav

ir w

ith R

itona

vir

bull N

on-n

ucle

otid

e re

vers

e tr

ansc

ript

ase

inhi

bito

rs (

NN

RT

Is)

ndash N

evir

apin

e

bull E

favi

renz

bull A

nti-T

B d

rugs

ndash R

ifam

pici

n an

d R

ifabu

tin

bull O

ther

dru

gs ndash

Gris

eofu

lvin

P

heno

barb

itone

C

arba

maz

epin

e P

heny

toin

All

the

abov

e do

not

app

ly i

n th

e fa

ce o

f ot

her

med

ical

con

ditio

ns t

hat

are

cont

ra-

indi

catio

ns f

or t

he v

ario

us m

etho

ds e

g k

now

n ca

rdio

vasc

ular

dis

ease

hep

atic

con

dishy

tions

sm

okin

g h

igh

bloo

d pr

essu

re a

nd th

rom

boem

bolic

dis

orde

rs

The

follo

win

g ta

ble

sum

mar

ises

maj

or is

sues

reg

ardi

ng u

se o

f diff

eren

t co

ntra

cept

ives

by H

IV-p

ositi

ve w

omen

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Abb

revi

atio

ns a

nd A

cron

yms

AFA

SS

Acc

epta

ble

Fea

sibl

e A

fford

able

Sus

tain

able

and

Saf

e

Ab

Ant

i-bod

y

AID

S A

cqui

red

Imm

une

Def

icie

ncy

Synd

rom

e

ALT

Ala

nine

Tra

nsfe

rase

AN

C

Ant

enat

al C

are

AR

M

Art

ifici

al R

uptu

re o

f Mem

bran

es

AR

T

Ant

iret

rovi

ral T

hera

py

A

RV

A

ntir

etro

vira

l

AZT

A

zido

thym

idin

e (Z

idov

udin

e or

ZD

V)

AZT

3TC

Com

bivi

r

3TC

Lam

ivud

ine

BC

C

Beh

avio

ur C

hang

e C

omm

unic

atio

n

BC

G

Bac

ille

Cal

met

te G

ueri

ne v

acci

ne

BFH

I B

aby

Frie

ndly

Hos

pita

l Ini

tiativ

e

BID

BD

ldquoT

wic

e a

dayrdquo

CD

C (K

) C

entr

es fo

r D

isea

se C

ontr

ol a

nd P

reve

ntio

n K

enya

CN

S C

entr

al N

ervo

us S

yste

m

CS

Cae

sare

an S

ectio

n

CT

Cou

nsel

ling

and

Test

ing

CTX

CTZ

Cot

rim

oxaz

ole

d4T

Stav

udin

e

D

ASC

O

Dis

tric

t AID

SST

I Coo

rdin

ator

G

uid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

5

12

DB

S D

ried

Blo

od S

pot s

peci

men

DN

A

Deo

xyri

bonu

clei

c A

cid

DR

H

Div

isio

n of

Rep

rodu

ctiv

e H

ealth

EC

V

Ext

erna

l Cep

halic

Ver

sion

EFV

Efa

vire

nz

EID

E

arly

Infa

nt D

iagn

osis

ELI

SA

Enz

yme

Link

ed Im

mun

osor

bent

Ass

ay

FBC

Fu

ll B

lood

Cou

nt

GTZ

G

erm

an T

echn

ical

Coo

pera

tion

HA

AR

T

Hig

hly

Act

ive

Ant

iret

rovi

ral T

hera

py

Hb

Hae

mog

lobi

n

HIV

H

uman

Imm

unod

efic

ienc

y Vi

rus

IATT

Inte

r-A

genc

y Ta

sk T

eam

IMC

I In

tegr

ated

Man

agem

ent o

f Chi

ldho

od Il

lnes

s

IPPT

Inte

rmitt

ent P

resu

mpt

ive

Trea

tmen

t for

Mal

aria

ITN

s In

sect

icid

es T

reat

ed N

ets

IUC

D

Intr

a U

teri

ne C

ontr

acep

tive

Dev

ice

KD

HS

Ken

ya D

emog

raph

ic a

nd H

ealth

Sur

vey

KE

PI

Ken

ya E

xpan

ded

Prog

ram

me

on Im

mun

izat

ion

KO

GS

Ken

ya O

bste

tric

al a

nd G

ynae

colo

gica

l Soc

iety

KN

H

Ken

yatt

a N

atio

nal H

ospi

tal

LAM

Lact

atio

nal A

men

orrh

oea

Met

hod

Mamp

E

Mon

itori

ng a

nd E

valu

atio

n

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

Cyt

omeg

alov

irus

infe

ctio

n (r

etin

itis

or in

fect

ion

of o

ther

org

ans)

9

Cen

tral

ner

vous

sys

tem

tox

opla

smos

is

10

HIV

enc

epha

lopa

thy

11

Ext

rapu

lmon

ary

cryp

toco

ccos

is in

clud

ing

men

ingi

tis

12

Dis

sem

inat

ed n

on-t

uber

culo

us m

ycob

acte

rial

infe

ctio

n

13

Pro

gres

sive

mul

tifoc

al le

ukoe

ncep

halo

path

y

14

Chr

onic

cry

ptos

pori

dios

is

15

Chr

onic

isos

poria

sis

16

Dis

sem

inat

ed m

ycos

is (

extr

apul

mon

ary

hist

opla

smos

is

or c

occi

diom

ycos

is)

17

Rec

urre

nt s

eptic

aem

ia (

incl

udin

g no

n-ty

phoi

dal S

alm

onel

la)

18

Lym

phom

a (c

ereb

ral o

r B

-cel

l non

-Hod

gkin

s)

19

Inv

asiv

e ce

rvic

al c

arci

nom

a

20

Aty

pica

l dis

sem

inat

ed le

ishm

ania

sis

21

Sym

ptom

atic

HIV

-ass

ocia

ted

neph

ropa

thy

or s

ympt

omat

ic H

IV-

asso

ciat

ed

22

Car

diom

yopa

thy

Ple

ase

note

S

igns

and s

ympto

ms

of

HIV

was

ting s

yndro

me

incl

ude

Unex

pla

ined

invo

lunta

ry w

eight

loss

(gt

10

base

line

body

wei

ght)

with o

bvi

ous

was

ting o

f body

mas

s in

dex

lt185

PLU

S

unex

pla

ined

chro

nic

dia

rrhoea

(lo

ose

or

wat

ery

stools

thre

e or

more

tim

es d

aily

) re

port

ed

for

longer

than

one

month

OR r

eport

s of

feve

r or

nig

ht

swea

ts f

or

more

than

one

month

w

ithout

oth

er c

ause

and lack

of

resp

onse

to a

ntibio

tics

or

antim

ala

rial ag

ents

M

ala

ria

must

be

excl

uded

in m

ala

ria

pro

ne

area

s

Fo

r th

e purp

ose

of

the

WH

O s

tagin

g s

yste

m

adole

sents

and a

dults

are

def

ined

as

adults

aged

ge15 y

ears

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

3

94

CLI

NIC

AL

STA

GE

3 1

Une

xpla

ined

sev

ere

wei

ght

loss

(gt1

0 o

f pr

esum

ed o

r m

easu

red

bo

dy w

eigh

t)

2

Une

xpla

ined

chr

onic

dia

rrho

ea fo

r lo

nger

tha

n on

e m

onth

3

Une

xpla

ined

per

sist

ent

feve

r (a

bove

37

5degC

inte

rmitt

ent

or c

onst

ant

for

long

er t

han

one

mon

th)

4

Per

sist

ent

oral

can

didi

asis

5

Ora

l hai

ry le

ukop

laki

a

6

Pul

mon

ary

tube

rcul

osis

7

Tub

ercu

lous

Lym

phad

enop

athy

8

Sev

ere

bact

eria

l inf

ectio

ns (

such

as

pneu

mon

ia

empy

ema

pyo

myo

sitis

bo

ne o

r jo

int

infe

ctio

n m

enin

gitis

or

bact

erae

mia

)

9

Acu

te n

ecro

tizin

g ul

cera

tive

stom

atiti

s g

ingi

vitis

or

perio

dont

itis

10

Une

xpla

ined

ana

emia

(lt8

gdl

) n

eutr

opae

nia

(lt0

5 times1

09 pe

rlitr

e) a

ndo

r ch

roni

c th

rom

bocy

topa

enia

(lt5

0times10

9 per

litr

e)

CLI

NIC

AL

STA

GE

4 1

HIV

was

ting

synd

rom

e

2

Pne

umoc

ystis

pne

umon

ia

3

Rec

urre

nt s

ever

e ba

cter

ial p

neum

onia

4

Chr

onic

her

pes

sim

plex

infe

ctio

n (o

rola

bial

ge

nita

l or

anor

ecta

l of

mor

e th

an o

ne

mon

thrsquos

dur

atio

n or

vis

cera

l at

any

site

)

5

Oes

opha

geal

can

didi

asis

(or

can

didi

asis

of

trac

hea

bro

nchi

or

lung

s)

6

Ext

rapu

lmon

ary

tube

rcul

osis

exc

ept

Tub

ercu

lous

Lym

ph a

deno

path

y

7

Kap

osirsquos

sar

com

a

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

MC

H

Mat

erna

l and

Chi

ld H

ealth

MoH

M

inis

try

of H

ealth

MSF

M

edic

ins

Sans

Fro

ntie

rs

M

TCT

Mot

her-

To-C

hild

Tra

nsm

issi

on

NA

SCO

P N

atio

nal A

IDS

and

STD

Con

trol

Pro

gram

me

NV

P

Nev

irap

ine

OD

ldquoO

nce

a D

ayrdquo

OI

Opp

ortu

nist

ic In

fect

ion

OPV

O

ral P

olio

Vac

cine

PASC

O

Prov

inci

al A

IDS

STI C

oord

inat

or

PCP

Pneu

moc

ystis

jiro

veci

i pne

umon

ia

PCR

Po

lym

eras

e C

hain

Rea

ctio

n

PI

Prot

ease

Inhi

bito

r

PLW

HA

Pe

rson

sPe

ople

Liv

ing

With

HIV

AID

S

PMTC

T

Prev

entio

n of

Mot

her

To C

hild

Tra

nsm

issi

on

RD

A

Rec

omm

ende

d D

aily

Allo

wan

ce

RH

Rep

rodu

ctiv

e H

ealth

RN

A

Rib

onuc

leic

Aci

d

SdN

VP

Si

ngle

dos

e N

evir

apin

e

SRH

Se

xual

and

Rep

rodu

ctiv

e H

ealth

STD

Se

xual

ly T

rans

mitt

ed D

isea

se

STI

Sexu

ally

Tra

nsm

itted

Infe

ctio

n

TB

Tube

rcul

osis

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

3

14

TBA

s Tr

aditi

onal

Bir

th A

tten

dant

s

TLC

To

tal L

ymph

ocyt

e C

ount

TT

Teta

nus

Toxo

id v

acci

ne

UN

ICE

F U

nite

d N

atio

ns C

hild

renrsquo

s Fu

nd

UN

GA

SS

Uni

ted

Nat

ions

Gen

eral

Ass

embl

y Sp

ecia

l Ses

sion

on

HIV

AID

S

UoN

Uni

vers

ity o

f Nai

robi

VC

T V

olun

tary

Cou

nsel

ling

and

Test

ing

VIA

V

isua

l Ins

pect

ion

usin

g A

ceto

ne

VD

RL

Ven

erea

l Dis

ease

Res

earc

h La

bora

tory

(tes

t for

syp

hilis

)

WH

O

Wor

ld H

ealth

Org

anis

atio

n

WR

P W

alte

r R

eed

Prog

ram

App

endi

x I

WH

O C

LIN

ICA

L S T

AG

ING

OF

HIV

AID

S FO

R A

DU

LTS

AN

D A

DO

LES-

CEN

TSW

ITH

CO

NFI

RM

ED H

IV IN

FEC

TIO

N

CLI

NIC

AL

STA

GE

1

bull

Asy

mpt

omat

ic

bull

Per

sist

ent

gene

raliz

ed ly

mph

aden

opat

hy

CLI

NIC

AL

STA

GE

2 1

Une

xpla

ined

mod

erat

e w

eigh

t lo

ss (

lt10

of

pres

umed

or

mea

sure

d bo

dy w

eigh

t)

2

Rec

urre

nt u

pper

res

pira

tory

tra

ct in

fect

ions

(si

nusi

tis

tons

illiti

s

otiti

s m

edia

and

pha

ryng

itis)

3

Her

pes

Zos

ter

4

Ang

ular

Che

ilitis

5

Rec

urre

nt o

ral u

lcer

atio

n

6

Pap

ular

pru

ritic

eru

ptio

ns

7

Seb

orrh

oeic

der

mat

itis

8

Fun

gal n

ail i

nfec

tions

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

5

92

Bib

liog

raph

y 1

Offic

e of

the

Pres

iden

t N

ational

AID

S C

ontr

ol Counci

l K

enya

Nat

ional H

IVA

IDS

Str

ate

gic

pla

n 2

0056

-20091

0

2

Rep

ublic

of

Ken

ya

Nat

ional AID

S C

ontr

ol C

ounci

l N

atio

nal H

IVA

IDS M

onitori

ng

and E

valu

atio

n F

ram

ework

3

Rep

ublic

of

Ken

ya

Nat

ional AID

S C

ontr

ol C

ounci

l N

atio

nal H

IVA

IDS M

onitori

ng

and E

valu

atio

n I

mple

men

tation M

anual

Job

Aid

sR

efer

ence

s 1

MoH

AN

C R

egis

ters

2

MoH

Mat

ernity

Reg

iste

rs

3

MoH

Post

-nata

l Reg

iste

rs

4

Mat

ernal

and C

hild

Wel

fare

Han

dbook

5

Rep

roduct

ive

Hea

lth S

ervi

ces

month

ly r

eport

6

MoH

Form

726

(Appen

dix

IV)

7

MoH

Form

727

8

MO

H F

orm

711

Exec

utiv

e Su

mm

ary

The

Rev

ised

Gui

delin

es (3

rd

editi

on) f

or P

reve

ntio

n of

Mot

her

to C

hild

Tra

nsm

issi

on(P

MTC

T) o

f H

IV a

nd A

IDS

addr

esse

s th

e ri

sks

of m

othe

r-to

-chi

ld t

rans

mis

sion

(MTC

T) o

f H

IV a

nd A

IDS

usin

g m

ore

effic

acio

us in

terv

entio

ns t

han

in t

he p

revi

ous

editi

ons

The

Gui

delin

es a

re i

n lin

e w

ith K

enya

rsquos N

atio

nal

Hea

lth S

ecto

r St

rate

gic

Plan

II

(NH

SSP

II)

and

are

anch

ored

on

the

Ken

ya N

atio

nal

AID

S St

rate

gic

Plan

(KN

ASP

) 20

00-2

010

whi

ch f

ocus

es o

n th

e pr

iori

ty a

reas

of

prev

entio

n of

new

inf

ecshy

tions

im

prov

ing

the

qual

ity o

f life

of p

eopl

e in

fect

ed a

nd a

ffect

ed b

y H

IV a

nd A

IDS

and

miti

gatio

n of

the

soc

ial a

nd e

cono

mic

impa

ct o

f the

infe

ctio

n O

ne o

f the

pri

ority

ar

eas

of N

HSS

P II

is

adhe

renc

e to

set

clin

ical

and

pub

lic h

ealth

sta

ndar

ds

The

Gui

delin

es w

ere

deve

lope

d th

roug

h a

part

icip

ator

y an

d co

nsul

tativ

e pr

oces

s th

at

drew

par

ticip

ants

fro

m p

ublic

hea

lth i

nstit

utio

ns

NG

Os

FB

Os

aca

dem

ic a

nd r

eshyse

arch

ins

titut

ions

and

dev

elop

men

t pa

rtne

rs

The

proc

ess

was

co-

ordi

nate

d by

N

ASC

OP

with

tech

nica

l and

fina

ncia

l sup

port

from

CD

C (K

)

HIV

infe

ctio

n ha

s re

vers

ed g

ains

rea

lised

in c

hild

hea

lth a

nd s

urvi

val i

n th

e la

st d

ecshy

ade

in K

enya

The

infe

ctio

n ha

s al

so c

ontr

ibut

ed s

igni

fican

tly t

o th

e co

mm

on c

ompl

ishyca

tions

of

preg

nanc

y in

man

y co

untr

ies

Glo

bally

mor

e th

an 6

300

00 c

hild

ren

wer

ein

fect

ed w

ith H

IV t

hrou

gh M

TCT

in 2

003

In

2007

K

enya

had

a p

opul

atio

n es

tishym

ated

at

34 m

illio

n t

he n

umbe

r of

bir

ths

per

annu

m w

as 1

73

mill

ion

the

HIV

prev

alen

ce a

mon

g pr

egna

nt m

othe

rs w

as 6

7 p

er c

ent

and

the

tota

l num

ber

of b

irth

s to

HIV

-infe

cted

mot

hers

exp

osed

to

MTC

T w

as 1

638

00

Ass

umin

g a

tran

smis

sion

rate

of 4

0 pe

r ce

nt a

nd in

the

abs

ence

of a

ny in

terv

entio

n t

he n

umbe

r of

HIV

pos

ishytiv

e in

fant

s pe

r an

num

wou

ld b

e 65

520

Ken

ya A

IDS

Indi

cato

r su

rvey

(KA

IS) 2

007

HIV

ser

opre

vale

nce

amon

g ad

ults

age

d 15

-49

year

s is

78

Var

ious

inte

rven

tions

hav

e be

en p

ut in

pla

ce t

o re

spon

d to

the

em

ergi

ng c

halle

nges

an

d co

nstr

aint

s to

MTC

T ac

ross

the

cou

ntry

Ana

lysi

s of

effe

ctiv

enes

s of

the

var

ious

ap

proa

ches

nee

ded

to m

anag

e ri

sks

of M

TCT

prov

ides

val

uabl

e in

sigh

ts th

at n

eces

sishy

tate

the

ado

ptio

n of

mor

e ef

ficac

ious

car

e an

d tr

eatm

ent

regi

men

s T

hese

ins

ight

s ha

ve in

form

ed t

he d

evel

opm

ent

of n

ew G

uide

lines

The

Gui

delin

es in

corp

orat

e th

ese

chan

ges

and

are

reco

mm

ende

d fo

r us

e by

hea

lth p

rofe

ssio

nals

and

hea

lth in

stitu

tions

at a

ll le

vels

of c

are

The

Gui

delin

es w

ill e

nhan

ce th

e ca

paci

ty o

f hea

lth c

are

prov

ider

sto

giv

e m

ore

effic

ient

and

effe

ctiv

e se

rvic

es t

o H

IV p

ositi

ve e

xpec

tant

mot

hers

and

ne

wbo

rns

The

Gui

delin

es h

ave

ten

chap

ters

and

cov

er th

e fo

llow

ing

just

ifyin

g th

e ne

ed fo

r sp

eshyci

fic m

anag

emen

t of

HIV

pos

itive

wom

en c

are

befo

re d

urin

g an

d af

ter

preg

nanc

yus

e of

ant

iret

rovi

ral t

hera

py in

pre

gnan

cy p

ostn

atal

car

e fa

mily

pla

nnin

g e

arly

inshy

fant

dia

gnos

is

feed

ing

car

e an

d fo

llow

-up

of H

IV-in

fect

ed i

nfan

ts

and

mon

itori

ng

and

eval

uatio

n A

dditi

onal

inf

orm

atio

n on

WH

O s

tagi

ng

cont

race

ptiv

e op

tions

for

PLW

As

and

a su

mm

ary

of A

RV

use

in P

MTC

T is

giv

en in

the

appe

ndic

es

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

1

16

The

Gui

delin

es h

ave

also

inc

orpo

rate

d ba

sic

info

rmat

ion

that

pro

gram

man

ager

sne

ed in

ord

er to

mak

e th

eir

inst

itutio

ns P

MTC

T-fr

iend

ly T

his

info

rmat

ion

is fo

und

in

the

boxe

s an

d ap

pend

ices

Sum

mar

ies

of t

he i

nfor

mat

ion

cont

aine

d in

the

tex

t ar

e fo

und

in th

e ta

bles

The

Gui

delin

es p

rovi

de a

bac

kgro

und

to t

he P

MTC

T pr

oble

m in

the

wor

ld i

n A

fric

a an

d in

Ken

ya T

hey

also

giv

e de

tails

on

HIV

in p

regn

ancy

the

tran

smis

sion

pat

tern

sof

MTC

T an

d de

scri

be t

he b

enef

its o

f pr

even

ting

mot

her-

to-c

hild

tra

nsm

issi

on(P

MTC

T) T

hey

also

pro

vide

info

rmat

ion

on in

terv

entio

ns n

eces

sary

to

redu

ce M

TCT

that

incl

ude

coun

selli

ng a

nd te

stin

g la

bora

tory

inve

stig

atio

ns o

bste

tric

inte

rven

tions

and

trea

tmen

tpro

phyl

axis

The

ante

nata

l man

agem

ent

for

HIV

pos

itive

wom

en i

nclu

ding

pol

icy

guid

e jo

b ai

dsw

ith s

umm

aris

ed e

ssen

tial p

acka

ge o

f int

egra

ted

ante

nata

l car

e se

rvic

es a

re d

etai

led

in C

hapt

er 2

Cha

pter

3 p

rovi

des

info

rmat

ion

on i

ntra

part

um c

are

Thi

s is

the

man

agem

ent

ofw

omen

from

the

onse

t of l

abou

r to

del

iver

y A

t thi

s st

age

it is

impo

rtan

t to

esta

blis

hth

e H

IV s

tatu

s of

wom

en p

rior

to d

eliv

ery

or d

urin

g la

bour

Gui

delin

es s

houl

d be

folshy

low

ed fo

r al

l wom

en a

dmitt

ed to

labo

ur a

nd d

eliv

ery

To

cond

uct v

agin

al d

eliv

erie

s fo

r H

IV p

ositi

ve w

omen

m

odifi

ed r

outin

e ca

re i

s gi

ven

The

gui

delin

es p

rovi

de a

reshy

min

der

on th

e ac

tiviti

es e

ssen

tial t

o ca

rry

out f

or s

afe

vagi

nal d

eliv

ery

for

all w

omen

no

t ju

st fo

r th

ose

infe

cted

with

HIV

It

is r

ecom

men

ded

that

the

re s

houl

d be

no

disshy

crim

inat

ion

or is

olat

ion

of H

IV p

ositi

ve w

omen

dur

ing

labo

ur a

nd d

eliv

ery

Del

iver

y th

roug

h el

ectiv

e ca

esar

ean

sect

ion

redu

ces

the

risk

of

HIV

MTC

T as

com

pare

d to

vagi

nal d

eliv

ery

amon

g H

IV p

ositi

ve w

omen

Whe

re C

S is

per

form

ed a

s an

em

erge

ncy

or e

lect

ivel

y a

ntib

iotic

s sh

ould

be

give

n

Ant

iret

rovi

ral (

AR

V) t

hera

py is

dis

cuss

ed in

det

ail i

n C

hapt

er 4

Thi

s in

clud

es t

hershy

apy

for

the

mot

her

befo

re la

bour

dur

ing

labo

ur a

nd a

fter

del

iver

y a

nd fo

r th

e in

fant

afte

r de

liver

y C

urre

ntly

N

evir

apin

e is

the

rec

omm

ende

d re

gim

en H

owev

er

shor

tco

urse

effi

caci

ous

AR

V d

rug

regi

men

s ca

n be

im

plem

ente

d in

res

ourc

e lim

ited

setshy

tings

AR

Vs

are

used

bot

h fo

r tr

eatm

ent

and

for

PMTC

T in

HIV

inf

ecte

d pr

egna

ntw

omen

and

thei

r ne

onat

es

Gui

delin

es f

or t

he p

ostp

artu

m c

are

of t

he m

othe

r an

d ca

re f

or H

IV e

xpos

ed in

fant

s ar

e de

taile

d in

Cha

pter

5 I

n C

hapt

er 6

the

Gui

de p

rovi

des

deta

iled

info

rmat

ion

on

late

pos

tnat

al c

are

and

fam

ily p

lann

ing

HIV

pos

itive

wom

en c

an u

se a

ll ty

pes

of fa

mshy

ily p

lann

ing

base

d on

sta

ndar

d el

igib

ility

cri

teri

a as

exp

licitl

y ou

tline

d in

the

text

Gui

delin

es fo

r in

fant

dia

gnos

is c

are

and

trea

tmen

t ar

e di

scus

sed

in C

hapt

er 7

Cur

shyre

ntly

the

re is

no

test

to

diffe

rent

iate

bet

wee

n an

tibod

ies

from

the

mot

her

and

thos

e pr

oduc

ed b

y th

e ba

by T

o id

entif

y H

IV in

fect

ed in

fant

s le

ss t

han

18 m

onth

s D

NA

or

RN

A ndash

PC

R te

st is

cur

rent

ly r

ecom

men

ded

HIV

exp

osed

infa

nts

at 6

wee

ks a

nd s

ick

infa

nts

at 1

2 m

onth

s sh

ould

hav

e ac

cess

to

DB

S fo

r D

NA

PC

R H

IV e

xpos

ed in

fant

ssh

ould

be

star

ted

on c

otri

mox

azol

e fr

om 6

wee

ks A

ll m

othe

rs w

ith 6

wee

k ol

d in

fant

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

E

Upt

ake

of c

ouns

ellin

g an

d te

stin

g in

Mat

erni

ty c

linic

Rat

io o

f m

ater

nity

clie

nts

with

unk

now

n H

IV s

tatu

s w

ho a

re c

ouns

elle

d an

d te

sted

for H

IV in

mat

erni

ty

Num

erat

or

Num

ber o

f pre

gnan

t wom

en a

dmitt

ed in

to m

ater

nity

with

un

know

n H

IV s

tatu

s th

at a

re c

ouns

elle

d an

d te

sted

for H

IV

durin

g la

bour

or a

fter d

eliv

ery

Den

omin

ator

N

umbe

r of p

regn

ant w

omen

adm

itted

into

mat

erni

ty

with

unk

now

n H

IV s

tatu

s

F

Mat

erni

ty m

othe

r AR

V pr

ophy

laxi

s up

take

R

atio

of H

IV in

fect

ed m

othe

rs in

mat

erni

ty c

linic

rece

ivin

g pr

even

tive

A

RV

pro

phyl

axis

Num

erat

or

Num

ber o

f HIV

-infe

cted

mot

hers

adm

itted

in m

ater

nity

takshy

ing

or re

porte

d to

hav

e ta

ken

the

mot

her d

ose(

s) o

f pre

venshy

tive

AR

V p

roph

ylax

is

Den

omin

ator

N

umbe

r of p

regn

ant w

omen

adm

itted

into

mat

erni

ty w

ho

are

HIV

-infe

cted

G

Infa

nt A

RV

prop

hyla

xis

upta

ke

Rat

io o

f inf

ants

bor

n to

HIV

-infe

cted

mot

hers

in m

ater

nity

clin

ic

rece

ivin

g pr

even

tive

AR

V p

roph

ylax

is

Num

erat

or

Num

ber o

f inf

ants

bor

n to

HIV

-infe

cted

mot

hers

who

rece

ive

prev

entiv

e

Den

omin

ator

N

umbe

r of i

nfan

ts b

orn

to H

IV-in

fect

ed m

othe

rs

Num

ber o

f pre

gnan

t wom

en a

dmitt

ed in

to m

ater

nity

who

are

H

IV-in

fect

ed is

use

d to

app

roxi

mat

e th

is n

umbe

r

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

7

90

With

the

mea

sure

men

ts li

sted

abo

ve t

he fo

llow

ing

perf

orm

ance

indi

cato

rs

for m

onito

ring

PMTC

T ac

tiviti

es a

re c

alcu

late

d

A

Upt

ake

of c

ouns

ellin

g an

d te

stin

g in

Ant

enat

al c

linic

R

atio

of a

nten

atal

clie

nts

who

wer

e co

unse

lled

and

test

ed fo

r HIV

Num

erat

or

This

is n

umbe

r of p

regn

ant w

omen

atte

ndin

g th

eir f

irst

ante

nata

l clin

ic v

isit

who

are

test

ed fo

r HIV

Den

omin

ator

N

umbe

r of n

ew v

isits

to th

e an

tena

tal c

linic

B

Ant

enat

al H

IV s

erop

reva

lenc

e

Rat

io o

f Ant

enat

al p

regn

ant w

omen

test

ed fo

r HIV

that

are

HIV

infe

cted

Num

erat

or

Num

ber o

f clie

nts

who

test

HIV

pos

itive

Den

omin

ator

To

tal n

umbe

r of p

regn

ant w

omen

test

ed fo

r HIV

in a

nten

ashyta

l clin

ic

C

Ant

enat

al m

othe

r AR

V pr

ophy

laxi

s up

take

R

atio

of k

now

n H

IV in

fect

ed p

regn

ant w

omen

in a

nten

atal

clin

ic

rece

ivin

g A

RV

pre

vent

ive

prop

hyla

xis

Num

erat

or

Tota

l num

ber o

f HIV

-infe

cted

pre

gnan

t wom

en in

ant

enat

al

clin

ic re

ceiv

ing

mot

her p

reve

ntiv

e A

RV

pro

phyl

axis

Den

omin

ator

To

tal n

umbe

r of p

regn

ant w

omen

who

are

HIV

-infe

cted

in

the

ante

nata

l clin

ic

D

Ant

enat

al in

fant

AR

V pr

ophy

laxi

s up

take

R

atio

of k

now

n H

IV-in

fect

ed p

regn

ant w

omen

in a

nten

atal

clin

ic w

ho

rece

ive

infa

nt d

ose(

s) o

f pre

vent

ive

AR

V p

roph

ylax

is

Num

erat

or

Tota

l num

ber o

f HIV

infe

cted

pre

gnan

t wom

en in

an

tena

tal c

linic

rece

ivin

g in

fant

dos

e(s)

pre

vent

ive

A

RV

pro

phyl

axis

Den

omin

ator

To

tal n

umbe

r of p

regn

ant w

omen

who

are

HIV

-infe

cted

in

the

ante

nata

l clin

ic

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

shou

ld h

ave

rout

ine

HIV

ant

ibod

y te

st

Gui

delin

es f

or f

eedi

ng in

fant

s an

d yo

ung

child

ren

born

to

HIV

infe

cted

mot

hers

are

di

scus

sed

in C

hapt

er 8

The

Min

istr

y of

Hea

lth r

ecom

men

ds p

rom

otio

n of

exc

lusi

vebr

east

feed

ing

for

the

first

6 m

onth

s of

life

Whe

re r

epla

cem

ent f

eedi

ng is

acc

epta

ble

feas

ible

af

ford

able

su

stai

nabl

e an

d sa

fe (

AFA

SS)

avoi

danc

e of

bre

astf

eedi

ng b

yH

IV-in

fect

ed w

omen

is

reco

mm

ende

d (W

HO

200

6) D

iscu

ssio

n on

diff

eren

t ty

pes

offe

edin

g al

tern

ativ

es t

o br

east

feed

ing

is c

aptu

red

in t

he t

ext

Thes

e op

tions

exi

st f

orth

e m

othe

r to

cho

ose

with

the

aid

of

coun

selli

ng I

deal

ly c

oupl

e de

cisi

on-m

akin

g is

enco

urag

ed f

or t

he H

IV p

ositi

ve m

othe

r F

or t

he H

IV n

egat

ive

mot

her

exc

lusi

ve

brea

stfe

edin

g is

rec

omm

ende

d fo

r 6

mon

ths

or le

ss fo

llow

ed b

y w

eani

ng

Car

e an

d fo

llow

-up

of c

hild

ren

of H

IV-in

fect

ed m

othe

rs is

dis

cuss

ed in

det

ail i

n C

hapshy

ter

9 A

ll ch

ildre

n bo

rn t

o H

IV i

nfec

ted

mot

hers

sho

uld

be f

ollo

wed

up

clos

ely

from

birt

h th

roug

h 2

year

s T

able

92

pro

vide

s th

e W

HO

rec

omm

ende

d fo

llow

up

deta

ils

Sim

ilarl

y t

he m

othe

rs s

houl

d be

sup

port

ed t

o pr

ovid

e op

timal

infa

nt fe

edin

g an

d to

av

oid

mix

ed fe

edin

g w

ithin

6 m

onth

s

In C

hapt

er 1

0 t

he G

uide

lines

exp

lain

the

ben

efits

of

mon

itori

ng a

nd e

valu

atio

n of

PMTC

T pr

ogra

ms

Mamp

E p

rovi

des

an o

ppor

tuni

ty t

o m

easu

re a

nd a

ppra

ise

perf

orm

shyan

ce w

ithin

def

ined

tim

e fr

ame

to e

nsur

e ac

com

plis

hmen

t of s

et g

oals

and

obj

ectiv

es

PMTC

T se

rvic

es m

ust

be g

uide

d by

tim

ely

and

accu

rate

dat

a re

port

ed f

rom

the

heal

th f

acili

ties

thr

ough

the

dis

tric

t an

d pr

ovin

cial

lev

els

to

the

natio

nal

leve

l at

NA

SCO

P

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

9

18

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

(xiii

) H

IV in

fect

ed in

mat

erni

ty w

ard

Num

ber

of p

regn

ant

wom

en a

dmitt

ed in

to

mat

erni

ty c

linic

who

are

HIV

infe

cted

In

clud

es b

oth

thos

e w

ho w

ere

adm

itted

al

read

y kn

owin

g th

ey a

re H

IV-i

nfec

ted

and

thos

e w

ho w

ere

test

ed a

nd r

ecei

ved

thei

r re

sults

in m

ater

nity

clin

ic T

his

is o

btai

ned

from

the

mat

erni

ty r

egis

ter

(xiv

) P

reve

ntiv

e A

RV

pro

phyl

axis

in m

ater

nity

war

d (m

othe

r do

se)

Num

ber

of

preg

nant

wom

en a

dmitt

ed in

mat

erni

ty t

akin

g or

rep

orte

d to

hav

e ta

ken

the

mot

her

dose

(s)

of p

reve

ntiv

e A

RV

pro

phyl

axis

T

his

is o

btai

ned

from

the

m

ater

nity

reg

iste

r

(xv)

Inf

ant

prev

entiv

e A

RV

pro

phyl

axis

in m

ater

nity

clin

ic

war

d N

umbe

r of

inshy

fant

s bo

rn in

mat

erni

ty r

ecei

ving

the

infa

nt p

reve

ntiv

e A

RV

pro

phyl

axis

in t

he

mat

erni

ty c

linic

T

his

is o

btai

ned

from

the

mat

erni

ty r

egis

ter

(xvi

) D

eliv

erie

s T

otal

num

ber

of p

regn

ant

wom

en d

eliv

erin

g at

the

hea

lth fa

cilit

y

(xvi

i) C

ouns

ellin

g on

infa

nt f

eedi

ng o

ptio

ns

Num

ber

of m

othe

rs d

eliv

erin

g at

the

he

alth

fac

ility

cou

nsel

led

on in

fant

fee

ding

opt

ions

T

his

is o

btai

ned

from

the

m

ater

nity

reg

iste

r

(xvi

ii) I

nfan

t te

stin

g at

6 w

eeks

bull N

umbe

r of

infa

nts

test

ed f

or H

IV a

t 6

wee

ks o

ld

bull N

umbe

r of

infa

nts

test

ing

HIV

-pos

itive

T

his

is o

btai

ned

from

labo

rato

ry

regi

ster

(xix

) R

efer

red

for

care

and

tre

atm

ent

bull N

umbe

r of

HIV

infe

cted

wom

en a

ttend

ing

ante

nata

l clin

ic t

hat

is r

efer

red

for

HIV

car

e an

d tr

eatm

ent

bull N

umbe

r of

HIV

infe

cted

wom

en in

mat

erni

ty t

hat

is r

efer

red

for

HIV

car

e an

d tr

eatm

ent

bull N

umbe

r H

IV in

fect

ed in

fant

s re

ferr

ed f

or H

IV c

are

and

trea

tmen

t T

his

is

ob

tain

ed f

rom

ant

enat

al a

nd m

ater

nity

reg

iste

rs

(xx)

Ini

tiate

d on

Cot

rim

oxaz

ole

Num

ber

of H

IV in

fect

ed p

regn

ant

wom

en a

ttend

ing

ante

nata

l clin

ic th

at h

as

been

initi

ated

on

Cot

rimox

azol

e T

his

is o

btai

ned

from

the

ant

enat

al r

egis

ter

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

9

88

Th

e da

ta is

pre

sent

ed u

sing

def

ined

per

form

ance

indi

cato

rs th

at in

clud

e th

e fo

llow

ing

(i)

New

clie

nts

first

ant

enat

al c

linic

vis

its

Num

ber

of p

regn

ant

wom

en a

ttend

ing

thei

r fir

st a

nten

atal

vis

it fo

r th

e cu

rren

t pr

egna

ncy

at t

he h

ealth

fac

ility

T

his

is

obta

ined

fro

m t

he a

nten

atal

reg

iste

r

(ii)

Ret

urn

visi

tsr

evis

its

Num

ber

of r

etur

n an

tena

tal c

linic

vis

itsr

evis

its

atte

nded

by

the

preg

nant

wom

en a

t th

e fa

cilit

y T

his

is o

btai

ned

from

the

an

tena

tal r

egis

ter

(iii)

C

ouns

ellin

g an

d te

stin

g fo

r H

IV in

ant

enat

al c

linic

Tot

al n

umbe

r of

pre

gnan

t w

omen

cou

nsel

led

and

test

ed f

or H

IV a

t th

e an

tena

tal c

linic

w

heth

er t

his

is d

one

on th

e fir

st a

nten

atal

vis

it or

a la

ter

visi

t T

his

is o

btai

ned

from

the

an

tena

tal r

egis

ter

(iv)

H

IV c

ouns

ellin

g an

d te

stin

g at

fir

st a

nten

atal

clin

ic v

isit

Num

ber

of p

regn

ant

wom

en a

tten

ding

the

ir fir

st a

nten

atal

clin

ic v

isit

for

curr

ent

preg

nanc

y w

ho a

re

test

ed f

or H

IV

Thi

s is

obt

aine

d fr

om t

he a

nten

atal

reg

iste

r

(v)

Lear

ning

HIV

sta

tus

in a

nten

atal

clin

ic

Num

ber

of a

nten

atal

clin

ic p

regn

ant

wom

en t

este

d fo

r H

IV w

ho r

ecei

ve t

heir

HIV

res

ults

w

heth

er t

his

is d

one

on t

he

first

ant

enat

al c

linic

vis

it or

at

a la

ter

visi

t T

his

is o

btai

ned

from

the

ant

enat

al

regi

ster

(vi)

HIV

infe

cted

in a

nten

atal

clin

ic

Num

ber

of a

nten

atal

clin

ic p

regn

ant

wom

en

who

are

HIV

-inf

ecte

d on

the

late

st t

est

durin

g th

e pr

egna

ncy

Thi

s is

obt

aine

d fr

om t

he a

nten

atal

reg

iste

r

(vii)

Pre

vent

ive

AR

V p

roph

ylax

is in

ant

enat

al c

linic

(m

othe

r do

se)

Num

ber

of

preg

nant

wom

en in

the

ant

enat

al c

linic

rec

eivi

ng t

he m

othe

r do

se(s

) of

pre

venshy

tive

AR

V p

roph

ylax

is

Thi

s is

obt

aine

d fr

om t

he a

nten

atal

reg

iste

r

(viii

) P

reve

ntiv

e A

RV

pro

phyl

axis

in a

nten

atal

clin

ic (

infa

nt d

ose)

N

umbe

r of

pr

egna

nt w

omen

in t

he A

nten

atal

clin

ic is

sued

with

the

infa

nt d

ose(

s) o

f pr

even

shytiv

e A

RV

pro

phyl

axis

T

his

is o

btai

ned

from

the

ant

enat

al r

egis

ter

(ix)

New

clie

nts

in m

ater

nity

clin

ic

Num

ber

of p

regn

ant

wom

en a

tten

ding

the

Mashy

tern

ity c

linic

for

the

firs

t tim

e T

his

is o

btai

ned

from

the

mat

erni

ty r

egis

ter

(x)

Unk

now

n H

IV s

tatu

s at

mat

erni

ty

Num

ber

of p

regn

ant

wom

en a

dmitt

ed in

to

the

mat

erni

ty w

ith u

nkno

wn

HIV

sta

tus

Thi

s is

obt

aine

d fr

om t

he m

ater

nity

reg

isshy

ter

(xi)

Cou

nsel

ling

and

test

ing

for

HIV

in m

ater

nity

war

dT

otal

num

ber

of p

regn

ant

wom

en a

dmitt

ed in

to m

ater

nity

with

unk

now

n st

atus

tha

t ar

e co

unse

lled

and

test

ed fo

r H

IV d

urin

g la

bour

or

afte

r de

liver

y T

his

is o

btai

ned

from

the

mat

erni

ty

regi

ster

(xii)

Lea

rnin

g H

IV s

tatu

s in

mat

erni

ty w

ard

Num

ber

of p

regn

ant

wom

en a

dmitt

ed

into

mat

erni

ty a

nd t

este

d fo

r H

IV w

ho r

ecei

ved

thei

r H

IV r

esul

ts

Thi

s is

obt

aine

d fr

om t

he m

ater

nity

reg

iste

r

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Cha

pter

1

Bac

kgro

und

11

THE

GLO

BA

L P A

ND

EMIC

Ove

r 38

mill

ion

peop

le a

re li

ving

with

HIV

AID

S w

orld

wid

e a

nd a

bout

two-

thir

ds o

r 25

m

illio

n of

PLW

HA

liv

e in

sub

-Sah

aran

Afr

ica1

H

IVA

IDS

mai

nly

affe

cts

peop

le o

fre

prod

uctiv

e ag

e an

d in

crea

sing

ly a

ffect

s w

omen

w

ho n

ow a

ccou

nt f

or 5

7 o

f ne

win

fect

ions

in s

ub-S

ahar

an A

fric

a w

here

wom

en a

re 3

0 m

ore

likel

y to

be

livin

g w

ith

HIV

AID

S th

an m

en a

nd y

oung

wom

en a

ged

15-2

4 ar

e ne

arly

four

tim

es m

ore

likel

y to

be

inf

ecte

d th

an t

heir

mal

e co

unte

rpar

ts2

Youn

g m

arri

ed w

omen

w

ho a

re o

ften

m

onog

amou

s h

ave

beco

me

one

of t

he g

roup

s m

ost

vuln

erab

le t

o H

IV i

n th

e re

gion

Th

is r

equi

res

new

and

rap

id r

espo

nses

that

bro

aden

the

focu

s be

yond

trad

ition

al ldquoh

igh

risk

rdquo gro

ups

like

com

mer

cial

sex

wor

kers

tru

ck d

rive

rs a

nd d

rug

user

s

To r

each

you

ng m

arri

ed w

omen

w

ho m

ay n

ot b

e aw

are

of t

heir

vul

nera

bilit

y H

IV

AID

S pr

even

tion

ca

re

and

supp

ort

activ

ities

m

ust

be

inte

grat

ed

into

al

read

yes

tabl

ishe

d he

alth

ser

vice

s th

at a

re u

sed

by t

he g

ener

al p

opul

atio

n A

n es

timat

ed

630

000

child

ren

wor

ld-w

ide

beca

me

infe

cted

with

HIV

in

2003

mdash m

ost

thro

ugh

MTC

T3

The

risk

of

an H

IV-in

fect

ed m

othe

r pa

ssin

g th

e vi

rus

to h

er i

nfan

t du

ring

pr

egna

ncy

labo

ur a

nd d

eliv

ery

or in

the

post

nata

l per

iod

is 1

in 3

if n

othi

ng is

don

e to

re

duce

this

ris

k I

n ot

her

wor

ds o

ut o

f 100

infa

nts

born

to w

omen

with

HIV

AID

S an

d w

ithou

t in

terv

entio

n 6

0-75

of t

hem

will

not

be

infe

cted

Of t

he o

ne-t

hird

who

bec

ome

infe

cted

abo

ut 5

-10

babi

es w

ill b

e in

fect

ed d

urin

g pr

egna

ncy

15

will

be

infe

cted

dur

ing

labo

ur a

nd d

eliv

ery

whi

le 5

-15

will

be

infe

cted

dur

ing

brea

stfe

edin

g l

arge

ly b

eing

de

pend

ent

on b

reas

tfee

ding

pra

ctic

es a

nd o

n th

e du

ratio

n of

bre

astfe

edin

g4 I

n 20

03

near

ly 5

000

00 c

hild

ren

died

of A

IDS-

rela

ted

caus

es M

ost

child

ren

born

with

HIV

die

befo

re th

ey r

each

thei

r fif

th b

irth

day

with

mos

t not

sur

vivi

ng b

eyon

d tw

o ye

ars5

The

high

rat

es o

f M

TCT

in d

evel

opin

g co

untr

ies

com

pare

d to

muc

h lo

wer

rat

es i

nri

cher

cou

ntri

es

illus

trat

e gr

owin

g in

equa

litie

s in

glo

bal

heal

th

In t

he w

ealth

y co

untr

ies

the

rat

e of

MTC

T is

les

s th

an 2

b

ecau

se o

f w

ides

prea

d ac

cess

to

antishy

retr

ovir

al th

erap

y (A

RT)

pla

nned

cae

sare

an s

ectio

ns (C

S) t

he m

eans

to s

afel

y fo

rmul

afe

ed a

nd a

cces

s to

qua

lity

med

ical

ser

vice

s I

n po

orer

cou

ntri

es li

ke K

enya

the

re is

a

30-4

0 c

hanc

e th

at a

n H

IV-p

ositi

ve b

reas

tfee

ding

mot

her

will

pas

s H

IV to

her

chi

ld in

th

e ab

senc

e of

the

se s

ervi

ces

In

such

set

tings

it

is c

ritic

al t

hat

prev

entio

n pr

oced

ures

be i

nteg

rate

d in

to e

xist

ing

sexu

al a

nd r

epro

duct

ive

heal

th (

SRH

) an

d m

ater

nal

and

child

hea

lth (

MC

H)

serv

ices

re

achi

ng a

s m

any

wom

en a

s po

ssib

le a

nd l

ower

ing

tran

smis

sion

rat

es A

lthou

gh p

harm

aceu

tical

com

pany

don

atio

ns d

onor

sup

port

and

othe

r go

vern

men

t in

itiat

ives

hav

e he

lped

exp

and

acce

ss t

o H

IV t

estin

g fo

r pr

egna

ntw

omen

and

use

of a

ntir

etro

vira

l dru

gs li

ke N

evir

apin

e w

hich

red

uce

the

chan

ce o

f HIV

tr

ansm

issi

on s

till o

nly

10

of p

regn

ant w

omen

glo

bally

hav

e ac

cess

to th

ese

drug

s6

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

7

20

HIV

AID

S tr

ansm

issi

on fr

om m

othe

r to

chi

ld in

Ken

ya is

one

of t

he b

igge

st h

ealth

and

de

velo

pmen

t cha

lleng

es in

Ken

ya A

ccor

ding

to th

e 20

03 D

emog

raph

ic a

nd H

ealth

Sur

shyve

y7 6

7

or

over

12

mill

ion

Ken

yan

adul

ts w

ere

livin

g w

ith H

IVA

IDS

in 2

003

The

re

has

been

a s

tead

y de

clin

e in

HIV

ser

opre

vale

nce

in K

enya

In

2005

the

pre

vale

nce

rate

w

as e

stim

ated

at 5

9

and

as

per

the

2006

sta

tistic

s th

e pr

eval

ence

rat

e am

ong

adul

tsha

d dr

oppe

d to

51

8

Acc

ordi

ng t

o 20

07 K

enya

AID

S In

dica

tor

Surv

ey (

KA

IS)8a

the

H

IV s

erop

reva

lenc

e in

Ken

ya is

cur

rent

ly 7

8

am

ong

adul

ts a

ged

15-4

9 ye

ars

bei

nghi

gher

in

wom

en (

87

) th

an i

n m

en (

56

) Y

oung

wom

en a

re m

ore

vuln

erab

le i

n K

enya

tha

n m

en a

s ev

iden

ced

by a

nea

rly

9 p

reva

lenc

e ra

te a

mon

g w

omen

and

unshy

der

5 a

mon

g m

en9

Ther

e ar

e w

ide

vari

atio

ns b

etw

een

urba

n an

d ru

ral

area

s b

etw

een

regi

ons

bet

wee

n ad

ults

and

you

ng p

eopl

e an

d be

twee

n m

en a

nd w

omen

The

re h

as b

een

a no

tabl

e dr

op

in t

he n

umbe

r of

new

inf

ectio

ns

with

an

estim

ated

60

000

new

inf

ectio

ns i

n 20

05

drop

ping

to 5

500

0 in

200

6 In

fant

s an

d yo

ung

child

ren

unde

r 15

yea

rs a

ccou

nt fo

r 16

of

all

new

HIV

infe

ctio

ns m

ainl

y as

a r

esul

t of M

TCT

Mos

t of t

he n

ew in

fect

ions

occ

ur

amon

g yo

ung

peop

le i

n w

hom

the

mai

n m

ode

of t

rans

mis

sion

is t

hrou

gh s

exua

l int

ershy

cour

se

Tabl

e 1

1 A

dult

HIV

-Pre

vale

nce

Estim

ate

by P

rovi

nce

in 2

006

Prov

ince

N

umbe

r of H

IV +

Pre

vale

nce

()

Nai

robi

Cen

tral

Coa

st

Eas

tern

N E

aste

rn

Nya

nza

Rift

Val

ley

Wes

tern

Tota

l

197

000

960

00

930

00

720

00

900

0 18

300

0

171

000

112

000

11

milli

on

Tota

l

101

41

59

28

14

78

38

53

51

Mal

e

80

17

50

11

09

61

26

42

35

Fem

ale

123

65

69

44

18

96

49

64

67

Mal

eFe

mal

e R

atio

15

38

14

40

20

16

19

15

19

all t

he d

ata

from

the

prov

ince

s (a

nd r

efer

ral h

ospi

tals

) Th

e ag

greg

ated

dat

a is

di

ssem

inat

ed t

o th

e H

ealth

Man

agem

ent

Info

rmat

ion

Syst

em N

atio

nal A

IDS

Con

trol

Cou

ncilrsquo

s (N

AC

C)

natio

nal

data

ban

k an

d re

sour

ce c

entr

e T

he f

ocal

pe

rson

s he

re a

re t

he d

irec

tor

NA

CC

and

the

Mamp

E m

anag

er D

ata

is d

isse

mishy

nate

d ba

ck to

the

prov

ince

s an

d re

ferr

al h

ospi

tals

for

use

in d

ecis

ion-

mak

ing

7

Dat

a flo

w f

rom

fac

ility

lev

el t

o na

tiona

l le

vel

At

the

heal

th f

acili

ty P

MTC

T in

divi

dual

le

vel d

ata

reco

rded

in t

he M

oH s

tand

ardi

sed

regi

ster

s (A

NC

Mashy

tern

ity a

nd P

ostn

atal

) is

sum

mar

ised

ag

greg

ated

on

a m

onth

ly b

asis

ont

o M

oH F

orm

726

F

orm

726

is

then

for

war

ded

upw

ards

to

the

dist

rict

Lev

el

(DA

SCO

rsquos O

ffice

) for

agg

rega

tion

of th

e D

istr

ict l

evel

dat

a on

to F

orm

727

Cop

shyie

s of

For

m 7

26 a

nd F

orm

727

are

forw

arde

d to

the

Nat

iona

l Offi

ce (N

ASC

OP)

w

ith a

noth

er c

opy

of F

orm

727

bei

ng s

ent t

o th

e Pr

ovin

cial

Offi

ce (P

ASC

O)

8

Dat

a di

ssem

inat

ion

Thi

s is

car

ried

out

at

all

leve

ls s

tart

ing

from

fac

ility

to

natio

nal l

evel

It i

s th

e re

spon

sibi

lity

of N

AC

C to

coo

rdin

ate

the

diss

emin

atio

n an

d us

e of

all

HIV

AID

S da

ta a

nd in

form

atio

n fo

r na

tiona

l res

pons

e J

APR

a

join

t pro

gram

me

of a

ll st

akeh

olde

rs in

HIV

AID

S re

ceiv

es a

nd u

ses

the

data

to

disc

uss

the

chal

leng

es a

chie

vem

ents

and

les

sons

lea

rnt

from

HIV

AID

S an

d gi

ves

feed

back

for n

atio

nal r

espo

nse

9

PMTC

T in

dica

tors

and

thei

r so

urce

s H

ealth

car

e fa

cilit

ies

colle

ct th

e fo

llow

ing

data

as

a m

inim

um t

o be

use

d in

the

mon

itori

ng o

f PM

TCT

prog

ram

s T

he

data

is

to b

e ag

greg

ated

on

a m

onth

ly b

asis

ont

o th

e M

inis

try

of H

ealth

In

tegr

ated

Mon

itori

ng a

nd E

valu

atio

n R

epor

t For

m M

oH 7

26 u

sing

dat

a fr

om

the

Min

istr

y of

Hea

lth

Ken

ya A

nten

atal

and

Mat

erni

ty R

egis

ters

(D

eliv

ery

Reg

iste

r) M

oH 4

05 a

nd M

oH 3

33 r

espe

ctiv

ely

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

2

1

86

102

O

PER

ATI

ON

AL

GU

IDEL

INES

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed in

the

mon

itorin

g an

d ev

alua

-tio

n of

PM

TCT

serv

ices

1

W

ithin

PM

TCT

prog

ram

s d

ata

is c

olle

cted

and

rep

orte

d at

the

fol

low

ing

leve

ls I

ndiv

idua

l fa

cilit

y d

istr

ict

prov

inci

al a

nd n

atio

nal

2

Indi

vidu

al l

evel

The

com

bine

d m

othe

r an

d ch

ild h

ealth

boo

klet

pro

vide

s de

shyta

iled

info

rmat

ion

on t

he w

oman

and

chi

ld i

nclu

ding

the

HIV

sta

tus

oth

er

HIV

car

e se

rvic

es d

rugs

del

iver

y in

form

atio

n im

mun

isat

ion

gro

wth

mon

itorshy

ing

and

othe

r par

amet

ers

3

Faci

lity

leve

l da

ta c

aptu

re t

ools

The

MoH

has

sta

ndar

dise

d re

gist

ers

for

reshy

cord

ing

data

at

faci

litie

s T

hese

inc

lude

the

Rev

ised

AN

C R

egis

ter

Rev

ised

M

ater

nity

Reg

iste

r an

d Po

st N

atal

Reg

iste

r an

d W

orkl

oad

MO

H 7

17 O

ther

re

gist

ers

incl

ude

Chi

ld H

ealth

and

Nut

ritio

n In

form

atio

n Sy

stem

and

Inshy

patie

nt M

orbi

dity

and

Mor

talit

y F

orm

711

and

the

Rep

rodu

ctiv

e H

ealth

Ser

shyvi

ces

mon

thly

rep

orts

are

use

d fo

r m

akin

g fa

cilit

y le

vel s

umm

arie

s on

PM

TCT

and

repr

oduc

tive

heal

th s

ervi

ces

3 F

acili

ty le

vel d

ata

capt

ure

tool

s T

he M

oH

has

stan

dard

ized

reg

iste

rs f

or r

ecor

ding

dat

a at

fac

ilitie

s T

hese

inc

lude

the

R

evis

ed A

NC

Reg

iste

r R

evis

ed M

ater

nity

Reg

iste

r an

d Po

st N

atal

Reg

iste

r an

d w

orkl

oad

MO

H 7

17 O

ther

reg

iste

rs in

clud

e C

hild

Hea

lth a

nd N

utri

tion

Info

rmat

ion

Syst

em a

nd I

n-pa

tient

mor

bidi

ty a

nd m

orta

lity

Fo

rm 7

26 a

nd

the

Rep

rodu

ctiv

e he

alth

ser

vice

s m

onth

ly r

epor

ts a

re u

sed

for

mak

ing

faci

lity

leve

l sum

mar

ies

on P

MTC

T an

d re

prod

uctiv

e he

alth

ser

vice

s

4

Dis

tric

t le

vel

data

For

m 7

27 i

s us

ed t

o su

mm

aris

e an

d re

port

dis

tric

t le

vel

data

Oth

er s

umm

ary

repo

rtin

g to

ols

are

also

use

d to

rep

ort

dist

rict

leve

l inshy

form

atio

n A

t th

e di

stri

ct le

vel

the

DAS

CO

rsquos of

fice

aggr

egat

es d

ata

from

sev

shyer

al h

ealth

faci

lity

spec

ific

Form

726

ont

o Fo

rm 7

27 th

at is

use

d to

sum

mar

ise

and

repo

rt d

istr

ict l

evel

dat

a

5

Prov

inci

al l

evel

dat

a A

t th

e pr

ovin

cial

lev

el t

he P

ASC

O r

ecei

ves

Form

727

da

ta f

rom

the

res

pect

ive

DA

SCO

rsquos of

fices

in

the

prov

ince

for

the

ir o

wn

data

us

e an

d re

cord

s A

cop

y of

the

sam

e is

sen

t to

the

Nat

iona

l Offi

ce (N

ASC

OP)

by

the

DA

SCO

rsquos of

fice

At

the

prov

inci

al le

vel

the

dist

rict

leve

l dat

a is

agg

reshy

gate

d to

giv

e th

e pr

ovin

cial

leve

l dat

a

6 N

atio

nal

leve

l da

ta

At

the

natio

nal

leve

l th

e M

ampE

Man

ager

rec

eive

s da

ta

from

the

PASC

Os

for

each

of t

he p

rovi

nces

Dat

a is

als

o re

ceiv

ed fr

om th

e R

eshyfe

rral

hos

pita

ls a

nd o

ther

fac

ilitie

s at

the

ref

erra

l ho

spita

l or

ter

tiary

lev

el

The

data

rec

eive

d at

the

nat

iona

l lev

el is

als

o co

pied

to

the

Hea

d of

NA

SCO

P an

d PM

TCT

prog

ram

me

man

ager

The

Mamp

E m

anag

er a

t NA

SCO

P ag

greg

ates

85

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

12

MA

GN

ITU

DE

OF

HIV

IN P

REG

NA

NC

YIN

KEN

YA

Ken

ya N

atio

nal

AID

SST

I C

ontr

ol P

rogr

amm

e (N

ASC

OP)

est

imat

es t

hat

ther

e w

ere

12

mill

ion

babi

es b

orn

in 2

006

in K

enya

and

that

as

man

y as

9

of p

regn

ant w

omen

inK

enya

wer

e liv

ing

with

HIV

AID

S10

At

leas

t 50

000

to

600

00 i

nfan

ts i

n K

enya

wer

e th

ough

t to

hav

e be

en i

nfec

ted

with

H

IV a

s a

resu

lt of

MTC

T th

at y

ear

With

an

estim

ated

pop

ulat

ion

of 3

72

mill

ion

in th

eye

ar 2

007

the

num

ber

of b

irth

s in

200

7 w

as 1

73

mill

ion

With

an

HIV

pre

vale

nce

of 6

7

the

num

ber

of H

IV -

expo

sed

babi

es is

114

101

and

at

leas

t 45

640

HIV

-pos

itive

bab

ies

are

born

ass

umin

g a

40

tran

smis

sion

(Tab

le 1

2)

Tabl

e 1

2 E

stim

ated

mag

nitu

de o

f MTC

T in

Ken

ya 2

007

Popu

latio

n (E

stim

ates

200

7)

372

mill

ion

Birt

hs p

er a

nnum

1

73 m

illio

n

HIV

pre

vale

nce

in m

othe

rs

67

Tota

l num

ber o

f birt

hs to

HIV

-infe

cted

mot

hers

exp

osed

14

110

1 to

MTC

T as

sum

ing

no m

ultip

le p

regn

ancy

Num

ber o

f HIV

pos

itive

infa

nts

per a

nnum

in K

enya

45

640

as

sum

ing

40

tran

smis

sion

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

22

13

RIS

KS

OF

T RA

NSM

ISSI

ON

OF

MTC

T A

T D

IFFE

REN

T

T

IME

P ER

IOD

S

In K

enya

an

estim

ated

40

000

to 5

000

0 in

fant

s ar

e in

fect

ed w

ith H

IV a

nnua

lly d

ue to

m

othe

r-to

-chi

ld t

rans

mis

sion

Th

is c

an o

ccur

in u

tero

dur

ing

labo

ur a

nd d

eliv

ery

and

thro

ugh

brea

stfe

edin

g D

urin

g pr

egna

ncy

abo

ut 5

to

8 pe

rcen

t of

HIV

-exp

osed

bab

ies

beco

me

infe

cted

thr

ough

tra

nsm

issi

on a

cros

s th

e pl

acen

ta L

abou

r an

d de

liver

y po

ses

the

grea

test

ris

k fo

r tr

ansm

issi

on w

ith 1

0 to

20

perc

ent

of e

xpos

ed i

nfan

ts b

ecom

ing

infe

cted

at t

his

time

Bre

astf

eedi

ng a

lso

expo

ses

infa

nts

to H

IV

Whe

n m

othe

rs b

reas

tfee

d fo

r 18

to

24m

onth

s an

othe

r 10

to 1

5 pe

rcen

t of i

nfan

ts b

ecom

e in

fect

ed T

hus

in n

on-b

reas

tfee

ding

po

pula

tions

with

out

antir

etro

vira

l tre

atm

ent

appr

oxim

atel

y 15

to

30 p

erce

nt in

fant

s w

ill b

ecom

e in

fect

ed

with

pro

long

ed b

reas

tfee

ding

25

to

45 p

erce

nt i

nfan

ts w

ill

beco

me

infe

cted

Tabl

e 1

3 T

rans

mis

sion

pat

tern

s in

bre

astfe

edin

g an

d no

n br

east

feed

ing

popu

latio

ns

Tran

smis

sion

rate

in

Tim

ing

No

Bre

astfe

edin

g B

reas

tfeed

ing

Bre

astfe

edin

g th

roug

h

thro

ugh

6

mon

ths

18 to

24

mon

ths

Dur

ing

preg

nanc

y 05

to 1

0 05

to 1

0 05

to 1

0

Dur

ing

labo

ur

10 to

20

10 to

20

10 to

20

Thro

ugh

brea

stfe

edin

g 10

to 2

0 05

to 1

0 05

to 1

0

Ear

ly (f

irst 2

mon

ths)

10

to 2

0 05

to 1

0 05

to 1

0

Late

(afte

r 2 m

onth

s)

10 to

20

01 to

05

05 to

10

Ove

rall

15 to

30

25 to

35

30 to

45

Sou

rce

De

Coc

k K

M (2

002)

Form

MoH

711

has

bee

n re

com

men

ded

to r

epla

ce F

orm

MoH

726

HIV

Mamp

E d

ata

flow

pip

elin

e fr

om t

he i

ndiv

idua

l he

alth

fac

ilitie

s t

o th

e di

stri

ct a

ndpr

ovin

cial

leve

ls u

p to

the

cent

ral o

r na

tiona

l lev

els

at N

ASC

OP

and

NA

CC

is s

umm

ashyri

sed

in F

igur

e 1

01

Figu

re 1

01

HIV

Mon

itorin

g an

d Ev

alua

tion

data

flow

pip

elin

e in

Ken

ya

HM

IS

NA

SC

OP

N

ACC

H

ead

Nat

iona

l Dat

a B

ank

amp

Res

ourc

e C

entre

M

E M

anag

er

The

Dire

ctor

P

rogr

amm

e M

anag

er

ME

Man

ager

Ref

erra

l Hos

pita

ls

CE

Os

Spe

cial

ists

The

Prov

ince

P

MO

P

AS

CO

P

AR

TO

PH

RIO

P

CO

The

Dis

trict

D

MO

D

AS

CO

Dat

a en

try

cler

k D

AR

TO

DH

RIO

Hea

lth F

acilit

y P

ublic

Sec

tor

FBO

etc

23

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

84

Cha

pter

10

Mon

itorin

g an

d Ev

alua

tion

of P

MTC

T Se

rvic

es

101

IN

TRO

DU

CTI

ON

PMTC

T pr

ogra

m m

onito

ring

and

eva

luat

ion

activ

ities

pro

vide

the

oppo

rtun

ity to

mea

sshyur

e an

d ap

prai

se p

erfo

rman

ce w

ithin

def

ined

par

amet

ers

that

ens

ure

acco

mpl

ishm

ent

of g

oals

and

obj

ectiv

es

Ken

ya is

com

mitt

ed to

the

ldquoThr

ee-o

nesrdquo

pri

ncip

les

whi

ch a

re

bull O

ne a

gree

d A

IDS

Act

ion

Fra

mew

ork

that

pro

vide

s th

e ba

sis

for

coor

dina

ting

the

wor

k pl

an o

f al

l par

tner

s

bull O

ne N

atio

nal A

IDS

Coo

rdin

atin

g A

utho

rity

with

a b

road

-bas

ed

mul

tisec

tora

l man

date

bull O

ne a

gree

d co

untr

y-le

vel M

onito

ring

and

Eva

luat

ion

(M

ampE

) sy

stem

In l

ine

with

thi

s t

he c

ount

ry h

as d

evel

oped

the

Nat

iona

l H

IVA

IDS

Mon

itori

ng a

ndE

valu

atio

n Fr

amew

ork

that

pro

vide

s st

akeh

olde

rs w

ith a

too

l fo

r w

ell

coor

dina

ted

in

terl

inke

d an

d fu

nctio

nal H

IVA

IDS

Mamp

E s

yste

m t

hat

allo

ws

for

effic

ient

mon

itori

ngof

int

erve

ntio

ns i

n ac

hiev

ing

the

natio

nal

prog

ram

mat

ic g

oals

usi

ng d

efin

ed t

arge

ts

This

pro

vide

s th

e fr

amew

ork

for M

ampE

act

iviti

es w

ithin

PM

TCT

prog

ram

s

Nat

iona

l PM

TCT

data

is

repo

rted

usi

ng M

oH I

nteg

rate

d M

onito

ring

and

Eva

luat

ion

Rep

ortin

g Fo

rms

For

m M

oH 7

11 o

r Fo

rm M

oH 7

27

Indi

vidu

al P

MTC

T da

ta is

col

shyle

cted

at

the

heal

th f

acili

ties

offe

ring

PM

TCT

serv

ices

usi

ng s

tand

ard

MoH

reg

iste

rs(A

NC

Mat

erni

ty a

nd P

ostn

atal

Reg

iste

rs)

On

mon

thly

bas

is t

he h

ealth

faci

litie

s w

ill a

ggre

gate

the

dat

a fr

om t

he r

egis

ters

on

to

Form

MoH

711

or

MO

H 7

26 w

hich

is th

en fo

rwar

ded

upw

ards

to th

e D

ASC

Orsquos

offic

e A

copy

is

left

at

the

heal

th f

acili

ty f

or t

heir

ow

n da

ta u

se

At

the

dist

rict

lev

el

the

DA

SCO

rsquos of

fice

aggr

egat

es d

ata

from

sev

eral

hea

lth f

acili

ty s

peci

fic F

orm

726

ont

o Fo

rm M

oH 7

27 (o

r Fo

rm 7

11) t

hat

is u

sed

to s

umm

aris

e an

d re

port

dis

tric

t le

vel d

ata

B

oth

Form

726

and

For

m M

oH 7

27 a

re th

en s

ent t

o N

ASC

OP

A c

opy

of th

e Fo

rm 7

27

or F

orm

711

is s

ent t

o th

e PA

SCO

and

ano

ther

to th

e he

alth

faci

litie

s in

the

dist

rict

for

thei

r ow

n da

ta u

se

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

14

RIS

K F

AC

TOR

SFO

R M

TCT

OF

HIV

M

any

fact

ors

are

know

n or

sus

pect

ed t

o in

crea

se t

he r

isk

of a

n H

IV in

fect

ed m

othe

r tr

ansm

ittin

g th

e vi

rus

to h

er i

nfan

t Th

ese

fact

ors

incl

ude

the

HIV

vir

al l

oad

in t

he

mot

her

as

wel

l as

othe

r m

ater

nal

obst

etri

cal

vira

l and

infa

nt fa

ctor

s (T

able

14

)

The

mos

t sig

nific

ant r

isk

fact

or a

ppea

rs to

be

the

HIV

vir

al lo

ad in

the

mot

her

thou

gh

the

othe

r fa

ctor

s m

ay a

lso

cont

ribu

te t

o in

crea

sing

an

infa

ntrsquos

expo

sure

or

susc

eptib

ilshyity

to

acqu

irin

g H

IV S

ome

fact

ors

may

cau

se a

bre

akdo

wn

in t

he p

rote

ctio

n of

fere

d to

the

foet

us b

y th

e pl

acen

ta w

hich

in n

orm

al c

ircu

mst

ance

s w

ould

not

allo

w H

IV to

cro

ssth

e pl

acen

ta fr

om m

othe

r to

foet

us

Tran

smis

sion

dur

ing

labo

ur a

nd d

eliv

ery

occu

rs w

hen

the

infa

nt s

ucks

im

bibe

s or

asshy

pira

tes

mat

erna

l bl

ood

or c

ervi

cal

secr

etio

ns t

hat

cont

ain

HIV

or

whe

n it

has

othe

r m

ucou

s m

embr

ane

expo

sure

Tab

le 1

4

Ris

k fa

ctor

s fo

r M

TCT

of H

IV

Stro

ng e

vide

nce

Lim

ited

evid

ence

VIR

AL

MA

TER

NA

L

OB

STE

TRIC

AL

FETA

LIN

FAN

T

BR

EA

ST-

FEE

DIN

G

Hig

h vi

ral l

oad

Imm

une

defic

ienc

y (lo

w

CD

4 co

unt)

HIV

infe

ctio

n ac

quire

d du

ring

preg

nanc

y o

r br

east

feed

ing

perio

d

Vagi

nal d

eliv

ery

(com

pare

d to

ele

ctiv

e ca

esar

ean

sect

ion)

ru

ptur

e of

the

mem

bran

es

for m

ore

than

4 h

ours

Prem

atur

ity

Dur

atio

n of

bre

astfe

edin

g

mix

ed fe

edin

g b

reas

t di

seas

e (m

astit

isc

rack

ed

nipp

les)

Vira

l res

ista

nce

(theo

retic

al p

ossi

bilit

y)

Vira

l gen

otyp

e an

d ph

enot

ype

Vita

min

A d

efic

ienc

y a

naem

ia s

exua

lly

trans

mitt

ed d

isea

ses

ch

orio

amni

oniti

s fr

eque

nt u

npro

tect

ed

sexu

al in

terc

ours

e m

ultip

le s

exua

l pa

rtner

s s

mok

ing

inje

ctin

g dr

ug a

buse

Inva

sive

or t

raum

atic

pro

cedu

res

in

stru

men

tal d

eliv

erie

s a

mni

ocen

tesi

s

epis

ioto

my

ext

erna

l cep

halic

ver

sion

(E

CV

) et

c i

ntra

partu

m h

aem

orrh

age

Lesi

ons

of s

kin

and

or m

ucou

s m

embr

anes

Ora

l thr

ush

(bab

y)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

3

24

15

BEN

EFIT

SO

F P R

EVEN

TIN

G M

OTH

ER-T

O-C

HIL

D

T

RA

NSM

ISSI

ON

OF

HIV

A

IDS

rela

ted

deat

hs a

re r

ever

sing

gai

ns m

ade

in c

hild

hea

lth a

nd s

urvi

val i

n K

enya

C

arin

g fo

r H

IV-in

fect

ed c

hild

ren

has

maj

or e

cono

mic

and

soc

ial

impa

cts

on f

amili

es

and

heal

th s

yste

ms

Thu

s at

the

nat

iona

l lev

el p

reve

ntin

g M

TCT

has

the

pote

ntia

l to

incr

ease

the

unde

rsta

ndin

g an

d ac

cept

ance

of t

he H

IVA

IDS

epid

emic

and

thos

e liv

ing

with

HIV

AID

S C

ouns

ellin

g t

estin

g an

d co

mm

unity

sen

sitis

atio

n ca

n co

ntri

bute

to

redu

cing

stig

ma

Red

uctio

n of

MTC

T of

HIV

bull

Dec

reas

es n

umbe

rs o

f H

IV in

fect

ed c

hild

ren

bull

Incr

ease

s ch

ild h

ealth

and

sur

viva

l

bull

Dec

reas

es t

he lo

ad o

n th

e he

alth

sys

tem

bull

Giv

es a

n op

port

unity

to im

prov

e an

d ex

pand

hea

lth s

ervi

ces

as w

ell a

s to

str

engt

hen

the

exis

ting

heal

th in

fras

truc

ture

16

BEN

EFIT

SO

F H

IV C

OU

NSE

LLIN

GA

ND T

ESTI

NG

(CT)

(a) I

t pro

mot

es b

ehav

iour

cha

nge

by

bull R

educ

ing

high

ris

k be

havi

our

for

HIV

bull Id

entif

ying

HIV

dis

cord

ant

coup

les

bull In

crea

sing

the

use

of

dual

met

hods

of f

amily

pla

nnin

g an

d S

TI

prev

entio

n

bull Im

prov

ing

ante

nata

l car

e

bull G

uidi

ng in

fant

fee

ding

(b) I

t ena

bles

pre

vent

ive

ther

apy

for

bull

Mal

aria

bull O

ppor

tuni

stic

infe

ctio

ns (

eg

Pne

umoc

ystis

jiro

veci

i pn

eum

onia

)

bull T

B

25

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

82

Foo

tnot

es

9

Use

oth

er o

ptions

for

child

ren o

ver

9 k

ilogra

ms

10

Use

reg

ula

r or

double

-str

ength

tab

lets

for

child

ren o

ver

16 k

ilogra

ms

NO

T A

PP

LIC

AB

LE

bullPsp

sm

ear

The

fram

ewor

k be

low

illu

stra

tes

poin

ts o

f int

egra

tion

of c

ompr

ehen

sive

HIV

ca

re p

acka

ge in

to e

xist

ing

child

hea

lth s

ervi

ces

Fram

ewor

k for

integ

ratio

n F

rom

Ped

iatr

ic H

IV P

reve

nti

on

to C

are

A

Co

nce

ptu

al F

ram

ewo

rk N

ewb

orn

In

fan

t W

om

an

H

IV e

duca

tion

Pre

gn

an

cy

prev

entio

n C

T

bull F

ocus

ed A

NC

incl

udin

g

AR

V p

roph

ylax

is s

tagi

ng

STI

syph

ilis

CT

Z p

roph

ylax

isA

RT

M

alar

ia tr

eatm

ent amp

pre

vent

ion

CD

4 w

here

ava

ilabl

e in

clud

ing

IPT

amp I

TNs

Infa

nt f

eedi

ng c

ouns

elin

g (I

FC)

Lab

ou

r an

d D

eliv

ery

U

nive

rsal

pre

caut

ions

CT

for

unt

este

d m

othe

rs in

clud

ing

bull D

eliv

ery

care

bull E

OC

-Em

erge

ncy

obst

etri

c ca

re

part

ner

bull R

efer

ral s

yste

m

AR

V p

roph

ylax

is

(mot

her

and

infa

nt)

AR

T C

TZ

pro

phyl

axis

Exc

lusi

ve b

reas

t fe

edin

g or

rep

lace

men

t fe

edin

g

Post

Na

tal

Ca

re

Infa

nt fe

edin

g co

unse

ling

bull B

reas

t hea

lth

Dia

gnos

is (

antib

ody)

if

bull Se

xual

hea

lth

expo

sure

unk

now

n bull

Fam

ily

plan

ning

D

NA

PC

R if

exp

osed

CT

Z p

roph

ylax

is I

FC-

infa

nt f

eedi

ng c

ouns

elin

g

CT

for

unt

este

d m

othe

rs

CT

for

par

tner

D

BS

resu

lt I

FC

IFC

Wea

ning

Bf

eedi

ng

cess

atio

n s

uppo

rt

bullBre

ast e

xam

D

iagn

osis

(an

tibod

y

bullPap

sm

ear

test

) C

T f

or n

egat

ive

wom

en a

nd p

artn

ers

Dia

gnos

is (

antib

ody

test

)

New

born

Ca

re

bull B

CG

bull P

olio

0

bull Is

sue

child

hea

th c

ard

bullEnt

er b

irth

wei

ght

HIV

an

d A

RV

Exp

osur

e st

atus

on

chi

ld h

ealth

car

d Tw

o w

eeks

Infa

nt fe

edin

g co

unse

ling

Six

wee

ks

Imm

uniz

atio

ngr

owth

mon

itori

ng

Ten

wee

ks

im

mun

izat

ion

GM

Fou

rtee

n w

eeks

Im

mun

izat

ion

grow

th m

onito

ring

Si

x m

onth

s

Com

plem

enta

ry fe

eds

Vita

min

A S

uppl

emen

tatio

n

9 m

onth

s

imm

uniz

atio

nG

M

12 amp

18

mon

ths

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

17

(c) I

t pro

mot

es a

cces

s to

ear

ly m

edic

al c

are

bull

Obs

tetr

ical

car

e

bull T

B th

erap

y

bull M

alar

ia t

reat

men

t

bull S

TI t

reat

men

t

bull A

RV

the

rapy

for

mot

her

and

fam

ily

(d) I

t hel

ps to

pla

n fo

r the

futu

re

bull In

fant

fee

ding

sup

port

sys

tem

s

bull F

amily

pla

nnin

g

bull P

erso

nal a

nd f

inan

cial

dec

isio

ns

(e) I

t ena

bles

pre

vent

ive

ther

apy

of m

alar

ia a

nd

othe

r opp

ortu

nist

ic in

fect

ions

suc

h a

PCP

(f) It

giv

es ti

me

to p

lan

for t

he fu

ture

eg

inf

ant

feed

ing

supp

ort s

yste

ms

TH

E F O

UR-P

RO

NG

ED A

PPR

OA

CH

TO P

MTC

T Th

e In

ter

Age

ncy

Task

Tea

m o

n Pr

even

tion

of H

IV T

rans

mis

sion

in p

regn

ant

wom

en

mot

hers

and

the

ir c

hild

ren

(IA

TT)

has

prop

osed

a f

our-

pron

ged

appr

oach

for

the

pre

shyve

ntio

n of

HIV

tra

nsm

issi

on t

hat

targ

ets

non-

preg

nant

and

pre

gnan

t w

omen

mot

hers

and

thei

r ch

ildre

n

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

1

26

The

four

pro

ngs

are

1 P

rimar

y pr

even

tion

of H

IV in

fect

ion

in w

omen

2 P

reve

ntio

n of

uni

nten

ded

preg

nanc

y am

ong

HIV

-inf

ecte

d w

omen

3 I

nter

vent

ions

to

redu

ce t

rans

mis

sion

fro

m H

IV-i

nfec

ted

preg

nant

and

la

ctat

ing

wom

en t

o th

eir

child

ren

4 C

are

and

supp

ort

of w

omen

ch

ildre

n an

d fa

mili

es in

fect

ed a

nd

affe

cted

by

HIV

and

AID

S (

The

PM

TC

T-p

lus)

Ove

rall

the

cov

erag

e of

PM

TCT

prog

ram

mes

and

the

upt

ake

of s

ervi

ces

prov

ided

thro

ugh

thes

e pr

ogra

mm

es

incl

udin

g H

IV

test

ing

and

coun

selli

ng

and

AR

V

prop

hyla

xis

are

still

ver

y lo

w I

n 20

06 w

orld

wid

e le

ss t

han

10

of

preg

nant

wom

ente

stin

g H

IV-p

ositi

ve r

ecei

ved

AR

V d

rugs

for

PMTC

T11

In K

enya

acc

ordi

ng to

the

2007

Ken

ya A

IDS

Indi

cato

r Su

rvey

(KA

IS) 7

the

re h

as b

een

a sm

all i

ncre

ase

in H

IV te

stin

g am

ong

wom

en a

nd m

en c

ompa

red

to th

e 20

03 K

DH

S

KA

IS s

how

s th

at t

houg

h a

vast

maj

ority

(83

)

of H

IV-in

fect

ed w

omen

and

men

in

Ken

ya d

o no

t kn

ow t

heir

HIV

sta

tus

the

re h

as b

een

a cl

ear

and

dram

atic

incr

ease

inco

vera

ge o

f HIV

-tes

ting

amon

g A

NC

clin

ic a

tten

dees

PMTC

T se

rvic

es a

re t

here

fore

im

port

ant

entr

y po

ints

for

HIV

pre

vent

ion

and

trea

tshym

ent

Ove

rall

AR

V c

over

age

for

HIV

infe

cted

peo

ple

who

nee

d tr

eatm

ent

in K

enya

ison

ly 3

5

bull 9

0

of K

enya

n w

omen

who

del

iver

ed in

the

last

4 y

ears

att

end

AN

C

bull 5

7 o

f th

ose

atte

ndin

g A

NC

tes

ted

for

HIV

bull A

mon

g H

IV in

fect

ed w

omen

with

rec

ent

birt

hs

47

wer

e te

sted

in

AN

C

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

(8)

HIV

dis

ease

sta

ging

in H

IV-in

fect

ed c

hild

ren

Dis

ease

sta

ging

with

or

with

out

labo

rato

ry s

uppo

rt f

ollo

ws

HIV

dia

gshyno

sis

Sta

ging

HIV

dis

ease

pro

vide

s a

guid

e to

the

prog

nosi

s an

d in

tershy

vent

ions

nee

ded

at th

e di

ffere

nt s

tage

s (R

efer

to C

hapt

er 5

and

8)

(9)

AR

V th

erap

y

Chi

ldre

n w

ho a

re e

ligib

le fo

r A

RT

shou

ld b

e lin

ked

with

the

AR

T pr

oshygr

am a

nd p

rovi

ded

with

trea

tmen

t acc

ordi

ng to

Nat

iona

l Gui

delin

es a

sso

on a

s an

HIV

dia

gnos

is i

s m

ade

Ear

ly t

reat

men

t si

gnifi

cant

ly r

eshydu

ces

mor

talit

y in

HIV

infe

cted

chi

ldre

n

(10)

C

omm

unic

atio

n

Com

mun

icat

ing

with

car

e-pr

ovid

ers

and

prov

idin

g ps

ycho

soci

al s

upshy

port

for

the

child

mot

her

care

give

r an

d fa

mily

are

a c

ruci

al c

ompo

nent

of

car

e

Pare

nts

care

give

rs a

ndo

r th

e ch

ild n

eed

to p

artic

ipat

e in

mak

ing

deci

shysi

ons

and

plan

ning

app

ropr

iate

car

e fo

r th

e ch

ild i

nclu

ding

dec

isio

nsab

out t

hera

py a

nd w

here

the

child

sho

uld

rece

ive

care

In

this

res

pect

he

alth

wor

kers

mus

t en

sure

tha

t th

e fa

mily

con

side

rs t

he s

ocia

l nee

ds

of H

IV in

fect

ed a

nd a

ffect

ed c

hild

ren

Hea

lth c

are

wor

kers

sho

uld

ensu

re th

at th

ey p

rovi

de a

dequ

ate

time

for

care

give

rs to

ask

que

stio

ns s

o th

at th

ey c

an fu

lly u

nder

stan

d th

e im

plishy

catio

ns o

f HIV

and

HIV

tes

ting

for

them

selv

es a

nd fo

r th

eir

child

ren

H

ealth

car

e w

orke

rs s

houl

d co

unse

l car

egiv

ers

on d

iscl

osur

e in

clud

ing

disc

losu

re to

the

child

(11)

R

efer

rals

Ref

erra

ls a

re a

n im

port

ant p

art o

f man

agin

g an

HIV

exp

osed

or

infe

cted

chi

ld

Thes

e in

clud

e re

ferr

als

to

bull H

ighe

r le

vels

of s

peci

alis

ed c

are

for

furt

her

inve

stig

atio

ns a

nd

trea

tmen

t

bull S

ocia

l sup

port

pro

gram

mes

bull C

omm

unity

-bas

ed c

are

prog

ram

mes

bull P

ITC

site

s fo

r pa

rent

s an

d si

blin

gs

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

2

7

80

Tabl

e 9

2 W

HO

Rec

omm

enda

tions

for

Follo

w-u

p of

an

HIV

-Exp

osed

Chi

ld

bull A

t birt

h (f

or in

fant

s de

liver

ed a

t ho

me)

bull A

t age

1 t

o 2

wee

ks (

mai

nly

for

infa

nt f

eedi

ng c

ouns

elin

g)

bull A

t ag

e 6

10

and

14

wee

ks (

for

imm

uniz

atio

n an

d in

fant

fee

ding

co

unse

ling)

bull A

fter

age

14

wee

ks

mon

thly

thr

ough

age

12

mon

ths

bull A

fter

age

12 m

onth

s e

very

3 m

onth

s th

roug

h 24

mon

ths

bull A

t 18

mon

ths

do

conf

irm

ator

y H

IV la

bora

tory

test

(if

ther

e ar

e no

re

sour

ces

for

an e

arlie

r an

tigen

-bas

ed t

est)

bull A

fter

2 ye

ars

a m

inim

um o

f ye

arly

vis

its

For t

he H

IV-in

fect

ed f

ollo

w th

ese

guid

elin

es

From

M

onito

r

6 w

eeks

ndash12

mon

ths

Mon

thly

12 ndash

24 m

onth

s Ev

ery

3 m

onth

s

24 m

onth

s an

d on

war

ds

Yea

rly i

f not

sym

ptom

atic

If sy

mpt

omat

ic f

ollo

w u

p as

nee

ded

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

18

OV

ERV

IEW

OF

THE

NEW

PM

TCT

GU

IDEL

INES

Ken

yarsquos

Min

istr

y of

Hea

lth (

MO

H)

thro

ugh

NA

SCO

P h

as t

aken

sev

eral

act

ions

to

expa

nd a

nd s

tren

gthe

n PM

TCT

inte

rven

tions

in

the

coun

try

In

2000

a

Nat

iona

lTe

chni

cal

Wor

king

Gro

up (

TWG

) on

PM

TCT

was

for

med

Th

e TW

G

co-c

hair

ed b

yN

ASC

OP

and

the

Div

isio

n of

Rep

rodu

ctiv

e H

ealth

co

ordi

nate

s im

plem

enta

tion

and

prov

ides

tec

hnic

al s

uppo

rt t

o th

e N

atio

nal

PMTC

T Pr

ogra

m

The

TWG

ser

ves

as a

foru

m t

o up

date

sta

keho

lder

s an

d di

scus

s ch

alle

nges

and

upc

omin

g ac

tiviti

es

The

TWG

is

also

res

pons

ible

for

upd

atin

g na

tiona

l gu

idel

ines

for

PM

TCT

The

nat

iona

l PM

TCT

prog

ram

was

offi

cial

ly l

aunc

hed

in 2

002

NA

SCO

P al

so e

stab

lishe

d se

vera

lpi

lot P

MTC

T si

tes

thro

ugho

ut th

e co

untr

y an

d pr

epar

ed n

atio

nal P

MTC

T gu

idel

ines

The

goal

of t

he n

atio

nal P

MTC

T pr

ogra

m is

in li

ne w

ith th

e go

al s

et o

ut a

t the

Uni

ted

Nat

ions

Gen

eral

Ass

embl

y Sp

ecia

l Ses

sion

on

HIV

AID

S (U

NG

ASS

) in

2001

to

redu

ceth

e pr

opor

tion

of in

fant

s in

fect

ed w

ith H

IV b

y 20

b

y th

e ye

ar 2

005

and

50

by

2010

In

Ken

ya t

he n

atio

nal P

MTC

T pr

ogra

m p

lann

ed t

o ex

tend

its

serv

ices

to

at le

ast

80

of

all

heal

th f

acili

ties

by 2

0071

2 A

ccor

ding

to

the

2003

PM

TCT

serv

ice

stat

istic

sap

prox

imat

ely

9 o

f al

l pr

egna

nt w

omen

rec

eive

d PM

TCT

serv

ices

in

that

yea

rC

urre

ntly

mor

e th

an 5

0 o

f al

l pr

egna

nt w

omen

in

Ken

ya r

ecei

ve P

MTC

T se

rvic

es

Thes

e gu

idel

ines

are

bas

ed o

n a

publ

ic h

ealth

app

roac

h to

car

e t

akin

g in

to c

onsi

dera

shytio

n is

sues

of

feas

ibili

ty a

nd a

ccep

tabi

lity

in

addi

tion

to e

ffica

cy a

nd c

ost-

bene

fit i

ndi

ffere

nt s

ettin

gs

The

guid

elin

es a

re e

xpec

ted

to i

mpr

ove

the

upta

ke

qual

ity a

nd

effe

ctiv

enes

s of

PM

TCT

serv

ices

in th

e co

untr

y

19

OB

JEC

TIV

ESA

ND O

RG

AN

ISA

TIO

NO

FTH

E G

UID

ELIN

ES

The

PMTC

T gu

idel

ines

are

par

t of

the

impl

emen

tatio

n in

stru

men

ts t

owar

ds u

nive

rsal

ac

cess

to

PMTC

T se

rvic

es a

nd a

res

pons

e to

the

cal

l to

actio

n to

war

ds H

IV-fr

ee a

ndA

IDS-

free

gen

erat

ion

Tog

ethe

r w

ith tw

o ot

her

guid

elin

es (A

RV

Ther

apy

in A

dults

and

Ad

oles

cent

s an

d AR

V Th

erap

y in

Inf

ants

and

You

ng C

hild

ren)

th

ey f

orm

a t

rilo

gy

aim

ed a

t co

ntex

tual

isin

g an

d m

ains

trea

min

g th

e W

HO

tri

logy

of

guid

elin

es o

n H

IVA

IDS

prev

entio

n an

d tr

eatm

ent

The

cont

ext

reso

urce

s an

d de

man

ds o

f PM

TCT

prog

ram

mes

diff

er g

reat

ly a

cros

s co

unshy

trie

s an

d ev

en a

cros

s pr

ogra

mm

es w

ithin

the

sam

e co

untr

y C

onsi

deri

ng t

his

vari

abilshy

ity t

hese

gui

delin

es in

clud

e th

e cu

rren

t con

sens

us o

n be

st p

ract

ices

as

wel

l as

alte

rnashy

tives

whi

ch m

ight

be

mor

e ap

prop

riat

e in

par

ticul

ar s

ettin

gs E

xper

ts a

gree

tha

t th

e ldquos

tate

of

the

artrdquo

in

PMTC

T is

cha

ngin

g ra

pidl

y an

d th

at r

ecom

men

datio

ns w

ill c

ershy

tain

ly a

lter

with

adv

ance

s in

med

ical

sci

ence

and

as

mor

e pr

ogra

mm

e ex

peri

ence

is

docu

men

ted

and

diss

emin

ated

The

are

as o

f A

RV

pro

phyl

axis

and

inf

ant

feed

ing

are

part

icul

arly

sub

ject

to r

apid

cha

nge

In 2

005

the

WH

O is

sued

pro

pose

d re

visi

ons

to it

s re

com

men

datio

ns o

n th

e us

e of

ant

ishyre

trov

iral

dru

gs f

or P

MTC

T T

he r

ecom

men

datio

ns w

ere

the

prod

uct

of e

xper

ts w

ho

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

9

28

conv

ened

to

disc

uss

impo

rtan

t ne

w i

nfor

mat

ion

conc

erni

ng t

he d

evel

opm

ent

of r

esis

shyta

nce

in w

omen

and

chi

ldre

n us

ing

sing

le d

ose

nevi

rapi

ne (S

dNV

P) fo

r PM

TCT

as w

ell

as n

ew c

linic

al fi

ndin

gs o

n st

rate

gies

that

mig

ht r

educ

e th

e de

velo

pmen

t of r

esis

tanc

e

Bas

ed o

n th

e ne

w W

HO

gui

delin

es K

enya

rsquos TW

G h

as d

evel

oped

sim

ple

pra

ctic

al a

nd

evid

ence

-bas

ed r

ecom

men

datio

ns o

n PM

TCT

that

wou

ld w

ork

in a

var

iety

of r

esou

rce-

limite

d en

viro

nmen

ts a

nd c

linic

al s

ituat

ions

that

con

fron

t hea

lthca

re w

orke

rs n

ot o

nly

in K

enya

but

als

o in

oth

er d

evel

opin

g co

untr

ies

110

U

SIN

GTH

E G

UID

ELIN

ES

Thes

e gu

idel

ines

are

inte

nded

prim

arily

for u

se b

y PM

TCT

prov

ider

s Th

ese

inclu

de n

urse

sm

idw

ives

clin

ical o

ffice

rs d

octo

rs c

ouns

ello

rs n

utrit

ioni

sts

and

othe

r he

alth

care

pro

fesshy

sion

als

They

will

als

o be

use

ful a

s a re

fere

nce

for p

rogr

amm

e m

anag

ers a

t fac

ility

dis

trict

pr

ovin

cial

and

nat

iona

l lev

els

thro

ugho

ut th

e he

alth

sec

tor

The

guid

elin

es a

re d

ivid

ed in

tote

n ch

apte

rs a

s out

lined

in T

able

15

The

spec

ific

obje

ctiv

es o

f the

new

PM

TCT

guid

elin

es a

re to

bull O

utlin

e th

e po

licy

issu

es in

pro

vidi

ng P

MT

CT

serv

ices

bull R

ecom

men

d op

erat

iona

l gui

delin

es to

be

follo

wed

by

heal

th c

are

prov

ider

s of

PM

TC

T se

rvic

es

bull E

nabl

e pr

ovid

ers

of P

MT

CT

to s

elec

t an

d pr

escr

ibe

AR

Vs

for

prop

hyla

xis

agai

nst

MT

CT

and

for

trea

tmen

t of

pre

gnan

t w

omen

in

fant

s an

d yo

ung

child

ren

bull S

tand

ardi

se t

he c

are

and

coun

selli

ng g

iven

by

PM

TC

T s

ervi

ce

prov

ider

s re

gard

ing

risk

of

MT

CT

and

on

PM

TC

T

bull I

mpr

ove

PM

TC

T se

rvic

es u

sing

eas

y-to

-use

job

aids

and

a

stan

dard

ised

Mamp

E s

yste

m

Prev

entin

g TB

Fo

r chi

ldre

n ex

pose

d to

sm

ear p

ositi

ve tu

berc

ulos

is

bull E

xclu

de a

ctiv

e T

B th

roug

h ca

refu

l his

tory

ph

ysic

al e

xam

and

in

vest

igat

ions

bull

If

ther

e is

no

evid

ence

of

activ

e T

B

star

t on

IN

H f

or p

roph

ylax

is f

or 6

m

onth

s (I

PT

) bull

If

TB

is p

rese

nt

star

t on

TB

tre

atm

ent

as p

er N

atio

nal T

B g

uide

lines

If

a ch

ild is

bor

n to

a m

othe

r with

act

ive

TB

bull S

tart

on

INH

pro

phyl

axis

(IP

T)

and

give

for

3 m

onth

s bull

Afte

r 3

mon

ths

do a

man

toux

bull

If

man

toux

is n

egat

ive

sto

p IN

H a

nd g

ive

BC

G

bull I

f man

toux

is p

ositi

ve a

t 3

mon

ths

con

tinue

for

a f

urth

er 3

mon

ths

bull A

t the

end

of

prop

hyla

xis

re-v

alua

te f

or a

ctiv

e T

B

|

If no

evi

denc

e of

act

ive

TB d

o no

t tre

at fo

r TB

|

If th

ere

is e

vide

nce

of a

ctiv

e TB

tre

at fo

r TB

as

per N

atio

nal

TB g

uide

lines

(6)

Trea

tmen

t of a

cute

infe

ctio

ns a

nd o

ther

HIV

-rel

ated

con

ditio

ns

HIV

-exp

osed

chi

ldre

n ar

e su

scep

tible

to c

omm

on in

fect

ions

as

wel

l as

OIs

for

the

HIV

infe

cted

and

HIV

may

alte

r th

e in

cide

nce

pre

senshy

tatio

n an

d re

spon

se t

o co

nven

tiona

l th

erap

y I

n so

me

case

s m

ore

aggr

essi

ve a

nd lo

nger

tre

atm

ent

cour

ses

may

be

nece

ssar

y a

s tr

eatshy

men

t fai

lure

s ar

e m

ore

freq

uent

(7)

Reg

ular

follo

w-u

p ca

re amp

refe

rral

s

Reg

ular

follo

w-u

p is

the

back

bone

to c

arin

g fo

r th

e H

IV e

xpos

ed c

hilshy

dren

and

ens

ures

opt

imal

hea

lthca

re a

nd p

sych

osoc

ial s

uppo

rt to

the

fam

ily W

HO

has

mad

e re

com

men

datio

ns o

n fr

eque

ncy

of fo

llow

-up

as s

how

n in

Tab

le 9

2 T

his

is t

he m

inim

um a

nd m

ore

freq

uent

con

shyta

ct w

ith t

he h

ealth

car

e sy

stem

may

be

indi

cate

d fo

r H

IV in

fect

ed

child

ren

and

espe

cial

ly if

they

are

on

anti-

retr

ovir

al tr

eatm

ent

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

2

9

78

Pro

phyl

axis

aga

inst

Pne

umoc

ysti

s ji

rove

cii

Pne

umon

ia (

PC

P)

in c

hild

ren

whe

re C

otri

mox

azol

e is

con

trai

ndic

ated

Ta

ble

15

The

Fou

r-Pr

onge

d A

ppro

ach

App

lied

to th

e PM

TCT

Gui

delin

e

Alte

rnat

ive

drug

s to

use

if C

TX is

con

train

dica

ted

are

give

n be

low

A s

econ

d ch

oice

wou

ld b

e ei

ther

dap

sone

or

atov

aqui

ne

Dap

sone

bull C

hild

ren

gt 1

mon

th

2 m

gkg

24

hour

s or

ally

onc

e da

ily

bull I

f bot

h C

TX

and

Dap

sone

are

con

trai

ndic

ated

(e

g

in c

hilshy

dren

with

G6P

D d

efic

ienc

y w

ho g

et h

aem

olys

is w

ith C

TX

and

D

apso

ne)

the

n us

e ei

ther

Ato

vaqu

one

bull

30m

gkg

day

for

age

1-3

mon

ths

bull H

ighe

r do

se 4

5mg

kgd

ay f

or a

ge 4

-24

mon

ths

OR

Aer

osol

ized

Pen

tam

idin

e

bull 3

00 m

g in

6 m

l wat

er v

ia in

hala

tion

nebu

lizer

onc

e m

onth

ly

bull c

hild

ren

gt 5

year

s

Cha

pter

CH

AP

TER

1

Bac

kgro

und

CH

AP

TER

2

Ant

enat

al C

are

and

Pre

vent

ion

of M

TCT

of H

IV

CH

AP

TER

3

Intra

partu

m C

are

Pron

g 1

Prim

ary

prev

entio

n of

HIV

in

fect

ion

in w

omen

Pron

g 2

Prev

entio

n of

un

inte

nded

pr

egna

ncy

amon

g H

IV in

fect

ed w

omen

Pron

g 3

Inte

rven

tions

to

redu

ce

tran

smis

sion

from

H

IV in

fect

ed

preg

nant

and

la

ctat

ing

wom

en to

th

eir c

hild

ren

Pron

g 4

Car

e an

d su

ppor

t of

wom

en c

hild

ren

and

fam

ilies

in

fect

ed a

nd

affe

cted

by

HIV

A

IDS

C

HA

PTE

R 4

U

se o

f Ant

iretro

vira

l D

rugs

in P

regn

ancy

fo

r Tre

atm

ent a

nd

Pre

vent

ion

of M

othe

r to

Chi

ld

Tran

smis

sion

of H

IV

Infe

ctio

n

CH

AP

TER

5

Imm

edia

te P

ostn

atal

an

d N

eona

tal C

are

CH

AP

TER

6

Late

Pos

tnat

al C

are

and

Fam

ily P

lann

ing

CH

AP

TER

7

HIV

Dia

gnos

is in

C

hild

ren

CH

AP

TER

8

Feed

ing

Infa

nts

and

Youn

g C

hild

ren

born

to

HIV

infe

cted

m

othe

rs

CH

AP

TER

9

Car

e an

d Fo

llow

-up

of C

hild

ren

of H

IV

infe

cted

mot

hers

C

HA

PTE

R 1

0

Mon

itorin

g an

d E

valu

atio

n of

PM

TCT

se

rvic

es

77

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

30

For

each

of t

hese

cha

pter

s (e

xcep

t ch

apte

r on

e on

bac

kgro

und)

the

gui

delin

es g

ive

anin

trod

uctio

n fo

llow

ed b

y po

licy

stat

emen

ts t

hen

oper

atio

nal g

uide

lines

of w

hat p

rovi

dshyer

s sh

ould

do

to r

educ

e m

othe

r-to

-chi

ld t

rans

mis

sion

of

HIV

and

or

to i

mpr

ove

thei

r pe

rfor

man

ce a

nd th

e ef

fect

iven

ess

of th

eir s

ervi

ces

A li

st o

f job

aid

s fo

r us

e by

the

hea

lthca

re p

rovi

der

follo

ws

the

oper

atio

nal g

uide

lines

and

whe

re n

eces

sary

a li

st o

f ap

pend

ices

and

add

ition

al d

ocum

ents

tha

t m

ay b

e re

shyfe

rred

to

but

are

cons

ider

ed t

oo b

ig o

r de

taile

d to

be

incl

uded

with

in t

he m

ain

body

of

the

guid

elin

es

Foo

tnot

es

1

UN

AID

S (

2004)

Rep

ort

on t

he

Glo

bal AID

S E

pid

emic

Ava

ilable

at

ww

wu

nai

ds

org

2

Ibid

2004

3

It

is

import

ant

to r

ecognis

e th

at t

he

use

of

the

phra

se M

TC

T in n

o w

ay is

inte

nded

to

pla

ce b

lam

e on t

he

moth

er

who m

ay o

r m

ay n

ot

know

her

HIV

sta

tus

who t

ransm

its

the

viru

s to

her

child

Pa

thfinder

ack

now

ledges

that

man

y tim

es p

regnant

wom

en

may

hav

e bee

n infe

cted

by

thei

r m

ale

par

tner

and d

o n

ot

hav

e th

e ab

ility

to n

egoti-

ate

safe

r se

x o

r to

see

k M

TC

T s

ervi

ces

for

fear

of

viole

nce

st

igm

a o

r ab

andonm

ent

if t

hei

r st

atu

s is

rev

eale

d

Path

finder

uphold

s th

e re

pro

duct

ive

rights

of

all w

om

en t

o

choose

if

and w

hen

to h

ave

child

ren

regar

dle

ss o

f H

IV-s

tatu

s

4

W

HO

CD

C

Dep

artm

ent

of

Hea

lth a

nd H

um

an S

ervi

ces

(2004)

Pre

vention o

f M

oth

er-t

o-C

hild

Tra

nsm

issi

on o

f H

IV

Gen

eric

Tra

inin

g P

acka

ge

Gen

eva

Sw

itze

r-la

nd

WH

O

5

U

NAID

S (

2004)

Rep

ort

on t

he

Glo

bal AID

S E

pid

emic

Ava

ilable

at

ww

wu

nai

ds

org

6

Polic

y Pro

ject

(2004)

Cove

rage

of

sele

cted

ser

vice

s fo

r H

IVA

IDS p

reve

ntion a

nd

care

in low

and m

iddle

-inco

me

countr

ies

in 2

003

Ava

ilable

at

ww

wp

olia

pro

ject

com

7

Cen

tral Bure

au o

f Sta

tist

ics

(CBS)

[Ken

ya]

Min

istr

y of

Hea

lth (

MO

H)

[Ken

ya]

and

ORC M

acro

(2004)

Ken

ya D

emogra

phic

and H

ealth S

urv

ey 2

003

Cal

vert

on

Mar

y-la

nd

CBSM

OH

an

d O

RC M

acr

o

8

Nat

ional AID

S C

ontr

ol Counci

l 2

007

8a

Ken

ya A

IDS I

ndic

ato

r Surv

ey 2

007

9

Ibid

2004

10

NASCO

P (

2002)

Surv

eilla

nce

data

as

cite

d in N

ASCO

PM

OH

(2

003)

Nat

ional

PM

CT

Str

ate

gic

Managem

ent

Pla

n 2

003-2

007

111

2 A

IDS in K

enya

Tre

nds

Inte

rven

tions

and I

mpact

7th

editio

n

(2005)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Who

Nee

ds P

CP

Prop

hyla

xis

bull A

ll in

fant

s bo

rn t

o H

IV-i

nfec

ted

mot

hers

irr

espe

ctiv

e of

any

ant

iret

rovi

ral

ther

apy

duri

ng p

regn

ancy

and

labo

ur

Pro

phyl

axis

con

tinue

s un

til th

e in

fant

is 1

2 m

onth

s or

is P

CR

neg

ativ

e or

ant

ibod

y ne

gativ

e w

hich

ever

co

mes

ear

lier

bull A

ll in

fant

s id

entif

ied

as H

IV-i

nfec

ted

duri

ng th

e fir

st y

ear

of li

fe b

y a

PC

R

test

or

by a

clin

ical

dia

gnos

is o

f H

IV in

fect

ion

and

a po

sitiv

e an

tibod

y te

st

bull C

hild

ren

olde

r th

an 1

2 m

onth

s w

ith s

ympt

omat

ic H

IV d

isea

se o

r an

A

IDS

-def

inin

g ill

ness

(W

HO

sta

ge I

I an

d III

se

e ch

apte

r 5)

or

with

CD

4 lt

15

or

TLC

150

0m

m3

bull A

ny c

hild

with

a h

isto

ry o

f P

CP

sho

uld

cont

inue

with

sec

onda

ry

prop

hyla

xis

(dai

ly C

T)

for

life

Clin

icia

ns s

houl

d cl

earl

y in

form

HIV

inf

ecte

d m

othe

rs a

t de

liver

y th

at t

heir

chi

ldre

n ne

ed p

roph

ylax

is a

gain

st P

CP

star

ting

at 6

wee

ks o

f age

unt

il it

is e

stab

lishe

d th

at th

e ch

ild i

s no

t H

IV i

nfec

ted

A p

ract

ical

way

to

ensu

re t

hat

mot

hers

and

oth

er h

ealth

wor

kers

are

inf

orm

ed i

s to

mak

e a

note

on

the

child

rsquos im

mun

izat

ion

card

at

birt

h st

atin

g ldquoP

leas

e gi

ve c

o-tr

imox

azol

e (5

mg

kgd

ay o

rally

dai

ly) f

rom

6 w

eeks

of a

gerdquo

Tabl

e 9

1 D

ose

of C

otrim

oxaz

ole

for P

CP

Prop

hyla

xis

Wei

ght o

f C

hild

(kg)

1ndash4

5ndash8

9ndash16

17ndash5

0

gt 50

CT

tabl

ets

20 m

g TM

P1

00

mg

SM

X p

edia

tric

stre

ngth

(120

mg)

1 ta

b

2 ta

bs

Cot

rimox

azol

e su

spen

sion

40

mg

TMP

200

mg

SM

X

5ml (

240

mg)

25

ml

5 m

l

10 m

l

CT

tabl

ets

80 m

g TM

P4

00 m

g S

MX

re

gula

r stre

ngth

(4

80 m

g)

frac14 ta

b

frac12 ta

b

1 ta

b

2 ta

bs

2 ta

bs

CT

Tabl

ets

160

mg

TMP

800

mg

SM

X

Dou

ble

stre

ngth

(9

60 m

g) -

frac14 ta

b

frac12 ta

b

1 ta

b

1 ta

b

In r

are

case

s a

s in

chi

ldre

n w

ith G

6PD

def

icie

ncy

CTX

may

be

cont

rain

dica

ted

G

uid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

3

1

76

(3)

Mon

itor

the

child

rsquos g

row

th a

nd d

evel

opm

ent

as a

mea

ns o

f id

entif

ying

the

ch

ild w

ho is

faili

ng to

thriv

e an

d al

so a

s a

tool

for m

onito

ring

the

effe

ct o

f int

ershy

vent

ions

(4)

Ens

ure

that

im

mun

isat

ions

are

sta

rted

and

com

plet

ed

acco

rdin

g to

the

re

com

men

datio

ns o

f the

nat

iona

l im

mun

isat

ion

sche

dule

|

Add

ition

al c

onsi

dera

tions

are

as

follo

ws

bull

Whe

n co

nsid

erin

g BC

G v

acci

natio

n at

a la

ter a

ge

(re-

vacc

inat

ion

for n

o sc

ar o

r mis

sed

earli

er v

acci

natio

n)

excl

ude

sym

ptom

atic

HIV

infe

ctio

n

bull

Do

not g

ive

yello

w fe

ver v

acci

ne to

sym

ptom

atic

HIV

-infe

cted

chi

lshydr

en H

owev

er a

sym

ptom

atic

chi

ldre

n in

end

emic

are

as s

houl

d re

shyce

ive

the

yello

w fe

ver v

acci

ne a

t 9 m

onth

s of

age

bull

Mea

sles

vac

cine

sho

uld

be g

iven

to H

IV in

fect

ed c

hild

ren

at 6

and

9

mon

ths

sinc

e H

IV in

fect

ed c

hild

ren

expe

rienc

e m

uch

mor

e se

vere

di

seas

e w

ith w

ild m

easl

es v

irus

whi

ch o

utw

eigh

s th

e ris

k of

a m

ilder

illn

ess

from

the

vacc

ine

(5)

Pro

vide

pro

phyl

axis

for o

ppor

tuni

stic

infe

ctio

ns

|

Pro

phyl

axis

aga

inst

Pne

umoc

ystis

jiro

veci

i Pne

umon

ia

bull

Pne

umoc

ystis

jiro

veci

i (fo

rmer

ly P

neum

ocys

tis c

arin

ii) p

neum

onia

(PC

P)

is a

sig

nific

ant c

ause

of m

orbi

dity

and

mor

talit

y am

ong

youn

g in

fant

s in

A

frica

Co-

trim

oxaz

ole

(CTX

) pro

phyl

axis

sig

nific

antly

redu

ces

the

inci

shyde

nce

and

seve

rity

of P

CP

Add

ition

al b

enef

its o

f co-

trim

oxaz

ole

incl

ude

prot

ectio

n ag

ains

t com

mon

bac

teria

l inf

ectio

ns t

oxop

lasm

osis

and

mashy

laria

All

child

ren

born

to H

IV in

fect

ed m

othe

rs s

houl

d re

ceiv

e pr

ophy

shyla

xis

agai

nst P

CP

at l

east

dur

ing

the

first

yea

r of l

ife o

r unt

il th

ey a

re

prov

en to

be

unin

fect

ed (s

ee b

ox b

elow

)

bull

CTX

is c

lear

ly th

e dr

ug o

f cho

ice

for p

roph

ylax

is b

ecau

se o

f its

hig

h

effic

acy

rela

tive

safe

ty l

ow c

ost a

nd b

road

ant

imic

robi

al s

pect

rum

In

cas

e of

CTX

hyp

erse

nsiti

vity

des

ensi

tizat

ion

is re

com

men

ded

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

CH

AP

TE

R 2

Ant

enat

al C

are

and

Prev

entio

n of

MTC

T of

HIV

21

INTR

OD

UC

TIO

N

HIV

inf

ectio

n ha

s em

erge

d in

Ken

ya a

s th

e m

ost

impo

rtan

t he

alth

ris

k fa

ctor

for

m

othe

rs a

nd t

heir

chi

ldre

n an

d ha

s a

grea

t im

pact

on

the

long

ter

m o

utco

me

ofpr

egna

ncy

and

child

sur

viva

l A

ll pr

egna

nt w

omen

sho

uld

be e

ncou

rage

d to

lear

n th

eir

HIV

infe

ctio

n st

atus

as

wel

l as

that

of t

heir

sex

ual p

artn

ers

O

nly

by k

now

ing

onersquos

H

IV s

tatu

s ca

n th

e he

alth

wor

kers

mak

e ap

prop

riat

e he

alth

car

e m

anag

emen

t re

com

men

datio

ns a

nd t

he c

oupl

e m

ake

appr

opri

ate

deci

sion

s ab

out

mai

ntai

ning

the

ir

heal

th a

nd t

hat

of t

heir

unb

orn

baby

Pr

e-co

ncep

tion

care

is

enco

urag

ed w

here

an

oppo

rtun

ity a

rise

s an

d a

birt

h pl

an is

dis

cuss

ed w

ith th

e pr

egna

nt w

oman

In m

ost

case

s t

he p

regn

ant

wom

an w

ill n

ot h

ave

HIV

infe

ctio

n P

regn

ancy

offe

rs a

n op

port

une

time

to d

iscu

ss p

reve

ntio

n of

HIV

inf

ectio

n as

man

y w

omen

com

e in

toco

ntac

t w

ith h

ealth

ser

vice

s fo

r th

e fir

st (

and

in s

ome

case

s th

e on

ly)

time

duri

ng

preg

nanc

y

In K

enya

50

o

f m

arri

ed H

IV p

ositi

ve p

erso

ns h

ave

an H

IV n

egat

ive

spou

se1

Ther

efor

e k

now

ing

the

HIV

inf

ectio

n st

atus

of

onersquos

par

tner

is

criti

cal

Add

ition

ally

th

is f

orm

s an

im

port

ant

entr

y po

int

for

esta

blis

hing

pre

vent

ion

with

po

sitiv

e (P

WP)

pro

gram

s am

ong

coup

les

as w

ell a

s pr

ovid

ing

acce

ss to

HIV

pre

vent

ion

ca

re a

nd tr

eatm

ent s

ervi

ces

for

the

who

le fa

mily

PMTC

T pr

ovid

es a

n op

port

unity

for

prev

entin

g ne

w p

aedi

atri

c H

IV in

fect

ions

as

wel

l as

for

reac

hing

the

10 to

20

of H

IV p

ositi

ve p

regn

ant w

omen

who

mee

t WH

O e

ligib

ilshyity

cri

teri

a fo

r in

itiat

ing

AR

T fo

r th

eir

own

heal

th N

ew in

fect

ions

and

hig

h vi

ral l

oads

duri

ng p

regn

ancy

pos

e th

e gr

eate

st r

isk

of M

TCT

to t

he u

nbor

n ba

by t

hus

prim

ary

prev

entio

n A

RV

pro

phyl

axis

as

wel

l as

trea

tmen

t at t

his

time

is c

ritic

al G

iven

that

25

perc

ent o

f wom

en in

Ken

ya h

ave

an u

nwan

ted

preg

nanc

y s

tren

gthe

ning

the

link

to F

P se

rvic

es a

nd c

ondo

m a

cces

s fo

r du

al p

rote

ctio

n of

fers

a c

hanc

e to

fur

ther

pre

vent

MTC

T2

22

OPE

RA

TIO

NA

L G

UID

ELIN

ES

Ant

enat

al c

are

and

prev

entio

n of

MTC

T du

ring

thi

s pe

riod

can

be

sum

mar

ised

usi

ngan

ess

entia

l pa

ckag

e of

int

egra

ted

ante

nata

l ca

re s

ervi

ces

as s

how

n in

Tab

le 2

1

This

ou

tline

s th

e pa

ckag

e of

ca

re

to

be

prov

ided

to

ev

ery

wom

an

atte

ndin

g A

NC

ser

vice

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

5

32

Tabl

e 2

1 Es

sent

ial P

acka

ge o

f Int

egra

ted

Ant

enat

al C

are

Serv

ices

Gro

up e

duca

tion

Incl

ude

info

rmat

ion

on fo

ur A

NC

vis

its b

reas

tfeed

ing

mat

erna

l and

infa

nt n

utrit

ion

per

sona

l hyg

iene

birt

h pr

epar

edne

ss d

ange

r sig

ns p

reve

ntio

n of

com

plic

atio

ns s

kille

d bi

rth a

ttend

ance

fam

ily p

lann

ing

imm

uniz

atio

n sc

hedu

le

post

-nat

al c

are

and

HIV

and

AID

S m

anag

emen

t

Clie

nt h

isto

ry O

btai

n ro

utin

e da

ta in

clud

ing

med

ical

obs

tetri

c a

nd p

sych

osoc

ial h

isto

ry D

eter

min

e dr

ug h

isto

ry k

now

n al

lerg

ies

and

use

of a

ltern

ativ

e m

edic

ines

suc

h as

her

bal p

rodu

cts

Phy

sica

l exa

min

atio

n In

clud

e vi

tal s

igns

ins

pect

ion

aus

culta

tion

and

palp

atio

n

Abd

omin

al a

nd g

enita

l exa

min

atio

n In

clud

e in

spec

tion

pal

patio

n fo

etal

aus

culta

tion

spe

culu

m a

nd b

iman

ual e

xam

inat

ions

w

here

indi

cate

d

AN

C P

rofil

e R

outin

e te

sts

for s

yphi

lis H

b b

lood

gro

up a

nd R

hesu

s fa

ctor

urin

alys

is a

nd p

rovi

de ra

pid

HIV

test

ing

to th

e pr

egna

nt w

oman

and

her

par

tner

if a

ccom

pany

ing

her

If in

dica

ted

chec

k sp

utum

for A

AFB

and

CD

4 co

unt

Cou

nsel

ing

on b

irth

prep

ared

ness

Sup

port

the

preg

nant

wom

an a

nd h

er p

artn

er to

dev

elop

an

indi

vidu

al b

irth

plan

that

in

clud

es p

lace

of d

eliv

ery

with

ski

lled

birth

atte

ndan

ce e

mer

genc

y tra

nspo

rt b

irth

com

pani

onsh

ip a

nd re

adin

ess

for i

nfan

t ca

re

Cou

nsel

ing

on p

regn

ancy

dan

ger s

igns

Pro

vide

wom

en w

ith in

form

atio

n an

d in

stru

ctio

ns o

n se

ekin

g ea

rly c

are

for p

regshy

nanc

y co

mpl

icat

ions

suc

h as

ble

edin

g fe

ver

seve

re h

eada

che

sw

olle

n fe

et f

its o

r con

vuls

ions

Cou

nsel

ing

on in

fant

feed

ing

All

wom

en re

quire

infa

nt-fe

edin

g co

unse

ling

and

supp

ort

Exc

lusi

ve b

reas

tfeed

ing

for s

ix

mon

ths

shou

ld b

e pr

omot

ed a

s th

e no

rm fo

r all

wom

en re

gard

less

of H

IV s

tatu

s W

omen

infe

cted

with

HIV

nee

d to

be

gu

ided

in th

e se

lect

ion

of s

afer

infa

nt-fe

edin

g op

tions

(ref

er to

WH

O g

uide

lines

and

MO

H c

ircul

ar o

n in

fant

and

you

ng c

hild

fe

edin

g)

Nut

ritio

nal a

sses

smen

t co

unse

ling

and

educ

atio

n In

clud

e iro

n m

ultiv

itam

in a

nd fo

late

sup

plem

enta

tion

mon

itor f

or a

naeshy

mia

ade

quat

e ca

loric

and

nut

rient

inta

ke a

nd re

com

men

d re

alis

tic d

iet a

djus

tmen

ts b

ased

on

loca

l res

ourc

es a

nd n

eeds

of

HIV

+ pr

egna

nt w

omen

(at l

east

10

mor

e of

the

RD

A)

Cou

nsel

ing

on H

IV a

nd A

IDS

Pro

vide

wom

en w

ith in

form

atio

n an

d in

stru

ctio

ns o

n se

ekin

g he

alth

car

e fo

r

sym

ptom

s of

HIV

dis

ease

pro

gres

sion

suc

h as

freq

uent

and

recu

rrent

illn

esse

s c

hron

ic p

ersi

sten

t dia

rrho

ea c

andi

dias

is

feve

r w

astin

g or

sig

ns o

f any

opp

ortu

nist

ic in

fect

ion

Lin

k w

omen

to A

IDS

trea

tmen

t and

oth

er s

uppo

rt pr

ogra

mm

es w

here

av

aila

ble

Cou

nsel

ing

the

HIV

neg

ativ

e w

oman

and

her

par

tner

Pro

vide

info

rmat

ion

on re

peat

test

ing

risk

redu

ctio

n an

d pa

rtner

test

ing

RTI

scr

eeni

ng A

ll w

omen

with

hig

h ris

k se

xual

his

tory

or p

rese

ntin

g w

ith s

igns

of R

TI s

uch

as a

bnor

mal

gen

ital d

isch

arge

ge

nita

l ulc

ers

and

pelv

ic in

flam

mat

ory

dise

ase

shou

ld b

e sc

reen

ed a

nd m

anag

ed a

ccor

ding

to K

enya

pro

toco

ls

Tube

rcul

osis

(TB

) A

ll w

omen

pre

sent

ing

for A

NC

ser

vice

s w

ith a

cou

gh o

f mor

e th

an 2

wee

ksrsquo d

urat

ion

shou

ld b

e sc

reen

ed

for T

B re

gard

less

of H

IV s

tatu

s F

ollo

w K

enya

pro

toco

ls fo

r scr

eeni

ng p

roph

ylax

is a

nd tr

eatm

ent

Teta

nus

toxo

id im

mun

isat

ions

Adm

inis

ter a

ccor

ding

to c

urre

nt K

EP

I TT

Imm

uniz

atio

n S

ched

ule

Dew

orm

ing

All

preg

nant

wom

en s

houl

d re

ceiv

e an

ti-he

lmin

thes

afte

r firs

t trim

este

r as

per t

he g

uide

lines

on

m

ater

nal n

utrit

ion

Ant

imal

aria

ls I

TNs

All

preg

nant

wom

en in

mal

aria

end

emic

are

as s

houl

d sl

eep

unde

r an

ITN

and

rece

ive

SP

inte

rmitt

ent

pres

umpt

ive

treat

men

t acc

ordi

ng to

the

Nat

iona

l Mal

aria

gui

delin

es

AR

V a

nd O

ppor

tuni

stic

Infe

ctio

ns p

roph

ylax

is (d

urin

g pr

egna

ncy)

Pro

vide

AR

V C

TX a

nd o

ther

pro

phyl

actic

m

edic

atio

ns a

ccor

ding

to th

e K

enya

AR

T pr

otoc

ol o

n O

I pro

phyl

axis

and

use

of A

RV

s in

pre

gnan

cy

AR

V tr

eatm

ent d

urin

g pr

egna

ncy

Pro

vide

HA

AR

T w

ithin

the

MC

H s

ettin

g ac

cord

ing

to th

e K

enya

pro

toco

l on

use

of A

RV

s

Est

ablis

h cl

ear r

efer

ral n

etw

orks

with

sen

ior c

linic

ians

Pre

vent

ion

with

Pos

itive

s E

ncou

rage

pos

itive

livi

ng d

iscl

osur

e c

orre

ct a

nd c

onsi

sten

t con

dom

use

and

pro

vide

psy

chos

oshyci

al s

uppo

rt to

the

affe

cted

fam

ilies

For

the

HIV

-infe

cted

and

affe

cted

fam

ilies

est

ablis

h an

dor

stre

ngth

en li

nkag

es to

car

e

treat

men

t and

sup

port

serv

ices

incl

udin

g po

st-p

artu

m fo

llow

up

Effe

ctiv

e co

ntra

cept

ion

plan

Cou

nsel

abo

ut o

ther

fam

ily p

lann

ing

met

hods

em

phas

izin

g on

par

tner

invo

lvem

ent

and

dual

pro

tect

ion

met

hods

to a

void

unw

ante

d pr

egna

ncy

new

infe

ctio

n re

-infe

ctio

n an

d fu

rther

tran

smis

sion

Sourc

e K

enya

Nat

ional PM

TC

T T

rain

ing C

urr

iculu

m

2005

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

92

OPE

RA

TIO

NA

L G

UID

ELIN

ES

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed in

the

care

and

fo

llow

-up

of c

hild

ren

of H

IV-in

fect

ed m

othe

rs

bull A

ll ch

ildre

n bo

rn t

o H

IV in

fect

ed m

othe

rs s

houl

d be

see

n in

the

he

alth

car

e fa

cilit

y w

ithin

tw

o w

eeks

of

deliv

ery

bull F

or a

ll H

IV e

xpos

ed in

fant

s m

onth

ly f

ollo

w u

p vi

sits

are

re

com

men

ded

begi

nnin

g at

six

wee

ks t

hrou

gh 2

yea

rs

bull W

here

pos

sibl

e v

isits

sho

uld

be li

nked

to

the

imm

unis

atio

n an

d

grow

th m

onito

ring

vis

its

bull A

ll H

IV e

xpos

ed in

fant

s sh

ould

be

star

ted

on C

otri

mox

azol

e

prop

hyla

xis

from

6 w

eeks

of

age

bull F

or in

fant

s w

ho te

st H

IV p

ositi

ve b

y D

NA

PC

R b

efor

e 18

mon

ths

or

by a

ntib

ody

test

aft

er 1

8 m

onth

s of

age

co

-trim

oxaz

ole

shou

ld b

e gi

ven

daily

for

life

bull F

or in

fant

s w

ho te

st H

IV n

egat

ive

|

If th

ey h

ave

stop

ped

brea

stfe

edin

g fo

r 2 m

onth

s or

mor

e s

top

C

otrim

oxaz

ole

|

If st

ill br

east

feed

ing

con

tinue

Cot

rimox

azol

e un

til tw

o m

onth

s af

ter

com

plet

e ce

ssat

ion

of b

reas

tfeed

ing

bull C

ompr

ehen

sive

car

e fo

r th

e H

IV e

xpos

ed o

r in

fect

ed in

fant

s sh

ould

be

pro

vide

d in

the

bro

ader

con

text

of

othe

r ch

ild h

ealth

car

e st

rate

gies

Hea

lth w

orke

rs s

houl

d pr

ovid

e th

e fo

llow

ing

pack

age

of c

are

as a

min

imum

to

thes

e ch

ildre

n

(1)

Con

firm

HIV

sta

tus

as e

arly

as

poss

ible

(R

efer

to C

hapt

er 7

)

(2)

M

othe

rs s

houl

d be

sup

porte

d to

pro

vide

opt

imal

infa

nt fe

edin

g an

d pa

rticu

larly

to

avoi

d m

ixed

feed

ing

in th

e fir

st 6

mon

ths

of li

fe I

t is

impo

rtant

that

infa

nt fe

edin

g ch

oice

s at

initi

atio

n of

feed

ing

follo

win

g ea

rly in

fant

dia

gnos

is a

t wea

ning

and

at

the

time

of in

trodu

ctio

n of

com

plem

enta

ry fe

eds

are

guid

ed b

y th

e A

FAS

S c

riter

ia

(Ref

er to

Cha

pter

8)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

3

3

74

Cha

pter

9

Car

e an

d Fo

llow

-up

of C

hild

ren

of H

IV-in

fect

ed M

othe

rs

91

INTR

OD

UC

TIO

N

PMTC

T in

terv

entio

ns re

duce

but

do

not e

limin

ate

the

risk

of H

IV tr

ansm

issi

on fr

om m

othshy

ers t

o th

eir i

nfan

ts a

nd y

oung

child

ren

Bot

h H

IV-in

fect

ed a

nd u

ninf

ecte

d ex

pose

d ch

ildre

n ha

ve in

crea

sed

risk

s of

infe

ctio

n an

d de

ath

from

com

mon

chi

ldho

od in

fect

ions

The

sur

shyvi

val o

f H

IV-e

xpos

ed c

hild

ren

whe

ther

or

not

they

are

inf

ecte

d i

s cl

osel

y lin

ked

to t

he

heal

th a

nd s

urvi

val o

f the

ir m

othe

rs T

here

fore

lon

g-te

rm b

enef

its o

f PM

TCT

prog

ram

s w

ill o

nly

be s

usta

ined

if t

here

is o

ngoi

ng c

ompr

ehen

sive

car

e fo

r th

e ch

ildre

n an

d th

eir

mot

hers

and

or c

are

give

rs

HIV

exp

osed

chi

ldre

n ar

e vu

lner

able

to

the

com

mon

illn

esse

s af

fect

ing

othe

r ch

ildre

n

Thes

e in

fect

ions

incl

ude

neon

atal

infe

ctio

ns m

alar

ia p

neum

onia

dia

rrho

ea m

easl

es a

nd

othe

r vac

cine

pre

vent

able

dis

ease

s H

IV in

fect

ed ch

ildre

n ar

e lik

ely

to s

uffe

r mor

e se

vere

ly

and

have

a h

ighe

r lik

elih

ood

of d

ying

from

com

mon

chi

ldho

od il

lnes

ses

than

non

-infe

cted

ch

ildre

n W

here

as m

alnu

triti

on c

ause

s 53

o

f all

child

hood

dea

ths

HIV

exp

osed

chi

ldre

n ar

e m

ore

vuln

erab

le to

it th

an n

on-in

fect

ed c

hild

ren

Thi

s is

bec

ause

HIV

exp

osed

child

ren

have

hig

her

calo

ric

requ

irem

ents

as

a re

sult

of th

eir

HIV

infe

ctio

n th

e pr

esen

ce o

f opp

orshy

tuni

stic

infe

ctio

ns a

nd o

ther

com

plic

atio

ns re

late

d to

AID

S

Regu

lar

follo

w u

p ca

re is

cri

tical

for

an in

fant

bor

n to

a m

othe

r w

ith H

IVA

IDS

The

com

shypr

ehen

sive

car

e of

HIV

exp

osed

chi

ldre

n in

clud

ing

nutr

ition

im

mun

isat

ion

mon

itori

ng o

f gr

owth

and

dev

elop

men

t pr

even

tion

and

trea

tmen

t of

opp

ortu

nist

ic in

fect

ions

and

ear

ly

infa

nt d

iagn

osis

of

HIV

is f

easi

ble

in r

esou

rce-

cons

trai

ned

sett

ings

and

sig

nific

antly

imshy

prov

es th

e su

rviv

al o

f the

se ch

ildre

n

23

JOB A

IDS

Prov

ider

s ar

e en

cour

aged

to re

fer t

o th

e ap

prop

riate

job

aid(

s) w

hen

deal

ing

with

spe

cific

issu

es

bull P

MT

CT

test

ing

and

coun

selli

ng t

ools

bull C

oupl

e co

unse

lling

tool

s

bull A

NC

alg

orith

ms

for

AR

V p

roph

ylax

is a

nd in

fant

fee

ding

gui

delin

es

as a

dapt

ed f

rom

WH

O g

uide

lines

bull P

reve

ntio

n w

ith p

ositi

ves

tool

kit

on d

iscl

osur

e

bull F

ocus

ed a

nte-

nata

l car

e

bull M

alar

ia in

pre

gnan

cy

bull T

B in

pre

gnan

cy

bull K

EP

I S

ched

ule

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

3

34

A ra

pid

HIV

test

ing

algo

rithm

for s

eria

l tes

ting

is il

lust

rate

d be

low

35

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Pre-Test Education and or Counselling

First HIV Rapid Test ndashDETERMINE

Negative TestResult

Counsel for Negative Result

Positive TestResult

Second HIV Rapid Test ndashBIOLINE

Positive Test ResultCounsel for

Positive Result

NegativeTestResult

Third HIV Rapid Test ndashUNIGOLD

Positive Test ResultCounsel for

Positive Result

Negative Test ResultCounsel for

Negative Result

Figure 32 Rapid HIV testing algorithm Serial testing

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

72

M

othe

r and

Chi

ld H

ealth

Boo

klet

71

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

36

Cha

pter

ref

eren

ces

Rep

ublic

of

Ken

ya M

inis

try

of

Hea

lth

Div

isio

n o

f Rep

roduct

ive

Hea

lth

National G

uid

e-lin

es f

or

Qual

ity

Obst

etri

cs a

nd P

erin

atal Car

e (

2004)

WH

O

UN

FPA

UN

ICEF

World B

ank

Manag

ing C

om

plic

atio

ns

in P

regnan

cy a

nd C

hild

birth

A g

uid

e fo

r m

idw

ives

and d

oct

ors

(2003)

WH

O

Sta

ndar

ds

for

Mat

ernal

and N

eonat

al C

are

(2006)

WH

O

Antire

trovi

ral dru

gs

for

trea

ting p

regnan

t w

om

en a

nd p

reve

nting H

IV infe

ctio

ns

in

infa

nts

in r

esourc

e lim

ited

set

tings

Tow

ard

s U

niv

ersa

l Acc

ess

Rec

om

men

dations

for

a public

hea

lth a

ppro

ach (

2006)

Min

istr

y of

Hea

lth

Nat

ional AID

S amp

STD

Contr

ol Pro

gra

mm

e (N

ASCO

P)

Guid

elin

es f

or

Antire

trovi

ral dru

g t

her

apy

in K

enya

(2005)

Min

istr

y of

Hea

lth

Ken

ya N

atio

nal

Rep

roduct

ive

Hea

lth I

nst

ruct

ional M

anual

for

Ser

vice

Pro

vider

s (M

arch

2005)

Nat

ional AID

S amp

STD

Contr

ol Pro

gra

mm

e K

enya

AID

S I

ndic

ator

Syr

vey

Foo

tnot

es

1

2Ken

ya D

emogra

phic

and H

ealth S

urv

ey (

KD

HS)

2003

37

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

70

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

CH

AP

TE

R 3

Intr

apar

tum

Car

e 3

1 IN

TRO

DU

CTI

ON

Intr

apar

tum

car

e is

the

man

agem

ent

of w

omen

fro

m t

he o

nset

of

labo

ur t

o de

liver

y T

his

peri

od p

oses

the

grea

test

ris

k fo

r tr

ansm

issi

on o

f HIV

from

the

mot

her

to th

e ch

ild (M

TCT)

w

ith 1

0 to

20

perc

ent o

f exp

osed

infa

nts

beco

min

g in

fect

ed a

t thi

s tim

e in

the

abse

nce

of a

ny

inte

rven

tion

1 In

the

con

text

of

HIV

AID

S it

is t

here

fore

im

port

ant

to e

stab

lish

the

HIV

stat

us o

f wom

en p

rior

to o

r du

ring

labo

ur a

nd d

eliv

ery

and

prov

ide

inte

rven

tions

aim

ed a

t re

duci

ng th

e ri

sk o

f tra

nsm

issi

on W

ith a

ppro

pria

te in

terv

entio

ns t

he r

isk

of M

TCT

can

bere

duce

d si

gnifi

cant

ly

32

OPE

RA

TIO

NA

L G

UID

ELIN

ES

a) O

ptim

al In

trap

artu

m C

are

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed fo

r all

wom

en a

dmitt

ed

to la

bour

and

del

iver

y un

its 2

3

1 M

inim

ise

vagi

nal e

xam

inat

ions

2 U

se a

sept

ic t

echn

ique

s in

con

duct

ing

deliv

ery

3 A

void

rou

tine

artif

icia

l rup

ture

of m

embr

anes

(A

RM

)

4 A

void

pro

long

ed la

bour

5 A

void

unn

eces

sary

trau

ma

duri

ng d

eliv

ery

6 M

inim

ise

the

risk

of p

ostp

artu

m h

aem

orrh

age

7 U

se s

afe

bloo

d tr

ansf

usio

n pr

actic

es

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

9

38

b) S

peci

fic M

anag

emen

t of H

IV P

ositi

ve P

regn

ant W

omen

Pro

phyl

acti

c A

ntir

etro

vira

l the

rapi

es4

The

AR

V p

roph

ylac

tic r

egim

en d

epen

ds o

n w

heth

er th

e m

othe

r ha

d A

RV

s du

ring

pre

gshyna

ncy

or n

ot T

hus

the

heal

th c

are

wor

ker s

houl

d es

tabl

ish

the

regi

men

use

d du

ring

th

e A

NC

whe

ther

the

wom

an h

ad ta

ken

the

SdN

VP

and

AZT

at t

he o

nset

of l

abou

r an

d de

term

ine

the

appr

opri

ate

intr

a-pa

rtum

AR

V c

are

as p

er th

e al

gori

thm

s on

pag

e80

(App

endi

x II

I) p

age

81 (A

ppen

dix

IV) a

nd a

s su

mm

aris

ed b

elow

No

AR

Vs t

aken

in p

regn

ancy

Mot

her i

n ea

rly la

bour

(up

to 4

cm c

ervi

cal d

ilata

tion)

bull

Int

rapa

rtum

per

iod

Giv

e m

othe

r S

dNV

P 2

00m

g A

ZT

600

mg

and

3T

C 1

50m

g st

at

bull P

ostp

artu

m m

othe

r G

ive

mot

her

AZ

T 3

00m

g an

d 3T

C 1

50m

g B

D

for

7 da

ys

bull P

ostp

artu

m p

erio

d G

ive

infa

nt S

d N

evir

apin

e 2

mg

kg w

ithin

72

hour

s of

birt

h P

LUS

3T

C 4

mg

kg B

D fo

r 1

wee

k an

d A

ZT

syr

up 4

mg

kg

BD

for

6 w

eeks

Mot

her r

ecei

ved

AZT

300

mg

BD

in P

regn

ancy

bull P

ostp

artu

m

Giv

e in

fant

Sd

Nev

irap

ine

2mg

kg w

ithin

72

hour

s of

birt

h

PLU

S 3

TC

4m

gkg

BD

for

1 w

eek

and

AZ

T sy

rup

4 m

gkg

BD

for

6 w

eeks

Mot

her r

ecei

ved

HA

AR

T in

Pre

gnan

cy

Reg

ardl

ess

of d

urat

ion

rece

ived

HA

AR

T bull

Giv

e m

othe

r A

RV

dos

e as

per

reg

imen

bull P

ostp

artu

m

Giv

e In

fant

Sd

Nev

irap

ine

2mg

kg w

ithin

72

hour

s of

bir

th

PLU

S 3

TC

4m

gkg

BD

for

1 w

eek

and

AZ

T sy

rup

4 m

gkg

BD

for

6 w

eeks

Mod

e of

del

iver

y E

lect

ive

caes

area

n se

ctio

n (C

S) r

educ

es t

he r

isk

of H

IV M

TCT

as c

ompa

red

to v

agin

al

deliv

ery

but

will

not

be

avai

labl

e in

man

y se

ttin

gs in

our

cou

ntry

Whe

re C

S is

per

shyfo

rmed

(ele

ctiv

e or

em

erge

ncy)

in H

IV p

ositi

ve w

omen

the

y sh

ould

rec

eive

pro

phyl

actic

an

tibio

tics

If

the

CS

is p

erfo

rmed

aft

er p

rolo

nged

lab

our

or r

uptu

re o

f m

embr

anes

lo

nger

cour

ses

of a

ntib

iotic

s sh

ould

be

cons

ider

ed

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

3

9

68

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Supp

ort d

urin

g la

bour

E

mot

iona

l su

ppor

t du

ring

lab

our

is i

mpo

rtan

t fo

r al

l w

omen

and

may

be

even

mor

ene

cess

ary

for

an H

IV p

ositi

ve w

oman

who

is c

once

rned

abo

ut h

er c

ondi

tion

and

risk

of

HIV

tran

smis

sion

to c

hild

Whe

neve

r po

ssib

le d

urin

g la

bour

war

d st

aff m

ust b

e se

nsishy

tive

to t

he fe

ars

and

conc

erns

of t

he H

IV p

ositi

ve m

othe

r ab

out

her

infe

ctio

n a

nd h

owm

uch

she

had

told

her

par

tner

Indu

ctio

n of

labo

ur

Indu

ctio

n of

labo

ur m

ay b

e as

soci

ated

with

incr

ease

d ri

sk o

f H

IV M

TCT

Car

eful

asshy

sess

men

t of

the

nee

d fo

r an

d de

sira

bilit

y of

ind

uctio

n ra

ther

tha

n C

S is

nec

essa

ry

Whe

n in

duct

ion

of la

bour

is c

hose

n m

embr

anes

sho

uld

be le

ft in

tact

for

as lo

ng a

s po

sshysi

ble

Syn

toci

non

shou

ld n

ot b

e us

ed w

ith in

tact

mem

bran

es

Indi

catio

ns fo

r ele

ctiv

e C

S A

lthou

gh e

lect

ive

CS

will

not

be

avai

labl

e in

mos

t hea

lth fa

cilit

ies

as a

rou

tine

for

HIV

posi

tive

wom

en t

here

may

be

som

e ca

ses

that

mer

it co

nsid

erat

ion

for

CS

The

se i

nshycl

ude

preg

nanc

ies

whe

re l

abou

r is

exp

ecte

d to

be

prol

onge

d or

whe

re o

ther

obs

tetr

ic

com

plic

atio

ns m

ay b

e as

soci

ated

with

incr

ease

d ri

sk o

f tra

nsm

issi

on (e

g a

brup

tio p

lashy

cent

ae

plac

enta

pra

evia

pr

e-te

rm r

uptu

re o

f m

embr

anes

pr

evio

us C

S an

d br

eech

pr

esen

tatio

n)

Man

agem

ent o

f lab

our a

nd d

eliv

ery

Labo

ur a

nd d

eliv

ery

man

agem

ent

shou

ld fo

llow

opt

imal

obs

tetr

ic m

anag

emen

t gu

ideshy

lines

(R

efer

to

Opt

imal

Int

rapa

rtum

car

e ab

ove

and

Nat

iona

l G

uide

lines

for

Qua

lity

Obs

tetr

ics

and

IMPA

C C

are

Man

ual)

RO

LEO

FTH

E C

OM

MU

NIT

Y

A la

rge

prop

ortio

n (6

0) o

f wom

en in

Ken

ya is

del

iver

ed o

utsid

e th

e he

alth

sys

tem

s by

fam

ilym

embe

rs n

eigh

bour

s and

TBA

s

bull T

here

is n

eed

to e

duca

te th

e co

mm

unity

on

the

risk

of M

TC

T an

d w

ays

of

prev

entio

n

bull T

hose

ass

istin

g th

e de

liver

ies

need

to u

nder

stan

d th

eir

own

risk

of in

fect

ion

and

how

to p

rote

ct th

emse

lves

bull T

he c

omm

unity

sho

uld

be e

ncou

rage

d to

faci

litat

e m

othe

rs to

del

iver

in

heal

th fa

cilit

ies

bull T

he c

omm

unity

sho

uld

be e

ncou

rage

d to

ref

er to

hea

lth fa

cilit

ies

all c

hild

ren

born

at h

ome

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

7

40

Fi

gure

81

Gui

delin

es fo

r Cou

nsel

ling

on H

IV a

nd In

fant

feed

ingJ

ob A

ids

Cha

pter

ref

eren

ces

an

d IE

C M

ater

ials

on

Infa

nt a

nd Y

oung

Chi

ld F

eedi

ng

1R

epublic

of

Ken

ya

Min

istr

y of

Hea

lth

Ess

ential

Obst

etric

Car

e M

anual

for

Hea

lth

Ser

vice

Pro

vider

s in

Ken

ya (

3rd

Editio

n J

an 2

006)

Foo

tnot

es

1 D

e Cock

KM

2002

2 K

enya

National

Rep

roduct

ive

Hea

lth I

nst

ruct

ion M

anual

for

Ser

vice

Pro

vider

s (2

006)

3 D

ivis

ion o

f Rep

roduct

ive

Hea

lth

Guid

elin

es f

or

Qual

ity

Obst

etri

cs a

nd P

erin

ata

l Car

e

(2004)

4 W

HO

Antire

tovi

ral dru

gs

for

trea

ting p

regnan

t w

om

en a

nd p

reve

nting H

IV infe

ctio

n in

infa

nts

to

ward

s univ

ersa

l acc

ess

(2006)

41

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

66

85

EXTR

AC

TSFR

OM

RES

EAR

CH

ON

I NFA

NT

F EED

ING

A

ND H

IVA

IDS

Evid

ence

ava

ilabl

e fr

om c

urre

nt re

sear

ch d

ata

show

s th

at

bull I

ncre

ased

ris

k of

mor

talit

y w

ith r

epla

cem

ent

feed

ing

is s

igni

fican

t

bull H

IV f

ree

surv

ival

rat

e at

18

mon

ths

of a

ge d

oes

not

sign

ifica

ntly

var

y be

twee

n a

brea

stfe

d an

d re

plac

emen

t fed

chi

ld

bull M

odifi

ed a

nim

alrsquos

milk

doe

s no

t pr

ovid

e ad

equa

te n

utrit

ion

for

ch

ildre

n le

ss t

han

6 m

onth

s he

nce

mic

ronu

trie

nts

shou

ld b

e gi

ven

un

der

thes

e ci

rcum

stan

ces

bull A

brup

t ce

ssat

ion

of b

reas

tfee

ding

is n

o lo

nger

rec

omm

ende

d

bull E

xclu

sive

bre

astf

eedi

ng u

p to

6 m

onth

s is

rec

omm

ende

d un

less

re

plac

emen

t fee

ding

can

mee

t AF

AS

S c

rite

ria

Cha

pter

4

Use

of A

ntire

trov

iral D

rugs

in P

regn

ancy

for T

reat

men

t and

for

Prev

entio

n of

Mot

her-

to-C

hild

Tra

nsm

issi

on o

f HIV

Infe

ctio

n

41

INTR

OD

UC

TIO

N

With

out

any

inte

rven

tion

up

to 4

0 pe

rcen

t of

HIV

pos

itive

wom

en w

ill t

rans

mit

the

infe

ctio

n to

the

ir c

hild

ren

duri

ng p

regn

ancy

lab

our

and

brea

stfe

edin

g U

se o

f ant

iret

shyro

vira

l dru

gs (A

RV

s) o

bste

tric

inte

rven

tions

and

avo

idan

ce o

f all

brea

stfe

edin

g fo

r pr

eshyve

ntio

n of

mot

her

to c

hild

tran

smis

sion

of H

IV in

fect

ion

(PM

TCT)

has

red

uced

the

risk

of m

othe

r to

chi

ld tr

ansm

issi

on o

f HIV

infe

ctio

n (M

TCT)

to le

ss th

an 2

per

cent

in d

evel

shyop

ed c

ount

ries

Shor

t cou

rse

effic

acio

us A

RV

dru

g re

gim

ens

can

redu

ce th

e ri

sk o

f MTC

T to

2-4

per

cent

and

can

be i

mpl

emen

ted

in r

esou

rce-

limite

d se

ttin

gs o

n a

popu

latio

n-ba

sed

publ

ic

heal

th s

cale

AR

Vs

are

used

bot

h fo

r th

e tr

eatm

ent

of H

IV d

isea

se a

nd fo

r PM

TCT

in

HIV

-infe

cted

pre

gnan

t w

omen

and

the

ir n

eona

tes

Ant

iret

rovi

ral t

reat

men

t (A

RT)

for

wom

en w

ho q

ualif

y fo

r it

pro

long

s an

d im

prov

es t

he q

ualit

y of

the

ir l

ives

The

sur

shyvi

val

of t

he c

hild

is

clos

ely

inte

rlin

ked

with

the

hea

lth a

nd s

urvi

val

of t

he m

othe

r

Wom

en e

ligib

le fo

r A

RT

shou

ld b

e st

arte

d on

trea

tmen

t as

soon

as

poss

ible

Pre

gnan

cy

is n

ot a

rea

son

to d

elay

AR

T W

omen

who

are

alr

eady

on

AR

T be

fore

bec

omin

g pr

egshy

nant

sho

uld

cont

inue

with

thei

r tr

eatm

ent

In c

erta

in s

ituat

ions

mod

ifica

tions

may

be

need

ed to

mak

e tr

eatm

ent s

afer

for

the

mot

her

and

the

unbo

rn b

aby

The

bene

fits

of u

sing

AR

Vs

to t

reat

HIV

-infe

cted

pre

gnan

t w

omen

and

or

PMTC

T ou

tshyw

eigh

the

ris

ks H

owev

er w

hen

AR

T or

oth

er s

hort

cou

rse

AR

V r

egim

ens

are

used

ba

selin

e ev

alua

tion

and

mon

itori

ng is

enc

oura

ged

to e

nsur

e th

e sa

fety

of t

he m

othe

rsan

d th

eir

new

born

s L

inka

ges

of H

IV-in

fect

ed p

regn

ant

wom

en a

nd t

heir

chi

ldre

n to

ot

her

care

and

sup

port

pro

gram

s at

hea

lth f

acili

ty a

nd c

omm

unity

lev

els

shou

ld b

e en

sure

d

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

5

42

42

OPE

RA

TIO

NA

L G

UID

ELIN

ES

All

HIV

-infe

cted

pre

gnan

t w

omen

sho

uld

be c

ouns

elle

d on

com

preh

ensi

ve H

IV c

are

incl

udin

g us

e of

AR

Vs

for

thei

r ow

n he

alth

and

for

PMTC

T

All

HIV

-infe

cted

pre

gnan

t wom

en s

houl

d ha

ve th

eir H

IV d

isea

se

stag

ed u

sing

bull W

HO

clin

ical

sta

ging

(se

e A

ppen

dix

1) a

nd

bull I

mm

unol

ogic

al s

tagi

ng (

CD

4 co

unt)

(se

e ta

ble

1)

The

wom

en s

houl

d al

so b

e sc

reen

ed a

nd tr

eate

d fo

r op

port

unis

tic in

fect

ions

(OIs

) inc

ludi

ngTu

berc

ulos

is (T

B)

All

HIV

-infe

cted

pre

gnan

t wom

en s

houl

d ha

ve b

asel

ine

labo

rato

ry a

nd o

ther

nec

essa

rydi

agno

stic

eva

luat

ions

Thes

e di

agno

stic

s sh

ould

incl

ude

bull R

outin

e an

tena

tal c

are

labo

rato

ry in

vest

igat

ions

that

are

nor

mal

ly

done

for

all

preg

nant

wom

en

haem

oglo

bin

(Hb)

rh

esus

blo

od

grou

p an

d A

BO

typ

ing

VD

RL

uri

ne a

naly

sis

and

scre

enin

g fo

r S

TI

bull A

LT a

nd c

reat

inin

e le

vels

for

wom

en e

ligib

le f

or H

AA

RT

Prop

hyla

xis

amp m

icro

nutr

ient

sup

plem

enta

tion

bull

Cot

rimox

azol

e (C

TX) o

ne d

oubl

e st

reng

th o

r tw

o si

ngle

stre

ngth

tabl

ets

once

dai

ly

bull

Mul

tivita

min

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

83

OPE

RA

TIO

NA

L G

UID

ELIN

ESO

N F

EED

ING

CH

ILD

REN

6 M

ON

THS

AN

DO

LDER

The

follo

win

g sh

ould

gui

de fe

edin

g fo

r chi

ldre

n 6

mon

ths

and

olde

r

bull A

t 6

mon

ths

oth

er f

orm

s of

milk

alo

ne a

re n

ot a

dequ

ate

to m

eet

the

baby

rsquos n

utrit

iona

l req

uire

men

ts

bull C

ompl

emen

tary

foo

ds s

houl

d be

intr

oduc

ed w

ith c

ontin

ued

br

east

feed

ing

or w

ith r

epla

cem

ent

feed

ing

until

a n

utrit

iona

lly

adeq

uate

die

t ca

n be

sus

tain

ed w

ithou

t m

ilk

bull A

brup

t ces

satio

n of

bre

astf

eedi

ng s

houl

d be

dis

cour

aged

to

avoi

d

trau

ma

for

both

the

mot

her

and

the

baby

bull M

ilk s

houl

d co

ntin

ue a

s an

impo

rtan

t co

mpo

nent

of

the

diet

bull C

ompl

emen

tary

foo

ds s

houl

d be

enr

iche

d fr

om lo

cally

ava

ilabl

e

fam

ily f

oods

84

NU

TRIT

ION

AL

CA

RE

AN

D S

UPP

OR

TO

F H

IV

INFE

CTE

DC

HIL

DR

EN

bull E

nerg

y ne

eds

for

asym

ptom

atic

HIV

infe

cted

chi

ldre

n in

crea

se b

y 10

pe

rcen

t to

mai

ntai

n gr

owth

as

com

pare

d to

the

non-

infe

cted

chi

ldre

n

bull T

here

is n

o ev

iden

ce o

f in

crea

sed

prot

ein

requ

irem

ents

The

re

quir

emen

ts s

houl

d be

bas

ed o

n in

divi

dual

sym

ptom

s an

d ne

eds

bull M

icro

nutr

ient

req

uire

men

ts d

o no

t ch

ange

W

HO

rec

omm

ends

not

m

ore

than

one

RD

A

(For

fur

ther

det

ails

re

fer

to K

enya

n G

uide

lines

on

nutr

ition

and

HIV

A

IDS

)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

3

64

82

OPE

RA

TIO

NA

L G

UID

ELIN

ESO

N I N

FAN

TFE

EDIN

G (0

-6 M

ON

THS)

The

follo

win

g sh

ould

gui

de in

fant

feed

ing

for t

he fi

rst 6

mon

ths

bull A

ll w

omen

and

men

irre

spec

tive

of th

eir

HIV

sta

tus

shou

ld r

ecei

ve

coun

selin

g an

d de

mon

stra

tions

on

how

to s

afel

y fe

ed t

heir

babi

es

duri

ng t

he a

nten

atal

and

pos

tnat

al f

ollo

w u

p

bull T

he m

ost

appr

opria

te in

fant

fee

ding

opt

ion

for

an H

IV in

fect

ed

mot

her

shou

ld c

ontin

ue t

o de

pend

on

indi

vidu

al c

ircu

mst

ance

s an

d

the

av

aila

ble

supp

ort

bull E

very

HIV

infe

cted

wom

an s

houl

d be

eva

luat

ed a

t ev

ery

visi

t to

ch

eck

whe

ther

her

soc

ial

econ

omic

and

hea

lth s

tatu

s ha

s ch

ange

d

suff

icie

ntly

eno

ugh

to a

ffec

t he

r in

fant

fee

ding

opt

ion

bull E

xclu

sive

bre

astf

eedi

ng fo

r H

IV in

fect

ed w

omen

for

the

firs

t 6

mon

ths

of t

he in

fant

rsquos li

fe is

adv

isab

le

unle

ss r

epla

cem

ent f

eedi

ng is

ac

cept

able

fea

sibl

e a

ffor

dabl

e s

usta

inab

le a

nd s

afe

for

them

and

th

eir

infa

nts

befo

re t

hat t

ime

bull W

hen

repl

acem

ent

feed

ing

is a

ccep

tabl

e f

easi

ble

aff

orda

ble

su

stai

nabl

e an

d sa

fe

avoi

danc

e of

exc

lusi

ve b

reas

tfee

ding

by

HIV

in

fect

ed w

omen

is r

ecom

men

ded

bull I

f th

e co

nditi

ons

for

repl

acem

ent

feed

ing

are

still

not

met

for

6

mon

ths

then

co

ntin

uatio

n of

bre

astf

eedi

ng w

ith a

dditi

onal

co

mpl

emen

tary

fee

ding

is r

ecom

men

ded

giv

ing

prio

rity

to t

he lo

cally

av

aila

ble

food

s

bull I

nfan

t fe

edin

g de

cisi

ons

for

all H

IV e

xpos

ed in

fant

s sh

ould

be

base

d on

the

AF

AS

S c

riter

ia e

ven

whe

re e

arly

infa

nt d

iagn

osis

(E

ID)

is

avai

labl

e

bull B

reas

tfeed

ing

mot

hers

of

infa

nts

and

youn

g ch

ildre

n w

ho a

re k

now

n to

be

HIV

infe

cted

sho

uld

be s

tron

gly

enco

urag

ed to

con

tinue

bre

ast

feed

ing

How

ever

br

east

feed

ing

HIV

infe

cted

mot

hers

sho

uld

be

give

n nu

triti

on s

uppo

rt (

nutr

ition

al c

ouns

elin

g e

duca

tion

foo

d an

d nu

triti

onal

sup

plem

ents

)

63

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

44

Sulp

hur-

base

d in

term

itten

t pr

esum

ptiv

e m

alar

ia t

reat

men

t (I

PT) s

houl

d no

t be

giv

en

to w

omen

who

are

on

CTX

pro

phyl

axis

AR

V us

e

bull A

RV

s ar

e us

ed fo

r tr

eatin

g H

IV-i

nfec

ted

elig

ible

wom

en a

ndo

r fo

r pr

even

tion

of m

othe

r-to

-chi

ld tr

ansm

issi

on

bull H

IV-i

nfec

ted

preg

nant

wom

en e

ligib

le f

or A

RT

sho

uld

initi

ate

AR

T

as s

oon

as p

ossi

ble

as s

how

n in

Tab

le 4

1

bull H

IV-i

nfec

ted

preg

nant

wom

en a

lread

y on

AR

T b

efor

e be

com

ing

preg

nant

sho

uld

cont

inue

AR

T

The

bab

y sh

ould

be

give

n A

RV

pr

ophy

laxi

s so

on a

fter

birt

h as

sho

wn

in T

able

42

Tabl

e 4

1 R

ecom

men

datio

ns fo

r ini

tiatin

g A

RV

trea

tmen

t in

preg

nant

w

omen

bas

ed o

n cl

inic

al s

tage

and

ava

ilabi

lity

of C

D4

Cou

nt

WH

O

CD

4 te

stin

g

CD

4 te

stin

g

Clin

ical

Sta

ge

not a

vaila

ble

avai

labl

e

1 D

o no

t Tre

at

Trea

t if C

D4le

350

cells

mm

3

2 D

o no

t Tre

at

Trea

t if C

D4 le

350

cells

mm

3

3 Tr

eat

Trea

t irre

spec

tive

of C

D4

coun

t (c

onsi

der C

D4

valu

es fo

r bet

ter

man

agem

ent)

4 Tr

eat

Trea

t irre

spec

tive

of C

D4

cell

coun

t

Sourc

e A

dopte

d f

rom

WH

O

Anti-r

etro

vira

l dru

gs

for

trea

ting p

regnant

wom

en a

nd p

re-

venting H

IV infe

ctio

ns

Tabl

e 4

2 R

ecom

men

ded

first

-line

AR

T re

gim

en fo

r tre

atin

g pr

egna

nt w

omen

and

pro

phyl

actic

regi

men

for i

nfan

ts

Mot

her

Ant

epar

tum

AZ

T +

3TC

+ N

VP D

aily

Intra

partu

m

AZT

+ 3T

C +

NVP

Dai

ly

Pos

tpar

tum

AZ

T +

3TC

+ N

VP D

aily

Infa

nt p

roph

ylax

is

Sd

NV

P 2

mg

kg s

tat w

ithin

72

hour

s 3T

C X

1 w

eek

(4

mg

kg B

ID)

AZT

X 6

wee

ks (4

mg

kg B

ID)

Mat

erna

l dos

ages

AZT

300

mg

BID

3TC

150

mg

BID

NV

P 2

00 m

g O

D fo

r tw

o w

eeks

the

reaf

ter 2

00 m

g B

ID

Infa

nt D

osag

es

NV

P

2mg

kg s

tat w

ithin

72

hour

s

AZT

4mg

kg B

ID X

6 w

eeks

3TC

4m

gkg

BID

X 1

wee

k

Cha

pter

8

Feed

ing

Infa

nts

and

Youn

g C

hild

ren

Bor

n to

HIV

Infe

cted

Mot

hers

81

INTR

OD

UC

TIO

N T

RA

NSM

ISSI

ON

OF

HIV

THR

OU

GH

B

REA

STFE

EDIN

G

In A

fric

a 3

to 4

out

of e

very

10

infa

nts

born

to H

IV in

fect

ed w

omen

acq

uire

HIV

infe

cshytio

n T

here

is t

here

fore

a 5

ndash 2

0 pe

rcen

t ri

sk o

f inf

ants

bor

n to

HIV

pos

itive

mot

hers

ac

quir

ing

infe

ctio

n th

roug

h br

east

-fe

edin

g if

ther

e ar

e no

inte

rven

tions

in

pla

ce

For

wom

en w

ho a

re i

nshyfe

cted

with

HIV

for

the

first

tim

e or

w

ho a

re r

e-in

fect

ed w

ith a

diff

eren

t st

rain

of H

IV d

urin

g th

e br

east

feed

shyin

g ph

ase

the

ris

k in

crea

ses

up t

o29

per

cen

t H

alf (

12)

of H

IV b

reas

t m

ilk t

rans

mis

sion

tak

es p

lace

by

6 w

eeks

and

thre

e qu

arte

rs (3

4) b

y 6

mon

ths

Mix

ed fe

edin

g in

crea

ses

the

risk

of

brea

st m

ilk t

rans

mis

sion

of

HIV

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

5

62

For

prop

hyla

xis

the

reco

mm

enda

tions

are

ran

ked

and

will

dep

end

on t

ime

of fi

rst

conshy

tact

with

the

wom

an H

IV-in

fect

ed p

regn

ant w

omen

who

are

not

elig

ible

for

AR

T or

in

72

3 C

OM

PREH

ENSI

VE

CA

RE

FOR H

IV-E

XPO

SED

CH

ILD

REN

w

hom

it is

not

pos

sibl

e to

sta

rt A

RT

imm

edia

tely

and

the

mot

her

is b

eing

see

n be

twee

n28

and

38

wee

ks o

f pr

egna

ncy

sho

uld

be s

tart

ed o

n re

com

men

ded

mor

e ef

ficac

ious

shor

t co

urse

pro

phyl

actic

AR

V r

egim

ens

as s

how

n in

Tab

le 4

3a

The

bab

y sh

ould

als

obe

giv

en A

RV

pro

phyl

axis

soo

n af

ter

birt

h as

sho

wn

in th

e sa

me

tabl

e T

he r

egim

ens

asou

tline

d be

low

are

for

prop

hyla

xis

and

not f

or tr

eatm

ent

MINI

STRY

OF H

EAL

TH

Tabl

e 4

3a R

ecom

men

ded

Firs

t Lin

e A

RV

prop

hyla

xis

ALGO

RITH

M FO

R EA

RLY

INFA

NTDI

AGNO

SISFO

R HI

VEX

POSE

DCH

ILDRE

N

to p

reve

nt H

IV in

fect

ion

in in

fant

s A

mon

g Pr

egna

nt W

omen

Pr

esen

ting

Bef

ore

38 W

eeks

Ran

king

Ti

me

of A

dmin

istr

atio

n

WEL

L CHI

LD

SICK

CHI

LD

(Man

age

pres

entin

g ill

ness

and

stab

ilize

)

STAR

T CO

TRIM

OXAZ

OLE

PROP

HYLA

XIS

FOR M

OR E

INFOR

MATIO

N C ON

TACT

THE N

ATI O

NAL A

IDS S

TD CO

NTRO

L PRO

GRAM

ME ( N

ASCO

P) PO

BOX

19 36

1-00

20 2 N

AIRO

BI TE

L 02

02 72

95 02

FAX 0

2 0 2 7

1 05 1

8

Exp

osur

e sta

tus s

houl

d be

det

erm

ined

for a

ll in

fants

of u

nkno

wn s

tatu

s at t

he

6 we

ek v

isit o

r firs

t con

t act

Coun

sel o

n inf

ant f

eedi

ng a

s per

nat

iona

l gui

delin

es

Conf

irma

tory

ABt

est

at 1

8 M

onth

s

Eval

uate

for

ART

star

t on

ARV

if el

igibl

e

If HI

V+ a

t 12

Mont

hs

Evalu

ate f

or A

RT

Start

on

ARV

if eli

gible

6 Wee

ks D

BS (P

CR)

HIV

+

If HI

V-sto

p CT

X if

not

BF

for a

t lea

st 2

Mont

hs

HI

V-

Antib

ody

test

ing

12 M

onth

s

Conf

irmat

ory

ABte

st at

18 M

onth

s

Conf

irmat

ory A

B te

st at

18 M

onth

s

Eval

uate

for A

RT

star

t on

ARV

if el

igible

If HIV

+ at

12

Mon

ths

Eval

uate

for A

RT

Star

t on

ARV

if el

igibl

e

If lt1

2 Mon

ths D

BS (P

CR)

If gt

12m

o An

tibod

y te

st

HIV

+

If HIV-

stop

CTX

if n

ot

BF

for a

t lea

st 2

Mont

hs

HI

V-

Antib

ody

testi

ng

12 M

onth

s

Conf

irma

tory

AB

test

at 1

8 Mo

nths

Exp

osur

e sta

tus s

hould

be de

term

ined

for a

ll in

fant

s of u

nkno

wn st

atus

at th

e 6w

eek

visit

or fi

rst c

onta

ct

Co

unse

l on

infa

nt fe

edin

g as

per n

atio

nal g

uideli

nes

Pre

gnan

cy

Labo

ur

Pos

tpar

tum

Mat

erna

l In

fant

Rec

omm

ende

d

AZT(

28-3

8 w

eeks

ge

stat

ion)

sd

NV

P

+ AZ

T+3T

C

AZT+

3TC

X

7 da

ys

sdN

VP

PL

US

3TC

X1

wee

k +

AZT

X

6 w

eeks

Tabl

e 4

3b b

elow

sho

ws

alte

rnat

ive

prop

hyla

ctic

regi

men

s fo

r w

omen

pre

sent

ing

befo

re 3

8 w

eeks

of p

regn

ancy

Ran

king

Ti

me

of A

dmin

istr

atio

n

Alte

rnat

ive

Min

imum

Pre

gnan

cy

AZT(

28-3

8 w

eeks

)

Labo

ur

sd N

VP

+

AZT(

600m

gs

stat

)

sdN

VP

+ A

ZT+3

TC

Pos

tpar

tum

AZT+

3TC

X

7 da

ys

Infa

nt

sdN

VP

+

3TC

X 7

da

ys +

AZT

X

6 w

eeks

sdN

VP

+

3TC

day

s +

AZT

X 6

wee

ks

HIV

-infe

cted

pre

gnan

t w

omen

who

are

see

n fo

r th

e fir

st t

ime

afte

r 38

wee

ks o

f pr

egshy

nanc

y or

in la

bour

sho

uld

be g

iven

AR

V p

roph

ylac

tic r

egim

ens

as s

how

n in

Tab

le 4

4

The

baby

sho

uld

also

be

give

n A

RV

pro

phyl

axis

soo

n af

ter

birt

h as

sho

wn

in t

he s

ame

Bot

h H

IV-in

fect

ed a

nd u

ninf

ecte

d ch

ildre

n re

quir

e co

mpr

ehen

sive

car

e (R

efer

to C

hap-

tabl

ete

r 8

and

9)

61

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

46

Tabl

e 4

4 A

RV

prop

hyla

xis

for P

MTC

T am

ong

preg

nant

wom

en w

ho

have

not

rece

ived

ant

enat

al A

RT

or p

roph

ylax

is

Ran

king

Ti

me

of A

dmin

istr

atio

n

La

bour

P

ostp

artu

m

Mat

erna

l In

fant

Rec

omm

ende

d

sdN

VP

AZ

T+3T

C

SdN

VP

+

X 7

days

P

LUS

3TC

X 1

wee

k +

AZT+

3TC

AZ

T X

6 w

eeks

Min

imum

sd

NV

P

-S

dNV

P

PLU

S 3

TC X

1 w

eek

+

AZT

X 6

wee

ks

Dos

ages

Mot

her

Bab

y

NV

P

200

mg

stat

2m

gkg

sta

t with

in 7

2 ho

urs

AZT

300

mg

BID

4m

gkg

BID

X 6

wee

ks

3TC

15

0 m

g BI

D

4mg

kg B

ID X

1 w

eek

Tabl

e 4

5 R

ecom

men

ded

HA

AR

T fo

r Pre

gnan

t Wom

en

base

d on

CD

4 C

ount

and

Sta

ge o

f Pre

gnan

cy

CD

4 C

ount

H

AA

RT

Trim

este

r C

ells

mm

3

72

2 H

IV P

OSI

TIV

EIN

FAN

TB

Y D

NA

PC

R

bull A

ll H

IV p

ositi

ve in

fant

s sh

ould

be

eval

uate

d fo

r el

igib

ility

for

antishy

retr

ovir

al tr

eatm

ent

and

linke

d to

car

e an

d tr

eatm

ent

as a

ppro

pria

te

bull W

HO

clin

ical

sta

ging

sho

uld

be d

one

for

all H

IV p

ositi

ve in

fant

s

Chi

ldre

n w

ho a

re a

t W

HO

Clin

ical

sta

ge 3

or

4 ar

e el

igib

le f

or

antir

etro

vira

l tre

atm

ent

bull A

ll H

IV p

ositi

ve in

fant

s sh

ould

be

asse

ssed

for

CD

4 co

unt

whe

re

poss

ible

and

ava

ilabl

e R

efer

to

AR

T g

uide

lines

for

CD

4 co

unts

tha

t de

term

ine

elig

ibili

ty f

or A

RT

for

chi

ldre

n of

diff

eren

t ag

e br

acke

ts

bull A

ll H

IV-p

ositi

ve in

fant

s sh

ould

hav

e a

visi

ble

guar

dian

or

care

-tak

er

befo

re t

hey

can

be s

tart

ed o

n A

RT

bull A

ll H

IV-p

ositi

ve in

fant

s sh

ould

be

star

ted

on C

otri

mox

azol

e fr

om 6

w

eeks

or

on f

irst

cont

act t

here

afte

r

bull A

ll H

IV-p

ositi

ve in

fant

s sh

ould

be

star

ted

on A

RT

if el

igib

le

bull B

reas

tfeed

ing

shou

ld b

e en

cour

aged

for

all

HIV

-pos

itive

infa

nts

for

a

min

imum

of t

wo

year

s (

Ref

er t

o C

hapt

er 8

)

bull F

or a

ll H

IV-p

ositi

ve in

fant

s p

erfo

rm a

ntib

ody

test

ing

at 9

mon

ths

12

mon

ths

and

conf

irm

at

18 m

onth

s

1st T

rimes

ter

2nd T

rimes

ter

3rd T

rimes

ter

lt250

A

ZT+

3TC

+NV

P

AZ

T+3T

C+N

VP

AZT+

3TC

+NVP

250-

350

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

gt 35

0

A

ZT+3

TC+L

PVr

OR

A

BC

+3TC

+LPV

r

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

47

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

60

72

OPE

RA

TIO

NA

L G

UID

ELIN

ES

72

0 G

UID

ELIN

ESFO

R H

IV D

IAG

NO

SIS

INC

HIL

DR

EN

bull P

erfo

rm r

outin

e ra

pid

HIV

ant

ibod

y te

sts

for

all m

othe

rs o

f 6

wee

k ol

d in

fant

s pr

esen

ting

with

unk

now

n st

atus

bull P

erfo

rm r

outin

e dr

y bl

ood

spot

s (D

BS

) fo

r D

NA

PC

R f

or a

ll in

fant

s kn

own

to b

e H

IV-e

xpos

ed a

t 6

wee

ks

bull P

erfo

rm r

outin

e an

tibod

y te

stin

g fo

r al

l sic

k in

fant

s in

out

patie

nt a

nd

paed

iatr

ic w

ards

to

esta

blis

h H

IV e

xpos

ure

infe

ctio

n st

atus

bull P

erfo

rm D

BS

for

all

HIV

-exp

osed

sic

k in

fant

s un

der

12 m

onth

s

bull A

ll H

IV-e

xpos

ed in

fant

s sh

ould

be

star

ted

on C

otri

mox

azol

e fr

om 6

w

eeks

of

age

or o

n fir

st c

onta

ct th

erea

fter

bull R

efer

to

chap

ter

on c

are

and

follo

w u

p of

the

HIV

-exp

osed

infe

cted

in

fant

72

1 H

IV N

EGA

TIV

EIN

FAN

TA

TA

GE

6 W

EEK

SO

RFI

RST

CO

NTA

CT

Perf

orm

ant

ibod

y te

stin

g at

9 m

onth

s an

d 12

mon

ths

of a

ge

bull I

f H

IV n

egat

ive

at 1

2 m

onth

s an

d st

ill b

reas

tfee

ding

co

ntin

ue

Cot

rim

oxaz

ole

bull I

f not

bre

astf

eedi

ng f

or a

t le

ast

2 m

onth

s s

top

Cot

rim

oxaz

ole

bull P

erfo

rm c

onfir

mat

ory

antib

ody

test

ing

at 1

8 m

onth

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Mat

erna

l dos

ages

AZT

30

0 m

g B

ID

3TC

15

0 m

g BI

D

NVP

200

mg

OD

for t

wo

wee

ks t

here

afte

r 200

mg

BID

AB

C

300m

g B

ID

LPV

r (4

001

00)

2 ta

blet

s B

ID

EFV

60

0mg

QID

Not

es I

mpo

rtan

t con

side

ratio

ns th

at m

odify

cho

ice

of A

RV

s du

ring

pre

gnan

cy in

clud

e C

D4

coun

t m

ater

nal a

naem

ia a

nd

stag

e of

pre

gnan

cy

bull 2

NR

TIs

(A

ZT

and

3TC

) ac

ting

as a

ldquotr

eatm

ent

back

bone

rdquo w

ith a

dditi

on o

f an

N

NR

TI (

NV

P)

rem

ains

the

pre

ferr

ed fi

rst-

line

AR

V t

hera

py in

res

ourc

e-po

or

sett

ings

bull P

rote

ase

inhi

bito

rs b

ased

reg

imen

s ar

e pr

efer

able

whe

n C

D4

coun

t is

high

er

than

250

bull R

epla

ce A

ZT

with

d4T

if H

blt 8

gm

dL

bull

EF

V m

ay b

e us

ed in

stea

d of

NV

P a

fter

first

trim

este

r

bull

Usu

ally

AR

V s

houl

d be

with

held

if C

D4

coun

t is

not

ava

ilabl

e or

not

don

e

AR

V is

how

ever

use

d fo

r P

MT

CT

and

or in

adv

ance

d H

IV d

isea

se (

WH

O

Sta

ge 3

or

4) ir

resp

ectiv

e of

CD

4 co

unt

Bab

ies

who

se

mot

hers

di

d no

t re

ceiv

e an

tepa

rtum

or

in

trap

artu

m

AR

Vpr

ophy

laxi

s sh

ould

be

give

n A

RV

pro

phyl

axis

as

show

n in

Tab

le 4

6

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

9

48

Tabl

e 4

6 A

RV

prop

hyla

ctic

regi

men

s fo

r inf

ants

bor

n to

H

IV-p

ositi

ve w

omen

who

hav

e no

t rec

eive

d an

tepa

rtum

or

intr

apar

tum

AR

T or

AR

V pr

ophy

laxi

s

Ran

king

T

ime

of a

dmin

istr

atio

n an

d In

fant

dos

age

sdN

VP (2

mg

kg s

tat)

PLU

S 3T

C (4

mg

kg B

ID) X

1 w

eek

+ AZ

T (4

mg

kg

BID

) X 6

wee

ks

Rec

omm

ende

d

sdN

VP (2

mg

kg s

tat)

Min

imum

sdN

VP

is g

iven

to th

e in

fant

with

in 7

2 ho

urs

of b

irth

Plea

se n

ote

A

t fir

st c

onta

ct a

ll H

IV i

nfec

ted

preg

nant

wom

en s

houl

d be

giv

en s

dNV

P ta

blet

s to

take

hom

e w

ith t

hem

The

y sh

ould

be

inst

ruct

ed t

o ta

ke t

he t

able

ts a

t th

e on

set

of la

shybo

ur i

f lab

our

occu

rs o

utsi

de h

ealth

faci

lity

sett

ings

The

y sh

ould

als

o be

giv

en N

VP

3T

C a

nd A

ZT s

yrup

for

thei

r ba

bies

to b

e ad

min

iste

red

soon

aft

er b

irth

Som

e w

omen

with

a C

D4

coun

t gr

eate

r th

an 2

50 c

ells

microl

on

Nev

irap

ine

(NV

P)-b

ased

AR

T m

ay d

evel

op N

VP

hype

rsen

sitiv

e re

actio

ns t

hat

can

be li

fe t

hrea

teni

ng I

n th

ese

guid

elin

es it

is r

ecom

men

ded

that

for

preg

nant

wom

en w

ith C

D4

mor

e th

an 2

50 N

VP-

base

d re

gim

en m

ay s

till

be u

sed

but

with

clo

se m

onito

ring

O

ther

wis

e th

e re

com

shym

ende

d re

gim

en to

use

with

CD

4 co

unt a

bove

250

is a

PI-

base

d H

AA

RT

regi

men

Whe

n si

ngle

dos

e N

VP

(sdN

VP)

is u

sed

in P

MTC

T s

ome

wom

en a

nd c

hild

ren

may

deshy

velo

p re

sist

ance

to

NV

P th

at m

ay l

imit

futu

re u

se o

f N

on-N

ucle

osid

e R

ever

se T

ranshy

scri

ptas

e In

hibi

tors

(NN

RTI

s) t

o tr

eat

them

Th

e ri

sk o

f NN

RTI

res

ista

nce

is p

artic

ushyla

rly

high

if

two

dose

s of

sdN

VP

are

give

n T

here

fore

SdN

VP

shou

ld n

ever

be

used

mor

e th

an o

nce

in a

ny o

ne p

regn

ancy

Whe

re p

ossi

ble

AZT

3TC

sho

uld

be g

iven

for

7 da

ys t

o co

ver

the

NV

P ta

il bo

th in

the

mot

her

and

the

baby

Th

e ba

by is

the

n co

ntin

shyue

d on

AZT

for

a to

tal o

f 6 w

eeks

for

prop

hyla

xis

agai

nst M

TCT

HIV

-infe

cted

pre

gnan

t w

omen

sta

rtin

g zi

dovu

dine

(A

ZT)

cont

aini

ng r

egim

ens

shou

ld

have

hae

mog

lobi

n (H

b) le

vels

abo

ve 8

gm

dl

The

Hb

leve

l sho

uld

be c

heck

ed m

onth

ly

for

the

first

thr

ee m

onth

s W

here

pos

sibl

e A

ZT s

houl

d be

use

d in

stea

d of

sta

vudi

ne(d

4T)

Clin

ical

judg

emen

t can

be

used

to e

stim

ate

Hb

leve

ls a

nd in

itiat

e AR

V pr

ophy

laxi

s if l

aboshy

rato

ry te

sts a

re u

nava

ilabl

e

Efa

vire

nz (

EFV

) m

ay b

e te

rato

geni

c if

used

in t

he f

irst

tri

mes

ter

If t

he p

atie

nt is

on

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Cha

pter

7

HIV

Dia

gnos

is in

Chi

ldre

n 7

1 IN

TRO

DU

CTI

ON

In g

ener

al

a ch

ild m

ay b

e te

sted

und

er a

num

ber

of c

ircu

mst

ance

s T

hese

inc

lude

sh

ortly

aft

er b

irth

for

earl

y di

agno

sis

of H

IV f

or th

e pu

rpos

es o

f ind

ivid

ual d

iagn

osis

in

a ch

ild w

ho is

ill (

eg

tho

se p

rese

ntin

g w

ith a

n H

IV r

elat

ed il

lnes

s) i

n ca

ses

whe

re a

child

has

eith

er b

een

expo

sed

or is

pot

entia

lly e

xpos

ed t

o H

IV e

g t

hrou

gh m

othe

r-to

shych

ild t

rans

mis

sion

se

xual

abu

se

sexu

al a

ctiv

ity

with

in a

hea

lthca

re s

ettin

g (e

g

thro

ugh

cont

amin

ated

nee

dles

or

rece

ipt

of p

oten

tially

infe

ctio

us b

lood

) th

roug

h ot

her

mea

ns a

nd in

orp

hans

Ear

ly i

nfan

t di

agno

sis

(EID

) re

fers

to

the

mak

ing

of H

IV d

iagn

osis

in

infa

nts

and

youn

g ch

ildre

n be

fore

18

mon

ths

of a

ge E

ID g

ives

an

oppo

rtun

ity fo

r ea

rly

iden

tific

ashytio

n of

HIV

infe

cted

infa

nts

(des

pite

PM

TCT)

and

ear

ly li

nkag

e to

car

e an

d tr

eatm

ent

Dis

ease

pro

gres

sion

in H

IV in

fect

ed in

fant

s is

fast

with

a h

igh

mor

talit

y ra

te (gt

50

)by

2 y

ears

of a

ge T

he m

edia

n ag

e of

dea

th in

the

first

two

year

s is

6 m

onth

s H

IV a

ntishy

body

tes

ting

amon

g ch

ildre

n ag

ed 1

8 m

onth

s or

mor

e is

abl

e to

det

erm

ine

whe

ther

a

child

is in

fect

ed o

r no

t

Dur

ing

preg

nanc

y m

othe

rs g

ive

thei

r ba

bies

ant

ibod

ies

to in

fect

ions

the

y ha

ve e

xper

ishyen

ced

and

thes

e an

tibod

ies

wan

e w

ith ti

me

Ant

ibod

y te

stin

g in

chi

ldre

n ag

ed le

ss th

an

18 m

onth

s id

entif

ies

child

ren

who

hav

e be

en e

xpos

ed to

thei

r m

othe

rsrsquo H

IV in

fect

ion

or

who

may

be

trul

y in

fect

ed a

nd a

re m

akin

g H

IV a

ntib

odie

s C

urre

ntly

the

re is

no

test

to

diff

eren

tiate

the

mot

herrsquos

ant

ibod

ies

from

tho

se p

rodu

ced

by t

he b

aby

In

orde

r to

id

entif

y th

e H

IV-in

fect

ed c

hild

age

d le

ss t

han

18 m

onth

s a

sec

ond

test

is r

equi

red

for

all b

abie

s te

stin

g po

sitiv

e on

ant

ibod

y te

stin

g or

kno

wn

to b

e H

IV-e

xpos

ed (m

othe

r is

H

IV-p

ositi

ve)

Infa

nt D

NA

(or

RN

A) P

CR

tes

ting

is t

he c

urre

nt r

ecom

men

ded

met

hod

for

EID

Sinc

e m

ost b

abie

s lo

se m

ater

nal a

ntib

odie

s (A

b) b

y 12

mon

ths

a n

egat

ive

antib

ody

test

will

ide

ntify

uni

nfec

ted

babi

es a

s lo

ng a

s th

ey a

re n

ot s

till

brea

stfe

edin

g A

pos

itive

antib

ody

test

at

12 m

onth

s a

lthou

gh h

ighl

y lik

ely

to b

e di

agno

stic

may

stil

l be

due

topa

ssiv

ely

carr

ied

mat

erna

l ant

ibod

ies

Suc

h te

sts

need

to

be c

onfir

med

by

PCR

tes

ting

or r

epea

t ant

ibod

y te

st a

t 18

mon

ths

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

9

58

CARE

SU

PPO

RTAN

DTR

EATM

ENT

FOR

HIV

PO

SITI

VEM

OTH

ERAN

DCH

ILD

HIV

-pos

itive

mot

hers

requ

ire c

are

and

supp

ort w

hich

incl

udes

bull

Cou

nsel

ing

bull P

roph

ylax

is a

nd tr

eatm

ent

bull L

ink

to s

uppo

rt g

roup

s an

d as

sess

men

t of

the

nee

d fo

r A

RT

bull E

arly

infa

nt d

iagn

osis

sho

uld

be p

rovi

ded

at s

ix w

eeks

usi

ng D

NA

shyP

CR

tes

ting

Cha

pter

ref

eren

ces

1

Rep

ublic

of

Ken

ya M

inis

try

of

Hea

lth

Div

isio

n o

f Rep

roduct

ive

Hea

lth

Pla

nnin

g

Guid

elin

es f

or

serv

ice

pro

vider

s

Rev

ised

in M

arch

2006

Foo

tnot

es

1

Pre

ble

and P

iwoz

2001

2

WH

O

Contr

ace

ptive

Elig

ibili

ty C

rite

ria

Guid

e

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

EFV

bef

ore

beco

min

g pr

egna

nt i

t sho

uld

be s

ubsi

tute

d w

ith N

VP

in th

e 1s

t tri

mes

ter

In c

ase

of s

ever

e hy

pere

mes

is g

ravi

daru

m A

RT

may

nee

d to

be

brie

fly in

terr

upte

d

On

aver

age

mot

her-

to-c

hild

tra

nsm

issi

on r

ates

are

15

for

sdN

VP

65

fo

r m

ore

effishy

caci

ous

dual

reg

imen

s an

d 2

4 fo

r 3-

drug

AR

V c

ombi

natio

n

Futu

re P

ersp

ectiv

es

Ext

ende

d pr

ophy

laxi

s w

ith 3

AR

V d

rug

com

bina

tions

sta

rtin

g du

ring

pre

gnan

cy a

nd

cont

inui

ng a

fter

del

iver

y fo

r a

peri

od o

f up

to

6 m

onth

s a

mon

g H

IV-in

fect

ed b

reas

t-fe

edin

g m

othe

rs h

as b

een

show

n in

a f

ew r

ecen

t an

d is

olat

ed s

tudi

es a

nd p

ilot

proshy

gram

me

to le

ad to

low

er b

reas

tfee

ding

-rel

ated

pos

tnat

al M

TCT

Thi

s ap

proa

ch m

ay b

e co

nsid

ered

whe

re th

is is

feas

ible

acc

epta

ble

saf

e an

d w

here

adh

eren

ce c

an b

e as

sure

d

Mor

e st

udie

s on

this

issu

e ar

e ex

pect

ed

Thre

e A

RV

dru

g co

mbi

natio

ns g

iven

to

HIV

pos

itive

pre

gnan

t w

omen

who

are

not

yet

el

igib

le fo

r in

itiat

ion

of A

RTs

for

thei

r ow

n he

alth

als

o le

ad to

low

er M

TCT

and

may

be

cons

ider

ed in

pro

gram

mes

with

the

capa

city

to in

itiat

e th

e re

gim

en a

nd fo

llow

up

such

wom

en S

uch

inte

rven

tion

is in

itiat

ed a

t ar

ound

28

wee

ks o

r so

on a

fter

and

sto

pped

af

ter

birt

h if

CD

4 co

unt i

s st

ill a

bove

350

cel

lsm

m3

App

endi

ces

Appen

dix

I

Appen

dix

II

Appen

dix

III

Appen

dix

IV

WH

O C

linic

al S

tagin

g o

f H

IVA

IDS f

or

Adults

and A

dole

scen

ts

w

ith c

onfirm

ed H

IV infe

ctio

n

Contr

acep

tive

Options

for

Peo

ple

Liv

ing w

ith H

IV

Sum

mar

y of

ARV D

rug U

se f

or

PMTCT o

f H

IV

In

tegra

ted M

onitori

ng a

nd E

valu

ation R

eport

Form

MO

H 7

26

Cha

pter

ref

eren

ces

1

Sum

mar

y of

ARV D

rugs

Adve

rse

Effec

ts a

nd M

anag

emen

t T

able

6-1

0

pages

101-1

12 o

f G

uid

elin

es f

or

Antire

trovi

ral D

rug T

her

apy

in K

enya

3rd

Editio

n

De-

cem

ber

2005

2

Dru

g I

nte

ract

ions

Tab

le 7

-10

pag

es 1

12-1

22 o

f G

uid

elin

es f

or

Antire

trovi

ral

Dru

g T

her

apy

in K

enya

3rd

editio

n

Dec

2005

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

7

50

Cha

pter

5

Imm

edia

te P

ostn

atal

and

Neo

nata

l Car

e 5

1 IN

TRO

DU

CTI

ON

Imm

edia

te p

ostn

atal

and

neo

nata

l car

e re

fers

to th

e pa

ckag

e of

ser

vice

s pr

ovid

ed to

the

mot

her

and

infa

nt b

efor

e th

ey le

ave

the

heal

th fa

cilit

y (u

p to

48

hour

s) a

fter

del

iver

yTh

e pe

riod

pro

vide

s an

opp

ortu

nity

to e

duca

te a

ll m

othe

rs a

bout

HIV

to

prov

ide

coun

shyse

lling

and

tes

ting

if it

was

not

don

e pr

evio

usly

and

to

rein

forc

e th

e ed

ucat

ion

proshy

vide

d du

ring

the

ant

enat

al p

erio

d B

oth

HIV

inf

ecte

d an

d H

IV u

ninf

ecte

d m

othe

rs

shou

ld r

ecei

ve th

is e

duca

tion

and

coun

selli

ng b

efor

e di

scha

rge

52

OPE

RA

TIO

NA

L G

UID

ELIN

ES

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed fo

r all

wom

en a

nd

infa

nts

in th

e im

med

iate

pos

t par

tum

per

iod

a)

Opt

imal

pos

tpar

tum

car

e

bull R

outin

e ca

re in

clud

ing

brea

st e

xam

inat

ion

exa

min

atio

n of

the

ute

rus

ex

amin

atio

n of

the

per

ineu

m a

nd lo

chia

pa

ssag

e of

uri

ne r

egul

arly

pr

oper

hyg

iene

to

prev

ent

infe

ctio

n c

heck

ing

for

sign

s of

ana

emia

fe

ver

and

tach

ycar

dia

bull D

iscu

ss m

ater

nal n

utri

tion

bull E

stab

lish

the

HIV

sta

tus

of t

he m

othe

rs in

clud

ing

thos

e gi

ving

birt

h ou

tsid

e th

e he

alth

inst

itutio

n se

tting

bull P

rovi

de H

IV C

T f

or m

othe

rs w

ith u

nkno

wn

HIV

sta

tus

bull E

ncou

rage

HIV

res

ults

dis

clos

ure

and

part

ner

test

ing

bull F

ollo

w t

he s

tand

ard

guid

elin

es o

n th

e ca

re o

f a n

ewbo

rn (

IMP

AC

C

are

Man

ual)

bull A

ll ba

bies

sho

uld

rece

ive

thei

r ro

utin

e im

mun

izat

ion

(OP

V a

nd B

CG

) in

th

eir

first

hou

rs o

f lif

e1

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Con

trac

eptio

n A

ll m

othe

rs r

egar

dles

s of

the

ir H

IV s

tatu

s h

ave

a ri

ght

to r

ecei

ve a

dequ

ate

info

rmashy

tion

on a

vaila

ble

met

hods

of f

amily

pla

nnin

g an

d to

mak

e an

info

rmed

cho

ice

on w

hat

is b

est

for

them

H

IV-in

fect

ed w

omen

who

are

not

bre

astf

eedi

ng s

houl

d in

itiat

e a

relia

ble

cont

race

ptiv

e m

etho

d by

2-4

wee

ks p

ostp

artu

m

This

is

in a

dditi

on t

o th

epr

oper

and

con

sist

ent

use

of t

he c

ondo

m a

s a

form

of

dual

pro

tect

ion

All

met

hods

of

cont

race

ptio

n ca

n be

use

d by

HIV

pos

itive

wom

en b

ased

on

stan

dard

med

ical

elig

ibili

tycr

iteri

a in

clud

ing

taki

ng c

are

of d

rug

inte

ract

ions

as

outli

ned

belo

w2

bull L

acta

tiona

l Am

enor

rhoe

a M

etho

d (L

AM

) S

uita

ble

for

excl

usiv

ely

brea

stfe

edin

g H

IV in

fect

ed w

omen

who

hav

e no

t re

sum

ed m

ense

s

bull H

orm

onal

con

trac

eptio

n A

ll ho

rmon

al c

ontr

acep

tives

can

be

used

in

HIV

pos

itive

wom

en in

clud

ing

thos

e on

HA

AR

T

Com

bine

d or

al

cont

race

ptiv

es a

re c

ontr

aind

icat

ed f

or u

se w

ith d

rugs

that

indu

ce

hepa

tic m

icro

-enz

yme

that

may

red

uce

the

effe

ctiv

enes

s of

hor

mon

al

cont

race

ptiv

es

Som

e an

ti-T

Bs

ant

iret

rovi

rals

an

tifun

gals

and

ant

i-ep

ilept

ics

and

in c

ondi

tions

tha

t ca

use

mal

abso

rptio

n8

bull I

ntra

-ute

rine

con

trac

eptiv

e de

vice

s (I

UC

Ds)

IU

CD

s ar

e no

t co

ntra

indi

cate

d in

HIV

pos

itive

wom

en

In s

ever

ely

imm

uno

supp

rese

d w

omen

use

sho

uld

not

be d

isco

ntin

ued

but

new

inse

rtio

n is

dis

cour

aged

as

it m

ay b

e as

soci

ated

with

incr

ease

d ri

sk o

f in

fect

ion

duri

ng t

he in

sert

ion

proc

ess

bull S

urgi

cal m

etho

ds S

urgi

cal c

ontr

acep

tion

shou

ld b

e of

fere

d to

HIV

po

sitiv

e w

omen

and

the

ir pa

rtne

rs

bull B

arri

er m

etho

ds

Fem

ale

and

mal

e co

ndom

s pr

ovid

e pr

otec

tion

agai

nst

ST

Ds

and

redu

ce t

he r

isk

of H

IV t

rans

mis

sion

and

sho

uld

be

enco

urag

ed a

lone

or

toge

ther

with

oth

er c

ontr

acep

tive

met

hods

bull S

perm

icid

es

Use

d in

con

junc

tion

with

bar

rier

met

hods

spe

rmic

ides

w

ill p

rovi

de a

dditi

onal

con

trac

eptiv

e pr

otec

tion

How

ever

sp

erm

icid

es s

houl

d no

t be

use

d al

one

as t

hey

can

incr

ease

the

ris

k of

HIV

acq

uisi

tion

bull E

mer

genc

y co

ntra

cept

ion

HIV

pos

itive

wom

en s

houl

d be

info

rmed

ab

out

emer

genc

y co

ntra

cept

ion

whe

re it

is a

vaila

ble

and

how

to

obta

in a

nd u

se it

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

1

56

Bre

ast c

are

in b

reas

tfeed

ing

mot

hers

bull E

ncou

rage

dai

ly c

lean

ing

of t

he b

reas

ts a

nd a

void

ing

the

appl

icat

ion

of lo

tions

bull T

reat

mat

erna

l vag

inal

can

didi

asis

and

infa

nt o

ral c

andi

dias

is

bull E

duca

te m

othe

r on

opt

imal

bre

astf

eedi

ng te

chni

que

incl

udin

g la

tchi

ng

on t

echn

ique

ex

lusi

ve b

reas

tfee

ding

and

rem

ovin

g ba

by f

rom

bre

ast

bull E

duca

te th

e m

othe

r on

bre

ast c

are

to p

reve

nt c

ompl

icat

ions

(cr

acki

ng

and

engo

rgem

ent)

bull E

xpre

ss a

nd h

eat

trea

t th

e m

ilk if

bre

ast

has

mas

titis

or

absc

ess

Opt

imal

pos

tpar

tum

car

e fo

r HIV

pos

itive

wom

en

Loch

ia

bull P

ut e

mph

asis

on

good

per

inea

l hyg

iene

and

pro

per

hand

ling

of b

ody

fluid

s

bull A

void

con

tam

inat

ing

the

baby

with

bod

y flu

ids

or w

ith b

eddi

ng s

oile

d w

ith lo

chia

bull S

hari

ng o

f be

ds b

y m

othe

rs in

the

hos

pita

l sho

uld

be d

isco

urag

ed

Cae

sare

an S

ectio

n

Bro

ad s

pect

rum

ant

ibio

tics

shou

ld b

e us

ed r

outin

ely

afte

r C

S

Esse

ntia

l mat

erna

l edu

catio

n an

d fo

llow

-up

bull M

onito

r fo

r br

east

and

pel

vic

infe

ctio

n at

all

post

nat

al c

linic

vis

its

bull E

duca

te o

n pr

ompt

hea

lth s

eeki

ng b

ehav

iour

bull H

ealth

edu

catio

n on

hyg

iene

lo

chia

and

bre

ast

care

bull A

void

sex

ual i

nter

cour

se f

or a

t lea

st 2

wee

ks a

fter

birt

h or

unt

il th

ere

is

no lo

nger

any

loch

ia r

ubra

or

sero

sa

bull D

o pa

p sm

ear

or V

IA a

t 4-

6 w

eeks

bull F

or e

very

sex

ual a

ctiv

ity

the

coup

le s

houl

d us

e co

ndom

s

bull D

iscu

ss f

amily

pla

nnin

g at

eve

ry o

ppor

tuni

ty a

nd p

rovi

de t

he

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Supp

ort

infa

nt fe

edin

g op

tions

For

all

HIV

neg

ativ

e w

omen

wom

en o

f unk

now

n H

IV

stat

us a

nd H

IV p

ositi

ve m

othe

rs o

ptin

g fo

r ex

clus

ive

brea

stfe

edin

g in

itiat

e br

east

feed

shyin

g w

ithin

hal

f hou

r of

bir

th a

nd fo

llow

oth

er g

uide

lines

as

per

Bab

y Fr

iend

ly H

ospi

tal

Initi

ativ

e2 (B

FHI)

bull G

ive

info

rmat

ion

on fa

mily

pla

nnin

g an

d du

al p

rote

ctio

n

bull C

ouns

el o

n H

IV r

isk

redu

ctio

n

bull S

ched

ule

post

nata

l clin

ic v

isits

at

2 w

eeks

and

at

4-6

wee

ks a

nd

com

plet

e m

othe

r-ch

ild b

ookl

et (

refe

r to

DR

H m

anua

l)

(b) S

peci

fic p

ostp

artu

m c

are

for H

IV p

ositi

ve w

omen

bull S

uppo

rt e

xclu

sive

bre

astf

eedi

ng u

nles

s m

othe

r ha

s ap

prop

riat

ely

opte

d fo

r an

d be

en c

ouns

elle

d on

rep

lace

men

t fe

edin

g an

tena

tally

bull I

nitia

te o

r co

ntin

ue c

o-tr

imox

azol

e pr

ophy

laxi

s -1

dou

ble

stre

ngth

tab

shyle

t da

ily

bull F

or H

IV p

ositi

ve m

othe

rs t

hat

rece

ived

sd

nevi

rapi

ne in

trap

artu

m

initi

shyat

e A

ZT

300m

g an

d 3T

C 1

50 m

g B

D f

or 1

wee

k

bull F

or n

ewly

dia

gnos

ed m

othe

rs

do H

IV s

tagi

ng

CD

4 co

unt

and

refe

r ap

prop

riat

ely

for

cont

inue

d ca

re

(c)

Spec

ific

care

for H

IV e

xpos

ed in

fant

s

bull F

or H

IV e

xpos

ed in

fant

s a

dmin

iste

r sd

NV

P 2

mg

kg s

tat

with

in 7

2 ho

urs

Giv

e A

ZT

4 m

gkg

BID

for

6 w

eeks

and

3T

C 4

mg

kg B

ID f

or 1

w

eek

Ref

er t

o C

hapt

er 4

bull R

efer

to C

hapt

er 8

for

deta

ils o

n in

fant

fee

ding

opt

ions

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

5

52

Cha

pter

ref

eren

ces

1

Rep

ublic

of

Ken

ya M

inis

try

of

Hea

lth

Div

isio

n o

f Rep

roduct

ive

Hea

lth

Nat

ional

Guid

elin

es f

or

Qual

ity

Obst

etri

cs a

nd P

erin

ata

l Car

e (2

004)

2

2R

epublic

of

Ken

ya M

inis

try

of

Hea

lth

Ess

ential

Obst

etri

c C

are

Man

ual

for

Hea

lth

Ser

vice

Pro

vider

s in

Ken

ya 3

rd E

ditio

n (

Jan 2

006)

Foo

tnot

es

1

WH

O r

ecom

men

ds

that

all

vacc

ines

should

be

giv

en t

o H

IV-s

ero-n

egat

ive

child

ren

and t

o a

sym

pto

mat

ic s

ero-p

osi

tive

s

The

only

vac

cines

to b

e w

ithhel

d f

rom

child

ren w

ith s

ympto

mat

ic A

IDS a

re B

CG

and

Yel

low

fev

er v

acc

ines

2

The

ldquoTen

Ste

psrdquo

of

BFH

I R

ecom

men

ded

Pra

ctic

es f

or

Mat

ernity

Ser

vice

s ad

apte

d f

or

W

HO

UN

ICEF

1989

Cha

pter

6

Late

Pos

tnat

al C

are

and

Fam

ily P

lann

ing

61

INTR

OD

UC

TIO

N

Late

pos

tnat

al c

are

is p

rovi

ded

to t

he m

othe

r an

d th

e ch

ild 4

8 ho

urs

to 6

wee

ks a

fter

deliv

ery

Dur

ing

this

per

iod

the

heal

th o

f the

mot

her

and

child

is a

sses

sed

and

clos

ely

mon

itore

d

The

risk

of M

TCT

duri

ng th

e po

stpa

rtum

per

iod

can

be r

educ

ed b

y pr

ovid

ing

HIV

cou

nshyse

lling

and

test

ing

pos

t-ex

posu

re p

roph

ylax

is fo

r ex

pose

d ba

bies

cou

nsel

ling

on a

ppro

shypr

iate

infa

nt fe

edin

g op

tions

and

bre

ast c

are

Pos

tpar

tum

car

e fo

r H

IV p

ositi

ve w

omen

shou

ld in

clud

e cl

inic

al s

tagi

ng C

D4

coun

t and

AR

T fo

r th

ose

who

qua

lify

Fam

ily p

lann

ing

serv

ices

are

am

ong

the

core

inte

rven

tions

of P

MTC

T pr

ovid

ed to

hel

pw

omen

det

erm

ine

futu

re c

hild

bear

ing

patt

erns

inc

ludi

ng t

he p

reve

ntio

n of

HIV

-in

fect

ed b

irth

s

Rep

rodu

ctiv

e he

alth

cou

nsel

ling

can

help

a w

oman

pra

ctis

e sa

fer

sex

and

dete

rmin

e he

r fu

ture

ch

ildbe

arin

g pa

tter

ns

on

a m

ore

resp

onsi

ble

and

info

rmed

bas

is1

62

OPE

RA

TIO

NA

L G

UID

ELIN

ES

Opt

imal

pos

tpar

tum

car

e fo

r all

wom

en

This

ent

ails

rou

tine

care

inc

ludi

ng b

reas

t ex

amin

atio

n e

xam

inat

ion

of t

he u

teru

s

exam

inat

ion

of t

he p

erin

eum

and

loch

ia p

assa

ge o

f uri

ne r

egul

arly

pro

per

hygi

ene

topr

even

t in

fect

ion

che

ckin

g fo

r si

gns

of a

nem

ia

feve

r an

d ta

chyc

ardi

a an

d do

ing

peri

neal

exe

rcis

es

Add

ition

al c

are

incl

udes

bull C

ouns

ellin

g an

d te

stin

g fo

r m

othe

rs o

f un

know

n H

IV s

tatu

s bull

Pro

visi

on o

f co

ndom

s an

d ris

k re

duct

ion

coun

selli

ng

bull C

ouns

ellin

g on

con

trac

eptiv

e op

tions

in

clud

ing

dual

met

hod

use

bull D

iscu

ssin

g m

ater

nal n

utrit

ion

bull M

alar

ia p

reve

ntio

n bull

Scr

eeni

ng f

or S

TI a

nd c

ervi

cal c

ance

r

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

3

54

ltlt ASCII85EncodePages false AllowTransparency false AutoPositionEPSFiles true AutoRotatePages None Binding Left CalGrayProfile (Dot Gain 20) CalRGBProfile (sRGB IEC61966-21) CalCMYKProfile (US Web Coated 050SWOP051 v2) sRGBProfile (sRGB IEC61966-21) CannotEmbedFontPolicy Warning CompatibilityLevel 14 CompressObjects Tags CompressPages true ConvertImagesToIndexed true PassThroughJPEGImages true CreateJobTicket false DefaultRenderingIntent Default DetectBlends true DetectCurves 00000 ColorConversionStrategy CMYK DoThumbnails false EmbedAllFonts false EmbedOpenType false ParseICCProfilesInComments true EmbedJobOptions true DSCReportingLevel 0 EmitDSCWarnings false EndPage -1 ImageMemory 1048576 LockDistillerParams false MaxSubsetPct 100 Optimize true OPM 1 ParseDSCComments true ParseDSCCommentsForDocInfo true PreserveCopyPage true PreserveDICMYKValues true PreserveEPSInfo true PreserveFlatness true PreserveHalftoneInfo false PreserveOPIComments true PreserveOverprintSettings true StartPage 1 SubsetFonts true TransferFunctionInfo Apply UCRandBGInfo Preserve UsePrologue false ColorSettingsFile () AlwaysEmbed [ true Arial-Black Arial-BoldItalicMT Arial-BoldMT Arial-ItalicMT ArialMT ArialNarrow ArialNarrow-Bold ArialNarrow-BoldItalic ArialNarrow-Italic ArialRoundedMTBold ArialUnicodeMS CenturySchoolbook CenturySchoolbook-Bold CenturySchoolbook-BoldItalic CenturySchoolbook-Italic Symbol Times-Bold Times-BoldItalic Times-Italic TimesNewRomanPS-BoldItalicMT TimesNewRomanPS-BoldMT TimesNewRomanPS-ItalicMT TimesNewRomanPSMT Times-Roman Verdana Verdana-Bold Verdana-BoldItalic Verdana-Italic Wingdings2 Wingdings3 Wingdings-Regular ] NeverEmbed [ true ] AntiAliasColorImages false CropColorImages true ColorImageMinResolution 300 ColorImageMinResolutionPolicy OK DownsampleColorImages true ColorImageDownsampleType Bicubic ColorImageResolution 300 ColorImageDepth -1 ColorImageMinDownsampleDepth 1 ColorImageDownsampleThreshold 150000 EncodeColorImages true ColorImageFilter DCTEncode AutoFilterColorImages true ColorImageAutoFilterStrategy JPEG ColorACSImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt ColorImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt JPEG2000ColorACSImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt JPEG2000ColorImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt AntiAliasGrayImages false CropGrayImages true GrayImageMinResolution 300 GrayImageMinResolutionPolicy OK DownsampleGrayImages true GrayImageDownsampleType Bicubic GrayImageResolution 300 GrayImageDepth -1 GrayImageMinDownsampleDepth 2 GrayImageDownsampleThreshold 150000 EncodeGrayImages true GrayImageFilter DCTEncode AutoFilterGrayImages true GrayImageAutoFilterStrategy JPEG GrayACSImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt GrayImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt JPEG2000GrayACSImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt JPEG2000GrayImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt AntiAliasMonoImages false CropMonoImages true MonoImageMinResolution 1200 MonoImageMinResolutionPolicy OK DownsampleMonoImages true MonoImageDownsampleType Bicubic MonoImageResolution 1200 MonoImageDepth -1 MonoImageDownsampleThreshold 150000 EncodeMonoImages true MonoImageFilter CCITTFaxEncode MonoImageDict ltlt K -1 gtgt AllowPSXObjects false CheckCompliance [ None ] PDFX1aCheck false PDFX3Check false PDFXCompliantPDFOnly false PDFXNoTrimBoxError true PDFXTrimBoxToMediaBoxOffset [ 000000 000000 000000 000000 ] PDFXSetBleedBoxToMediaBox true PDFXBleedBoxToTrimBoxOffset [ 000000 000000 000000 000000 ] PDFXOutputIntentProfile () PDFXOutputConditionIdentifier () PDFXOutputCondition () PDFXRegistryName () PDFXTrapped False CreateJDFFile false Description ltlt ARA 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 BGR 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 CHS ltFEFF4f7f75288fd94e9b8bbe5b9a521b5efa7684002000410064006f006200650020005000440046002065876863900275284e8e9ad88d2891cf76845370524d53705237300260a853ef4ee54f7f75280020004100630072006f0062006100740020548c002000410064006f00620065002000520065006100640065007200200035002e003000204ee553ca66f49ad87248672c676562535f00521b5efa768400200050004400460020658768633002gt CHT ltFEFF4f7f752890194e9b8a2d7f6e5efa7acb7684002000410064006f006200650020005000440046002065874ef69069752865bc9ad854c18cea76845370524d5370523786557406300260a853ef4ee54f7f75280020004100630072006f0062006100740020548c002000410064006f00620065002000520065006100640065007200200035002e003000204ee553ca66f49ad87248672c4f86958b555f5df25efa7acb76840020005000440046002065874ef63002gt CZE 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 DAN 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 DEU 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 ESP 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 ETI 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 FRA 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 GRE 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 HEB ltFEFF05D405E905EA05DE05E905D5002005D105D405D205D305E805D505EA002005D005DC05D4002005DB05D305D9002005DC05D905E605D505E8002005DE05E105DE05DB05D9002000410064006F006200650020005000440046002005D405DE05D505EA05D005DE05D905DD002005DC05D405D305E405E105EA002005E705D305DD002D05D305E405D505E1002005D005D905DB05D505EA05D905EA002E002005DE05E105DE05DB05D90020005000440046002005E905E005D505E605E805D5002005E005D905EA05E005D905DD002005DC05E405EA05D905D705D4002005D105D005DE05E605E205D505EA0020004100630072006F006200610074002005D5002D00410064006F00620065002000520065006100640065007200200035002E0030002005D505D205E805E105D005D505EA002005DE05EA05E705D305DE05D505EA002005D905D505EA05E8002E05D005DE05D905DD002005DC002D005000440046002F0058002D0033002C002005E205D905D905E005D5002005D105DE05D305E805D905DA002005DC05DE05E905EA05DE05E9002005E905DC0020004100630072006F006200610074002E002005DE05E105DE05DB05D90020005000440046002005E905E005D505E605E805D5002005E005D905EA05E005D905DD002005DC05E405EA05D905D705D4002005D105D005DE05E605E205D505EA0020004100630072006F006200610074002005D5002D00410064006F00620065002000520065006100640065007200200035002E0030002005D505D205E805E105D005D505EA002005DE05EA05E705D305DE05D505EA002005D905D505EA05E8002Egt HRV (Za stvaranje Adobe PDF dokumenata najpogodnijih za visokokvalitetni ispis prije tiskanja koristite ove postavke Stvoreni PDF dokumenti mogu se otvoriti Acrobat i Adobe Reader 50 i kasnijim verzijama) HUN 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 ITA 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 JPN ltFEFF9ad854c18cea306a30d730ea30d730ec30b951fa529b7528002000410064006f0062006500200050004400460020658766f8306e4f5c6210306b4f7f75283057307e305930023053306e8a2d5b9a30674f5c62103055308c305f0020005000440046002030d530a130a430eb306f3001004100630072006f0062006100740020304a30883073002000410064006f00620065002000520065006100640065007200200035002e003000204ee5964d3067958b304f30533068304c3067304d307e305930023053306e8a2d5b9a306b306f30d530a930f330c8306e57cb30818fbc307f304c5fc59808306730593002gt KOR ltFEFFc7740020c124c815c7440020c0acc6a9d558c5ec0020ace0d488c9c80020c2dcd5d80020c778c1c4c5d00020ac00c7a50020c801d569d55c002000410064006f0062006500200050004400460020bb38c11cb97c0020c791c131d569b2c8b2e4002e0020c774b807ac8c0020c791c131b41c00200050004400460020bb38c11cb2940020004100630072006f0062006100740020bc0f002000410064006f00620065002000520065006100640065007200200035002e00300020c774c0c1c5d0c11c0020c5f40020c2180020c788c2b5b2c8b2e4002egt LTH 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 LVI 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 NLD (Gebruik deze instellingen om Adobe PDF-documenten te maken die zijn geoptimaliseerd voor prepress-afdrukken van hoge kwaliteit De gemaakte PDF-documenten kunnen worden geopend met Acrobat en Adobe Reader 50 en hoger) NOR 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 POL ltFEFF0055007300740061007700690065006e0069006100200064006f002000740077006f0072007a0065006e0069006100200064006f006b0075006d0065006e007400f300770020005000440046002000700072007a0065007a006e00610063007a006f006e00790063006800200064006f002000770079006400720075006b00f30077002000770020007700790073006f006b00690065006a0020006a0061006b006f015b00630069002e002000200044006f006b0075006d0065006e0074007900200050004400460020006d006f017c006e00610020006f007400770069006500720061010700200077002000700072006f006700720061006d006900650020004100630072006f00620061007400200069002000410064006f00620065002000520065006100640065007200200035002e0030002000690020006e006f00770073007a0079006d002egt PTB ltFEFF005500740069006c0069007a006500200065007300730061007300200063006f006e00660069006700750072006100e700f50065007300200064006500200066006f0072006d00610020006100200063007200690061007200200064006f00630075006d0065006e0074006f0073002000410064006f0062006500200050004400460020006d00610069007300200061006400650071007500610064006f00730020007000610072006100200070007200e9002d0069006d0070007200650073007300f50065007300200064006500200061006c007400610020007100750061006c00690064006100640065002e0020004f007300200064006f00630075006d0065006e0074006f00730020005000440046002000630072006900610064006f007300200070006f00640065006d0020007300650072002000610062006500720074006f007300200063006f006d0020006f0020004100630072006f006200610074002000650020006f002000410064006f00620065002000520065006100640065007200200035002e0030002000650020007600650072007300f50065007300200070006f00730074006500720069006f007200650073002egt RUM ltFEFF005500740069006c0069007a00610163006900200061006300650073007400650020007300650074010300720069002000700065006e007400720075002000610020006300720065006100200064006f00630075006d0065006e00740065002000410064006f006200650020005000440046002000610064006500630076006100740065002000700065006e0074007200750020007400690070010300720069007200650061002000700072006500700072006500730073002000640065002000630061006c006900740061007400650020007300750070006500720069006f006100720103002e002000200044006f00630075006d0065006e00740065006c00650020005000440046002000630072006500610074006500200070006f00740020006600690020006400650073006300680069007300650020006300750020004100630072006f006200610074002c002000410064006f00620065002000520065006100640065007200200035002e00300020015f00690020007600650072007300690075006e0069006c006500200075006c0074006500720069006f006100720065002egt RUS 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 SKY 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 SLV 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 SUO 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 SVE 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 TUR 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 UKR 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 ENU (Use these settings to create Adobe PDF documents best suited for high-quality prepress printing Created PDF documents can be opened with Acrobat and Adobe Reader 50 and later) gtgt Namespace [ (Adobe) (Common) (10) ] OtherNamespaces [ ltlt AsReaderSpreads false CropImagesToFrames true ErrorControl WarnAndContinue FlattenerIgnoreSpreadOverrides false IncludeGuidesGrids false IncludeNonPrinting false IncludeSlug false Namespace [ (Adobe) (InDesign) (40) ] OmitPlacedBitmaps false OmitPlacedEPS false OmitPlacedPDF false SimulateOverprint Legacy gtgt ltlt AddBleedMarks false AddColorBars false AddCropMarks false AddPageInfo false AddRegMarks false ConvertColors ConvertToCMYK DestinationProfileName () DestinationProfileSelector DocumentCMYK Downsample16BitImages true FlattenerPreset ltlt PresetSelector MediumResolution gtgt FormElements false GenerateStructure false IncludeBookmarks false IncludeHyperlinks false IncludeInteractive false IncludeLayers false IncludeProfiles false MultimediaHandling UseObjectSettings Namespace [ (Adobe) (CreativeSuite) (20) ] PDFXOutputIntentProfileSelector DocumentCMYK PreserveEditing true UntaggedCMYKHandling LeaveUntagged UntaggedRGBHandling UseDocumentProfile UseDocumentBleed false gtgt ]gtgt setdistillerparamsltlt HWResolution [2400 2400] PageSize [612000 792000]gtgt setpagedevice

A

ppen

dix

VII

I Li

st o

f Con

trib

utor

s

Dr

Ayi

si R

ober

t K

Dep

uty

Hea

d N

ASC

OP

PMTC

T Pr

grm

Mng

r

MO

H-N

ASC

OP

Dr

Abd

alla

h S

aade

H

IV T

rain

er J

HPI

EG

O

Ms

Ake

lola

Rut

h

Nut

ritio

n amp

HIV

Man

ager

MO

H-N

ASC

OP

Mr

Dey

a J

osph

at

PMTC

T Pr

ogra

m O

ffice

r M

OH

-NA

SCO

P

Dr

Die

lem

ans

Pau

l

Mat

erna

l Neo

nata

l Hea

lth (M

NH

) Adv

isor

EH

SD

RH

Ms

Gitu

to A

nnie

W

Prog

ram

Offi

cer

MO

H-D

RH

Dr

Inw

ani

Iren

e

Paed

iatr

icia

n IC

AR

T K

NH

Mr

Isav

wa

Ant

hony

D

ata

Prog

ram

Man

ager

CD

C K

enya

Dr

Kar

anja

Dom

inic

PM

TCT

Prog

ram

Man

ager

PA

THFI

ND

ER

Inte

rnat

iona

l

Dr

Kia

rie

Jam

es N

PM

TCT

Prog

ram

Man

ager

KN

HU

ON

Dr

Kig

en B

atile

l Pr

ogra

m M

anag

er M

OH

-DR

H

Ms

Koe

ch R

osel

ine

Pr

ogra

m O

ffice

r M

OH

-DR

H

Dr

Mac

hari

a S

heila

R

H S

ervi

ces

Spec

ialis

t U

SAID

K

Dr

Mat

u L

ucy

PM

TCT

Prog

ram

Man

ager

USA

IDK

Ms

Mau

a J

udith

Pr

ogra

m O

ffice

r D

RH

-MO

H

Prof

Mbo

ri-N

gach

a D

Se

nior

Tec

hnic

al A

dvis

or A

ssoc

iate

Pro

fess

or

of P

aedi

atri

cs C

DC

Ken

ya U

oN

Dr

Mud

any

Mild

red

Te

chni

cal A

dvis

or C

DC

Ken

ya

Ms

Muh

enje

Ody

lia

Beh

avio

ral S

cien

tist

CD

C K

enya

Ms

Mut

sots

o W

infr

ed

PMTC

T Te

chni

cal A

dvis

orP

rogr

am M

anag

er C

DC

Ken

ya

Ms

Mut

uku

Ter

esia

H

IV T

rain

er J

HPI

EG

O

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

3

104

App

endi

x V

II

103

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Ms

Mw

anga

ngi

Alic

e Pr

ogra

m O

ffice

r D

RH

-MO

H

Ms

Mw

angi

Nan

cy

PMTC

T A

dmin

istr

ativ

e A

ssis

tant

CD

C K

enya

Mr

Ndw

iga

Fra

ncis

Pr

ogra

m O

ffice

r M

OH

-NA

SCO

P

Prof

Ndu

ati

Rut

h

Ass

ocia

te P

rofe

ssor

of P

aedi

atri

cs U

oN

Dr

Nju

guna

Cha

rles

Pr

ogra

m A

ssoc

iate

MSH

RPM

Plu

s

Mr

Nya

beri

Dav

id

Prog

ram

Offi

cer

MO

H-D

RH

Mr

Ode

ra J

W

Prog

ram

Coo

rdin

ator

GTZ

Ms

Olu

och

Pat

rici

a Te

chni

cal A

dvis

or C

DC

Ken

ya

Mr

Olu

och

Tom

Te

chni

cal A

dvis

or C

DC

Ken

ya

Dr

Onrsquo

gech

Joh

n

Prog

ram

Coo

rdin

ator

KN

H

Dr

Otie

no-N

yuny

a B

Se

nior

Lec

ture

rH

ead

of D

epar

tmen

t PM

TCT

Dir

ecto

rM

oi U

nive

rsity

AM

PATH

Dr

Oum

a C

hris

PM

TCT

Prog

ram

Offi

cer

UN

ICE

F

Dr

Saw

e F

redr

ick

K

Dep

uty

Dir

ecto

r W

RP

Mr

Soo

Leo

nard

Pr

ogra

m M

anag

er W

RP

Dr

Vak

il S

obha

N

Tech

nica

l Adv

isor

AR

T Pr

ogra

m N

ASC

OP

Ms

Way

ua R

uth

Prog

ram

Offi

cer

MO

H-D

RH

Dr

Yon

ga I

sabe

lla

PMTC

T Te

chni

cal A

dvis

or E

GPA

F

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

Tabl

e of

Con

tent

s Li

st o

f con

trib

utor

s 3

Tabl

e of

con

tent

s 5

Ack

now

ledg

emen

ts

10

Fore

wor

d 11

Abb

revi

atio

ns a

nd A

cron

yms

12

Exe

cutiv

e Su

mm

ary

16

Cha

pter

1

Bac

kgro

und

20

11T

he G

loba

l Pan

dem

ic

20

12

Mag

nitu

de o

f HIV

in P

regn

ancy

in

22

13

Ris

ks o

f Tra

nsm

issi

on o

f MTC

T at

Diff

eren

t Tim

e Pe

riod

s 23

14

Ris

k Fa

ctor

s of

MTC

T of

HIV

24

15

Ben

efits

of P

MTC

T of

HIV

25

16

Ben

efits

of H

IV C

ouns

ellin

g amp

Tes

ting

25

17

The

Four

-pro

nged

App

roac

h to

PM

TCT

26

18

Ove

rvie

w o

f the

New

PM

TCT

Gui

delin

es

28

19

Obj

ectiv

es amp

Org

anis

atio

n of

the

Gui

delin

es

28

110

U

sing

the

Gui

delin

es

29

Cha

pter

2 A

nten

atal

Car

e an

d Pr

even

tion

of M

TCT

of H

IV

32

21

Intr

oduc

tion

32

5

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4 B

acte

riolo

gica

l con

firm

atio

n

App

ropr

iate

clin

ical

sam

ples

incl

ude

sput

um

gast

ric

aspi

rate

s an

d ce

rtai

n ot

her

mat

eria

ls

Sin

ce m

ost

TB

in c

hild

ren

is in

infa

nts

and

youn

g ch

ildre

n s

putu

m

indu

ctio

n m

ay b

e do

ne fi

rst

or g

astr

ic a

spira

tions

and

exp

ecto

ratio

ns

a S

putu

m In

duct

ion

Spu

tum

indu

ctio

n is

saf

e an

d ef

fect

ive

in c

hild

ren

of a

ll ag

es a

nd t

he b

acte

rial

yi

elds

a]r

e as

goo

d or

bet

ter

that

for

gas

tric

asp

irate

s

b G

astr

ic a

spira

tion

Thi

s is

per

form

ed in

you

ng c

hild

ren

who

are

una

ble

or u

nwill

ing

to

expe

ctor

ate

sput

um

A g

astr

ic a

spir

ate

shou

ld b

e ob

tain

ed o

n ea

ch o

f th

e th

ree

cons

ecut

ive

mor

ning

s

c E

xpec

tora

tions

S

putu

m s

houl

d al

way

s be

obt

aine

d in

adu

lts a

nd o

lder

chi

ldre

n gt1

0 ye

ars

of

age

susp

ecte

d of

hav

ing

pulm

onar

y T

B

Bac

teri

al y

ield

s ar

e hi

gher

in o

lder

chi

ldre

n

Thr

ee s

putu

m s

peci

men

s sh

ould

be

obta

ined

an

on-

the

ndashspo

t sp

ecim

en (

at t

he

first

eva

luat

ion)

an

ear

ly m

orni

ng s

peci

men

and

a s

econ

d on

-the

-spo

t sp

ecim

en

Spu

tum

indu

ctio

n is

saf

e an

d ef

fect

ive

in c

hild

ren

of a

ll ag

es a

nd t

he b

acte

rial

yi

elds

are

as

good

or

bett

er t

han

for

gast

ric a

spira

tes

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

102

NO

TES

1 H

isto

ry

bull A

sk f

or s

ympt

oms

cons

iste

nt w

ith T

B in

clud

ing

chro

nic

coug

hgt 2

wee

ks

feve

r- b

ody

tem

pera

ture

of

38 o C

for

14 d

ays

afte

r co

mm

on c

ause

s su

ch a

s m

alar

ia a

nd p

neum

onia

hav

e be

en e

xclu

ded

wei

ght

loss

or

failu

re t

o th

rive

(

also

look

at

the

grow

th c

hart

) a

nd o

r ni

ght

swea

ts

Enq

uire

whe

ther

the

pat

ient

has

bee

n in

clo

se c

onta

ct w

ith s

mea

r-po

sitiv

e pu

lshym

onar

y T

B (

usua

lly a

par

ent

or o

ther

mem

ber

of th

e fa

mily

)

2 C

linic

al e

xam

inat

ion

a P

hysi

cal s

igns

hig

hly

sugg

estiv

e of

ext

ra p

ulm

onar

y T

B

bull O

ften

the

mai

n cl

inic

al f

indi

ng is

just

fai

lure

to

thriv

e

bull G

ibus

es

peci

ally

of

rece

nt o

nset

(re

sulti

ng f

rom

ver

tebr

al T

B)

bull N

on-p

ainf

ul e

nlar

ged

cerv

ical

lym

phad

enop

athy

with

fis

tula

for

mat

ion

b P

hysi

cal s

igns

req

uiri

ng in

vest

igat

ions

to

excl

ude

extr

a pu

lmon

ary

TB

bull M

enin

gitis

not

res

pond

ing

to a

ntib

iotic

s tr

eatm

ent

bull P

leur

al e

ffus

ion

bull P

eric

ardi

al e

ffus

ion

bull D

iste

nded

abd

omen

with

asc

itis

bull N

on-p

ainf

ul e

nlar

ged

lym

ph n

odes

with

out

fistu

la f

orm

atio

n

bull N

on-p

ainf

ul e

nlar

ged

join

t

Sig

ns o

f tu

berc

ulin

hyp

erse

nsiti

vity

3 M

anto

ux te

st

A m

anto

ux t

est

shou

ld b

e re

gard

ed p

ositi

ve a

s fo

llow

s

bull I

n hi

gh-r

isk

child

ren

(inc

lude

s H

IV-i

nfec

ted

child

ren

and

seve

rely

mal

shyno

uris

hed

child

ren

) gt

5mm

dia

met

er o

f in

dura

tion

bull I

n al

l oth

er c

hild

ren(

whe

ther

the

y ha

ve r

ecei

ved

BC

G o

r no

t)

gt10m

m d

ishyam

eter

of i

ndur

atio

n

101

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

22

Ope

ratio

nal G

uide

lines

32

23

Job

Aid

s 34

24

App

endi

ces

13

Cha

pter

3 I

ntra

part

um C

are

38

31

Intr

oduc

tion

38

32

Ope

ratio

nal G

uide

lines

38

Cha

pter

4

Use

of A

RVs

in P

regn

ancy

for T

reat

men

t amp P

MTC

T of

HIV

infe

ctio

n 42

41

Intr

oduc

tion

42

42

Ope

ratio

nal G

uide

lines

43

Cha

pter

5 I

mm

edia

te P

ostn

atal

and

Neo

nata

l Car

e

51

51

Intr

oduc

tion

51

52

Ope

ratio

nal G

uide

lines

51

Cha

pter

6 L

ate

Post

nata

l Car

e an

d Fa

mily

Pla

nnin

g

54

61

Intr

oduc

tion

54

62

Ope

ratio

nal G

uide

lines

54

Cha

pter

7 H

IV D

iagn

osis

in C

hild

ren

58

71

Intr

oduc

tion

58

72

Ope

ratio

nal G

uide

lines

59

72

0 G

uide

lines

for

HIV

Dia

gnos

is in

Chi

ldre

n

59

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

72

1 H

IV N

egat

ive

Infa

nt a

t 6 w

eeks

or

Firs

t Con

tact

59

72

2 H

IV P

ositi

ve In

fant

by

DN

A P

CR

60

72

3 C

ompr

ehen

sive

Car

e fo

r H

IV-e

xpos

ed In

fant

61

D

IAG

NO

STIC

ALG

OR

ITH

MFO

R P

ULM

ON

AR

Y T

B IN

CH

ILD

REN

Cha

pter

8

Feed

ing

Infa

nts

and

Youn

g C

hild

ren

Bor

n to

HIV

infe

cted

mot

hers

62

81

Intr

oduc

tion

62

82

Ope

ratio

nal G

uide

lines

on

Infa

nt F

eedi

ng (0

-6 m

onth

s)

63

83

Ope

ratio

nal G

uide

lines

on

Feed

ing

Chi

ldre

n 6

mon

ths

and

olde

r 64

84

Nut

ritio

nal C

are

and

Supp

ort o

f HIV

infe

cted

Chi

ldre

n 64

85

Ext

ract

s fr

om R

esea

rch

on In

fant

Fee

ding

and

HIV

AID

S 65

Cha

pter

9

Car

e an

d Fo

llow

up

of C

hild

ren

of H

IV-in

fect

ed m

othe

rs 7

3

91

Intr

oduc

tion

73

92

Ope

ratio

nal G

uide

lines

74

Cha

pter

10

Mon

itorin

g an

d Ev

alua

tion

of P

MTC

T se

rvic

es

83

101

In

trod

uctio

n 83

102

O

pera

tiona

l Gui

delin

es

85

Bib

liogr

aphy

91

Job

Aid

sR

efer

ence

s

91

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

App

endi

x V

I

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

100

App

endi

x V

C

OM

MO

N A

DV

ERSE

EFF

ECTS

OF

AR

V U

SE D

UR

ING

PR

EGN

AN

CY

Cla

ss

Adv

erse

effe

cts

Nuc

leos

ide

Nuc

leot

ide

Rev

erse

Tra

nscr

ipta

se In

hibi

tors

( NR

TIs)

Zido

vudi

ne(A

ZT)

Nau

seau

La

miv

idin

e (3

TC)

Dia

rhoe

a

Stav

udin

e (d

4T)

Hyp

erse

nsiti

vity

(AB

C)

Aba

cavi

r(A

BC

) A

naem

ia(A

ZT)

Teno

fovi

r(TF

VTD

F)

Emitr

icita

bine

(FTC

)

Non

- Nuc

leos

ide

Rev

erse

Tra

nscr

ipta

se In

hibi

tors

(NN

RTI

s)

Nev

irapi

ne(N

VP)

Del

avird

in

Efav

irenz

(EFV

)

Pro

teas

e In

hibi

tors

(PIs

)

Saqu

inav

ir(SQ

V)

Indi

navi

r(ID

V)

Rito

navi

r(R

TV)

Nel

finav

ir(N

LF)

Lopi

navi

rrito

navi

r(LP

Vr)

A

taza

navi

r(A

TV)

Fose

mpr

enav

ir Ti

pana

vir(

TPV)

D

arun

avir(

DR

V)

Ras

h

Elev

ated

live

r enz

ymes

(c

omm

on w

ith N

VP in

hig

h C

D4

co

unt)

EFV

CN

S ef

fect

s(se

datio

n in

-so

mni

a v

ivid

dre

ams

diz

zine

ss

conf

usio

n fe

elin

g of

lsquod

isen

gage

men

trsquo

Tera

toge

nici

ty

GI i

ntol

eran

ce

Hep

atot

oxic

ity

Lipo

dyst

roph

y

Dys

lipid

emia

s

Insu

lin re

sist

ance

Hyp

ergl

ycae

mia

La

ctic

aci

dosi

s an

d he

patic

ste

a-to

sis

Cou

nsel

ing

and

Follo

w-u

p Ti

ps

May

not

be

wel

l-tol

erat

ed in

ear

l pr

egna

ncy

whe

n

mor

ning

sic

knes

s is

com

mon

M

ay in

crea

se ri

sk o

f non

-ad

here

nce

May

hav

e in

adeq

uate

blo

od le

vels

A

ll A

RVs

sho

uld

be d

isco

ntin

ued

and

rest

arte

d w

hen

Namp

V is

gon

e or

effe

ctiv

ely

trea

ted

Fo

llow

-up

labs

CB

C L

FTs

If ra

sh in

1st

2 w

ks d

o no

t inc

reas

e N

VP d

ose

and

cont

act c

linic

ian

Mild

rash

may

be

man

aged

with

an

tihis

tam

ines

A

void

cor

ticos

tero

ids

durin

g N

VP

dose

esc

alat

ion

EFV

shou

ld b

e ta

ken

initi

ally

at

bed

time

Avo

id E

FV in

wom

en o

f hig

h ch

ild-b

earin

g po

tent

ial

Do

not o

pera

te h

eavy

mac

hine

ry

Mon

itor g

luco

se le

vels

A

sk re

gula

rly fo

r sym

ptom

s of

hy

perg

lyca

emia

M

onito

r hep

atic

tran

sam

inas

es

(ALT

and

AST

) par

ticul

arly

dur

ing

the

first

18

wee

ks o

f the

rapy

w

hen

this

toxi

city

is m

ost l

ikel

y Ta

ke w

ith fo

od

Ant

iem

etic

s A

ntim

otili

ty

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

App

endi

ces

92

App

endi

x I

WH

O C

linic

al S

tagi

ng o

f HIV

AID

S fo

r A

dults

and

A

dole

scen

ts w

ith C

onfir

med

HIV

infe

ctio

n 92

App

endi

x II

C

ontr

acep

tive

Opt

ions

for

Peop

le L

ivin

g w

ith H

IV

95

App

endi

x II

I U

se o

f AR

Vs

for

Trea

tmen

t and

PM

TCT

of H

IV in

AN

C

97

App

endi

x IV

Use

Of A

RV

s fo

r PM

TCT

of H

IV in

Lab

our

And

Del

iver

y U

nit

98

App

endi

x V

Com

mon

Adv

erse

Effe

cts

of A

RV

Use

Dur

ing

Preg

nanc

y 99

App

endi

x V

I D

iagn

ostic

alg

orith

m fo

r pu

lmon

ary

TB in

Chi

ldre

n 10

0

App

endi

x V

II I

nteg

rate

d M

onito

ring

and

Eval

uatio

n Re

port

For

m M

OH

726

10

3

App

endi

x V

III

Rep

rodu

ctiv

e H

ealth

HIV

AID

S R

epor

t For

m M

OH

711

10

4

Lis

t of T

able

s

Tabl

e 1

1 A

dult

HIV

-pre

vale

nce

Est

imat

e by

Pro

vinc

e in

200

6 21

Tabl

e 1

2 E

stim

ated

Mag

nitu

de o

f MTC

T in

Ken

ya 2

007

22

Tabl

e 1

3 Tr

ansm

ission

Pat

tern

s in

Brea

stfee

ding

and

Non

bre

astfe

edin

g Pop

ulat

ions

23

Tabl

e 1

4 R

isk

Fact

ors

for

MTC

T of

HIV

24

Tabl

e 1

5 Th

e Fo

ur-p

rong

ed A

ppro

ach

App

lied

to th

e PM

TCT

Gui

delin

es

30

Tabl

e 2

1 E

ssen

tial P

acka

ge o

f Int

egra

ted

Ant

enat

al C

are

Serv

ices

33

Tabl

e 4

1 R

ecom

men

datio

ns fo

r In

itiat

ing

AR

V T

reat

men

t in

Preg

nant

Wom

en B

ased

on

Clin

ical

Sta

ge a

nd A

vaila

bilit

y of

CD

4 co

unt

44

Tabl

e 4

2 R

ecom

men

ded

Firs

t Lin

e A

RT

Reg

imen

for

Trea

ting

Preg

nant

Wom

en a

nd P

roph

ylac

tic R

egim

en fo

r In

fant

s 45

Tabl

e 4

3a R

ecom

men

ded

Firs

t Lin

e A

RV

Pro

phyl

axis

to P

reve

nt H

IV

46

Infe

ctio

n in

Infa

nts

Am

ong

preg

nant

Wom

en P

rese

ntin

gB

efor

e 38

Wee

ks

Tabl

e 4

3b A

ltern

ativ

e A

RV

Pro

phyl

axis

to P

reve

nt H

IV In

fect

ion

in In

fant

s 4

6 A

mon

g Pr

egna

nt W

omen

Pre

sent

ing

Bef

ore

38 W

eeks

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

9

9

47

IV

Wom

en w

ho h

ave

not r

ecei

ved

Intr

apar

tum

AR

T or

A

RV

Pro

phyl

axis

with

H

IV

Infe

ctio

n

Tabl

e 4

4 A

RV

Pro

phyl

axis

for

PMTC

T am

ong

Preg

nant

Wom

en w

ho h

ave

not r

ecei

ved

Ant

enat

al A

RT

or P

roph

ylax

is

App

endi

x Ta

ble

45

Cho

ice

of H

AA

RT

for

Preg

nant

Wom

en b

ased

on

CD

4 co

unt

47

Tabl

e 4

6 A

RV

Pro

phyl

actic

Reg

imen

s fo

r In

fant

s B

orn

to H

IV-p

ositi

ve

49

Tabl

e 9

1 D

ose

of C

o-tr

imox

azol

e fo

r PC

P pr

ophy

laxi

s 76

Tabl

e 9

2 W

HO

Rec

omm

enda

tions

for

Follo

w-u

p of

an

HIV

-exp

osed

Chi

ld

79

Tabl

e 10

1 C

ontr

acep

tive

Met

hods

for

Use

in C

oupl

es a

nd W

omen

Liv

ing

96

Figu

re 2

1 R

apid

HIV

Ser

ial T

estin

g A

lgor

ithm

35

Figu

re 8

1 G

uide

lines

for

Cou

nsel

ling

on H

IV a

nd In

fant

feed

ing

66

Job

Aid

s an

d IE

C M

ater

ials

on

Infa

nt a

nd Y

oung

Chi

ld F

eedi

ng

67

List

of F

igur

es

Figu

re 1

01

Mon

itori

ng a

nd E

valu

atio

n D

ata

Flow

in K

enya

84

September 0 8

USE OF ARVs FOR PMTCT OF HIV IN LABOUR AND DELIVERY UNITSALL MOTHERS

1 History 2 Examination3 Establish motherrsquos HIV status4 Offer HIV counseling and testing for mother with unknown HIV status5 Provide standard obstetrical management and care

HIV NEGATIVECounsel on risk reduction

HIV POSITIVE

Establish Motherrsquos use of ARVs in pregnancy and give appropriate ARVs as shown in boxesbelow

Regardless of Duration received HAART

Action

i Give mother ARV dose as per regimen

ii Post partu m Infant Give Infant sd Nevi rapine 2mgkg with in 72 hours of birthPL US 3T C 4mgkg BD for 1 w eek an d AZT syrup 4 m gkg BD for 6 w eeks

iii Post partum mother Continue w ith AR Vs as per regimen

MOTHE R RECEIVED HAART IN PREGNANCY

F OR MORE INFORMAT ION CONT ACT THE NATIONAL AIDSSTD CONTROL PROGRAMME (NASCOP)PO BO X 19361-00202 NAIROBI TEL 0202729502 FAX 020 2710518

MINISTRY OF HEALTH

bull G ive mo ther sd Nevirap ine 200m g AZT 600mg and 3TC 150 mg stat

bull Post partum Infant Give Infant sd Nevirapine 2mgkg within 72 ho urs of birth PL US

3TC syrup 4mg kg BD for 1 week and AZT syrup 4 mg kg BD fo r 6 w eeks

bull Post partum mother Give moth er AZT 300mg amp 3TC 150 mg BID for 7 d ays

MO THER RECEIVED AZT IN PREGNANCY OR NO ARVs TAKE N IN PREGNANCY

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

98

MINISTRY OF HEALTH

USE OF ARVs FOR TREATMENT AND PMTCT OF HIV IN ANC

App

endi

x II

I

Ack

now

ledg

emen

ts

ALL M O THERS1 History 2 Health Information3 Examination4 In vestigations (with informed consent for HIV test)

HIV NEGATIVE1 P rov id e pos t-te s t HIV pr ev e nti v e

i nter ve ntion s defi ned i n na tion alHT C gui de li nes

2 Re fe r for othe r p os t-te st HIVp re ve ntive inte rv e nti ons no tavai lable in the cli nic b ut avail ab le w ithi n the fa c ili ty

HIV PO SI TI VE1 C ounsel on risk reduction2 Per form WH O clinical staging for H IV disease3 D etermine CD 4 level (if testing facilities available)4 D etermine Gestation age and HB level5 Give ARVrsquos as shown below6 Provide or refer for other post-test HIV interventions defined in national HTC

guidelines

1 WHO clin ica l stage I o r II w ith CD4 cell co unt gt 350mm3 OR 2 WHO clin ica l stage I o r II no CD4 cell co unt do ne3 HB =8 gdl OR n o clinical feat ures of anaemia

bull Initiate AZT 30 0mg BD daily at 28 weeks gestation or any time periodimmediately there after

bull Monitor for clinical featur es of anemia and treatbull Dispense ANC Nev ir apine 200mg PLUS AZT 600mg + 3TC 1 50mg for

moth er to tak e at onset of labourbull Dispense NVP syrup to give infant at birth

bull At on set o f l abo uro Administer Nevirapine 20 0mg AZT 600mg 3TC 150 mg

stat to moth erbull Post p artum

o Give Infa nt sd Nevirapine 2mgk g within 72 hours ofbirth PLUS 3TC 4mg BD for 1 w eek and AZT syrup 4 mgkg BD for 6 w eeks

o Give mother AZT30 0 mg 3 TC 150 BID for 7 day s

1 WHO clinical stag e I or II with CD4 c ell count gt 35 0 mm3 OR 2 WHO clinical stag e I or II w ith no C D4 c ell c ount done

bull Dispense ANC Nevirapine 2 00mg PLUS AZ T 600 mg + 3TC 150mgfo r mo ther to take at onse t of labour

bull Dispense NVP sy rup to give infant at birthbull At Onset of lab our

o Administe r sd Nevirapine AZT 6 00 mg and 3TC1 50mg stat

bull Po st Par tu mo G iv e Infant sd Nev ir apine 2mg kg w ithin 72

h ours of bir th PLUS 3T C 4mgkg BD fo r 1 week a nd AZT syrup 4mgkg BD for 6 we eks

o G iv e mother AZ T300 mg 3TC 1 50 mg BID for 7d ays

1 Any gest ational age2 WHO clin ica l stage III or IV of HIV dis ease regardles s of CD4 cell count OR3 WHO clin ica l stages I or II of HIV d is ease with CD4 cell count =350mm3 ()

bull Refer to Clinician for Evaluation and initiation of NNRTI based ART as pernation al ART guidelines

bull At O nset of Lab ou ro G ive mo ther ARV dos e as per r egimen

bull Post par tumo G ive Infan t sd Nev ira pine 2mgkg within 72 hours of b irth PLUS

3TC 4mgkg and AZT syr up 4 mgkg BD for 6 weeks o G ive mo ther ARVs as per regimen

4 If no HAART av ailable man age the wo man as ind icated in box no2 a nd refer to ARTsite appro priately

F O R M OR E IN FOR M AT IO N CO N T AC T T H E N ATI ON A L A IDS STD C O NTR O L PR O G RAM ME ( N ASC O P)P O B OX 19361-00202 N AIR OBI TEL 0202729502 FAX 020 2710518

EL IGIBL E FO R T R EATMEN T

N O T E LIG IBLE FO R TR EA TM ET AN D PR ESE NTING B ELO W 3 8 W EE KSGESTA TIO N N OT ELIGIB LE FOR TREA TMEN T AN D PR ESE NTING gt 3 8 W EEK S

GE STATIO N

Plea se notebull Pregnan t w omen with WHO clinical stag e I or II plus CD4 cell co unt gt250 mm3 and = 350 mm3 can be initiated on ART wher e a PI based HAART re gimen is av ailable NVP hypersen sitivity h as been previously r eported amon g women in this gr oup initiated on N NRT I based

ART re gimens Where PI ba sed ART reg imen is not av ailab le r efer the patient to a site whe re th e regimen is availab le or c ontinue to ma nage th e w oman a s is indicated in box No 2bull The grading of ana emia in pregna ncy is gt 8-10 Milda nemia gt 6 -8 Moderate anem ia lt 6 Sever e anemiabull Treatment if common p ath ologies ruled out Mild anae mia haematinics irrespectiv e of gestatio n Moder ate a naemia tr ansfusion if close to term gt36 weeks otherwise give haema tinics Severe an aemia transfus ion irr espe ctive of ge statio n Do not stop AZT if Hb dr op s but

would manage it as above and only stop if continues to fall or fails to res pon d des pite transfusion

The

thir

d ed

ition

of

Gui

delin

es f

or P

reve

ntio

n of

Mot

her-

to-C

hild

Tra

nsm

issi

on o

f H

IV A

IDS

in K

enya

is a

res

ult o

f effo

rts

of m

any

indi

vidu

als

and

orga

niza

tions

in th

eco

untr

y T

he T

echn

ical

Wor

king

Gro

up o

n PM

TCT

led

thes

e ef

fort

s M

embe

rs o

f the

te

am r

evie

wed

all

the

mod

ules

rev

ised

and

in s

ome

case

s re

-wro

te th

e m

odul

es b

ased

on

the

seco

nd e

ditio

n to

mak

e th

em u

p to

dat

e an

d in

line

with

cur

rent

sci

entif

ic e

vishy

denc

e an

d ex

peri

ence

We

ackn

owle

dge

the

cont

ribu

tors

and

rev

iew

ers

of t

he c

urre

ntan

d pr

evio

us e

ditio

ns O

f sp

ecia

l m

entio

n ar

e th

e fo

llow

ing

Ken

ya O

bste

tric

al a

nd

Gyn

aeco

logi

cal S

ocie

ty (K

OG

S) t

he U

nive

rsity

of N

airo

bi a

nd M

oi U

nive

rsity

We

wou

ld l

ike

to t

hank

the

fol

low

ing

inst

itutio

ns f

or t

echn

ical

as

wel

l as

fin

anci

al

supp

ort

duri

ng t

he r

evis

ion

of t

he g

uide

lines

N

atio

nal A

IDS

and

STD

Con

trol

Pro

shygr

amm

e (N

ASC

OP)

the

Div

isio

n of

Rep

rodu

ctiv

e H

ealth

Cen

ters

for

Dis

ease

Con

trol

and

Prev

entio

n (C

DC

) It

is n

ot p

ossi

ble

to m

entio

n al

l ind

ivid

uals

and

org

aniz

atio

ns

that

par

ticip

ated

in th

is im

port

ant e

xerc

ise

To

all o

f you

Asa

nte

Sana

Min

istr

y of

Hea

lth

September 2008

97

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

10

Fore

wor

d

The

Min

istr

y of

Hea

lth (

MoH

) is

com

mitt

ed t

o de

velo

pmen

t of

effe

ctiv

e PM

TCT

proshy

gram

mes

Gui

delin

es a

re a

n im

port

ant

part

of t

he G

over

nmen

t st

rate

gy t

o re

duce

MTC

Tan

d is

in

line

with

the

Nat

iona

l H

ealth

Sec

tor

Stra

tegi

c Pl

an I

I (N

HSS

PII)

and

Ken

yaN

atio

nal A

IDS

Stra

tegi

c Pl

an (K

NA

SP) 2

000-

2010

whi

ch fo

cuse

s on

pri

ority

are

as o

f pre

shyve

ntio

n of

new

infe

ctio

ns i

mpr

ovin

g qu

ality

of l

ife o

f tho

se in

fect

ed a

nd a

ffect

ed a

nd m

itishy

gatio

n of

soc

ial a

nd e

cono

mic

impa

ct o

f the

infe

ctio

n

MTC

T is

the

pre

dom

inan

t m

ode

of t

rans

mis

sion

of

HIV

in

infa

nts

and

youn

g ch

ildre

n

This

tra

nsm

issi

on o

ccur

s du

ring

pre

gnan

cy

labo

ur a

nd d

eliv

ery

and

am

ong

brea

stfe

d ba

bies

in

the

post

-par

tum

per

iod

Mem

bers

of t

he T

echn

ical

Wor

king

Gro

up (T

WG

) on

PMTC

T re

view

ed t

he m

odul

es o

f the

se

cond

edi

tion

rev

ised

and

in s

ome

case

s re

-wro

te th

e m

odul

es b

ased

on

up to

dat

e kn

owlshy

edge

and

in

line

with

cur

rent

sci

entif

ic e

vide

nce

and

expe

rien

ce T

he T

WG

con

sist

s of

agr

oup

of p

rofe

ssio

nals

dra

wn

from

var

ious

dis

cipl

ines

tha

t ar

e im

plem

entin

g an

dor

man

shyag

ing

PMTC

T T

he g

roup

ado

pted

and

ada

pted

the

late

st r

ecom

men

datio

ns o

f the

WH

O o

nPM

TCT

as w

ell a

s va

riou

s na

tiona

l gui

delin

es o

n H

IV p

reve

ntio

n tr

eatm

ent a

nd c

are

A f

our-

pron

ged

appr

oach

thr

ough

the

var

ious

rep

rodu

ctiv

e lif

e cy

cles

as

prop

osed

by

the

Inte

r-A

genc

y Ta

sk T

eam

(IA

TT)

on c

hild

ren

and

HIV

and

AID

S w

as a

dopt

ed i

n th

ese

guid

elin

es w

ith e

mph

asis

bei

ng p

lace

on

all t

he fo

ur p

rong

s

For

any

of t

he P

MTC

T in

terv

entio

ns t

o be

suc

cess

fully

impl

emen

ted

coun

selin

g an

d te

stshy

ing

(CT)

mus

t fir

st b

e do

ne R

outin

e H

IV te

stin

g w

ith o

pt-o

ut o

ptio

n is

rec

omm

ende

d T

his

is fo

llow

ed b

y ap

prop

riat

e m

edic

al s

urgi

cal i

nter

vent

ions

incl

udin

g an

tiret

rovi

ral p

roph

yshyla

xis

saf

er o

bste

tric

pra

ctic

es a

s w

ell a

s in

fant

feed

ing

coun

selin

g an

d pr

ovis

ion

of a

ppro

shypr

iate

infa

nt fe

edin

g H

IV-p

ositi

ve w

omen

are

ass

esse

d cl

inic

ally

usi

ng W

HO

sta

ging

and

whe

re f

easi

ble

imm

unol

ogic

al a

sses

smen

t us

ing

CD

4 ce

ll co

unt

HIV

exp

osed

infa

nts

are

test

ed th

roug

h ea

rly

infa

nt d

iagn

osis

(EID

)

In th

ese

guid

elin

es m

ore

effic

acio

us r

egim

ens

are

intr

oduc

ed fo

r th

e fir

st ti

me

whi

le in

forshy

mat

ion

and

coun

selin

g on

inf

ant

feed

ing

follo

ws

the

AFA

SS (

Ava

ilabl

e f

easi

ble

acc

eptshy

able

saf

e an

d su

stai

nabl

e) c

rite

ria

The

mod

ule

on m

onito

ring

and

eva

luat

ion

addr

esse

s is

sues

of d

ata

colle

ctio

n c

olla

tion

and

repo

rtin

g as

wel

l as

use

of d

ata

for

deci

sion

-mak

ing

at th

e fa

cilit

y-le

vel

We

hope

that

app

ropr

iate

impl

emen

tatio

n in

stru

men

ts w

ill b

e us

ed to

ope

ratio

naliz

e th

ese

guid

elin

es

Tabl

e 11

1

Con

trac

eptiv

e M

etho

ds fo

r Use

in

Cou

ples

and

Wom

en L

ivin

g w

ith H

IV In

fect

ion

MET

HO

D

CO

MM

ENTS

Con

dom

s bull

M

ale

amp f

emal

e co

ndom

s av

aila

ble

bull

P

rovi

de d

ual p

rote

ctio

n ag

ains

t STI

sH

IV

amp p

regn

ancy

bull

R

equi

re a

ttent

ion

amp ca

re

for c

orre

ct u

se e

ach

time

bull

M

ay re

quire

co-

oper

atio

n of

par

tner

Hor

mon

al

bull V

ery

effe

ctiv

e an

d ea

sy to

use

M

etho

ds

bull S

uita

ble

for s

hort-

or lo

ng-

term

use

bull

Rev

ersi

ble

bull A

ssoc

iate

d w

ith n

on-

cont

race

ptiv

e he

alth

ben

efits

bull

Ser

ious

com

plic

atio

ns

extre

mel

y ra

re

Intra

uter

ine

bull

H

ighl

y ef

fect

ive

long

-term

C

ontra

cept

ive

reve

rsib

le m

etho

d

Dev

ice

bull

Rem

ains

in p

lace

up

to 1

2 ye

ars

bull

A

lmos

t 100

per

cent

ef

fect

ive

bull

H

as n

o ef

fect

on

ferti

lity

whe

n us

ed b

y nu

llipar

ous

wom

en

bull

Sho

uld

not b

e pr

ovid

ed to

w

omen

with

hig

h ris

k se

xual

life

styl

e bull

B

acte

rial S

TIs

shou

ld b

e sc

reen

ed fo

r and

or

treat

ed a

s a

prec

autio

n pr

ior t

o in

serti

on o

f IU

CD

Ste

riliz

atio

n bull

Goo

d v

ery

effe

ctiv

e fo

r co

uple

s or

indi

vidu

als

who

w

ant n

o m

ore

child

ren

bull S

afe

sim

ple

surg

ical

pr

oced

ure

Con

side

red

perm

anen

t

US

E IN

HIV

PO

SITI

VE

PA

TIE

NTS

bull

Can

and

sho

uld

be u

sed

at a

ll st

ages

of H

IV

infe

ctio

n bull

C

an a

nd s

houl

d be

use

d by

pat

ient

s on

AR

T

bull

Cor

rect

and

con

sist

ent u

se b

y H

IV in

fect

ed p

atie

nts

is

reco

mm

ende

d re

gard

less

of t

he u

se o

f oth

er m

etho

ds

of c

ontra

cept

ion

(dua

l con

trace

ptio

n)

bull C

an b

e us

ed w

ithou

t res

trict

ion

in H

IV+

wom

en n

ot o

n AR

T bull

Can

be

used

with

out r

estri

ctio

n in

all

HIV

+ w

omen

for

emer

genc

y co

ntra

cept

ion

bull S

ome

AR

V dr

ugs

may

redu

ce m

etho

d ef

fect

iven

ess

bull

DM

PA

Im

plan

ts c

an h

owev

er b

e us

ed w

ith A

RT

reshy

inje

ctio

n of

DM

PA

sho

uld

be d

one

at 1

0-12

wee

ks

bull If

horm

onal

met

hod

is c

hose

n c

ondo

ms

shou

ld s

till b

e us

ed c

orre

ctly

and

con

sist

ently

bull

Attr

activ

e m

etho

d fo

r wom

en w

ith H

IV w

ho d

esire

ver

y re

liabl

e pr

egna

ncy

prot

ectio

n bull

C

an b

e in

serte

d in

HIV

+ w

omen

who

do

not h

ave

WH

O

Sta

ge 4

dis

ease

AID

S d

efin

ing

illne

ss

bull

For w

omen

with

sta

ge 4

dis

ease

IUD

can

be

inse

rted

once

they

are

on

ART

and

have

con

trolle

d sy

mpt

oms

of s

ever

e ill

ness

bull N

o m

edic

al re

ason

s to

den

y st

eriliz

atio

n to

clie

nts

w

ith H

IV

bull P

roce

dure

may

be

dela

yed

in e

vent

of a

cute

HIV

-rel

ated

in

fect

ion

or s

tage

4 d

isea

se p

endi

ng im

mun

e re

cons

titut

ion

bull E

ncou

rage

con

dom

use

as

wel

l

DM

PA =

Dep

ot M

edro

xypr

oges

tero

ne A

ceta

te (D

epo-

Prov

era)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

1

96

App

endi

x II

CO

NTR

AC

EPTI

VE

OPT

ION

SFO

R P

EOPL

E L I

VIN

G W

ITH

HIV

It

has

bee

n sh

own

in a

num

ber

of s

tudi

es o

f coh

orts

of H

IV p

ositi

ve w

omen

tha

t so

me

choo

se t

o co

ntin

ue s

exua

l act

ivity

des

pite

kno

wle

dge

of t

heir

sta

tus

Evi

denc

e of

con

shyce

ptio

n ha

s de

mon

stra

ted

that

fert

ility

in H

IV p

ositi

ve w

omen

for

the

mos

t pa

rt is

unshy

affe

cted

H

owev

er c

erta

in c

ondi

tions

may

affe

ct fe

rtili

ty s

uch

as lo

w b

ody

mas

s in

dex

A

IDS

and

inte

rcur

rent

illn

ess

esp

ecia

lly t

uber

culo

sis

Put

ting

wom

en w

ho a

re H

IV

infe

cted

on

cont

race

ptiv

es is

one

of t

he m

eans

of p

reve

ntin

g m

othe

r to

chi

ld t

rans

mis

shysi

on o

f HIV

(PM

TCT)

It is

the

rig

ht o

f HIV

infe

cted

wom

en t

o m

ake

thei

r ow

n de

cisi

ons

rega

rdin

g re

prod

ucshy

tion

The

y m

ay w

ish

to h

ave

mor

e ba

bies

lim

it th

eir

fam

ilies

or

avoi

d pr

egna

ncy

alto

shyge

ther

The

hea

lth c

are

prov

ider

s th

ey c

onsu

lt sh

ould

ena

ble

them

to

mak

e in

form

edch

oice

s by

them

selv

es

The

follo

win

g co

ntra

cept

ive

met

hods

are

ava

ilabl

e in

Ken

ya -

pro

gest

eron

e on

ly p

ills

lo

w d

ose

com

bine

d or

al c

ontr

acep

tives

de

pot

med

roxy

prog

este

rone

ace

tate

(D

MPA

shyde

po)

levo

norg

estr

el a

nd e

tono

gest

rel i

mpl

ants

Em

erge

ncy

cont

race

ptiv

e pi

lls c

oppe

rin

trau

teri

ne c

ontr

acep

tive

devi

ces

bar

rier

met

hods

fem

ale

and

mal

e st

erili

satio

n ar

e al

so a

vaila

ble

Som

e dr

ugs

inte

ract

with

hor

mon

al c

ontr

acep

tives

A

nd c

oncu

rren

t us

e sh

ould

be

avoi

ded

The

se d

rugs

incl

ude

bull P

rote

ase

inhi

bito

rs ndash

Rito

navi

r N

elfin

avir

Lop

inav

ir w

ith R

itona

vir

bull N

on-n

ucle

otid

e re

vers

e tr

ansc

ript

ase

inhi

bito

rs (

NN

RT

Is)

ndash N

evir

apin

e

bull E

favi

renz

bull A

nti-T

B d

rugs

ndash R

ifam

pici

n an

d R

ifabu

tin

bull O

ther

dru

gs ndash

Gris

eofu

lvin

P

heno

barb

itone

C

arba

maz

epin

e P

heny

toin

All

the

abov

e do

not

app

ly i

n th

e fa

ce o

f ot

her

med

ical

con

ditio

ns t

hat

are

cont

ra-

indi

catio

ns f

or t

he v

ario

us m

etho

ds e

g k

now

n ca

rdio

vasc

ular

dis

ease

hep

atic

con

dishy

tions

sm

okin

g h

igh

bloo

d pr

essu

re a

nd th

rom

boem

bolic

dis

orde

rs

The

follo

win

g ta

ble

sum

mar

ises

maj

or is

sues

reg

ardi

ng u

se o

f diff

eren

t co

ntra

cept

ives

by H

IV-p

ositi

ve w

omen

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Abb

revi

atio

ns a

nd A

cron

yms

AFA

SS

Acc

epta

ble

Fea

sibl

e A

fford

able

Sus

tain

able

and

Saf

e

Ab

Ant

i-bod

y

AID

S A

cqui

red

Imm

une

Def

icie

ncy

Synd

rom

e

ALT

Ala

nine

Tra

nsfe

rase

AN

C

Ant

enat

al C

are

AR

M

Art

ifici

al R

uptu

re o

f Mem

bran

es

AR

T

Ant

iret

rovi

ral T

hera

py

A

RV

A

ntir

etro

vira

l

AZT

A

zido

thym

idin

e (Z

idov

udin

e or

ZD

V)

AZT

3TC

Com

bivi

r

3TC

Lam

ivud

ine

BC

C

Beh

avio

ur C

hang

e C

omm

unic

atio

n

BC

G

Bac

ille

Cal

met

te G

ueri

ne v

acci

ne

BFH

I B

aby

Frie

ndly

Hos

pita

l Ini

tiativ

e

BID

BD

ldquoT

wic

e a

dayrdquo

CD

C (K

) C

entr

es fo

r D

isea

se C

ontr

ol a

nd P

reve

ntio

n K

enya

CN

S C

entr

al N

ervo

us S

yste

m

CS

Cae

sare

an S

ectio

n

CT

Cou

nsel

ling

and

Test

ing

CTX

CTZ

Cot

rim

oxaz

ole

d4T

Stav

udin

e

D

ASC

O

Dis

tric

t AID

SST

I Coo

rdin

ator

G

uid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

5

12

DB

S D

ried

Blo

od S

pot s

peci

men

DN

A

Deo

xyri

bonu

clei

c A

cid

DR

H

Div

isio

n of

Rep

rodu

ctiv

e H

ealth

EC

V

Ext

erna

l Cep

halic

Ver

sion

EFV

Efa

vire

nz

EID

E

arly

Infa

nt D

iagn

osis

ELI

SA

Enz

yme

Link

ed Im

mun

osor

bent

Ass

ay

FBC

Fu

ll B

lood

Cou

nt

GTZ

G

erm

an T

echn

ical

Coo

pera

tion

HA

AR

T

Hig

hly

Act

ive

Ant

iret

rovi

ral T

hera

py

Hb

Hae

mog

lobi

n

HIV

H

uman

Imm

unod

efic

ienc

y Vi

rus

IATT

Inte

r-A

genc

y Ta

sk T

eam

IMC

I In

tegr

ated

Man

agem

ent o

f Chi

ldho

od Il

lnes

s

IPPT

Inte

rmitt

ent P

resu

mpt

ive

Trea

tmen

t for

Mal

aria

ITN

s In

sect

icid

es T

reat

ed N

ets

IUC

D

Intr

a U

teri

ne C

ontr

acep

tive

Dev

ice

KD

HS

Ken

ya D

emog

raph

ic a

nd H

ealth

Sur

vey

KE

PI

Ken

ya E

xpan

ded

Prog

ram

me

on Im

mun

izat

ion

KO

GS

Ken

ya O

bste

tric

al a

nd G

ynae

colo

gica

l Soc

iety

KN

H

Ken

yatt

a N

atio

nal H

ospi

tal

LAM

Lact

atio

nal A

men

orrh

oea

Met

hod

Mamp

E

Mon

itori

ng a

nd E

valu

atio

n

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

Cyt

omeg

alov

irus

infe

ctio

n (r

etin

itis

or in

fect

ion

of o

ther

org

ans)

9

Cen

tral

ner

vous

sys

tem

tox

opla

smos

is

10

HIV

enc

epha

lopa

thy

11

Ext

rapu

lmon

ary

cryp

toco

ccos

is in

clud

ing

men

ingi

tis

12

Dis

sem

inat

ed n

on-t

uber

culo

us m

ycob

acte

rial

infe

ctio

n

13

Pro

gres

sive

mul

tifoc

al le

ukoe

ncep

halo

path

y

14

Chr

onic

cry

ptos

pori

dios

is

15

Chr

onic

isos

poria

sis

16

Dis

sem

inat

ed m

ycos

is (

extr

apul

mon

ary

hist

opla

smos

is

or c

occi

diom

ycos

is)

17

Rec

urre

nt s

eptic

aem

ia (

incl

udin

g no

n-ty

phoi

dal S

alm

onel

la)

18

Lym

phom

a (c

ereb

ral o

r B

-cel

l non

-Hod

gkin

s)

19

Inv

asiv

e ce

rvic

al c

arci

nom

a

20

Aty

pica

l dis

sem

inat

ed le

ishm

ania

sis

21

Sym

ptom

atic

HIV

-ass

ocia

ted

neph

ropa

thy

or s

ympt

omat

ic H

IV-

asso

ciat

ed

22

Car

diom

yopa

thy

Ple

ase

note

S

igns

and s

ympto

ms

of

HIV

was

ting s

yndro

me

incl

ude

Unex

pla

ined

invo

lunta

ry w

eight

loss

(gt

10

base

line

body

wei

ght)

with o

bvi

ous

was

ting o

f body

mas

s in

dex

lt185

PLU

S

unex

pla

ined

chro

nic

dia

rrhoea

(lo

ose

or

wat

ery

stools

thre

e or

more

tim

es d

aily

) re

port

ed

for

longer

than

one

month

OR r

eport

s of

feve

r or

nig

ht

swea

ts f

or

more

than

one

month

w

ithout

oth

er c

ause

and lack

of

resp

onse

to a

ntibio

tics

or

antim

ala

rial ag

ents

M

ala

ria

must

be

excl

uded

in m

ala

ria

pro

ne

area

s

Fo

r th

e purp

ose

of

the

WH

O s

tagin

g s

yste

m

adole

sents

and a

dults

are

def

ined

as

adults

aged

ge15 y

ears

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

3

94

CLI

NIC

AL

STA

GE

3 1

Une

xpla

ined

sev

ere

wei

ght

loss

(gt1

0 o

f pr

esum

ed o

r m

easu

red

bo

dy w

eigh

t)

2

Une

xpla

ined

chr

onic

dia

rrho

ea fo

r lo

nger

tha

n on

e m

onth

3

Une

xpla

ined

per

sist

ent

feve

r (a

bove

37

5degC

inte

rmitt

ent

or c

onst

ant

for

long

er t

han

one

mon

th)

4

Per

sist

ent

oral

can

didi

asis

5

Ora

l hai

ry le

ukop

laki

a

6

Pul

mon

ary

tube

rcul

osis

7

Tub

ercu

lous

Lym

phad

enop

athy

8

Sev

ere

bact

eria

l inf

ectio

ns (

such

as

pneu

mon

ia

empy

ema

pyo

myo

sitis

bo

ne o

r jo

int

infe

ctio

n m

enin

gitis

or

bact

erae

mia

)

9

Acu

te n

ecro

tizin

g ul

cera

tive

stom

atiti

s g

ingi

vitis

or

perio

dont

itis

10

Une

xpla

ined

ana

emia

(lt8

gdl

) n

eutr

opae

nia

(lt0

5 times1

09 pe

rlitr

e) a

ndo

r ch

roni

c th

rom

bocy

topa

enia

(lt5

0times10

9 per

litr

e)

CLI

NIC

AL

STA

GE

4 1

HIV

was

ting

synd

rom

e

2

Pne

umoc

ystis

pne

umon

ia

3

Rec

urre

nt s

ever

e ba

cter

ial p

neum

onia

4

Chr

onic

her

pes

sim

plex

infe

ctio

n (o

rola

bial

ge

nita

l or

anor

ecta

l of

mor

e th

an o

ne

mon

thrsquos

dur

atio

n or

vis

cera

l at

any

site

)

5

Oes

opha

geal

can

didi

asis

(or

can

didi

asis

of

trac

hea

bro

nchi

or

lung

s)

6

Ext

rapu

lmon

ary

tube

rcul

osis

exc

ept

Tub

ercu

lous

Lym

ph a

deno

path

y

7

Kap

osirsquos

sar

com

a

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

MC

H

Mat

erna

l and

Chi

ld H

ealth

MoH

M

inis

try

of H

ealth

MSF

M

edic

ins

Sans

Fro

ntie

rs

M

TCT

Mot

her-

To-C

hild

Tra

nsm

issi

on

NA

SCO

P N

atio

nal A

IDS

and

STD

Con

trol

Pro

gram

me

NV

P

Nev

irap

ine

OD

ldquoO

nce

a D

ayrdquo

OI

Opp

ortu

nist

ic In

fect

ion

OPV

O

ral P

olio

Vac

cine

PASC

O

Prov

inci

al A

IDS

STI C

oord

inat

or

PCP

Pneu

moc

ystis

jiro

veci

i pne

umon

ia

PCR

Po

lym

eras

e C

hain

Rea

ctio

n

PI

Prot

ease

Inhi

bito

r

PLW

HA

Pe

rson

sPe

ople

Liv

ing

With

HIV

AID

S

PMTC

T

Prev

entio

n of

Mot

her

To C

hild

Tra

nsm

issi

on

RD

A

Rec

omm

ende

d D

aily

Allo

wan

ce

RH

Rep

rodu

ctiv

e H

ealth

RN

A

Rib

onuc

leic

Aci

d

SdN

VP

Si

ngle

dos

e N

evir

apin

e

SRH

Se

xual

and

Rep

rodu

ctiv

e H

ealth

STD

Se

xual

ly T

rans

mitt

ed D

isea

se

STI

Sexu

ally

Tra

nsm

itted

Infe

ctio

n

TB

Tube

rcul

osis

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

3

14

TBA

s Tr

aditi

onal

Bir

th A

tten

dant

s

TLC

To

tal L

ymph

ocyt

e C

ount

TT

Teta

nus

Toxo

id v

acci

ne

UN

ICE

F U

nite

d N

atio

ns C

hild

renrsquo

s Fu

nd

UN

GA

SS

Uni

ted

Nat

ions

Gen

eral

Ass

embl

y Sp

ecia

l Ses

sion

on

HIV

AID

S

UoN

Uni

vers

ity o

f Nai

robi

VC

T V

olun

tary

Cou

nsel

ling

and

Test

ing

VIA

V

isua

l Ins

pect

ion

usin

g A

ceto

ne

VD

RL

Ven

erea

l Dis

ease

Res

earc

h La

bora

tory

(tes

t for

syp

hilis

)

WH

O

Wor

ld H

ealth

Org

anis

atio

n

WR

P W

alte

r R

eed

Prog

ram

App

endi

x I

WH

O C

LIN

ICA

L S T

AG

ING

OF

HIV

AID

S FO

R A

DU

LTS

AN

D A

DO

LES-

CEN

TSW

ITH

CO

NFI

RM

ED H

IV IN

FEC

TIO

N

CLI

NIC

AL

STA

GE

1

bull

Asy

mpt

omat

ic

bull

Per

sist

ent

gene

raliz

ed ly

mph

aden

opat

hy

CLI

NIC

AL

STA

GE

2 1

Une

xpla

ined

mod

erat

e w

eigh

t lo

ss (

lt10

of

pres

umed

or

mea

sure

d bo

dy w

eigh

t)

2

Rec

urre

nt u

pper

res

pira

tory

tra

ct in

fect

ions

(si

nusi

tis

tons

illiti

s

otiti

s m

edia

and

pha

ryng

itis)

3

Her

pes

Zos

ter

4

Ang

ular

Che

ilitis

5

Rec

urre

nt o

ral u

lcer

atio

n

6

Pap

ular

pru

ritic

eru

ptio

ns

7

Seb

orrh

oeic

der

mat

itis

8

Fun

gal n

ail i

nfec

tions

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

5

92

Bib

liog

raph

y 1

Offic

e of

the

Pres

iden

t N

ational

AID

S C

ontr

ol Counci

l K

enya

Nat

ional H

IVA

IDS

Str

ate

gic

pla

n 2

0056

-20091

0

2

Rep

ublic

of

Ken

ya

Nat

ional AID

S C

ontr

ol C

ounci

l N

atio

nal H

IVA

IDS M

onitori

ng

and E

valu

atio

n F

ram

ework

3

Rep

ublic

of

Ken

ya

Nat

ional AID

S C

ontr

ol C

ounci

l N

atio

nal H

IVA

IDS M

onitori

ng

and E

valu

atio

n I

mple

men

tation M

anual

Job

Aid

sR

efer

ence

s 1

MoH

AN

C R

egis

ters

2

MoH

Mat

ernity

Reg

iste

rs

3

MoH

Post

-nata

l Reg

iste

rs

4

Mat

ernal

and C

hild

Wel

fare

Han

dbook

5

Rep

roduct

ive

Hea

lth S

ervi

ces

month

ly r

eport

6

MoH

Form

726

(Appen

dix

IV)

7

MoH

Form

727

8

MO

H F

orm

711

Exec

utiv

e Su

mm

ary

The

Rev

ised

Gui

delin

es (3

rd

editi

on) f

or P

reve

ntio

n of

Mot

her

to C

hild

Tra

nsm

issi

on(P

MTC

T) o

f H

IV a

nd A

IDS

addr

esse

s th

e ri

sks

of m

othe

r-to

-chi

ld t

rans

mis

sion

(MTC

T) o

f H

IV a

nd A

IDS

usin

g m

ore

effic

acio

us in

terv

entio

ns t

han

in t

he p

revi

ous

editi

ons

The

Gui

delin

es a

re i

n lin

e w

ith K

enya

rsquos N

atio

nal

Hea

lth S

ecto

r St

rate

gic

Plan

II

(NH

SSP

II)

and

are

anch

ored

on

the

Ken

ya N

atio

nal

AID

S St

rate

gic

Plan

(KN

ASP

) 20

00-2

010

whi

ch f

ocus

es o

n th

e pr

iori

ty a

reas

of

prev

entio

n of

new

inf

ecshy

tions

im

prov

ing

the

qual

ity o

f life

of p

eopl

e in

fect

ed a

nd a

ffect

ed b

y H

IV a

nd A

IDS

and

miti

gatio

n of

the

soc

ial a

nd e

cono

mic

impa

ct o

f the

infe

ctio

n O

ne o

f the

pri

ority

ar

eas

of N

HSS

P II

is

adhe

renc

e to

set

clin

ical

and

pub

lic h

ealth

sta

ndar

ds

The

Gui

delin

es w

ere

deve

lope

d th

roug

h a

part

icip

ator

y an

d co

nsul

tativ

e pr

oces

s th

at

drew

par

ticip

ants

fro

m p

ublic

hea

lth i

nstit

utio

ns

NG

Os

FB

Os

aca

dem

ic a

nd r

eshyse

arch

ins

titut

ions

and

dev

elop

men

t pa

rtne

rs

The

proc

ess

was

co-

ordi

nate

d by

N

ASC

OP

with

tech

nica

l and

fina

ncia

l sup

port

from

CD

C (K

)

HIV

infe

ctio

n ha

s re

vers

ed g

ains

rea

lised

in c

hild

hea

lth a

nd s

urvi

val i

n th

e la

st d

ecshy

ade

in K

enya

The

infe

ctio

n ha

s al

so c

ontr

ibut

ed s

igni

fican

tly t

o th

e co

mm

on c

ompl

ishyca

tions

of

preg

nanc

y in

man

y co

untr

ies

Glo

bally

mor

e th

an 6

300

00 c

hild

ren

wer

ein

fect

ed w

ith H

IV t

hrou

gh M

TCT

in 2

003

In

2007

K

enya

had

a p

opul

atio

n es

tishym

ated

at

34 m

illio

n t

he n

umbe

r of

bir

ths

per

annu

m w

as 1

73

mill

ion

the

HIV

prev

alen

ce a

mon

g pr

egna

nt m

othe

rs w

as 6

7 p

er c

ent

and

the

tota

l num

ber

of b

irth

s to

HIV

-infe

cted

mot

hers

exp

osed

to

MTC

T w

as 1

638

00

Ass

umin

g a

tran

smis

sion

rate

of 4

0 pe

r ce

nt a

nd in

the

abs

ence

of a

ny in

terv

entio

n t

he n

umbe

r of

HIV

pos

ishytiv

e in

fant

s pe

r an

num

wou

ld b

e 65

520

Ken

ya A

IDS

Indi

cato

r su

rvey

(KA

IS) 2

007

HIV

ser

opre

vale

nce

amon

g ad

ults

age

d 15

-49

year

s is

78

Var

ious

inte

rven

tions

hav

e be

en p

ut in

pla

ce t

o re

spon

d to

the

em

ergi

ng c

halle

nges

an

d co

nstr

aint

s to

MTC

T ac

ross

the

cou

ntry

Ana

lysi

s of

effe

ctiv

enes

s of

the

var

ious

ap

proa

ches

nee

ded

to m

anag

e ri

sks

of M

TCT

prov

ides

val

uabl

e in

sigh

ts th

at n

eces

sishy

tate

the

ado

ptio

n of

mor

e ef

ficac

ious

car

e an

d tr

eatm

ent

regi

men

s T

hese

ins

ight

s ha

ve in

form

ed t

he d

evel

opm

ent

of n

ew G

uide

lines

The

Gui

delin

es in

corp

orat

e th

ese

chan

ges

and

are

reco

mm

ende

d fo

r us

e by

hea

lth p

rofe

ssio

nals

and

hea

lth in

stitu

tions

at a

ll le

vels

of c

are

The

Gui

delin

es w

ill e

nhan

ce th

e ca

paci

ty o

f hea

lth c

are

prov

ider

sto

giv

e m

ore

effic

ient

and

effe

ctiv

e se

rvic

es t

o H

IV p

ositi

ve e

xpec

tant

mot

hers

and

ne

wbo

rns

The

Gui

delin

es h

ave

ten

chap

ters

and

cov

er th

e fo

llow

ing

just

ifyin

g th

e ne

ed fo

r sp

eshyci

fic m

anag

emen

t of

HIV

pos

itive

wom

en c

are

befo

re d

urin

g an

d af

ter

preg

nanc

yus

e of

ant

iret

rovi

ral t

hera

py in

pre

gnan

cy p

ostn

atal

car

e fa

mily

pla

nnin

g e

arly

inshy

fant

dia

gnos

is

feed

ing

car

e an

d fo

llow

-up

of H

IV-in

fect

ed i

nfan

ts

and

mon

itori

ng

and

eval

uatio

n A

dditi

onal

inf

orm

atio

n on

WH

O s

tagi

ng

cont

race

ptiv

e op

tions

for

PLW

As

and

a su

mm

ary

of A

RV

use

in P

MTC

T is

giv

en in

the

appe

ndic

es

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

1

16

The

Gui

delin

es h

ave

also

inc

orpo

rate

d ba

sic

info

rmat

ion

that

pro

gram

man

ager

sne

ed in

ord

er to

mak

e th

eir

inst

itutio

ns P

MTC

T-fr

iend

ly T

his

info

rmat

ion

is fo

und

in

the

boxe

s an

d ap

pend

ices

Sum

mar

ies

of t

he i

nfor

mat

ion

cont

aine

d in

the

tex

t ar

e fo

und

in th

e ta

bles

The

Gui

delin

es p

rovi

de a

bac

kgro

und

to t

he P

MTC

T pr

oble

m in

the

wor

ld i

n A

fric

a an

d in

Ken

ya T

hey

also

giv

e de

tails

on

HIV

in p

regn

ancy

the

tran

smis

sion

pat

tern

sof

MTC

T an

d de

scri

be t

he b

enef

its o

f pr

even

ting

mot

her-

to-c

hild

tra

nsm

issi

on(P

MTC

T) T

hey

also

pro

vide

info

rmat

ion

on in

terv

entio

ns n

eces

sary

to

redu

ce M

TCT

that

incl

ude

coun

selli

ng a

nd te

stin

g la

bora

tory

inve

stig

atio

ns o

bste

tric

inte

rven

tions

and

trea

tmen

tpro

phyl

axis

The

ante

nata

l man

agem

ent

for

HIV

pos

itive

wom

en i

nclu

ding

pol

icy

guid

e jo

b ai

dsw

ith s

umm

aris

ed e

ssen

tial p

acka

ge o

f int

egra

ted

ante

nata

l car

e se

rvic

es a

re d

etai

led

in C

hapt

er 2

Cha

pter

3 p

rovi

des

info

rmat

ion

on i

ntra

part

um c

are

Thi

s is

the

man

agem

ent

ofw

omen

from

the

onse

t of l

abou

r to

del

iver

y A

t thi

s st

age

it is

impo

rtan

t to

esta

blis

hth

e H

IV s

tatu

s of

wom

en p

rior

to d

eliv

ery

or d

urin

g la

bour

Gui

delin

es s

houl

d be

folshy

low

ed fo

r al

l wom

en a

dmitt

ed to

labo

ur a

nd d

eliv

ery

To

cond

uct v

agin

al d

eliv

erie

s fo

r H

IV p

ositi

ve w

omen

m

odifi

ed r

outin

e ca

re i

s gi

ven

The

gui

delin

es p

rovi

de a

reshy

min

der

on th

e ac

tiviti

es e

ssen

tial t

o ca

rry

out f

or s

afe

vagi

nal d

eliv

ery

for

all w

omen

no

t ju

st fo

r th

ose

infe

cted

with

HIV

It

is r

ecom

men

ded

that

the

re s

houl

d be

no

disshy

crim

inat

ion

or is

olat

ion

of H

IV p

ositi

ve w

omen

dur

ing

labo

ur a

nd d

eliv

ery

Del

iver

y th

roug

h el

ectiv

e ca

esar

ean

sect

ion

redu

ces

the

risk

of

HIV

MTC

T as

com

pare

d to

vagi

nal d

eliv

ery

amon

g H

IV p

ositi

ve w

omen

Whe

re C

S is

per

form

ed a

s an

em

erge

ncy

or e

lect

ivel

y a

ntib

iotic

s sh

ould

be

give

n

Ant

iret

rovi

ral (

AR

V) t

hera

py is

dis

cuss

ed in

det

ail i

n C

hapt

er 4

Thi

s in

clud

es t

hershy

apy

for

the

mot

her

befo

re la

bour

dur

ing

labo

ur a

nd a

fter

del

iver

y a

nd fo

r th

e in

fant

afte

r de

liver

y C

urre

ntly

N

evir

apin

e is

the

rec

omm

ende

d re

gim

en H

owev

er

shor

tco

urse

effi

caci

ous

AR

V d

rug

regi

men

s ca

n be

im

plem

ente

d in

res

ourc

e lim

ited

setshy

tings

AR

Vs

are

used

bot

h fo

r tr

eatm

ent

and

for

PMTC

T in

HIV

inf

ecte

d pr

egna

ntw

omen

and

thei

r ne

onat

es

Gui

delin

es f

or t

he p

ostp

artu

m c

are

of t

he m

othe

r an

d ca

re f

or H

IV e

xpos

ed in

fant

s ar

e de

taile

d in

Cha

pter

5 I

n C

hapt

er 6

the

Gui

de p

rovi

des

deta

iled

info

rmat

ion

on

late

pos

tnat

al c

are

and

fam

ily p

lann

ing

HIV

pos

itive

wom

en c

an u

se a

ll ty

pes

of fa

mshy

ily p

lann

ing

base

d on

sta

ndar

d el

igib

ility

cri

teri

a as

exp

licitl

y ou

tline

d in

the

text

Gui

delin

es fo

r in

fant

dia

gnos

is c

are

and

trea

tmen

t ar

e di

scus

sed

in C

hapt

er 7

Cur

shyre

ntly

the

re is

no

test

to

diffe

rent

iate

bet

wee

n an

tibod

ies

from

the

mot

her

and

thos

e pr

oduc

ed b

y th

e ba

by T

o id

entif

y H

IV in

fect

ed in

fant

s le

ss t

han

18 m

onth

s D

NA

or

RN

A ndash

PC

R te

st is

cur

rent

ly r

ecom

men

ded

HIV

exp

osed

infa

nts

at 6

wee

ks a

nd s

ick

infa

nts

at 1

2 m

onth

s sh

ould

hav

e ac

cess

to

DB

S fo

r D

NA

PC

R H

IV e

xpos

ed in

fant

ssh

ould

be

star

ted

on c

otri

mox

azol

e fr

om 6

wee

ks A

ll m

othe

rs w

ith 6

wee

k ol

d in

fant

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

E

Upt

ake

of c

ouns

ellin

g an

d te

stin

g in

Mat

erni

ty c

linic

Rat

io o

f m

ater

nity

clie

nts

with

unk

now

n H

IV s

tatu

s w

ho a

re c

ouns

elle

d an

d te

sted

for H

IV in

mat

erni

ty

Num

erat

or

Num

ber o

f pre

gnan

t wom

en a

dmitt

ed in

to m

ater

nity

with

un

know

n H

IV s

tatu

s th

at a

re c

ouns

elle

d an

d te

sted

for H

IV

durin

g la

bour

or a

fter d

eliv

ery

Den

omin

ator

N

umbe

r of p

regn

ant w

omen

adm

itted

into

mat

erni

ty

with

unk

now

n H

IV s

tatu

s

F

Mat

erni

ty m

othe

r AR

V pr

ophy

laxi

s up

take

R

atio

of H

IV in

fect

ed m

othe

rs in

mat

erni

ty c

linic

rece

ivin

g pr

even

tive

A

RV

pro

phyl

axis

Num

erat

or

Num

ber o

f HIV

-infe

cted

mot

hers

adm

itted

in m

ater

nity

takshy

ing

or re

porte

d to

hav

e ta

ken

the

mot

her d

ose(

s) o

f pre

venshy

tive

AR

V p

roph

ylax

is

Den

omin

ator

N

umbe

r of p

regn

ant w

omen

adm

itted

into

mat

erni

ty w

ho

are

HIV

-infe

cted

G

Infa

nt A

RV

prop

hyla

xis

upta

ke

Rat

io o

f inf

ants

bor

n to

HIV

-infe

cted

mot

hers

in m

ater

nity

clin

ic

rece

ivin

g pr

even

tive

AR

V p

roph

ylax

is

Num

erat

or

Num

ber o

f inf

ants

bor

n to

HIV

-infe

cted

mot

hers

who

rece

ive

prev

entiv

e

Den

omin

ator

N

umbe

r of i

nfan

ts b

orn

to H

IV-in

fect

ed m

othe

rs

Num

ber o

f pre

gnan

t wom

en a

dmitt

ed in

to m

ater

nity

who

are

H

IV-in

fect

ed is

use

d to

app

roxi

mat

e th

is n

umbe

r

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

7

90

With

the

mea

sure

men

ts li

sted

abo

ve t

he fo

llow

ing

perf

orm

ance

indi

cato

rs

for m

onito

ring

PMTC

T ac

tiviti

es a

re c

alcu

late

d

A

Upt

ake

of c

ouns

ellin

g an

d te

stin

g in

Ant

enat

al c

linic

R

atio

of a

nten

atal

clie

nts

who

wer

e co

unse

lled

and

test

ed fo

r HIV

Num

erat

or

This

is n

umbe

r of p

regn

ant w

omen

atte

ndin

g th

eir f

irst

ante

nata

l clin

ic v

isit

who

are

test

ed fo

r HIV

Den

omin

ator

N

umbe

r of n

ew v

isits

to th

e an

tena

tal c

linic

B

Ant

enat

al H

IV s

erop

reva

lenc

e

Rat

io o

f Ant

enat

al p

regn

ant w

omen

test

ed fo

r HIV

that

are

HIV

infe

cted

Num

erat

or

Num

ber o

f clie

nts

who

test

HIV

pos

itive

Den

omin

ator

To

tal n

umbe

r of p

regn

ant w

omen

test

ed fo

r HIV

in a

nten

ashyta

l clin

ic

C

Ant

enat

al m

othe

r AR

V pr

ophy

laxi

s up

take

R

atio

of k

now

n H

IV in

fect

ed p

regn

ant w

omen

in a

nten

atal

clin

ic

rece

ivin

g A

RV

pre

vent

ive

prop

hyla

xis

Num

erat

or

Tota

l num

ber o

f HIV

-infe

cted

pre

gnan

t wom

en in

ant

enat

al

clin

ic re

ceiv

ing

mot

her p

reve

ntiv

e A

RV

pro

phyl

axis

Den

omin

ator

To

tal n

umbe

r of p

regn

ant w

omen

who

are

HIV

-infe

cted

in

the

ante

nata

l clin

ic

D

Ant

enat

al in

fant

AR

V pr

ophy

laxi

s up

take

R

atio

of k

now

n H

IV-in

fect

ed p

regn

ant w

omen

in a

nten

atal

clin

ic w

ho

rece

ive

infa

nt d

ose(

s) o

f pre

vent

ive

AR

V p

roph

ylax

is

Num

erat

or

Tota

l num

ber o

f HIV

infe

cted

pre

gnan

t wom

en in

an

tena

tal c

linic

rece

ivin

g in

fant

dos

e(s)

pre

vent

ive

A

RV

pro

phyl

axis

Den

omin

ator

To

tal n

umbe

r of p

regn

ant w

omen

who

are

HIV

-infe

cted

in

the

ante

nata

l clin

ic

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

shou

ld h

ave

rout

ine

HIV

ant

ibod

y te

st

Gui

delin

es f

or f

eedi

ng in

fant

s an

d yo

ung

child

ren

born

to

HIV

infe

cted

mot

hers

are

di

scus

sed

in C

hapt

er 8

The

Min

istr

y of

Hea

lth r

ecom

men

ds p

rom

otio

n of

exc

lusi

vebr

east

feed

ing

for

the

first

6 m

onth

s of

life

Whe

re r

epla

cem

ent f

eedi

ng is

acc

epta

ble

feas

ible

af

ford

able

su

stai

nabl

e an

d sa

fe (

AFA

SS)

avoi

danc

e of

bre

astf

eedi

ng b

yH

IV-in

fect

ed w

omen

is

reco

mm

ende

d (W

HO

200

6) D

iscu

ssio

n on

diff

eren

t ty

pes

offe

edin

g al

tern

ativ

es t

o br

east

feed

ing

is c

aptu

red

in t

he t

ext

Thes

e op

tions

exi

st f

orth

e m

othe

r to

cho

ose

with

the

aid

of

coun

selli

ng I

deal

ly c

oupl

e de

cisi

on-m

akin

g is

enco

urag

ed f

or t

he H

IV p

ositi

ve m

othe

r F

or t

he H

IV n

egat

ive

mot

her

exc

lusi

ve

brea

stfe

edin

g is

rec

omm

ende

d fo

r 6

mon

ths

or le

ss fo

llow

ed b

y w

eani

ng

Car

e an

d fo

llow

-up

of c

hild

ren

of H

IV-in

fect

ed m

othe

rs is

dis

cuss

ed in

det

ail i

n C

hapshy

ter

9 A

ll ch

ildre

n bo

rn t

o H

IV i

nfec

ted

mot

hers

sho

uld

be f

ollo

wed

up

clos

ely

from

birt

h th

roug

h 2

year

s T

able

92

pro

vide

s th

e W

HO

rec

omm

ende

d fo

llow

up

deta

ils

Sim

ilarl

y t

he m

othe

rs s

houl

d be

sup

port

ed t

o pr

ovid

e op

timal

infa

nt fe

edin

g an

d to

av

oid

mix

ed fe

edin

g w

ithin

6 m

onth

s

In C

hapt

er 1

0 t

he G

uide

lines

exp

lain

the

ben

efits

of

mon

itori

ng a

nd e

valu

atio

n of

PMTC

T pr

ogra

ms

Mamp

E p

rovi

des

an o

ppor

tuni

ty t

o m

easu

re a

nd a

ppra

ise

perf

orm

shyan

ce w

ithin

def

ined

tim

e fr

ame

to e

nsur

e ac

com

plis

hmen

t of s

et g

oals

and

obj

ectiv

es

PMTC

T se

rvic

es m

ust

be g

uide

d by

tim

ely

and

accu

rate

dat

a re

port

ed f

rom

the

heal

th f

acili

ties

thr

ough

the

dis

tric

t an

d pr

ovin

cial

lev

els

to

the

natio

nal

leve

l at

NA

SCO

P

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

9

18

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

(xiii

) H

IV in

fect

ed in

mat

erni

ty w

ard

Num

ber

of p

regn

ant

wom

en a

dmitt

ed in

to

mat

erni

ty c

linic

who

are

HIV

infe

cted

In

clud

es b

oth

thos

e w

ho w

ere

adm

itted

al

read

y kn

owin

g th

ey a

re H

IV-i

nfec

ted

and

thos

e w

ho w

ere

test

ed a

nd r

ecei

ved

thei

r re

sults

in m

ater

nity

clin

ic T

his

is o

btai

ned

from

the

mat

erni

ty r

egis

ter

(xiv

) P

reve

ntiv

e A

RV

pro

phyl

axis

in m

ater

nity

war

d (m

othe

r do

se)

Num

ber

of

preg

nant

wom

en a

dmitt

ed in

mat

erni

ty t

akin

g or

rep

orte

d to

hav

e ta

ken

the

mot

her

dose

(s)

of p

reve

ntiv

e A

RV

pro

phyl

axis

T

his

is o

btai

ned

from

the

m

ater

nity

reg

iste

r

(xv)

Inf

ant

prev

entiv

e A

RV

pro

phyl

axis

in m

ater

nity

clin

ic

war

d N

umbe

r of

inshy

fant

s bo

rn in

mat

erni

ty r

ecei

ving

the

infa

nt p

reve

ntiv

e A

RV

pro

phyl

axis

in t

he

mat

erni

ty c

linic

T

his

is o

btai

ned

from

the

mat

erni

ty r

egis

ter

(xvi

) D

eliv

erie

s T

otal

num

ber

of p

regn

ant

wom

en d

eliv

erin

g at

the

hea

lth fa

cilit

y

(xvi

i) C

ouns

ellin

g on

infa

nt f

eedi

ng o

ptio

ns

Num

ber

of m

othe

rs d

eliv

erin

g at

the

he

alth

fac

ility

cou

nsel

led

on in

fant

fee

ding

opt

ions

T

his

is o

btai

ned

from

the

m

ater

nity

reg

iste

r

(xvi

ii) I

nfan

t te

stin

g at

6 w

eeks

bull N

umbe

r of

infa

nts

test

ed f

or H

IV a

t 6

wee

ks o

ld

bull N

umbe

r of

infa

nts

test

ing

HIV

-pos

itive

T

his

is o

btai

ned

from

labo

rato

ry

regi

ster

(xix

) R

efer

red

for

care

and

tre

atm

ent

bull N

umbe

r of

HIV

infe

cted

wom

en a

ttend

ing

ante

nata

l clin

ic t

hat

is r

efer

red

for

HIV

car

e an

d tr

eatm

ent

bull N

umbe

r of

HIV

infe

cted

wom

en in

mat

erni

ty t

hat

is r

efer

red

for

HIV

car

e an

d tr

eatm

ent

bull N

umbe

r H

IV in

fect

ed in

fant

s re

ferr

ed f

or H

IV c

are

and

trea

tmen

t T

his

is

ob

tain

ed f

rom

ant

enat

al a

nd m

ater

nity

reg

iste

rs

(xx)

Ini

tiate

d on

Cot

rim

oxaz

ole

Num

ber

of H

IV in

fect

ed p

regn

ant

wom

en a

ttend

ing

ante

nata

l clin

ic th

at h

as

been

initi

ated

on

Cot

rimox

azol

e T

his

is o

btai

ned

from

the

ant

enat

al r

egis

ter

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

9

88

Th

e da

ta is

pre

sent

ed u

sing

def

ined

per

form

ance

indi

cato

rs th

at in

clud

e th

e fo

llow

ing

(i)

New

clie

nts

first

ant

enat

al c

linic

vis

its

Num

ber

of p

regn

ant

wom

en a

ttend

ing

thei

r fir

st a

nten

atal

vis

it fo

r th

e cu

rren

t pr

egna

ncy

at t

he h

ealth

fac

ility

T

his

is

obta

ined

fro

m t

he a

nten

atal

reg

iste

r

(ii)

Ret

urn

visi

tsr

evis

its

Num

ber

of r

etur

n an

tena

tal c

linic

vis

itsr

evis

its

atte

nded

by

the

preg

nant

wom

en a

t th

e fa

cilit

y T

his

is o

btai

ned

from

the

an

tena

tal r

egis

ter

(iii)

C

ouns

ellin

g an

d te

stin

g fo

r H

IV in

ant

enat

al c

linic

Tot

al n

umbe

r of

pre

gnan

t w

omen

cou

nsel

led

and

test

ed f

or H

IV a

t th

e an

tena

tal c

linic

w

heth

er t

his

is d

one

on th

e fir

st a

nten

atal

vis

it or

a la

ter

visi

t T

his

is o

btai

ned

from

the

an

tena

tal r

egis

ter

(iv)

H

IV c

ouns

ellin

g an

d te

stin

g at

fir

st a

nten

atal

clin

ic v

isit

Num

ber

of p

regn

ant

wom

en a

tten

ding

the

ir fir

st a

nten

atal

clin

ic v

isit

for

curr

ent

preg

nanc

y w

ho a

re

test

ed f

or H

IV

Thi

s is

obt

aine

d fr

om t

he a

nten

atal

reg

iste

r

(v)

Lear

ning

HIV

sta

tus

in a

nten

atal

clin

ic

Num

ber

of a

nten

atal

clin

ic p

regn

ant

wom

en t

este

d fo

r H

IV w

ho r

ecei

ve t

heir

HIV

res

ults

w

heth

er t

his

is d

one

on t

he

first

ant

enat

al c

linic

vis

it or

at

a la

ter

visi

t T

his

is o

btai

ned

from

the

ant

enat

al

regi

ster

(vi)

HIV

infe

cted

in a

nten

atal

clin

ic

Num

ber

of a

nten

atal

clin

ic p

regn

ant

wom

en

who

are

HIV

-inf

ecte

d on

the

late

st t

est

durin

g th

e pr

egna

ncy

Thi

s is

obt

aine

d fr

om t

he a

nten

atal

reg

iste

r

(vii)

Pre

vent

ive

AR

V p

roph

ylax

is in

ant

enat

al c

linic

(m

othe

r do

se)

Num

ber

of

preg

nant

wom

en in

the

ant

enat

al c

linic

rec

eivi

ng t

he m

othe

r do

se(s

) of

pre

venshy

tive

AR

V p

roph

ylax

is

Thi

s is

obt

aine

d fr

om t

he a

nten

atal

reg

iste

r

(viii

) P

reve

ntiv

e A

RV

pro

phyl

axis

in a

nten

atal

clin

ic (

infa

nt d

ose)

N

umbe

r of

pr

egna

nt w

omen

in t

he A

nten

atal

clin

ic is

sued

with

the

infa

nt d

ose(

s) o

f pr

even

shytiv

e A

RV

pro

phyl

axis

T

his

is o

btai

ned

from

the

ant

enat

al r

egis

ter

(ix)

New

clie

nts

in m

ater

nity

clin

ic

Num

ber

of p

regn

ant

wom

en a

tten

ding

the

Mashy

tern

ity c

linic

for

the

firs

t tim

e T

his

is o

btai

ned

from

the

mat

erni

ty r

egis

ter

(x)

Unk

now

n H

IV s

tatu

s at

mat

erni

ty

Num

ber

of p

regn

ant

wom

en a

dmitt

ed in

to

the

mat

erni

ty w

ith u

nkno

wn

HIV

sta

tus

Thi

s is

obt

aine

d fr

om t

he m

ater

nity

reg

isshy

ter

(xi)

Cou

nsel

ling

and

test

ing

for

HIV

in m

ater

nity

war

dT

otal

num

ber

of p

regn

ant

wom

en a

dmitt

ed in

to m

ater

nity

with

unk

now

n st

atus

tha

t ar

e co

unse

lled

and

test

ed fo

r H

IV d

urin

g la

bour

or

afte

r de

liver

y T

his

is o

btai

ned

from

the

mat

erni

ty

regi

ster

(xii)

Lea

rnin

g H

IV s

tatu

s in

mat

erni

ty w

ard

Num

ber

of p

regn

ant

wom

en a

dmitt

ed

into

mat

erni

ty a

nd t

este

d fo

r H

IV w

ho r

ecei

ved

thei

r H

IV r

esul

ts

Thi

s is

obt

aine

d fr

om t

he m

ater

nity

reg

iste

r

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Cha

pter

1

Bac

kgro

und

11

THE

GLO

BA

L P A

ND

EMIC

Ove

r 38

mill

ion

peop

le a

re li

ving

with

HIV

AID

S w

orld

wid

e a

nd a

bout

two-

thir

ds o

r 25

m

illio

n of

PLW

HA

liv

e in

sub

-Sah

aran

Afr

ica1

H

IVA

IDS

mai

nly

affe

cts

peop

le o

fre

prod

uctiv

e ag

e an

d in

crea

sing

ly a

ffect

s w

omen

w

ho n

ow a

ccou

nt f

or 5

7 o

f ne

win

fect

ions

in s

ub-S

ahar

an A

fric

a w

here

wom

en a

re 3

0 m

ore

likel

y to

be

livin

g w

ith

HIV

AID

S th

an m

en a

nd y

oung

wom

en a

ged

15-2

4 ar

e ne

arly

four

tim

es m

ore

likel

y to

be

inf

ecte

d th

an t

heir

mal

e co

unte

rpar

ts2

Youn

g m

arri

ed w

omen

w

ho a

re o

ften

m

onog

amou

s h

ave

beco

me

one

of t

he g

roup

s m

ost

vuln

erab

le t

o H

IV i

n th

e re

gion

Th

is r

equi

res

new

and

rap

id r

espo

nses

that

bro

aden

the

focu

s be

yond

trad

ition

al ldquoh

igh

risk

rdquo gro

ups

like

com

mer

cial

sex

wor

kers

tru

ck d

rive

rs a

nd d

rug

user

s

To r

each

you

ng m

arri

ed w

omen

w

ho m

ay n

ot b

e aw

are

of t

heir

vul

nera

bilit

y H

IV

AID

S pr

even

tion

ca

re

and

supp

ort

activ

ities

m

ust

be

inte

grat

ed

into

al

read

yes

tabl

ishe

d he

alth

ser

vice

s th

at a

re u

sed

by t

he g

ener

al p

opul

atio

n A

n es

timat

ed

630

000

child

ren

wor

ld-w

ide

beca

me

infe

cted

with

HIV

in

2003

mdash m

ost

thro

ugh

MTC

T3

The

risk

of

an H

IV-in

fect

ed m

othe

r pa

ssin

g th

e vi

rus

to h

er i

nfan

t du

ring

pr

egna

ncy

labo

ur a

nd d

eliv

ery

or in

the

post

nata

l per

iod

is 1

in 3

if n

othi

ng is

don

e to

re

duce

this

ris

k I

n ot

her

wor

ds o

ut o

f 100

infa

nts

born

to w

omen

with

HIV

AID

S an

d w

ithou

t in

terv

entio

n 6

0-75

of t

hem

will

not

be

infe

cted

Of t

he o

ne-t

hird

who

bec

ome

infe

cted

abo

ut 5

-10

babi

es w

ill b

e in

fect

ed d

urin

g pr

egna

ncy

15

will

be

infe

cted

dur

ing

labo

ur a

nd d

eliv

ery

whi

le 5

-15

will

be

infe

cted

dur

ing

brea

stfe

edin

g l

arge

ly b

eing

de

pend

ent

on b

reas

tfee

ding

pra

ctic

es a

nd o

n th

e du

ratio

n of

bre

astfe

edin

g4 I

n 20

03

near

ly 5

000

00 c

hild

ren

died

of A

IDS-

rela

ted

caus

es M

ost

child

ren

born

with

HIV

die

befo

re th

ey r

each

thei

r fif

th b

irth

day

with

mos

t not

sur

vivi

ng b

eyon

d tw

o ye

ars5

The

high

rat

es o

f M

TCT

in d

evel

opin

g co

untr

ies

com

pare

d to

muc

h lo

wer

rat

es i

nri

cher

cou

ntri

es

illus

trat

e gr

owin

g in

equa

litie

s in

glo

bal

heal

th

In t

he w

ealth

y co

untr

ies

the

rat

e of

MTC

T is

les

s th

an 2

b

ecau

se o

f w

ides

prea

d ac

cess

to

antishy

retr

ovir

al th

erap

y (A

RT)

pla

nned

cae

sare

an s

ectio

ns (C

S) t

he m

eans

to s

afel

y fo

rmul

afe

ed a

nd a

cces

s to

qua

lity

med

ical

ser

vice

s I

n po

orer

cou

ntri

es li

ke K

enya

the

re is

a

30-4

0 c

hanc

e th

at a

n H

IV-p

ositi

ve b

reas

tfee

ding

mot

her

will

pas

s H

IV to

her

chi

ld in

th

e ab

senc

e of

the

se s

ervi

ces

In

such

set

tings

it

is c

ritic

al t

hat

prev

entio

n pr

oced

ures

be i

nteg

rate

d in

to e

xist

ing

sexu

al a

nd r

epro

duct

ive

heal

th (

SRH

) an

d m

ater

nal

and

child

hea

lth (

MC

H)

serv

ices

re

achi

ng a

s m

any

wom

en a

s po

ssib

le a

nd l

ower

ing

tran

smis

sion

rat

es A

lthou

gh p

harm

aceu

tical

com

pany

don

atio

ns d

onor

sup

port

and

othe

r go

vern

men

t in

itiat

ives

hav

e he

lped

exp

and

acce

ss t

o H

IV t

estin

g fo

r pr

egna

ntw

omen

and

use

of a

ntir

etro

vira

l dru

gs li

ke N

evir

apin

e w

hich

red

uce

the

chan

ce o

f HIV

tr

ansm

issi

on s

till o

nly

10

of p

regn

ant w

omen

glo

bally

hav

e ac

cess

to th

ese

drug

s6

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

7

20

HIV

AID

S tr

ansm

issi

on fr

om m

othe

r to

chi

ld in

Ken

ya is

one

of t

he b

igge

st h

ealth

and

de

velo

pmen

t cha

lleng

es in

Ken

ya A

ccor

ding

to th

e 20

03 D

emog

raph

ic a

nd H

ealth

Sur

shyve

y7 6

7

or

over

12

mill

ion

Ken

yan

adul

ts w

ere

livin

g w

ith H

IVA

IDS

in 2

003

The

re

has

been

a s

tead

y de

clin

e in

HIV

ser

opre

vale

nce

in K

enya

In

2005

the

pre

vale

nce

rate

w

as e

stim

ated

at 5

9

and

as

per

the

2006

sta

tistic

s th

e pr

eval

ence

rat

e am

ong

adul

tsha

d dr

oppe

d to

51

8

Acc

ordi

ng t

o 20

07 K

enya

AID

S In

dica

tor

Surv

ey (

KA

IS)8a

the

H

IV s

erop

reva

lenc

e in

Ken

ya is

cur

rent

ly 7

8

am

ong

adul

ts a

ged

15-4

9 ye

ars

bei

nghi

gher

in

wom

en (

87

) th

an i

n m

en (

56

) Y

oung

wom

en a

re m

ore

vuln

erab

le i

n K

enya

tha

n m

en a

s ev

iden

ced

by a

nea

rly

9 p

reva

lenc

e ra

te a

mon

g w

omen

and

unshy

der

5 a

mon

g m

en9

Ther

e ar

e w

ide

vari

atio

ns b

etw

een

urba

n an

d ru

ral

area

s b

etw

een

regi

ons

bet

wee

n ad

ults

and

you

ng p

eopl

e an

d be

twee

n m

en a

nd w

omen

The

re h

as b

een

a no

tabl

e dr

op

in t

he n

umbe

r of

new

inf

ectio

ns

with

an

estim

ated

60

000

new

inf

ectio

ns i

n 20

05

drop

ping

to 5

500

0 in

200

6 In

fant

s an

d yo

ung

child

ren

unde

r 15

yea

rs a

ccou

nt fo

r 16

of

all

new

HIV

infe

ctio

ns m

ainl

y as

a r

esul

t of M

TCT

Mos

t of t

he n

ew in

fect

ions

occ

ur

amon

g yo

ung

peop

le i

n w

hom

the

mai

n m

ode

of t

rans

mis

sion

is t

hrou

gh s

exua

l int

ershy

cour

se

Tabl

e 1

1 A

dult

HIV

-Pre

vale

nce

Estim

ate

by P

rovi

nce

in 2

006

Prov

ince

N

umbe

r of H

IV +

Pre

vale

nce

()

Nai

robi

Cen

tral

Coa

st

Eas

tern

N E

aste

rn

Nya

nza

Rift

Val

ley

Wes

tern

Tota

l

197

000

960

00

930

00

720

00

900

0 18

300

0

171

000

112

000

11

milli

on

Tota

l

101

41

59

28

14

78

38

53

51

Mal

e

80

17

50

11

09

61

26

42

35

Fem

ale

123

65

69

44

18

96

49

64

67

Mal

eFe

mal

e R

atio

15

38

14

40

20

16

19

15

19

all t

he d

ata

from

the

prov

ince

s (a

nd r

efer

ral h

ospi

tals

) Th

e ag

greg

ated

dat

a is

di

ssem

inat

ed t

o th

e H

ealth

Man

agem

ent

Info

rmat

ion

Syst

em N

atio

nal A

IDS

Con

trol

Cou

ncilrsquo

s (N

AC

C)

natio

nal

data

ban

k an

d re

sour

ce c

entr

e T

he f

ocal

pe

rson

s he

re a

re t

he d

irec

tor

NA

CC

and

the

Mamp

E m

anag

er D

ata

is d

isse

mishy

nate

d ba

ck to

the

prov

ince

s an

d re

ferr

al h

ospi

tals

for

use

in d

ecis

ion-

mak

ing

7

Dat

a flo

w f

rom

fac

ility

lev

el t

o na

tiona

l le

vel

At

the

heal

th f

acili

ty P

MTC

T in

divi

dual

le

vel d

ata

reco

rded

in t

he M

oH s

tand

ardi

sed

regi

ster

s (A

NC

Mashy

tern

ity a

nd P

ostn

atal

) is

sum

mar

ised

ag

greg

ated

on

a m

onth

ly b

asis

ont

o M

oH F

orm

726

F

orm

726

is

then

for

war

ded

upw

ards

to

the

dist

rict

Lev

el

(DA

SCO

rsquos O

ffice

) for

agg

rega

tion

of th

e D

istr

ict l

evel

dat

a on

to F

orm

727

Cop

shyie

s of

For

m 7

26 a

nd F

orm

727

are

forw

arde

d to

the

Nat

iona

l Offi

ce (N

ASC

OP)

w

ith a

noth

er c

opy

of F

orm

727

bei

ng s

ent t

o th

e Pr

ovin

cial

Offi

ce (P

ASC

O)

8

Dat

a di

ssem

inat

ion

Thi

s is

car

ried

out

at

all

leve

ls s

tart

ing

from

fac

ility

to

natio

nal l

evel

It i

s th

e re

spon

sibi

lity

of N

AC

C to

coo

rdin

ate

the

diss

emin

atio

n an

d us

e of

all

HIV

AID

S da

ta a

nd in

form

atio

n fo

r na

tiona

l res

pons

e J

APR

a

join

t pro

gram

me

of a

ll st

akeh

olde

rs in

HIV

AID

S re

ceiv

es a

nd u

ses

the

data

to

disc

uss

the

chal

leng

es a

chie

vem

ents

and

les

sons

lea

rnt

from

HIV

AID

S an

d gi

ves

feed

back

for n

atio

nal r

espo

nse

9

PMTC

T in

dica

tors

and

thei

r so

urce

s H

ealth

car

e fa

cilit

ies

colle

ct th

e fo

llow

ing

data

as

a m

inim

um t

o be

use

d in

the

mon

itori

ng o

f PM

TCT

prog

ram

s T

he

data

is

to b

e ag

greg

ated

on

a m

onth

ly b

asis

ont

o th

e M

inis

try

of H

ealth

In

tegr

ated

Mon

itori

ng a

nd E

valu

atio

n R

epor

t For

m M

oH 7

26 u

sing

dat

a fr

om

the

Min

istr

y of

Hea

lth

Ken

ya A

nten

atal

and

Mat

erni

ty R

egis

ters

(D

eliv

ery

Reg

iste

r) M

oH 4

05 a

nd M

oH 3

33 r

espe

ctiv

ely

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

2

1

86

102

O

PER

ATI

ON

AL

GU

IDEL

INES

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed in

the

mon

itorin

g an

d ev

alua

-tio

n of

PM

TCT

serv

ices

1

W

ithin

PM

TCT

prog

ram

s d

ata

is c

olle

cted

and

rep

orte

d at

the

fol

low

ing

leve

ls I

ndiv

idua

l fa

cilit

y d

istr

ict

prov

inci

al a

nd n

atio

nal

2

Indi

vidu

al l

evel

The

com

bine

d m

othe

r an

d ch

ild h

ealth

boo

klet

pro

vide

s de

shyta

iled

info

rmat

ion

on t

he w

oman

and

chi

ld i

nclu

ding

the

HIV

sta

tus

oth

er

HIV

car

e se

rvic

es d

rugs

del

iver

y in

form

atio

n im

mun

isat

ion

gro

wth

mon

itorshy

ing

and

othe

r par

amet

ers

3

Faci

lity

leve

l da

ta c

aptu

re t

ools

The

MoH

has

sta

ndar

dise

d re

gist

ers

for

reshy

cord

ing

data

at

faci

litie

s T

hese

inc

lude

the

Rev

ised

AN

C R

egis

ter

Rev

ised

M

ater

nity

Reg

iste

r an

d Po

st N

atal

Reg

iste

r an

d W

orkl

oad

MO

H 7

17 O

ther

re

gist

ers

incl

ude

Chi

ld H

ealth

and

Nut

ritio

n In

form

atio

n Sy

stem

and

Inshy

patie

nt M

orbi

dity

and

Mor

talit

y F

orm

711

and

the

Rep

rodu

ctiv

e H

ealth

Ser

shyvi

ces

mon

thly

rep

orts

are

use

d fo

r m

akin

g fa

cilit

y le

vel s

umm

arie

s on

PM

TCT

and

repr

oduc

tive

heal

th s

ervi

ces

3 F

acili

ty le

vel d

ata

capt

ure

tool

s T

he M

oH

has

stan

dard

ized

reg

iste

rs f

or r

ecor

ding

dat

a at

fac

ilitie

s T

hese

inc

lude

the

R

evis

ed A

NC

Reg

iste

r R

evis

ed M

ater

nity

Reg

iste

r an

d Po

st N

atal

Reg

iste

r an

d w

orkl

oad

MO

H 7

17 O

ther

reg

iste

rs in

clud

e C

hild

Hea

lth a

nd N

utri

tion

Info

rmat

ion

Syst

em a

nd I

n-pa

tient

mor

bidi

ty a

nd m

orta

lity

Fo

rm 7

26 a

nd

the

Rep

rodu

ctiv

e he

alth

ser

vice

s m

onth

ly r

epor

ts a

re u

sed

for

mak

ing

faci

lity

leve

l sum

mar

ies

on P

MTC

T an

d re

prod

uctiv

e he

alth

ser

vice

s

4

Dis

tric

t le

vel

data

For

m 7

27 i

s us

ed t

o su

mm

aris

e an

d re

port

dis

tric

t le

vel

data

Oth

er s

umm

ary

repo

rtin

g to

ols

are

also

use

d to

rep

ort

dist

rict

leve

l inshy

form

atio

n A

t th

e di

stri

ct le

vel

the

DAS

CO

rsquos of

fice

aggr

egat

es d

ata

from

sev

shyer

al h

ealth

faci

lity

spec

ific

Form

726

ont

o Fo

rm 7

27 th

at is

use

d to

sum

mar

ise

and

repo

rt d

istr

ict l

evel

dat

a

5

Prov

inci

al l

evel

dat

a A

t th

e pr

ovin

cial

lev

el t

he P

ASC

O r

ecei

ves

Form

727

da

ta f

rom

the

res

pect

ive

DA

SCO

rsquos of

fices

in

the

prov

ince

for

the

ir o

wn

data

us

e an

d re

cord

s A

cop

y of

the

sam

e is

sen

t to

the

Nat

iona

l Offi

ce (N

ASC

OP)

by

the

DA

SCO

rsquos of

fice

At

the

prov

inci

al le

vel

the

dist

rict

leve

l dat

a is

agg

reshy

gate

d to

giv

e th

e pr

ovin

cial

leve

l dat

a

6 N

atio

nal

leve

l da

ta

At

the

natio

nal

leve

l th

e M

ampE

Man

ager

rec

eive

s da

ta

from

the

PASC

Os

for

each

of t

he p

rovi

nces

Dat

a is

als

o re

ceiv

ed fr

om th

e R

eshyfe

rral

hos

pita

ls a

nd o

ther

fac

ilitie

s at

the

ref

erra

l ho

spita

l or

ter

tiary

lev

el

The

data

rec

eive

d at

the

nat

iona

l lev

el is

als

o co

pied

to

the

Hea

d of

NA

SCO

P an

d PM

TCT

prog

ram

me

man

ager

The

Mamp

E m

anag

er a

t NA

SCO

P ag

greg

ates

85

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

12

MA

GN

ITU

DE

OF

HIV

IN P

REG

NA

NC

YIN

KEN

YA

Ken

ya N

atio

nal

AID

SST

I C

ontr

ol P

rogr

amm

e (N

ASC

OP)

est

imat

es t

hat

ther

e w

ere

12

mill

ion

babi

es b

orn

in 2

006

in K

enya

and

that

as

man

y as

9

of p

regn

ant w

omen

inK

enya

wer

e liv

ing

with

HIV

AID

S10

At

leas

t 50

000

to

600

00 i

nfan

ts i

n K

enya

wer

e th

ough

t to

hav

e be

en i

nfec

ted

with

H

IV a

s a

resu

lt of

MTC

T th

at y

ear

With

an

estim

ated

pop

ulat

ion

of 3

72

mill

ion

in th

eye

ar 2

007

the

num

ber

of b

irth

s in

200

7 w

as 1

73

mill

ion

With

an

HIV

pre

vale

nce

of 6

7

the

num

ber

of H

IV -

expo

sed

babi

es is

114

101

and

at

leas

t 45

640

HIV

-pos

itive

bab

ies

are

born

ass

umin

g a

40

tran

smis

sion

(Tab

le 1

2)

Tabl

e 1

2 E

stim

ated

mag

nitu

de o

f MTC

T in

Ken

ya 2

007

Popu

latio

n (E

stim

ates

200

7)

372

mill

ion

Birt

hs p

er a

nnum

1

73 m

illio

n

HIV

pre

vale

nce

in m

othe

rs

67

Tota

l num

ber o

f birt

hs to

HIV

-infe

cted

mot

hers

exp

osed

14

110

1 to

MTC

T as

sum

ing

no m

ultip

le p

regn

ancy

Num

ber o

f HIV

pos

itive

infa

nts

per a

nnum

in K

enya

45

640

as

sum

ing

40

tran

smis

sion

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

22

13

RIS

KS

OF

T RA

NSM

ISSI

ON

OF

MTC

T A

T D

IFFE

REN

T

T

IME

P ER

IOD

S

In K

enya

an

estim

ated

40

000

to 5

000

0 in

fant

s ar

e in

fect

ed w

ith H

IV a

nnua

lly d

ue to

m

othe

r-to

-chi

ld t

rans

mis

sion

Th

is c

an o

ccur

in u

tero

dur

ing

labo

ur a

nd d

eliv

ery

and

thro

ugh

brea

stfe

edin

g D

urin

g pr

egna

ncy

abo

ut 5

to

8 pe

rcen

t of

HIV

-exp

osed

bab

ies

beco

me

infe

cted

thr

ough

tra

nsm

issi

on a

cros

s th

e pl

acen

ta L

abou

r an

d de

liver

y po

ses

the

grea

test

ris

k fo

r tr

ansm

issi

on w

ith 1

0 to

20

perc

ent

of e

xpos

ed i

nfan

ts b

ecom

ing

infe

cted

at t

his

time

Bre

astf

eedi

ng a

lso

expo

ses

infa

nts

to H

IV

Whe

n m

othe

rs b

reas

tfee

d fo

r 18

to

24m

onth

s an

othe

r 10

to 1

5 pe

rcen

t of i

nfan

ts b

ecom

e in

fect

ed T

hus

in n

on-b

reas

tfee

ding

po

pula

tions

with

out

antir

etro

vira

l tre

atm

ent

appr

oxim

atel

y 15

to

30 p

erce

nt in

fant

s w

ill b

ecom

e in

fect

ed

with

pro

long

ed b

reas

tfee

ding

25

to

45 p

erce

nt i

nfan

ts w

ill

beco

me

infe

cted

Tabl

e 1

3 T

rans

mis

sion

pat

tern

s in

bre

astfe

edin

g an

d no

n br

east

feed

ing

popu

latio

ns

Tran

smis

sion

rate

in

Tim

ing

No

Bre

astfe

edin

g B

reas

tfeed

ing

Bre

astfe

edin

g th

roug

h

thro

ugh

6

mon

ths

18 to

24

mon

ths

Dur

ing

preg

nanc

y 05

to 1

0 05

to 1

0 05

to 1

0

Dur

ing

labo

ur

10 to

20

10 to

20

10 to

20

Thro

ugh

brea

stfe

edin

g 10

to 2

0 05

to 1

0 05

to 1

0

Ear

ly (f

irst 2

mon

ths)

10

to 2

0 05

to 1

0 05

to 1

0

Late

(afte

r 2 m

onth

s)

10 to

20

01 to

05

05 to

10

Ove

rall

15 to

30

25 to

35

30 to

45

Sou

rce

De

Coc

k K

M (2

002)

Form

MoH

711

has

bee

n re

com

men

ded

to r

epla

ce F

orm

MoH

726

HIV

Mamp

E d

ata

flow

pip

elin

e fr

om t

he i

ndiv

idua

l he

alth

fac

ilitie

s t

o th

e di

stri

ct a

ndpr

ovin

cial

leve

ls u

p to

the

cent

ral o

r na

tiona

l lev

els

at N

ASC

OP

and

NA

CC

is s

umm

ashyri

sed

in F

igur

e 1

01

Figu

re 1

01

HIV

Mon

itorin

g an

d Ev

alua

tion

data

flow

pip

elin

e in

Ken

ya

HM

IS

NA

SC

OP

N

ACC

H

ead

Nat

iona

l Dat

a B

ank

amp

Res

ourc

e C

entre

M

E M

anag

er

The

Dire

ctor

P

rogr

amm

e M

anag

er

ME

Man

ager

Ref

erra

l Hos

pita

ls

CE

Os

Spe

cial

ists

The

Prov

ince

P

MO

P

AS

CO

P

AR

TO

PH

RIO

P

CO

The

Dis

trict

D

MO

D

AS

CO

Dat

a en

try

cler

k D

AR

TO

DH

RIO

Hea

lth F

acilit

y P

ublic

Sec

tor

FBO

etc

23

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

84

Cha

pter

10

Mon

itorin

g an

d Ev

alua

tion

of P

MTC

T Se

rvic

es

101

IN

TRO

DU

CTI

ON

PMTC

T pr

ogra

m m

onito

ring

and

eva

luat

ion

activ

ities

pro

vide

the

oppo

rtun

ity to

mea

sshyur

e an

d ap

prai

se p

erfo

rman

ce w

ithin

def

ined

par

amet

ers

that

ens

ure

acco

mpl

ishm

ent

of g

oals

and

obj

ectiv

es

Ken

ya is

com

mitt

ed to

the

ldquoThr

ee-o

nesrdquo

pri

ncip

les

whi

ch a

re

bull O

ne a

gree

d A

IDS

Act

ion

Fra

mew

ork

that

pro

vide

s th

e ba

sis

for

coor

dina

ting

the

wor

k pl

an o

f al

l par

tner

s

bull O

ne N

atio

nal A

IDS

Coo

rdin

atin

g A

utho

rity

with

a b

road

-bas

ed

mul

tisec

tora

l man

date

bull O

ne a

gree

d co

untr

y-le

vel M

onito

ring

and

Eva

luat

ion

(M

ampE

) sy

stem

In l

ine

with

thi

s t

he c

ount

ry h

as d

evel

oped

the

Nat

iona

l H

IVA

IDS

Mon

itori

ng a

ndE

valu

atio

n Fr

amew

ork

that

pro

vide

s st

akeh

olde

rs w

ith a

too

l fo

r w

ell

coor

dina

ted

in

terl

inke

d an

d fu

nctio

nal H

IVA

IDS

Mamp

E s

yste

m t

hat

allo

ws

for

effic

ient

mon

itori

ngof

int

erve

ntio

ns i

n ac

hiev

ing

the

natio

nal

prog

ram

mat

ic g

oals

usi

ng d

efin

ed t

arge

ts

This

pro

vide

s th

e fr

amew

ork

for M

ampE

act

iviti

es w

ithin

PM

TCT

prog

ram

s

Nat

iona

l PM

TCT

data

is

repo

rted

usi

ng M

oH I

nteg

rate

d M

onito

ring

and

Eva

luat

ion

Rep

ortin

g Fo

rms

For

m M

oH 7

11 o

r Fo

rm M

oH 7

27

Indi

vidu

al P

MTC

T da

ta is

col

shyle

cted

at

the

heal

th f

acili

ties

offe

ring

PM

TCT

serv

ices

usi

ng s

tand

ard

MoH

reg

iste

rs(A

NC

Mat

erni

ty a

nd P

ostn

atal

Reg

iste

rs)

On

mon

thly

bas

is t

he h

ealth

faci

litie

s w

ill a

ggre

gate

the

dat

a fr

om t

he r

egis

ters

on

to

Form

MoH

711

or

MO

H 7

26 w

hich

is th

en fo

rwar

ded

upw

ards

to th

e D

ASC

Orsquos

offic

e A

copy

is

left

at

the

heal

th f

acili

ty f

or t

heir

ow

n da

ta u

se

At

the

dist

rict

lev

el

the

DA

SCO

rsquos of

fice

aggr

egat

es d

ata

from

sev

eral

hea

lth f

acili

ty s

peci

fic F

orm

726

ont

o Fo

rm M

oH 7

27 (o

r Fo

rm 7

11) t

hat

is u

sed

to s

umm

aris

e an

d re

port

dis

tric

t le

vel d

ata

B

oth

Form

726

and

For

m M

oH 7

27 a

re th

en s

ent t

o N

ASC

OP

A c

opy

of th

e Fo

rm 7

27

or F

orm

711

is s

ent t

o th

e PA

SCO

and

ano

ther

to th

e he

alth

faci

litie

s in

the

dist

rict

for

thei

r ow

n da

ta u

se

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

14

RIS

K F

AC

TOR

SFO

R M

TCT

OF

HIV

M

any

fact

ors

are

know

n or

sus

pect

ed t

o in

crea

se t

he r

isk

of a

n H

IV in

fect

ed m

othe

r tr

ansm

ittin

g th

e vi

rus

to h

er i

nfan

t Th

ese

fact

ors

incl

ude

the

HIV

vir

al l

oad

in t

he

mot

her

as

wel

l as

othe

r m

ater

nal

obst

etri

cal

vira

l and

infa

nt fa

ctor

s (T

able

14

)

The

mos

t sig

nific

ant r

isk

fact

or a

ppea

rs to

be

the

HIV

vir

al lo

ad in

the

mot

her

thou

gh

the

othe

r fa

ctor

s m

ay a

lso

cont

ribu

te t

o in

crea

sing

an

infa

ntrsquos

expo

sure

or

susc

eptib

ilshyity

to

acqu

irin

g H

IV S

ome

fact

ors

may

cau

se a

bre

akdo

wn

in t

he p

rote

ctio

n of

fere

d to

the

foet

us b

y th

e pl

acen

ta w

hich

in n

orm

al c

ircu

mst

ance

s w

ould

not

allo

w H

IV to

cro

ssth

e pl

acen

ta fr

om m

othe

r to

foet

us

Tran

smis

sion

dur

ing

labo

ur a

nd d

eliv

ery

occu

rs w

hen

the

infa

nt s

ucks

im

bibe

s or

asshy

pira

tes

mat

erna

l bl

ood

or c

ervi

cal

secr

etio

ns t

hat

cont

ain

HIV

or

whe

n it

has

othe

r m

ucou

s m

embr

ane

expo

sure

Tab

le 1

4

Ris

k fa

ctor

s fo

r M

TCT

of H

IV

Stro

ng e

vide

nce

Lim

ited

evid

ence

VIR

AL

MA

TER

NA

L

OB

STE

TRIC

AL

FETA

LIN

FAN

T

BR

EA

ST-

FEE

DIN

G

Hig

h vi

ral l

oad

Imm

une

defic

ienc

y (lo

w

CD

4 co

unt)

HIV

infe

ctio

n ac

quire

d du

ring

preg

nanc

y o

r br

east

feed

ing

perio

d

Vagi

nal d

eliv

ery

(com

pare

d to

ele

ctiv

e ca

esar

ean

sect

ion)

ru

ptur

e of

the

mem

bran

es

for m

ore

than

4 h

ours

Prem

atur

ity

Dur

atio

n of

bre

astfe

edin

g

mix

ed fe

edin

g b

reas

t di

seas

e (m

astit

isc

rack

ed

nipp

les)

Vira

l res

ista

nce

(theo

retic

al p

ossi

bilit

y)

Vira

l gen

otyp

e an

d ph

enot

ype

Vita

min

A d

efic

ienc

y a

naem

ia s

exua

lly

trans

mitt

ed d

isea

ses

ch

orio

amni

oniti

s fr

eque

nt u

npro

tect

ed

sexu

al in

terc

ours

e m

ultip

le s

exua

l pa

rtner

s s

mok

ing

inje

ctin

g dr

ug a

buse

Inva

sive

or t

raum

atic

pro

cedu

res

in

stru

men

tal d

eliv

erie

s a

mni

ocen

tesi

s

epis

ioto

my

ext

erna

l cep

halic

ver

sion

(E

CV

) et

c i

ntra

partu

m h

aem

orrh

age

Lesi

ons

of s

kin

and

or m

ucou

s m

embr

anes

Ora

l thr

ush

(bab

y)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

3

24

15

BEN

EFIT

SO

F P R

EVEN

TIN

G M

OTH

ER-T

O-C

HIL

D

T

RA

NSM

ISSI

ON

OF

HIV

A

IDS

rela

ted

deat

hs a

re r

ever

sing

gai

ns m

ade

in c

hild

hea

lth a

nd s

urvi

val i

n K

enya

C

arin

g fo

r H

IV-in

fect

ed c

hild

ren

has

maj

or e

cono

mic

and

soc

ial

impa

cts

on f

amili

es

and

heal

th s

yste

ms

Thu

s at

the

nat

iona

l lev

el p

reve

ntin

g M

TCT

has

the

pote

ntia

l to

incr

ease

the

unde

rsta

ndin

g an

d ac

cept

ance

of t

he H

IVA

IDS

epid

emic

and

thos

e liv

ing

with

HIV

AID

S C

ouns

ellin

g t

estin

g an

d co

mm

unity

sen

sitis

atio

n ca

n co

ntri

bute

to

redu

cing

stig

ma

Red

uctio

n of

MTC

T of

HIV

bull

Dec

reas

es n

umbe

rs o

f H

IV in

fect

ed c

hild

ren

bull

Incr

ease

s ch

ild h

ealth

and

sur

viva

l

bull

Dec

reas

es t

he lo

ad o

n th

e he

alth

sys

tem

bull

Giv

es a

n op

port

unity

to im

prov

e an

d ex

pand

hea

lth s

ervi

ces

as w

ell a

s to

str

engt

hen

the

exis

ting

heal

th in

fras

truc

ture

16

BEN

EFIT

SO

F H

IV C

OU

NSE

LLIN

GA

ND T

ESTI

NG

(CT)

(a) I

t pro

mot

es b

ehav

iour

cha

nge

by

bull R

educ

ing

high

ris

k be

havi

our

for

HIV

bull Id

entif

ying

HIV

dis

cord

ant

coup

les

bull In

crea

sing

the

use

of

dual

met

hods

of f

amily

pla

nnin

g an

d S

TI

prev

entio

n

bull Im

prov

ing

ante

nata

l car

e

bull G

uidi

ng in

fant

fee

ding

(b) I

t ena

bles

pre

vent

ive

ther

apy

for

bull

Mal

aria

bull O

ppor

tuni

stic

infe

ctio

ns (

eg

Pne

umoc

ystis

jiro

veci

i pn

eum

onia

)

bull T

B

25

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

82

Foo

tnot

es

9

Use

oth

er o

ptions

for

child

ren o

ver

9 k

ilogra

ms

10

Use

reg

ula

r or

double

-str

ength

tab

lets

for

child

ren o

ver

16 k

ilogra

ms

NO

T A

PP

LIC

AB

LE

bullPsp

sm

ear

The

fram

ewor

k be

low

illu

stra

tes

poin

ts o

f int

egra

tion

of c

ompr

ehen

sive

HIV

ca

re p

acka

ge in

to e

xist

ing

child

hea

lth s

ervi

ces

Fram

ewor

k for

integ

ratio

n F

rom

Ped

iatr

ic H

IV P

reve

nti

on

to C

are

A

Co

nce

ptu

al F

ram

ewo

rk N

ewb

orn

In

fan

t W

om

an

H

IV e

duca

tion

Pre

gn

an

cy

prev

entio

n C

T

bull F

ocus

ed A

NC

incl

udin

g

AR

V p

roph

ylax

is s

tagi

ng

STI

syph

ilis

CT

Z p

roph

ylax

isA

RT

M

alar

ia tr

eatm

ent amp

pre

vent

ion

CD

4 w

here

ava

ilabl

e in

clud

ing

IPT

amp I

TNs

Infa

nt f

eedi

ng c

ouns

elin

g (I

FC)

Lab

ou

r an

d D

eliv

ery

U

nive

rsal

pre

caut

ions

CT

for

unt

este

d m

othe

rs in

clud

ing

bull D

eliv

ery

care

bull E

OC

-Em

erge

ncy

obst

etri

c ca

re

part

ner

bull R

efer

ral s

yste

m

AR

V p

roph

ylax

is

(mot

her

and

infa

nt)

AR

T C

TZ

pro

phyl

axis

Exc

lusi

ve b

reas

t fe

edin

g or

rep

lace

men

t fe

edin

g

Post

Na

tal

Ca

re

Infa

nt fe

edin

g co

unse

ling

bull B

reas

t hea

lth

Dia

gnos

is (

antib

ody)

if

bull Se

xual

hea

lth

expo

sure

unk

now

n bull

Fam

ily

plan

ning

D

NA

PC

R if

exp

osed

CT

Z p

roph

ylax

is I

FC-

infa

nt f

eedi

ng c

ouns

elin

g

CT

for

unt

este

d m

othe

rs

CT

for

par

tner

D

BS

resu

lt I

FC

IFC

Wea

ning

Bf

eedi

ng

cess

atio

n s

uppo

rt

bullBre

ast e

xam

D

iagn

osis

(an

tibod

y

bullPap

sm

ear

test

) C

T f

or n

egat

ive

wom

en a

nd p

artn

ers

Dia

gnos

is (

antib

ody

test

)

New

born

Ca

re

bull B

CG

bull P

olio

0

bull Is

sue

child

hea

th c

ard

bullEnt

er b

irth

wei

ght

HIV

an

d A

RV

Exp

osur

e st

atus

on

chi

ld h

ealth

car

d Tw

o w

eeks

Infa

nt fe

edin

g co

unse

ling

Six

wee

ks

Imm

uniz

atio

ngr

owth

mon

itori

ng

Ten

wee

ks

im

mun

izat

ion

GM

Fou

rtee

n w

eeks

Im

mun

izat

ion

grow

th m

onito

ring

Si

x m

onth

s

Com

plem

enta

ry fe

eds

Vita

min

A S

uppl

emen

tatio

n

9 m

onth

s

imm

uniz

atio

nG

M

12 amp

18

mon

ths

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

17

(c) I

t pro

mot

es a

cces

s to

ear

ly m

edic

al c

are

bull

Obs

tetr

ical

car

e

bull T

B th

erap

y

bull M

alar

ia t

reat

men

t

bull S

TI t

reat

men

t

bull A

RV

the

rapy

for

mot

her

and

fam

ily

(d) I

t hel

ps to

pla

n fo

r the

futu

re

bull In

fant

fee

ding

sup

port

sys

tem

s

bull F

amily

pla

nnin

g

bull P

erso

nal a

nd f

inan

cial

dec

isio

ns

(e) I

t ena

bles

pre

vent

ive

ther

apy

of m

alar

ia a

nd

othe

r opp

ortu

nist

ic in

fect

ions

suc

h a

PCP

(f) It

giv

es ti

me

to p

lan

for t

he fu

ture

eg

inf

ant

feed

ing

supp

ort s

yste

ms

TH

E F O

UR-P

RO

NG

ED A

PPR

OA

CH

TO P

MTC

T Th

e In

ter

Age

ncy

Task

Tea

m o

n Pr

even

tion

of H

IV T

rans

mis

sion

in p

regn

ant

wom

en

mot

hers

and

the

ir c

hild

ren

(IA

TT)

has

prop

osed

a f

our-

pron

ged

appr

oach

for

the

pre

shyve

ntio

n of

HIV

tra

nsm

issi

on t

hat

targ

ets

non-

preg

nant

and

pre

gnan

t w

omen

mot

hers

and

thei

r ch

ildre

n

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

1

26

The

four

pro

ngs

are

1 P

rimar

y pr

even

tion

of H

IV in

fect

ion

in w

omen

2 P

reve

ntio

n of

uni

nten

ded

preg

nanc

y am

ong

HIV

-inf

ecte

d w

omen

3 I

nter

vent

ions

to

redu

ce t

rans

mis

sion

fro

m H

IV-i

nfec

ted

preg

nant

and

la

ctat

ing

wom

en t

o th

eir

child

ren

4 C

are

and

supp

ort

of w

omen

ch

ildre

n an

d fa

mili

es in

fect

ed a

nd

affe

cted

by

HIV

and

AID

S (

The

PM

TC

T-p

lus)

Ove

rall

the

cov

erag

e of

PM

TCT

prog

ram

mes

and

the

upt

ake

of s

ervi

ces

prov

ided

thro

ugh

thes

e pr

ogra

mm

es

incl

udin

g H

IV

test

ing

and

coun

selli

ng

and

AR

V

prop

hyla

xis

are

still

ver

y lo

w I

n 20

06 w

orld

wid

e le

ss t

han

10

of

preg

nant

wom

ente

stin

g H

IV-p

ositi

ve r

ecei

ved

AR

V d

rugs

for

PMTC

T11

In K

enya

acc

ordi

ng to

the

2007

Ken

ya A

IDS

Indi

cato

r Su

rvey

(KA

IS) 7

the

re h

as b

een

a sm

all i

ncre

ase

in H

IV te

stin

g am

ong

wom

en a

nd m

en c

ompa

red

to th

e 20

03 K

DH

S

KA

IS s

how

s th

at t

houg

h a

vast

maj

ority

(83

)

of H

IV-in

fect

ed w

omen

and

men

in

Ken

ya d

o no

t kn

ow t

heir

HIV

sta

tus

the

re h

as b

een

a cl

ear

and

dram

atic

incr

ease

inco

vera

ge o

f HIV

-tes

ting

amon

g A

NC

clin

ic a

tten

dees

PMTC

T se

rvic

es a

re t

here

fore

im

port

ant

entr

y po

ints

for

HIV

pre

vent

ion

and

trea

tshym

ent

Ove

rall

AR

V c

over

age

for

HIV

infe

cted

peo

ple

who

nee

d tr

eatm

ent

in K

enya

ison

ly 3

5

bull 9

0

of K

enya

n w

omen

who

del

iver

ed in

the

last

4 y

ears

att

end

AN

C

bull 5

7 o

f th

ose

atte

ndin

g A

NC

tes

ted

for

HIV

bull A

mon

g H

IV in

fect

ed w

omen

with

rec

ent

birt

hs

47

wer

e te

sted

in

AN

C

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

(8)

HIV

dis

ease

sta

ging

in H

IV-in

fect

ed c

hild

ren

Dis

ease

sta

ging

with

or

with

out

labo

rato

ry s

uppo

rt f

ollo

ws

HIV

dia

gshyno

sis

Sta

ging

HIV

dis

ease

pro

vide

s a

guid

e to

the

prog

nosi

s an

d in

tershy

vent

ions

nee

ded

at th

e di

ffere

nt s

tage

s (R

efer

to C

hapt

er 5

and

8)

(9)

AR

V th

erap

y

Chi

ldre

n w

ho a

re e

ligib

le fo

r A

RT

shou

ld b

e lin

ked

with

the

AR

T pr

oshygr

am a

nd p

rovi

ded

with

trea

tmen

t acc

ordi

ng to

Nat

iona

l Gui

delin

es a

sso

on a

s an

HIV

dia

gnos

is i

s m

ade

Ear

ly t

reat

men

t si

gnifi

cant

ly r

eshydu

ces

mor

talit

y in

HIV

infe

cted

chi

ldre

n

(10)

C

omm

unic

atio

n

Com

mun

icat

ing

with

car

e-pr

ovid

ers

and

prov

idin

g ps

ycho

soci

al s

upshy

port

for

the

child

mot

her

care

give

r an

d fa

mily

are

a c

ruci

al c

ompo

nent

of

car

e

Pare

nts

care

give

rs a

ndo

r th

e ch

ild n

eed

to p

artic

ipat

e in

mak

ing

deci

shysi

ons

and

plan

ning

app

ropr

iate

car

e fo

r th

e ch

ild i

nclu

ding

dec

isio

nsab

out t

hera

py a

nd w

here

the

child

sho

uld

rece

ive

care

In

this

res

pect

he

alth

wor

kers

mus

t en

sure

tha

t th

e fa

mily

con

side

rs t

he s

ocia

l nee

ds

of H

IV in

fect

ed a

nd a

ffect

ed c

hild

ren

Hea

lth c

are

wor

kers

sho

uld

ensu

re th

at th

ey p

rovi

de a

dequ

ate

time

for

care

give

rs to

ask

que

stio

ns s

o th

at th

ey c

an fu

lly u

nder

stan

d th

e im

plishy

catio

ns o

f HIV

and

HIV

tes

ting

for

them

selv

es a

nd fo

r th

eir

child

ren

H

ealth

car

e w

orke

rs s

houl

d co

unse

l car

egiv

ers

on d

iscl

osur

e in

clud

ing

disc

losu

re to

the

child

(11)

R

efer

rals

Ref

erra

ls a

re a

n im

port

ant p

art o

f man

agin

g an

HIV

exp

osed

or

infe

cted

chi

ld

Thes

e in

clud

e re

ferr

als

to

bull H

ighe

r le

vels

of s

peci

alis

ed c

are

for

furt

her

inve

stig

atio

ns a

nd

trea

tmen

t

bull S

ocia

l sup

port

pro

gram

mes

bull C

omm

unity

-bas

ed c

are

prog

ram

mes

bull P

ITC

site

s fo

r pa

rent

s an

d si

blin

gs

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

2

7

80

Tabl

e 9

2 W

HO

Rec

omm

enda

tions

for

Follo

w-u

p of

an

HIV

-Exp

osed

Chi

ld

bull A

t birt

h (f

or in

fant

s de

liver

ed a

t ho

me)

bull A

t age

1 t

o 2

wee

ks (

mai

nly

for

infa

nt f

eedi

ng c

ouns

elin

g)

bull A

t ag

e 6

10

and

14

wee

ks (

for

imm

uniz

atio

n an

d in

fant

fee

ding

co

unse

ling)

bull A

fter

age

14

wee

ks

mon

thly

thr

ough

age

12

mon

ths

bull A

fter

age

12 m

onth

s e

very

3 m

onth

s th

roug

h 24

mon

ths

bull A

t 18

mon

ths

do

conf

irm

ator

y H

IV la

bora

tory

test

(if

ther

e ar

e no

re

sour

ces

for

an e

arlie

r an

tigen

-bas

ed t

est)

bull A

fter

2 ye

ars

a m

inim

um o

f ye

arly

vis

its

For t

he H

IV-in

fect

ed f

ollo

w th

ese

guid

elin

es

From

M

onito

r

6 w

eeks

ndash12

mon

ths

Mon

thly

12 ndash

24 m

onth

s Ev

ery

3 m

onth

s

24 m

onth

s an

d on

war

ds

Yea

rly i

f not

sym

ptom

atic

If sy

mpt

omat

ic f

ollo

w u

p as

nee

ded

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

18

OV

ERV

IEW

OF

THE

NEW

PM

TCT

GU

IDEL

INES

Ken

yarsquos

Min

istr

y of

Hea

lth (

MO

H)

thro

ugh

NA

SCO

P h

as t

aken

sev

eral

act

ions

to

expa

nd a

nd s

tren

gthe

n PM

TCT

inte

rven

tions

in

the

coun

try

In

2000

a

Nat

iona

lTe

chni

cal

Wor

king

Gro

up (

TWG

) on

PM

TCT

was

for

med

Th

e TW

G

co-c

hair

ed b

yN

ASC

OP

and

the

Div

isio

n of

Rep

rodu

ctiv

e H

ealth

co

ordi

nate

s im

plem

enta

tion

and

prov

ides

tec

hnic

al s

uppo

rt t

o th

e N

atio

nal

PMTC

T Pr

ogra

m

The

TWG

ser

ves

as a

foru

m t

o up

date

sta

keho

lder

s an

d di

scus

s ch

alle

nges

and

upc

omin

g ac

tiviti

es

The

TWG

is

also

res

pons

ible

for

upd

atin

g na

tiona

l gu

idel

ines

for

PM

TCT

The

nat

iona

l PM

TCT

prog

ram

was

offi

cial

ly l

aunc

hed

in 2

002

NA

SCO

P al

so e

stab

lishe

d se

vera

lpi

lot P

MTC

T si

tes

thro

ugho

ut th

e co

untr

y an

d pr

epar

ed n

atio

nal P

MTC

T gu

idel

ines

The

goal

of t

he n

atio

nal P

MTC

T pr

ogra

m is

in li

ne w

ith th

e go

al s

et o

ut a

t the

Uni

ted

Nat

ions

Gen

eral

Ass

embl

y Sp

ecia

l Ses

sion

on

HIV

AID

S (U

NG

ASS

) in

2001

to

redu

ceth

e pr

opor

tion

of in

fant

s in

fect

ed w

ith H

IV b

y 20

b

y th

e ye

ar 2

005

and

50

by

2010

In

Ken

ya t

he n

atio

nal P

MTC

T pr

ogra

m p

lann

ed t

o ex

tend

its

serv

ices

to

at le

ast

80

of

all

heal

th f

acili

ties

by 2

0071

2 A

ccor

ding

to

the

2003

PM

TCT

serv

ice

stat

istic

sap

prox

imat

ely

9 o

f al

l pr

egna

nt w

omen

rec

eive

d PM

TCT

serv

ices

in

that

yea

rC

urre

ntly

mor

e th

an 5

0 o

f al

l pr

egna

nt w

omen

in

Ken

ya r

ecei

ve P

MTC

T se

rvic

es

Thes

e gu

idel

ines

are

bas

ed o

n a

publ

ic h

ealth

app

roac

h to

car

e t

akin

g in

to c

onsi

dera

shytio

n is

sues

of

feas

ibili

ty a

nd a

ccep

tabi

lity

in

addi

tion

to e

ffica

cy a

nd c

ost-

bene

fit i

ndi

ffere

nt s

ettin

gs

The

guid

elin

es a

re e

xpec

ted

to i

mpr

ove

the

upta

ke

qual

ity a

nd

effe

ctiv

enes

s of

PM

TCT

serv

ices

in th

e co

untr

y

19

OB

JEC

TIV

ESA

ND O

RG

AN

ISA

TIO

NO

FTH

E G

UID

ELIN

ES

The

PMTC

T gu

idel

ines

are

par

t of

the

impl

emen

tatio

n in

stru

men

ts t

owar

ds u

nive

rsal

ac

cess

to

PMTC

T se

rvic

es a

nd a

res

pons

e to

the

cal

l to

actio

n to

war

ds H

IV-fr

ee a

ndA

IDS-

free

gen

erat

ion

Tog

ethe

r w

ith tw

o ot

her

guid

elin

es (A

RV

Ther

apy

in A

dults

and

Ad

oles

cent

s an

d AR

V Th

erap

y in

Inf

ants

and

You

ng C

hild

ren)

th

ey f

orm

a t

rilo

gy

aim

ed a

t co

ntex

tual

isin

g an

d m

ains

trea

min

g th

e W

HO

tri

logy

of

guid

elin

es o

n H

IVA

IDS

prev

entio

n an

d tr

eatm

ent

The

cont

ext

reso

urce

s an

d de

man

ds o

f PM

TCT

prog

ram

mes

diff

er g

reat

ly a

cros

s co

unshy

trie

s an

d ev

en a

cros

s pr

ogra

mm

es w

ithin

the

sam

e co

untr

y C

onsi

deri

ng t

his

vari

abilshy

ity t

hese

gui

delin

es in

clud

e th

e cu

rren

t con

sens

us o

n be

st p

ract

ices

as

wel

l as

alte

rnashy

tives

whi

ch m

ight

be

mor

e ap

prop

riat

e in

par

ticul

ar s

ettin

gs E

xper

ts a

gree

tha

t th

e ldquos

tate

of

the

artrdquo

in

PMTC

T is

cha

ngin

g ra

pidl

y an

d th

at r

ecom

men

datio

ns w

ill c

ershy

tain

ly a

lter

with

adv

ance

s in

med

ical

sci

ence

and

as

mor

e pr

ogra

mm

e ex

peri

ence

is

docu

men

ted

and

diss

emin

ated

The

are

as o

f A

RV

pro

phyl

axis

and

inf

ant

feed

ing

are

part

icul

arly

sub

ject

to r

apid

cha

nge

In 2

005

the

WH

O is

sued

pro

pose

d re

visi

ons

to it

s re

com

men

datio

ns o

n th

e us

e of

ant

ishyre

trov

iral

dru

gs f

or P

MTC

T T

he r

ecom

men

datio

ns w

ere

the

prod

uct

of e

xper

ts w

ho

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

9

28

conv

ened

to

disc

uss

impo

rtan

t ne

w i

nfor

mat

ion

conc

erni

ng t

he d

evel

opm

ent

of r

esis

shyta

nce

in w

omen

and

chi

ldre

n us

ing

sing

le d

ose

nevi

rapi

ne (S

dNV

P) fo

r PM

TCT

as w

ell

as n

ew c

linic

al fi

ndin

gs o

n st

rate

gies

that

mig

ht r

educ

e th

e de

velo

pmen

t of r

esis

tanc

e

Bas

ed o

n th

e ne

w W

HO

gui

delin

es K

enya

rsquos TW

G h

as d

evel

oped

sim

ple

pra

ctic

al a

nd

evid

ence

-bas

ed r

ecom

men

datio

ns o

n PM

TCT

that

wou

ld w

ork

in a

var

iety

of r

esou

rce-

limite

d en

viro

nmen

ts a

nd c

linic

al s

ituat

ions

that

con

fron

t hea

lthca

re w

orke

rs n

ot o

nly

in K

enya

but

als

o in

oth

er d

evel

opin

g co

untr

ies

110

U

SIN

GTH

E G

UID

ELIN

ES

Thes

e gu

idel

ines

are

inte

nded

prim

arily

for u

se b

y PM

TCT

prov

ider

s Th

ese

inclu

de n

urse

sm

idw

ives

clin

ical o

ffice

rs d

octo

rs c

ouns

ello

rs n

utrit

ioni

sts

and

othe

r he

alth

care

pro

fesshy

sion

als

They

will

als

o be

use

ful a

s a re

fere

nce

for p

rogr

amm

e m

anag

ers a

t fac

ility

dis

trict

pr

ovin

cial

and

nat

iona

l lev

els

thro

ugho

ut th

e he

alth

sec

tor

The

guid

elin

es a

re d

ivid

ed in

tote

n ch

apte

rs a

s out

lined

in T

able

15

The

spec

ific

obje

ctiv

es o

f the

new

PM

TCT

guid

elin

es a

re to

bull O

utlin

e th

e po

licy

issu

es in

pro

vidi

ng P

MT

CT

serv

ices

bull R

ecom

men

d op

erat

iona

l gui

delin

es to

be

follo

wed

by

heal

th c

are

prov

ider

s of

PM

TC

T se

rvic

es

bull E

nabl

e pr

ovid

ers

of P

MT

CT

to s

elec

t an

d pr

escr

ibe

AR

Vs

for

prop

hyla

xis

agai

nst

MT

CT

and

for

trea

tmen

t of

pre

gnan

t w

omen

in

fant

s an

d yo

ung

child

ren

bull S

tand

ardi

se t

he c

are

and

coun

selli

ng g

iven

by

PM

TC

T s

ervi

ce

prov

ider

s re

gard

ing

risk

of

MT

CT

and

on

PM

TC

T

bull I

mpr

ove

PM

TC

T se

rvic

es u

sing

eas

y-to

-use

job

aids

and

a

stan

dard

ised

Mamp

E s

yste

m

Prev

entin

g TB

Fo

r chi

ldre

n ex

pose

d to

sm

ear p

ositi

ve tu

berc

ulos

is

bull E

xclu

de a

ctiv

e T

B th

roug

h ca

refu

l his

tory

ph

ysic

al e

xam

and

in

vest

igat

ions

bull

If

ther

e is

no

evid

ence

of

activ

e T

B

star

t on

IN

H f

or p

roph

ylax

is f

or 6

m

onth

s (I

PT

) bull

If

TB

is p

rese

nt

star

t on

TB

tre

atm

ent

as p

er N

atio

nal T

B g

uide

lines

If

a ch

ild is

bor

n to

a m

othe

r with

act

ive

TB

bull S

tart

on

INH

pro

phyl

axis

(IP

T)

and

give

for

3 m

onth

s bull

Afte

r 3

mon

ths

do a

man

toux

bull

If

man

toux

is n

egat

ive

sto

p IN

H a

nd g

ive

BC

G

bull I

f man

toux

is p

ositi

ve a

t 3

mon

ths

con

tinue

for

a f

urth

er 3

mon

ths

bull A

t the

end

of

prop

hyla

xis

re-v

alua

te f

or a

ctiv

e T

B

|

If no

evi

denc

e of

act

ive

TB d

o no

t tre

at fo

r TB

|

If th

ere

is e

vide

nce

of a

ctiv

e TB

tre

at fo

r TB

as

per N

atio

nal

TB g

uide

lines

(6)

Trea

tmen

t of a

cute

infe

ctio

ns a

nd o

ther

HIV

-rel

ated

con

ditio

ns

HIV

-exp

osed

chi

ldre

n ar

e su

scep

tible

to c

omm

on in

fect

ions

as

wel

l as

OIs

for

the

HIV

infe

cted

and

HIV

may

alte

r th

e in

cide

nce

pre

senshy

tatio

n an

d re

spon

se t

o co

nven

tiona

l th

erap

y I

n so

me

case

s m

ore

aggr

essi

ve a

nd lo

nger

tre

atm

ent

cour

ses

may

be

nece

ssar

y a

s tr

eatshy

men

t fai

lure

s ar

e m

ore

freq

uent

(7)

Reg

ular

follo

w-u

p ca

re amp

refe

rral

s

Reg

ular

follo

w-u

p is

the

back

bone

to c

arin

g fo

r th

e H

IV e

xpos

ed c

hilshy

dren

and

ens

ures

opt

imal

hea

lthca

re a

nd p

sych

osoc

ial s

uppo

rt to

the

fam

ily W

HO

has

mad

e re

com

men

datio

ns o

n fr

eque

ncy

of fo

llow

-up

as s

how

n in

Tab

le 9

2 T

his

is t

he m

inim

um a

nd m

ore

freq

uent

con

shyta

ct w

ith t

he h

ealth

car

e sy

stem

may

be

indi

cate

d fo

r H

IV in

fect

ed

child

ren

and

espe

cial

ly if

they

are

on

anti-

retr

ovir

al tr

eatm

ent

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

2

9

78

Pro

phyl

axis

aga

inst

Pne

umoc

ysti

s ji

rove

cii

Pne

umon

ia (

PC

P)

in c

hild

ren

whe

re C

otri

mox

azol

e is

con

trai

ndic

ated

Ta

ble

15

The

Fou

r-Pr

onge

d A

ppro

ach

App

lied

to th

e PM

TCT

Gui

delin

e

Alte

rnat

ive

drug

s to

use

if C

TX is

con

train

dica

ted

are

give

n be

low

A s

econ

d ch

oice

wou

ld b

e ei

ther

dap

sone

or

atov

aqui

ne

Dap

sone

bull C

hild

ren

gt 1

mon

th

2 m

gkg

24

hour

s or

ally

onc

e da

ily

bull I

f bot

h C

TX

and

Dap

sone

are

con

trai

ndic

ated

(e

g

in c

hilshy

dren

with

G6P

D d

efic

ienc

y w

ho g

et h

aem

olys

is w

ith C

TX

and

D

apso

ne)

the

n us

e ei

ther

Ato

vaqu

one

bull

30m

gkg

day

for

age

1-3

mon

ths

bull H

ighe

r do

se 4

5mg

kgd

ay f

or a

ge 4

-24

mon

ths

OR

Aer

osol

ized

Pen

tam

idin

e

bull 3

00 m

g in

6 m

l wat

er v

ia in

hala

tion

nebu

lizer

onc

e m

onth

ly

bull c

hild

ren

gt 5

year

s

Cha

pter

CH

AP

TER

1

Bac

kgro

und

CH

AP

TER

2

Ant

enat

al C

are

and

Pre

vent

ion

of M

TCT

of H

IV

CH

AP

TER

3

Intra

partu

m C

are

Pron

g 1

Prim

ary

prev

entio

n of

HIV

in

fect

ion

in w

omen

Pron

g 2

Prev

entio

n of

un

inte

nded

pr

egna

ncy

amon

g H

IV in

fect

ed w

omen

Pron

g 3

Inte

rven

tions

to

redu

ce

tran

smis

sion

from

H

IV in

fect

ed

preg

nant

and

la

ctat

ing

wom

en to

th

eir c

hild

ren

Pron

g 4

Car

e an

d su

ppor

t of

wom

en c

hild

ren

and

fam

ilies

in

fect

ed a

nd

affe

cted

by

HIV

A

IDS

C

HA

PTE

R 4

U

se o

f Ant

iretro

vira

l D

rugs

in P

regn

ancy

fo

r Tre

atm

ent a

nd

Pre

vent

ion

of M

othe

r to

Chi

ld

Tran

smis

sion

of H

IV

Infe

ctio

n

CH

AP

TER

5

Imm

edia

te P

ostn

atal

an

d N

eona

tal C

are

CH

AP

TER

6

Late

Pos

tnat

al C

are

and

Fam

ily P

lann

ing

CH

AP

TER

7

HIV

Dia

gnos

is in

C

hild

ren

CH

AP

TER

8

Feed

ing

Infa

nts

and

Youn

g C

hild

ren

born

to

HIV

infe

cted

m

othe

rs

CH

AP

TER

9

Car

e an

d Fo

llow

-up

of C

hild

ren

of H

IV

infe

cted

mot

hers

C

HA

PTE

R 1

0

Mon

itorin

g an

d E

valu

atio

n of

PM

TCT

se

rvic

es

77

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

30

For

each

of t

hese

cha

pter

s (e

xcep

t ch

apte

r on

e on

bac

kgro

und)

the

gui

delin

es g

ive

anin

trod

uctio

n fo

llow

ed b

y po

licy

stat

emen

ts t

hen

oper

atio

nal g

uide

lines

of w

hat p

rovi

dshyer

s sh

ould

do

to r

educ

e m

othe

r-to

-chi

ld t

rans

mis

sion

of

HIV

and

or

to i

mpr

ove

thei

r pe

rfor

man

ce a

nd th

e ef

fect

iven

ess

of th

eir s

ervi

ces

A li

st o

f job

aid

s fo

r us

e by

the

hea

lthca

re p

rovi

der

follo

ws

the

oper

atio

nal g

uide

lines

and

whe

re n

eces

sary

a li

st o

f ap

pend

ices

and

add

ition

al d

ocum

ents

tha

t m

ay b

e re

shyfe

rred

to

but

are

cons

ider

ed t

oo b

ig o

r de

taile

d to

be

incl

uded

with

in t

he m

ain

body

of

the

guid

elin

es

Foo

tnot

es

1

UN

AID

S (

2004)

Rep

ort

on t

he

Glo

bal AID

S E

pid

emic

Ava

ilable

at

ww

wu

nai

ds

org

2

Ibid

2004

3

It

is

import

ant

to r

ecognis

e th

at t

he

use

of

the

phra

se M

TC

T in n

o w

ay is

inte

nded

to

pla

ce b

lam

e on t

he

moth

er

who m

ay o

r m

ay n

ot

know

her

HIV

sta

tus

who t

ransm

its

the

viru

s to

her

child

Pa

thfinder

ack

now

ledges

that

man

y tim

es p

regnant

wom

en

may

hav

e bee

n infe

cted

by

thei

r m

ale

par

tner

and d

o n

ot

hav

e th

e ab

ility

to n

egoti-

ate

safe

r se

x o

r to

see

k M

TC

T s

ervi

ces

for

fear

of

viole

nce

st

igm

a o

r ab

andonm

ent

if t

hei

r st

atu

s is

rev

eale

d

Path

finder

uphold

s th

e re

pro

duct

ive

rights

of

all w

om

en t

o

choose

if

and w

hen

to h

ave

child

ren

regar

dle

ss o

f H

IV-s

tatu

s

4

W

HO

CD

C

Dep

artm

ent

of

Hea

lth a

nd H

um

an S

ervi

ces

(2004)

Pre

vention o

f M

oth

er-t

o-C

hild

Tra

nsm

issi

on o

f H

IV

Gen

eric

Tra

inin

g P

acka

ge

Gen

eva

Sw

itze

r-la

nd

WH

O

5

U

NAID

S (

2004)

Rep

ort

on t

he

Glo

bal AID

S E

pid

emic

Ava

ilable

at

ww

wu

nai

ds

org

6

Polic

y Pro

ject

(2004)

Cove

rage

of

sele

cted

ser

vice

s fo

r H

IVA

IDS p

reve

ntion a

nd

care

in low

and m

iddle

-inco

me

countr

ies

in 2

003

Ava

ilable

at

ww

wp

olia

pro

ject

com

7

Cen

tral Bure

au o

f Sta

tist

ics

(CBS)

[Ken

ya]

Min

istr

y of

Hea

lth (

MO

H)

[Ken

ya]

and

ORC M

acro

(2004)

Ken

ya D

emogra

phic

and H

ealth S

urv

ey 2

003

Cal

vert

on

Mar

y-la

nd

CBSM

OH

an

d O

RC M

acr

o

8

Nat

ional AID

S C

ontr

ol Counci

l 2

007

8a

Ken

ya A

IDS I

ndic

ato

r Surv

ey 2

007

9

Ibid

2004

10

NASCO

P (

2002)

Surv

eilla

nce

data

as

cite

d in N

ASCO

PM

OH

(2

003)

Nat

ional

PM

CT

Str

ate

gic

Managem

ent

Pla

n 2

003-2

007

111

2 A

IDS in K

enya

Tre

nds

Inte

rven

tions

and I

mpact

7th

editio

n

(2005)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Who

Nee

ds P

CP

Prop

hyla

xis

bull A

ll in

fant

s bo

rn t

o H

IV-i

nfec

ted

mot

hers

irr

espe

ctiv

e of

any

ant

iret

rovi

ral

ther

apy

duri

ng p

regn

ancy

and

labo

ur

Pro

phyl

axis

con

tinue

s un

til th

e in

fant

is 1

2 m

onth

s or

is P

CR

neg

ativ

e or

ant

ibod

y ne

gativ

e w

hich

ever

co

mes

ear

lier

bull A

ll in

fant

s id

entif

ied

as H

IV-i

nfec

ted

duri

ng th

e fir

st y

ear

of li

fe b

y a

PC

R

test

or

by a

clin

ical

dia

gnos

is o

f H

IV in

fect

ion

and

a po

sitiv

e an

tibod

y te

st

bull C

hild

ren

olde

r th

an 1

2 m

onth

s w

ith s

ympt

omat

ic H

IV d

isea

se o

r an

A

IDS

-def

inin

g ill

ness

(W

HO

sta

ge I

I an

d III

se

e ch

apte

r 5)

or

with

CD

4 lt

15

or

TLC

150

0m

m3

bull A

ny c

hild

with

a h

isto

ry o

f P

CP

sho

uld

cont

inue

with

sec

onda

ry

prop

hyla

xis

(dai

ly C

T)

for

life

Clin

icia

ns s

houl

d cl

earl

y in

form

HIV

inf

ecte

d m

othe

rs a

t de

liver

y th

at t

heir

chi

ldre

n ne

ed p

roph

ylax

is a

gain

st P

CP

star

ting

at 6

wee

ks o

f age

unt

il it

is e

stab

lishe

d th

at th

e ch

ild i

s no

t H

IV i

nfec

ted

A p

ract

ical

way

to

ensu

re t

hat

mot

hers

and

oth

er h

ealth

wor

kers

are

inf

orm

ed i

s to

mak

e a

note

on

the

child

rsquos im

mun

izat

ion

card

at

birt

h st

atin

g ldquoP

leas

e gi

ve c

o-tr

imox

azol

e (5

mg

kgd

ay o

rally

dai

ly) f

rom

6 w

eeks

of a

gerdquo

Tabl

e 9

1 D

ose

of C

otrim

oxaz

ole

for P

CP

Prop

hyla

xis

Wei

ght o

f C

hild

(kg)

1ndash4

5ndash8

9ndash16

17ndash5

0

gt 50

CT

tabl

ets

20 m

g TM

P1

00

mg

SM

X p

edia

tric

stre

ngth

(120

mg)

1 ta

b

2 ta

bs

Cot

rimox

azol

e su

spen

sion

40

mg

TMP

200

mg

SM

X

5ml (

240

mg)

25

ml

5 m

l

10 m

l

CT

tabl

ets

80 m

g TM

P4

00 m

g S

MX

re

gula

r stre

ngth

(4

80 m

g)

frac14 ta

b

frac12 ta

b

1 ta

b

2 ta

bs

2 ta

bs

CT

Tabl

ets

160

mg

TMP

800

mg

SM

X

Dou

ble

stre

ngth

(9

60 m

g) -

frac14 ta

b

frac12 ta

b

1 ta

b

1 ta

b

In r

are

case

s a

s in

chi

ldre

n w

ith G

6PD

def

icie

ncy

CTX

may

be

cont

rain

dica

ted

G

uid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

3

1

76

(3)

Mon

itor

the

child

rsquos g

row

th a

nd d

evel

opm

ent

as a

mea

ns o

f id

entif

ying

the

ch

ild w

ho is

faili

ng to

thriv

e an

d al

so a

s a

tool

for m

onito

ring

the

effe

ct o

f int

ershy

vent

ions

(4)

Ens

ure

that

im

mun

isat

ions

are

sta

rted

and

com

plet

ed

acco

rdin

g to

the

re

com

men

datio

ns o

f the

nat

iona

l im

mun

isat

ion

sche

dule

|

Add

ition

al c

onsi

dera

tions

are

as

follo

ws

bull

Whe

n co

nsid

erin

g BC

G v

acci

natio

n at

a la

ter a

ge

(re-

vacc

inat

ion

for n

o sc

ar o

r mis

sed

earli

er v

acci

natio

n)

excl

ude

sym

ptom

atic

HIV

infe

ctio

n

bull

Do

not g

ive

yello

w fe

ver v

acci

ne to

sym

ptom

atic

HIV

-infe

cted

chi

lshydr

en H

owev

er a

sym

ptom

atic

chi

ldre

n in

end

emic

are

as s

houl

d re

shyce

ive

the

yello

w fe

ver v

acci

ne a

t 9 m

onth

s of

age

bull

Mea

sles

vac

cine

sho

uld

be g

iven

to H

IV in

fect

ed c

hild

ren

at 6

and

9

mon

ths

sinc

e H

IV in

fect

ed c

hild

ren

expe

rienc

e m

uch

mor

e se

vere

di

seas

e w

ith w

ild m

easl

es v

irus

whi

ch o

utw

eigh

s th

e ris

k of

a m

ilder

illn

ess

from

the

vacc

ine

(5)

Pro

vide

pro

phyl

axis

for o

ppor

tuni

stic

infe

ctio

ns

|

Pro

phyl

axis

aga

inst

Pne

umoc

ystis

jiro

veci

i Pne

umon

ia

bull

Pne

umoc

ystis

jiro

veci

i (fo

rmer

ly P

neum

ocys

tis c

arin

ii) p

neum

onia

(PC

P)

is a

sig

nific

ant c

ause

of m

orbi

dity

and

mor

talit

y am

ong

youn

g in

fant

s in

A

frica

Co-

trim

oxaz

ole

(CTX

) pro

phyl

axis

sig

nific

antly

redu

ces

the

inci

shyde

nce

and

seve

rity

of P

CP

Add

ition

al b

enef

its o

f co-

trim

oxaz

ole

incl

ude

prot

ectio

n ag

ains

t com

mon

bac

teria

l inf

ectio

ns t

oxop

lasm

osis

and

mashy

laria

All

child

ren

born

to H

IV in

fect

ed m

othe

rs s

houl

d re

ceiv

e pr

ophy

shyla

xis

agai

nst P

CP

at l

east

dur

ing

the

first

yea

r of l

ife o

r unt

il th

ey a

re

prov

en to

be

unin

fect

ed (s

ee b

ox b

elow

)

bull

CTX

is c

lear

ly th

e dr

ug o

f cho

ice

for p

roph

ylax

is b

ecau

se o

f its

hig

h

effic

acy

rela

tive

safe

ty l

ow c

ost a

nd b

road

ant

imic

robi

al s

pect

rum

In

cas

e of

CTX

hyp

erse

nsiti

vity

des

ensi

tizat

ion

is re

com

men

ded

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

CH

AP

TE

R 2

Ant

enat

al C

are

and

Prev

entio

n of

MTC

T of

HIV

21

INTR

OD

UC

TIO

N

HIV

inf

ectio

n ha

s em

erge

d in

Ken

ya a

s th

e m

ost

impo

rtan

t he

alth

ris

k fa

ctor

for

m

othe

rs a

nd t

heir

chi

ldre

n an

d ha

s a

grea

t im

pact

on

the

long

ter

m o

utco

me

ofpr

egna

ncy

and

child

sur

viva

l A

ll pr

egna

nt w

omen

sho

uld

be e

ncou

rage

d to

lear

n th

eir

HIV

infe

ctio

n st

atus

as

wel

l as

that

of t

heir

sex

ual p

artn

ers

O

nly

by k

now

ing

onersquos

H

IV s

tatu

s ca

n th

e he

alth

wor

kers

mak

e ap

prop

riat

e he

alth

car

e m

anag

emen

t re

com

men

datio

ns a

nd t

he c

oupl

e m

ake

appr

opri

ate

deci

sion

s ab

out

mai

ntai

ning

the

ir

heal

th a

nd t

hat

of t

heir

unb

orn

baby

Pr

e-co

ncep

tion

care

is

enco

urag

ed w

here

an

oppo

rtun

ity a

rise

s an

d a

birt

h pl

an is

dis

cuss

ed w

ith th

e pr

egna

nt w

oman

In m

ost

case

s t

he p

regn

ant

wom

an w

ill n

ot h

ave

HIV

infe

ctio

n P

regn

ancy

offe

rs a

n op

port

une

time

to d

iscu

ss p

reve

ntio

n of

HIV

inf

ectio

n as

man

y w

omen

com

e in

toco

ntac

t w

ith h

ealth

ser

vice

s fo

r th

e fir

st (

and

in s

ome

case

s th

e on

ly)

time

duri

ng

preg

nanc

y

In K

enya

50

o

f m

arri

ed H

IV p

ositi

ve p

erso

ns h

ave

an H

IV n

egat

ive

spou

se1

Ther

efor

e k

now

ing

the

HIV

inf

ectio

n st

atus

of

onersquos

par

tner

is

criti

cal

Add

ition

ally

th

is f

orm

s an

im

port

ant

entr

y po

int

for

esta

blis

hing

pre

vent

ion

with

po

sitiv

e (P

WP)

pro

gram

s am

ong

coup

les

as w

ell a

s pr

ovid

ing

acce

ss to

HIV

pre

vent

ion

ca

re a

nd tr

eatm

ent s

ervi

ces

for

the

who

le fa

mily

PMTC

T pr

ovid

es a

n op

port

unity

for

prev

entin

g ne

w p

aedi

atri

c H

IV in

fect

ions

as

wel

l as

for

reac

hing

the

10 to

20

of H

IV p

ositi

ve p

regn

ant w

omen

who

mee

t WH

O e

ligib

ilshyity

cri

teri

a fo

r in

itiat

ing

AR

T fo

r th

eir

own

heal

th N

ew in

fect

ions

and

hig

h vi

ral l

oads

duri

ng p

regn

ancy

pos

e th

e gr

eate

st r

isk

of M

TCT

to t

he u

nbor

n ba

by t

hus

prim

ary

prev

entio

n A

RV

pro

phyl

axis

as

wel

l as

trea

tmen

t at t

his

time

is c

ritic

al G

iven

that

25

perc

ent o

f wom

en in

Ken

ya h

ave

an u

nwan

ted

preg

nanc

y s

tren

gthe

ning

the

link

to F

P se

rvic

es a

nd c

ondo

m a

cces

s fo

r du

al p

rote

ctio

n of

fers

a c

hanc

e to

fur

ther

pre

vent

MTC

T2

22

OPE

RA

TIO

NA

L G

UID

ELIN

ES

Ant

enat

al c

are

and

prev

entio

n of

MTC

T du

ring

thi

s pe

riod

can

be

sum

mar

ised

usi

ngan

ess

entia

l pa

ckag

e of

int

egra

ted

ante

nata

l ca

re s

ervi

ces

as s

how

n in

Tab

le 2

1

This

ou

tline

s th

e pa

ckag

e of

ca

re

to

be

prov

ided

to

ev

ery

wom

an

atte

ndin

g A

NC

ser

vice

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

5

32

Tabl

e 2

1 Es

sent

ial P

acka

ge o

f Int

egra

ted

Ant

enat

al C

are

Serv

ices

Gro

up e

duca

tion

Incl

ude

info

rmat

ion

on fo

ur A

NC

vis

its b

reas

tfeed

ing

mat

erna

l and

infa

nt n

utrit

ion

per

sona

l hyg

iene

birt

h pr

epar

edne

ss d

ange

r sig

ns p

reve

ntio

n of

com

plic

atio

ns s

kille

d bi

rth a

ttend

ance

fam

ily p

lann

ing

imm

uniz

atio

n sc

hedu

le

post

-nat

al c

are

and

HIV

and

AID

S m

anag

emen

t

Clie

nt h

isto

ry O

btai

n ro

utin

e da

ta in

clud

ing

med

ical

obs

tetri

c a

nd p

sych

osoc

ial h

isto

ry D

eter

min

e dr

ug h

isto

ry k

now

n al

lerg

ies

and

use

of a

ltern

ativ

e m

edic

ines

suc

h as

her

bal p

rodu

cts

Phy

sica

l exa

min

atio

n In

clud

e vi

tal s

igns

ins

pect

ion

aus

culta

tion

and

palp

atio

n

Abd

omin

al a

nd g

enita

l exa

min

atio

n In

clud

e in

spec

tion

pal

patio

n fo

etal

aus

culta

tion

spe

culu

m a

nd b

iman

ual e

xam

inat

ions

w

here

indi

cate

d

AN

C P

rofil

e R

outin

e te

sts

for s

yphi

lis H

b b

lood

gro

up a

nd R

hesu

s fa

ctor

urin

alys

is a

nd p

rovi

de ra

pid

HIV

test

ing

to th

e pr

egna

nt w

oman

and

her

par

tner

if a

ccom

pany

ing

her

If in

dica

ted

chec

k sp

utum

for A

AFB

and

CD

4 co

unt

Cou

nsel

ing

on b

irth

prep

ared

ness

Sup

port

the

preg

nant

wom

an a

nd h

er p

artn

er to

dev

elop

an

indi

vidu

al b

irth

plan

that

in

clud

es p

lace

of d

eliv

ery

with

ski

lled

birth

atte

ndan

ce e

mer

genc

y tra

nspo

rt b

irth

com

pani

onsh

ip a

nd re

adin

ess

for i

nfan

t ca

re

Cou

nsel

ing

on p

regn

ancy

dan

ger s

igns

Pro

vide

wom

en w

ith in

form

atio

n an

d in

stru

ctio

ns o

n se

ekin

g ea

rly c

are

for p

regshy

nanc

y co

mpl

icat

ions

suc

h as

ble

edin

g fe

ver

seve

re h

eada

che

sw

olle

n fe

et f

its o

r con

vuls

ions

Cou

nsel

ing

on in

fant

feed

ing

All

wom

en re

quire

infa

nt-fe

edin

g co

unse

ling

and

supp

ort

Exc

lusi

ve b

reas

tfeed

ing

for s

ix

mon

ths

shou

ld b

e pr

omot

ed a

s th

e no

rm fo

r all

wom

en re

gard

less

of H

IV s

tatu

s W

omen

infe

cted

with

HIV

nee

d to

be

gu

ided

in th

e se

lect

ion

of s

afer

infa

nt-fe

edin

g op

tions

(ref

er to

WH

O g

uide

lines

and

MO

H c

ircul

ar o

n in

fant

and

you

ng c

hild

fe

edin

g)

Nut

ritio

nal a

sses

smen

t co

unse

ling

and

educ

atio

n In

clud

e iro

n m

ultiv

itam

in a

nd fo

late

sup

plem

enta

tion

mon

itor f

or a

naeshy

mia

ade

quat

e ca

loric

and

nut

rient

inta

ke a

nd re

com

men

d re

alis

tic d

iet a

djus

tmen

ts b

ased

on

loca

l res

ourc

es a

nd n

eeds

of

HIV

+ pr

egna

nt w

omen

(at l

east

10

mor

e of

the

RD

A)

Cou

nsel

ing

on H

IV a

nd A

IDS

Pro

vide

wom

en w

ith in

form

atio

n an

d in

stru

ctio

ns o

n se

ekin

g he

alth

car

e fo

r

sym

ptom

s of

HIV

dis

ease

pro

gres

sion

suc

h as

freq

uent

and

recu

rrent

illn

esse

s c

hron

ic p

ersi

sten

t dia

rrho

ea c

andi

dias

is

feve

r w

astin

g or

sig

ns o

f any

opp

ortu

nist

ic in

fect

ion

Lin

k w

omen

to A

IDS

trea

tmen

t and

oth

er s

uppo

rt pr

ogra

mm

es w

here

av

aila

ble

Cou

nsel

ing

the

HIV

neg

ativ

e w

oman

and

her

par

tner

Pro

vide

info

rmat

ion

on re

peat

test

ing

risk

redu

ctio

n an

d pa

rtner

test

ing

RTI

scr

eeni

ng A

ll w

omen

with

hig

h ris

k se

xual

his

tory

or p

rese

ntin

g w

ith s

igns

of R

TI s

uch

as a

bnor

mal

gen

ital d

isch

arge

ge

nita

l ulc

ers

and

pelv

ic in

flam

mat

ory

dise

ase

shou

ld b

e sc

reen

ed a

nd m

anag

ed a

ccor

ding

to K

enya

pro

toco

ls

Tube

rcul

osis

(TB

) A

ll w

omen

pre

sent

ing

for A

NC

ser

vice

s w

ith a

cou

gh o

f mor

e th

an 2

wee

ksrsquo d

urat

ion

shou

ld b

e sc

reen

ed

for T

B re

gard

less

of H

IV s

tatu

s F

ollo

w K

enya

pro

toco

ls fo

r scr

eeni

ng p

roph

ylax

is a

nd tr

eatm

ent

Teta

nus

toxo

id im

mun

isat

ions

Adm

inis

ter a

ccor

ding

to c

urre

nt K

EP

I TT

Imm

uniz

atio

n S

ched

ule

Dew

orm

ing

All

preg

nant

wom

en s

houl

d re

ceiv

e an

ti-he

lmin

thes

afte

r firs

t trim

este

r as

per t

he g

uide

lines

on

m

ater

nal n

utrit

ion

Ant

imal

aria

ls I

TNs

All

preg

nant

wom

en in

mal

aria

end

emic

are

as s

houl

d sl

eep

unde

r an

ITN

and

rece

ive

SP

inte

rmitt

ent

pres

umpt

ive

treat

men

t acc

ordi

ng to

the

Nat

iona

l Mal

aria

gui

delin

es

AR

V a

nd O

ppor

tuni

stic

Infe

ctio

ns p

roph

ylax

is (d

urin

g pr

egna

ncy)

Pro

vide

AR

V C

TX a

nd o

ther

pro

phyl

actic

m

edic

atio

ns a

ccor

ding

to th

e K

enya

AR

T pr

otoc

ol o

n O

I pro

phyl

axis

and

use

of A

RV

s in

pre

gnan

cy

AR

V tr

eatm

ent d

urin

g pr

egna

ncy

Pro

vide

HA

AR

T w

ithin

the

MC

H s

ettin

g ac

cord

ing

to th

e K

enya

pro

toco

l on

use

of A

RV

s

Est

ablis

h cl

ear r

efer

ral n

etw

orks

with

sen

ior c

linic

ians

Pre

vent

ion

with

Pos

itive

s E

ncou

rage

pos

itive

livi

ng d

iscl

osur

e c

orre

ct a

nd c

onsi

sten

t con

dom

use

and

pro

vide

psy

chos

oshyci

al s

uppo

rt to

the

affe

cted

fam

ilies

For

the

HIV

-infe

cted

and

affe

cted

fam

ilies

est

ablis

h an

dor

stre

ngth

en li

nkag

es to

car

e

treat

men

t and

sup

port

serv

ices

incl

udin

g po

st-p

artu

m fo

llow

up

Effe

ctiv

e co

ntra

cept

ion

plan

Cou

nsel

abo

ut o

ther

fam

ily p

lann

ing

met

hods

em

phas

izin

g on

par

tner

invo

lvem

ent

and

dual

pro

tect

ion

met

hods

to a

void

unw

ante

d pr

egna

ncy

new

infe

ctio

n re

-infe

ctio

n an

d fu

rther

tran

smis

sion

Sourc

e K

enya

Nat

ional PM

TC

T T

rain

ing C

urr

iculu

m

2005

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

92

OPE

RA

TIO

NA

L G

UID

ELIN

ES

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed in

the

care

and

fo

llow

-up

of c

hild

ren

of H

IV-in

fect

ed m

othe

rs

bull A

ll ch

ildre

n bo

rn t

o H

IV in

fect

ed m

othe

rs s

houl

d be

see

n in

the

he

alth

car

e fa

cilit

y w

ithin

tw

o w

eeks

of

deliv

ery

bull F

or a

ll H

IV e

xpos

ed in

fant

s m

onth

ly f

ollo

w u

p vi

sits

are

re

com

men

ded

begi

nnin

g at

six

wee

ks t

hrou

gh 2

yea

rs

bull W

here

pos

sibl

e v

isits

sho

uld

be li

nked

to

the

imm

unis

atio

n an

d

grow

th m

onito

ring

vis

its

bull A

ll H

IV e

xpos

ed in

fant

s sh

ould

be

star

ted

on C

otri

mox

azol

e

prop

hyla

xis

from

6 w

eeks

of

age

bull F

or in

fant

s w

ho te

st H

IV p

ositi

ve b

y D

NA

PC

R b

efor

e 18

mon

ths

or

by a

ntib

ody

test

aft

er 1

8 m

onth

s of

age

co

-trim

oxaz

ole

shou

ld b

e gi

ven

daily

for

life

bull F

or in

fant

s w

ho te

st H

IV n

egat

ive

|

If th

ey h

ave

stop

ped

brea

stfe

edin

g fo

r 2 m

onth

s or

mor

e s

top

C

otrim

oxaz

ole

|

If st

ill br

east

feed

ing

con

tinue

Cot

rimox

azol

e un

til tw

o m

onth

s af

ter

com

plet

e ce

ssat

ion

of b

reas

tfeed

ing

bull C

ompr

ehen

sive

car

e fo

r th

e H

IV e

xpos

ed o

r in

fect

ed in

fant

s sh

ould

be

pro

vide

d in

the

bro

ader

con

text

of

othe

r ch

ild h

ealth

car

e st

rate

gies

Hea

lth w

orke

rs s

houl

d pr

ovid

e th

e fo

llow

ing

pack

age

of c

are

as a

min

imum

to

thes

e ch

ildre

n

(1)

Con

firm

HIV

sta

tus

as e

arly

as

poss

ible

(R

efer

to C

hapt

er 7

)

(2)

M

othe

rs s

houl

d be

sup

porte

d to

pro

vide

opt

imal

infa

nt fe

edin

g an

d pa

rticu

larly

to

avoi

d m

ixed

feed

ing

in th

e fir

st 6

mon

ths

of li

fe I

t is

impo

rtant

that

infa

nt fe

edin

g ch

oice

s at

initi

atio

n of

feed

ing

follo

win

g ea

rly in

fant

dia

gnos

is a

t wea

ning

and

at

the

time

of in

trodu

ctio

n of

com

plem

enta

ry fe

eds

are

guid

ed b

y th

e A

FAS

S c

riter

ia

(Ref

er to

Cha

pter

8)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

3

3

74

Cha

pter

9

Car

e an

d Fo

llow

-up

of C

hild

ren

of H

IV-in

fect

ed M

othe

rs

91

INTR

OD

UC

TIO

N

PMTC

T in

terv

entio

ns re

duce

but

do

not e

limin

ate

the

risk

of H

IV tr

ansm

issi

on fr

om m

othshy

ers t

o th

eir i

nfan

ts a

nd y

oung

child

ren

Bot

h H

IV-in

fect

ed a

nd u

ninf

ecte

d ex

pose

d ch

ildre

n ha

ve in

crea

sed

risk

s of

infe

ctio

n an

d de

ath

from

com

mon

chi

ldho

od in

fect

ions

The

sur

shyvi

val o

f H

IV-e

xpos

ed c

hild

ren

whe

ther

or

not

they

are

inf

ecte

d i

s cl

osel

y lin

ked

to t

he

heal

th a

nd s

urvi

val o

f the

ir m

othe

rs T

here

fore

lon

g-te

rm b

enef

its o

f PM

TCT

prog

ram

s w

ill o

nly

be s

usta

ined

if t

here

is o

ngoi

ng c

ompr

ehen

sive

car

e fo

r th

e ch

ildre

n an

d th

eir

mot

hers

and

or c

are

give

rs

HIV

exp

osed

chi

ldre

n ar

e vu

lner

able

to

the

com

mon

illn

esse

s af

fect

ing

othe

r ch

ildre

n

Thes

e in

fect

ions

incl

ude

neon

atal

infe

ctio

ns m

alar

ia p

neum

onia

dia

rrho

ea m

easl

es a

nd

othe

r vac

cine

pre

vent

able

dis

ease

s H

IV in

fect

ed ch

ildre

n ar

e lik

ely

to s

uffe

r mor

e se

vere

ly

and

have

a h

ighe

r lik

elih

ood

of d

ying

from

com

mon

chi

ldho

od il

lnes

ses

than

non

-infe

cted

ch

ildre

n W

here

as m

alnu

triti

on c

ause

s 53

o

f all

child

hood

dea

ths

HIV

exp

osed

chi

ldre

n ar

e m

ore

vuln

erab

le to

it th

an n

on-in

fect

ed c

hild

ren

Thi

s is

bec

ause

HIV

exp

osed

child

ren

have

hig

her

calo

ric

requ

irem

ents

as

a re

sult

of th

eir

HIV

infe

ctio

n th

e pr

esen

ce o

f opp

orshy

tuni

stic

infe

ctio

ns a

nd o

ther

com

plic

atio

ns re

late

d to

AID

S

Regu

lar

follo

w u

p ca

re is

cri

tical

for

an in

fant

bor

n to

a m

othe

r w

ith H

IVA

IDS

The

com

shypr

ehen

sive

car

e of

HIV

exp

osed

chi

ldre

n in

clud

ing

nutr

ition

im

mun

isat

ion

mon

itori

ng o

f gr

owth

and

dev

elop

men

t pr

even

tion

and

trea

tmen

t of

opp

ortu

nist

ic in

fect

ions

and

ear

ly

infa

nt d

iagn

osis

of

HIV

is f

easi

ble

in r

esou

rce-

cons

trai

ned

sett

ings

and

sig

nific

antly

imshy

prov

es th

e su

rviv

al o

f the

se ch

ildre

n

23

JOB A

IDS

Prov

ider

s ar

e en

cour

aged

to re

fer t

o th

e ap

prop

riate

job

aid(

s) w

hen

deal

ing

with

spe

cific

issu

es

bull P

MT

CT

test

ing

and

coun

selli

ng t

ools

bull C

oupl

e co

unse

lling

tool

s

bull A

NC

alg

orith

ms

for

AR

V p

roph

ylax

is a

nd in

fant

fee

ding

gui

delin

es

as a

dapt

ed f

rom

WH

O g

uide

lines

bull P

reve

ntio

n w

ith p

ositi

ves

tool

kit

on d

iscl

osur

e

bull F

ocus

ed a

nte-

nata

l car

e

bull M

alar

ia in

pre

gnan

cy

bull T

B in

pre

gnan

cy

bull K

EP

I S

ched

ule

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

3

34

A ra

pid

HIV

test

ing

algo

rithm

for s

eria

l tes

ting

is il

lust

rate

d be

low

35

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Pre-Test Education and or Counselling

First HIV Rapid Test ndashDETERMINE

Negative TestResult

Counsel for Negative Result

Positive TestResult

Second HIV Rapid Test ndashBIOLINE

Positive Test ResultCounsel for

Positive Result

NegativeTestResult

Third HIV Rapid Test ndashUNIGOLD

Positive Test ResultCounsel for

Positive Result

Negative Test ResultCounsel for

Negative Result

Figure 32 Rapid HIV testing algorithm Serial testing

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

72

M

othe

r and

Chi

ld H

ealth

Boo

klet

71

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

36

Cha

pter

ref

eren

ces

Rep

ublic

of

Ken

ya M

inis

try

of

Hea

lth

Div

isio

n o

f Rep

roduct

ive

Hea

lth

National G

uid

e-lin

es f

or

Qual

ity

Obst

etri

cs a

nd P

erin

atal Car

e (

2004)

WH

O

UN

FPA

UN

ICEF

World B

ank

Manag

ing C

om

plic

atio

ns

in P

regnan

cy a

nd C

hild

birth

A g

uid

e fo

r m

idw

ives

and d

oct

ors

(2003)

WH

O

Sta

ndar

ds

for

Mat

ernal

and N

eonat

al C

are

(2006)

WH

O

Antire

trovi

ral dru

gs

for

trea

ting p

regnan

t w

om

en a

nd p

reve

nting H

IV infe

ctio

ns

in

infa

nts

in r

esourc

e lim

ited

set

tings

Tow

ard

s U

niv

ersa

l Acc

ess

Rec

om

men

dations

for

a public

hea

lth a

ppro

ach (

2006)

Min

istr

y of

Hea

lth

Nat

ional AID

S amp

STD

Contr

ol Pro

gra

mm

e (N

ASCO

P)

Guid

elin

es f

or

Antire

trovi

ral dru

g t

her

apy

in K

enya

(2005)

Min

istr

y of

Hea

lth

Ken

ya N

atio

nal

Rep

roduct

ive

Hea

lth I

nst

ruct

ional M

anual

for

Ser

vice

Pro

vider

s (M

arch

2005)

Nat

ional AID

S amp

STD

Contr

ol Pro

gra

mm

e K

enya

AID

S I

ndic

ator

Syr

vey

Foo

tnot

es

1

2Ken

ya D

emogra

phic

and H

ealth S

urv

ey (

KD

HS)

2003

37

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

70

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

CH

AP

TE

R 3

Intr

apar

tum

Car

e 3

1 IN

TRO

DU

CTI

ON

Intr

apar

tum

car

e is

the

man

agem

ent

of w

omen

fro

m t

he o

nset

of

labo

ur t

o de

liver

y T

his

peri

od p

oses

the

grea

test

ris

k fo

r tr

ansm

issi

on o

f HIV

from

the

mot

her

to th

e ch

ild (M

TCT)

w

ith 1

0 to

20

perc

ent o

f exp

osed

infa

nts

beco

min

g in

fect

ed a

t thi

s tim

e in

the

abse

nce

of a

ny

inte

rven

tion

1 In

the

con

text

of

HIV

AID

S it

is t

here

fore

im

port

ant

to e

stab

lish

the

HIV

stat

us o

f wom

en p

rior

to o

r du

ring

labo

ur a

nd d

eliv

ery

and

prov

ide

inte

rven

tions

aim

ed a

t re

duci

ng th

e ri

sk o

f tra

nsm

issi

on W

ith a

ppro

pria

te in

terv

entio

ns t

he r

isk

of M

TCT

can

bere

duce

d si

gnifi

cant

ly

32

OPE

RA

TIO

NA

L G

UID

ELIN

ES

a) O

ptim

al In

trap

artu

m C

are

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed fo

r all

wom

en a

dmitt

ed

to la

bour

and

del

iver

y un

its 2

3

1 M

inim

ise

vagi

nal e

xam

inat

ions

2 U

se a

sept

ic t

echn

ique

s in

con

duct

ing

deliv

ery

3 A

void

rou

tine

artif

icia

l rup

ture

of m

embr

anes

(A

RM

)

4 A

void

pro

long

ed la

bour

5 A

void

unn

eces

sary

trau

ma

duri

ng d

eliv

ery

6 M

inim

ise

the

risk

of p

ostp

artu

m h

aem

orrh

age

7 U

se s

afe

bloo

d tr

ansf

usio

n pr

actic

es

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

9

38

b) S

peci

fic M

anag

emen

t of H

IV P

ositi

ve P

regn

ant W

omen

Pro

phyl

acti

c A

ntir

etro

vira

l the

rapi

es4

The

AR

V p

roph

ylac

tic r

egim

en d

epen

ds o

n w

heth

er th

e m

othe

r ha

d A

RV

s du

ring

pre

gshyna

ncy

or n

ot T

hus

the

heal

th c

are

wor

ker s

houl

d es

tabl

ish

the

regi

men

use

d du

ring

th

e A

NC

whe

ther

the

wom

an h

ad ta

ken

the

SdN

VP

and

AZT

at t

he o

nset

of l

abou

r an

d de

term

ine

the

appr

opri

ate

intr

a-pa

rtum

AR

V c

are

as p

er th

e al

gori

thm

s on

pag

e80

(App

endi

x II

I) p

age

81 (A

ppen

dix

IV) a

nd a

s su

mm

aris

ed b

elow

No

AR

Vs t

aken

in p

regn

ancy

Mot

her i

n ea

rly la

bour

(up

to 4

cm c

ervi

cal d

ilata

tion)

bull

Int

rapa

rtum

per

iod

Giv

e m

othe

r S

dNV

P 2

00m

g A

ZT

600

mg

and

3T

C 1

50m

g st

at

bull P

ostp

artu

m m

othe

r G

ive

mot

her

AZ

T 3

00m

g an

d 3T

C 1

50m

g B

D

for

7 da

ys

bull P

ostp

artu

m p

erio

d G

ive

infa

nt S

d N

evir

apin

e 2

mg

kg w

ithin

72

hour

s of

birt

h P

LUS

3T

C 4

mg

kg B

D fo

r 1

wee

k an

d A

ZT

syr

up 4

mg

kg

BD

for

6 w

eeks

Mot

her r

ecei

ved

AZT

300

mg

BD

in P

regn

ancy

bull P

ostp

artu

m

Giv

e in

fant

Sd

Nev

irap

ine

2mg

kg w

ithin

72

hour

s of

birt

h

PLU

S 3

TC

4m

gkg

BD

for

1 w

eek

and

AZ

T sy

rup

4 m

gkg

BD

for

6 w

eeks

Mot

her r

ecei

ved

HA

AR

T in

Pre

gnan

cy

Reg

ardl

ess

of d

urat

ion

rece

ived

HA

AR

T bull

Giv

e m

othe

r A

RV

dos

e as

per

reg

imen

bull P

ostp

artu

m

Giv

e In

fant

Sd

Nev

irap

ine

2mg

kg w

ithin

72

hour

s of

bir

th

PLU

S 3

TC

4m

gkg

BD

for

1 w

eek

and

AZ

T sy

rup

4 m

gkg

BD

for

6 w

eeks

Mod

e of

del

iver

y E

lect

ive

caes

area

n se

ctio

n (C

S) r

educ

es t

he r

isk

of H

IV M

TCT

as c

ompa

red

to v

agin

al

deliv

ery

but

will

not

be

avai

labl

e in

man

y se

ttin

gs in

our

cou

ntry

Whe

re C

S is

per

shyfo

rmed

(ele

ctiv

e or

em

erge

ncy)

in H

IV p

ositi

ve w

omen

the

y sh

ould

rec

eive

pro

phyl

actic

an

tibio

tics

If

the

CS

is p

erfo

rmed

aft

er p

rolo

nged

lab

our

or r

uptu

re o

f m

embr

anes

lo

nger

cour

ses

of a

ntib

iotic

s sh

ould

be

cons

ider

ed

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

3

9

68

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Supp

ort d

urin

g la

bour

E

mot

iona

l su

ppor

t du

ring

lab

our

is i

mpo

rtan

t fo

r al

l w

omen

and

may

be

even

mor

ene

cess

ary

for

an H

IV p

ositi

ve w

oman

who

is c

once

rned

abo

ut h

er c

ondi

tion

and

risk

of

HIV

tran

smis

sion

to c

hild

Whe

neve

r po

ssib

le d

urin

g la

bour

war

d st

aff m

ust b

e se

nsishy

tive

to t

he fe

ars

and

conc

erns

of t

he H

IV p

ositi

ve m

othe

r ab

out

her

infe

ctio

n a

nd h

owm

uch

she

had

told

her

par

tner

Indu

ctio

n of

labo

ur

Indu

ctio

n of

labo

ur m

ay b

e as

soci

ated

with

incr

ease

d ri

sk o

f H

IV M

TCT

Car

eful

asshy

sess

men

t of

the

nee

d fo

r an

d de

sira

bilit

y of

ind

uctio

n ra

ther

tha

n C

S is

nec

essa

ry

Whe

n in

duct

ion

of la

bour

is c

hose

n m

embr

anes

sho

uld

be le

ft in

tact

for

as lo

ng a

s po

sshysi

ble

Syn

toci

non

shou

ld n

ot b

e us

ed w

ith in

tact

mem

bran

es

Indi

catio

ns fo

r ele

ctiv

e C

S A

lthou

gh e

lect

ive

CS

will

not

be

avai

labl

e in

mos

t hea

lth fa

cilit

ies

as a

rou

tine

for

HIV

posi

tive

wom

en t

here

may

be

som

e ca

ses

that

mer

it co

nsid

erat

ion

for

CS

The

se i

nshycl

ude

preg

nanc

ies

whe

re l

abou

r is

exp

ecte

d to

be

prol

onge

d or

whe

re o

ther

obs

tetr

ic

com

plic

atio

ns m

ay b

e as

soci

ated

with

incr

ease

d ri

sk o

f tra

nsm

issi

on (e

g a

brup

tio p

lashy

cent

ae

plac

enta

pra

evia

pr

e-te

rm r

uptu

re o

f m

embr

anes

pr

evio

us C

S an

d br

eech

pr

esen

tatio

n)

Man

agem

ent o

f lab

our a

nd d

eliv

ery

Labo

ur a

nd d

eliv

ery

man

agem

ent

shou

ld fo

llow

opt

imal

obs

tetr

ic m

anag

emen

t gu

ideshy

lines

(R

efer

to

Opt

imal

Int

rapa

rtum

car

e ab

ove

and

Nat

iona

l G

uide

lines

for

Qua

lity

Obs

tetr

ics

and

IMPA

C C

are

Man

ual)

RO

LEO

FTH

E C

OM

MU

NIT

Y

A la

rge

prop

ortio

n (6

0) o

f wom

en in

Ken

ya is

del

iver

ed o

utsid

e th

e he

alth

sys

tem

s by

fam

ilym

embe

rs n

eigh

bour

s and

TBA

s

bull T

here

is n

eed

to e

duca

te th

e co

mm

unity

on

the

risk

of M

TC

T an

d w

ays

of

prev

entio

n

bull T

hose

ass

istin

g th

e de

liver

ies

need

to u

nder

stan

d th

eir

own

risk

of in

fect

ion

and

how

to p

rote

ct th

emse

lves

bull T

he c

omm

unity

sho

uld

be e

ncou

rage

d to

faci

litat

e m

othe

rs to

del

iver

in

heal

th fa

cilit

ies

bull T

he c

omm

unity

sho

uld

be e

ncou

rage

d to

ref

er to

hea

lth fa

cilit

ies

all c

hild

ren

born

at h

ome

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

7

40

Fi

gure

81

Gui

delin

es fo

r Cou

nsel

ling

on H

IV a

nd In

fant

feed

ingJ

ob A

ids

Cha

pter

ref

eren

ces

an

d IE

C M

ater

ials

on

Infa

nt a

nd Y

oung

Chi

ld F

eedi

ng

1R

epublic

of

Ken

ya

Min

istr

y of

Hea

lth

Ess

ential

Obst

etric

Car

e M

anual

for

Hea

lth

Ser

vice

Pro

vider

s in

Ken

ya (

3rd

Editio

n J

an 2

006)

Foo

tnot

es

1 D

e Cock

KM

2002

2 K

enya

National

Rep

roduct

ive

Hea

lth I

nst

ruct

ion M

anual

for

Ser

vice

Pro

vider

s (2

006)

3 D

ivis

ion o

f Rep

roduct

ive

Hea

lth

Guid

elin

es f

or

Qual

ity

Obst

etri

cs a

nd P

erin

ata

l Car

e

(2004)

4 W

HO

Antire

tovi

ral dru

gs

for

trea

ting p

regnan

t w

om

en a

nd p

reve

nting H

IV infe

ctio

n in

infa

nts

to

ward

s univ

ersa

l acc

ess

(2006)

41

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

66

85

EXTR

AC

TSFR

OM

RES

EAR

CH

ON

I NFA

NT

F EED

ING

A

ND H

IVA

IDS

Evid

ence

ava

ilabl

e fr

om c

urre

nt re

sear

ch d

ata

show

s th

at

bull I

ncre

ased

ris

k of

mor

talit

y w

ith r

epla

cem

ent

feed

ing

is s

igni

fican

t

bull H

IV f

ree

surv

ival

rat

e at

18

mon

ths

of a

ge d

oes

not

sign

ifica

ntly

var

y be

twee

n a

brea

stfe

d an

d re

plac

emen

t fed

chi

ld

bull M

odifi

ed a

nim

alrsquos

milk

doe

s no

t pr

ovid

e ad

equa

te n

utrit

ion

for

ch

ildre

n le

ss t

han

6 m

onth

s he

nce

mic

ronu

trie

nts

shou

ld b

e gi

ven

un

der

thes

e ci

rcum

stan

ces

bull A

brup

t ce

ssat

ion

of b

reas

tfee

ding

is n

o lo

nger

rec

omm

ende

d

bull E

xclu

sive

bre

astf

eedi

ng u

p to

6 m

onth

s is

rec

omm

ende

d un

less

re

plac

emen

t fee

ding

can

mee

t AF

AS

S c

rite

ria

Cha

pter

4

Use

of A

ntire

trov

iral D

rugs

in P

regn

ancy

for T

reat

men

t and

for

Prev

entio

n of

Mot

her-

to-C

hild

Tra

nsm

issi

on o

f HIV

Infe

ctio

n

41

INTR

OD

UC

TIO

N

With

out

any

inte

rven

tion

up

to 4

0 pe

rcen

t of

HIV

pos

itive

wom

en w

ill t

rans

mit

the

infe

ctio

n to

the

ir c

hild

ren

duri

ng p

regn

ancy

lab

our

and

brea

stfe

edin

g U

se o

f ant

iret

shyro

vira

l dru

gs (A

RV

s) o

bste

tric

inte

rven

tions

and

avo

idan

ce o

f all

brea

stfe

edin

g fo

r pr

eshyve

ntio

n of

mot

her

to c

hild

tran

smis

sion

of H

IV in

fect

ion

(PM

TCT)

has

red

uced

the

risk

of m

othe

r to

chi

ld tr

ansm

issi

on o

f HIV

infe

ctio

n (M

TCT)

to le

ss th

an 2

per

cent

in d

evel

shyop

ed c

ount

ries

Shor

t cou

rse

effic

acio

us A

RV

dru

g re

gim

ens

can

redu

ce th

e ri

sk o

f MTC

T to

2-4

per

cent

and

can

be i

mpl

emen

ted

in r

esou

rce-

limite

d se

ttin

gs o

n a

popu

latio

n-ba

sed

publ

ic

heal

th s

cale

AR

Vs

are

used

bot

h fo

r th

e tr

eatm

ent

of H

IV d

isea

se a

nd fo

r PM

TCT

in

HIV

-infe

cted

pre

gnan

t w

omen

and

the

ir n

eona

tes

Ant

iret

rovi

ral t

reat

men

t (A

RT)

for

wom

en w

ho q

ualif

y fo

r it

pro

long

s an

d im

prov

es t

he q

ualit

y of

the

ir l

ives

The

sur

shyvi

val

of t

he c

hild

is

clos

ely

inte

rlin

ked

with

the

hea

lth a

nd s

urvi

val

of t

he m

othe

r

Wom

en e

ligib

le fo

r A

RT

shou

ld b

e st

arte

d on

trea

tmen

t as

soon

as

poss

ible

Pre

gnan

cy

is n

ot a

rea

son

to d

elay

AR

T W

omen

who

are

alr

eady

on

AR

T be

fore

bec

omin

g pr

egshy

nant

sho

uld

cont

inue

with

thei

r tr

eatm

ent

In c

erta

in s

ituat

ions

mod

ifica

tions

may

be

need

ed to

mak

e tr

eatm

ent s

afer

for

the

mot

her

and

the

unbo

rn b

aby

The

bene

fits

of u

sing

AR

Vs

to t

reat

HIV

-infe

cted

pre

gnan

t w

omen

and

or

PMTC

T ou

tshyw

eigh

the

ris

ks H

owev

er w

hen

AR

T or

oth

er s

hort

cou

rse

AR

V r

egim

ens

are

used

ba

selin

e ev

alua

tion

and

mon

itori

ng is

enc

oura

ged

to e

nsur

e th

e sa

fety

of t

he m

othe

rsan

d th

eir

new

born

s L

inka

ges

of H

IV-in

fect

ed p

regn

ant

wom

en a

nd t

heir

chi

ldre

n to

ot

her

care

and

sup

port

pro

gram

s at

hea

lth f

acili

ty a

nd c

omm

unity

lev

els

shou

ld b

e en

sure

d

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

5

42

42

OPE

RA

TIO

NA

L G

UID

ELIN

ES

All

HIV

-infe

cted

pre

gnan

t w

omen

sho

uld

be c

ouns

elle

d on

com

preh

ensi

ve H

IV c

are

incl

udin

g us

e of

AR

Vs

for

thei

r ow

n he

alth

and

for

PMTC

T

All

HIV

-infe

cted

pre

gnan

t wom

en s

houl

d ha

ve th

eir H

IV d

isea

se

stag

ed u

sing

bull W

HO

clin

ical

sta

ging

(se

e A

ppen

dix

1) a

nd

bull I

mm

unol

ogic

al s

tagi

ng (

CD

4 co

unt)

(se

e ta

ble

1)

The

wom

en s

houl

d al

so b

e sc

reen

ed a

nd tr

eate

d fo

r op

port

unis

tic in

fect

ions

(OIs

) inc

ludi

ngTu

berc

ulos

is (T

B)

All

HIV

-infe

cted

pre

gnan

t wom

en s

houl

d ha

ve b

asel

ine

labo

rato

ry a

nd o

ther

nec

essa

rydi

agno

stic

eva

luat

ions

Thes

e di

agno

stic

s sh

ould

incl

ude

bull R

outin

e an

tena

tal c

are

labo

rato

ry in

vest

igat

ions

that

are

nor

mal

ly

done

for

all

preg

nant

wom

en

haem

oglo

bin

(Hb)

rh

esus

blo

od

grou

p an

d A

BO

typ

ing

VD

RL

uri

ne a

naly

sis

and

scre

enin

g fo

r S

TI

bull A

LT a

nd c

reat

inin

e le

vels

for

wom

en e

ligib

le f

or H

AA

RT

Prop

hyla

xis

amp m

icro

nutr

ient

sup

plem

enta

tion

bull

Cot

rimox

azol

e (C

TX) o

ne d

oubl

e st

reng

th o

r tw

o si

ngle

stre

ngth

tabl

ets

once

dai

ly

bull

Mul

tivita

min

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

83

OPE

RA

TIO

NA

L G

UID

ELIN

ESO

N F

EED

ING

CH

ILD

REN

6 M

ON

THS

AN

DO

LDER

The

follo

win

g sh

ould

gui

de fe

edin

g fo

r chi

ldre

n 6

mon

ths

and

olde

r

bull A

t 6

mon

ths

oth

er f

orm

s of

milk

alo

ne a

re n

ot a

dequ

ate

to m

eet

the

baby

rsquos n

utrit

iona

l req

uire

men

ts

bull C

ompl

emen

tary

foo

ds s

houl

d be

intr

oduc

ed w

ith c

ontin

ued

br

east

feed

ing

or w

ith r

epla

cem

ent

feed

ing

until

a n

utrit

iona

lly

adeq

uate

die

t ca

n be

sus

tain

ed w

ithou

t m

ilk

bull A

brup

t ces

satio

n of

bre

astf

eedi

ng s

houl

d be

dis

cour

aged

to

avoi

d

trau

ma

for

both

the

mot

her

and

the

baby

bull M

ilk s

houl

d co

ntin

ue a

s an

impo

rtan

t co

mpo

nent

of

the

diet

bull C

ompl

emen

tary

foo

ds s

houl

d be

enr

iche

d fr

om lo

cally

ava

ilabl

e

fam

ily f

oods

84

NU

TRIT

ION

AL

CA

RE

AN

D S

UPP

OR

TO

F H

IV

INFE

CTE

DC

HIL

DR

EN

bull E

nerg

y ne

eds

for

asym

ptom

atic

HIV

infe

cted

chi

ldre

n in

crea

se b

y 10

pe

rcen

t to

mai

ntai

n gr

owth

as

com

pare

d to

the

non-

infe

cted

chi

ldre

n

bull T

here

is n

o ev

iden

ce o

f in

crea

sed

prot

ein

requ

irem

ents

The

re

quir

emen

ts s

houl

d be

bas

ed o

n in

divi

dual

sym

ptom

s an

d ne

eds

bull M

icro

nutr

ient

req

uire

men

ts d

o no

t ch

ange

W

HO

rec

omm

ends

not

m

ore

than

one

RD

A

(For

fur

ther

det

ails

re

fer

to K

enya

n G

uide

lines

on

nutr

ition

and

HIV

A

IDS

)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

3

64

82

OPE

RA

TIO

NA

L G

UID

ELIN

ESO

N I N

FAN

TFE

EDIN

G (0

-6 M

ON

THS)

The

follo

win

g sh

ould

gui

de in

fant

feed

ing

for t

he fi

rst 6

mon

ths

bull A

ll w

omen

and

men

irre

spec

tive

of th

eir

HIV

sta

tus

shou

ld r

ecei

ve

coun

selin

g an

d de

mon

stra

tions

on

how

to s

afel

y fe

ed t

heir

babi

es

duri

ng t

he a

nten

atal

and

pos

tnat

al f

ollo

w u

p

bull T

he m

ost

appr

opria

te in

fant

fee

ding

opt

ion

for

an H

IV in

fect

ed

mot

her

shou

ld c

ontin

ue t

o de

pend

on

indi

vidu

al c

ircu

mst

ance

s an

d

the

av

aila

ble

supp

ort

bull E

very

HIV

infe

cted

wom

an s

houl

d be

eva

luat

ed a

t ev

ery

visi

t to

ch

eck

whe

ther

her

soc

ial

econ

omic

and

hea

lth s

tatu

s ha

s ch

ange

d

suff

icie

ntly

eno

ugh

to a

ffec

t he

r in

fant

fee

ding

opt

ion

bull E

xclu

sive

bre

astf

eedi

ng fo

r H

IV in

fect

ed w

omen

for

the

firs

t 6

mon

ths

of t

he in

fant

rsquos li

fe is

adv

isab

le

unle

ss r

epla

cem

ent f

eedi

ng is

ac

cept

able

fea

sibl

e a

ffor

dabl

e s

usta

inab

le a

nd s

afe

for

them

and

th

eir

infa

nts

befo

re t

hat t

ime

bull W

hen

repl

acem

ent

feed

ing

is a

ccep

tabl

e f

easi

ble

aff

orda

ble

su

stai

nabl

e an

d sa

fe

avoi

danc

e of

exc

lusi

ve b

reas

tfee

ding

by

HIV

in

fect

ed w

omen

is r

ecom

men

ded

bull I

f th

e co

nditi

ons

for

repl

acem

ent

feed

ing

are

still

not

met

for

6

mon

ths

then

co

ntin

uatio

n of

bre

astf

eedi

ng w

ith a

dditi

onal

co

mpl

emen

tary

fee

ding

is r

ecom

men

ded

giv

ing

prio

rity

to t

he lo

cally

av

aila

ble

food

s

bull I

nfan

t fe

edin

g de

cisi

ons

for

all H

IV e

xpos

ed in

fant

s sh

ould

be

base

d on

the

AF

AS

S c

riter

ia e

ven

whe

re e

arly

infa

nt d

iagn

osis

(E

ID)

is

avai

labl

e

bull B

reas

tfeed

ing

mot

hers

of

infa

nts

and

youn

g ch

ildre

n w

ho a

re k

now

n to

be

HIV

infe

cted

sho

uld

be s

tron

gly

enco

urag

ed to

con

tinue

bre

ast

feed

ing

How

ever

br

east

feed

ing

HIV

infe

cted

mot

hers

sho

uld

be

give

n nu

triti

on s

uppo

rt (

nutr

ition

al c

ouns

elin

g e

duca

tion

foo

d an

d nu

triti

onal

sup

plem

ents

)

63

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

44

Sulp

hur-

base

d in

term

itten

t pr

esum

ptiv

e m

alar

ia t

reat

men

t (I

PT) s

houl

d no

t be

giv

en

to w

omen

who

are

on

CTX

pro

phyl

axis

AR

V us

e

bull A

RV

s ar

e us

ed fo

r tr

eatin

g H

IV-i

nfec

ted

elig

ible

wom

en a

ndo

r fo

r pr

even

tion

of m

othe

r-to

-chi

ld tr

ansm

issi

on

bull H

IV-i

nfec

ted

preg

nant

wom

en e

ligib

le f

or A

RT

sho

uld

initi

ate

AR

T

as s

oon

as p

ossi

ble

as s

how

n in

Tab

le 4

1

bull H

IV-i

nfec

ted

preg

nant

wom

en a

lread

y on

AR

T b

efor

e be

com

ing

preg

nant

sho

uld

cont

inue

AR

T

The

bab

y sh

ould

be

give

n A

RV

pr

ophy

laxi

s so

on a

fter

birt

h as

sho

wn

in T

able

42

Tabl

e 4

1 R

ecom

men

datio

ns fo

r ini

tiatin

g A

RV

trea

tmen

t in

preg

nant

w

omen

bas

ed o

n cl

inic

al s

tage

and

ava

ilabi

lity

of C

D4

Cou

nt

WH

O

CD

4 te

stin

g

CD

4 te

stin

g

Clin

ical

Sta

ge

not a

vaila

ble

avai

labl

e

1 D

o no

t Tre

at

Trea

t if C

D4le

350

cells

mm

3

2 D

o no

t Tre

at

Trea

t if C

D4 le

350

cells

mm

3

3 Tr

eat

Trea

t irre

spec

tive

of C

D4

coun

t (c

onsi

der C

D4

valu

es fo

r bet

ter

man

agem

ent)

4 Tr

eat

Trea

t irre

spec

tive

of C

D4

cell

coun

t

Sourc

e A

dopte

d f

rom

WH

O

Anti-r

etro

vira

l dru

gs

for

trea

ting p

regnant

wom

en a

nd p

re-

venting H

IV infe

ctio

ns

Tabl

e 4

2 R

ecom

men

ded

first

-line

AR

T re

gim

en fo

r tre

atin

g pr

egna

nt w

omen

and

pro

phyl

actic

regi

men

for i

nfan

ts

Mot

her

Ant

epar

tum

AZ

T +

3TC

+ N

VP D

aily

Intra

partu

m

AZT

+ 3T

C +

NVP

Dai

ly

Pos

tpar

tum

AZ

T +

3TC

+ N

VP D

aily

Infa

nt p

roph

ylax

is

Sd

NV

P 2

mg

kg s

tat w

ithin

72

hour

s 3T

C X

1 w

eek

(4

mg

kg B

ID)

AZT

X 6

wee

ks (4

mg

kg B

ID)

Mat

erna

l dos

ages

AZT

300

mg

BID

3TC

150

mg

BID

NV

P 2

00 m

g O

D fo

r tw

o w

eeks

the

reaf

ter 2

00 m

g B

ID

Infa

nt D

osag

es

NV

P

2mg

kg s

tat w

ithin

72

hour

s

AZT

4mg

kg B

ID X

6 w

eeks

3TC

4m

gkg

BID

X 1

wee

k

Cha

pter

8

Feed

ing

Infa

nts

and

Youn

g C

hild

ren

Bor

n to

HIV

Infe

cted

Mot

hers

81

INTR

OD

UC

TIO

N T

RA

NSM

ISSI

ON

OF

HIV

THR

OU

GH

B

REA

STFE

EDIN

G

In A

fric

a 3

to 4

out

of e

very

10

infa

nts

born

to H

IV in

fect

ed w

omen

acq

uire

HIV

infe

cshytio

n T

here

is t

here

fore

a 5

ndash 2

0 pe

rcen

t ri

sk o

f inf

ants

bor

n to

HIV

pos

itive

mot

hers

ac

quir

ing

infe

ctio

n th

roug

h br

east

-fe

edin

g if

ther

e ar

e no

inte

rven

tions

in

pla

ce

For

wom

en w

ho a

re i

nshyfe

cted

with

HIV

for

the

first

tim

e or

w

ho a

re r

e-in

fect

ed w

ith a

diff

eren

t st

rain

of H

IV d

urin

g th

e br

east

feed

shyin

g ph

ase

the

ris

k in

crea

ses

up t

o29

per

cen

t H

alf (

12)

of H

IV b

reas

t m

ilk t

rans

mis

sion

tak

es p

lace

by

6 w

eeks

and

thre

e qu

arte

rs (3

4) b

y 6

mon

ths

Mix

ed fe

edin

g in

crea

ses

the

risk

of

brea

st m

ilk t

rans

mis

sion

of

HIV

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

5

62

For

prop

hyla

xis

the

reco

mm

enda

tions

are

ran

ked

and

will

dep

end

on t

ime

of fi

rst

conshy

tact

with

the

wom

an H

IV-in

fect

ed p

regn

ant w

omen

who

are

not

elig

ible

for

AR

T or

in

72

3 C

OM

PREH

ENSI

VE

CA

RE

FOR H

IV-E

XPO

SED

CH

ILD

REN

w

hom

it is

not

pos

sibl

e to

sta

rt A

RT

imm

edia

tely

and

the

mot

her

is b

eing

see

n be

twee

n28

and

38

wee

ks o

f pr

egna

ncy

sho

uld

be s

tart

ed o

n re

com

men

ded

mor

e ef

ficac

ious

shor

t co

urse

pro

phyl

actic

AR

V r

egim

ens

as s

how

n in

Tab

le 4

3a

The

bab

y sh

ould

als

obe

giv

en A

RV

pro

phyl

axis

soo

n af

ter

birt

h as

sho

wn

in th

e sa

me

tabl

e T

he r

egim

ens

asou

tline

d be

low

are

for

prop

hyla

xis

and

not f

or tr

eatm

ent

MINI

STRY

OF H

EAL

TH

Tabl

e 4

3a R

ecom

men

ded

Firs

t Lin

e A

RV

prop

hyla

xis

ALGO

RITH

M FO

R EA

RLY

INFA

NTDI

AGNO

SISFO

R HI

VEX

POSE

DCH

ILDRE

N

to p

reve

nt H

IV in

fect

ion

in in

fant

s A

mon

g Pr

egna

nt W

omen

Pr

esen

ting

Bef

ore

38 W

eeks

Ran

king

Ti

me

of A

dmin

istr

atio

n

WEL

L CHI

LD

SICK

CHI

LD

(Man

age

pres

entin

g ill

ness

and

stab

ilize

)

STAR

T CO

TRIM

OXAZ

OLE

PROP

HYLA

XIS

FOR M

OR E

INFOR

MATIO

N C ON

TACT

THE N

ATI O

NAL A

IDS S

TD CO

NTRO

L PRO

GRAM

ME ( N

ASCO

P) PO

BOX

19 36

1-00

20 2 N

AIRO

BI TE

L 02

02 72

95 02

FAX 0

2 0 2 7

1 05 1

8

Exp

osur

e sta

tus s

houl

d be

det

erm

ined

for a

ll in

fants

of u

nkno

wn s

tatu

s at t

he

6 we

ek v

isit o

r firs

t con

t act

Coun

sel o

n inf

ant f

eedi

ng a

s per

nat

iona

l gui

delin

es

Conf

irma

tory

ABt

est

at 1

8 M

onth

s

Eval

uate

for

ART

star

t on

ARV

if el

igibl

e

If HI

V+ a

t 12

Mont

hs

Evalu

ate f

or A

RT

Start

on

ARV

if eli

gible

6 Wee

ks D

BS (P

CR)

HIV

+

If HI

V-sto

p CT

X if

not

BF

for a

t lea

st 2

Mont

hs

HI

V-

Antib

ody

test

ing

12 M

onth

s

Conf

irmat

ory

ABte

st at

18 M

onth

s

Conf

irmat

ory A

B te

st at

18 M

onth

s

Eval

uate

for A

RT

star

t on

ARV

if el

igible

If HIV

+ at

12

Mon

ths

Eval

uate

for A

RT

Star

t on

ARV

if el

igibl

e

If lt1

2 Mon

ths D

BS (P

CR)

If gt

12m

o An

tibod

y te

st

HIV

+

If HIV-

stop

CTX

if n

ot

BF

for a

t lea

st 2

Mont

hs

HI

V-

Antib

ody

testi

ng

12 M

onth

s

Conf

irma

tory

AB

test

at 1

8 Mo

nths

Exp

osur

e sta

tus s

hould

be de

term

ined

for a

ll in

fant

s of u

nkno

wn st

atus

at th

e 6w

eek

visit

or fi

rst c

onta

ct

Co

unse

l on

infa

nt fe

edin

g as

per n

atio

nal g

uideli

nes

Pre

gnan

cy

Labo

ur

Pos

tpar

tum

Mat

erna

l In

fant

Rec

omm

ende

d

AZT(

28-3

8 w

eeks

ge

stat

ion)

sd

NV

P

+ AZ

T+3T

C

AZT+

3TC

X

7 da

ys

sdN

VP

PL

US

3TC

X1

wee

k +

AZT

X

6 w

eeks

Tabl

e 4

3b b

elow

sho

ws

alte

rnat

ive

prop

hyla

ctic

regi

men

s fo

r w

omen

pre

sent

ing

befo

re 3

8 w

eeks

of p

regn

ancy

Ran

king

Ti

me

of A

dmin

istr

atio

n

Alte

rnat

ive

Min

imum

Pre

gnan

cy

AZT(

28-3

8 w

eeks

)

Labo

ur

sd N

VP

+

AZT(

600m

gs

stat

)

sdN

VP

+ A

ZT+3

TC

Pos

tpar

tum

AZT+

3TC

X

7 da

ys

Infa

nt

sdN

VP

+

3TC

X 7

da

ys +

AZT

X

6 w

eeks

sdN

VP

+

3TC

day

s +

AZT

X 6

wee

ks

HIV

-infe

cted

pre

gnan

t w

omen

who

are

see

n fo

r th

e fir

st t

ime

afte

r 38

wee

ks o

f pr

egshy

nanc

y or

in la

bour

sho

uld

be g

iven

AR

V p

roph

ylac

tic r

egim

ens

as s

how

n in

Tab

le 4

4

The

baby

sho

uld

also

be

give

n A

RV

pro

phyl

axis

soo

n af

ter

birt

h as

sho

wn

in t

he s

ame

Bot

h H

IV-in

fect

ed a

nd u

ninf

ecte

d ch

ildre

n re

quir

e co

mpr

ehen

sive

car

e (R

efer

to C

hap-

tabl

ete

r 8

and

9)

61

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

46

Tabl

e 4

4 A

RV

prop

hyla

xis

for P

MTC

T am

ong

preg

nant

wom

en w

ho

have

not

rece

ived

ant

enat

al A

RT

or p

roph

ylax

is

Ran

king

Ti

me

of A

dmin

istr

atio

n

La

bour

P

ostp

artu

m

Mat

erna

l In

fant

Rec

omm

ende

d

sdN

VP

AZ

T+3T

C

SdN

VP

+

X 7

days

P

LUS

3TC

X 1

wee

k +

AZT+

3TC

AZ

T X

6 w

eeks

Min

imum

sd

NV

P

-S

dNV

P

PLU

S 3

TC X

1 w

eek

+

AZT

X 6

wee

ks

Dos

ages

Mot

her

Bab

y

NV

P

200

mg

stat

2m

gkg

sta

t with

in 7

2 ho

urs

AZT

300

mg

BID

4m

gkg

BID

X 6

wee

ks

3TC

15

0 m

g BI

D

4mg

kg B

ID X

1 w

eek

Tabl

e 4

5 R

ecom

men

ded

HA

AR

T fo

r Pre

gnan

t Wom

en

base

d on

CD

4 C

ount

and

Sta

ge o

f Pre

gnan

cy

CD

4 C

ount

H

AA

RT

Trim

este

r C

ells

mm

3

72

2 H

IV P

OSI

TIV

EIN

FAN

TB

Y D

NA

PC

R

bull A

ll H

IV p

ositi

ve in

fant

s sh

ould

be

eval

uate

d fo

r el

igib

ility

for

antishy

retr

ovir

al tr

eatm

ent

and

linke

d to

car

e an

d tr

eatm

ent

as a

ppro

pria

te

bull W

HO

clin

ical

sta

ging

sho

uld

be d

one

for

all H

IV p

ositi

ve in

fant

s

Chi

ldre

n w

ho a

re a

t W

HO

Clin

ical

sta

ge 3

or

4 ar

e el

igib

le f

or

antir

etro

vira

l tre

atm

ent

bull A

ll H

IV p

ositi

ve in

fant

s sh

ould

be

asse

ssed

for

CD

4 co

unt

whe

re

poss

ible

and

ava

ilabl

e R

efer

to

AR

T g

uide

lines

for

CD

4 co

unts

tha

t de

term

ine

elig

ibili

ty f

or A

RT

for

chi

ldre

n of

diff

eren

t ag

e br

acke

ts

bull A

ll H

IV-p

ositi

ve in

fant

s sh

ould

hav

e a

visi

ble

guar

dian

or

care

-tak

er

befo

re t

hey

can

be s

tart

ed o

n A

RT

bull A

ll H

IV-p

ositi

ve in

fant

s sh

ould

be

star

ted

on C

otri

mox

azol

e fr

om 6

w

eeks

or

on f

irst

cont

act t

here

afte

r

bull A

ll H

IV-p

ositi

ve in

fant

s sh

ould

be

star

ted

on A

RT

if el

igib

le

bull B

reas

tfeed

ing

shou

ld b

e en

cour

aged

for

all

HIV

-pos

itive

infa

nts

for

a

min

imum

of t

wo

year

s (

Ref

er t

o C

hapt

er 8

)

bull F

or a

ll H

IV-p

ositi

ve in

fant

s p

erfo

rm a

ntib

ody

test

ing

at 9

mon

ths

12

mon

ths

and

conf

irm

at

18 m

onth

s

1st T

rimes

ter

2nd T

rimes

ter

3rd T

rimes

ter

lt250

A

ZT+

3TC

+NV

P

AZ

T+3T

C+N

VP

AZT+

3TC

+NVP

250-

350

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

gt 35

0

A

ZT+3

TC+L

PVr

OR

A

BC

+3TC

+LPV

r

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

47

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

60

72

OPE

RA

TIO

NA

L G

UID

ELIN

ES

72

0 G

UID

ELIN

ESFO

R H

IV D

IAG

NO

SIS

INC

HIL

DR

EN

bull P

erfo

rm r

outin

e ra

pid

HIV

ant

ibod

y te

sts

for

all m

othe

rs o

f 6

wee

k ol

d in

fant

s pr

esen

ting

with

unk

now

n st

atus

bull P

erfo

rm r

outin

e dr

y bl

ood

spot

s (D

BS

) fo

r D

NA

PC

R f

or a

ll in

fant

s kn

own

to b

e H

IV-e

xpos

ed a

t 6

wee

ks

bull P

erfo

rm r

outin

e an

tibod

y te

stin

g fo

r al

l sic

k in

fant

s in

out

patie

nt a

nd

paed

iatr

ic w

ards

to

esta

blis

h H

IV e

xpos

ure

infe

ctio

n st

atus

bull P

erfo

rm D

BS

for

all

HIV

-exp

osed

sic

k in

fant

s un

der

12 m

onth

s

bull A

ll H

IV-e

xpos

ed in

fant

s sh

ould

be

star

ted

on C

otri

mox

azol

e fr

om 6

w

eeks

of

age

or o

n fir

st c

onta

ct th

erea

fter

bull R

efer

to

chap

ter

on c

are

and

follo

w u

p of

the

HIV

-exp

osed

infe

cted

in

fant

72

1 H

IV N

EGA

TIV

EIN

FAN

TA

TA

GE

6 W

EEK

SO

RFI

RST

CO

NTA

CT

Perf

orm

ant

ibod

y te

stin

g at

9 m

onth

s an

d 12

mon

ths

of a

ge

bull I

f H

IV n

egat

ive

at 1

2 m

onth

s an

d st

ill b

reas

tfee

ding

co

ntin

ue

Cot

rim

oxaz

ole

bull I

f not

bre

astf

eedi

ng f

or a

t le

ast

2 m

onth

s s

top

Cot

rim

oxaz

ole

bull P

erfo

rm c

onfir

mat

ory

antib

ody

test

ing

at 1

8 m

onth

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Mat

erna

l dos

ages

AZT

30

0 m

g B

ID

3TC

15

0 m

g BI

D

NVP

200

mg

OD

for t

wo

wee

ks t

here

afte

r 200

mg

BID

AB

C

300m

g B

ID

LPV

r (4

001

00)

2 ta

blet

s B

ID

EFV

60

0mg

QID

Not

es I

mpo

rtan

t con

side

ratio

ns th

at m

odify

cho

ice

of A

RV

s du

ring

pre

gnan

cy in

clud

e C

D4

coun

t m

ater

nal a

naem

ia a

nd

stag

e of

pre

gnan

cy

bull 2

NR

TIs

(A

ZT

and

3TC

) ac

ting

as a

ldquotr

eatm

ent

back

bone

rdquo w

ith a

dditi

on o

f an

N

NR

TI (

NV

P)

rem

ains

the

pre

ferr

ed fi

rst-

line

AR

V t

hera

py in

res

ourc

e-po

or

sett

ings

bull P

rote

ase

inhi

bito

rs b

ased

reg

imen

s ar

e pr

efer

able

whe

n C

D4

coun

t is

high

er

than

250

bull R

epla

ce A

ZT

with

d4T

if H

blt 8

gm

dL

bull

EF

V m

ay b

e us

ed in

stea

d of

NV

P a

fter

first

trim

este

r

bull

Usu

ally

AR

V s

houl

d be

with

held

if C

D4

coun

t is

not

ava

ilabl

e or

not

don

e

AR

V is

how

ever

use

d fo

r P

MT

CT

and

or in

adv

ance

d H

IV d

isea

se (

WH

O

Sta

ge 3

or

4) ir

resp

ectiv

e of

CD

4 co

unt

Bab

ies

who

se

mot

hers

di

d no

t re

ceiv

e an

tepa

rtum

or

in

trap

artu

m

AR

Vpr

ophy

laxi

s sh

ould

be

give

n A

RV

pro

phyl

axis

as

show

n in

Tab

le 4

6

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

9

48

Tabl

e 4

6 A

RV

prop

hyla

ctic

regi

men

s fo

r inf

ants

bor

n to

H

IV-p

ositi

ve w

omen

who

hav

e no

t rec

eive

d an

tepa

rtum

or

intr

apar

tum

AR

T or

AR

V pr

ophy

laxi

s

Ran

king

T

ime

of a

dmin

istr

atio

n an

d In

fant

dos

age

sdN

VP (2

mg

kg s

tat)

PLU

S 3T

C (4

mg

kg B

ID) X

1 w

eek

+ AZ

T (4

mg

kg

BID

) X 6

wee

ks

Rec

omm

ende

d

sdN

VP (2

mg

kg s

tat)

Min

imum

sdN

VP

is g

iven

to th

e in

fant

with

in 7

2 ho

urs

of b

irth

Plea

se n

ote

A

t fir

st c

onta

ct a

ll H

IV i

nfec

ted

preg

nant

wom

en s

houl

d be

giv

en s

dNV

P ta

blet

s to

take

hom

e w

ith t

hem

The

y sh

ould

be

inst

ruct

ed t

o ta

ke t

he t

able

ts a

t th

e on

set

of la

shybo

ur i

f lab

our

occu

rs o

utsi

de h

ealth

faci

lity

sett

ings

The

y sh

ould

als

o be

giv

en N

VP

3T

C a

nd A

ZT s

yrup

for

thei

r ba

bies

to b

e ad

min

iste

red

soon

aft

er b

irth

Som

e w

omen

with

a C

D4

coun

t gr

eate

r th

an 2

50 c

ells

microl

on

Nev

irap

ine

(NV

P)-b

ased

AR

T m

ay d

evel

op N

VP

hype

rsen

sitiv

e re

actio

ns t

hat

can

be li

fe t

hrea

teni

ng I

n th

ese

guid

elin

es it

is r

ecom

men

ded

that

for

preg

nant

wom

en w

ith C

D4

mor

e th

an 2

50 N

VP-

base

d re

gim

en m

ay s

till

be u

sed

but

with

clo

se m

onito

ring

O

ther

wis

e th

e re

com

shym

ende

d re

gim

en to

use

with

CD

4 co

unt a

bove

250

is a

PI-

base

d H

AA

RT

regi

men

Whe

n si

ngle

dos

e N

VP

(sdN

VP)

is u

sed

in P

MTC

T s

ome

wom

en a

nd c

hild

ren

may

deshy

velo

p re

sist

ance

to

NV

P th

at m

ay l

imit

futu

re u

se o

f N

on-N

ucle

osid

e R

ever

se T

ranshy

scri

ptas

e In

hibi

tors

(NN

RTI

s) t

o tr

eat

them

Th

e ri

sk o

f NN

RTI

res

ista

nce

is p

artic

ushyla

rly

high

if

two

dose

s of

sdN

VP

are

give

n T

here

fore

SdN

VP

shou

ld n

ever

be

used

mor

e th

an o

nce

in a

ny o

ne p

regn

ancy

Whe

re p

ossi

ble

AZT

3TC

sho

uld

be g

iven

for

7 da

ys t

o co

ver

the

NV

P ta

il bo

th in

the

mot

her

and

the

baby

Th

e ba

by is

the

n co

ntin

shyue

d on

AZT

for

a to

tal o

f 6 w

eeks

for

prop

hyla

xis

agai

nst M

TCT

HIV

-infe

cted

pre

gnan

t w

omen

sta

rtin

g zi

dovu

dine

(A

ZT)

cont

aini

ng r

egim

ens

shou

ld

have

hae

mog

lobi

n (H

b) le

vels

abo

ve 8

gm

dl

The

Hb

leve

l sho

uld

be c

heck

ed m

onth

ly

for

the

first

thr

ee m

onth

s W

here

pos

sibl

e A

ZT s

houl

d be

use

d in

stea

d of

sta

vudi

ne(d

4T)

Clin

ical

judg

emen

t can

be

used

to e

stim

ate

Hb

leve

ls a

nd in

itiat

e AR

V pr

ophy

laxi

s if l

aboshy

rato

ry te

sts a

re u

nava

ilabl

e

Efa

vire

nz (

EFV

) m

ay b

e te

rato

geni

c if

used

in t

he f

irst

tri

mes

ter

If t

he p

atie

nt is

on

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Cha

pter

7

HIV

Dia

gnos

is in

Chi

ldre

n 7

1 IN

TRO

DU

CTI

ON

In g

ener

al

a ch

ild m

ay b

e te

sted

und

er a

num

ber

of c

ircu

mst

ance

s T

hese

inc

lude

sh

ortly

aft

er b

irth

for

earl

y di

agno

sis

of H

IV f

or th

e pu

rpos

es o

f ind

ivid

ual d

iagn

osis

in

a ch

ild w

ho is

ill (

eg

tho

se p

rese

ntin

g w

ith a

n H

IV r

elat

ed il

lnes

s) i

n ca

ses

whe

re a

child

has

eith

er b

een

expo

sed

or is

pot

entia

lly e

xpos

ed t

o H

IV e

g t

hrou

gh m

othe

r-to

shych

ild t

rans

mis

sion

se

xual

abu

se

sexu

al a

ctiv

ity

with

in a

hea

lthca

re s

ettin

g (e

g

thro

ugh

cont

amin

ated

nee

dles

or

rece

ipt

of p

oten

tially

infe

ctio

us b

lood

) th

roug

h ot

her

mea

ns a

nd in

orp

hans

Ear

ly i

nfan

t di

agno

sis

(EID

) re

fers

to

the

mak

ing

of H

IV d

iagn

osis

in

infa

nts

and

youn

g ch

ildre

n be

fore

18

mon

ths

of a

ge E

ID g

ives

an

oppo

rtun

ity fo

r ea

rly

iden

tific

ashytio

n of

HIV

infe

cted

infa

nts

(des

pite

PM

TCT)

and

ear

ly li

nkag

e to

car

e an

d tr

eatm

ent

Dis

ease

pro

gres

sion

in H

IV in

fect

ed in

fant

s is

fast

with

a h

igh

mor

talit

y ra

te (gt

50

)by

2 y

ears

of a

ge T

he m

edia

n ag

e of

dea

th in

the

first

two

year

s is

6 m

onth

s H

IV a

ntishy

body

tes

ting

amon

g ch

ildre

n ag

ed 1

8 m

onth

s or

mor

e is

abl

e to

det

erm

ine

whe

ther

a

child

is in

fect

ed o

r no

t

Dur

ing

preg

nanc

y m

othe

rs g

ive

thei

r ba

bies

ant

ibod

ies

to in

fect

ions

the

y ha

ve e

xper

ishyen

ced

and

thes

e an

tibod

ies

wan

e w

ith ti

me

Ant

ibod

y te

stin

g in

chi

ldre

n ag

ed le

ss th

an

18 m

onth

s id

entif

ies

child

ren

who

hav

e be

en e

xpos

ed to

thei

r m

othe

rsrsquo H

IV in

fect

ion

or

who

may

be

trul

y in

fect

ed a

nd a

re m

akin

g H

IV a

ntib

odie

s C

urre

ntly

the

re is

no

test

to

diff

eren

tiate

the

mot

herrsquos

ant

ibod

ies

from

tho

se p

rodu

ced

by t

he b

aby

In

orde

r to

id

entif

y th

e H

IV-in

fect

ed c

hild

age

d le

ss t

han

18 m

onth

s a

sec

ond

test

is r

equi

red

for

all b

abie

s te

stin

g po

sitiv

e on

ant

ibod

y te

stin

g or

kno

wn

to b

e H

IV-e

xpos

ed (m

othe

r is

H

IV-p

ositi

ve)

Infa

nt D

NA

(or

RN

A) P

CR

tes

ting

is t

he c

urre

nt r

ecom

men

ded

met

hod

for

EID

Sinc

e m

ost b

abie

s lo

se m

ater

nal a

ntib

odie

s (A

b) b

y 12

mon

ths

a n

egat

ive

antib

ody

test

will

ide

ntify

uni

nfec

ted

babi

es a

s lo

ng a

s th

ey a

re n

ot s

till

brea

stfe

edin

g A

pos

itive

antib

ody

test

at

12 m

onth

s a

lthou

gh h

ighl

y lik

ely

to b

e di

agno

stic

may

stil

l be

due

topa

ssiv

ely

carr

ied

mat

erna

l ant

ibod

ies

Suc

h te

sts

need

to

be c

onfir

med

by

PCR

tes

ting

or r

epea

t ant

ibod

y te

st a

t 18

mon

ths

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

9

58

CARE

SU

PPO

RTAN

DTR

EATM

ENT

FOR

HIV

PO

SITI

VEM

OTH

ERAN

DCH

ILD

HIV

-pos

itive

mot

hers

requ

ire c

are

and

supp

ort w

hich

incl

udes

bull

Cou

nsel

ing

bull P

roph

ylax

is a

nd tr

eatm

ent

bull L

ink

to s

uppo

rt g

roup

s an

d as

sess

men

t of

the

nee

d fo

r A

RT

bull E

arly

infa

nt d

iagn

osis

sho

uld

be p

rovi

ded

at s

ix w

eeks

usi

ng D

NA

shyP

CR

tes

ting

Cha

pter

ref

eren

ces

1

Rep

ublic

of

Ken

ya M

inis

try

of

Hea

lth

Div

isio

n o

f Rep

roduct

ive

Hea

lth

Pla

nnin

g

Guid

elin

es f

or

serv

ice

pro

vider

s

Rev

ised

in M

arch

2006

Foo

tnot

es

1

Pre

ble

and P

iwoz

2001

2

WH

O

Contr

ace

ptive

Elig

ibili

ty C

rite

ria

Guid

e

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

EFV

bef

ore

beco

min

g pr

egna

nt i

t sho

uld

be s

ubsi

tute

d w

ith N

VP

in th

e 1s

t tri

mes

ter

In c

ase

of s

ever

e hy

pere

mes

is g

ravi

daru

m A

RT

may

nee

d to

be

brie

fly in

terr

upte

d

On

aver

age

mot

her-

to-c

hild

tra

nsm

issi

on r

ates

are

15

for

sdN

VP

65

fo

r m

ore

effishy

caci

ous

dual

reg

imen

s an

d 2

4 fo

r 3-

drug

AR

V c

ombi

natio

n

Futu

re P

ersp

ectiv

es

Ext

ende

d pr

ophy

laxi

s w

ith 3

AR

V d

rug

com

bina

tions

sta

rtin

g du

ring

pre

gnan

cy a

nd

cont

inui

ng a

fter

del

iver

y fo

r a

peri

od o

f up

to

6 m

onth

s a

mon

g H

IV-in

fect

ed b

reas

t-fe

edin

g m

othe

rs h

as b

een

show

n in

a f

ew r

ecen

t an

d is

olat

ed s

tudi

es a

nd p

ilot

proshy

gram

me

to le

ad to

low

er b

reas

tfee

ding

-rel

ated

pos

tnat

al M

TCT

Thi

s ap

proa

ch m

ay b

e co

nsid

ered

whe

re th

is is

feas

ible

acc

epta

ble

saf

e an

d w

here

adh

eren

ce c

an b

e as

sure

d

Mor

e st

udie

s on

this

issu

e ar

e ex

pect

ed

Thre

e A

RV

dru

g co

mbi

natio

ns g

iven

to

HIV

pos

itive

pre

gnan

t w

omen

who

are

not

yet

el

igib

le fo

r in

itiat

ion

of A

RTs

for

thei

r ow

n he

alth

als

o le

ad to

low

er M

TCT

and

may

be

cons

ider

ed in

pro

gram

mes

with

the

capa

city

to in

itiat

e th

e re

gim

en a

nd fo

llow

up

such

wom

en S

uch

inte

rven

tion

is in

itiat

ed a

t ar

ound

28

wee

ks o

r so

on a

fter

and

sto

pped

af

ter

birt

h if

CD

4 co

unt i

s st

ill a

bove

350

cel

lsm

m3

App

endi

ces

Appen

dix

I

Appen

dix

II

Appen

dix

III

Appen

dix

IV

WH

O C

linic

al S

tagin

g o

f H

IVA

IDS f

or

Adults

and A

dole

scen

ts

w

ith c

onfirm

ed H

IV infe

ctio

n

Contr

acep

tive

Options

for

Peo

ple

Liv

ing w

ith H

IV

Sum

mar

y of

ARV D

rug U

se f

or

PMTCT o

f H

IV

In

tegra

ted M

onitori

ng a

nd E

valu

ation R

eport

Form

MO

H 7

26

Cha

pter

ref

eren

ces

1

Sum

mar

y of

ARV D

rugs

Adve

rse

Effec

ts a

nd M

anag

emen

t T

able

6-1

0

pages

101-1

12 o

f G

uid

elin

es f

or

Antire

trovi

ral D

rug T

her

apy

in K

enya

3rd

Editio

n

De-

cem

ber

2005

2

Dru

g I

nte

ract

ions

Tab

le 7

-10

pag

es 1

12-1

22 o

f G

uid

elin

es f

or

Antire

trovi

ral

Dru

g T

her

apy

in K

enya

3rd

editio

n

Dec

2005

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

7

50

Cha

pter

5

Imm

edia

te P

ostn

atal

and

Neo

nata

l Car

e 5

1 IN

TRO

DU

CTI

ON

Imm

edia

te p

ostn

atal

and

neo

nata

l car

e re

fers

to th

e pa

ckag

e of

ser

vice

s pr

ovid

ed to

the

mot

her

and

infa

nt b

efor

e th

ey le

ave

the

heal

th fa

cilit

y (u

p to

48

hour

s) a

fter

del

iver

yTh

e pe

riod

pro

vide

s an

opp

ortu

nity

to e

duca

te a

ll m

othe

rs a

bout

HIV

to

prov

ide

coun

shyse

lling

and

tes

ting

if it

was

not

don

e pr

evio

usly

and

to

rein

forc

e th

e ed

ucat

ion

proshy

vide

d du

ring

the

ant

enat

al p

erio

d B

oth

HIV

inf

ecte

d an

d H

IV u

ninf

ecte

d m

othe

rs

shou

ld r

ecei

ve th

is e

duca

tion

and

coun

selli

ng b

efor

e di

scha

rge

52

OPE

RA

TIO

NA

L G

UID

ELIN

ES

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed fo

r all

wom

en a

nd

infa

nts

in th

e im

med

iate

pos

t par

tum

per

iod

a)

Opt

imal

pos

tpar

tum

car

e

bull R

outin

e ca

re in

clud

ing

brea

st e

xam

inat

ion

exa

min

atio

n of

the

ute

rus

ex

amin

atio

n of

the

per

ineu

m a

nd lo

chia

pa

ssag

e of

uri

ne r

egul

arly

pr

oper

hyg

iene

to

prev

ent

infe

ctio

n c

heck

ing

for

sign

s of

ana

emia

fe

ver

and

tach

ycar

dia

bull D

iscu

ss m

ater

nal n

utri

tion

bull E

stab

lish

the

HIV

sta

tus

of t

he m

othe

rs in

clud

ing

thos

e gi

ving

birt

h ou

tsid

e th

e he

alth

inst

itutio

n se

tting

bull P

rovi

de H

IV C

T f

or m

othe

rs w

ith u

nkno

wn

HIV

sta

tus

bull E

ncou

rage

HIV

res

ults

dis

clos

ure

and

part

ner

test

ing

bull F

ollo

w t

he s

tand

ard

guid

elin

es o

n th

e ca

re o

f a n

ewbo

rn (

IMP

AC

C

are

Man

ual)

bull A

ll ba

bies

sho

uld

rece

ive

thei

r ro

utin

e im

mun

izat

ion

(OP

V a

nd B

CG

) in

th

eir

first

hou

rs o

f lif

e1

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Con

trac

eptio

n A

ll m

othe

rs r

egar

dles

s of

the

ir H

IV s

tatu

s h

ave

a ri

ght

to r

ecei

ve a

dequ

ate

info

rmashy

tion

on a

vaila

ble

met

hods

of f

amily

pla

nnin

g an

d to

mak

e an

info

rmed

cho

ice

on w

hat

is b

est

for

them

H

IV-in

fect

ed w

omen

who

are

not

bre

astf

eedi

ng s

houl

d in

itiat

e a

relia

ble

cont

race

ptiv

e m

etho

d by

2-4

wee

ks p

ostp

artu

m

This

is

in a

dditi

on t

o th

epr

oper

and

con

sist

ent

use

of t

he c

ondo

m a

s a

form

of

dual

pro

tect

ion

All

met

hods

of

cont

race

ptio

n ca

n be

use

d by

HIV

pos

itive

wom

en b

ased

on

stan

dard

med

ical

elig

ibili

tycr

iteri

a in

clud

ing

taki

ng c

are

of d

rug

inte

ract

ions

as

outli

ned

belo

w2

bull L

acta

tiona

l Am

enor

rhoe

a M

etho

d (L

AM

) S

uita

ble

for

excl

usiv

ely

brea

stfe

edin

g H

IV in

fect

ed w

omen

who

hav

e no

t re

sum

ed m

ense

s

bull H

orm

onal

con

trac

eptio

n A

ll ho

rmon

al c

ontr

acep

tives

can

be

used

in

HIV

pos

itive

wom

en in

clud

ing

thos

e on

HA

AR

T

Com

bine

d or

al

cont

race

ptiv

es a

re c

ontr

aind

icat

ed f

or u

se w

ith d

rugs

that

indu

ce

hepa

tic m

icro

-enz

yme

that

may

red

uce

the

effe

ctiv

enes

s of

hor

mon

al

cont

race

ptiv

es

Som

e an

ti-T

Bs

ant

iret

rovi

rals

an

tifun

gals

and

ant

i-ep

ilept

ics

and

in c

ondi

tions

tha

t ca

use

mal

abso

rptio

n8

bull I

ntra

-ute

rine

con

trac

eptiv

e de

vice

s (I

UC

Ds)

IU

CD

s ar

e no

t co

ntra

indi

cate

d in

HIV

pos

itive

wom

en

In s

ever

ely

imm

uno

supp

rese

d w

omen

use

sho

uld

not

be d

isco

ntin

ued

but

new

inse

rtio

n is

dis

cour

aged

as

it m

ay b

e as

soci

ated

with

incr

ease

d ri

sk o

f in

fect

ion

duri

ng t

he in

sert

ion

proc

ess

bull S

urgi

cal m

etho

ds S

urgi

cal c

ontr

acep

tion

shou

ld b

e of

fere

d to

HIV

po

sitiv

e w

omen

and

the

ir pa

rtne

rs

bull B

arri

er m

etho

ds

Fem

ale

and

mal

e co

ndom

s pr

ovid

e pr

otec

tion

agai

nst

ST

Ds

and

redu

ce t

he r

isk

of H

IV t

rans

mis

sion

and

sho

uld

be

enco

urag

ed a

lone

or

toge

ther

with

oth

er c

ontr

acep

tive

met

hods

bull S

perm

icid

es

Use

d in

con

junc

tion

with

bar

rier

met

hods

spe

rmic

ides

w

ill p

rovi

de a

dditi

onal

con

trac

eptiv

e pr

otec

tion

How

ever

sp

erm

icid

es s

houl

d no

t be

use

d al

one

as t

hey

can

incr

ease

the

ris

k of

HIV

acq

uisi

tion

bull E

mer

genc

y co

ntra

cept

ion

HIV

pos

itive

wom

en s

houl

d be

info

rmed

ab

out

emer

genc

y co

ntra

cept

ion

whe

re it

is a

vaila

ble

and

how

to

obta

in a

nd u

se it

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

1

56

Bre

ast c

are

in b

reas

tfeed

ing

mot

hers

bull E

ncou

rage

dai

ly c

lean

ing

of t

he b

reas

ts a

nd a

void

ing

the

appl

icat

ion

of lo

tions

bull T

reat

mat

erna

l vag

inal

can

didi

asis

and

infa

nt o

ral c

andi

dias

is

bull E

duca

te m

othe

r on

opt

imal

bre

astf

eedi

ng te

chni

que

incl

udin

g la

tchi

ng

on t

echn

ique

ex

lusi

ve b

reas

tfee

ding

and

rem

ovin

g ba

by f

rom

bre

ast

bull E

duca

te th

e m

othe

r on

bre

ast c

are

to p

reve

nt c

ompl

icat

ions

(cr

acki

ng

and

engo

rgem

ent)

bull E

xpre

ss a

nd h

eat

trea

t th

e m

ilk if

bre

ast

has

mas

titis

or

absc

ess

Opt

imal

pos

tpar

tum

car

e fo

r HIV

pos

itive

wom

en

Loch

ia

bull P

ut e

mph

asis

on

good

per

inea

l hyg

iene

and

pro

per

hand

ling

of b

ody

fluid

s

bull A

void

con

tam

inat

ing

the

baby

with

bod

y flu

ids

or w

ith b

eddi

ng s

oile

d w

ith lo

chia

bull S

hari

ng o

f be

ds b

y m

othe

rs in

the

hos

pita

l sho

uld

be d

isco

urag

ed

Cae

sare

an S

ectio

n

Bro

ad s

pect

rum

ant

ibio

tics

shou

ld b

e us

ed r

outin

ely

afte

r C

S

Esse

ntia

l mat

erna

l edu

catio

n an

d fo

llow

-up

bull M

onito

r fo

r br

east

and

pel

vic

infe

ctio

n at

all

post

nat

al c

linic

vis

its

bull E

duca

te o

n pr

ompt

hea

lth s

eeki

ng b

ehav

iour

bull H

ealth

edu

catio

n on

hyg

iene

lo

chia

and

bre

ast

care

bull A

void

sex

ual i

nter

cour

se f

or a

t lea

st 2

wee

ks a

fter

birt

h or

unt

il th

ere

is

no lo

nger

any

loch

ia r

ubra

or

sero

sa

bull D

o pa

p sm

ear

or V

IA a

t 4-

6 w

eeks

bull F

or e

very

sex

ual a

ctiv

ity

the

coup

le s

houl

d us

e co

ndom

s

bull D

iscu

ss f

amily

pla

nnin

g at

eve

ry o

ppor

tuni

ty a

nd p

rovi

de t

he

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Supp

ort

infa

nt fe

edin

g op

tions

For

all

HIV

neg

ativ

e w

omen

wom

en o

f unk

now

n H

IV

stat

us a

nd H

IV p

ositi

ve m

othe

rs o

ptin

g fo

r ex

clus

ive

brea

stfe

edin

g in

itiat

e br

east

feed

shyin

g w

ithin

hal

f hou

r of

bir

th a

nd fo

llow

oth

er g

uide

lines

as

per

Bab

y Fr

iend

ly H

ospi

tal

Initi

ativ

e2 (B

FHI)

bull G

ive

info

rmat

ion

on fa

mily

pla

nnin

g an

d du

al p

rote

ctio

n

bull C

ouns

el o

n H

IV r

isk

redu

ctio

n

bull S

ched

ule

post

nata

l clin

ic v

isits

at

2 w

eeks

and

at

4-6

wee

ks a

nd

com

plet

e m

othe

r-ch

ild b

ookl

et (

refe

r to

DR

H m

anua

l)

(b) S

peci

fic p

ostp

artu

m c

are

for H

IV p

ositi

ve w

omen

bull S

uppo

rt e

xclu

sive

bre

astf

eedi

ng u

nles

s m

othe

r ha

s ap

prop

riat

ely

opte

d fo

r an

d be

en c

ouns

elle

d on

rep

lace

men

t fe

edin

g an

tena

tally

bull I

nitia

te o

r co

ntin

ue c

o-tr

imox

azol

e pr

ophy

laxi

s -1

dou

ble

stre

ngth

tab

shyle

t da

ily

bull F

or H

IV p

ositi

ve m

othe

rs t

hat

rece

ived

sd

nevi

rapi

ne in

trap

artu

m

initi

shyat

e A

ZT

300m

g an

d 3T

C 1

50 m

g B

D f

or 1

wee

k

bull F

or n

ewly

dia

gnos

ed m

othe

rs

do H

IV s

tagi

ng

CD

4 co

unt

and

refe

r ap

prop

riat

ely

for

cont

inue

d ca

re

(c)

Spec

ific

care

for H

IV e

xpos

ed in

fant

s

bull F

or H

IV e

xpos

ed in

fant

s a

dmin

iste

r sd

NV

P 2

mg

kg s

tat

with

in 7

2 ho

urs

Giv

e A

ZT

4 m

gkg

BID

for

6 w

eeks

and

3T

C 4

mg

kg B

ID f

or 1

w

eek

Ref

er t

o C

hapt

er 4

bull R

efer

to C

hapt

er 8

for

deta

ils o

n in

fant

fee

ding

opt

ions

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

5

52

Cha

pter

ref

eren

ces

1

Rep

ublic

of

Ken

ya M

inis

try

of

Hea

lth

Div

isio

n o

f Rep

roduct

ive

Hea

lth

Nat

ional

Guid

elin

es f

or

Qual

ity

Obst

etri

cs a

nd P

erin

ata

l Car

e (2

004)

2

2R

epublic

of

Ken

ya M

inis

try

of

Hea

lth

Ess

ential

Obst

etri

c C

are

Man

ual

for

Hea

lth

Ser

vice

Pro

vider

s in

Ken

ya 3

rd E

ditio

n (

Jan 2

006)

Foo

tnot

es

1

WH

O r

ecom

men

ds

that

all

vacc

ines

should

be

giv

en t

o H

IV-s

ero-n

egat

ive

child

ren

and t

o a

sym

pto

mat

ic s

ero-p

osi

tive

s

The

only

vac

cines

to b

e w

ithhel

d f

rom

child

ren w

ith s

ympto

mat

ic A

IDS a

re B

CG

and

Yel

low

fev

er v

acc

ines

2

The

ldquoTen

Ste

psrdquo

of

BFH

I R

ecom

men

ded

Pra

ctic

es f

or

Mat

ernity

Ser

vice

s ad

apte

d f

or

W

HO

UN

ICEF

1989

Cha

pter

6

Late

Pos

tnat

al C

are

and

Fam

ily P

lann

ing

61

INTR

OD

UC

TIO

N

Late

pos

tnat

al c

are

is p

rovi

ded

to t

he m

othe

r an

d th

e ch

ild 4

8 ho

urs

to 6

wee

ks a

fter

deliv

ery

Dur

ing

this

per

iod

the

heal

th o

f the

mot

her

and

child

is a

sses

sed

and

clos

ely

mon

itore

d

The

risk

of M

TCT

duri

ng th

e po

stpa

rtum

per

iod

can

be r

educ

ed b

y pr

ovid

ing

HIV

cou

nshyse

lling

and

test

ing

pos

t-ex

posu

re p

roph

ylax

is fo

r ex

pose

d ba

bies

cou

nsel

ling

on a

ppro

shypr

iate

infa

nt fe

edin

g op

tions

and

bre

ast c

are

Pos

tpar

tum

car

e fo

r H

IV p

ositi

ve w

omen

shou

ld in

clud

e cl

inic

al s

tagi

ng C

D4

coun

t and

AR

T fo

r th

ose

who

qua

lify

Fam

ily p

lann

ing

serv

ices

are

am

ong

the

core

inte

rven

tions

of P

MTC

T pr

ovid

ed to

hel

pw

omen

det

erm

ine

futu

re c

hild

bear

ing

patt

erns

inc

ludi

ng t

he p

reve

ntio

n of

HIV

-in

fect

ed b

irth

s

Rep

rodu

ctiv

e he

alth

cou

nsel

ling

can

help

a w

oman

pra

ctis

e sa

fer

sex

and

dete

rmin

e he

r fu

ture

ch

ildbe

arin

g pa

tter

ns

on

a m

ore

resp

onsi

ble

and

info

rmed

bas

is1

62

OPE

RA

TIO

NA

L G

UID

ELIN

ES

Opt

imal

pos

tpar

tum

car

e fo

r all

wom

en

This

ent

ails

rou

tine

care

inc

ludi

ng b

reas

t ex

amin

atio

n e

xam

inat

ion

of t

he u

teru

s

exam

inat

ion

of t

he p

erin

eum

and

loch

ia p

assa

ge o

f uri

ne r

egul

arly

pro

per

hygi

ene

topr

even

t in

fect

ion

che

ckin

g fo

r si

gns

of a

nem

ia

feve

r an

d ta

chyc

ardi

a an

d do

ing

peri

neal

exe

rcis

es

Add

ition

al c

are

incl

udes

bull C

ouns

ellin

g an

d te

stin

g fo

r m

othe

rs o

f un

know

n H

IV s

tatu

s bull

Pro

visi

on o

f co

ndom

s an

d ris

k re

duct

ion

coun

selli

ng

bull C

ouns

ellin

g on

con

trac

eptiv

e op

tions

in

clud

ing

dual

met

hod

use

bull D

iscu

ssin

g m

ater

nal n

utrit

ion

bull M

alar

ia p

reve

ntio

n bull

Scr

eeni

ng f

or S

TI a

nd c

ervi

cal c

ance

r

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

3

54

ltlt ASCII85EncodePages false AllowTransparency false AutoPositionEPSFiles true AutoRotatePages None Binding Left CalGrayProfile (Dot Gain 20) CalRGBProfile (sRGB IEC61966-21) CalCMYKProfile (US Web Coated 050SWOP051 v2) sRGBProfile (sRGB IEC61966-21) CannotEmbedFontPolicy Warning CompatibilityLevel 14 CompressObjects Tags CompressPages true ConvertImagesToIndexed true PassThroughJPEGImages true CreateJobTicket false DefaultRenderingIntent Default DetectBlends true DetectCurves 00000 ColorConversionStrategy CMYK DoThumbnails false EmbedAllFonts false EmbedOpenType false ParseICCProfilesInComments true EmbedJobOptions true DSCReportingLevel 0 EmitDSCWarnings false EndPage -1 ImageMemory 1048576 LockDistillerParams false MaxSubsetPct 100 Optimize true OPM 1 ParseDSCComments true ParseDSCCommentsForDocInfo true PreserveCopyPage true PreserveDICMYKValues true PreserveEPSInfo true PreserveFlatness true PreserveHalftoneInfo false PreserveOPIComments true PreserveOverprintSettings true StartPage 1 SubsetFonts true TransferFunctionInfo Apply UCRandBGInfo Preserve UsePrologue false ColorSettingsFile () AlwaysEmbed [ true Arial-Black Arial-BoldItalicMT Arial-BoldMT Arial-ItalicMT ArialMT ArialNarrow ArialNarrow-Bold ArialNarrow-BoldItalic ArialNarrow-Italic ArialRoundedMTBold ArialUnicodeMS CenturySchoolbook CenturySchoolbook-Bold CenturySchoolbook-BoldItalic CenturySchoolbook-Italic Symbol Times-Bold Times-BoldItalic Times-Italic TimesNewRomanPS-BoldItalicMT TimesNewRomanPS-BoldMT TimesNewRomanPS-ItalicMT TimesNewRomanPSMT Times-Roman Verdana Verdana-Bold Verdana-BoldItalic Verdana-Italic Wingdings2 Wingdings3 Wingdings-Regular ] NeverEmbed [ true ] AntiAliasColorImages false CropColorImages true ColorImageMinResolution 300 ColorImageMinResolutionPolicy OK DownsampleColorImages true ColorImageDownsampleType Bicubic ColorImageResolution 300 ColorImageDepth -1 ColorImageMinDownsampleDepth 1 ColorImageDownsampleThreshold 150000 EncodeColorImages true ColorImageFilter DCTEncode AutoFilterColorImages true ColorImageAutoFilterStrategy JPEG ColorACSImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt ColorImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt JPEG2000ColorACSImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt JPEG2000ColorImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt AntiAliasGrayImages false CropGrayImages true GrayImageMinResolution 300 GrayImageMinResolutionPolicy OK DownsampleGrayImages true GrayImageDownsampleType Bicubic GrayImageResolution 300 GrayImageDepth -1 GrayImageMinDownsampleDepth 2 GrayImageDownsampleThreshold 150000 EncodeGrayImages true GrayImageFilter DCTEncode AutoFilterGrayImages true GrayImageAutoFilterStrategy JPEG GrayACSImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt GrayImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt JPEG2000GrayACSImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt JPEG2000GrayImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt AntiAliasMonoImages false CropMonoImages true MonoImageMinResolution 1200 MonoImageMinResolutionPolicy OK DownsampleMonoImages true MonoImageDownsampleType Bicubic MonoImageResolution 1200 MonoImageDepth -1 MonoImageDownsampleThreshold 150000 EncodeMonoImages true MonoImageFilter CCITTFaxEncode MonoImageDict ltlt K -1 gtgt AllowPSXObjects false CheckCompliance [ None ] PDFX1aCheck false PDFX3Check false PDFXCompliantPDFOnly false PDFXNoTrimBoxError true PDFXTrimBoxToMediaBoxOffset [ 000000 000000 000000 000000 ] PDFXSetBleedBoxToMediaBox true PDFXBleedBoxToTrimBoxOffset [ 000000 000000 000000 000000 ] PDFXOutputIntentProfile () PDFXOutputConditionIdentifier () PDFXOutputCondition () PDFXRegistryName () PDFXTrapped False CreateJDFFile false Description ltlt ARA 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 BGR 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 CHS ltFEFF4f7f75288fd94e9b8bbe5b9a521b5efa7684002000410064006f006200650020005000440046002065876863900275284e8e9ad88d2891cf76845370524d53705237300260a853ef4ee54f7f75280020004100630072006f0062006100740020548c002000410064006f00620065002000520065006100640065007200200035002e003000204ee553ca66f49ad87248672c676562535f00521b5efa768400200050004400460020658768633002gt CHT ltFEFF4f7f752890194e9b8a2d7f6e5efa7acb7684002000410064006f006200650020005000440046002065874ef69069752865bc9ad854c18cea76845370524d5370523786557406300260a853ef4ee54f7f75280020004100630072006f0062006100740020548c002000410064006f00620065002000520065006100640065007200200035002e003000204ee553ca66f49ad87248672c4f86958b555f5df25efa7acb76840020005000440046002065874ef63002gt CZE ltFEFF005400610074006f0020006e006100730074006100760065006e00ed00200070006f0075017e0069006a007400650020006b0020007600790074007600e101590065006e00ed00200064006f006b0075006d0065006e0074016f002000410064006f006200650020005000440046002c0020006b00740065007200e90020007300650020006e0065006a006c00e90070006500200068006f006400ed002000700072006f0020006b00760061006c00690074006e00ed0020007400690073006b00200061002000700072006500700072006500730073002e002000200056007900740076006f01590065006e00e900200064006f006b0075006d0065006e007400790020005000440046002000620075006400650020006d006f017e006e00e90020006f007400650076015900ed007400200076002000700072006f006700720061006d0065006300680020004100630072006f00620061007400200061002000410064006f00620065002000520065006100640065007200200035002e0030002000610020006e006f0076011b006a016100ed00630068002egt DAN 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 DEU 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 ESP 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 ETI 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 FRA 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 GRE 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 HEB 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 HRV (Za stvaranje Adobe PDF dokumenata najpogodnijih za visokokvalitetni ispis prije tiskanja koristite ove postavke Stvoreni PDF dokumenti mogu se otvoriti Acrobat i Adobe Reader 50 i kasnijim verzijama) HUN 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 ITA 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 JPN ltFEFF9ad854c18cea306a30d730ea30d730ec30b951fa529b7528002000410064006f0062006500200050004400460020658766f8306e4f5c6210306b4f7f75283057307e305930023053306e8a2d5b9a30674f5c62103055308c305f0020005000440046002030d530a130a430eb306f3001004100630072006f0062006100740020304a30883073002000410064006f00620065002000520065006100640065007200200035002e003000204ee5964d3067958b304f30533068304c3067304d307e305930023053306e8a2d5b9a306b306f30d530a930f330c8306e57cb30818fbc307f304c5fc59808306730593002gt KOR ltFEFFc7740020c124c815c7440020c0acc6a9d558c5ec0020ace0d488c9c80020c2dcd5d80020c778c1c4c5d00020ac00c7a50020c801d569d55c002000410064006f0062006500200050004400460020bb38c11cb97c0020c791c131d569b2c8b2e4002e0020c774b807ac8c0020c791c131b41c00200050004400460020bb38c11cb2940020004100630072006f0062006100740020bc0f002000410064006f00620065002000520065006100640065007200200035002e00300020c774c0c1c5d0c11c0020c5f40020c2180020c788c2b5b2c8b2e4002egt LTH 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 LVI 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 NLD (Gebruik deze instellingen om Adobe PDF-documenten te maken die zijn geoptimaliseerd voor prepress-afdrukken van hoge kwaliteit De gemaakte PDF-documenten kunnen worden geopend met Acrobat en Adobe Reader 50 en hoger) NOR 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 POL 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 PTB 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 RUM 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 RUS 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 SKY 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 SLV 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 SUO 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 SVE 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 TUR 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 UKR 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 ENU (Use these settings to create Adobe PDF documents best suited for high-quality prepress printing Created PDF documents can be opened with Acrobat and Adobe Reader 50 and later) gtgt Namespace [ (Adobe) (Common) (10) ] OtherNamespaces [ ltlt AsReaderSpreads false CropImagesToFrames true ErrorControl WarnAndContinue FlattenerIgnoreSpreadOverrides false IncludeGuidesGrids false IncludeNonPrinting false IncludeSlug false Namespace [ (Adobe) (InDesign) (40) ] OmitPlacedBitmaps false OmitPlacedEPS false OmitPlacedPDF false SimulateOverprint Legacy gtgt ltlt AddBleedMarks false AddColorBars false AddCropMarks false AddPageInfo false AddRegMarks false ConvertColors ConvertToCMYK DestinationProfileName () DestinationProfileSelector DocumentCMYK Downsample16BitImages true FlattenerPreset ltlt PresetSelector MediumResolution gtgt FormElements false GenerateStructure false IncludeBookmarks false IncludeHyperlinks false IncludeInteractive false IncludeLayers false IncludeProfiles false MultimediaHandling UseObjectSettings Namespace [ (Adobe) (CreativeSuite) (20) ] PDFXOutputIntentProfileSelector DocumentCMYK PreserveEditing true UntaggedCMYKHandling LeaveUntagged UntaggedRGBHandling UseDocumentProfile UseDocumentBleed false gtgt ]gtgt setdistillerparamsltlt HWResolution [2400 2400] PageSize [612000 792000]gtgt setpagedevice

App

endi

x V

II

103

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Ms

Mw

anga

ngi

Alic

e Pr

ogra

m O

ffice

r D

RH

-MO

H

Ms

Mw

angi

Nan

cy

PMTC

T A

dmin

istr

ativ

e A

ssis

tant

CD

C K

enya

Mr

Ndw

iga

Fra

ncis

Pr

ogra

m O

ffice

r M

OH

-NA

SCO

P

Prof

Ndu

ati

Rut

h

Ass

ocia

te P

rofe

ssor

of P

aedi

atri

cs U

oN

Dr

Nju

guna

Cha

rles

Pr

ogra

m A

ssoc

iate

MSH

RPM

Plu

s

Mr

Nya

beri

Dav

id

Prog

ram

Offi

cer

MO

H-D

RH

Mr

Ode

ra J

W

Prog

ram

Coo

rdin

ator

GTZ

Ms

Olu

och

Pat

rici

a Te

chni

cal A

dvis

or C

DC

Ken

ya

Mr

Olu

och

Tom

Te

chni

cal A

dvis

or C

DC

Ken

ya

Dr

Onrsquo

gech

Joh

n

Prog

ram

Coo

rdin

ator

KN

H

Dr

Otie

no-N

yuny

a B

Se

nior

Lec

ture

rH

ead

of D

epar

tmen

t PM

TCT

Dir

ecto

rM

oi U

nive

rsity

AM

PATH

Dr

Oum

a C

hris

PM

TCT

Prog

ram

Offi

cer

UN

ICE

F

Dr

Saw

e F

redr

ick

K

Dep

uty

Dir

ecto

r W

RP

Mr

Soo

Leo

nard

Pr

ogra

m M

anag

er W

RP

Dr

Vak

il S

obha

N

Tech

nica

l Adv

isor

AR

T Pr

ogra

m N

ASC

OP

Ms

Way

ua R

uth

Prog

ram

Offi

cer

MO

H-D

RH

Dr

Yon

ga I

sabe

lla

PMTC

T Te

chni

cal A

dvis

or E

GPA

F

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

Tabl

e of

Con

tent

s Li

st o

f con

trib

utor

s 3

Tabl

e of

con

tent

s 5

Ack

now

ledg

emen

ts

10

Fore

wor

d 11

Abb

revi

atio

ns a

nd A

cron

yms

12

Exe

cutiv

e Su

mm

ary

16

Cha

pter

1

Bac

kgro

und

20

11T

he G

loba

l Pan

dem

ic

20

12

Mag

nitu

de o

f HIV

in P

regn

ancy

in

22

13

Ris

ks o

f Tra

nsm

issi

on o

f MTC

T at

Diff

eren

t Tim

e Pe

riod

s 23

14

Ris

k Fa

ctor

s of

MTC

T of

HIV

24

15

Ben

efits

of P

MTC

T of

HIV

25

16

Ben

efits

of H

IV C

ouns

ellin

g amp

Tes

ting

25

17

The

Four

-pro

nged

App

roac

h to

PM

TCT

26

18

Ove

rvie

w o

f the

New

PM

TCT

Gui

delin

es

28

19

Obj

ectiv

es amp

Org

anis

atio

n of

the

Gui

delin

es

28

110

U

sing

the

Gui

delin

es

29

Cha

pter

2 A

nten

atal

Car

e an

d Pr

even

tion

of M

TCT

of H

IV

32

21

Intr

oduc

tion

32

5

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4 B

acte

riolo

gica

l con

firm

atio

n

App

ropr

iate

clin

ical

sam

ples

incl

ude

sput

um

gast

ric

aspi

rate

s an

d ce

rtai

n ot

her

mat

eria

ls

Sin

ce m

ost

TB

in c

hild

ren

is in

infa

nts

and

youn

g ch

ildre

n s

putu

m

indu

ctio

n m

ay b

e do

ne fi

rst

or g

astr

ic a

spira

tions

and

exp

ecto

ratio

ns

a S

putu

m In

duct

ion

Spu

tum

indu

ctio

n is

saf

e an

d ef

fect

ive

in c

hild

ren

of a

ll ag

es a

nd t

he b

acte

rial

yi

elds

a]r

e as

goo

d or

bet

ter

that

for

gas

tric

asp

irate

s

b G

astr

ic a

spira

tion

Thi

s is

per

form

ed in

you

ng c

hild

ren

who

are

una

ble

or u

nwill

ing

to

expe

ctor

ate

sput

um

A g

astr

ic a

spir

ate

shou

ld b

e ob

tain

ed o

n ea

ch o

f th

e th

ree

cons

ecut

ive

mor

ning

s

c E

xpec

tora

tions

S

putu

m s

houl

d al

way

s be

obt

aine

d in

adu

lts a

nd o

lder

chi

ldre

n gt1

0 ye

ars

of

age

susp

ecte

d of

hav

ing

pulm

onar

y T

B

Bac

teri

al y

ield

s ar

e hi

gher

in o

lder

chi

ldre

n

Thr

ee s

putu

m s

peci

men

s sh

ould

be

obta

ined

an

on-

the

ndashspo

t sp

ecim

en (

at t

he

first

eva

luat

ion)

an

ear

ly m

orni

ng s

peci

men

and

a s

econ

d on

-the

-spo

t sp

ecim

en

Spu

tum

indu

ctio

n is

saf

e an

d ef

fect

ive

in c

hild

ren

of a

ll ag

es a

nd t

he b

acte

rial

yi

elds

are

as

good

or

bett

er t

han

for

gast

ric a

spira

tes

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

102

NO

TES

1 H

isto

ry

bull A

sk f

or s

ympt

oms

cons

iste

nt w

ith T

B in

clud

ing

chro

nic

coug

hgt 2

wee

ks

feve

r- b

ody

tem

pera

ture

of

38 o C

for

14 d

ays

afte

r co

mm

on c

ause

s su

ch a

s m

alar

ia a

nd p

neum

onia

hav

e be

en e

xclu

ded

wei

ght

loss

or

failu

re t

o th

rive

(

also

look

at

the

grow

th c

hart

) a

nd o

r ni

ght

swea

ts

Enq

uire

whe

ther

the

pat

ient

has

bee

n in

clo

se c

onta

ct w

ith s

mea

r-po

sitiv

e pu

lshym

onar

y T

B (

usua

lly a

par

ent

or o

ther

mem

ber

of th

e fa

mily

)

2 C

linic

al e

xam

inat

ion

a P

hysi

cal s

igns

hig

hly

sugg

estiv

e of

ext

ra p

ulm

onar

y T

B

bull O

ften

the

mai

n cl

inic

al f

indi

ng is

just

fai

lure

to

thriv

e

bull G

ibus

es

peci

ally

of

rece

nt o

nset

(re

sulti

ng f

rom

ver

tebr

al T

B)

bull N

on-p

ainf

ul e

nlar

ged

cerv

ical

lym

phad

enop

athy

with

fis

tula

for

mat

ion

b P

hysi

cal s

igns

req

uiri

ng in

vest

igat

ions

to

excl

ude

extr

a pu

lmon

ary

TB

bull M

enin

gitis

not

res

pond

ing

to a

ntib

iotic

s tr

eatm

ent

bull P

leur

al e

ffus

ion

bull P

eric

ardi

al e

ffus

ion

bull D

iste

nded

abd

omen

with

asc

itis

bull N

on-p

ainf

ul e

nlar

ged

lym

ph n

odes

with

out

fistu

la f

orm

atio

n

bull N

on-p

ainf

ul e

nlar

ged

join

t

Sig

ns o

f tu

berc

ulin

hyp

erse

nsiti

vity

3 M

anto

ux te

st

A m

anto

ux t

est

shou

ld b

e re

gard

ed p

ositi

ve a

s fo

llow

s

bull I

n hi

gh-r

isk

child

ren

(inc

lude

s H

IV-i

nfec

ted

child

ren

and

seve

rely

mal

shyno

uris

hed

child

ren

) gt

5mm

dia

met

er o

f in

dura

tion

bull I

n al

l oth

er c

hild

ren(

whe

ther

the

y ha

ve r

ecei

ved

BC

G o

r no

t)

gt10m

m d

ishyam

eter

of i

ndur

atio

n

101

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

22

Ope

ratio

nal G

uide

lines

32

23

Job

Aid

s 34

24

App

endi

ces

13

Cha

pter

3 I

ntra

part

um C

are

38

31

Intr

oduc

tion

38

32

Ope

ratio

nal G

uide

lines

38

Cha

pter

4

Use

of A

RVs

in P

regn

ancy

for T

reat

men

t amp P

MTC

T of

HIV

infe

ctio

n 42

41

Intr

oduc

tion

42

42

Ope

ratio

nal G

uide

lines

43

Cha

pter

5 I

mm

edia

te P

ostn

atal

and

Neo

nata

l Car

e

51

51

Intr

oduc

tion

51

52

Ope

ratio

nal G

uide

lines

51

Cha

pter

6 L

ate

Post

nata

l Car

e an

d Fa

mily

Pla

nnin

g

54

61

Intr

oduc

tion

54

62

Ope

ratio

nal G

uide

lines

54

Cha

pter

7 H

IV D

iagn

osis

in C

hild

ren

58

71

Intr

oduc

tion

58

72

Ope

ratio

nal G

uide

lines

59

72

0 G

uide

lines

for

HIV

Dia

gnos

is in

Chi

ldre

n

59

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

72

1 H

IV N

egat

ive

Infa

nt a

t 6 w

eeks

or

Firs

t Con

tact

59

72

2 H

IV P

ositi

ve In

fant

by

DN

A P

CR

60

72

3 C

ompr

ehen

sive

Car

e fo

r H

IV-e

xpos

ed In

fant

61

D

IAG

NO

STIC

ALG

OR

ITH

MFO

R P

ULM

ON

AR

Y T

B IN

CH

ILD

REN

Cha

pter

8

Feed

ing

Infa

nts

and

Youn

g C

hild

ren

Bor

n to

HIV

infe

cted

mot

hers

62

81

Intr

oduc

tion

62

82

Ope

ratio

nal G

uide

lines

on

Infa

nt F

eedi

ng (0

-6 m

onth

s)

63

83

Ope

ratio

nal G

uide

lines

on

Feed

ing

Chi

ldre

n 6

mon

ths

and

olde

r 64

84

Nut

ritio

nal C

are

and

Supp

ort o

f HIV

infe

cted

Chi

ldre

n 64

85

Ext

ract

s fr

om R

esea

rch

on In

fant

Fee

ding

and

HIV

AID

S 65

Cha

pter

9

Car

e an

d Fo

llow

up

of C

hild

ren

of H

IV-in

fect

ed m

othe

rs 7

3

91

Intr

oduc

tion

73

92

Ope

ratio

nal G

uide

lines

74

Cha

pter

10

Mon

itorin

g an

d Ev

alua

tion

of P

MTC

T se

rvic

es

83

101

In

trod

uctio

n 83

102

O

pera

tiona

l Gui

delin

es

85

Bib

liogr

aphy

91

Job

Aid

sR

efer

ence

s

91

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

App

endi

x V

I

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

100

App

endi

x V

C

OM

MO

N A

DV

ERSE

EFF

ECTS

OF

AR

V U

SE D

UR

ING

PR

EGN

AN

CY

Cla

ss

Adv

erse

effe

cts

Nuc

leos

ide

Nuc

leot

ide

Rev

erse

Tra

nscr

ipta

se In

hibi

tors

( NR

TIs)

Zido

vudi

ne(A

ZT)

Nau

seau

La

miv

idin

e (3

TC)

Dia

rhoe

a

Stav

udin

e (d

4T)

Hyp

erse

nsiti

vity

(AB

C)

Aba

cavi

r(A

BC

) A

naem

ia(A

ZT)

Teno

fovi

r(TF

VTD

F)

Emitr

icita

bine

(FTC

)

Non

- Nuc

leos

ide

Rev

erse

Tra

nscr

ipta

se In

hibi

tors

(NN

RTI

s)

Nev

irapi

ne(N

VP)

Del

avird

in

Efav

irenz

(EFV

)

Pro

teas

e In

hibi

tors

(PIs

)

Saqu

inav

ir(SQ

V)

Indi

navi

r(ID

V)

Rito

navi

r(R

TV)

Nel

finav

ir(N

LF)

Lopi

navi

rrito

navi

r(LP

Vr)

A

taza

navi

r(A

TV)

Fose

mpr

enav

ir Ti

pana

vir(

TPV)

D

arun

avir(

DR

V)

Ras

h

Elev

ated

live

r enz

ymes

(c

omm

on w

ith N

VP in

hig

h C

D4

co

unt)

EFV

CN

S ef

fect

s(se

datio

n in

-so

mni

a v

ivid

dre

ams

diz

zine

ss

conf

usio

n fe

elin

g of

lsquod

isen

gage

men

trsquo

Tera

toge

nici

ty

GI i

ntol

eran

ce

Hep

atot

oxic

ity

Lipo

dyst

roph

y

Dys

lipid

emia

s

Insu

lin re

sist

ance

Hyp

ergl

ycae

mia

La

ctic

aci

dosi

s an

d he

patic

ste

a-to

sis

Cou

nsel

ing

and

Follo

w-u

p Ti

ps

May

not

be

wel

l-tol

erat

ed in

ear

l pr

egna

ncy

whe

n

mor

ning

sic

knes

s is

com

mon

M

ay in

crea

se ri

sk o

f non

-ad

here

nce

May

hav

e in

adeq

uate

blo

od le

vels

A

ll A

RVs

sho

uld

be d

isco

ntin

ued

and

rest

arte

d w

hen

Namp

V is

gon

e or

effe

ctiv

ely

trea

ted

Fo

llow

-up

labs

CB

C L

FTs

If ra

sh in

1st

2 w

ks d

o no

t inc

reas

e N

VP d

ose

and

cont

act c

linic

ian

Mild

rash

may

be

man

aged

with

an

tihis

tam

ines

A

void

cor

ticos

tero

ids

durin

g N

VP

dose

esc

alat

ion

EFV

shou

ld b

e ta

ken

initi

ally

at

bed

time

Avo

id E

FV in

wom

en o

f hig

h ch

ild-b

earin

g po

tent

ial

Do

not o

pera

te h

eavy

mac

hine

ry

Mon

itor g

luco

se le

vels

A

sk re

gula

rly fo

r sym

ptom

s of

hy

perg

lyca

emia

M

onito

r hep

atic

tran

sam

inas

es

(ALT

and

AST

) par

ticul

arly

dur

ing

the

first

18

wee

ks o

f the

rapy

w

hen

this

toxi

city

is m

ost l

ikel

y Ta

ke w

ith fo

od

Ant

iem

etic

s A

ntim

otili

ty

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

App

endi

ces

92

App

endi

x I

WH

O C

linic

al S

tagi

ng o

f HIV

AID

S fo

r A

dults

and

A

dole

scen

ts w

ith C

onfir

med

HIV

infe

ctio

n 92

App

endi

x II

C

ontr

acep

tive

Opt

ions

for

Peop

le L

ivin

g w

ith H

IV

95

App

endi

x II

I U

se o

f AR

Vs

for

Trea

tmen

t and

PM

TCT

of H

IV in

AN

C

97

App

endi

x IV

Use

Of A

RV

s fo

r PM

TCT

of H

IV in

Lab

our

And

Del

iver

y U

nit

98

App

endi

x V

Com

mon

Adv

erse

Effe

cts

of A

RV

Use

Dur

ing

Preg

nanc

y 99

App

endi

x V

I D

iagn

ostic

alg

orith

m fo

r pu

lmon

ary

TB in

Chi

ldre

n 10

0

App

endi

x V

II I

nteg

rate

d M

onito

ring

and

Eval

uatio

n Re

port

For

m M

OH

726

10

3

App

endi

x V

III

Rep

rodu

ctiv

e H

ealth

HIV

AID

S R

epor

t For

m M

OH

711

10

4

Lis

t of T

able

s

Tabl

e 1

1 A

dult

HIV

-pre

vale

nce

Est

imat

e by

Pro

vinc

e in

200

6 21

Tabl

e 1

2 E

stim

ated

Mag

nitu

de o

f MTC

T in

Ken

ya 2

007

22

Tabl

e 1

3 Tr

ansm

ission

Pat

tern

s in

Brea

stfee

ding

and

Non

bre

astfe

edin

g Pop

ulat

ions

23

Tabl

e 1

4 R

isk

Fact

ors

for

MTC

T of

HIV

24

Tabl

e 1

5 Th

e Fo

ur-p

rong

ed A

ppro

ach

App

lied

to th

e PM

TCT

Gui

delin

es

30

Tabl

e 2

1 E

ssen

tial P

acka

ge o

f Int

egra

ted

Ant

enat

al C

are

Serv

ices

33

Tabl

e 4

1 R

ecom

men

datio

ns fo

r In

itiat

ing

AR

V T

reat

men

t in

Preg

nant

Wom

en B

ased

on

Clin

ical

Sta

ge a

nd A

vaila

bilit

y of

CD

4 co

unt

44

Tabl

e 4

2 R

ecom

men

ded

Firs

t Lin

e A

RT

Reg

imen

for

Trea

ting

Preg

nant

Wom

en a

nd P

roph

ylac

tic R

egim

en fo

r In

fant

s 45

Tabl

e 4

3a R

ecom

men

ded

Firs

t Lin

e A

RV

Pro

phyl

axis

to P

reve

nt H

IV

46

Infe

ctio

n in

Infa

nts

Am

ong

preg

nant

Wom

en P

rese

ntin

gB

efor

e 38

Wee

ks

Tabl

e 4

3b A

ltern

ativ

e A

RV

Pro

phyl

axis

to P

reve

nt H

IV In

fect

ion

in In

fant

s 4

6 A

mon

g Pr

egna

nt W

omen

Pre

sent

ing

Bef

ore

38 W

eeks

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

9

9

47

IV

Wom

en w

ho h

ave

not r

ecei

ved

Intr

apar

tum

AR

T or

A

RV

Pro

phyl

axis

with

H

IV

Infe

ctio

n

Tabl

e 4

4 A

RV

Pro

phyl

axis

for

PMTC

T am

ong

Preg

nant

Wom

en w

ho h

ave

not r

ecei

ved

Ant

enat

al A

RT

or P

roph

ylax

is

App

endi

x Ta

ble

45

Cho

ice

of H

AA

RT

for

Preg

nant

Wom

en b

ased

on

CD

4 co

unt

47

Tabl

e 4

6 A

RV

Pro

phyl

actic

Reg

imen

s fo

r In

fant

s B

orn

to H

IV-p

ositi

ve

49

Tabl

e 9

1 D

ose

of C

o-tr

imox

azol

e fo

r PC

P pr

ophy

laxi

s 76

Tabl

e 9

2 W

HO

Rec

omm

enda

tions

for

Follo

w-u

p of

an

HIV

-exp

osed

Chi

ld

79

Tabl

e 10

1 C

ontr

acep

tive

Met

hods

for

Use

in C

oupl

es a

nd W

omen

Liv

ing

96

Figu

re 2

1 R

apid

HIV

Ser

ial T

estin

g A

lgor

ithm

35

Figu

re 8

1 G

uide

lines

for

Cou

nsel

ling

on H

IV a

nd In

fant

feed

ing

66

Job

Aid

s an

d IE

C M

ater

ials

on

Infa

nt a

nd Y

oung

Chi

ld F

eedi

ng

67

List

of F

igur

es

Figu

re 1

01

Mon

itori

ng a

nd E

valu

atio

n D

ata

Flow

in K

enya

84

September 0 8

USE OF ARVs FOR PMTCT OF HIV IN LABOUR AND DELIVERY UNITSALL MOTHERS

1 History 2 Examination3 Establish motherrsquos HIV status4 Offer HIV counseling and testing for mother with unknown HIV status5 Provide standard obstetrical management and care

HIV NEGATIVECounsel on risk reduction

HIV POSITIVE

Establish Motherrsquos use of ARVs in pregnancy and give appropriate ARVs as shown in boxesbelow

Regardless of Duration received HAART

Action

i Give mother ARV dose as per regimen

ii Post partu m Infant Give Infant sd Nevi rapine 2mgkg with in 72 hours of birthPL US 3T C 4mgkg BD for 1 w eek an d AZT syrup 4 m gkg BD for 6 w eeks

iii Post partum mother Continue w ith AR Vs as per regimen

MOTHE R RECEIVED HAART IN PREGNANCY

F OR MORE INFORMAT ION CONT ACT THE NATIONAL AIDSSTD CONTROL PROGRAMME (NASCOP)PO BO X 19361-00202 NAIROBI TEL 0202729502 FAX 020 2710518

MINISTRY OF HEALTH

bull G ive mo ther sd Nevirap ine 200m g AZT 600mg and 3TC 150 mg stat

bull Post partum Infant Give Infant sd Nevirapine 2mgkg within 72 ho urs of birth PL US

3TC syrup 4mg kg BD for 1 week and AZT syrup 4 mg kg BD fo r 6 w eeks

bull Post partum mother Give moth er AZT 300mg amp 3TC 150 mg BID for 7 d ays

MO THER RECEIVED AZT IN PREGNANCY OR NO ARVs TAKE N IN PREGNANCY

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

98

MINISTRY OF HEALTH

USE OF ARVs FOR TREATMENT AND PMTCT OF HIV IN ANC

App

endi

x II

I

Ack

now

ledg

emen

ts

ALL M O THERS1 History 2 Health Information3 Examination4 In vestigations (with informed consent for HIV test)

HIV NEGATIVE1 P rov id e pos t-te s t HIV pr ev e nti v e

i nter ve ntion s defi ned i n na tion alHT C gui de li nes

2 Re fe r for othe r p os t-te st HIVp re ve ntive inte rv e nti ons no tavai lable in the cli nic b ut avail ab le w ithi n the fa c ili ty

HIV PO SI TI VE1 C ounsel on risk reduction2 Per form WH O clinical staging for H IV disease3 D etermine CD 4 level (if testing facilities available)4 D etermine Gestation age and HB level5 Give ARVrsquos as shown below6 Provide or refer for other post-test HIV interventions defined in national HTC

guidelines

1 WHO clin ica l stage I o r II w ith CD4 cell co unt gt 350mm3 OR 2 WHO clin ica l stage I o r II no CD4 cell co unt do ne3 HB =8 gdl OR n o clinical feat ures of anaemia

bull Initiate AZT 30 0mg BD daily at 28 weeks gestation or any time periodimmediately there after

bull Monitor for clinical featur es of anemia and treatbull Dispense ANC Nev ir apine 200mg PLUS AZT 600mg + 3TC 1 50mg for

moth er to tak e at onset of labourbull Dispense NVP syrup to give infant at birth

bull At on set o f l abo uro Administer Nevirapine 20 0mg AZT 600mg 3TC 150 mg

stat to moth erbull Post p artum

o Give Infa nt sd Nevirapine 2mgk g within 72 hours ofbirth PLUS 3TC 4mg BD for 1 w eek and AZT syrup 4 mgkg BD for 6 w eeks

o Give mother AZT30 0 mg 3 TC 150 BID for 7 day s

1 WHO clinical stag e I or II with CD4 c ell count gt 35 0 mm3 OR 2 WHO clinical stag e I or II w ith no C D4 c ell c ount done

bull Dispense ANC Nevirapine 2 00mg PLUS AZ T 600 mg + 3TC 150mgfo r mo ther to take at onse t of labour

bull Dispense NVP sy rup to give infant at birthbull At Onset of lab our

o Administe r sd Nevirapine AZT 6 00 mg and 3TC1 50mg stat

bull Po st Par tu mo G iv e Infant sd Nev ir apine 2mg kg w ithin 72

h ours of bir th PLUS 3T C 4mgkg BD fo r 1 week a nd AZT syrup 4mgkg BD for 6 we eks

o G iv e mother AZ T300 mg 3TC 1 50 mg BID for 7d ays

1 Any gest ational age2 WHO clin ica l stage III or IV of HIV dis ease regardles s of CD4 cell count OR3 WHO clin ica l stages I or II of HIV d is ease with CD4 cell count =350mm3 ()

bull Refer to Clinician for Evaluation and initiation of NNRTI based ART as pernation al ART guidelines

bull At O nset of Lab ou ro G ive mo ther ARV dos e as per r egimen

bull Post par tumo G ive Infan t sd Nev ira pine 2mgkg within 72 hours of b irth PLUS

3TC 4mgkg and AZT syr up 4 mgkg BD for 6 weeks o G ive mo ther ARVs as per regimen

4 If no HAART av ailable man age the wo man as ind icated in box no2 a nd refer to ARTsite appro priately

F O R M OR E IN FOR M AT IO N CO N T AC T T H E N ATI ON A L A IDS STD C O NTR O L PR O G RAM ME ( N ASC O P)P O B OX 19361-00202 N AIR OBI TEL 0202729502 FAX 020 2710518

EL IGIBL E FO R T R EATMEN T

N O T E LIG IBLE FO R TR EA TM ET AN D PR ESE NTING B ELO W 3 8 W EE KSGESTA TIO N N OT ELIGIB LE FOR TREA TMEN T AN D PR ESE NTING gt 3 8 W EEK S

GE STATIO N

Plea se notebull Pregnan t w omen with WHO clinical stag e I or II plus CD4 cell co unt gt250 mm3 and = 350 mm3 can be initiated on ART wher e a PI based HAART re gimen is av ailable NVP hypersen sitivity h as been previously r eported amon g women in this gr oup initiated on N NRT I based

ART re gimens Where PI ba sed ART reg imen is not av ailab le r efer the patient to a site whe re th e regimen is availab le or c ontinue to ma nage th e w oman a s is indicated in box No 2bull The grading of ana emia in pregna ncy is gt 8-10 Milda nemia gt 6 -8 Moderate anem ia lt 6 Sever e anemiabull Treatment if common p ath ologies ruled out Mild anae mia haematinics irrespectiv e of gestatio n Moder ate a naemia tr ansfusion if close to term gt36 weeks otherwise give haema tinics Severe an aemia transfus ion irr espe ctive of ge statio n Do not stop AZT if Hb dr op s but

would manage it as above and only stop if continues to fall or fails to res pon d des pite transfusion

The

thir

d ed

ition

of

Gui

delin

es f

or P

reve

ntio

n of

Mot

her-

to-C

hild

Tra

nsm

issi

on o

f H

IV A

IDS

in K

enya

is a

res

ult o

f effo

rts

of m

any

indi

vidu

als

and

orga

niza

tions

in th

eco

untr

y T

he T

echn

ical

Wor

king

Gro

up o

n PM

TCT

led

thes

e ef

fort

s M

embe

rs o

f the

te

am r

evie

wed

all

the

mod

ules

rev

ised

and

in s

ome

case

s re

-wro

te th

e m

odul

es b

ased

on

the

seco

nd e

ditio

n to

mak

e th

em u

p to

dat

e an

d in

line

with

cur

rent

sci

entif

ic e

vishy

denc

e an

d ex

peri

ence

We

ackn

owle

dge

the

cont

ribu

tors

and

rev

iew

ers

of t

he c

urre

ntan

d pr

evio

us e

ditio

ns O

f sp

ecia

l m

entio

n ar

e th

e fo

llow

ing

Ken

ya O

bste

tric

al a

nd

Gyn

aeco

logi

cal S

ocie

ty (K

OG

S) t

he U

nive

rsity

of N

airo

bi a

nd M

oi U

nive

rsity

We

wou

ld l

ike

to t

hank

the

fol

low

ing

inst

itutio

ns f

or t

echn

ical

as

wel

l as

fin

anci

al

supp

ort

duri

ng t

he r

evis

ion

of t

he g

uide

lines

N

atio

nal A

IDS

and

STD

Con

trol

Pro

shygr

amm

e (N

ASC

OP)

the

Div

isio

n of

Rep

rodu

ctiv

e H

ealth

Cen

ters

for

Dis

ease

Con

trol

and

Prev

entio

n (C

DC

) It

is n

ot p

ossi

ble

to m

entio

n al

l ind

ivid

uals

and

org

aniz

atio

ns

that

par

ticip

ated

in th

is im

port

ant e

xerc

ise

To

all o

f you

Asa

nte

Sana

Min

istr

y of

Hea

lth

September 2008

97

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

10

Fore

wor

d

The

Min

istr

y of

Hea

lth (

MoH

) is

com

mitt

ed t

o de

velo

pmen

t of

effe

ctiv

e PM

TCT

proshy

gram

mes

Gui

delin

es a

re a

n im

port

ant

part

of t

he G

over

nmen

t st

rate

gy t

o re

duce

MTC

Tan

d is

in

line

with

the

Nat

iona

l H

ealth

Sec

tor

Stra

tegi

c Pl

an I

I (N

HSS

PII)

and

Ken

yaN

atio

nal A

IDS

Stra

tegi

c Pl

an (K

NA

SP) 2

000-

2010

whi

ch fo

cuse

s on

pri

ority

are

as o

f pre

shyve

ntio

n of

new

infe

ctio

ns i

mpr

ovin

g qu

ality

of l

ife o

f tho

se in

fect

ed a

nd a

ffect

ed a

nd m

itishy

gatio

n of

soc

ial a

nd e

cono

mic

impa

ct o

f the

infe

ctio

n

MTC

T is

the

pre

dom

inan

t m

ode

of t

rans

mis

sion

of

HIV

in

infa

nts

and

youn

g ch

ildre

n

This

tra

nsm

issi

on o

ccur

s du

ring

pre

gnan

cy

labo

ur a

nd d

eliv

ery

and

am

ong

brea

stfe

d ba

bies

in

the

post

-par

tum

per

iod

Mem

bers

of t

he T

echn

ical

Wor

king

Gro

up (T

WG

) on

PMTC

T re

view

ed t

he m

odul

es o

f the

se

cond

edi

tion

rev

ised

and

in s

ome

case

s re

-wro

te th

e m

odul

es b

ased

on

up to

dat

e kn

owlshy

edge

and

in

line

with

cur

rent

sci

entif

ic e

vide

nce

and

expe

rien

ce T

he T

WG

con

sist

s of

agr

oup

of p

rofe

ssio

nals

dra

wn

from

var

ious

dis

cipl

ines

tha

t ar

e im

plem

entin

g an

dor

man

shyag

ing

PMTC

T T

he g

roup

ado

pted

and

ada

pted

the

late

st r

ecom

men

datio

ns o

f the

WH

O o

nPM

TCT

as w

ell a

s va

riou

s na

tiona

l gui

delin

es o

n H

IV p

reve

ntio

n tr

eatm

ent a

nd c

are

A f

our-

pron

ged

appr

oach

thr

ough

the

var

ious

rep

rodu

ctiv

e lif

e cy

cles

as

prop

osed

by

the

Inte

r-A

genc

y Ta

sk T

eam

(IA

TT)

on c

hild

ren

and

HIV

and

AID

S w

as a

dopt

ed i

n th

ese

guid

elin

es w

ith e

mph

asis

bei

ng p

lace

on

all t

he fo

ur p

rong

s

For

any

of t

he P

MTC

T in

terv

entio

ns t

o be

suc

cess

fully

impl

emen

ted

coun

selin

g an

d te

stshy

ing

(CT)

mus

t fir

st b

e do

ne R

outin

e H

IV te

stin

g w

ith o

pt-o

ut o

ptio

n is

rec

omm

ende

d T

his

is fo

llow

ed b

y ap

prop

riat

e m

edic

al s

urgi

cal i

nter

vent

ions

incl

udin

g an

tiret

rovi

ral p

roph

yshyla

xis

saf

er o

bste

tric

pra

ctic

es a

s w

ell a

s in

fant

feed

ing

coun

selin

g an

d pr

ovis

ion

of a

ppro

shypr

iate

infa

nt fe

edin

g H

IV-p

ositi

ve w

omen

are

ass

esse

d cl

inic

ally

usi

ng W

HO

sta

ging

and

whe

re f

easi

ble

imm

unol

ogic

al a

sses

smen

t us

ing

CD

4 ce

ll co

unt

HIV

exp

osed

infa

nts

are

test

ed th

roug

h ea

rly

infa

nt d

iagn

osis

(EID

)

In th

ese

guid

elin

es m

ore

effic

acio

us r

egim

ens

are

intr

oduc

ed fo

r th

e fir

st ti

me

whi

le in

forshy

mat

ion

and

coun

selin

g on

inf

ant

feed

ing

follo

ws

the

AFA

SS (

Ava

ilabl

e f

easi

ble

acc

eptshy

able

saf

e an

d su

stai

nabl

e) c

rite

ria

The

mod

ule

on m

onito

ring

and

eva

luat

ion

addr

esse

s is

sues

of d

ata

colle

ctio

n c

olla

tion

and

repo

rtin

g as

wel

l as

use

of d

ata

for

deci

sion

-mak

ing

at th

e fa

cilit

y-le

vel

We

hope

that

app

ropr

iate

impl

emen

tatio

n in

stru

men

ts w

ill b

e us

ed to

ope

ratio

naliz

e th

ese

guid

elin

es

Tabl

e 11

1

Con

trac

eptiv

e M

etho

ds fo

r Use

in

Cou

ples

and

Wom

en L

ivin

g w

ith H

IV In

fect

ion

MET

HO

D

CO

MM

ENTS

Con

dom

s bull

M

ale

amp f

emal

e co

ndom

s av

aila

ble

bull

P

rovi

de d

ual p

rote

ctio

n ag

ains

t STI

sH

IV

amp p

regn

ancy

bull

R

equi

re a

ttent

ion

amp ca

re

for c

orre

ct u

se e

ach

time

bull

M

ay re

quire

co-

oper

atio

n of

par

tner

Hor

mon

al

bull V

ery

effe

ctiv

e an

d ea

sy to

use

M

etho

ds

bull S

uita

ble

for s

hort-

or lo

ng-

term

use

bull

Rev

ersi

ble

bull A

ssoc

iate

d w

ith n

on-

cont

race

ptiv

e he

alth

ben

efits

bull

Ser

ious

com

plic

atio

ns

extre

mel

y ra

re

Intra

uter

ine

bull

H

ighl

y ef

fect

ive

long

-term

C

ontra

cept

ive

reve

rsib

le m

etho

d

Dev

ice

bull

Rem

ains

in p

lace

up

to 1

2 ye

ars

bull

A

lmos

t 100

per

cent

ef

fect

ive

bull

H

as n

o ef

fect

on

ferti

lity

whe

n us

ed b

y nu

llipar

ous

wom

en

bull

Sho

uld

not b

e pr

ovid

ed to

w

omen

with

hig

h ris

k se

xual

life

styl

e bull

B

acte

rial S

TIs

shou

ld b

e sc

reen

ed fo

r and

or

treat

ed a

s a

prec

autio

n pr

ior t

o in

serti

on o

f IU

CD

Ste

riliz

atio

n bull

Goo

d v

ery

effe

ctiv

e fo

r co

uple

s or

indi

vidu

als

who

w

ant n

o m

ore

child

ren

bull S

afe

sim

ple

surg

ical

pr

oced

ure

Con

side

red

perm

anen

t

US

E IN

HIV

PO

SITI

VE

PA

TIE

NTS

bull

Can

and

sho

uld

be u

sed

at a

ll st

ages

of H

IV

infe

ctio

n bull

C

an a

nd s

houl

d be

use

d by

pat

ient

s on

AR

T

bull

Cor

rect

and

con

sist

ent u

se b

y H

IV in

fect

ed p

atie

nts

is

reco

mm

ende

d re

gard

less

of t

he u

se o

f oth

er m

etho

ds

of c

ontra

cept

ion

(dua

l con

trace

ptio

n)

bull C

an b

e us

ed w

ithou

t res

trict

ion

in H

IV+

wom

en n

ot o

n AR

T bull

Can

be

used

with

out r

estri

ctio

n in

all

HIV

+ w

omen

for

emer

genc

y co

ntra

cept

ion

bull S

ome

AR

V dr

ugs

may

redu

ce m

etho

d ef

fect

iven

ess

bull

DM

PA

Im

plan

ts c

an h

owev

er b

e us

ed w

ith A

RT

reshy

inje

ctio

n of

DM

PA

sho

uld

be d

one

at 1

0-12

wee

ks

bull If

horm

onal

met

hod

is c

hose

n c

ondo

ms

shou

ld s

till b

e us

ed c

orre

ctly

and

con

sist

ently

bull

Attr

activ

e m

etho

d fo

r wom

en w

ith H

IV w

ho d

esire

ver

y re

liabl

e pr

egna

ncy

prot

ectio

n bull

C

an b

e in

serte

d in

HIV

+ w

omen

who

do

not h

ave

WH

O

Sta

ge 4

dis

ease

AID

S d

efin

ing

illne

ss

bull

For w

omen

with

sta

ge 4

dis

ease

IUD

can

be

inse

rted

once

they

are

on

ART

and

have

con

trolle

d sy

mpt

oms

of s

ever

e ill

ness

bull N

o m

edic

al re

ason

s to

den

y st

eriliz

atio

n to

clie

nts

w

ith H

IV

bull P

roce

dure

may

be

dela

yed

in e

vent

of a

cute

HIV

-rel

ated

in

fect

ion

or s

tage

4 d

isea

se p

endi

ng im

mun

e re

cons

titut

ion

bull E

ncou

rage

con

dom

use

as

wel

l

DM

PA =

Dep

ot M

edro

xypr

oges

tero

ne A

ceta

te (D

epo-

Prov

era)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

1

96

App

endi

x II

CO

NTR

AC

EPTI

VE

OPT

ION

SFO

R P

EOPL

E L I

VIN

G W

ITH

HIV

It

has

bee

n sh

own

in a

num

ber

of s

tudi

es o

f coh

orts

of H

IV p

ositi

ve w

omen

tha

t so

me

choo

se t

o co

ntin

ue s

exua

l act

ivity

des

pite

kno

wle

dge

of t

heir

sta

tus

Evi

denc

e of

con

shyce

ptio

n ha

s de

mon

stra

ted

that

fert

ility

in H

IV p

ositi

ve w

omen

for

the

mos

t pa

rt is

unshy

affe

cted

H

owev

er c

erta

in c

ondi

tions

may

affe

ct fe

rtili

ty s

uch

as lo

w b

ody

mas

s in

dex

A

IDS

and

inte

rcur

rent

illn

ess

esp

ecia

lly t

uber

culo

sis

Put

ting

wom

en w

ho a

re H

IV

infe

cted

on

cont

race

ptiv

es is

one

of t

he m

eans

of p

reve

ntin

g m

othe

r to

chi

ld t

rans

mis

shysi

on o

f HIV

(PM

TCT)

It is

the

rig

ht o

f HIV

infe

cted

wom

en t

o m

ake

thei

r ow

n de

cisi

ons

rega

rdin

g re

prod

ucshy

tion

The

y m

ay w

ish

to h

ave

mor

e ba

bies

lim

it th

eir

fam

ilies

or

avoi

d pr

egna

ncy

alto

shyge

ther

The

hea

lth c

are

prov

ider

s th

ey c

onsu

lt sh

ould

ena

ble

them

to

mak

e in

form

edch

oice

s by

them

selv

es

The

follo

win

g co

ntra

cept

ive

met

hods

are

ava

ilabl

e in

Ken

ya -

pro

gest

eron

e on

ly p

ills

lo

w d

ose

com

bine

d or

al c

ontr

acep

tives

de

pot

med

roxy

prog

este

rone

ace

tate

(D

MPA

shyde

po)

levo

norg

estr

el a

nd e

tono

gest

rel i

mpl

ants

Em

erge

ncy

cont

race

ptiv

e pi

lls c

oppe

rin

trau

teri

ne c

ontr

acep

tive

devi

ces

bar

rier

met

hods

fem

ale

and

mal

e st

erili

satio

n ar

e al

so a

vaila

ble

Som

e dr

ugs

inte

ract

with

hor

mon

al c

ontr

acep

tives

A

nd c

oncu

rren

t us

e sh

ould

be

avoi

ded

The

se d

rugs

incl

ude

bull P

rote

ase

inhi

bito

rs ndash

Rito

navi

r N

elfin

avir

Lop

inav

ir w

ith R

itona

vir

bull N

on-n

ucle

otid

e re

vers

e tr

ansc

ript

ase

inhi

bito

rs (

NN

RT

Is)

ndash N

evir

apin

e

bull E

favi

renz

bull A

nti-T

B d

rugs

ndash R

ifam

pici

n an

d R

ifabu

tin

bull O

ther

dru

gs ndash

Gris

eofu

lvin

P

heno

barb

itone

C

arba

maz

epin

e P

heny

toin

All

the

abov

e do

not

app

ly i

n th

e fa

ce o

f ot

her

med

ical

con

ditio

ns t

hat

are

cont

ra-

indi

catio

ns f

or t

he v

ario

us m

etho

ds e

g k

now

n ca

rdio

vasc

ular

dis

ease

hep

atic

con

dishy

tions

sm

okin

g h

igh

bloo

d pr

essu

re a

nd th

rom

boem

bolic

dis

orde

rs

The

follo

win

g ta

ble

sum

mar

ises

maj

or is

sues

reg

ardi

ng u

se o

f diff

eren

t co

ntra

cept

ives

by H

IV-p

ositi

ve w

omen

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Abb

revi

atio

ns a

nd A

cron

yms

AFA

SS

Acc

epta

ble

Fea

sibl

e A

fford

able

Sus

tain

able

and

Saf

e

Ab

Ant

i-bod

y

AID

S A

cqui

red

Imm

une

Def

icie

ncy

Synd

rom

e

ALT

Ala

nine

Tra

nsfe

rase

AN

C

Ant

enat

al C

are

AR

M

Art

ifici

al R

uptu

re o

f Mem

bran

es

AR

T

Ant

iret

rovi

ral T

hera

py

A

RV

A

ntir

etro

vira

l

AZT

A

zido

thym

idin

e (Z

idov

udin

e or

ZD

V)

AZT

3TC

Com

bivi

r

3TC

Lam

ivud

ine

BC

C

Beh

avio

ur C

hang

e C

omm

unic

atio

n

BC

G

Bac

ille

Cal

met

te G

ueri

ne v

acci

ne

BFH

I B

aby

Frie

ndly

Hos

pita

l Ini

tiativ

e

BID

BD

ldquoT

wic

e a

dayrdquo

CD

C (K

) C

entr

es fo

r D

isea

se C

ontr

ol a

nd P

reve

ntio

n K

enya

CN

S C

entr

al N

ervo

us S

yste

m

CS

Cae

sare

an S

ectio

n

CT

Cou

nsel

ling

and

Test

ing

CTX

CTZ

Cot

rim

oxaz

ole

d4T

Stav

udin

e

D

ASC

O

Dis

tric

t AID

SST

I Coo

rdin

ator

G

uid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

5

12

DB

S D

ried

Blo

od S

pot s

peci

men

DN

A

Deo

xyri

bonu

clei

c A

cid

DR

H

Div

isio

n of

Rep

rodu

ctiv

e H

ealth

EC

V

Ext

erna

l Cep

halic

Ver

sion

EFV

Efa

vire

nz

EID

E

arly

Infa

nt D

iagn

osis

ELI

SA

Enz

yme

Link

ed Im

mun

osor

bent

Ass

ay

FBC

Fu

ll B

lood

Cou

nt

GTZ

G

erm

an T

echn

ical

Coo

pera

tion

HA

AR

T

Hig

hly

Act

ive

Ant

iret

rovi

ral T

hera

py

Hb

Hae

mog

lobi

n

HIV

H

uman

Imm

unod

efic

ienc

y Vi

rus

IATT

Inte

r-A

genc

y Ta

sk T

eam

IMC

I In

tegr

ated

Man

agem

ent o

f Chi

ldho

od Il

lnes

s

IPPT

Inte

rmitt

ent P

resu

mpt

ive

Trea

tmen

t for

Mal

aria

ITN

s In

sect

icid

es T

reat

ed N

ets

IUC

D

Intr

a U

teri

ne C

ontr

acep

tive

Dev

ice

KD

HS

Ken

ya D

emog

raph

ic a

nd H

ealth

Sur

vey

KE

PI

Ken

ya E

xpan

ded

Prog

ram

me

on Im

mun

izat

ion

KO

GS

Ken

ya O

bste

tric

al a

nd G

ynae

colo

gica

l Soc

iety

KN

H

Ken

yatt

a N

atio

nal H

ospi

tal

LAM

Lact

atio

nal A

men

orrh

oea

Met

hod

Mamp

E

Mon

itori

ng a

nd E

valu

atio

n

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

Cyt

omeg

alov

irus

infe

ctio

n (r

etin

itis

or in

fect

ion

of o

ther

org

ans)

9

Cen

tral

ner

vous

sys

tem

tox

opla

smos

is

10

HIV

enc

epha

lopa

thy

11

Ext

rapu

lmon

ary

cryp

toco

ccos

is in

clud

ing

men

ingi

tis

12

Dis

sem

inat

ed n

on-t

uber

culo

us m

ycob

acte

rial

infe

ctio

n

13

Pro

gres

sive

mul

tifoc

al le

ukoe

ncep

halo

path

y

14

Chr

onic

cry

ptos

pori

dios

is

15

Chr

onic

isos

poria

sis

16

Dis

sem

inat

ed m

ycos

is (

extr

apul

mon

ary

hist

opla

smos

is

or c

occi

diom

ycos

is)

17

Rec

urre

nt s

eptic

aem

ia (

incl

udin

g no

n-ty

phoi

dal S

alm

onel

la)

18

Lym

phom

a (c

ereb

ral o

r B

-cel

l non

-Hod

gkin

s)

19

Inv

asiv

e ce

rvic

al c

arci

nom

a

20

Aty

pica

l dis

sem

inat

ed le

ishm

ania

sis

21

Sym

ptom

atic

HIV

-ass

ocia

ted

neph

ropa

thy

or s

ympt

omat

ic H

IV-

asso

ciat

ed

22

Car

diom

yopa

thy

Ple

ase

note

S

igns

and s

ympto

ms

of

HIV

was

ting s

yndro

me

incl

ude

Unex

pla

ined

invo

lunta

ry w

eight

loss

(gt

10

base

line

body

wei

ght)

with o

bvi

ous

was

ting o

f body

mas

s in

dex

lt185

PLU

S

unex

pla

ined

chro

nic

dia

rrhoea

(lo

ose

or

wat

ery

stools

thre

e or

more

tim

es d

aily

) re

port

ed

for

longer

than

one

month

OR r

eport

s of

feve

r or

nig

ht

swea

ts f

or

more

than

one

month

w

ithout

oth

er c

ause

and lack

of

resp

onse

to a

ntibio

tics

or

antim

ala

rial ag

ents

M

ala

ria

must

be

excl

uded

in m

ala

ria

pro

ne

area

s

Fo

r th

e purp

ose

of

the

WH

O s

tagin

g s

yste

m

adole

sents

and a

dults

are

def

ined

as

adults

aged

ge15 y

ears

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

3

94

CLI

NIC

AL

STA

GE

3 1

Une

xpla

ined

sev

ere

wei

ght

loss

(gt1

0 o

f pr

esum

ed o

r m

easu

red

bo

dy w

eigh

t)

2

Une

xpla

ined

chr

onic

dia

rrho

ea fo

r lo

nger

tha

n on

e m

onth

3

Une

xpla

ined

per

sist

ent

feve

r (a

bove

37

5degC

inte

rmitt

ent

or c

onst

ant

for

long

er t

han

one

mon

th)

4

Per

sist

ent

oral

can

didi

asis

5

Ora

l hai

ry le

ukop

laki

a

6

Pul

mon

ary

tube

rcul

osis

7

Tub

ercu

lous

Lym

phad

enop

athy

8

Sev

ere

bact

eria

l inf

ectio

ns (

such

as

pneu

mon

ia

empy

ema

pyo

myo

sitis

bo

ne o

r jo

int

infe

ctio

n m

enin

gitis

or

bact

erae

mia

)

9

Acu

te n

ecro

tizin

g ul

cera

tive

stom

atiti

s g

ingi

vitis

or

perio

dont

itis

10

Une

xpla

ined

ana

emia

(lt8

gdl

) n

eutr

opae

nia

(lt0

5 times1

09 pe

rlitr

e) a

ndo

r ch

roni

c th

rom

bocy

topa

enia

(lt5

0times10

9 per

litr

e)

CLI

NIC

AL

STA

GE

4 1

HIV

was

ting

synd

rom

e

2

Pne

umoc

ystis

pne

umon

ia

3

Rec

urre

nt s

ever

e ba

cter

ial p

neum

onia

4

Chr

onic

her

pes

sim

plex

infe

ctio

n (o

rola

bial

ge

nita

l or

anor

ecta

l of

mor

e th

an o

ne

mon

thrsquos

dur

atio

n or

vis

cera

l at

any

site

)

5

Oes

opha

geal

can

didi

asis

(or

can

didi

asis

of

trac

hea

bro

nchi

or

lung

s)

6

Ext

rapu

lmon

ary

tube

rcul

osis

exc

ept

Tub

ercu

lous

Lym

ph a

deno

path

y

7

Kap

osirsquos

sar

com

a

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

MC

H

Mat

erna

l and

Chi

ld H

ealth

MoH

M

inis

try

of H

ealth

MSF

M

edic

ins

Sans

Fro

ntie

rs

M

TCT

Mot

her-

To-C

hild

Tra

nsm

issi

on

NA

SCO

P N

atio

nal A

IDS

and

STD

Con

trol

Pro

gram

me

NV

P

Nev

irap

ine

OD

ldquoO

nce

a D

ayrdquo

OI

Opp

ortu

nist

ic In

fect

ion

OPV

O

ral P

olio

Vac

cine

PASC

O

Prov

inci

al A

IDS

STI C

oord

inat

or

PCP

Pneu

moc

ystis

jiro

veci

i pne

umon

ia

PCR

Po

lym

eras

e C

hain

Rea

ctio

n

PI

Prot

ease

Inhi

bito

r

PLW

HA

Pe

rson

sPe

ople

Liv

ing

With

HIV

AID

S

PMTC

T

Prev

entio

n of

Mot

her

To C

hild

Tra

nsm

issi

on

RD

A

Rec

omm

ende

d D

aily

Allo

wan

ce

RH

Rep

rodu

ctiv

e H

ealth

RN

A

Rib

onuc

leic

Aci

d

SdN

VP

Si

ngle

dos

e N

evir

apin

e

SRH

Se

xual

and

Rep

rodu

ctiv

e H

ealth

STD

Se

xual

ly T

rans

mitt

ed D

isea

se

STI

Sexu

ally

Tra

nsm

itted

Infe

ctio

n

TB

Tube

rcul

osis

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

3

14

TBA

s Tr

aditi

onal

Bir

th A

tten

dant

s

TLC

To

tal L

ymph

ocyt

e C

ount

TT

Teta

nus

Toxo

id v

acci

ne

UN

ICE

F U

nite

d N

atio

ns C

hild

renrsquo

s Fu

nd

UN

GA

SS

Uni

ted

Nat

ions

Gen

eral

Ass

embl

y Sp

ecia

l Ses

sion

on

HIV

AID

S

UoN

Uni

vers

ity o

f Nai

robi

VC

T V

olun

tary

Cou

nsel

ling

and

Test

ing

VIA

V

isua

l Ins

pect

ion

usin

g A

ceto

ne

VD

RL

Ven

erea

l Dis

ease

Res

earc

h La

bora

tory

(tes

t for

syp

hilis

)

WH

O

Wor

ld H

ealth

Org

anis

atio

n

WR

P W

alte

r R

eed

Prog

ram

App

endi

x I

WH

O C

LIN

ICA

L S T

AG

ING

OF

HIV

AID

S FO

R A

DU

LTS

AN

D A

DO

LES-

CEN

TSW

ITH

CO

NFI

RM

ED H

IV IN

FEC

TIO

N

CLI

NIC

AL

STA

GE

1

bull

Asy

mpt

omat

ic

bull

Per

sist

ent

gene

raliz

ed ly

mph

aden

opat

hy

CLI

NIC

AL

STA

GE

2 1

Une

xpla

ined

mod

erat

e w

eigh

t lo

ss (

lt10

of

pres

umed

or

mea

sure

d bo

dy w

eigh

t)

2

Rec

urre

nt u

pper

res

pira

tory

tra

ct in

fect

ions

(si

nusi

tis

tons

illiti

s

otiti

s m

edia

and

pha

ryng

itis)

3

Her

pes

Zos

ter

4

Ang

ular

Che

ilitis

5

Rec

urre

nt o

ral u

lcer

atio

n

6

Pap

ular

pru

ritic

eru

ptio

ns

7

Seb

orrh

oeic

der

mat

itis

8

Fun

gal n

ail i

nfec

tions

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

5

92

Bib

liog

raph

y 1

Offic

e of

the

Pres

iden

t N

ational

AID

S C

ontr

ol Counci

l K

enya

Nat

ional H

IVA

IDS

Str

ate

gic

pla

n 2

0056

-20091

0

2

Rep

ublic

of

Ken

ya

Nat

ional AID

S C

ontr

ol C

ounci

l N

atio

nal H

IVA

IDS M

onitori

ng

and E

valu

atio

n F

ram

ework

3

Rep

ublic

of

Ken

ya

Nat

ional AID

S C

ontr

ol C

ounci

l N

atio

nal H

IVA

IDS M

onitori

ng

and E

valu

atio

n I

mple

men

tation M

anual

Job

Aid

sR

efer

ence

s 1

MoH

AN

C R

egis

ters

2

MoH

Mat

ernity

Reg

iste

rs

3

MoH

Post

-nata

l Reg

iste

rs

4

Mat

ernal

and C

hild

Wel

fare

Han

dbook

5

Rep

roduct

ive

Hea

lth S

ervi

ces

month

ly r

eport

6

MoH

Form

726

(Appen

dix

IV)

7

MoH

Form

727

8

MO

H F

orm

711

Exec

utiv

e Su

mm

ary

The

Rev

ised

Gui

delin

es (3

rd

editi

on) f

or P

reve

ntio

n of

Mot

her

to C

hild

Tra

nsm

issi

on(P

MTC

T) o

f H

IV a

nd A

IDS

addr

esse

s th

e ri

sks

of m

othe

r-to

-chi

ld t

rans

mis

sion

(MTC

T) o

f H

IV a

nd A

IDS

usin

g m

ore

effic

acio

us in

terv

entio

ns t

han

in t

he p

revi

ous

editi

ons

The

Gui

delin

es a

re i

n lin

e w

ith K

enya

rsquos N

atio

nal

Hea

lth S

ecto

r St

rate

gic

Plan

II

(NH

SSP

II)

and

are

anch

ored

on

the

Ken

ya N

atio

nal

AID

S St

rate

gic

Plan

(KN

ASP

) 20

00-2

010

whi

ch f

ocus

es o

n th

e pr

iori

ty a

reas

of

prev

entio

n of

new

inf

ecshy

tions

im

prov

ing

the

qual

ity o

f life

of p

eopl

e in

fect

ed a

nd a

ffect

ed b

y H

IV a

nd A

IDS

and

miti

gatio

n of

the

soc

ial a

nd e

cono

mic

impa

ct o

f the

infe

ctio

n O

ne o

f the

pri

ority

ar

eas

of N

HSS

P II

is

adhe

renc

e to

set

clin

ical

and

pub

lic h

ealth

sta

ndar

ds

The

Gui

delin

es w

ere

deve

lope

d th

roug

h a

part

icip

ator

y an

d co

nsul

tativ

e pr

oces

s th

at

drew

par

ticip

ants

fro

m p

ublic

hea

lth i

nstit

utio

ns

NG

Os

FB

Os

aca

dem

ic a

nd r

eshyse

arch

ins

titut

ions

and

dev

elop

men

t pa

rtne

rs

The

proc

ess

was

co-

ordi

nate

d by

N

ASC

OP

with

tech

nica

l and

fina

ncia

l sup

port

from

CD

C (K

)

HIV

infe

ctio

n ha

s re

vers

ed g

ains

rea

lised

in c

hild

hea

lth a

nd s

urvi

val i

n th

e la

st d

ecshy

ade

in K

enya

The

infe

ctio

n ha

s al

so c

ontr

ibut

ed s

igni

fican

tly t

o th

e co

mm

on c

ompl

ishyca

tions

of

preg

nanc

y in

man

y co

untr

ies

Glo

bally

mor

e th

an 6

300

00 c

hild

ren

wer

ein

fect

ed w

ith H

IV t

hrou

gh M

TCT

in 2

003

In

2007

K

enya

had

a p

opul

atio

n es

tishym

ated

at

34 m

illio

n t

he n

umbe

r of

bir

ths

per

annu

m w

as 1

73

mill

ion

the

HIV

prev

alen

ce a

mon

g pr

egna

nt m

othe

rs w

as 6

7 p

er c

ent

and

the

tota

l num

ber

of b

irth

s to

HIV

-infe

cted

mot

hers

exp

osed

to

MTC

T w

as 1

638

00

Ass

umin

g a

tran

smis

sion

rate

of 4

0 pe

r ce

nt a

nd in

the

abs

ence

of a

ny in

terv

entio

n t

he n

umbe

r of

HIV

pos

ishytiv

e in

fant

s pe

r an

num

wou

ld b

e 65

520

Ken

ya A

IDS

Indi

cato

r su

rvey

(KA

IS) 2

007

HIV

ser

opre

vale

nce

amon

g ad

ults

age

d 15

-49

year

s is

78

Var

ious

inte

rven

tions

hav

e be

en p

ut in

pla

ce t

o re

spon

d to

the

em

ergi

ng c

halle

nges

an

d co

nstr

aint

s to

MTC

T ac

ross

the

cou

ntry

Ana

lysi

s of

effe

ctiv

enes

s of

the

var

ious

ap

proa

ches

nee

ded

to m

anag

e ri

sks

of M

TCT

prov

ides

val

uabl

e in

sigh

ts th

at n

eces

sishy

tate

the

ado

ptio

n of

mor

e ef

ficac

ious

car

e an

d tr

eatm

ent

regi

men

s T

hese

ins

ight

s ha

ve in

form

ed t

he d

evel

opm

ent

of n

ew G

uide

lines

The

Gui

delin

es in

corp

orat

e th

ese

chan

ges

and

are

reco

mm

ende

d fo

r us

e by

hea

lth p

rofe

ssio

nals

and

hea

lth in

stitu

tions

at a

ll le

vels

of c

are

The

Gui

delin

es w

ill e

nhan

ce th

e ca

paci

ty o

f hea

lth c

are

prov

ider

sto

giv

e m

ore

effic

ient

and

effe

ctiv

e se

rvic

es t

o H

IV p

ositi

ve e

xpec

tant

mot

hers

and

ne

wbo

rns

The

Gui

delin

es h

ave

ten

chap

ters

and

cov

er th

e fo

llow

ing

just

ifyin

g th

e ne

ed fo

r sp

eshyci

fic m

anag

emen

t of

HIV

pos

itive

wom

en c

are

befo

re d

urin

g an

d af

ter

preg

nanc

yus

e of

ant

iret

rovi

ral t

hera

py in

pre

gnan

cy p

ostn

atal

car

e fa

mily

pla

nnin

g e

arly

inshy

fant

dia

gnos

is

feed

ing

car

e an

d fo

llow

-up

of H

IV-in

fect

ed i

nfan

ts

and

mon

itori

ng

and

eval

uatio

n A

dditi

onal

inf

orm

atio

n on

WH

O s

tagi

ng

cont

race

ptiv

e op

tions

for

PLW

As

and

a su

mm

ary

of A

RV

use

in P

MTC

T is

giv

en in

the

appe

ndic

es

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

9

1

16

The

Gui

delin

es h

ave

also

inc

orpo

rate

d ba

sic

info

rmat

ion

that

pro

gram

man

ager

sne

ed in

ord

er to

mak

e th

eir

inst

itutio

ns P

MTC

T-fr

iend

ly T

his

info

rmat

ion

is fo

und

in

the

boxe

s an

d ap

pend

ices

Sum

mar

ies

of t

he i

nfor

mat

ion

cont

aine

d in

the

tex

t ar

e fo

und

in th

e ta

bles

The

Gui

delin

es p

rovi

de a

bac

kgro

und

to t

he P

MTC

T pr

oble

m in

the

wor

ld i

n A

fric

a an

d in

Ken

ya T

hey

also

giv

e de

tails

on

HIV

in p

regn

ancy

the

tran

smis

sion

pat

tern

sof

MTC

T an

d de

scri

be t

he b

enef

its o

f pr

even

ting

mot

her-

to-c

hild

tra

nsm

issi

on(P

MTC

T) T

hey

also

pro

vide

info

rmat

ion

on in

terv

entio

ns n

eces

sary

to

redu

ce M

TCT

that

incl

ude

coun

selli

ng a

nd te

stin

g la

bora

tory

inve

stig

atio

ns o

bste

tric

inte

rven

tions

and

trea

tmen

tpro

phyl

axis

The

ante

nata

l man

agem

ent

for

HIV

pos

itive

wom

en i

nclu

ding

pol

icy

guid

e jo

b ai

dsw

ith s

umm

aris

ed e

ssen

tial p

acka

ge o

f int

egra

ted

ante

nata

l car

e se

rvic

es a

re d

etai

led

in C

hapt

er 2

Cha

pter

3 p

rovi

des

info

rmat

ion

on i

ntra

part

um c

are

Thi

s is

the

man

agem

ent

ofw

omen

from

the

onse

t of l

abou

r to

del

iver

y A

t thi

s st

age

it is

impo

rtan

t to

esta

blis

hth

e H

IV s

tatu

s of

wom

en p

rior

to d

eliv

ery

or d

urin

g la

bour

Gui

delin

es s

houl

d be

folshy

low

ed fo

r al

l wom

en a

dmitt

ed to

labo

ur a

nd d

eliv

ery

To

cond

uct v

agin

al d

eliv

erie

s fo

r H

IV p

ositi

ve w

omen

m

odifi

ed r

outin

e ca

re i

s gi

ven

The

gui

delin

es p

rovi

de a

reshy

min

der

on th

e ac

tiviti

es e

ssen

tial t

o ca

rry

out f

or s

afe

vagi

nal d

eliv

ery

for

all w

omen

no

t ju

st fo

r th

ose

infe

cted

with

HIV

It

is r

ecom

men

ded

that

the

re s

houl

d be

no

disshy

crim

inat

ion

or is

olat

ion

of H

IV p

ositi

ve w

omen

dur

ing

labo

ur a

nd d

eliv

ery

Del

iver

y th

roug

h el

ectiv

e ca

esar

ean

sect

ion

redu

ces

the

risk

of

HIV

MTC

T as

com

pare

d to

vagi

nal d

eliv

ery

amon

g H

IV p

ositi

ve w

omen

Whe

re C

S is

per

form

ed a

s an

em

erge

ncy

or e

lect

ivel

y a

ntib

iotic

s sh

ould

be

give

n

Ant

iret

rovi

ral (

AR

V) t

hera

py is

dis

cuss

ed in

det

ail i

n C

hapt

er 4

Thi

s in

clud

es t

hershy

apy

for

the

mot

her

befo

re la

bour

dur

ing

labo

ur a

nd a

fter

del

iver

y a

nd fo

r th

e in

fant

afte

r de

liver

y C

urre

ntly

N

evir

apin

e is

the

rec

omm

ende

d re

gim

en H

owev

er

shor

tco

urse

effi

caci

ous

AR

V d

rug

regi

men

s ca

n be

im

plem

ente

d in

res

ourc

e lim

ited

setshy

tings

AR

Vs

are

used

bot

h fo

r tr

eatm

ent

and

for

PMTC

T in

HIV

inf

ecte

d pr

egna

ntw

omen

and

thei

r ne

onat

es

Gui

delin

es f

or t

he p

ostp

artu

m c

are

of t

he m

othe

r an

d ca

re f

or H

IV e

xpos

ed in

fant

s ar

e de

taile

d in

Cha

pter

5 I

n C

hapt

er 6

the

Gui

de p

rovi

des

deta

iled

info

rmat

ion

on

late

pos

tnat

al c

are

and

fam

ily p

lann

ing

HIV

pos

itive

wom

en c

an u

se a

ll ty

pes

of fa

mshy

ily p

lann

ing

base

d on

sta

ndar

d el

igib

ility

cri

teri

a as

exp

licitl

y ou

tline

d in

the

text

Gui

delin

es fo

r in

fant

dia

gnos

is c

are

and

trea

tmen

t ar

e di

scus

sed

in C

hapt

er 7

Cur

shyre

ntly

the

re is

no

test

to

diffe

rent

iate

bet

wee

n an

tibod

ies

from

the

mot

her

and

thos

e pr

oduc

ed b

y th

e ba

by T

o id

entif

y H

IV in

fect

ed in

fant

s le

ss t

han

18 m

onth

s D

NA

or

RN

A ndash

PC

R te

st is

cur

rent

ly r

ecom

men

ded

HIV

exp

osed

infa

nts

at 6

wee

ks a

nd s

ick

infa

nts

at 1

2 m

onth

s sh

ould

hav

e ac

cess

to

DB

S fo

r D

NA

PC

R H

IV e

xpos

ed in

fant

ssh

ould

be

star

ted

on c

otri

mox

azol

e fr

om 6

wee

ks A

ll m

othe

rs w

ith 6

wee

k ol

d in

fant

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

E

Upt

ake

of c

ouns

ellin

g an

d te

stin

g in

Mat

erni

ty c

linic

Rat

io o

f m

ater

nity

clie

nts

with

unk

now

n H

IV s

tatu

s w

ho a

re c

ouns

elle

d an

d te

sted

for H

IV in

mat

erni

ty

Num

erat

or

Num

ber o

f pre

gnan

t wom

en a

dmitt

ed in

to m

ater

nity

with

un

know

n H

IV s

tatu

s th

at a

re c

ouns

elle

d an

d te

sted

for H

IV

durin

g la

bour

or a

fter d

eliv

ery

Den

omin

ator

N

umbe

r of p

regn

ant w

omen

adm

itted

into

mat

erni

ty

with

unk

now

n H

IV s

tatu

s

F

Mat

erni

ty m

othe

r AR

V pr

ophy

laxi

s up

take

R

atio

of H

IV in

fect

ed m

othe

rs in

mat

erni

ty c

linic

rece

ivin

g pr

even

tive

A

RV

pro

phyl

axis

Num

erat

or

Num

ber o

f HIV

-infe

cted

mot

hers

adm

itted

in m

ater

nity

takshy

ing

or re

porte

d to

hav

e ta

ken

the

mot

her d

ose(

s) o

f pre

venshy

tive

AR

V p

roph

ylax

is

Den

omin

ator

N

umbe

r of p

regn

ant w

omen

adm

itted

into

mat

erni

ty w

ho

are

HIV

-infe

cted

G

Infa

nt A

RV

prop

hyla

xis

upta

ke

Rat

io o

f inf

ants

bor

n to

HIV

-infe

cted

mot

hers

in m

ater

nity

clin

ic

rece

ivin

g pr

even

tive

AR

V p

roph

ylax

is

Num

erat

or

Num

ber o

f inf

ants

bor

n to

HIV

-infe

cted

mot

hers

who

rece

ive

prev

entiv

e

Den

omin

ator

N

umbe

r of i

nfan

ts b

orn

to H

IV-in

fect

ed m

othe

rs

Num

ber o

f pre

gnan

t wom

en a

dmitt

ed in

to m

ater

nity

who

are

H

IV-in

fect

ed is

use

d to

app

roxi

mat

e th

is n

umbe

r

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

7

90

With

the

mea

sure

men

ts li

sted

abo

ve t

he fo

llow

ing

perf

orm

ance

indi

cato

rs

for m

onito

ring

PMTC

T ac

tiviti

es a

re c

alcu

late

d

A

Upt

ake

of c

ouns

ellin

g an

d te

stin

g in

Ant

enat

al c

linic

R

atio

of a

nten

atal

clie

nts

who

wer

e co

unse

lled

and

test

ed fo

r HIV

Num

erat

or

This

is n

umbe

r of p

regn

ant w

omen

atte

ndin

g th

eir f

irst

ante

nata

l clin

ic v

isit

who

are

test

ed fo

r HIV

Den

omin

ator

N

umbe

r of n

ew v

isits

to th

e an

tena

tal c

linic

B

Ant

enat

al H

IV s

erop

reva

lenc

e

Rat

io o

f Ant

enat

al p

regn

ant w

omen

test

ed fo

r HIV

that

are

HIV

infe

cted

Num

erat

or

Num

ber o

f clie

nts

who

test

HIV

pos

itive

Den

omin

ator

To

tal n

umbe

r of p

regn

ant w

omen

test

ed fo

r HIV

in a

nten

ashyta

l clin

ic

C

Ant

enat

al m

othe

r AR

V pr

ophy

laxi

s up

take

R

atio

of k

now

n H

IV in

fect

ed p

regn

ant w

omen

in a

nten

atal

clin

ic

rece

ivin

g A

RV

pre

vent

ive

prop

hyla

xis

Num

erat

or

Tota

l num

ber o

f HIV

-infe

cted

pre

gnan

t wom

en in

ant

enat

al

clin

ic re

ceiv

ing

mot

her p

reve

ntiv

e A

RV

pro

phyl

axis

Den

omin

ator

To

tal n

umbe

r of p

regn

ant w

omen

who

are

HIV

-infe

cted

in

the

ante

nata

l clin

ic

D

Ant

enat

al in

fant

AR

V pr

ophy

laxi

s up

take

R

atio

of k

now

n H

IV-in

fect

ed p

regn

ant w

omen

in a

nten

atal

clin

ic w

ho

rece

ive

infa

nt d

ose(

s) o

f pre

vent

ive

AR

V p

roph

ylax

is

Num

erat

or

Tota

l num

ber o

f HIV

infe

cted

pre

gnan

t wom

en in

an

tena

tal c

linic

rece

ivin

g in

fant

dos

e(s)

pre

vent

ive

A

RV

pro

phyl

axis

Den

omin

ator

To

tal n

umbe

r of p

regn

ant w

omen

who

are

HIV

-infe

cted

in

the

ante

nata

l clin

ic

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

shou

ld h

ave

rout

ine

HIV

ant

ibod

y te

st

Gui

delin

es f

or f

eedi

ng in

fant

s an

d yo

ung

child

ren

born

to

HIV

infe

cted

mot

hers

are

di

scus

sed

in C

hapt

er 8

The

Min

istr

y of

Hea

lth r

ecom

men

ds p

rom

otio

n of

exc

lusi

vebr

east

feed

ing

for

the

first

6 m

onth

s of

life

Whe

re r

epla

cem

ent f

eedi

ng is

acc

epta

ble

feas

ible

af

ford

able

su

stai

nabl

e an

d sa

fe (

AFA

SS)

avoi

danc

e of

bre

astf

eedi

ng b

yH

IV-in

fect

ed w

omen

is

reco

mm

ende

d (W

HO

200

6) D

iscu

ssio

n on

diff

eren

t ty

pes

offe

edin

g al

tern

ativ

es t

o br

east

feed

ing

is c

aptu

red

in t

he t

ext

Thes

e op

tions

exi

st f

orth

e m

othe

r to

cho

ose

with

the

aid

of

coun

selli

ng I

deal

ly c

oupl

e de

cisi

on-m

akin

g is

enco

urag

ed f

or t

he H

IV p

ositi

ve m

othe

r F

or t

he H

IV n

egat

ive

mot

her

exc

lusi

ve

brea

stfe

edin

g is

rec

omm

ende

d fo

r 6

mon

ths

or le

ss fo

llow

ed b

y w

eani

ng

Car

e an

d fo

llow

-up

of c

hild

ren

of H

IV-in

fect

ed m

othe

rs is

dis

cuss

ed in

det

ail i

n C

hapshy

ter

9 A

ll ch

ildre

n bo

rn t

o H

IV i

nfec

ted

mot

hers

sho

uld

be f

ollo

wed

up

clos

ely

from

birt

h th

roug

h 2

year

s T

able

92

pro

vide

s th

e W

HO

rec

omm

ende

d fo

llow

up

deta

ils

Sim

ilarl

y t

he m

othe

rs s

houl

d be

sup

port

ed t

o pr

ovid

e op

timal

infa

nt fe

edin

g an

d to

av

oid

mix

ed fe

edin

g w

ithin

6 m

onth

s

In C

hapt

er 1

0 t

he G

uide

lines

exp

lain

the

ben

efits

of

mon

itori

ng a

nd e

valu

atio

n of

PMTC

T pr

ogra

ms

Mamp

E p

rovi

des

an o

ppor

tuni

ty t

o m

easu

re a

nd a

ppra

ise

perf

orm

shyan

ce w

ithin

def

ined

tim

e fr

ame

to e

nsur

e ac

com

plis

hmen

t of s

et g

oals

and

obj

ectiv

es

PMTC

T se

rvic

es m

ust

be g

uide

d by

tim

ely

and

accu

rate

dat

a re

port

ed f

rom

the

heal

th f

acili

ties

thr

ough

the

dis

tric

t an

d pr

ovin

cial

lev

els

to

the

natio

nal

leve

l at

NA

SCO

P

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

9

18

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

(xiii

) H

IV in

fect

ed in

mat

erni

ty w

ard

Num

ber

of p

regn

ant

wom

en a

dmitt

ed in

to

mat

erni

ty c

linic

who

are

HIV

infe

cted

In

clud

es b

oth

thos

e w

ho w

ere

adm

itted

al

read

y kn

owin

g th

ey a

re H

IV-i

nfec

ted

and

thos

e w

ho w

ere

test

ed a

nd r

ecei

ved

thei

r re

sults

in m

ater

nity

clin

ic T

his

is o

btai

ned

from

the

mat

erni

ty r

egis

ter

(xiv

) P

reve

ntiv

e A

RV

pro

phyl

axis

in m

ater

nity

war

d (m

othe

r do

se)

Num

ber

of

preg

nant

wom

en a

dmitt

ed in

mat

erni

ty t

akin

g or

rep

orte

d to

hav

e ta

ken

the

mot

her

dose

(s)

of p

reve

ntiv

e A

RV

pro

phyl

axis

T

his

is o

btai

ned

from

the

m

ater

nity

reg

iste

r

(xv)

Inf

ant

prev

entiv

e A

RV

pro

phyl

axis

in m

ater

nity

clin

ic

war

d N

umbe

r of

inshy

fant

s bo

rn in

mat

erni

ty r

ecei

ving

the

infa

nt p

reve

ntiv

e A

RV

pro

phyl

axis

in t

he

mat

erni

ty c

linic

T

his

is o

btai

ned

from

the

mat

erni

ty r

egis

ter

(xvi

) D

eliv

erie

s T

otal

num

ber

of p

regn

ant

wom

en d

eliv

erin

g at

the

hea

lth fa

cilit

y

(xvi

i) C

ouns

ellin

g on

infa

nt f

eedi

ng o

ptio

ns

Num

ber

of m

othe

rs d

eliv

erin

g at

the

he

alth

fac

ility

cou

nsel

led

on in

fant

fee

ding

opt

ions

T

his

is o

btai

ned

from

the

m

ater

nity

reg

iste

r

(xvi

ii) I

nfan

t te

stin

g at

6 w

eeks

bull N

umbe

r of

infa

nts

test

ed f

or H

IV a

t 6

wee

ks o

ld

bull N

umbe

r of

infa

nts

test

ing

HIV

-pos

itive

T

his

is o

btai

ned

from

labo

rato

ry

regi

ster

(xix

) R

efer

red

for

care

and

tre

atm

ent

bull N

umbe

r of

HIV

infe

cted

wom

en a

ttend

ing

ante

nata

l clin

ic t

hat

is r

efer

red

for

HIV

car

e an

d tr

eatm

ent

bull N

umbe

r of

HIV

infe

cted

wom

en in

mat

erni

ty t

hat

is r

efer

red

for

HIV

car

e an

d tr

eatm

ent

bull N

umbe

r H

IV in

fect

ed in

fant

s re

ferr

ed f

or H

IV c

are

and

trea

tmen

t T

his

is

ob

tain

ed f

rom

ant

enat

al a

nd m

ater

nity

reg

iste

rs

(xx)

Ini

tiate

d on

Cot

rim

oxaz

ole

Num

ber

of H

IV in

fect

ed p

regn

ant

wom

en a

ttend

ing

ante

nata

l clin

ic th

at h

as

been

initi

ated

on

Cot

rimox

azol

e T

his

is o

btai

ned

from

the

ant

enat

al r

egis

ter

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

1

9

88

Th

e da

ta is

pre

sent

ed u

sing

def

ined

per

form

ance

indi

cato

rs th

at in

clud

e th

e fo

llow

ing

(i)

New

clie

nts

first

ant

enat

al c

linic

vis

its

Num

ber

of p

regn

ant

wom

en a

ttend

ing

thei

r fir

st a

nten

atal

vis

it fo

r th

e cu

rren

t pr

egna

ncy

at t

he h

ealth

fac

ility

T

his

is

obta

ined

fro

m t

he a

nten

atal

reg

iste

r

(ii)

Ret

urn

visi

tsr

evis

its

Num

ber

of r

etur

n an

tena

tal c

linic

vis

itsr

evis

its

atte

nded

by

the

preg

nant

wom

en a

t th

e fa

cilit

y T

his

is o

btai

ned

from

the

an

tena

tal r

egis

ter

(iii)

C

ouns

ellin

g an

d te

stin

g fo

r H

IV in

ant

enat

al c

linic

Tot

al n

umbe

r of

pre

gnan

t w

omen

cou

nsel

led

and

test

ed f

or H

IV a

t th

e an

tena

tal c

linic

w

heth

er t

his

is d

one

on th

e fir

st a

nten

atal

vis

it or

a la

ter

visi

t T

his

is o

btai

ned

from

the

an

tena

tal r

egis

ter

(iv)

H

IV c

ouns

ellin

g an

d te

stin

g at

fir

st a

nten

atal

clin

ic v

isit

Num

ber

of p

regn

ant

wom

en a

tten

ding

the

ir fir

st a

nten

atal

clin

ic v

isit

for

curr

ent

preg

nanc

y w

ho a

re

test

ed f

or H

IV

Thi

s is

obt

aine

d fr

om t

he a

nten

atal

reg

iste

r

(v)

Lear

ning

HIV

sta

tus

in a

nten

atal

clin

ic

Num

ber

of a

nten

atal

clin

ic p

regn

ant

wom

en t

este

d fo

r H

IV w

ho r

ecei

ve t

heir

HIV

res

ults

w

heth

er t

his

is d

one

on t

he

first

ant

enat

al c

linic

vis

it or

at

a la

ter

visi

t T

his

is o

btai

ned

from

the

ant

enat

al

regi

ster

(vi)

HIV

infe

cted

in a

nten

atal

clin

ic

Num

ber

of a

nten

atal

clin

ic p

regn

ant

wom

en

who

are

HIV

-inf

ecte

d on

the

late

st t

est

durin

g th

e pr

egna

ncy

Thi

s is

obt

aine

d fr

om t

he a

nten

atal

reg

iste

r

(vii)

Pre

vent

ive

AR

V p

roph

ylax

is in

ant

enat

al c

linic

(m

othe

r do

se)

Num

ber

of

preg

nant

wom

en in

the

ant

enat

al c

linic

rec

eivi

ng t

he m

othe

r do

se(s

) of

pre

venshy

tive

AR

V p

roph

ylax

is

Thi

s is

obt

aine

d fr

om t

he a

nten

atal

reg

iste

r

(viii

) P

reve

ntiv

e A

RV

pro

phyl

axis

in a

nten

atal

clin

ic (

infa

nt d

ose)

N

umbe

r of

pr

egna

nt w

omen

in t

he A

nten

atal

clin

ic is

sued

with

the

infa

nt d

ose(

s) o

f pr

even

shytiv

e A

RV

pro

phyl

axis

T

his

is o

btai

ned

from

the

ant

enat

al r

egis

ter

(ix)

New

clie

nts

in m

ater

nity

clin

ic

Num

ber

of p

regn

ant

wom

en a

tten

ding

the

Mashy

tern

ity c

linic

for

the

firs

t tim

e T

his

is o

btai

ned

from

the

mat

erni

ty r

egis

ter

(x)

Unk

now

n H

IV s

tatu

s at

mat

erni

ty

Num

ber

of p

regn

ant

wom

en a

dmitt

ed in

to

the

mat

erni

ty w

ith u

nkno

wn

HIV

sta

tus

Thi

s is

obt

aine

d fr

om t

he m

ater

nity

reg

isshy

ter

(xi)

Cou

nsel

ling

and

test

ing

for

HIV

in m

ater

nity

war

dT

otal

num

ber

of p

regn

ant

wom

en a

dmitt

ed in

to m

ater

nity

with

unk

now

n st

atus

tha

t ar

e co

unse

lled

and

test

ed fo

r H

IV d

urin

g la

bour

or

afte

r de

liver

y T

his

is o

btai

ned

from

the

mat

erni

ty

regi

ster

(xii)

Lea

rnin

g H

IV s

tatu

s in

mat

erni

ty w

ard

Num

ber

of p

regn

ant

wom

en a

dmitt

ed

into

mat

erni

ty a

nd t

este

d fo

r H

IV w

ho r

ecei

ved

thei

r H

IV r

esul

ts

Thi

s is

obt

aine

d fr

om t

he m

ater

nity

reg

iste

r

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Cha

pter

1

Bac

kgro

und

11

THE

GLO

BA

L P A

ND

EMIC

Ove

r 38

mill

ion

peop

le a

re li

ving

with

HIV

AID

S w

orld

wid

e a

nd a

bout

two-

thir

ds o

r 25

m

illio

n of

PLW

HA

liv

e in

sub

-Sah

aran

Afr

ica1

H

IVA

IDS

mai

nly

affe

cts

peop

le o

fre

prod

uctiv

e ag

e an

d in

crea

sing

ly a

ffect

s w

omen

w

ho n

ow a

ccou

nt f

or 5

7 o

f ne

win

fect

ions

in s

ub-S

ahar

an A

fric

a w

here

wom

en a

re 3

0 m

ore

likel

y to

be

livin

g w

ith

HIV

AID

S th

an m

en a

nd y

oung

wom

en a

ged

15-2

4 ar

e ne

arly

four

tim

es m

ore

likel

y to

be

inf

ecte

d th

an t

heir

mal

e co

unte

rpar

ts2

Youn

g m

arri

ed w

omen

w

ho a

re o

ften

m

onog

amou

s h

ave

beco

me

one

of t

he g

roup

s m

ost

vuln

erab

le t

o H

IV i

n th

e re

gion

Th

is r

equi

res

new

and

rap

id r

espo

nses

that

bro

aden

the

focu

s be

yond

trad

ition

al ldquoh

igh

risk

rdquo gro

ups

like

com

mer

cial

sex

wor

kers

tru

ck d

rive

rs a

nd d

rug

user

s

To r

each

you

ng m

arri

ed w

omen

w

ho m

ay n

ot b

e aw

are

of t

heir

vul

nera

bilit

y H

IV

AID

S pr

even

tion

ca

re

and

supp

ort

activ

ities

m

ust

be

inte

grat

ed

into

al

read

yes

tabl

ishe

d he

alth

ser

vice

s th

at a

re u

sed

by t

he g

ener

al p

opul

atio

n A

n es

timat

ed

630

000

child

ren

wor

ld-w

ide

beca

me

infe

cted

with

HIV

in

2003

mdash m

ost

thro

ugh

MTC

T3

The

risk

of

an H

IV-in

fect

ed m

othe

r pa

ssin

g th

e vi

rus

to h

er i

nfan

t du

ring

pr

egna

ncy

labo

ur a

nd d

eliv

ery

or in

the

post

nata

l per

iod

is 1

in 3

if n

othi

ng is

don

e to

re

duce

this

ris

k I

n ot

her

wor

ds o

ut o

f 100

infa

nts

born

to w

omen

with

HIV

AID

S an

d w

ithou

t in

terv

entio

n 6

0-75

of t

hem

will

not

be

infe

cted

Of t

he o

ne-t

hird

who

bec

ome

infe

cted

abo

ut 5

-10

babi

es w

ill b

e in

fect

ed d

urin

g pr

egna

ncy

15

will

be

infe

cted

dur

ing

labo

ur a

nd d

eliv

ery

whi

le 5

-15

will

be

infe

cted

dur

ing

brea

stfe

edin

g l

arge

ly b

eing

de

pend

ent

on b

reas

tfee

ding

pra

ctic

es a

nd o

n th

e du

ratio

n of

bre

astfe

edin

g4 I

n 20

03

near

ly 5

000

00 c

hild

ren

died

of A

IDS-

rela

ted

caus

es M

ost

child

ren

born

with

HIV

die

befo

re th

ey r

each

thei

r fif

th b

irth

day

with

mos

t not

sur

vivi

ng b

eyon

d tw

o ye

ars5

The

high

rat

es o

f M

TCT

in d

evel

opin

g co

untr

ies

com

pare

d to

muc

h lo

wer

rat

es i

nri

cher

cou

ntri

es

illus

trat

e gr

owin

g in

equa

litie

s in

glo

bal

heal

th

In t

he w

ealth

y co

untr

ies

the

rat

e of

MTC

T is

les

s th

an 2

b

ecau

se o

f w

ides

prea

d ac

cess

to

antishy

retr

ovir

al th

erap

y (A

RT)

pla

nned

cae

sare

an s

ectio

ns (C

S) t

he m

eans

to s

afel

y fo

rmul

afe

ed a

nd a

cces

s to

qua

lity

med

ical

ser

vice

s I

n po

orer

cou

ntri

es li

ke K

enya

the

re is

a

30-4

0 c

hanc

e th

at a

n H

IV-p

ositi

ve b

reas

tfee

ding

mot

her

will

pas

s H

IV to

her

chi

ld in

th

e ab

senc

e of

the

se s

ervi

ces

In

such

set

tings

it

is c

ritic

al t

hat

prev

entio

n pr

oced

ures

be i

nteg

rate

d in

to e

xist

ing

sexu

al a

nd r

epro

duct

ive

heal

th (

SRH

) an

d m

ater

nal

and

child

hea

lth (

MC

H)

serv

ices

re

achi

ng a

s m

any

wom

en a

s po

ssib

le a

nd l

ower

ing

tran

smis

sion

rat

es A

lthou

gh p

harm

aceu

tical

com

pany

don

atio

ns d

onor

sup

port

and

othe

r go

vern

men

t in

itiat

ives

hav

e he

lped

exp

and

acce

ss t

o H

IV t

estin

g fo

r pr

egna

ntw

omen

and

use

of a

ntir

etro

vira

l dru

gs li

ke N

evir

apin

e w

hich

red

uce

the

chan

ce o

f HIV

tr

ansm

issi

on s

till o

nly

10

of p

regn

ant w

omen

glo

bally

hav

e ac

cess

to th

ese

drug

s6

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

7

20

HIV

AID

S tr

ansm

issi

on fr

om m

othe

r to

chi

ld in

Ken

ya is

one

of t

he b

igge

st h

ealth

and

de

velo

pmen

t cha

lleng

es in

Ken

ya A

ccor

ding

to th

e 20

03 D

emog

raph

ic a

nd H

ealth

Sur

shyve

y7 6

7

or

over

12

mill

ion

Ken

yan

adul

ts w

ere

livin

g w

ith H

IVA

IDS

in 2

003

The

re

has

been

a s

tead

y de

clin

e in

HIV

ser

opre

vale

nce

in K

enya

In

2005

the

pre

vale

nce

rate

w

as e

stim

ated

at 5

9

and

as

per

the

2006

sta

tistic

s th

e pr

eval

ence

rat

e am

ong

adul

tsha

d dr

oppe

d to

51

8

Acc

ordi

ng t

o 20

07 K

enya

AID

S In

dica

tor

Surv

ey (

KA

IS)8a

the

H

IV s

erop

reva

lenc

e in

Ken

ya is

cur

rent

ly 7

8

am

ong

adul

ts a

ged

15-4

9 ye

ars

bei

nghi

gher

in

wom

en (

87

) th

an i

n m

en (

56

) Y

oung

wom

en a

re m

ore

vuln

erab

le i

n K

enya

tha

n m

en a

s ev

iden

ced

by a

nea

rly

9 p

reva

lenc

e ra

te a

mon

g w

omen

and

unshy

der

5 a

mon

g m

en9

Ther

e ar

e w

ide

vari

atio

ns b

etw

een

urba

n an

d ru

ral

area

s b

etw

een

regi

ons

bet

wee

n ad

ults

and

you

ng p

eopl

e an

d be

twee

n m

en a

nd w

omen

The

re h

as b

een

a no

tabl

e dr

op

in t

he n

umbe

r of

new

inf

ectio

ns

with

an

estim

ated

60

000

new

inf

ectio

ns i

n 20

05

drop

ping

to 5

500

0 in

200

6 In

fant

s an

d yo

ung

child

ren

unde

r 15

yea

rs a

ccou

nt fo

r 16

of

all

new

HIV

infe

ctio

ns m

ainl

y as

a r

esul

t of M

TCT

Mos

t of t

he n

ew in

fect

ions

occ

ur

amon

g yo

ung

peop

le i

n w

hom

the

mai

n m

ode

of t

rans

mis

sion

is t

hrou

gh s

exua

l int

ershy

cour

se

Tabl

e 1

1 A

dult

HIV

-Pre

vale

nce

Estim

ate

by P

rovi

nce

in 2

006

Prov

ince

N

umbe

r of H

IV +

Pre

vale

nce

()

Nai

robi

Cen

tral

Coa

st

Eas

tern

N E

aste

rn

Nya

nza

Rift

Val

ley

Wes

tern

Tota

l

197

000

960

00

930

00

720

00

900

0 18

300

0

171

000

112

000

11

milli

on

Tota

l

101

41

59

28

14

78

38

53

51

Mal

e

80

17

50

11

09

61

26

42

35

Fem

ale

123

65

69

44

18

96

49

64

67

Mal

eFe

mal

e R

atio

15

38

14

40

20

16

19

15

19

all t

he d

ata

from

the

prov

ince

s (a

nd r

efer

ral h

ospi

tals

) Th

e ag

greg

ated

dat

a is

di

ssem

inat

ed t

o th

e H

ealth

Man

agem

ent

Info

rmat

ion

Syst

em N

atio

nal A

IDS

Con

trol

Cou

ncilrsquo

s (N

AC

C)

natio

nal

data

ban

k an

d re

sour

ce c

entr

e T

he f

ocal

pe

rson

s he

re a

re t

he d

irec

tor

NA

CC

and

the

Mamp

E m

anag

er D

ata

is d

isse

mishy

nate

d ba

ck to

the

prov

ince

s an

d re

ferr

al h

ospi

tals

for

use

in d

ecis

ion-

mak

ing

7

Dat

a flo

w f

rom

fac

ility

lev

el t

o na

tiona

l le

vel

At

the

heal

th f

acili

ty P

MTC

T in

divi

dual

le

vel d

ata

reco

rded

in t

he M

oH s

tand

ardi

sed

regi

ster

s (A

NC

Mashy

tern

ity a

nd P

ostn

atal

) is

sum

mar

ised

ag

greg

ated

on

a m

onth

ly b

asis

ont

o M

oH F

orm

726

F

orm

726

is

then

for

war

ded

upw

ards

to

the

dist

rict

Lev

el

(DA

SCO

rsquos O

ffice

) for

agg

rega

tion

of th

e D

istr

ict l

evel

dat

a on

to F

orm

727

Cop

shyie

s of

For

m 7

26 a

nd F

orm

727

are

forw

arde

d to

the

Nat

iona

l Offi

ce (N

ASC

OP)

w

ith a

noth

er c

opy

of F

orm

727

bei

ng s

ent t

o th

e Pr

ovin

cial

Offi

ce (P

ASC

O)

8

Dat

a di

ssem

inat

ion

Thi

s is

car

ried

out

at

all

leve

ls s

tart

ing

from

fac

ility

to

natio

nal l

evel

It i

s th

e re

spon

sibi

lity

of N

AC

C to

coo

rdin

ate

the

diss

emin

atio

n an

d us

e of

all

HIV

AID

S da

ta a

nd in

form

atio

n fo

r na

tiona

l res

pons

e J

APR

a

join

t pro

gram

me

of a

ll st

akeh

olde

rs in

HIV

AID

S re

ceiv

es a

nd u

ses

the

data

to

disc

uss

the

chal

leng

es a

chie

vem

ents

and

les

sons

lea

rnt

from

HIV

AID

S an

d gi

ves

feed

back

for n

atio

nal r

espo

nse

9

PMTC

T in

dica

tors

and

thei

r so

urce

s H

ealth

car

e fa

cilit

ies

colle

ct th

e fo

llow

ing

data

as

a m

inim

um t

o be

use

d in

the

mon

itori

ng o

f PM

TCT

prog

ram

s T

he

data

is

to b

e ag

greg

ated

on

a m

onth

ly b

asis

ont

o th

e M

inis

try

of H

ealth

In

tegr

ated

Mon

itori

ng a

nd E

valu

atio

n R

epor

t For

m M

oH 7

26 u

sing

dat

a fr

om

the

Min

istr

y of

Hea

lth

Ken

ya A

nten

atal

and

Mat

erni

ty R

egis

ters

(D

eliv

ery

Reg

iste

r) M

oH 4

05 a

nd M

oH 3

33 r

espe

ctiv

ely

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

2

1

86

102

O

PER

ATI

ON

AL

GU

IDEL

INES

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed in

the

mon

itorin

g an

d ev

alua

-tio

n of

PM

TCT

serv

ices

1

W

ithin

PM

TCT

prog

ram

s d

ata

is c

olle

cted

and

rep

orte

d at

the

fol

low

ing

leve

ls I

ndiv

idua

l fa

cilit

y d

istr

ict

prov

inci

al a

nd n

atio

nal

2

Indi

vidu

al l

evel

The

com

bine

d m

othe

r an

d ch

ild h

ealth

boo

klet

pro

vide

s de

shyta

iled

info

rmat

ion

on t

he w

oman

and

chi

ld i

nclu

ding

the

HIV

sta

tus

oth

er

HIV

car

e se

rvic

es d

rugs

del

iver

y in

form

atio

n im

mun

isat

ion

gro

wth

mon

itorshy

ing

and

othe

r par

amet

ers

3

Faci

lity

leve

l da

ta c

aptu

re t

ools

The

MoH

has

sta

ndar

dise

d re

gist

ers

for

reshy

cord

ing

data

at

faci

litie

s T

hese

inc

lude

the

Rev

ised

AN

C R

egis

ter

Rev

ised

M

ater

nity

Reg

iste

r an

d Po

st N

atal

Reg

iste

r an

d W

orkl

oad

MO

H 7

17 O

ther

re

gist

ers

incl

ude

Chi

ld H

ealth

and

Nut

ritio

n In

form

atio

n Sy

stem

and

Inshy

patie

nt M

orbi

dity

and

Mor

talit

y F

orm

711

and

the

Rep

rodu

ctiv

e H

ealth

Ser

shyvi

ces

mon

thly

rep

orts

are

use

d fo

r m

akin

g fa

cilit

y le

vel s

umm

arie

s on

PM

TCT

and

repr

oduc

tive

heal

th s

ervi

ces

3 F

acili

ty le

vel d

ata

capt

ure

tool

s T

he M

oH

has

stan

dard

ized

reg

iste

rs f

or r

ecor

ding

dat

a at

fac

ilitie

s T

hese

inc

lude

the

R

evis

ed A

NC

Reg

iste

r R

evis

ed M

ater

nity

Reg

iste

r an

d Po

st N

atal

Reg

iste

r an

d w

orkl

oad

MO

H 7

17 O

ther

reg

iste

rs in

clud

e C

hild

Hea

lth a

nd N

utri

tion

Info

rmat

ion

Syst

em a

nd I

n-pa

tient

mor

bidi

ty a

nd m

orta

lity

Fo

rm 7

26 a

nd

the

Rep

rodu

ctiv

e he

alth

ser

vice

s m

onth

ly r

epor

ts a

re u

sed

for

mak

ing

faci

lity

leve

l sum

mar

ies

on P

MTC

T an

d re

prod

uctiv

e he

alth

ser

vice

s

4

Dis

tric

t le

vel

data

For

m 7

27 i

s us

ed t

o su

mm

aris

e an

d re

port

dis

tric

t le

vel

data

Oth

er s

umm

ary

repo

rtin

g to

ols

are

also

use

d to

rep

ort

dist

rict

leve

l inshy

form

atio

n A

t th

e di

stri

ct le

vel

the

DAS

CO

rsquos of

fice

aggr

egat

es d

ata

from

sev

shyer

al h

ealth

faci

lity

spec

ific

Form

726

ont

o Fo

rm 7

27 th

at is

use

d to

sum

mar

ise

and

repo

rt d

istr

ict l

evel

dat

a

5

Prov

inci

al l

evel

dat

a A

t th

e pr

ovin

cial

lev

el t

he P

ASC

O r

ecei

ves

Form

727

da

ta f

rom

the

res

pect

ive

DA

SCO

rsquos of

fices

in

the

prov

ince

for

the

ir o

wn

data

us

e an

d re

cord

s A

cop

y of

the

sam

e is

sen

t to

the

Nat

iona

l Offi

ce (N

ASC

OP)

by

the

DA

SCO

rsquos of

fice

At

the

prov

inci

al le

vel

the

dist

rict

leve

l dat

a is

agg

reshy

gate

d to

giv

e th

e pr

ovin

cial

leve

l dat

a

6 N

atio

nal

leve

l da

ta

At

the

natio

nal

leve

l th

e M

ampE

Man

ager

rec

eive

s da

ta

from

the

PASC

Os

for

each

of t

he p

rovi

nces

Dat

a is

als

o re

ceiv

ed fr

om th

e R

eshyfe

rral

hos

pita

ls a

nd o

ther

fac

ilitie

s at

the

ref

erra

l ho

spita

l or

ter

tiary

lev

el

The

data

rec

eive

d at

the

nat

iona

l lev

el is

als

o co

pied

to

the

Hea

d of

NA

SCO

P an

d PM

TCT

prog

ram

me

man

ager

The

Mamp

E m

anag

er a

t NA

SCO

P ag

greg

ates

85

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

12

MA

GN

ITU

DE

OF

HIV

IN P

REG

NA

NC

YIN

KEN

YA

Ken

ya N

atio

nal

AID

SST

I C

ontr

ol P

rogr

amm

e (N

ASC

OP)

est

imat

es t

hat

ther

e w

ere

12

mill

ion

babi

es b

orn

in 2

006

in K

enya

and

that

as

man

y as

9

of p

regn

ant w

omen

inK

enya

wer

e liv

ing

with

HIV

AID

S10

At

leas

t 50

000

to

600

00 i

nfan

ts i

n K

enya

wer

e th

ough

t to

hav

e be

en i

nfec

ted

with

H

IV a

s a

resu

lt of

MTC

T th

at y

ear

With

an

estim

ated

pop

ulat

ion

of 3

72

mill

ion

in th

eye

ar 2

007

the

num

ber

of b

irth

s in

200

7 w

as 1

73

mill

ion

With

an

HIV

pre

vale

nce

of 6

7

the

num

ber

of H

IV -

expo

sed

babi

es is

114

101

and

at

leas

t 45

640

HIV

-pos

itive

bab

ies

are

born

ass

umin

g a

40

tran

smis

sion

(Tab

le 1

2)

Tabl

e 1

2 E

stim

ated

mag

nitu

de o

f MTC

T in

Ken

ya 2

007

Popu

latio

n (E

stim

ates

200

7)

372

mill

ion

Birt

hs p

er a

nnum

1

73 m

illio

n

HIV

pre

vale

nce

in m

othe

rs

67

Tota

l num

ber o

f birt

hs to

HIV

-infe

cted

mot

hers

exp

osed

14

110

1 to

MTC

T as

sum

ing

no m

ultip

le p

regn

ancy

Num

ber o

f HIV

pos

itive

infa

nts

per a

nnum

in K

enya

45

640

as

sum

ing

40

tran

smis

sion

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

22

13

RIS

KS

OF

T RA

NSM

ISSI

ON

OF

MTC

T A

T D

IFFE

REN

T

T

IME

P ER

IOD

S

In K

enya

an

estim

ated

40

000

to 5

000

0 in

fant

s ar

e in

fect

ed w

ith H

IV a

nnua

lly d

ue to

m

othe

r-to

-chi

ld t

rans

mis

sion

Th

is c

an o

ccur

in u

tero

dur

ing

labo

ur a

nd d

eliv

ery

and

thro

ugh

brea

stfe

edin

g D

urin

g pr

egna

ncy

abo

ut 5

to

8 pe

rcen

t of

HIV

-exp

osed

bab

ies

beco

me

infe

cted

thr

ough

tra

nsm

issi

on a

cros

s th

e pl

acen

ta L

abou

r an

d de

liver

y po

ses

the

grea

test

ris

k fo

r tr

ansm

issi

on w

ith 1

0 to

20

perc

ent

of e

xpos

ed i

nfan

ts b

ecom

ing

infe

cted

at t

his

time

Bre

astf

eedi

ng a

lso

expo

ses

infa

nts

to H

IV

Whe

n m

othe

rs b

reas

tfee

d fo

r 18

to

24m

onth

s an

othe

r 10

to 1

5 pe

rcen

t of i

nfan

ts b

ecom

e in

fect

ed T

hus

in n

on-b

reas

tfee

ding

po

pula

tions

with

out

antir

etro

vira

l tre

atm

ent

appr

oxim

atel

y 15

to

30 p

erce

nt in

fant

s w

ill b

ecom

e in

fect

ed

with

pro

long

ed b

reas

tfee

ding

25

to

45 p

erce

nt i

nfan

ts w

ill

beco

me

infe

cted

Tabl

e 1

3 T

rans

mis

sion

pat

tern

s in

bre

astfe

edin

g an

d no

n br

east

feed

ing

popu

latio

ns

Tran

smis

sion

rate

in

Tim

ing

No

Bre

astfe

edin

g B

reas

tfeed

ing

Bre

astfe

edin

g th

roug

h

thro

ugh

6

mon

ths

18 to

24

mon

ths

Dur

ing

preg

nanc

y 05

to 1

0 05

to 1

0 05

to 1

0

Dur

ing

labo

ur

10 to

20

10 to

20

10 to

20

Thro

ugh

brea

stfe

edin

g 10

to 2

0 05

to 1

0 05

to 1

0

Ear

ly (f

irst 2

mon

ths)

10

to 2

0 05

to 1

0 05

to 1

0

Late

(afte

r 2 m

onth

s)

10 to

20

01 to

05

05 to

10

Ove

rall

15 to

30

25 to

35

30 to

45

Sou

rce

De

Coc

k K

M (2

002)

Form

MoH

711

has

bee

n re

com

men

ded

to r

epla

ce F

orm

MoH

726

HIV

Mamp

E d

ata

flow

pip

elin

e fr

om t

he i

ndiv

idua

l he

alth

fac

ilitie

s t

o th

e di

stri

ct a

ndpr

ovin

cial

leve

ls u

p to

the

cent

ral o

r na

tiona

l lev

els

at N

ASC

OP

and

NA

CC

is s

umm

ashyri

sed

in F

igur

e 1

01

Figu

re 1

01

HIV

Mon

itorin

g an

d Ev

alua

tion

data

flow

pip

elin

e in

Ken

ya

HM

IS

NA

SC

OP

N

ACC

H

ead

Nat

iona

l Dat

a B

ank

amp

Res

ourc

e C

entre

M

E M

anag

er

The

Dire

ctor

P

rogr

amm

e M

anag

er

ME

Man

ager

Ref

erra

l Hos

pita

ls

CE

Os

Spe

cial

ists

The

Prov

ince

P

MO

P

AS

CO

P

AR

TO

PH

RIO

P

CO

The

Dis

trict

D

MO

D

AS

CO

Dat

a en

try

cler

k D

AR

TO

DH

RIO

Hea

lth F

acilit

y P

ublic

Sec

tor

FBO

etc

23

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

84

Cha

pter

10

Mon

itorin

g an

d Ev

alua

tion

of P

MTC

T Se

rvic

es

101

IN

TRO

DU

CTI

ON

PMTC

T pr

ogra

m m

onito

ring

and

eva

luat

ion

activ

ities

pro

vide

the

oppo

rtun

ity to

mea

sshyur

e an

d ap

prai

se p

erfo

rman

ce w

ithin

def

ined

par

amet

ers

that

ens

ure

acco

mpl

ishm

ent

of g

oals

and

obj

ectiv

es

Ken

ya is

com

mitt

ed to

the

ldquoThr

ee-o

nesrdquo

pri

ncip

les

whi

ch a

re

bull O

ne a

gree

d A

IDS

Act

ion

Fra

mew

ork

that

pro

vide

s th

e ba

sis

for

coor

dina

ting

the

wor

k pl

an o

f al

l par

tner

s

bull O

ne N

atio

nal A

IDS

Coo

rdin

atin

g A

utho

rity

with

a b

road

-bas

ed

mul

tisec

tora

l man

date

bull O

ne a

gree

d co

untr

y-le

vel M

onito

ring

and

Eva

luat

ion

(M

ampE

) sy

stem

In l

ine

with

thi

s t

he c

ount

ry h

as d

evel

oped

the

Nat

iona

l H

IVA

IDS

Mon

itori

ng a

ndE

valu

atio

n Fr

amew

ork

that

pro

vide

s st

akeh

olde

rs w

ith a

too

l fo

r w

ell

coor

dina

ted

in

terl

inke

d an

d fu

nctio

nal H

IVA

IDS

Mamp

E s

yste

m t

hat

allo

ws

for

effic

ient

mon

itori

ngof

int

erve

ntio

ns i

n ac

hiev

ing

the

natio

nal

prog

ram

mat

ic g

oals

usi

ng d

efin

ed t

arge

ts

This

pro

vide

s th

e fr

amew

ork

for M

ampE

act

iviti

es w

ithin

PM

TCT

prog

ram

s

Nat

iona

l PM

TCT

data

is

repo

rted

usi

ng M

oH I

nteg

rate

d M

onito

ring

and

Eva

luat

ion

Rep

ortin

g Fo

rms

For

m M

oH 7

11 o

r Fo

rm M

oH 7

27

Indi

vidu

al P

MTC

T da

ta is

col

shyle

cted

at

the

heal

th f

acili

ties

offe

ring

PM

TCT

serv

ices

usi

ng s

tand

ard

MoH

reg

iste

rs(A

NC

Mat

erni

ty a

nd P

ostn

atal

Reg

iste

rs)

On

mon

thly

bas

is t

he h

ealth

faci

litie

s w

ill a

ggre

gate

the

dat

a fr

om t

he r

egis

ters

on

to

Form

MoH

711

or

MO

H 7

26 w

hich

is th

en fo

rwar

ded

upw

ards

to th

e D

ASC

Orsquos

offic

e A

copy

is

left

at

the

heal

th f

acili

ty f

or t

heir

ow

n da

ta u

se

At

the

dist

rict

lev

el

the

DA

SCO

rsquos of

fice

aggr

egat

es d

ata

from

sev

eral

hea

lth f

acili

ty s

peci

fic F

orm

726

ont

o Fo

rm M

oH 7

27 (o

r Fo

rm 7

11) t

hat

is u

sed

to s

umm

aris

e an

d re

port

dis

tric

t le

vel d

ata

B

oth

Form

726

and

For

m M

oH 7

27 a

re th

en s

ent t

o N

ASC

OP

A c

opy

of th

e Fo

rm 7

27

or F

orm

711

is s

ent t

o th

e PA

SCO

and

ano

ther

to th

e he

alth

faci

litie

s in

the

dist

rict

for

thei

r ow

n da

ta u

se

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

14

RIS

K F

AC

TOR

SFO

R M

TCT

OF

HIV

M

any

fact

ors

are

know

n or

sus

pect

ed t

o in

crea

se t

he r

isk

of a

n H

IV in

fect

ed m

othe

r tr

ansm

ittin

g th

e vi

rus

to h

er i

nfan

t Th

ese

fact

ors

incl

ude

the

HIV

vir

al l

oad

in t

he

mot

her

as

wel

l as

othe

r m

ater

nal

obst

etri

cal

vira

l and

infa

nt fa

ctor

s (T

able

14

)

The

mos

t sig

nific

ant r

isk

fact

or a

ppea

rs to

be

the

HIV

vir

al lo

ad in

the

mot

her

thou

gh

the

othe

r fa

ctor

s m

ay a

lso

cont

ribu

te t

o in

crea

sing

an

infa

ntrsquos

expo

sure

or

susc

eptib

ilshyity

to

acqu

irin

g H

IV S

ome

fact

ors

may

cau

se a

bre

akdo

wn

in t

he p

rote

ctio

n of

fere

d to

the

foet

us b

y th

e pl

acen

ta w

hich

in n

orm

al c

ircu

mst

ance

s w

ould

not

allo

w H

IV to

cro

ssth

e pl

acen

ta fr

om m

othe

r to

foet

us

Tran

smis

sion

dur

ing

labo

ur a

nd d

eliv

ery

occu

rs w

hen

the

infa

nt s

ucks

im

bibe

s or

asshy

pira

tes

mat

erna

l bl

ood

or c

ervi

cal

secr

etio

ns t

hat

cont

ain

HIV

or

whe

n it

has

othe

r m

ucou

s m

embr

ane

expo

sure

Tab

le 1

4

Ris

k fa

ctor

s fo

r M

TCT

of H

IV

Stro

ng e

vide

nce

Lim

ited

evid

ence

VIR

AL

MA

TER

NA

L

OB

STE

TRIC

AL

FETA

LIN

FAN

T

BR

EA

ST-

FEE

DIN

G

Hig

h vi

ral l

oad

Imm

une

defic

ienc

y (lo

w

CD

4 co

unt)

HIV

infe

ctio

n ac

quire

d du

ring

preg

nanc

y o

r br

east

feed

ing

perio

d

Vagi

nal d

eliv

ery

(com

pare

d to

ele

ctiv

e ca

esar

ean

sect

ion)

ru

ptur

e of

the

mem

bran

es

for m

ore

than

4 h

ours

Prem

atur

ity

Dur

atio

n of

bre

astfe

edin

g

mix

ed fe

edin

g b

reas

t di

seas

e (m

astit

isc

rack

ed

nipp

les)

Vira

l res

ista

nce

(theo

retic

al p

ossi

bilit

y)

Vira

l gen

otyp

e an

d ph

enot

ype

Vita

min

A d

efic

ienc

y a

naem

ia s

exua

lly

trans

mitt

ed d

isea

ses

ch

orio

amni

oniti

s fr

eque

nt u

npro

tect

ed

sexu

al in

terc

ours

e m

ultip

le s

exua

l pa

rtner

s s

mok

ing

inje

ctin

g dr

ug a

buse

Inva

sive

or t

raum

atic

pro

cedu

res

in

stru

men

tal d

eliv

erie

s a

mni

ocen

tesi

s

epis

ioto

my

ext

erna

l cep

halic

ver

sion

(E

CV

) et

c i

ntra

partu

m h

aem

orrh

age

Lesi

ons

of s

kin

and

or m

ucou

s m

embr

anes

Ora

l thr

ush

(bab

y)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

3

24

15

BEN

EFIT

SO

F P R

EVEN

TIN

G M

OTH

ER-T

O-C

HIL

D

T

RA

NSM

ISSI

ON

OF

HIV

A

IDS

rela

ted

deat

hs a

re r

ever

sing

gai

ns m

ade

in c

hild

hea

lth a

nd s

urvi

val i

n K

enya

C

arin

g fo

r H

IV-in

fect

ed c

hild

ren

has

maj

or e

cono

mic

and

soc

ial

impa

cts

on f

amili

es

and

heal

th s

yste

ms

Thu

s at

the

nat

iona

l lev

el p

reve

ntin

g M

TCT

has

the

pote

ntia

l to

incr

ease

the

unde

rsta

ndin

g an

d ac

cept

ance

of t

he H

IVA

IDS

epid

emic

and

thos

e liv

ing

with

HIV

AID

S C

ouns

ellin

g t

estin

g an

d co

mm

unity

sen

sitis

atio

n ca

n co

ntri

bute

to

redu

cing

stig

ma

Red

uctio

n of

MTC

T of

HIV

bull

Dec

reas

es n

umbe

rs o

f H

IV in

fect

ed c

hild

ren

bull

Incr

ease

s ch

ild h

ealth

and

sur

viva

l

bull

Dec

reas

es t

he lo

ad o

n th

e he

alth

sys

tem

bull

Giv

es a

n op

port

unity

to im

prov

e an

d ex

pand

hea

lth s

ervi

ces

as w

ell a

s to

str

engt

hen

the

exis

ting

heal

th in

fras

truc

ture

16

BEN

EFIT

SO

F H

IV C

OU

NSE

LLIN

GA

ND T

ESTI

NG

(CT)

(a) I

t pro

mot

es b

ehav

iour

cha

nge

by

bull R

educ

ing

high

ris

k be

havi

our

for

HIV

bull Id

entif

ying

HIV

dis

cord

ant

coup

les

bull In

crea

sing

the

use

of

dual

met

hods

of f

amily

pla

nnin

g an

d S

TI

prev

entio

n

bull Im

prov

ing

ante

nata

l car

e

bull G

uidi

ng in

fant

fee

ding

(b) I

t ena

bles

pre

vent

ive

ther

apy

for

bull

Mal

aria

bull O

ppor

tuni

stic

infe

ctio

ns (

eg

Pne

umoc

ystis

jiro

veci

i pn

eum

onia

)

bull T

B

25

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

82

Foo

tnot

es

9

Use

oth

er o

ptions

for

child

ren o

ver

9 k

ilogra

ms

10

Use

reg

ula

r or

double

-str

ength

tab

lets

for

child

ren o

ver

16 k

ilogra

ms

NO

T A

PP

LIC

AB

LE

bullPsp

sm

ear

The

fram

ewor

k be

low

illu

stra

tes

poin

ts o

f int

egra

tion

of c

ompr

ehen

sive

HIV

ca

re p

acka

ge in

to e

xist

ing

child

hea

lth s

ervi

ces

Fram

ewor

k for

integ

ratio

n F

rom

Ped

iatr

ic H

IV P

reve

nti

on

to C

are

A

Co

nce

ptu

al F

ram

ewo

rk N

ewb

orn

In

fan

t W

om

an

H

IV e

duca

tion

Pre

gn

an

cy

prev

entio

n C

T

bull F

ocus

ed A

NC

incl

udin

g

AR

V p

roph

ylax

is s

tagi

ng

STI

syph

ilis

CT

Z p

roph

ylax

isA

RT

M

alar

ia tr

eatm

ent amp

pre

vent

ion

CD

4 w

here

ava

ilabl

e in

clud

ing

IPT

amp I

TNs

Infa

nt f

eedi

ng c

ouns

elin

g (I

FC)

Lab

ou

r an

d D

eliv

ery

U

nive

rsal

pre

caut

ions

CT

for

unt

este

d m

othe

rs in

clud

ing

bull D

eliv

ery

care

bull E

OC

-Em

erge

ncy

obst

etri

c ca

re

part

ner

bull R

efer

ral s

yste

m

AR

V p

roph

ylax

is

(mot

her

and

infa

nt)

AR

T C

TZ

pro

phyl

axis

Exc

lusi

ve b

reas

t fe

edin

g or

rep

lace

men

t fe

edin

g

Post

Na

tal

Ca

re

Infa

nt fe

edin

g co

unse

ling

bull B

reas

t hea

lth

Dia

gnos

is (

antib

ody)

if

bull Se

xual

hea

lth

expo

sure

unk

now

n bull

Fam

ily

plan

ning

D

NA

PC

R if

exp

osed

CT

Z p

roph

ylax

is I

FC-

infa

nt f

eedi

ng c

ouns

elin

g

CT

for

unt

este

d m

othe

rs

CT

for

par

tner

D

BS

resu

lt I

FC

IFC

Wea

ning

Bf

eedi

ng

cess

atio

n s

uppo

rt

bullBre

ast e

xam

D

iagn

osis

(an

tibod

y

bullPap

sm

ear

test

) C

T f

or n

egat

ive

wom

en a

nd p

artn

ers

Dia

gnos

is (

antib

ody

test

)

New

born

Ca

re

bull B

CG

bull P

olio

0

bull Is

sue

child

hea

th c

ard

bullEnt

er b

irth

wei

ght

HIV

an

d A

RV

Exp

osur

e st

atus

on

chi

ld h

ealth

car

d Tw

o w

eeks

Infa

nt fe

edin

g co

unse

ling

Six

wee

ks

Imm

uniz

atio

ngr

owth

mon

itori

ng

Ten

wee

ks

im

mun

izat

ion

GM

Fou

rtee

n w

eeks

Im

mun

izat

ion

grow

th m

onito

ring

Si

x m

onth

s

Com

plem

enta

ry fe

eds

Vita

min

A S

uppl

emen

tatio

n

9 m

onth

s

imm

uniz

atio

nG

M

12 amp

18

mon

ths

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

17

(c) I

t pro

mot

es a

cces

s to

ear

ly m

edic

al c

are

bull

Obs

tetr

ical

car

e

bull T

B th

erap

y

bull M

alar

ia t

reat

men

t

bull S

TI t

reat

men

t

bull A

RV

the

rapy

for

mot

her

and

fam

ily

(d) I

t hel

ps to

pla

n fo

r the

futu

re

bull In

fant

fee

ding

sup

port

sys

tem

s

bull F

amily

pla

nnin

g

bull P

erso

nal a

nd f

inan

cial

dec

isio

ns

(e) I

t ena

bles

pre

vent

ive

ther

apy

of m

alar

ia a

nd

othe

r opp

ortu

nist

ic in

fect

ions

suc

h a

PCP

(f) It

giv

es ti

me

to p

lan

for t

he fu

ture

eg

inf

ant

feed

ing

supp

ort s

yste

ms

TH

E F O

UR-P

RO

NG

ED A

PPR

OA

CH

TO P

MTC

T Th

e In

ter

Age

ncy

Task

Tea

m o

n Pr

even

tion

of H

IV T

rans

mis

sion

in p

regn

ant

wom

en

mot

hers

and

the

ir c

hild

ren

(IA

TT)

has

prop

osed

a f

our-

pron

ged

appr

oach

for

the

pre

shyve

ntio

n of

HIV

tra

nsm

issi

on t

hat

targ

ets

non-

preg

nant

and

pre

gnan

t w

omen

mot

hers

and

thei

r ch

ildre

n

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

8

1

26

The

four

pro

ngs

are

1 P

rimar

y pr

even

tion

of H

IV in

fect

ion

in w

omen

2 P

reve

ntio

n of

uni

nten

ded

preg

nanc

y am

ong

HIV

-inf

ecte

d w

omen

3 I

nter

vent

ions

to

redu

ce t

rans

mis

sion

fro

m H

IV-i

nfec

ted

preg

nant

and

la

ctat

ing

wom

en t

o th

eir

child

ren

4 C

are

and

supp

ort

of w

omen

ch

ildre

n an

d fa

mili

es in

fect

ed a

nd

affe

cted

by

HIV

and

AID

S (

The

PM

TC

T-p

lus)

Ove

rall

the

cov

erag

e of

PM

TCT

prog

ram

mes

and

the

upt

ake

of s

ervi

ces

prov

ided

thro

ugh

thes

e pr

ogra

mm

es

incl

udin

g H

IV

test

ing

and

coun

selli

ng

and

AR

V

prop

hyla

xis

are

still

ver

y lo

w I

n 20

06 w

orld

wid

e le

ss t

han

10

of

preg

nant

wom

ente

stin

g H

IV-p

ositi

ve r

ecei

ved

AR

V d

rugs

for

PMTC

T11

In K

enya

acc

ordi

ng to

the

2007

Ken

ya A

IDS

Indi

cato

r Su

rvey

(KA

IS) 7

the

re h

as b

een

a sm

all i

ncre

ase

in H

IV te

stin

g am

ong

wom

en a

nd m

en c

ompa

red

to th

e 20

03 K

DH

S

KA

IS s

how

s th

at t

houg

h a

vast

maj

ority

(83

)

of H

IV-in

fect

ed w

omen

and

men

in

Ken

ya d

o no

t kn

ow t

heir

HIV

sta

tus

the

re h

as b

een

a cl

ear

and

dram

atic

incr

ease

inco

vera

ge o

f HIV

-tes

ting

amon

g A

NC

clin

ic a

tten

dees

PMTC

T se

rvic

es a

re t

here

fore

im

port

ant

entr

y po

ints

for

HIV

pre

vent

ion

and

trea

tshym

ent

Ove

rall

AR

V c

over

age

for

HIV

infe

cted

peo

ple

who

nee

d tr

eatm

ent

in K

enya

ison

ly 3

5

bull 9

0

of K

enya

n w

omen

who

del

iver

ed in

the

last

4 y

ears

att

end

AN

C

bull 5

7 o

f th

ose

atte

ndin

g A

NC

tes

ted

for

HIV

bull A

mon

g H

IV in

fect

ed w

omen

with

rec

ent

birt

hs

47

wer

e te

sted

in

AN

C

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

(8)

HIV

dis

ease

sta

ging

in H

IV-in

fect

ed c

hild

ren

Dis

ease

sta

ging

with

or

with

out

labo

rato

ry s

uppo

rt f

ollo

ws

HIV

dia

gshyno

sis

Sta

ging

HIV

dis

ease

pro

vide

s a

guid

e to

the

prog

nosi

s an

d in

tershy

vent

ions

nee

ded

at th

e di

ffere

nt s

tage

s (R

efer

to C

hapt

er 5

and

8)

(9)

AR

V th

erap

y

Chi

ldre

n w

ho a

re e

ligib

le fo

r A

RT

shou

ld b

e lin

ked

with

the

AR

T pr

oshygr

am a

nd p

rovi

ded

with

trea

tmen

t acc

ordi

ng to

Nat

iona

l Gui

delin

es a

sso

on a

s an

HIV

dia

gnos

is i

s m

ade

Ear

ly t

reat

men

t si

gnifi

cant

ly r

eshydu

ces

mor

talit

y in

HIV

infe

cted

chi

ldre

n

(10)

C

omm

unic

atio

n

Com

mun

icat

ing

with

car

e-pr

ovid

ers

and

prov

idin

g ps

ycho

soci

al s

upshy

port

for

the

child

mot

her

care

give

r an

d fa

mily

are

a c

ruci

al c

ompo

nent

of

car

e

Pare

nts

care

give

rs a

ndo

r th

e ch

ild n

eed

to p

artic

ipat

e in

mak

ing

deci

shysi

ons

and

plan

ning

app

ropr

iate

car

e fo

r th

e ch

ild i

nclu

ding

dec

isio

nsab

out t

hera

py a

nd w

here

the

child

sho

uld

rece

ive

care

In

this

res

pect

he

alth

wor

kers

mus

t en

sure

tha

t th

e fa

mily

con

side

rs t

he s

ocia

l nee

ds

of H

IV in

fect

ed a

nd a

ffect

ed c

hild

ren

Hea

lth c

are

wor

kers

sho

uld

ensu

re th

at th

ey p

rovi

de a

dequ

ate

time

for

care

give

rs to

ask

que

stio

ns s

o th

at th

ey c

an fu

lly u

nder

stan

d th

e im

plishy

catio

ns o

f HIV

and

HIV

tes

ting

for

them

selv

es a

nd fo

r th

eir

child

ren

H

ealth

car

e w

orke

rs s

houl

d co

unse

l car

egiv

ers

on d

iscl

osur

e in

clud

ing

disc

losu

re to

the

child

(11)

R

efer

rals

Ref

erra

ls a

re a

n im

port

ant p

art o

f man

agin

g an

HIV

exp

osed

or

infe

cted

chi

ld

Thes

e in

clud

e re

ferr

als

to

bull H

ighe

r le

vels

of s

peci

alis

ed c

are

for

furt

her

inve

stig

atio

ns a

nd

trea

tmen

t

bull S

ocia

l sup

port

pro

gram

mes

bull C

omm

unity

-bas

ed c

are

prog

ram

mes

bull P

ITC

site

s fo

r pa

rent

s an

d si

blin

gs

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

2

7

80

Tabl

e 9

2 W

HO

Rec

omm

enda

tions

for

Follo

w-u

p of

an

HIV

-Exp

osed

Chi

ld

bull A

t birt

h (f

or in

fant

s de

liver

ed a

t ho

me)

bull A

t age

1 t

o 2

wee

ks (

mai

nly

for

infa

nt f

eedi

ng c

ouns

elin

g)

bull A

t ag

e 6

10

and

14

wee

ks (

for

imm

uniz

atio

n an

d in

fant

fee

ding

co

unse

ling)

bull A

fter

age

14

wee

ks

mon

thly

thr

ough

age

12

mon

ths

bull A

fter

age

12 m

onth

s e

very

3 m

onth

s th

roug

h 24

mon

ths

bull A

t 18

mon

ths

do

conf

irm

ator

y H

IV la

bora

tory

test

(if

ther

e ar

e no

re

sour

ces

for

an e

arlie

r an

tigen

-bas

ed t

est)

bull A

fter

2 ye

ars

a m

inim

um o

f ye

arly

vis

its

For t

he H

IV-in

fect

ed f

ollo

w th

ese

guid

elin

es

From

M

onito

r

6 w

eeks

ndash12

mon

ths

Mon

thly

12 ndash

24 m

onth

s Ev

ery

3 m

onth

s

24 m

onth

s an

d on

war

ds

Yea

rly i

f not

sym

ptom

atic

If sy

mpt

omat

ic f

ollo

w u

p as

nee

ded

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

18

OV

ERV

IEW

OF

THE

NEW

PM

TCT

GU

IDEL

INES

Ken

yarsquos

Min

istr

y of

Hea

lth (

MO

H)

thro

ugh

NA

SCO

P h

as t

aken

sev

eral

act

ions

to

expa

nd a

nd s

tren

gthe

n PM

TCT

inte

rven

tions

in

the

coun

try

In

2000

a

Nat

iona

lTe

chni

cal

Wor

king

Gro

up (

TWG

) on

PM

TCT

was

for

med

Th

e TW

G

co-c

hair

ed b

yN

ASC

OP

and

the

Div

isio

n of

Rep

rodu

ctiv

e H

ealth

co

ordi

nate

s im

plem

enta

tion

and

prov

ides

tec

hnic

al s

uppo

rt t

o th

e N

atio

nal

PMTC

T Pr

ogra

m

The

TWG

ser

ves

as a

foru

m t

o up

date

sta

keho

lder

s an

d di

scus

s ch

alle

nges

and

upc

omin

g ac

tiviti

es

The

TWG

is

also

res

pons

ible

for

upd

atin

g na

tiona

l gu

idel

ines

for

PM

TCT

The

nat

iona

l PM

TCT

prog

ram

was

offi

cial

ly l

aunc

hed

in 2

002

NA

SCO

P al

so e

stab

lishe

d se

vera

lpi

lot P

MTC

T si

tes

thro

ugho

ut th

e co

untr

y an

d pr

epar

ed n

atio

nal P

MTC

T gu

idel

ines

The

goal

of t

he n

atio

nal P

MTC

T pr

ogra

m is

in li

ne w

ith th

e go

al s

et o

ut a

t the

Uni

ted

Nat

ions

Gen

eral

Ass

embl

y Sp

ecia

l Ses

sion

on

HIV

AID

S (U

NG

ASS

) in

2001

to

redu

ceth

e pr

opor

tion

of in

fant

s in

fect

ed w

ith H

IV b

y 20

b

y th

e ye

ar 2

005

and

50

by

2010

In

Ken

ya t

he n

atio

nal P

MTC

T pr

ogra

m p

lann

ed t

o ex

tend

its

serv

ices

to

at le

ast

80

of

all

heal

th f

acili

ties

by 2

0071

2 A

ccor

ding

to

the

2003

PM

TCT

serv

ice

stat

istic

sap

prox

imat

ely

9 o

f al

l pr

egna

nt w

omen

rec

eive

d PM

TCT

serv

ices

in

that

yea

rC

urre

ntly

mor

e th

an 5

0 o

f al

l pr

egna

nt w

omen

in

Ken

ya r

ecei

ve P

MTC

T se

rvic

es

Thes

e gu

idel

ines

are

bas

ed o

n a

publ

ic h

ealth

app

roac

h to

car

e t

akin

g in

to c

onsi

dera

shytio

n is

sues

of

feas

ibili

ty a

nd a

ccep

tabi

lity

in

addi

tion

to e

ffica

cy a

nd c

ost-

bene

fit i

ndi

ffere

nt s

ettin

gs

The

guid

elin

es a

re e

xpec

ted

to i

mpr

ove

the

upta

ke

qual

ity a

nd

effe

ctiv

enes

s of

PM

TCT

serv

ices

in th

e co

untr

y

19

OB

JEC

TIV

ESA

ND O

RG

AN

ISA

TIO

NO

FTH

E G

UID

ELIN

ES

The

PMTC

T gu

idel

ines

are

par

t of

the

impl

emen

tatio

n in

stru

men

ts t

owar

ds u

nive

rsal

ac

cess

to

PMTC

T se

rvic

es a

nd a

res

pons

e to

the

cal

l to

actio

n to

war

ds H

IV-fr

ee a

ndA

IDS-

free

gen

erat

ion

Tog

ethe

r w

ith tw

o ot

her

guid

elin

es (A

RV

Ther

apy

in A

dults

and

Ad

oles

cent

s an

d AR

V Th

erap

y in

Inf

ants

and

You

ng C

hild

ren)

th

ey f

orm

a t

rilo

gy

aim

ed a

t co

ntex

tual

isin

g an

d m

ains

trea

min

g th

e W

HO

tri

logy

of

guid

elin

es o

n H

IVA

IDS

prev

entio

n an

d tr

eatm

ent

The

cont

ext

reso

urce

s an

d de

man

ds o

f PM

TCT

prog

ram

mes

diff

er g

reat

ly a

cros

s co

unshy

trie

s an

d ev

en a

cros

s pr

ogra

mm

es w

ithin

the

sam

e co

untr

y C

onsi

deri

ng t

his

vari

abilshy

ity t

hese

gui

delin

es in

clud

e th

e cu

rren

t con

sens

us o

n be

st p

ract

ices

as

wel

l as

alte

rnashy

tives

whi

ch m

ight

be

mor

e ap

prop

riat

e in

par

ticul

ar s

ettin

gs E

xper

ts a

gree

tha

t th

e ldquos

tate

of

the

artrdquo

in

PMTC

T is

cha

ngin

g ra

pidl

y an

d th

at r

ecom

men

datio

ns w

ill c

ershy

tain

ly a

lter

with

adv

ance

s in

med

ical

sci

ence

and

as

mor

e pr

ogra

mm

e ex

peri

ence

is

docu

men

ted

and

diss

emin

ated

The

are

as o

f A

RV

pro

phyl

axis

and

inf

ant

feed

ing

are

part

icul

arly

sub

ject

to r

apid

cha

nge

In 2

005

the

WH

O is

sued

pro

pose

d re

visi

ons

to it

s re

com

men

datio

ns o

n th

e us

e of

ant

ishyre

trov

iral

dru

gs f

or P

MTC

T T

he r

ecom

men

datio

ns w

ere

the

prod

uct

of e

xper

ts w

ho

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

9

28

conv

ened

to

disc

uss

impo

rtan

t ne

w i

nfor

mat

ion

conc

erni

ng t

he d

evel

opm

ent

of r

esis

shyta

nce

in w

omen

and

chi

ldre

n us

ing

sing

le d

ose

nevi

rapi

ne (S

dNV

P) fo

r PM

TCT

as w

ell

as n

ew c

linic

al fi

ndin

gs o

n st

rate

gies

that

mig

ht r

educ

e th

e de

velo

pmen

t of r

esis

tanc

e

Bas

ed o

n th

e ne

w W

HO

gui

delin

es K

enya

rsquos TW

G h

as d

evel

oped

sim

ple

pra

ctic

al a

nd

evid

ence

-bas

ed r

ecom

men

datio

ns o

n PM

TCT

that

wou

ld w

ork

in a

var

iety

of r

esou

rce-

limite

d en

viro

nmen

ts a

nd c

linic

al s

ituat

ions

that

con

fron

t hea

lthca

re w

orke

rs n

ot o

nly

in K

enya

but

als

o in

oth

er d

evel

opin

g co

untr

ies

110

U

SIN

GTH

E G

UID

ELIN

ES

Thes

e gu

idel

ines

are

inte

nded

prim

arily

for u

se b

y PM

TCT

prov

ider

s Th

ese

inclu

de n

urse

sm

idw

ives

clin

ical o

ffice

rs d

octo

rs c

ouns

ello

rs n

utrit

ioni

sts

and

othe

r he

alth

care

pro

fesshy

sion

als

They

will

als

o be

use

ful a

s a re

fere

nce

for p

rogr

amm

e m

anag

ers a

t fac

ility

dis

trict

pr

ovin

cial

and

nat

iona

l lev

els

thro

ugho

ut th

e he

alth

sec

tor

The

guid

elin

es a

re d

ivid

ed in

tote

n ch

apte

rs a

s out

lined

in T

able

15

The

spec

ific

obje

ctiv

es o

f the

new

PM

TCT

guid

elin

es a

re to

bull O

utlin

e th

e po

licy

issu

es in

pro

vidi

ng P

MT

CT

serv

ices

bull R

ecom

men

d op

erat

iona

l gui

delin

es to

be

follo

wed

by

heal

th c

are

prov

ider

s of

PM

TC

T se

rvic

es

bull E

nabl

e pr

ovid

ers

of P

MT

CT

to s

elec

t an

d pr

escr

ibe

AR

Vs

for

prop

hyla

xis

agai

nst

MT

CT

and

for

trea

tmen

t of

pre

gnan

t w

omen

in

fant

s an

d yo

ung

child

ren

bull S

tand

ardi

se t

he c

are

and

coun

selli

ng g

iven

by

PM

TC

T s

ervi

ce

prov

ider

s re

gard

ing

risk

of

MT

CT

and

on

PM

TC

T

bull I

mpr

ove

PM

TC

T se

rvic

es u

sing

eas

y-to

-use

job

aids

and

a

stan

dard

ised

Mamp

E s

yste

m

Prev

entin

g TB

Fo

r chi

ldre

n ex

pose

d to

sm

ear p

ositi

ve tu

berc

ulos

is

bull E

xclu

de a

ctiv

e T

B th

roug

h ca

refu

l his

tory

ph

ysic

al e

xam

and

in

vest

igat

ions

bull

If

ther

e is

no

evid

ence

of

activ

e T

B

star

t on

IN

H f

or p

roph

ylax

is f

or 6

m

onth

s (I

PT

) bull

If

TB

is p

rese

nt

star

t on

TB

tre

atm

ent

as p

er N

atio

nal T

B g

uide

lines

If

a ch

ild is

bor

n to

a m

othe

r with

act

ive

TB

bull S

tart

on

INH

pro

phyl

axis

(IP

T)

and

give

for

3 m

onth

s bull

Afte

r 3

mon

ths

do a

man

toux

bull

If

man

toux

is n

egat

ive

sto

p IN

H a

nd g

ive

BC

G

bull I

f man

toux

is p

ositi

ve a

t 3

mon

ths

con

tinue

for

a f

urth

er 3

mon

ths

bull A

t the

end

of

prop

hyla

xis

re-v

alua

te f

or a

ctiv

e T

B

|

If no

evi

denc

e of

act

ive

TB d

o no

t tre

at fo

r TB

|

If th

ere

is e

vide

nce

of a

ctiv

e TB

tre

at fo

r TB

as

per N

atio

nal

TB g

uide

lines

(6)

Trea

tmen

t of a

cute

infe

ctio

ns a

nd o

ther

HIV

-rel

ated

con

ditio

ns

HIV

-exp

osed

chi

ldre

n ar

e su

scep

tible

to c

omm

on in

fect

ions

as

wel

l as

OIs

for

the

HIV

infe

cted

and

HIV

may

alte

r th

e in

cide

nce

pre

senshy

tatio

n an

d re

spon

se t

o co

nven

tiona

l th

erap

y I

n so

me

case

s m

ore

aggr

essi

ve a

nd lo

nger

tre

atm

ent

cour

ses

may

be

nece

ssar

y a

s tr

eatshy

men

t fai

lure

s ar

e m

ore

freq

uent

(7)

Reg

ular

follo

w-u

p ca

re amp

refe

rral

s

Reg

ular

follo

w-u

p is

the

back

bone

to c

arin

g fo

r th

e H

IV e

xpos

ed c

hilshy

dren

and

ens

ures

opt

imal

hea

lthca

re a

nd p

sych

osoc

ial s

uppo

rt to

the

fam

ily W

HO

has

mad

e re

com

men

datio

ns o

n fr

eque

ncy

of fo

llow

-up

as s

how

n in

Tab

le 9

2 T

his

is t

he m

inim

um a

nd m

ore

freq

uent

con

shyta

ct w

ith t

he h

ealth

car

e sy

stem

may

be

indi

cate

d fo

r H

IV in

fect

ed

child

ren

and

espe

cial

ly if

they

are

on

anti-

retr

ovir

al tr

eatm

ent

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

2

9

78

Pro

phyl

axis

aga

inst

Pne

umoc

ysti

s ji

rove

cii

Pne

umon

ia (

PC

P)

in c

hild

ren

whe

re C

otri

mox

azol

e is

con

trai

ndic

ated

Ta

ble

15

The

Fou

r-Pr

onge

d A

ppro

ach

App

lied

to th

e PM

TCT

Gui

delin

e

Alte

rnat

ive

drug

s to

use

if C

TX is

con

train

dica

ted

are

give

n be

low

A s

econ

d ch

oice

wou

ld b

e ei

ther

dap

sone

or

atov

aqui

ne

Dap

sone

bull C

hild

ren

gt 1

mon

th

2 m

gkg

24

hour

s or

ally

onc

e da

ily

bull I

f bot

h C

TX

and

Dap

sone

are

con

trai

ndic

ated

(e

g

in c

hilshy

dren

with

G6P

D d

efic

ienc

y w

ho g

et h

aem

olys

is w

ith C

TX

and

D

apso

ne)

the

n us

e ei

ther

Ato

vaqu

one

bull

30m

gkg

day

for

age

1-3

mon

ths

bull H

ighe

r do

se 4

5mg

kgd

ay f

or a

ge 4

-24

mon

ths

OR

Aer

osol

ized

Pen

tam

idin

e

bull 3

00 m

g in

6 m

l wat

er v

ia in

hala

tion

nebu

lizer

onc

e m

onth

ly

bull c

hild

ren

gt 5

year

s

Cha

pter

CH

AP

TER

1

Bac

kgro

und

CH

AP

TER

2

Ant

enat

al C

are

and

Pre

vent

ion

of M

TCT

of H

IV

CH

AP

TER

3

Intra

partu

m C

are

Pron

g 1

Prim

ary

prev

entio

n of

HIV

in

fect

ion

in w

omen

Pron

g 2

Prev

entio

n of

un

inte

nded

pr

egna

ncy

amon

g H

IV in

fect

ed w

omen

Pron

g 3

Inte

rven

tions

to

redu

ce

tran

smis

sion

from

H

IV in

fect

ed

preg

nant

and

la

ctat

ing

wom

en to

th

eir c

hild

ren

Pron

g 4

Car

e an

d su

ppor

t of

wom

en c

hild

ren

and

fam

ilies

in

fect

ed a

nd

affe

cted

by

HIV

A

IDS

C

HA

PTE

R 4

U

se o

f Ant

iretro

vira

l D

rugs

in P

regn

ancy

fo

r Tre

atm

ent a

nd

Pre

vent

ion

of M

othe

r to

Chi

ld

Tran

smis

sion

of H

IV

Infe

ctio

n

CH

AP

TER

5

Imm

edia

te P

ostn

atal

an

d N

eona

tal C

are

CH

AP

TER

6

Late

Pos

tnat

al C

are

and

Fam

ily P

lann

ing

CH

AP

TER

7

HIV

Dia

gnos

is in

C

hild

ren

CH

AP

TER

8

Feed

ing

Infa

nts

and

Youn

g C

hild

ren

born

to

HIV

infe

cted

m

othe

rs

CH

AP

TER

9

Car

e an

d Fo

llow

-up

of C

hild

ren

of H

IV

infe

cted

mot

hers

C

HA

PTE

R 1

0

Mon

itorin

g an

d E

valu

atio

n of

PM

TCT

se

rvic

es

77

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

30

For

each

of t

hese

cha

pter

s (e

xcep

t ch

apte

r on

e on

bac

kgro

und)

the

gui

delin

es g

ive

anin

trod

uctio

n fo

llow

ed b

y po

licy

stat

emen

ts t

hen

oper

atio

nal g

uide

lines

of w

hat p

rovi

dshyer

s sh

ould

do

to r

educ

e m

othe

r-to

-chi

ld t

rans

mis

sion

of

HIV

and

or

to i

mpr

ove

thei

r pe

rfor

man

ce a

nd th

e ef

fect

iven

ess

of th

eir s

ervi

ces

A li

st o

f job

aid

s fo

r us

e by

the

hea

lthca

re p

rovi

der

follo

ws

the

oper

atio

nal g

uide

lines

and

whe

re n

eces

sary

a li

st o

f ap

pend

ices

and

add

ition

al d

ocum

ents

tha

t m

ay b

e re

shyfe

rred

to

but

are

cons

ider

ed t

oo b

ig o

r de

taile

d to

be

incl

uded

with

in t

he m

ain

body

of

the

guid

elin

es

Foo

tnot

es

1

UN

AID

S (

2004)

Rep

ort

on t

he

Glo

bal AID

S E

pid

emic

Ava

ilable

at

ww

wu

nai

ds

org

2

Ibid

2004

3

It

is

import

ant

to r

ecognis

e th

at t

he

use

of

the

phra

se M

TC

T in n

o w

ay is

inte

nded

to

pla

ce b

lam

e on t

he

moth

er

who m

ay o

r m

ay n

ot

know

her

HIV

sta

tus

who t

ransm

its

the

viru

s to

her

child

Pa

thfinder

ack

now

ledges

that

man

y tim

es p

regnant

wom

en

may

hav

e bee

n infe

cted

by

thei

r m

ale

par

tner

and d

o n

ot

hav

e th

e ab

ility

to n

egoti-

ate

safe

r se

x o

r to

see

k M

TC

T s

ervi

ces

for

fear

of

viole

nce

st

igm

a o

r ab

andonm

ent

if t

hei

r st

atu

s is

rev

eale

d

Path

finder

uphold

s th

e re

pro

duct

ive

rights

of

all w

om

en t

o

choose

if

and w

hen

to h

ave

child

ren

regar

dle

ss o

f H

IV-s

tatu

s

4

W

HO

CD

C

Dep

artm

ent

of

Hea

lth a

nd H

um

an S

ervi

ces

(2004)

Pre

vention o

f M

oth

er-t

o-C

hild

Tra

nsm

issi

on o

f H

IV

Gen

eric

Tra

inin

g P

acka

ge

Gen

eva

Sw

itze

r-la

nd

WH

O

5

U

NAID

S (

2004)

Rep

ort

on t

he

Glo

bal AID

S E

pid

emic

Ava

ilable

at

ww

wu

nai

ds

org

6

Polic

y Pro

ject

(2004)

Cove

rage

of

sele

cted

ser

vice

s fo

r H

IVA

IDS p

reve

ntion a

nd

care

in low

and m

iddle

-inco

me

countr

ies

in 2

003

Ava

ilable

at

ww

wp

olia

pro

ject

com

7

Cen

tral Bure

au o

f Sta

tist

ics

(CBS)

[Ken

ya]

Min

istr

y of

Hea

lth (

MO

H)

[Ken

ya]

and

ORC M

acro

(2004)

Ken

ya D

emogra

phic

and H

ealth S

urv

ey 2

003

Cal

vert

on

Mar

y-la

nd

CBSM

OH

an

d O

RC M

acr

o

8

Nat

ional AID

S C

ontr

ol Counci

l 2

007

8a

Ken

ya A

IDS I

ndic

ato

r Surv

ey 2

007

9

Ibid

2004

10

NASCO

P (

2002)

Surv

eilla

nce

data

as

cite

d in N

ASCO

PM

OH

(2

003)

Nat

ional

PM

CT

Str

ate

gic

Managem

ent

Pla

n 2

003-2

007

111

2 A

IDS in K

enya

Tre

nds

Inte

rven

tions

and I

mpact

7th

editio

n

(2005)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Who

Nee

ds P

CP

Prop

hyla

xis

bull A

ll in

fant

s bo

rn t

o H

IV-i

nfec

ted

mot

hers

irr

espe

ctiv

e of

any

ant

iret

rovi

ral

ther

apy

duri

ng p

regn

ancy

and

labo

ur

Pro

phyl

axis

con

tinue

s un

til th

e in

fant

is 1

2 m

onth

s or

is P

CR

neg

ativ

e or

ant

ibod

y ne

gativ

e w

hich

ever

co

mes

ear

lier

bull A

ll in

fant

s id

entif

ied

as H

IV-i

nfec

ted

duri

ng th

e fir

st y

ear

of li

fe b

y a

PC

R

test

or

by a

clin

ical

dia

gnos

is o

f H

IV in

fect

ion

and

a po

sitiv

e an

tibod

y te

st

bull C

hild

ren

olde

r th

an 1

2 m

onth

s w

ith s

ympt

omat

ic H

IV d

isea

se o

r an

A

IDS

-def

inin

g ill

ness

(W

HO

sta

ge I

I an

d III

se

e ch

apte

r 5)

or

with

CD

4 lt

15

or

TLC

150

0m

m3

bull A

ny c

hild

with

a h

isto

ry o

f P

CP

sho

uld

cont

inue

with

sec

onda

ry

prop

hyla

xis

(dai

ly C

T)

for

life

Clin

icia

ns s

houl

d cl

earl

y in

form

HIV

inf

ecte

d m

othe

rs a

t de

liver

y th

at t

heir

chi

ldre

n ne

ed p

roph

ylax

is a

gain

st P

CP

star

ting

at 6

wee

ks o

f age

unt

il it

is e

stab

lishe

d th

at th

e ch

ild i

s no

t H

IV i

nfec

ted

A p

ract

ical

way

to

ensu

re t

hat

mot

hers

and

oth

er h

ealth

wor

kers

are

inf

orm

ed i

s to

mak

e a

note

on

the

child

rsquos im

mun

izat

ion

card

at

birt

h st

atin

g ldquoP

leas

e gi

ve c

o-tr

imox

azol

e (5

mg

kgd

ay o

rally

dai

ly) f

rom

6 w

eeks

of a

gerdquo

Tabl

e 9

1 D

ose

of C

otrim

oxaz

ole

for P

CP

Prop

hyla

xis

Wei

ght o

f C

hild

(kg)

1ndash4

5ndash8

9ndash16

17ndash5

0

gt 50

CT

tabl

ets

20 m

g TM

P1

00

mg

SM

X p

edia

tric

stre

ngth

(120

mg)

1 ta

b

2 ta

bs

Cot

rimox

azol

e su

spen

sion

40

mg

TMP

200

mg

SM

X

5ml (

240

mg)

25

ml

5 m

l

10 m

l

CT

tabl

ets

80 m

g TM

P4

00 m

g S

MX

re

gula

r stre

ngth

(4

80 m

g)

frac14 ta

b

frac12 ta

b

1 ta

b

2 ta

bs

2 ta

bs

CT

Tabl

ets

160

mg

TMP

800

mg

SM

X

Dou

ble

stre

ngth

(9

60 m

g) -

frac14 ta

b

frac12 ta

b

1 ta

b

1 ta

b

In r

are

case

s a

s in

chi

ldre

n w

ith G

6PD

def

icie

ncy

CTX

may

be

cont

rain

dica

ted

G

uid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

3

1

76

(3)

Mon

itor

the

child

rsquos g

row

th a

nd d

evel

opm

ent

as a

mea

ns o

f id

entif

ying

the

ch

ild w

ho is

faili

ng to

thriv

e an

d al

so a

s a

tool

for m

onito

ring

the

effe

ct o

f int

ershy

vent

ions

(4)

Ens

ure

that

im

mun

isat

ions

are

sta

rted

and

com

plet

ed

acco

rdin

g to

the

re

com

men

datio

ns o

f the

nat

iona

l im

mun

isat

ion

sche

dule

|

Add

ition

al c

onsi

dera

tions

are

as

follo

ws

bull

Whe

n co

nsid

erin

g BC

G v

acci

natio

n at

a la

ter a

ge

(re-

vacc

inat

ion

for n

o sc

ar o

r mis

sed

earli

er v

acci

natio

n)

excl

ude

sym

ptom

atic

HIV

infe

ctio

n

bull

Do

not g

ive

yello

w fe

ver v

acci

ne to

sym

ptom

atic

HIV

-infe

cted

chi

lshydr

en H

owev

er a

sym

ptom

atic

chi

ldre

n in

end

emic

are

as s

houl

d re

shyce

ive

the

yello

w fe

ver v

acci

ne a

t 9 m

onth

s of

age

bull

Mea

sles

vac

cine

sho

uld

be g

iven

to H

IV in

fect

ed c

hild

ren

at 6

and

9

mon

ths

sinc

e H

IV in

fect

ed c

hild

ren

expe

rienc

e m

uch

mor

e se

vere

di

seas

e w

ith w

ild m

easl

es v

irus

whi

ch o

utw

eigh

s th

e ris

k of

a m

ilder

illn

ess

from

the

vacc

ine

(5)

Pro

vide

pro

phyl

axis

for o

ppor

tuni

stic

infe

ctio

ns

|

Pro

phyl

axis

aga

inst

Pne

umoc

ystis

jiro

veci

i Pne

umon

ia

bull

Pne

umoc

ystis

jiro

veci

i (fo

rmer

ly P

neum

ocys

tis c

arin

ii) p

neum

onia

(PC

P)

is a

sig

nific

ant c

ause

of m

orbi

dity

and

mor

talit

y am

ong

youn

g in

fant

s in

A

frica

Co-

trim

oxaz

ole

(CTX

) pro

phyl

axis

sig

nific

antly

redu

ces

the

inci

shyde

nce

and

seve

rity

of P

CP

Add

ition

al b

enef

its o

f co-

trim

oxaz

ole

incl

ude

prot

ectio

n ag

ains

t com

mon

bac

teria

l inf

ectio

ns t

oxop

lasm

osis

and

mashy

laria

All

child

ren

born

to H

IV in

fect

ed m

othe

rs s

houl

d re

ceiv

e pr

ophy

shyla

xis

agai

nst P

CP

at l

east

dur

ing

the

first

yea

r of l

ife o

r unt

il th

ey a

re

prov

en to

be

unin

fect

ed (s

ee b

ox b

elow

)

bull

CTX

is c

lear

ly th

e dr

ug o

f cho

ice

for p

roph

ylax

is b

ecau

se o

f its

hig

h

effic

acy

rela

tive

safe

ty l

ow c

ost a

nd b

road

ant

imic

robi

al s

pect

rum

In

cas

e of

CTX

hyp

erse

nsiti

vity

des

ensi

tizat

ion

is re

com

men

ded

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

CH

AP

TE

R 2

Ant

enat

al C

are

and

Prev

entio

n of

MTC

T of

HIV

21

INTR

OD

UC

TIO

N

HIV

inf

ectio

n ha

s em

erge

d in

Ken

ya a

s th

e m

ost

impo

rtan

t he

alth

ris

k fa

ctor

for

m

othe

rs a

nd t

heir

chi

ldre

n an

d ha

s a

grea

t im

pact

on

the

long

ter

m o

utco

me

ofpr

egna

ncy

and

child

sur

viva

l A

ll pr

egna

nt w

omen

sho

uld

be e

ncou

rage

d to

lear

n th

eir

HIV

infe

ctio

n st

atus

as

wel

l as

that

of t

heir

sex

ual p

artn

ers

O

nly

by k

now

ing

onersquos

H

IV s

tatu

s ca

n th

e he

alth

wor

kers

mak

e ap

prop

riat

e he

alth

car

e m

anag

emen

t re

com

men

datio

ns a

nd t

he c

oupl

e m

ake

appr

opri

ate

deci

sion

s ab

out

mai

ntai

ning

the

ir

heal

th a

nd t

hat

of t

heir

unb

orn

baby

Pr

e-co

ncep

tion

care

is

enco

urag

ed w

here

an

oppo

rtun

ity a

rise

s an

d a

birt

h pl

an is

dis

cuss

ed w

ith th

e pr

egna

nt w

oman

In m

ost

case

s t

he p

regn

ant

wom

an w

ill n

ot h

ave

HIV

infe

ctio

n P

regn

ancy

offe

rs a

n op

port

une

time

to d

iscu

ss p

reve

ntio

n of

HIV

inf

ectio

n as

man

y w

omen

com

e in

toco

ntac

t w

ith h

ealth

ser

vice

s fo

r th

e fir

st (

and

in s

ome

case

s th

e on

ly)

time

duri

ng

preg

nanc

y

In K

enya

50

o

f m

arri

ed H

IV p

ositi

ve p

erso

ns h

ave

an H

IV n

egat

ive

spou

se1

Ther

efor

e k

now

ing

the

HIV

inf

ectio

n st

atus

of

onersquos

par

tner

is

criti

cal

Add

ition

ally

th

is f

orm

s an

im

port

ant

entr

y po

int

for

esta

blis

hing

pre

vent

ion

with

po

sitiv

e (P

WP)

pro

gram

s am

ong

coup

les

as w

ell a

s pr

ovid

ing

acce

ss to

HIV

pre

vent

ion

ca

re a

nd tr

eatm

ent s

ervi

ces

for

the

who

le fa

mily

PMTC

T pr

ovid

es a

n op

port

unity

for

prev

entin

g ne

w p

aedi

atri

c H

IV in

fect

ions

as

wel

l as

for

reac

hing

the

10 to

20

of H

IV p

ositi

ve p

regn

ant w

omen

who

mee

t WH

O e

ligib

ilshyity

cri

teri

a fo

r in

itiat

ing

AR

T fo

r th

eir

own

heal

th N

ew in

fect

ions

and

hig

h vi

ral l

oads

duri

ng p

regn

ancy

pos

e th

e gr

eate

st r

isk

of M

TCT

to t

he u

nbor

n ba

by t

hus

prim

ary

prev

entio

n A

RV

pro

phyl

axis

as

wel

l as

trea

tmen

t at t

his

time

is c

ritic

al G

iven

that

25

perc

ent o

f wom

en in

Ken

ya h

ave

an u

nwan

ted

preg

nanc

y s

tren

gthe

ning

the

link

to F

P se

rvic

es a

nd c

ondo

m a

cces

s fo

r du

al p

rote

ctio

n of

fers

a c

hanc

e to

fur

ther

pre

vent

MTC

T2

22

OPE

RA

TIO

NA

L G

UID

ELIN

ES

Ant

enat

al c

are

and

prev

entio

n of

MTC

T du

ring

thi

s pe

riod

can

be

sum

mar

ised

usi

ngan

ess

entia

l pa

ckag

e of

int

egra

ted

ante

nata

l ca

re s

ervi

ces

as s

how

n in

Tab

le 2

1

This

ou

tline

s th

e pa

ckag

e of

ca

re

to

be

prov

ided

to

ev

ery

wom

an

atte

ndin

g A

NC

ser

vice

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

5

32

Tabl

e 2

1 Es

sent

ial P

acka

ge o

f Int

egra

ted

Ant

enat

al C

are

Serv

ices

Gro

up e

duca

tion

Incl

ude

info

rmat

ion

on fo

ur A

NC

vis

its b

reas

tfeed

ing

mat

erna

l and

infa

nt n

utrit

ion

per

sona

l hyg

iene

birt

h pr

epar

edne

ss d

ange

r sig

ns p

reve

ntio

n of

com

plic

atio

ns s

kille

d bi

rth a

ttend

ance

fam

ily p

lann

ing

imm

uniz

atio

n sc

hedu

le

post

-nat

al c

are

and

HIV

and

AID

S m

anag

emen

t

Clie

nt h

isto

ry O

btai

n ro

utin

e da

ta in

clud

ing

med

ical

obs

tetri

c a

nd p

sych

osoc

ial h

isto

ry D

eter

min

e dr

ug h

isto

ry k

now

n al

lerg

ies

and

use

of a

ltern

ativ

e m

edic

ines

suc

h as

her

bal p

rodu

cts

Phy

sica

l exa

min

atio

n In

clud

e vi

tal s

igns

ins

pect

ion

aus

culta

tion

and

palp

atio

n

Abd

omin

al a

nd g

enita

l exa

min

atio

n In

clud

e in

spec

tion

pal

patio

n fo

etal

aus

culta

tion

spe

culu

m a

nd b

iman

ual e

xam

inat

ions

w

here

indi

cate

d

AN

C P

rofil

e R

outin

e te

sts

for s

yphi

lis H

b b

lood

gro

up a

nd R

hesu

s fa

ctor

urin

alys

is a

nd p

rovi

de ra

pid

HIV

test

ing

to th

e pr

egna

nt w

oman

and

her

par

tner

if a

ccom

pany

ing

her

If in

dica

ted

chec

k sp

utum

for A

AFB

and

CD

4 co

unt

Cou

nsel

ing

on b

irth

prep

ared

ness

Sup

port

the

preg

nant

wom

an a

nd h

er p

artn

er to

dev

elop

an

indi

vidu

al b

irth

plan

that

in

clud

es p

lace

of d

eliv

ery

with

ski

lled

birth

atte

ndan

ce e

mer

genc

y tra

nspo

rt b

irth

com

pani

onsh

ip a

nd re

adin

ess

for i

nfan

t ca

re

Cou

nsel

ing

on p

regn

ancy

dan

ger s

igns

Pro

vide

wom

en w

ith in

form

atio

n an

d in

stru

ctio

ns o

n se

ekin

g ea

rly c

are

for p

regshy

nanc

y co

mpl

icat

ions

suc

h as

ble

edin

g fe

ver

seve

re h

eada

che

sw

olle

n fe

et f

its o

r con

vuls

ions

Cou

nsel

ing

on in

fant

feed

ing

All

wom

en re

quire

infa

nt-fe

edin

g co

unse

ling

and

supp

ort

Exc

lusi

ve b

reas

tfeed

ing

for s

ix

mon

ths

shou

ld b

e pr

omot

ed a

s th

e no

rm fo

r all

wom

en re

gard

less

of H

IV s

tatu

s W

omen

infe

cted

with

HIV

nee

d to

be

gu

ided

in th

e se

lect

ion

of s

afer

infa

nt-fe

edin

g op

tions

(ref

er to

WH

O g

uide

lines

and

MO

H c

ircul

ar o

n in

fant

and

you

ng c

hild

fe

edin

g)

Nut

ritio

nal a

sses

smen

t co

unse

ling

and

educ

atio

n In

clud

e iro

n m

ultiv

itam

in a

nd fo

late

sup

plem

enta

tion

mon

itor f

or a

naeshy

mia

ade

quat

e ca

loric

and

nut

rient

inta

ke a

nd re

com

men

d re

alis

tic d

iet a

djus

tmen

ts b

ased

on

loca

l res

ourc

es a

nd n

eeds

of

HIV

+ pr

egna

nt w

omen

(at l

east

10

mor

e of

the

RD

A)

Cou

nsel

ing

on H

IV a

nd A

IDS

Pro

vide

wom

en w

ith in

form

atio

n an

d in

stru

ctio

ns o

n se

ekin

g he

alth

car

e fo

r

sym

ptom

s of

HIV

dis

ease

pro

gres

sion

suc

h as

freq

uent

and

recu

rrent

illn

esse

s c

hron

ic p

ersi

sten

t dia

rrho

ea c

andi

dias

is

feve

r w

astin

g or

sig

ns o

f any

opp

ortu

nist

ic in

fect

ion

Lin

k w

omen

to A

IDS

trea

tmen

t and

oth

er s

uppo

rt pr

ogra

mm

es w

here

av

aila

ble

Cou

nsel

ing

the

HIV

neg

ativ

e w

oman

and

her

par

tner

Pro

vide

info

rmat

ion

on re

peat

test

ing

risk

redu

ctio

n an

d pa

rtner

test

ing

RTI

scr

eeni

ng A

ll w

omen

with

hig

h ris

k se

xual

his

tory

or p

rese

ntin

g w

ith s

igns

of R

TI s

uch

as a

bnor

mal

gen

ital d

isch

arge

ge

nita

l ulc

ers

and

pelv

ic in

flam

mat

ory

dise

ase

shou

ld b

e sc

reen

ed a

nd m

anag

ed a

ccor

ding

to K

enya

pro

toco

ls

Tube

rcul

osis

(TB

) A

ll w

omen

pre

sent

ing

for A

NC

ser

vice

s w

ith a

cou

gh o

f mor

e th

an 2

wee

ksrsquo d

urat

ion

shou

ld b

e sc

reen

ed

for T

B re

gard

less

of H

IV s

tatu

s F

ollo

w K

enya

pro

toco

ls fo

r scr

eeni

ng p

roph

ylax

is a

nd tr

eatm

ent

Teta

nus

toxo

id im

mun

isat

ions

Adm

inis

ter a

ccor

ding

to c

urre

nt K

EP

I TT

Imm

uniz

atio

n S

ched

ule

Dew

orm

ing

All

preg

nant

wom

en s

houl

d re

ceiv

e an

ti-he

lmin

thes

afte

r firs

t trim

este

r as

per t

he g

uide

lines

on

m

ater

nal n

utrit

ion

Ant

imal

aria

ls I

TNs

All

preg

nant

wom

en in

mal

aria

end

emic

are

as s

houl

d sl

eep

unde

r an

ITN

and

rece

ive

SP

inte

rmitt

ent

pres

umpt

ive

treat

men

t acc

ordi

ng to

the

Nat

iona

l Mal

aria

gui

delin

es

AR

V a

nd O

ppor

tuni

stic

Infe

ctio

ns p

roph

ylax

is (d

urin

g pr

egna

ncy)

Pro

vide

AR

V C

TX a

nd o

ther

pro

phyl

actic

m

edic

atio

ns a

ccor

ding

to th

e K

enya

AR

T pr

otoc

ol o

n O

I pro

phyl

axis

and

use

of A

RV

s in

pre

gnan

cy

AR

V tr

eatm

ent d

urin

g pr

egna

ncy

Pro

vide

HA

AR

T w

ithin

the

MC

H s

ettin

g ac

cord

ing

to th

e K

enya

pro

toco

l on

use

of A

RV

s

Est

ablis

h cl

ear r

efer

ral n

etw

orks

with

sen

ior c

linic

ians

Pre

vent

ion

with

Pos

itive

s E

ncou

rage

pos

itive

livi

ng d

iscl

osur

e c

orre

ct a

nd c

onsi

sten

t con

dom

use

and

pro

vide

psy

chos

oshyci

al s

uppo

rt to

the

affe

cted

fam

ilies

For

the

HIV

-infe

cted

and

affe

cted

fam

ilies

est

ablis

h an

dor

stre

ngth

en li

nkag

es to

car

e

treat

men

t and

sup

port

serv

ices

incl

udin

g po

st-p

artu

m fo

llow

up

Effe

ctiv

e co

ntra

cept

ion

plan

Cou

nsel

abo

ut o

ther

fam

ily p

lann

ing

met

hods

em

phas

izin

g on

par

tner

invo

lvem

ent

and

dual

pro

tect

ion

met

hods

to a

void

unw

ante

d pr

egna

ncy

new

infe

ctio

n re

-infe

ctio

n an

d fu

rther

tran

smis

sion

Sourc

e K

enya

Nat

ional PM

TC

T T

rain

ing C

urr

iculu

m

2005

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

92

OPE

RA

TIO

NA

L G

UID

ELIN

ES

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed in

the

care

and

fo

llow

-up

of c

hild

ren

of H

IV-in

fect

ed m

othe

rs

bull A

ll ch

ildre

n bo

rn t

o H

IV in

fect

ed m

othe

rs s

houl

d be

see

n in

the

he

alth

car

e fa

cilit

y w

ithin

tw

o w

eeks

of

deliv

ery

bull F

or a

ll H

IV e

xpos

ed in

fant

s m

onth

ly f

ollo

w u

p vi

sits

are

re

com

men

ded

begi

nnin

g at

six

wee

ks t

hrou

gh 2

yea

rs

bull W

here

pos

sibl

e v

isits

sho

uld

be li

nked

to

the

imm

unis

atio

n an

d

grow

th m

onito

ring

vis

its

bull A

ll H

IV e

xpos

ed in

fant

s sh

ould

be

star

ted

on C

otri

mox

azol

e

prop

hyla

xis

from

6 w

eeks

of

age

bull F

or in

fant

s w

ho te

st H

IV p

ositi

ve b

y D

NA

PC

R b

efor

e 18

mon

ths

or

by a

ntib

ody

test

aft

er 1

8 m

onth

s of

age

co

-trim

oxaz

ole

shou

ld b

e gi

ven

daily

for

life

bull F

or in

fant

s w

ho te

st H

IV n

egat

ive

|

If th

ey h

ave

stop

ped

brea

stfe

edin

g fo

r 2 m

onth

s or

mor

e s

top

C

otrim

oxaz

ole

|

If st

ill br

east

feed

ing

con

tinue

Cot

rimox

azol

e un

til tw

o m

onth

s af

ter

com

plet

e ce

ssat

ion

of b

reas

tfeed

ing

bull C

ompr

ehen

sive

car

e fo

r th

e H

IV e

xpos

ed o

r in

fect

ed in

fant

s sh

ould

be

pro

vide

d in

the

bro

ader

con

text

of

othe

r ch

ild h

ealth

car

e st

rate

gies

Hea

lth w

orke

rs s

houl

d pr

ovid

e th

e fo

llow

ing

pack

age

of c

are

as a

min

imum

to

thes

e ch

ildre

n

(1)

Con

firm

HIV

sta

tus

as e

arly

as

poss

ible

(R

efer

to C

hapt

er 7

)

(2)

M

othe

rs s

houl

d be

sup

porte

d to

pro

vide

opt

imal

infa

nt fe

edin

g an

d pa

rticu

larly

to

avoi

d m

ixed

feed

ing

in th

e fir

st 6

mon

ths

of li

fe I

t is

impo

rtant

that

infa

nt fe

edin

g ch

oice

s at

initi

atio

n of

feed

ing

follo

win

g ea

rly in

fant

dia

gnos

is a

t wea

ning

and

at

the

time

of in

trodu

ctio

n of

com

plem

enta

ry fe

eds

are

guid

ed b

y th

e A

FAS

S c

riter

ia

(Ref

er to

Cha

pter

8)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

3

3

74

Cha

pter

9

Car

e an

d Fo

llow

-up

of C

hild

ren

of H

IV-in

fect

ed M

othe

rs

91

INTR

OD

UC

TIO

N

PMTC

T in

terv

entio

ns re

duce

but

do

not e

limin

ate

the

risk

of H

IV tr

ansm

issi

on fr

om m

othshy

ers t

o th

eir i

nfan

ts a

nd y

oung

child

ren

Bot

h H

IV-in

fect

ed a

nd u

ninf

ecte

d ex

pose

d ch

ildre

n ha

ve in

crea

sed

risk

s of

infe

ctio

n an

d de

ath

from

com

mon

chi

ldho

od in

fect

ions

The

sur

shyvi

val o

f H

IV-e

xpos

ed c

hild

ren

whe

ther

or

not

they

are

inf

ecte

d i

s cl

osel

y lin

ked

to t

he

heal

th a

nd s

urvi

val o

f the

ir m

othe

rs T

here

fore

lon

g-te

rm b

enef

its o

f PM

TCT

prog

ram

s w

ill o

nly

be s

usta

ined

if t

here

is o

ngoi

ng c

ompr

ehen

sive

car

e fo

r th

e ch

ildre

n an

d th

eir

mot

hers

and

or c

are

give

rs

HIV

exp

osed

chi

ldre

n ar

e vu

lner

able

to

the

com

mon

illn

esse

s af

fect

ing

othe

r ch

ildre

n

Thes

e in

fect

ions

incl

ude

neon

atal

infe

ctio

ns m

alar

ia p

neum

onia

dia

rrho

ea m

easl

es a

nd

othe

r vac

cine

pre

vent

able

dis

ease

s H

IV in

fect

ed ch

ildre

n ar

e lik

ely

to s

uffe

r mor

e se

vere

ly

and

have

a h

ighe

r lik

elih

ood

of d

ying

from

com

mon

chi

ldho

od il

lnes

ses

than

non

-infe

cted

ch

ildre

n W

here

as m

alnu

triti

on c

ause

s 53

o

f all

child

hood

dea

ths

HIV

exp

osed

chi

ldre

n ar

e m

ore

vuln

erab

le to

it th

an n

on-in

fect

ed c

hild

ren

Thi

s is

bec

ause

HIV

exp

osed

child

ren

have

hig

her

calo

ric

requ

irem

ents

as

a re

sult

of th

eir

HIV

infe

ctio

n th

e pr

esen

ce o

f opp

orshy

tuni

stic

infe

ctio

ns a

nd o

ther

com

plic

atio

ns re

late

d to

AID

S

Regu

lar

follo

w u

p ca

re is

cri

tical

for

an in

fant

bor

n to

a m

othe

r w

ith H

IVA

IDS

The

com

shypr

ehen

sive

car

e of

HIV

exp

osed

chi

ldre

n in

clud

ing

nutr

ition

im

mun

isat

ion

mon

itori

ng o

f gr

owth

and

dev

elop

men

t pr

even

tion

and

trea

tmen

t of

opp

ortu

nist

ic in

fect

ions

and

ear

ly

infa

nt d

iagn

osis

of

HIV

is f

easi

ble

in r

esou

rce-

cons

trai

ned

sett

ings

and

sig

nific

antly

imshy

prov

es th

e su

rviv

al o

f the

se ch

ildre

n

23

JOB A

IDS

Prov

ider

s ar

e en

cour

aged

to re

fer t

o th

e ap

prop

riate

job

aid(

s) w

hen

deal

ing

with

spe

cific

issu

es

bull P

MT

CT

test

ing

and

coun

selli

ng t

ools

bull C

oupl

e co

unse

lling

tool

s

bull A

NC

alg

orith

ms

for

AR

V p

roph

ylax

is a

nd in

fant

fee

ding

gui

delin

es

as a

dapt

ed f

rom

WH

O g

uide

lines

bull P

reve

ntio

n w

ith p

ositi

ves

tool

kit

on d

iscl

osur

e

bull F

ocus

ed a

nte-

nata

l car

e

bull M

alar

ia in

pre

gnan

cy

bull T

B in

pre

gnan

cy

bull K

EP

I S

ched

ule

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

7

3

34

A ra

pid

HIV

test

ing

algo

rithm

for s

eria

l tes

ting

is il

lust

rate

d be

low

35

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Pre-Test Education and or Counselling

First HIV Rapid Test ndashDETERMINE

Negative TestResult

Counsel for Negative Result

Positive TestResult

Second HIV Rapid Test ndashBIOLINE

Positive Test ResultCounsel for

Positive Result

NegativeTestResult

Third HIV Rapid Test ndashUNIGOLD

Positive Test ResultCounsel for

Positive Result

Negative Test ResultCounsel for

Negative Result

Figure 32 Rapid HIV testing algorithm Serial testing

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

72

M

othe

r and

Chi

ld H

ealth

Boo

klet

71

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

36

Cha

pter

ref

eren

ces

Rep

ublic

of

Ken

ya M

inis

try

of

Hea

lth

Div

isio

n o

f Rep

roduct

ive

Hea

lth

National G

uid

e-lin

es f

or

Qual

ity

Obst

etri

cs a

nd P

erin

atal Car

e (

2004)

WH

O

UN

FPA

UN

ICEF

World B

ank

Manag

ing C

om

plic

atio

ns

in P

regnan

cy a

nd C

hild

birth

A g

uid

e fo

r m

idw

ives

and d

oct

ors

(2003)

WH

O

Sta

ndar

ds

for

Mat

ernal

and N

eonat

al C

are

(2006)

WH

O

Antire

trovi

ral dru

gs

for

trea

ting p

regnan

t w

om

en a

nd p

reve

nting H

IV infe

ctio

ns

in

infa

nts

in r

esourc

e lim

ited

set

tings

Tow

ard

s U

niv

ersa

l Acc

ess

Rec

om

men

dations

for

a public

hea

lth a

ppro

ach (

2006)

Min

istr

y of

Hea

lth

Nat

ional AID

S amp

STD

Contr

ol Pro

gra

mm

e (N

ASCO

P)

Guid

elin

es f

or

Antire

trovi

ral dru

g t

her

apy

in K

enya

(2005)

Min

istr

y of

Hea

lth

Ken

ya N

atio

nal

Rep

roduct

ive

Hea

lth I

nst

ruct

ional M

anual

for

Ser

vice

Pro

vider

s (M

arch

2005)

Nat

ional AID

S amp

STD

Contr

ol Pro

gra

mm

e K

enya

AID

S I

ndic

ator

Syr

vey

Foo

tnot

es

1

2Ken

ya D

emogra

phic

and H

ealth S

urv

ey (

KD

HS)

2003

37

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

70

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

CH

AP

TE

R 3

Intr

apar

tum

Car

e 3

1 IN

TRO

DU

CTI

ON

Intr

apar

tum

car

e is

the

man

agem

ent

of w

omen

fro

m t

he o

nset

of

labo

ur t

o de

liver

y T

his

peri

od p

oses

the

grea

test

ris

k fo

r tr

ansm

issi

on o

f HIV

from

the

mot

her

to th

e ch

ild (M

TCT)

w

ith 1

0 to

20

perc

ent o

f exp

osed

infa

nts

beco

min

g in

fect

ed a

t thi

s tim

e in

the

abse

nce

of a

ny

inte

rven

tion

1 In

the

con

text

of

HIV

AID

S it

is t

here

fore

im

port

ant

to e

stab

lish

the

HIV

stat

us o

f wom

en p

rior

to o

r du

ring

labo

ur a

nd d

eliv

ery

and

prov

ide

inte

rven

tions

aim

ed a

t re

duci

ng th

e ri

sk o

f tra

nsm

issi

on W

ith a

ppro

pria

te in

terv

entio

ns t

he r

isk

of M

TCT

can

bere

duce

d si

gnifi

cant

ly

32

OPE

RA

TIO

NA

L G

UID

ELIN

ES

a) O

ptim

al In

trap

artu

m C

are

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed fo

r all

wom

en a

dmitt

ed

to la

bour

and

del

iver

y un

its 2

3

1 M

inim

ise

vagi

nal e

xam

inat

ions

2 U

se a

sept

ic t

echn

ique

s in

con

duct

ing

deliv

ery

3 A

void

rou

tine

artif

icia

l rup

ture

of m

embr

anes

(A

RM

)

4 A

void

pro

long

ed la

bour

5 A

void

unn

eces

sary

trau

ma

duri

ng d

eliv

ery

6 M

inim

ise

the

risk

of p

ostp

artu

m h

aem

orrh

age

7 U

se s

afe

bloo

d tr

ansf

usio

n pr

actic

es

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

9

38

b) S

peci

fic M

anag

emen

t of H

IV P

ositi

ve P

regn

ant W

omen

Pro

phyl

acti

c A

ntir

etro

vira

l the

rapi

es4

The

AR

V p

roph

ylac

tic r

egim

en d

epen

ds o

n w

heth

er th

e m

othe

r ha

d A

RV

s du

ring

pre

gshyna

ncy

or n

ot T

hus

the

heal

th c

are

wor

ker s

houl

d es

tabl

ish

the

regi

men

use

d du

ring

th

e A

NC

whe

ther

the

wom

an h

ad ta

ken

the

SdN

VP

and

AZT

at t

he o

nset

of l

abou

r an

d de

term

ine

the

appr

opri

ate

intr

a-pa

rtum

AR

V c

are

as p

er th

e al

gori

thm

s on

pag

e80

(App

endi

x II

I) p

age

81 (A

ppen

dix

IV) a

nd a

s su

mm

aris

ed b

elow

No

AR

Vs t

aken

in p

regn

ancy

Mot

her i

n ea

rly la

bour

(up

to 4

cm c

ervi

cal d

ilata

tion)

bull

Int

rapa

rtum

per

iod

Giv

e m

othe

r S

dNV

P 2

00m

g A

ZT

600

mg

and

3T

C 1

50m

g st

at

bull P

ostp

artu

m m

othe

r G

ive

mot

her

AZ

T 3

00m

g an

d 3T

C 1

50m

g B

D

for

7 da

ys

bull P

ostp

artu

m p

erio

d G

ive

infa

nt S

d N

evir

apin

e 2

mg

kg w

ithin

72

hour

s of

birt

h P

LUS

3T

C 4

mg

kg B

D fo

r 1

wee

k an

d A

ZT

syr

up 4

mg

kg

BD

for

6 w

eeks

Mot

her r

ecei

ved

AZT

300

mg

BD

in P

regn

ancy

bull P

ostp

artu

m

Giv

e in

fant

Sd

Nev

irap

ine

2mg

kg w

ithin

72

hour

s of

birt

h

PLU

S 3

TC

4m

gkg

BD

for

1 w

eek

and

AZ

T sy

rup

4 m

gkg

BD

for

6 w

eeks

Mot

her r

ecei

ved

HA

AR

T in

Pre

gnan

cy

Reg

ardl

ess

of d

urat

ion

rece

ived

HA

AR

T bull

Giv

e m

othe

r A

RV

dos

e as

per

reg

imen

bull P

ostp

artu

m

Giv

e In

fant

Sd

Nev

irap

ine

2mg

kg w

ithin

72

hour

s of

bir

th

PLU

S 3

TC

4m

gkg

BD

for

1 w

eek

and

AZ

T sy

rup

4 m

gkg

BD

for

6 w

eeks

Mod

e of

del

iver

y E

lect

ive

caes

area

n se

ctio

n (C

S) r

educ

es t

he r

isk

of H

IV M

TCT

as c

ompa

red

to v

agin

al

deliv

ery

but

will

not

be

avai

labl

e in

man

y se

ttin

gs in

our

cou

ntry

Whe

re C

S is

per

shyfo

rmed

(ele

ctiv

e or

em

erge

ncy)

in H

IV p

ositi

ve w

omen

the

y sh

ould

rec

eive

pro

phyl

actic

an

tibio

tics

If

the

CS

is p

erfo

rmed

aft

er p

rolo

nged

lab

our

or r

uptu

re o

f m

embr

anes

lo

nger

cour

ses

of a

ntib

iotic

s sh

ould

be

cons

ider

ed

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

3

9

68

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Supp

ort d

urin

g la

bour

E

mot

iona

l su

ppor

t du

ring

lab

our

is i

mpo

rtan

t fo

r al

l w

omen

and

may

be

even

mor

ene

cess

ary

for

an H

IV p

ositi

ve w

oman

who

is c

once

rned

abo

ut h

er c

ondi

tion

and

risk

of

HIV

tran

smis

sion

to c

hild

Whe

neve

r po

ssib

le d

urin

g la

bour

war

d st

aff m

ust b

e se

nsishy

tive

to t

he fe

ars

and

conc

erns

of t

he H

IV p

ositi

ve m

othe

r ab

out

her

infe

ctio

n a

nd h

owm

uch

she

had

told

her

par

tner

Indu

ctio

n of

labo

ur

Indu

ctio

n of

labo

ur m

ay b

e as

soci

ated

with

incr

ease

d ri

sk o

f H

IV M

TCT

Car

eful

asshy

sess

men

t of

the

nee

d fo

r an

d de

sira

bilit

y of

ind

uctio

n ra

ther

tha

n C

S is

nec

essa

ry

Whe

n in

duct

ion

of la

bour

is c

hose

n m

embr

anes

sho

uld

be le

ft in

tact

for

as lo

ng a

s po

sshysi

ble

Syn

toci

non

shou

ld n

ot b

e us

ed w

ith in

tact

mem

bran

es

Indi

catio

ns fo

r ele

ctiv

e C

S A

lthou

gh e

lect

ive

CS

will

not

be

avai

labl

e in

mos

t hea

lth fa

cilit

ies

as a

rou

tine

for

HIV

posi

tive

wom

en t

here

may

be

som

e ca

ses

that

mer

it co

nsid

erat

ion

for

CS

The

se i

nshycl

ude

preg

nanc

ies

whe

re l

abou

r is

exp

ecte

d to

be

prol

onge

d or

whe

re o

ther

obs

tetr

ic

com

plic

atio

ns m

ay b

e as

soci

ated

with

incr

ease

d ri

sk o

f tra

nsm

issi

on (e

g a

brup

tio p

lashy

cent

ae

plac

enta

pra

evia

pr

e-te

rm r

uptu

re o

f m

embr

anes

pr

evio

us C

S an

d br

eech

pr

esen

tatio

n)

Man

agem

ent o

f lab

our a

nd d

eliv

ery

Labo

ur a

nd d

eliv

ery

man

agem

ent

shou

ld fo

llow

opt

imal

obs

tetr

ic m

anag

emen

t gu

ideshy

lines

(R

efer

to

Opt

imal

Int

rapa

rtum

car

e ab

ove

and

Nat

iona

l G

uide

lines

for

Qua

lity

Obs

tetr

ics

and

IMPA

C C

are

Man

ual)

RO

LEO

FTH

E C

OM

MU

NIT

Y

A la

rge

prop

ortio

n (6

0) o

f wom

en in

Ken

ya is

del

iver

ed o

utsid

e th

e he

alth

sys

tem

s by

fam

ilym

embe

rs n

eigh

bour

s and

TBA

s

bull T

here

is n

eed

to e

duca

te th

e co

mm

unity

on

the

risk

of M

TC

T an

d w

ays

of

prev

entio

n

bull T

hose

ass

istin

g th

e de

liver

ies

need

to u

nder

stan

d th

eir

own

risk

of in

fect

ion

and

how

to p

rote

ct th

emse

lves

bull T

he c

omm

unity

sho

uld

be e

ncou

rage

d to

faci

litat

e m

othe

rs to

del

iver

in

heal

th fa

cilit

ies

bull T

he c

omm

unity

sho

uld

be e

ncou

rage

d to

ref

er to

hea

lth fa

cilit

ies

all c

hild

ren

born

at h

ome

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

7

40

Fi

gure

81

Gui

delin

es fo

r Cou

nsel

ling

on H

IV a

nd In

fant

feed

ingJ

ob A

ids

Cha

pter

ref

eren

ces

an

d IE

C M

ater

ials

on

Infa

nt a

nd Y

oung

Chi

ld F

eedi

ng

1R

epublic

of

Ken

ya

Min

istr

y of

Hea

lth

Ess

ential

Obst

etric

Car

e M

anual

for

Hea

lth

Ser

vice

Pro

vider

s in

Ken

ya (

3rd

Editio

n J

an 2

006)

Foo

tnot

es

1 D

e Cock

KM

2002

2 K

enya

National

Rep

roduct

ive

Hea

lth I

nst

ruct

ion M

anual

for

Ser

vice

Pro

vider

s (2

006)

3 D

ivis

ion o

f Rep

roduct

ive

Hea

lth

Guid

elin

es f

or

Qual

ity

Obst

etri

cs a

nd P

erin

ata

l Car

e

(2004)

4 W

HO

Antire

tovi

ral dru

gs

for

trea

ting p

regnan

t w

om

en a

nd p

reve

nting H

IV infe

ctio

n in

infa

nts

to

ward

s univ

ersa

l acc

ess

(2006)

41

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

66

85

EXTR

AC

TSFR

OM

RES

EAR

CH

ON

I NFA

NT

F EED

ING

A

ND H

IVA

IDS

Evid

ence

ava

ilabl

e fr

om c

urre

nt re

sear

ch d

ata

show

s th

at

bull I

ncre

ased

ris

k of

mor

talit

y w

ith r

epla

cem

ent

feed

ing

is s

igni

fican

t

bull H

IV f

ree

surv

ival

rat

e at

18

mon

ths

of a

ge d

oes

not

sign

ifica

ntly

var

y be

twee

n a

brea

stfe

d an

d re

plac

emen

t fed

chi

ld

bull M

odifi

ed a

nim

alrsquos

milk

doe

s no

t pr

ovid

e ad

equa

te n

utrit

ion

for

ch

ildre

n le

ss t

han

6 m

onth

s he

nce

mic

ronu

trie

nts

shou

ld b

e gi

ven

un

der

thes

e ci

rcum

stan

ces

bull A

brup

t ce

ssat

ion

of b

reas

tfee

ding

is n

o lo

nger

rec

omm

ende

d

bull E

xclu

sive

bre

astf

eedi

ng u

p to

6 m

onth

s is

rec

omm

ende

d un

less

re

plac

emen

t fee

ding

can

mee

t AF

AS

S c

rite

ria

Cha

pter

4

Use

of A

ntire

trov

iral D

rugs

in P

regn

ancy

for T

reat

men

t and

for

Prev

entio

n of

Mot

her-

to-C

hild

Tra

nsm

issi

on o

f HIV

Infe

ctio

n

41

INTR

OD

UC

TIO

N

With

out

any

inte

rven

tion

up

to 4

0 pe

rcen

t of

HIV

pos

itive

wom

en w

ill t

rans

mit

the

infe

ctio

n to

the

ir c

hild

ren

duri

ng p

regn

ancy

lab

our

and

brea

stfe

edin

g U

se o

f ant

iret

shyro

vira

l dru

gs (A

RV

s) o

bste

tric

inte

rven

tions

and

avo

idan

ce o

f all

brea

stfe

edin

g fo

r pr

eshyve

ntio

n of

mot

her

to c

hild

tran

smis

sion

of H

IV in

fect

ion

(PM

TCT)

has

red

uced

the

risk

of m

othe

r to

chi

ld tr

ansm

issi

on o

f HIV

infe

ctio

n (M

TCT)

to le

ss th

an 2

per

cent

in d

evel

shyop

ed c

ount

ries

Shor

t cou

rse

effic

acio

us A

RV

dru

g re

gim

ens

can

redu

ce th

e ri

sk o

f MTC

T to

2-4

per

cent

and

can

be i

mpl

emen

ted

in r

esou

rce-

limite

d se

ttin

gs o

n a

popu

latio

n-ba

sed

publ

ic

heal

th s

cale

AR

Vs

are

used

bot

h fo

r th

e tr

eatm

ent

of H

IV d

isea

se a

nd fo

r PM

TCT

in

HIV

-infe

cted

pre

gnan

t w

omen

and

the

ir n

eona

tes

Ant

iret

rovi

ral t

reat

men

t (A

RT)

for

wom

en w

ho q

ualif

y fo

r it

pro

long

s an

d im

prov

es t

he q

ualit

y of

the

ir l

ives

The

sur

shyvi

val

of t

he c

hild

is

clos

ely

inte

rlin

ked

with

the

hea

lth a

nd s

urvi

val

of t

he m

othe

r

Wom

en e

ligib

le fo

r A

RT

shou

ld b

e st

arte

d on

trea

tmen

t as

soon

as

poss

ible

Pre

gnan

cy

is n

ot a

rea

son

to d

elay

AR

T W

omen

who

are

alr

eady

on

AR

T be

fore

bec

omin

g pr

egshy

nant

sho

uld

cont

inue

with

thei

r tr

eatm

ent

In c

erta

in s

ituat

ions

mod

ifica

tions

may

be

need

ed to

mak

e tr

eatm

ent s

afer

for

the

mot

her

and

the

unbo

rn b

aby

The

bene

fits

of u

sing

AR

Vs

to t

reat

HIV

-infe

cted

pre

gnan

t w

omen

and

or

PMTC

T ou

tshyw

eigh

the

ris

ks H

owev

er w

hen

AR

T or

oth

er s

hort

cou

rse

AR

V r

egim

ens

are

used

ba

selin

e ev

alua

tion

and

mon

itori

ng is

enc

oura

ged

to e

nsur

e th

e sa

fety

of t

he m

othe

rsan

d th

eir

new

born

s L

inka

ges

of H

IV-in

fect

ed p

regn

ant

wom

en a

nd t

heir

chi

ldre

n to

ot

her

care

and

sup

port

pro

gram

s at

hea

lth f

acili

ty a

nd c

omm

unity

lev

els

shou

ld b

e en

sure

d

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

6

5

42

42

OPE

RA

TIO

NA

L G

UID

ELIN

ES

All

HIV

-infe

cted

pre

gnan

t w

omen

sho

uld

be c

ouns

elle

d on

com

preh

ensi

ve H

IV c

are

incl

udin

g us

e of

AR

Vs

for

thei

r ow

n he

alth

and

for

PMTC

T

All

HIV

-infe

cted

pre

gnan

t wom

en s

houl

d ha

ve th

eir H

IV d

isea

se

stag

ed u

sing

bull W

HO

clin

ical

sta

ging

(se

e A

ppen

dix

1) a

nd

bull I

mm

unol

ogic

al s

tagi

ng (

CD

4 co

unt)

(se

e ta

ble

1)

The

wom

en s

houl

d al

so b

e sc

reen

ed a

nd tr

eate

d fo

r op

port

unis

tic in

fect

ions

(OIs

) inc

ludi

ngTu

berc

ulos

is (T

B)

All

HIV

-infe

cted

pre

gnan

t wom

en s

houl

d ha

ve b

asel

ine

labo

rato

ry a

nd o

ther

nec

essa

rydi

agno

stic

eva

luat

ions

Thes

e di

agno

stic

s sh

ould

incl

ude

bull R

outin

e an

tena

tal c

are

labo

rato

ry in

vest

igat

ions

that

are

nor

mal

ly

done

for

all

preg

nant

wom

en

haem

oglo

bin

(Hb)

rh

esus

blo

od

grou

p an

d A

BO

typ

ing

VD

RL

uri

ne a

naly

sis

and

scre

enin

g fo

r S

TI

bull A

LT a

nd c

reat

inin

e le

vels

for

wom

en e

ligib

le f

or H

AA

RT

Prop

hyla

xis

amp m

icro

nutr

ient

sup

plem

enta

tion

bull

Cot

rimox

azol

e (C

TX) o

ne d

oubl

e st

reng

th o

r tw

o si

ngle

stre

ngth

tabl

ets

once

dai

ly

bull

Mul

tivita

min

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

83

OPE

RA

TIO

NA

L G

UID

ELIN

ESO

N F

EED

ING

CH

ILD

REN

6 M

ON

THS

AN

DO

LDER

The

follo

win

g sh

ould

gui

de fe

edin

g fo

r chi

ldre

n 6

mon

ths

and

olde

r

bull A

t 6

mon

ths

oth

er f

orm

s of

milk

alo

ne a

re n

ot a

dequ

ate

to m

eet

the

baby

rsquos n

utrit

iona

l req

uire

men

ts

bull C

ompl

emen

tary

foo

ds s

houl

d be

intr

oduc

ed w

ith c

ontin

ued

br

east

feed

ing

or w

ith r

epla

cem

ent

feed

ing

until

a n

utrit

iona

lly

adeq

uate

die

t ca

n be

sus

tain

ed w

ithou

t m

ilk

bull A

brup

t ces

satio

n of

bre

astf

eedi

ng s

houl

d be

dis

cour

aged

to

avoi

d

trau

ma

for

both

the

mot

her

and

the

baby

bull M

ilk s

houl

d co

ntin

ue a

s an

impo

rtan

t co

mpo

nent

of

the

diet

bull C

ompl

emen

tary

foo

ds s

houl

d be

enr

iche

d fr

om lo

cally

ava

ilabl

e

fam

ily f

oods

84

NU

TRIT

ION

AL

CA

RE

AN

D S

UPP

OR

TO

F H

IV

INFE

CTE

DC

HIL

DR

EN

bull E

nerg

y ne

eds

for

asym

ptom

atic

HIV

infe

cted

chi

ldre

n in

crea

se b

y 10

pe

rcen

t to

mai

ntai

n gr

owth

as

com

pare

d to

the

non-

infe

cted

chi

ldre

n

bull T

here

is n

o ev

iden

ce o

f in

crea

sed

prot

ein

requ

irem

ents

The

re

quir

emen

ts s

houl

d be

bas

ed o

n in

divi

dual

sym

ptom

s an

d ne

eds

bull M

icro

nutr

ient

req

uire

men

ts d

o no

t ch

ange

W

HO

rec

omm

ends

not

m

ore

than

one

RD

A

(For

fur

ther

det

ails

re

fer

to K

enya

n G

uide

lines

on

nutr

ition

and

HIV

A

IDS

)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

3

64

82

OPE

RA

TIO

NA

L G

UID

ELIN

ESO

N I N

FAN

TFE

EDIN

G (0

-6 M

ON

THS)

The

follo

win

g sh

ould

gui

de in

fant

feed

ing

for t

he fi

rst 6

mon

ths

bull A

ll w

omen

and

men

irre

spec

tive

of th

eir

HIV

sta

tus

shou

ld r

ecei

ve

coun

selin

g an

d de

mon

stra

tions

on

how

to s

afel

y fe

ed t

heir

babi

es

duri

ng t

he a

nten

atal

and

pos

tnat

al f

ollo

w u

p

bull T

he m

ost

appr

opria

te in

fant

fee

ding

opt

ion

for

an H

IV in

fect

ed

mot

her

shou

ld c

ontin

ue t

o de

pend

on

indi

vidu

al c

ircu

mst

ance

s an

d

the

av

aila

ble

supp

ort

bull E

very

HIV

infe

cted

wom

an s

houl

d be

eva

luat

ed a

t ev

ery

visi

t to

ch

eck

whe

ther

her

soc

ial

econ

omic

and

hea

lth s

tatu

s ha

s ch

ange

d

suff

icie

ntly

eno

ugh

to a

ffec

t he

r in

fant

fee

ding

opt

ion

bull E

xclu

sive

bre

astf

eedi

ng fo

r H

IV in

fect

ed w

omen

for

the

firs

t 6

mon

ths

of t

he in

fant

rsquos li

fe is

adv

isab

le

unle

ss r

epla

cem

ent f

eedi

ng is

ac

cept

able

fea

sibl

e a

ffor

dabl

e s

usta

inab

le a

nd s

afe

for

them

and

th

eir

infa

nts

befo

re t

hat t

ime

bull W

hen

repl

acem

ent

feed

ing

is a

ccep

tabl

e f

easi

ble

aff

orda

ble

su

stai

nabl

e an

d sa

fe

avoi

danc

e of

exc

lusi

ve b

reas

tfee

ding

by

HIV

in

fect

ed w

omen

is r

ecom

men

ded

bull I

f th

e co

nditi

ons

for

repl

acem

ent

feed

ing

are

still

not

met

for

6

mon

ths

then

co

ntin

uatio

n of

bre

astf

eedi

ng w

ith a

dditi

onal

co

mpl

emen

tary

fee

ding

is r

ecom

men

ded

giv

ing

prio

rity

to t

he lo

cally

av

aila

ble

food

s

bull I

nfan

t fe

edin

g de

cisi

ons

for

all H

IV e

xpos

ed in

fant

s sh

ould

be

base

d on

the

AF

AS

S c

riter

ia e

ven

whe

re e

arly

infa

nt d

iagn

osis

(E

ID)

is

avai

labl

e

bull B

reas

tfeed

ing

mot

hers

of

infa

nts

and

youn

g ch

ildre

n w

ho a

re k

now

n to

be

HIV

infe

cted

sho

uld

be s

tron

gly

enco

urag

ed to

con

tinue

bre

ast

feed

ing

How

ever

br

east

feed

ing

HIV

infe

cted

mot

hers

sho

uld

be

give

n nu

triti

on s

uppo

rt (

nutr

ition

al c

ouns

elin

g e

duca

tion

foo

d an

d nu

triti

onal

sup

plem

ents

)

63

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

44

Sulp

hur-

base

d in

term

itten

t pr

esum

ptiv

e m

alar

ia t

reat

men

t (I

PT) s

houl

d no

t be

giv

en

to w

omen

who

are

on

CTX

pro

phyl

axis

AR

V us

e

bull A

RV

s ar

e us

ed fo

r tr

eatin

g H

IV-i

nfec

ted

elig

ible

wom

en a

ndo

r fo

r pr

even

tion

of m

othe

r-to

-chi

ld tr

ansm

issi

on

bull H

IV-i

nfec

ted

preg

nant

wom

en e

ligib

le f

or A

RT

sho

uld

initi

ate

AR

T

as s

oon

as p

ossi

ble

as s

how

n in

Tab

le 4

1

bull H

IV-i

nfec

ted

preg

nant

wom

en a

lread

y on

AR

T b

efor

e be

com

ing

preg

nant

sho

uld

cont

inue

AR

T

The

bab

y sh

ould

be

give

n A

RV

pr

ophy

laxi

s so

on a

fter

birt

h as

sho

wn

in T

able

42

Tabl

e 4

1 R

ecom

men

datio

ns fo

r ini

tiatin

g A

RV

trea

tmen

t in

preg

nant

w

omen

bas

ed o

n cl

inic

al s

tage

and

ava

ilabi

lity

of C

D4

Cou

nt

WH

O

CD

4 te

stin

g

CD

4 te

stin

g

Clin

ical

Sta

ge

not a

vaila

ble

avai

labl

e

1 D

o no

t Tre

at

Trea

t if C

D4le

350

cells

mm

3

2 D

o no

t Tre

at

Trea

t if C

D4 le

350

cells

mm

3

3 Tr

eat

Trea

t irre

spec

tive

of C

D4

coun

t (c

onsi

der C

D4

valu

es fo

r bet

ter

man

agem

ent)

4 Tr

eat

Trea

t irre

spec

tive

of C

D4

cell

coun

t

Sourc

e A

dopte

d f

rom

WH

O

Anti-r

etro

vira

l dru

gs

for

trea

ting p

regnant

wom

en a

nd p

re-

venting H

IV infe

ctio

ns

Tabl

e 4

2 R

ecom

men

ded

first

-line

AR

T re

gim

en fo

r tre

atin

g pr

egna

nt w

omen

and

pro

phyl

actic

regi

men

for i

nfan

ts

Mot

her

Ant

epar

tum

AZ

T +

3TC

+ N

VP D

aily

Intra

partu

m

AZT

+ 3T

C +

NVP

Dai

ly

Pos

tpar

tum

AZ

T +

3TC

+ N

VP D

aily

Infa

nt p

roph

ylax

is

Sd

NV

P 2

mg

kg s

tat w

ithin

72

hour

s 3T

C X

1 w

eek

(4

mg

kg B

ID)

AZT

X 6

wee

ks (4

mg

kg B

ID)

Mat

erna

l dos

ages

AZT

300

mg

BID

3TC

150

mg

BID

NV

P 2

00 m

g O

D fo

r tw

o w

eeks

the

reaf

ter 2

00 m

g B

ID

Infa

nt D

osag

es

NV

P

2mg

kg s

tat w

ithin

72

hour

s

AZT

4mg

kg B

ID X

6 w

eeks

3TC

4m

gkg

BID

X 1

wee

k

Cha

pter

8

Feed

ing

Infa

nts

and

Youn

g C

hild

ren

Bor

n to

HIV

Infe

cted

Mot

hers

81

INTR

OD

UC

TIO

N T

RA

NSM

ISSI

ON

OF

HIV

THR

OU

GH

B

REA

STFE

EDIN

G

In A

fric

a 3

to 4

out

of e

very

10

infa

nts

born

to H

IV in

fect

ed w

omen

acq

uire

HIV

infe

cshytio

n T

here

is t

here

fore

a 5

ndash 2

0 pe

rcen

t ri

sk o

f inf

ants

bor

n to

HIV

pos

itive

mot

hers

ac

quir

ing

infe

ctio

n th

roug

h br

east

-fe

edin

g if

ther

e ar

e no

inte

rven

tions

in

pla

ce

For

wom

en w

ho a

re i

nshyfe

cted

with

HIV

for

the

first

tim

e or

w

ho a

re r

e-in

fect

ed w

ith a

diff

eren

t st

rain

of H

IV d

urin

g th

e br

east

feed

shyin

g ph

ase

the

ris

k in

crea

ses

up t

o29

per

cen

t H

alf (

12)

of H

IV b

reas

t m

ilk t

rans

mis

sion

tak

es p

lace

by

6 w

eeks

and

thre

e qu

arte

rs (3

4) b

y 6

mon

ths

Mix

ed fe

edin

g in

crea

ses

the

risk

of

brea

st m

ilk t

rans

mis

sion

of

HIV

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

5

62

For

prop

hyla

xis

the

reco

mm

enda

tions

are

ran

ked

and

will

dep

end

on t

ime

of fi

rst

conshy

tact

with

the

wom

an H

IV-in

fect

ed p

regn

ant w

omen

who

are

not

elig

ible

for

AR

T or

in

72

3 C

OM

PREH

ENSI

VE

CA

RE

FOR H

IV-E

XPO

SED

CH

ILD

REN

w

hom

it is

not

pos

sibl

e to

sta

rt A

RT

imm

edia

tely

and

the

mot

her

is b

eing

see

n be

twee

n28

and

38

wee

ks o

f pr

egna

ncy

sho

uld

be s

tart

ed o

n re

com

men

ded

mor

e ef

ficac

ious

shor

t co

urse

pro

phyl

actic

AR

V r

egim

ens

as s

how

n in

Tab

le 4

3a

The

bab

y sh

ould

als

obe

giv

en A

RV

pro

phyl

axis

soo

n af

ter

birt

h as

sho

wn

in th

e sa

me

tabl

e T

he r

egim

ens

asou

tline

d be

low

are

for

prop

hyla

xis

and

not f

or tr

eatm

ent

MINI

STRY

OF H

EAL

TH

Tabl

e 4

3a R

ecom

men

ded

Firs

t Lin

e A

RV

prop

hyla

xis

ALGO

RITH

M FO

R EA

RLY

INFA

NTDI

AGNO

SISFO

R HI

VEX

POSE

DCH

ILDRE

N

to p

reve

nt H

IV in

fect

ion

in in

fant

s A

mon

g Pr

egna

nt W

omen

Pr

esen

ting

Bef

ore

38 W

eeks

Ran

king

Ti

me

of A

dmin

istr

atio

n

WEL

L CHI

LD

SICK

CHI

LD

(Man

age

pres

entin

g ill

ness

and

stab

ilize

)

STAR

T CO

TRIM

OXAZ

OLE

PROP

HYLA

XIS

FOR M

OR E

INFOR

MATIO

N C ON

TACT

THE N

ATI O

NAL A

IDS S

TD CO

NTRO

L PRO

GRAM

ME ( N

ASCO

P) PO

BOX

19 36

1-00

20 2 N

AIRO

BI TE

L 02

02 72

95 02

FAX 0

2 0 2 7

1 05 1

8

Exp

osur

e sta

tus s

houl

d be

det

erm

ined

for a

ll in

fants

of u

nkno

wn s

tatu

s at t

he

6 we

ek v

isit o

r firs

t con

t act

Coun

sel o

n inf

ant f

eedi

ng a

s per

nat

iona

l gui

delin

es

Conf

irma

tory

ABt

est

at 1

8 M

onth

s

Eval

uate

for

ART

star

t on

ARV

if el

igibl

e

If HI

V+ a

t 12

Mont

hs

Evalu

ate f

or A

RT

Start

on

ARV

if eli

gible

6 Wee

ks D

BS (P

CR)

HIV

+

If HI

V-sto

p CT

X if

not

BF

for a

t lea

st 2

Mont

hs

HI

V-

Antib

ody

test

ing

12 M

onth

s

Conf

irmat

ory

ABte

st at

18 M

onth

s

Conf

irmat

ory A

B te

st at

18 M

onth

s

Eval

uate

for A

RT

star

t on

ARV

if el

igible

If HIV

+ at

12

Mon

ths

Eval

uate

for A

RT

Star

t on

ARV

if el

igibl

e

If lt1

2 Mon

ths D

BS (P

CR)

If gt

12m

o An

tibod

y te

st

HIV

+

If HIV-

stop

CTX

if n

ot

BF

for a

t lea

st 2

Mont

hs

HI

V-

Antib

ody

testi

ng

12 M

onth

s

Conf

irma

tory

AB

test

at 1

8 Mo

nths

Exp

osur

e sta

tus s

hould

be de

term

ined

for a

ll in

fant

s of u

nkno

wn st

atus

at th

e 6w

eek

visit

or fi

rst c

onta

ct

Co

unse

l on

infa

nt fe

edin

g as

per n

atio

nal g

uideli

nes

Pre

gnan

cy

Labo

ur

Pos

tpar

tum

Mat

erna

l In

fant

Rec

omm

ende

d

AZT(

28-3

8 w

eeks

ge

stat

ion)

sd

NV

P

+ AZ

T+3T

C

AZT+

3TC

X

7 da

ys

sdN

VP

PL

US

3TC

X1

wee

k +

AZT

X

6 w

eeks

Tabl

e 4

3b b

elow

sho

ws

alte

rnat

ive

prop

hyla

ctic

regi

men

s fo

r w

omen

pre

sent

ing

befo

re 3

8 w

eeks

of p

regn

ancy

Ran

king

Ti

me

of A

dmin

istr

atio

n

Alte

rnat

ive

Min

imum

Pre

gnan

cy

AZT(

28-3

8 w

eeks

)

Labo

ur

sd N

VP

+

AZT(

600m

gs

stat

)

sdN

VP

+ A

ZT+3

TC

Pos

tpar

tum

AZT+

3TC

X

7 da

ys

Infa

nt

sdN

VP

+

3TC

X 7

da

ys +

AZT

X

6 w

eeks

sdN

VP

+

3TC

day

s +

AZT

X 6

wee

ks

HIV

-infe

cted

pre

gnan

t w

omen

who

are

see

n fo

r th

e fir

st t

ime

afte

r 38

wee

ks o

f pr

egshy

nanc

y or

in la

bour

sho

uld

be g

iven

AR

V p

roph

ylac

tic r

egim

ens

as s

how

n in

Tab

le 4

4

The

baby

sho

uld

also

be

give

n A

RV

pro

phyl

axis

soo

n af

ter

birt

h as

sho

wn

in t

he s

ame

Bot

h H

IV-in

fect

ed a

nd u

ninf

ecte

d ch

ildre

n re

quir

e co

mpr

ehen

sive

car

e (R

efer

to C

hap-

tabl

ete

r 8

and

9)

61

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

46

Tabl

e 4

4 A

RV

prop

hyla

xis

for P

MTC

T am

ong

preg

nant

wom

en w

ho

have

not

rece

ived

ant

enat

al A

RT

or p

roph

ylax

is

Ran

king

Ti

me

of A

dmin

istr

atio

n

La

bour

P

ostp

artu

m

Mat

erna

l In

fant

Rec

omm

ende

d

sdN

VP

AZ

T+3T

C

SdN

VP

+

X 7

days

P

LUS

3TC

X 1

wee

k +

AZT+

3TC

AZ

T X

6 w

eeks

Min

imum

sd

NV

P

-S

dNV

P

PLU

S 3

TC X

1 w

eek

+

AZT

X 6

wee

ks

Dos

ages

Mot

her

Bab

y

NV

P

200

mg

stat

2m

gkg

sta

t with

in 7

2 ho

urs

AZT

300

mg

BID

4m

gkg

BID

X 6

wee

ks

3TC

15

0 m

g BI

D

4mg

kg B

ID X

1 w

eek

Tabl

e 4

5 R

ecom

men

ded

HA

AR

T fo

r Pre

gnan

t Wom

en

base

d on

CD

4 C

ount

and

Sta

ge o

f Pre

gnan

cy

CD

4 C

ount

H

AA

RT

Trim

este

r C

ells

mm

3

72

2 H

IV P

OSI

TIV

EIN

FAN

TB

Y D

NA

PC

R

bull A

ll H

IV p

ositi

ve in

fant

s sh

ould

be

eval

uate

d fo

r el

igib

ility

for

antishy

retr

ovir

al tr

eatm

ent

and

linke

d to

car

e an

d tr

eatm

ent

as a

ppro

pria

te

bull W

HO

clin

ical

sta

ging

sho

uld

be d

one

for

all H

IV p

ositi

ve in

fant

s

Chi

ldre

n w

ho a

re a

t W

HO

Clin

ical

sta

ge 3

or

4 ar

e el

igib

le f

or

antir

etro

vira

l tre

atm

ent

bull A

ll H

IV p

ositi

ve in

fant

s sh

ould

be

asse

ssed

for

CD

4 co

unt

whe

re

poss

ible

and

ava

ilabl

e R

efer

to

AR

T g

uide

lines

for

CD

4 co

unts

tha

t de

term

ine

elig

ibili

ty f

or A

RT

for

chi

ldre

n of

diff

eren

t ag

e br

acke

ts

bull A

ll H

IV-p

ositi

ve in

fant

s sh

ould

hav

e a

visi

ble

guar

dian

or

care

-tak

er

befo

re t

hey

can

be s

tart

ed o

n A

RT

bull A

ll H

IV-p

ositi

ve in

fant

s sh

ould

be

star

ted

on C

otri

mox

azol

e fr

om 6

w

eeks

or

on f

irst

cont

act t

here

afte

r

bull A

ll H

IV-p

ositi

ve in

fant

s sh

ould

be

star

ted

on A

RT

if el

igib

le

bull B

reas

tfeed

ing

shou

ld b

e en

cour

aged

for

all

HIV

-pos

itive

infa

nts

for

a

min

imum

of t

wo

year

s (

Ref

er t

o C

hapt

er 8

)

bull F

or a

ll H

IV-p

ositi

ve in

fant

s p

erfo

rm a

ntib

ody

test

ing

at 9

mon

ths

12

mon

ths

and

conf

irm

at

18 m

onth

s

1st T

rimes

ter

2nd T

rimes

ter

3rd T

rimes

ter

lt250

A

ZT+

3TC

+NV

P

AZ

T+3T

C+N

VP

AZT+

3TC

+NVP

250-

350

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

gt 35

0

A

ZT+3

TC+L

PVr

OR

A

BC

+3TC

+LPV

r

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

AZT

+3TC

+LPV

r O

R

AB

C+3

TC+L

PVr

47

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

60

72

OPE

RA

TIO

NA

L G

UID

ELIN

ES

72

0 G

UID

ELIN

ESFO

R H

IV D

IAG

NO

SIS

INC

HIL

DR

EN

bull P

erfo

rm r

outin

e ra

pid

HIV

ant

ibod

y te

sts

for

all m

othe

rs o

f 6

wee

k ol

d in

fant

s pr

esen

ting

with

unk

now

n st

atus

bull P

erfo

rm r

outin

e dr

y bl

ood

spot

s (D

BS

) fo

r D

NA

PC

R f

or a

ll in

fant

s kn

own

to b

e H

IV-e

xpos

ed a

t 6

wee

ks

bull P

erfo

rm r

outin

e an

tibod

y te

stin

g fo

r al

l sic

k in

fant

s in

out

patie

nt a

nd

paed

iatr

ic w

ards

to

esta

blis

h H

IV e

xpos

ure

infe

ctio

n st

atus

bull P

erfo

rm D

BS

for

all

HIV

-exp

osed

sic

k in

fant

s un

der

12 m

onth

s

bull A

ll H

IV-e

xpos

ed in

fant

s sh

ould

be

star

ted

on C

otri

mox

azol

e fr

om 6

w

eeks

of

age

or o

n fir

st c

onta

ct th

erea

fter

bull R

efer

to

chap

ter

on c

are

and

follo

w u

p of

the

HIV

-exp

osed

infe

cted

in

fant

72

1 H

IV N

EGA

TIV

EIN

FAN

TA

TA

GE

6 W

EEK

SO

RFI

RST

CO

NTA

CT

Perf

orm

ant

ibod

y te

stin

g at

9 m

onth

s an

d 12

mon

ths

of a

ge

bull I

f H

IV n

egat

ive

at 1

2 m

onth

s an

d st

ill b

reas

tfee

ding

co

ntin

ue

Cot

rim

oxaz

ole

bull I

f not

bre

astf

eedi

ng f

or a

t le

ast

2 m

onth

s s

top

Cot

rim

oxaz

ole

bull P

erfo

rm c

onfir

mat

ory

antib

ody

test

ing

at 1

8 m

onth

s

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Mat

erna

l dos

ages

AZT

30

0 m

g B

ID

3TC

15

0 m

g BI

D

NVP

200

mg

OD

for t

wo

wee

ks t

here

afte

r 200

mg

BID

AB

C

300m

g B

ID

LPV

r (4

001

00)

2 ta

blet

s B

ID

EFV

60

0mg

QID

Not

es I

mpo

rtan

t con

side

ratio

ns th

at m

odify

cho

ice

of A

RV

s du

ring

pre

gnan

cy in

clud

e C

D4

coun

t m

ater

nal a

naem

ia a

nd

stag

e of

pre

gnan

cy

bull 2

NR

TIs

(A

ZT

and

3TC

) ac

ting

as a

ldquotr

eatm

ent

back

bone

rdquo w

ith a

dditi

on o

f an

N

NR

TI (

NV

P)

rem

ains

the

pre

ferr

ed fi

rst-

line

AR

V t

hera

py in

res

ourc

e-po

or

sett

ings

bull P

rote

ase

inhi

bito

rs b

ased

reg

imen

s ar

e pr

efer

able

whe

n C

D4

coun

t is

high

er

than

250

bull R

epla

ce A

ZT

with

d4T

if H

blt 8

gm

dL

bull

EF

V m

ay b

e us

ed in

stea

d of

NV

P a

fter

first

trim

este

r

bull

Usu

ally

AR

V s

houl

d be

with

held

if C

D4

coun

t is

not

ava

ilabl

e or

not

don

e

AR

V is

how

ever

use

d fo

r P

MT

CT

and

or in

adv

ance

d H

IV d

isea

se (

WH

O

Sta

ge 3

or

4) ir

resp

ectiv

e of

CD

4 co

unt

Bab

ies

who

se

mot

hers

di

d no

t re

ceiv

e an

tepa

rtum

or

in

trap

artu

m

AR

Vpr

ophy

laxi

s sh

ould

be

give

n A

RV

pro

phyl

axis

as

show

n in

Tab

le 4

6

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

9

48

Tabl

e 4

6 A

RV

prop

hyla

ctic

regi

men

s fo

r inf

ants

bor

n to

H

IV-p

ositi

ve w

omen

who

hav

e no

t rec

eive

d an

tepa

rtum

or

intr

apar

tum

AR

T or

AR

V pr

ophy

laxi

s

Ran

king

T

ime

of a

dmin

istr

atio

n an

d In

fant

dos

age

sdN

VP (2

mg

kg s

tat)

PLU

S 3T

C (4

mg

kg B

ID) X

1 w

eek

+ AZ

T (4

mg

kg

BID

) X 6

wee

ks

Rec

omm

ende

d

sdN

VP (2

mg

kg s

tat)

Min

imum

sdN

VP

is g

iven

to th

e in

fant

with

in 7

2 ho

urs

of b

irth

Plea

se n

ote

A

t fir

st c

onta

ct a

ll H

IV i

nfec

ted

preg

nant

wom

en s

houl

d be

giv

en s

dNV

P ta

blet

s to

take

hom

e w

ith t

hem

The

y sh

ould

be

inst

ruct

ed t

o ta

ke t

he t

able

ts a

t th

e on

set

of la

shybo

ur i

f lab

our

occu

rs o

utsi

de h

ealth

faci

lity

sett

ings

The

y sh

ould

als

o be

giv

en N

VP

3T

C a

nd A

ZT s

yrup

for

thei

r ba

bies

to b

e ad

min

iste

red

soon

aft

er b

irth

Som

e w

omen

with

a C

D4

coun

t gr

eate

r th

an 2

50 c

ells

microl

on

Nev

irap

ine

(NV

P)-b

ased

AR

T m

ay d

evel

op N

VP

hype

rsen

sitiv

e re

actio

ns t

hat

can

be li

fe t

hrea

teni

ng I

n th

ese

guid

elin

es it

is r

ecom

men

ded

that

for

preg

nant

wom

en w

ith C

D4

mor

e th

an 2

50 N

VP-

base

d re

gim

en m

ay s

till

be u

sed

but

with

clo

se m

onito

ring

O

ther

wis

e th

e re

com

shym

ende

d re

gim

en to

use

with

CD

4 co

unt a

bove

250

is a

PI-

base

d H

AA

RT

regi

men

Whe

n si

ngle

dos

e N

VP

(sdN

VP)

is u

sed

in P

MTC

T s

ome

wom

en a

nd c

hild

ren

may

deshy

velo

p re

sist

ance

to

NV

P th

at m

ay l

imit

futu

re u

se o

f N

on-N

ucle

osid

e R

ever

se T

ranshy

scri

ptas

e In

hibi

tors

(NN

RTI

s) t

o tr

eat

them

Th

e ri

sk o

f NN

RTI

res

ista

nce

is p

artic

ushyla

rly

high

if

two

dose

s of

sdN

VP

are

give

n T

here

fore

SdN

VP

shou

ld n

ever

be

used

mor

e th

an o

nce

in a

ny o

ne p

regn

ancy

Whe

re p

ossi

ble

AZT

3TC

sho

uld

be g

iven

for

7 da

ys t

o co

ver

the

NV

P ta

il bo

th in

the

mot

her

and

the

baby

Th

e ba

by is

the

n co

ntin

shyue

d on

AZT

for

a to

tal o

f 6 w

eeks

for

prop

hyla

xis

agai

nst M

TCT

HIV

-infe

cted

pre

gnan

t w

omen

sta

rtin

g zi

dovu

dine

(A

ZT)

cont

aini

ng r

egim

ens

shou

ld

have

hae

mog

lobi

n (H

b) le

vels

abo

ve 8

gm

dl

The

Hb

leve

l sho

uld

be c

heck

ed m

onth

ly

for

the

first

thr

ee m

onth

s W

here

pos

sibl

e A

ZT s

houl

d be

use

d in

stea

d of

sta

vudi

ne(d

4T)

Clin

ical

judg

emen

t can

be

used

to e

stim

ate

Hb

leve

ls a

nd in

itiat

e AR

V pr

ophy

laxi

s if l

aboshy

rato

ry te

sts a

re u

nava

ilabl

e

Efa

vire

nz (

EFV

) m

ay b

e te

rato

geni

c if

used

in t

he f

irst

tri

mes

ter

If t

he p

atie

nt is

on

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Cha

pter

7

HIV

Dia

gnos

is in

Chi

ldre

n 7

1 IN

TRO

DU

CTI

ON

In g

ener

al

a ch

ild m

ay b

e te

sted

und

er a

num

ber

of c

ircu

mst

ance

s T

hese

inc

lude

sh

ortly

aft

er b

irth

for

earl

y di

agno

sis

of H

IV f

or th

e pu

rpos

es o

f ind

ivid

ual d

iagn

osis

in

a ch

ild w

ho is

ill (

eg

tho

se p

rese

ntin

g w

ith a

n H

IV r

elat

ed il

lnes

s) i

n ca

ses

whe

re a

child

has

eith

er b

een

expo

sed

or is

pot

entia

lly e

xpos

ed t

o H

IV e

g t

hrou

gh m

othe

r-to

shych

ild t

rans

mis

sion

se

xual

abu

se

sexu

al a

ctiv

ity

with

in a

hea

lthca

re s

ettin

g (e

g

thro

ugh

cont

amin

ated

nee

dles

or

rece

ipt

of p

oten

tially

infe

ctio

us b

lood

) th

roug

h ot

her

mea

ns a

nd in

orp

hans

Ear

ly i

nfan

t di

agno

sis

(EID

) re

fers

to

the

mak

ing

of H

IV d

iagn

osis

in

infa

nts

and

youn

g ch

ildre

n be

fore

18

mon

ths

of a

ge E

ID g

ives

an

oppo

rtun

ity fo

r ea

rly

iden

tific

ashytio

n of

HIV

infe

cted

infa

nts

(des

pite

PM

TCT)

and

ear

ly li

nkag

e to

car

e an

d tr

eatm

ent

Dis

ease

pro

gres

sion

in H

IV in

fect

ed in

fant

s is

fast

with

a h

igh

mor

talit

y ra

te (gt

50

)by

2 y

ears

of a

ge T

he m

edia

n ag

e of

dea

th in

the

first

two

year

s is

6 m

onth

s H

IV a

ntishy

body

tes

ting

amon

g ch

ildre

n ag

ed 1

8 m

onth

s or

mor

e is

abl

e to

det

erm

ine

whe

ther

a

child

is in

fect

ed o

r no

t

Dur

ing

preg

nanc

y m

othe

rs g

ive

thei

r ba

bies

ant

ibod

ies

to in

fect

ions

the

y ha

ve e

xper

ishyen

ced

and

thes

e an

tibod

ies

wan

e w

ith ti

me

Ant

ibod

y te

stin

g in

chi

ldre

n ag

ed le

ss th

an

18 m

onth

s id

entif

ies

child

ren

who

hav

e be

en e

xpos

ed to

thei

r m

othe

rsrsquo H

IV in

fect

ion

or

who

may

be

trul

y in

fect

ed a

nd a

re m

akin

g H

IV a

ntib

odie

s C

urre

ntly

the

re is

no

test

to

diff

eren

tiate

the

mot

herrsquos

ant

ibod

ies

from

tho

se p

rodu

ced

by t

he b

aby

In

orde

r to

id

entif

y th

e H

IV-in

fect

ed c

hild

age

d le

ss t

han

18 m

onth

s a

sec

ond

test

is r

equi

red

for

all b

abie

s te

stin

g po

sitiv

e on

ant

ibod

y te

stin

g or

kno

wn

to b

e H

IV-e

xpos

ed (m

othe

r is

H

IV-p

ositi

ve)

Infa

nt D

NA

(or

RN

A) P

CR

tes

ting

is t

he c

urre

nt r

ecom

men

ded

met

hod

for

EID

Sinc

e m

ost b

abie

s lo

se m

ater

nal a

ntib

odie

s (A

b) b

y 12

mon

ths

a n

egat

ive

antib

ody

test

will

ide

ntify

uni

nfec

ted

babi

es a

s lo

ng a

s th

ey a

re n

ot s

till

brea

stfe

edin

g A

pos

itive

antib

ody

test

at

12 m

onth

s a

lthou

gh h

ighl

y lik

ely

to b

e di

agno

stic

may

stil

l be

due

topa

ssiv

ely

carr

ied

mat

erna

l ant

ibod

ies

Suc

h te

sts

need

to

be c

onfir

med

by

PCR

tes

ting

or r

epea

t ant

ibod

y te

st a

t 18

mon

ths

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

4

9

58

CARE

SU

PPO

RTAN

DTR

EATM

ENT

FOR

HIV

PO

SITI

VEM

OTH

ERAN

DCH

ILD

HIV

-pos

itive

mot

hers

requ

ire c

are

and

supp

ort w

hich

incl

udes

bull

Cou

nsel

ing

bull P

roph

ylax

is a

nd tr

eatm

ent

bull L

ink

to s

uppo

rt g

roup

s an

d as

sess

men

t of

the

nee

d fo

r A

RT

bull E

arly

infa

nt d

iagn

osis

sho

uld

be p

rovi

ded

at s

ix w

eeks

usi

ng D

NA

shyP

CR

tes

ting

Cha

pter

ref

eren

ces

1

Rep

ublic

of

Ken

ya M

inis

try

of

Hea

lth

Div

isio

n o

f Rep

roduct

ive

Hea

lth

Pla

nnin

g

Guid

elin

es f

or

serv

ice

pro

vider

s

Rev

ised

in M

arch

2006

Foo

tnot

es

1

Pre

ble

and P

iwoz

2001

2

WH

O

Contr

ace

ptive

Elig

ibili

ty C

rite

ria

Guid

e

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

EFV

bef

ore

beco

min

g pr

egna

nt i

t sho

uld

be s

ubsi

tute

d w

ith N

VP

in th

e 1s

t tri

mes

ter

In c

ase

of s

ever

e hy

pere

mes

is g

ravi

daru

m A

RT

may

nee

d to

be

brie

fly in

terr

upte

d

On

aver

age

mot

her-

to-c

hild

tra

nsm

issi

on r

ates

are

15

for

sdN

VP

65

fo

r m

ore

effishy

caci

ous

dual

reg

imen

s an

d 2

4 fo

r 3-

drug

AR

V c

ombi

natio

n

Futu

re P

ersp

ectiv

es

Ext

ende

d pr

ophy

laxi

s w

ith 3

AR

V d

rug

com

bina

tions

sta

rtin

g du

ring

pre

gnan

cy a

nd

cont

inui

ng a

fter

del

iver

y fo

r a

peri

od o

f up

to

6 m

onth

s a

mon

g H

IV-in

fect

ed b

reas

t-fe

edin

g m

othe

rs h

as b

een

show

n in

a f

ew r

ecen

t an

d is

olat

ed s

tudi

es a

nd p

ilot

proshy

gram

me

to le

ad to

low

er b

reas

tfee

ding

-rel

ated

pos

tnat

al M

TCT

Thi

s ap

proa

ch m

ay b

e co

nsid

ered

whe

re th

is is

feas

ible

acc

epta

ble

saf

e an

d w

here

adh

eren

ce c

an b

e as

sure

d

Mor

e st

udie

s on

this

issu

e ar

e ex

pect

ed

Thre

e A

RV

dru

g co

mbi

natio

ns g

iven

to

HIV

pos

itive

pre

gnan

t w

omen

who

are

not

yet

el

igib

le fo

r in

itiat

ion

of A

RTs

for

thei

r ow

n he

alth

als

o le

ad to

low

er M

TCT

and

may

be

cons

ider

ed in

pro

gram

mes

with

the

capa

city

to in

itiat

e th

e re

gim

en a

nd fo

llow

up

such

wom

en S

uch

inte

rven

tion

is in

itiat

ed a

t ar

ound

28

wee

ks o

r so

on a

fter

and

sto

pped

af

ter

birt

h if

CD

4 co

unt i

s st

ill a

bove

350

cel

lsm

m3

App

endi

ces

Appen

dix

I

Appen

dix

II

Appen

dix

III

Appen

dix

IV

WH

O C

linic

al S

tagin

g o

f H

IVA

IDS f

or

Adults

and A

dole

scen

ts

w

ith c

onfirm

ed H

IV infe

ctio

n

Contr

acep

tive

Options

for

Peo

ple

Liv

ing w

ith H

IV

Sum

mar

y of

ARV D

rug U

se f

or

PMTCT o

f H

IV

In

tegra

ted M

onitori

ng a

nd E

valu

ation R

eport

Form

MO

H 7

26

Cha

pter

ref

eren

ces

1

Sum

mar

y of

ARV D

rugs

Adve

rse

Effec

ts a

nd M

anag

emen

t T

able

6-1

0

pages

101-1

12 o

f G

uid

elin

es f

or

Antire

trovi

ral D

rug T

her

apy

in K

enya

3rd

Editio

n

De-

cem

ber

2005

2

Dru

g I

nte

ract

ions

Tab

le 7

-10

pag

es 1

12-1

22 o

f G

uid

elin

es f

or

Antire

trovi

ral

Dru

g T

her

apy

in K

enya

3rd

editio

n

Dec

2005

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

7

50

Cha

pter

5

Imm

edia

te P

ostn

atal

and

Neo

nata

l Car

e 5

1 IN

TRO

DU

CTI

ON

Imm

edia

te p

ostn

atal

and

neo

nata

l car

e re

fers

to th

e pa

ckag

e of

ser

vice

s pr

ovid

ed to

the

mot

her

and

infa

nt b

efor

e th

ey le

ave

the

heal

th fa

cilit

y (u

p to

48

hour

s) a

fter

del

iver

yTh

e pe

riod

pro

vide

s an

opp

ortu

nity

to e

duca

te a

ll m

othe

rs a

bout

HIV

to

prov

ide

coun

shyse

lling

and

tes

ting

if it

was

not

don

e pr

evio

usly

and

to

rein

forc

e th

e ed

ucat

ion

proshy

vide

d du

ring

the

ant

enat

al p

erio

d B

oth

HIV

inf

ecte

d an

d H

IV u

ninf

ecte

d m

othe

rs

shou

ld r

ecei

ve th

is e

duca

tion

and

coun

selli

ng b

efor

e di

scha

rge

52

OPE

RA

TIO

NA

L G

UID

ELIN

ES

The

follo

win

g gu

idel

ines

sho

uld

be fo

llow

ed fo

r all

wom

en a

nd

infa

nts

in th

e im

med

iate

pos

t par

tum

per

iod

a)

Opt

imal

pos

tpar

tum

car

e

bull R

outin

e ca

re in

clud

ing

brea

st e

xam

inat

ion

exa

min

atio

n of

the

ute

rus

ex

amin

atio

n of

the

per

ineu

m a

nd lo

chia

pa

ssag

e of

uri

ne r

egul

arly

pr

oper

hyg

iene

to

prev

ent

infe

ctio

n c

heck

ing

for

sign

s of

ana

emia

fe

ver

and

tach

ycar

dia

bull D

iscu

ss m

ater

nal n

utri

tion

bull E

stab

lish

the

HIV

sta

tus

of t

he m

othe

rs in

clud

ing

thos

e gi

ving

birt

h ou

tsid

e th

e he

alth

inst

itutio

n se

tting

bull P

rovi

de H

IV C

T f

or m

othe

rs w

ith u

nkno

wn

HIV

sta

tus

bull E

ncou

rage

HIV

res

ults

dis

clos

ure

and

part

ner

test

ing

bull F

ollo

w t

he s

tand

ard

guid

elin

es o

n th

e ca

re o

f a n

ewbo

rn (

IMP

AC

C

are

Man

ual)

bull A

ll ba

bies

sho

uld

rece

ive

thei

r ro

utin

e im

mun

izat

ion

(OP

V a

nd B

CG

) in

th

eir

first

hou

rs o

f lif

e1

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Con

trac

eptio

n A

ll m

othe

rs r

egar

dles

s of

the

ir H

IV s

tatu

s h

ave

a ri

ght

to r

ecei

ve a

dequ

ate

info

rmashy

tion

on a

vaila

ble

met

hods

of f

amily

pla

nnin

g an

d to

mak

e an

info

rmed

cho

ice

on w

hat

is b

est

for

them

H

IV-in

fect

ed w

omen

who

are

not

bre

astf

eedi

ng s

houl

d in

itiat

e a

relia

ble

cont

race

ptiv

e m

etho

d by

2-4

wee

ks p

ostp

artu

m

This

is

in a

dditi

on t

o th

epr

oper

and

con

sist

ent

use

of t

he c

ondo

m a

s a

form

of

dual

pro

tect

ion

All

met

hods

of

cont

race

ptio

n ca

n be

use

d by

HIV

pos

itive

wom

en b

ased

on

stan

dard

med

ical

elig

ibili

tycr

iteri

a in

clud

ing

taki

ng c

are

of d

rug

inte

ract

ions

as

outli

ned

belo

w2

bull L

acta

tiona

l Am

enor

rhoe

a M

etho

d (L

AM

) S

uita

ble

for

excl

usiv

ely

brea

stfe

edin

g H

IV in

fect

ed w

omen

who

hav

e no

t re

sum

ed m

ense

s

bull H

orm

onal

con

trac

eptio

n A

ll ho

rmon

al c

ontr

acep

tives

can

be

used

in

HIV

pos

itive

wom

en in

clud

ing

thos

e on

HA

AR

T

Com

bine

d or

al

cont

race

ptiv

es a

re c

ontr

aind

icat

ed f

or u

se w

ith d

rugs

that

indu

ce

hepa

tic m

icro

-enz

yme

that

may

red

uce

the

effe

ctiv

enes

s of

hor

mon

al

cont

race

ptiv

es

Som

e an

ti-T

Bs

ant

iret

rovi

rals

an

tifun

gals

and

ant

i-ep

ilept

ics

and

in c

ondi

tions

tha

t ca

use

mal

abso

rptio

n8

bull I

ntra

-ute

rine

con

trac

eptiv

e de

vice

s (I

UC

Ds)

IU

CD

s ar

e no

t co

ntra

indi

cate

d in

HIV

pos

itive

wom

en

In s

ever

ely

imm

uno

supp

rese

d w

omen

use

sho

uld

not

be d

isco

ntin

ued

but

new

inse

rtio

n is

dis

cour

aged

as

it m

ay b

e as

soci

ated

with

incr

ease

d ri

sk o

f in

fect

ion

duri

ng t

he in

sert

ion

proc

ess

bull S

urgi

cal m

etho

ds S

urgi

cal c

ontr

acep

tion

shou

ld b

e of

fere

d to

HIV

po

sitiv

e w

omen

and

the

ir pa

rtne

rs

bull B

arri

er m

etho

ds

Fem

ale

and

mal

e co

ndom

s pr

ovid

e pr

otec

tion

agai

nst

ST

Ds

and

redu

ce t

he r

isk

of H

IV t

rans

mis

sion

and

sho

uld

be

enco

urag

ed a

lone

or

toge

ther

with

oth

er c

ontr

acep

tive

met

hods

bull S

perm

icid

es

Use

d in

con

junc

tion

with

bar

rier

met

hods

spe

rmic

ides

w

ill p

rovi

de a

dditi

onal

con

trac

eptiv

e pr

otec

tion

How

ever

sp

erm

icid

es s

houl

d no

t be

use

d al

one

as t

hey

can

incr

ease

the

ris

k of

HIV

acq

uisi

tion

bull E

mer

genc

y co

ntra

cept

ion

HIV

pos

itive

wom

en s

houl

d be

info

rmed

ab

out

emer

genc

y co

ntra

cept

ion

whe

re it

is a

vaila

ble

and

how

to

obta

in a

nd u

se it

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

1

56

Bre

ast c

are

in b

reas

tfeed

ing

mot

hers

bull E

ncou

rage

dai

ly c

lean

ing

of t

he b

reas

ts a

nd a

void

ing

the

appl

icat

ion

of lo

tions

bull T

reat

mat

erna

l vag

inal

can

didi

asis

and

infa

nt o

ral c

andi

dias

is

bull E

duca

te m

othe

r on

opt

imal

bre

astf

eedi

ng te

chni

que

incl

udin

g la

tchi

ng

on t

echn

ique

ex

lusi

ve b

reas

tfee

ding

and

rem

ovin

g ba

by f

rom

bre

ast

bull E

duca

te th

e m

othe

r on

bre

ast c

are

to p

reve

nt c

ompl

icat

ions

(cr

acki

ng

and

engo

rgem

ent)

bull E

xpre

ss a

nd h

eat

trea

t th

e m

ilk if

bre

ast

has

mas

titis

or

absc

ess

Opt

imal

pos

tpar

tum

car

e fo

r HIV

pos

itive

wom

en

Loch

ia

bull P

ut e

mph

asis

on

good

per

inea

l hyg

iene

and

pro

per

hand

ling

of b

ody

fluid

s

bull A

void

con

tam

inat

ing

the

baby

with

bod

y flu

ids

or w

ith b

eddi

ng s

oile

d w

ith lo

chia

bull S

hari

ng o

f be

ds b

y m

othe

rs in

the

hos

pita

l sho

uld

be d

isco

urag

ed

Cae

sare

an S

ectio

n

Bro

ad s

pect

rum

ant

ibio

tics

shou

ld b

e us

ed r

outin

ely

afte

r C

S

Esse

ntia

l mat

erna

l edu

catio

n an

d fo

llow

-up

bull M

onito

r fo

r br

east

and

pel

vic

infe

ctio

n at

all

post

nat

al c

linic

vis

its

bull E

duca

te o

n pr

ompt

hea

lth s

eeki

ng b

ehav

iour

bull H

ealth

edu

catio

n on

hyg

iene

lo

chia

and

bre

ast

care

bull A

void

sex

ual i

nter

cour

se f

or a

t lea

st 2

wee

ks a

fter

birt

h or

unt

il th

ere

is

no lo

nger

any

loch

ia r

ubra

or

sero

sa

bull D

o pa

p sm

ear

or V

IA a

t 4-

6 w

eeks

bull F

or e

very

sex

ual a

ctiv

ity

the

coup

le s

houl

d us

e co

ndom

s

bull D

iscu

ss f

amily

pla

nnin

g at

eve

ry o

ppor

tuni

ty a

nd p

rovi

de t

he

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Supp

ort

infa

nt fe

edin

g op

tions

For

all

HIV

neg

ativ

e w

omen

wom

en o

f unk

now

n H

IV

stat

us a

nd H

IV p

ositi

ve m

othe

rs o

ptin

g fo

r ex

clus

ive

brea

stfe

edin

g in

itiat

e br

east

feed

shyin

g w

ithin

hal

f hou

r of

bir

th a

nd fo

llow

oth

er g

uide

lines

as

per

Bab

y Fr

iend

ly H

ospi

tal

Initi

ativ

e2 (B

FHI)

bull G

ive

info

rmat

ion

on fa

mily

pla

nnin

g an

d du

al p

rote

ctio

n

bull C

ouns

el o

n H

IV r

isk

redu

ctio

n

bull S

ched

ule

post

nata

l clin

ic v

isits

at

2 w

eeks

and

at

4-6

wee

ks a

nd

com

plet

e m

othe

r-ch

ild b

ookl

et (

refe

r to

DR

H m

anua

l)

(b) S

peci

fic p

ostp

artu

m c

are

for H

IV p

ositi

ve w

omen

bull S

uppo

rt e

xclu

sive

bre

astf

eedi

ng u

nles

s m

othe

r ha

s ap

prop

riat

ely

opte

d fo

r an

d be

en c

ouns

elle

d on

rep

lace

men

t fe

edin

g an

tena

tally

bull I

nitia

te o

r co

ntin

ue c

o-tr

imox

azol

e pr

ophy

laxi

s -1

dou

ble

stre

ngth

tab

shyle

t da

ily

bull F

or H

IV p

ositi

ve m

othe

rs t

hat

rece

ived

sd

nevi

rapi

ne in

trap

artu

m

initi

shyat

e A

ZT

300m

g an

d 3T

C 1

50 m

g B

D f

or 1

wee

k

bull F

or n

ewly

dia

gnos

ed m

othe

rs

do H

IV s

tagi

ng

CD

4 co

unt

and

refe

r ap

prop

riat

ely

for

cont

inue

d ca

re

(c)

Spec

ific

care

for H

IV e

xpos

ed in

fant

s

bull F

or H

IV e

xpos

ed in

fant

s a

dmin

iste

r sd

NV

P 2

mg

kg s

tat

with

in 7

2 ho

urs

Giv

e A

ZT

4 m

gkg

BID

for

6 w

eeks

and

3T

C 4

mg

kg B

ID f

or 1

w

eek

Ref

er t

o C

hapt

er 4

bull R

efer

to C

hapt

er 8

for

deta

ils o

n in

fant

fee

ding

opt

ions

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

5

52

Cha

pter

ref

eren

ces

1

Rep

ublic

of

Ken

ya M

inis

try

of

Hea

lth

Div

isio

n o

f Rep

roduct

ive

Hea

lth

Nat

ional

Guid

elin

es f

or

Qual

ity

Obst

etri

cs a

nd P

erin

ata

l Car

e (2

004)

2

2R

epublic

of

Ken

ya M

inis

try

of

Hea

lth

Ess

ential

Obst

etri

c C

are

Man

ual

for

Hea

lth

Ser

vice

Pro

vider

s in

Ken

ya 3

rd E

ditio

n (

Jan 2

006)

Foo

tnot

es

1

WH

O r

ecom

men

ds

that

all

vacc

ines

should

be

giv

en t

o H

IV-s

ero-n

egat

ive

child

ren

and t

o a

sym

pto

mat

ic s

ero-p

osi

tive

s

The

only

vac

cines

to b

e w

ithhel

d f

rom

child

ren w

ith s

ympto

mat

ic A

IDS a

re B

CG

and

Yel

low

fev

er v

acc

ines

2

The

ldquoTen

Ste

psrdquo

of

BFH

I R

ecom

men

ded

Pra

ctic

es f

or

Mat

ernity

Ser

vice

s ad

apte

d f

or

W

HO

UN

ICEF

1989

Cha

pter

6

Late

Pos

tnat

al C

are

and

Fam

ily P

lann

ing

61

INTR

OD

UC

TIO

N

Late

pos

tnat

al c

are

is p

rovi

ded

to t

he m

othe

r an

d th

e ch

ild 4

8 ho

urs

to 6

wee

ks a

fter

deliv

ery

Dur

ing

this

per

iod

the

heal

th o

f the

mot

her

and

child

is a

sses

sed

and

clos

ely

mon

itore

d

The

risk

of M

TCT

duri

ng th

e po

stpa

rtum

per

iod

can

be r

educ

ed b

y pr

ovid

ing

HIV

cou

nshyse

lling

and

test

ing

pos

t-ex

posu

re p

roph

ylax

is fo

r ex

pose

d ba

bies

cou

nsel

ling

on a

ppro

shypr

iate

infa

nt fe

edin

g op

tions

and

bre

ast c

are

Pos

tpar

tum

car

e fo

r H

IV p

ositi

ve w

omen

shou

ld in

clud

e cl

inic

al s

tagi

ng C

D4

coun

t and

AR

T fo

r th

ose

who

qua

lify

Fam

ily p

lann

ing

serv

ices

are

am

ong

the

core

inte

rven

tions

of P

MTC

T pr

ovid

ed to

hel

pw

omen

det

erm

ine

futu

re c

hild

bear

ing

patt

erns

inc

ludi

ng t

he p

reve

ntio

n of

HIV

-in

fect

ed b

irth

s

Rep

rodu

ctiv

e he

alth

cou

nsel

ling

can

help

a w

oman

pra

ctis

e sa

fer

sex

and

dete

rmin

e he

r fu

ture

ch

ildbe

arin

g pa

tter

ns

on

a m

ore

resp

onsi

ble

and

info

rmed

bas

is1

62

OPE

RA

TIO

NA

L G

UID

ELIN

ES

Opt

imal

pos

tpar

tum

car

e fo

r all

wom

en

This

ent

ails

rou

tine

care

inc

ludi

ng b

reas

t ex

amin

atio

n e

xam

inat

ion

of t

he u

teru

s

exam

inat

ion

of t

he p

erin

eum

and

loch

ia p

assa

ge o

f uri

ne r

egul

arly

pro

per

hygi

ene

topr

even

t in

fect

ion

che

ckin

g fo

r si

gns

of a

nem

ia

feve

r an

d ta

chyc

ardi

a an

d do

ing

peri

neal

exe

rcis

es

Add

ition

al c

are

incl

udes

bull C

ouns

ellin

g an

d te

stin

g fo

r m

othe

rs o

f un

know

n H

IV s

tatu

s bull

Pro

visi

on o

f co

ndom

s an

d ris

k re

duct

ion

coun

selli

ng

bull C

ouns

ellin

g on

con

trac

eptiv

e op

tions

in

clud

ing

dual

met

hod

use

bull D

iscu

ssin

g m

ater

nal n

utrit

ion

bull M

alar

ia p

reve

ntio

n bull

Scr

eeni

ng f

or S

TI a

nd c

ervi

cal c

ance

r

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

Guid

elin

es for

Prev

ention o

f M

oth

er t

o C

hild

Tra

nsm

issi

on (

PM

TCT)

of H

IVA

IDS in K

enya

(3rd

Editio

n)

5

3

54

ltlt ASCII85EncodePages false AllowTransparency false AutoPositionEPSFiles true AutoRotatePages None Binding Left CalGrayProfile (Dot Gain 20) CalRGBProfile (sRGB IEC61966-21) CalCMYKProfile (US Web Coated 050SWOP051 v2) sRGBProfile (sRGB IEC61966-21) CannotEmbedFontPolicy Warning CompatibilityLevel 14 CompressObjects Tags CompressPages true ConvertImagesToIndexed true PassThroughJPEGImages true CreateJobTicket false DefaultRenderingIntent Default DetectBlends true DetectCurves 00000 ColorConversionStrategy CMYK DoThumbnails false EmbedAllFonts false EmbedOpenType false ParseICCProfilesInComments true EmbedJobOptions true DSCReportingLevel 0 EmitDSCWarnings false EndPage -1 ImageMemory 1048576 LockDistillerParams false MaxSubsetPct 100 Optimize true OPM 1 ParseDSCComments true ParseDSCCommentsForDocInfo true PreserveCopyPage true PreserveDICMYKValues true PreserveEPSInfo true PreserveFlatness true PreserveHalftoneInfo false PreserveOPIComments true PreserveOverprintSettings true StartPage 1 SubsetFonts true TransferFunctionInfo Apply UCRandBGInfo Preserve UsePrologue false ColorSettingsFile () AlwaysEmbed [ true Arial-Black Arial-BoldItalicMT Arial-BoldMT Arial-ItalicMT ArialMT ArialNarrow ArialNarrow-Bold ArialNarrow-BoldItalic ArialNarrow-Italic ArialRoundedMTBold ArialUnicodeMS CenturySchoolbook CenturySchoolbook-Bold CenturySchoolbook-BoldItalic CenturySchoolbook-Italic Symbol Times-Bold Times-BoldItalic Times-Italic TimesNewRomanPS-BoldItalicMT TimesNewRomanPS-BoldMT TimesNewRomanPS-ItalicMT TimesNewRomanPSMT Times-Roman Verdana Verdana-Bold Verdana-BoldItalic Verdana-Italic Wingdings2 Wingdings3 Wingdings-Regular ] NeverEmbed [ true ] AntiAliasColorImages false CropColorImages true ColorImageMinResolution 300 ColorImageMinResolutionPolicy OK DownsampleColorImages true ColorImageDownsampleType Bicubic ColorImageResolution 300 ColorImageDepth -1 ColorImageMinDownsampleDepth 1 ColorImageDownsampleThreshold 150000 EncodeColorImages true ColorImageFilter DCTEncode AutoFilterColorImages true ColorImageAutoFilterStrategy JPEG ColorACSImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt ColorImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt JPEG2000ColorACSImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt JPEG2000ColorImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt AntiAliasGrayImages false CropGrayImages true GrayImageMinResolution 300 GrayImageMinResolutionPolicy OK DownsampleGrayImages true GrayImageDownsampleType Bicubic GrayImageResolution 300 GrayImageDepth -1 GrayImageMinDownsampleDepth 2 GrayImageDownsampleThreshold 150000 EncodeGrayImages true GrayImageFilter DCTEncode AutoFilterGrayImages true GrayImageAutoFilterStrategy JPEG GrayACSImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt GrayImageDict ltlt QFactor 015 HSamples [1 1 1 1] VSamples [1 1 1 1] gtgt JPEG2000GrayACSImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt JPEG2000GrayImageDict ltlt TileWidth 256 TileHeight 256 Quality 30 gtgt AntiAliasMonoImages false CropMonoImages true MonoImageMinResolution 1200 MonoImageMinResolutionPolicy OK DownsampleMonoImages true MonoImageDownsampleType Bicubic MonoImageResolution 1200 MonoImageDepth -1 MonoImageDownsampleThreshold 150000 EncodeMonoImages true MonoImageFilter CCITTFaxEncode MonoImageDict ltlt K -1 gtgt AllowPSXObjects false CheckCompliance [ None ] PDFX1aCheck false PDFX3Check false PDFXCompliantPDFOnly false PDFXNoTrimBoxError true PDFXTrimBoxToMediaBoxOffset [ 000000 000000 000000 000000 ] PDFXSetBleedBoxToMediaBox true PDFXBleedBoxToTrimBoxOffset [ 000000 000000 000000 000000 ] PDFXOutputIntentProfile () PDFXOutputConditionIdentifier () PDFXOutputCondition () PDFXRegistryName () PDFXTrapped False CreateJDFFile false Description ltlt ARA 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 BGR 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 CHS ltFEFF4f7f75288fd94e9b8bbe5b9a521b5efa7684002000410064006f006200650020005000440046002065876863900275284e8e9ad88d2891cf76845370524d53705237300260a853ef4ee54f7f75280020004100630072006f0062006100740020548c002000410064006f00620065002000520065006100640065007200200035002e003000204ee553ca66f49ad87248672c676562535f00521b5efa768400200050004400460020658768633002gt CHT ltFEFF4f7f752890194e9b8a2d7f6e5efa7acb7684002000410064006f006200650020005000440046002065874ef69069752865bc9ad854c18cea76845370524d5370523786557406300260a853ef4ee54f7f75280020004100630072006f0062006100740020548c002000410064006f00620065002000520065006100640065007200200035002e003000204ee553ca66f49ad87248672c4f86958b555f5df25efa7acb76840020005000440046002065874ef63002gt CZE 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 DAN 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 DEU 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 ESP ltFEFF005500740069006c0069006300650020006500730074006100200063006f006e0066006900670075007200610063006900f3006e0020007000610072006100200063007200650061007200200064006f00630075006d0065006e0074006f00730020005000440046002000640065002000410064006f0062006500200061006400650063007500610064006f00730020007000610072006100200069006d0070007200650073006900f3006e0020007000720065002d0065006400690074006f007200690061006c00200064006500200061006c00740061002000630061006c0069006400610064002e002000530065002000700075006500640065006e00200061006200720069007200200064006f00630075006d0065006e0074006f00730020005000440046002000630072006500610064006f007300200063006f006e0020004100630072006f006200610074002c002000410064006f00620065002000520065006100640065007200200035002e003000200079002000760065007200730069006f006e0065007300200070006f00730074006500720069006f007200650073002egt ETI 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 FRA 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 GRE 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 HEB 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 HRV (Za stvaranje Adobe PDF dokumenata najpogodnijih za visokokvalitetni ispis prije tiskanja koristite ove postavke Stvoreni PDF dokumenti mogu se otvoriti Acrobat i Adobe Reader 50 i kasnijim verzijama) HUN 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 ITA 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 JPN ltFEFF9ad854c18cea306a30d730ea30d730ec30b951fa529b7528002000410064006f0062006500200050004400460020658766f8306e4f5c6210306b4f7f75283057307e305930023053306e8a2d5b9a30674f5c62103055308c305f0020005000440046002030d530a130a430eb306f3001004100630072006f0062006100740020304a30883073002000410064006f00620065002000520065006100640065007200200035002e003000204ee5964d3067958b304f30533068304c3067304d307e305930023053306e8a2d5b9a306b306f30d530a930f330c8306e57cb30818fbc307f304c5fc59808306730593002gt KOR ltFEFFc7740020c124c815c7440020c0acc6a9d558c5ec0020ace0d488c9c80020c2dcd5d80020c778c1c4c5d00020ac00c7a50020c801d569d55c002000410064006f0062006500200050004400460020bb38c11cb97c0020c791c131d569b2c8b2e4002e0020c774b807ac8c0020c791c131b41c00200050004400460020bb38c11cb2940020004100630072006f0062006100740020bc0f002000410064006f00620065002000520065006100640065007200200035002e00300020c774c0c1c5d0c11c0020c5f40020c2180020c788c2b5b2c8b2e4002egt LTH 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 LVI 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 NLD (Gebruik deze instellingen om Adobe PDF-documenten te maken die zijn geoptimaliseerd voor prepress-afdrukken van hoge kwaliteit De gemaakte PDF-documenten kunnen worden geopend met Acrobat en Adobe Reader 50 en hoger) NOR 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 POL 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 PTB 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 RUM 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 RUS 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 SKY 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 SLV 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 SUO 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 SVE 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 TUR ltFEFF005900fc006b00730065006b0020006b0061006c006900740065006c0069002000f6006e002000790061007a006401310072006d00610020006200610073006b013100730131006e006100200065006e0020006900790069002000750079006100620069006c006500630065006b002000410064006f006200650020005000440046002000620065006c00670065006c0065007200690020006f006c0075015f007400750072006d0061006b0020006900e70069006e00200062007500200061007900610072006c0061007201310020006b0075006c006c0061006e0131006e002e00200020004f006c0075015f0074007500720075006c0061006e0020005000440046002000620065006c00670065006c0065007200690020004100630072006f006200610074002000760065002000410064006f00620065002000520065006100640065007200200035002e003000200076006500200073006f006e0072006100730131006e00640061006b00690020007300fc007200fc006d006c00650072006c00650020006100e70131006c006100620069006c00690072002egt UKR 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 ENU (Use these settings to create Adobe PDF documents best suited for high-quality prepress printing Created PDF documents can be opened with Acrobat and Adobe Reader 50 and later) gtgt Namespace [ (Adobe) (Common) (10) ] OtherNamespaces [ ltlt AsReaderSpreads false CropImagesToFrames true ErrorControl WarnAndContinue FlattenerIgnoreSpreadOverrides false IncludeGuidesGrids false IncludeNonPrinting false IncludeSlug false Namespace [ (Adobe) (InDesign) (40) ] OmitPlacedBitmaps false OmitPlacedEPS false OmitPlacedPDF false SimulateOverprint Legacy gtgt ltlt AddBleedMarks false AddColorBars false AddCropMarks false AddPageInfo false AddRegMarks false ConvertColors ConvertToCMYK DestinationProfileName () DestinationProfileSelector DocumentCMYK Downsample16BitImages true FlattenerPreset ltlt PresetSelector MediumResolution gtgt FormElements false GenerateStructure false IncludeBookmarks false IncludeHyperlinks false IncludeInteractive false IncludeLayers false IncludeProfiles false MultimediaHandling UseObjectSettings Namespace [ (Adobe) (CreativeSuite) (20) ] PDFXOutputIntentProfileSelector DocumentCMYK PreserveEditing true UntaggedCMYKHandling LeaveUntagged UntaggedRGBHandling UseDocumentProfile UseDocumentBleed false gtgt ]gtgt setdistillerparamsltlt HWResolution [2400 2400] PageSize [612000 792000]gtgt setpagedevice